Citrus Sinensis ID: 018100
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.919 | 0.728 | 0.702 | 1e-139 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.922 | 0.787 | 0.673 | 1e-136 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.831 | 0.724 | 0.683 | 1e-124 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.864 | 0.732 | 0.513 | 4e-90 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.806 | 0.683 | 0.537 | 1e-87 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.795 | 0.582 | 0.541 | 1e-87 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.786 | 0.692 | 0.556 | 5e-86 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.847 | 0.786 | 0.490 | 7e-85 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.811 | 0.597 | 0.524 | 2e-84 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.811 | 0.711 | 0.508 | 1e-83 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 495 bits (1275), Expect = e-139, Method: Compositional matrix adjust.
Identities = 236/336 (70%), Positives = 271/336 (80%), Gaps = 4/336 (1%)
Query: 18 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
QI A T FRELAAAT NF ++ LGEGGFGRVYKG L+S Q VA+KQLDRNG+QGNRE
Sbjct: 68 QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNRE 127
Query: 78 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 137
FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGS+EDHLHDL P K+ LDWN R
Sbjct: 128 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMR 187
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
MKIAAGAA+GLE+LHDKA PPVIYRD K SNILLD G+HPKLSDFGLAKLGP GD +HVS
Sbjct: 188 MKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVS 247
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257
TRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GRKA+D+ EQ+LVAWARP
Sbjct: 248 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARP 307
Query: 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317
LF DR + +ADP L+G++P R YQALAVA+MC+ EQ RP+IADVVTAL+YLA+Q
Sbjct: 308 LFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQA 367
Query: 318 YESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 353
Y+ + + + G T+ D GG GS+
Sbjct: 368 YDPSKDDSRRNRDERGARLITRNDD----GGGSGSK 399
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-136, Method: Compositional matrix adjust.
Identities = 235/349 (67%), Positives = 272/349 (77%), Gaps = 16/349 (4%)
Query: 16 SDQIT---AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV 72
+DQ+T AQT TF+ELA AT NFRS+ LGEGGFG+V+KG +E ++Q VAIKQLDRNGV
Sbjct: 80 NDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGV 139
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QG REF+VEVL LSL HPNLV LIG+CA+GDQRLLVYEYMP GS+EDHLH L GKKPL
Sbjct: 140 QGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPL 199
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
DWNTRMKIAAGAARGLEYLHD+ PPVIYRDLKCSNILL Y PKLSDFGLAK+GP GD
Sbjct: 200 DWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGD 259
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
THVSTRVMGTYGYCAP+YA TGQLT KSD+YSFGVVLLE+++GRKA+D +K +Q+LV
Sbjct: 260 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLV 319
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
WARPLF+DR + DP LQGQYP RG YQALA++AMCV EQP MRPV++DVV AL +
Sbjct: 320 GWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNF 379
Query: 313 LASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSERERTRKLK 361
LAS KY DP +P+ + G K + R E +R +K
Sbjct: 380 LASSKY------------DPNSPSSSSG-KNPSFHRDRDDEEKRPHLVK 415
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 205/300 (68%), Positives = 251/300 (83%)
Query: 16 SDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN 75
++ I AQT +FRELA ATKNFR E L+GEGGFGRVYKG LE VA+KQLDRNG+QGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 76 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 135
+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDHL DL+P + PLDW+
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195
TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSDFGLAKLGPVGD H
Sbjct: 179 TRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255
VS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +DT++ EQ+LV WA
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWA 298
Query: 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315
+P+F++ +R +ADP L+G +P + QA+AVAAMC+ E+ +RP+++DVVTAL +L +
Sbjct: 299 QPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 175/341 (51%), Positives = 223/341 (65%), Gaps = 29/341 (8%)
Query: 22 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 72
+ TF EL AT+NFR +SLLGEGGFG V+KG+++ VA+K+L G
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QG++E+L EV L L HPNLV L+GYC +G+ RLLVYE+MP GS+E+HL G +PL
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHL--FRRGAQPL 186
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
W RMK+A GAA+GL +LHD AK VIYRD K +NILLD ++ KLSDFGLAK GP GD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
THVST+VMGT+GY APEY TG+LT KSDVYSFGVVLLE+LSGR+AVD SK EQSLV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
WA P D+ + I D L GQYP +G Y A ++A C++ +RP +++V+ L
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365
Query: 313 LASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 353
L S K PGT G+++ +++ RGS
Sbjct: 366 LESTK--------------PGTGV---GNRQAQIDSPRGSN 389
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 163/303 (53%), Positives = 210/303 (69%), Gaps = 12/303 (3%)
Query: 22 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 72
+ TF EL ATKNFR ++LLGEGGFG V+KG+++ + VA+KQL G
Sbjct: 72 KAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGF 131
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QG++E+L EV L L HPNLV L+GYCA+G+ RLLVYE+MP GS+E+HL G +PL
Sbjct: 132 QGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRRGAQPL 189
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
W RMK+A GAA+GL +LH+ AK VIYRD K +NILLD ++ KLSDFGLAK GP GD
Sbjct: 190 TWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
NTHVST+V+GT+GY APEY TG+LT KSDVYSFGVVLLE++SGR+A+D S E SLV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
WA P D+ + I D +L GQYP +G + A +A C++ +RP +++V+ L
Sbjct: 309 DWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQ 368
Query: 313 LAS 315
L S
Sbjct: 369 LES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 162/299 (54%), Positives = 206/299 (68%), Gaps = 12/299 (4%)
Query: 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLES---------INQDVAIKQLDRNGVQG 74
TF +L +T+NFR ESLLGEGGFG V+KG++E VA+K L+ +G+QG
Sbjct: 130 FTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQG 189
Query: 75 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 134
++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+HL S PL W
Sbjct: 190 HKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPW 246
Query: 135 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194
+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSDFGLAK P T
Sbjct: 247 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKT 306
Query: 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254
HVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D ++ E +LV W
Sbjct: 307 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 366
Query: 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313
ARP D+ R + DP L+G + +G + +AA C+ P +RP ++DVV AL L
Sbjct: 367 ARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 163/293 (55%), Positives = 203/293 (69%), Gaps = 9/293 (3%)
Query: 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGVQGNRE 77
T EL TK+FR + +LGEGGFG VYKGY++ + VA+K L++ G+QG+RE
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 78 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 137
+L EV L L HPNLV LIGYC + D RLLVYE+M GS+E+HL PL W+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHL--FRKTTAPLSWSRR 174
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
M IA GAA+GL +LH+ A+ PVIYRD K SNILLD Y KLSDFGLAK GP GD THVS
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257
TRVMGTYGY APEY TG LT +SDVYSFGVVLLE+L+GRK+VD ++ + EQ+LV WARP
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
D+ + I DP L+ QY R +A ++A C+ + P RP+++DVV L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 346
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 158/322 (49%), Positives = 216/322 (67%), Gaps = 16/322 (4%)
Query: 22 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 72
+ + EL +AT+NFR +S++GEGGFG V+KG+++ + +A+K+L++ G
Sbjct: 54 KNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGF 113
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QG+RE+L E+ L L HPNLV LIGYC + + RLLVYE+M GS+E+HL +PL
Sbjct: 114 QGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPL 173
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
WNTR+++A GAARGL +LH+ A+P VIYRD K SNILLD Y+ KLSDFGLA+ GP+GD
Sbjct: 174 SWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGD 232
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
N+HVSTRVMGT GY APEY TG L++KSDVYSFGVVLLE+LSGR+A+D ++ E +LV
Sbjct: 233 NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLV 292
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM---CVHEQPDMRPVIADVVTA 309
WARP ++ R + DP LQGQY +AL +A + C+ RP + ++V
Sbjct: 293 DWARPYLTNKRRLLRVMDPRLQGQY---SLTRALKIAVLALDCISIDAKSRPTMNEIVKT 349
Query: 310 LAYLASQKYESDAEKVQSPCLD 331
+ L QK S ++ +D
Sbjct: 350 MEELHIQKEASKEQQNPQISID 371
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 160/305 (52%), Positives = 206/305 (67%), Gaps = 12/305 (3%)
Query: 22 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLES---------INQDVAIKQLDRNGV 72
+ +F +L AT+NFR ESLLGEGGFG V+KG++E VA+K L+ +G+
Sbjct: 122 KKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGL 181
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QG++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+HL S PL
Sbjct: 182 QGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPL 238
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
W+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSDFGLAK P
Sbjct: 239 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEG 298
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
THVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D ++ E +LV
Sbjct: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
WARP D+ R + DP L+G + +G + +AA C+ +RP +++VV L
Sbjct: 359 EWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKP 418
Query: 313 LASQK 317
L K
Sbjct: 419 LPHLK 423
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 154/303 (50%), Positives = 207/303 (68%), Gaps = 10/303 (3%)
Query: 22 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 72
++ TF EL AAT+NFR +S+LGEGGFG V+KG+++ +A+K+L+++G
Sbjct: 55 KSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGW 114
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QG++E+L EV L HPNLV LIGYC + + RLLVYE+MP GS+E+HL +PL
Sbjct: 115 QGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPL 174
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
W R+K+A GAA+GL +LH+ A+ VIYRD K SNILLD Y+ KLSDFGLAK GP GD
Sbjct: 175 SWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGD 233
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
+HVSTR+MGTYGY APEY TG LT KSDVYS+GVVLLE+LSGR+AVD ++ EQ LV
Sbjct: 234 KSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLV 293
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
WARPL ++ + + D LQ QY + +A C+ + +RP + +VV+ L +
Sbjct: 294 EWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEH 353
Query: 313 LAS 315
+ +
Sbjct: 354 IQT 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | ||||||
| 225439781 | 396 | PREDICTED: serine/threonine-protein kina | 0.994 | 0.906 | 0.782 | 1e-165 | |
| 351721314 | 383 | protein kinase-like protein [Glycine max | 0.936 | 0.882 | 0.813 | 1e-163 | |
| 356548196 | 383 | PREDICTED: serine/threonine-protein kina | 0.936 | 0.882 | 0.810 | 1e-162 | |
| 255568454 | 389 | receptor serine-threonine protein kinase | 0.947 | 0.879 | 0.795 | 1e-162 | |
| 224069304 | 393 | predicted protein [Populus trichocarpa] | 0.916 | 0.842 | 0.833 | 1e-161 | |
| 357510543 | 377 | Serine/threonine protein kinase PBS1 [Me | 0.930 | 0.891 | 0.810 | 1e-161 | |
| 356505176 | 379 | PREDICTED: serine/threonine-protein kina | 0.936 | 0.891 | 0.804 | 1e-160 | |
| 449440049 | 395 | PREDICTED: serine/threonine-protein kina | 0.966 | 0.883 | 0.777 | 1e-160 | |
| 356572387 | 380 | PREDICTED: serine/threonine-protein kina | 0.936 | 0.889 | 0.799 | 1e-160 | |
| 217074768 | 417 | unknown [Medicago truncatula] gi|3885097 | 0.903 | 0.781 | 0.825 | 1e-159 |
| >gi|225439781|ref|XP_002276042.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297741502|emb|CBI32634.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1509), Expect = e-165, Method: Compositional matrix adjust.
Identities = 281/359 (78%), Positives = 309/359 (86%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
N S VKEAS++G D I AQT TFRELAAATKNFR E LLGEGGFGRVYKG + + NQ
Sbjct: 37 NPSFNVKEASKNGGPDHIAAQTFTFRELAAATKNFRGECLLGEGGFGRVYKGRIANTNQA 96
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDH
Sbjct: 97 VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDH 156
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
LHD+S GKK LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL +HPKLSD
Sbjct: 157 LHDVSLGKKRLDWNTRMKIAAGAAKGLEYLHDKASPPVIYRDLKCSNILLGEDFHPKLSD 216
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D
Sbjct: 217 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
SKAA E +LVAWARPLF+DR + +ADP LQGQYP RG YQALAVAAMCV EQP++RP
Sbjct: 277 NSKAAGEHNLVAWARPLFKDRRKFLHMADPMLQGQYPLRGLYQALAVAAMCVQEQPNLRP 336
Query: 302 VIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSERERTRKL 360
+I DVVTAL YLA+Q Y+ D + VQS + P TP R K D +RKL GS+++RTR+L
Sbjct: 337 LIVDVVTALTYLAAQTYDPDTQPVQSSRVAPSTPPRAKKDGDRKLPSSAGSQKDRTRRL 395
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721314|ref|NP_001237717.1| protein kinase-like protein [Glycine max] gi|223452496|gb|ACM89575.1| protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1492), Expect = e-163, Method: Compositional matrix adjust.
Identities = 275/338 (81%), Positives = 303/338 (89%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
NSS+ KE+S++G + I AQT +FRELA AT+NF++E LLGEGGFGRVYKG LE+INQ
Sbjct: 43 NSSMNSKESSKNGNPEHIAAQTFSFRELATATRNFKAECLLGEGGFGRVYKGRLENINQI 102
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+EDH
Sbjct: 103 VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLEDH 162
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
LHD+SPGKK LDWNTRMKIAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKLSD
Sbjct: 163 LHDISPGKKELDWNTRMKIAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 222
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D
Sbjct: 223 FGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 282
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
SKAA EQ+LVAWARPLF+DR + S +ADP LQGQYP RG YQALAVAAMCV EQ +MRP
Sbjct: 283 NSKAAGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPSRGLYQALAVAAMCVQEQANMRP 342
Query: 302 VIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 339
VIADVVTAL+YLA QKY+ + + VQS L PGTP R+K
Sbjct: 343 VIADVVTALSYLALQKYDPNTQTVQSSRLAPGTPPRSK 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548196|ref|XP_003542489.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-162, Method: Compositional matrix adjust.
Identities = 274/338 (81%), Positives = 303/338 (89%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
N S+ K +S++G + I AQT +FRELA AT+NFR+E LLGEGGFGRVYKG LE+INQ
Sbjct: 43 NPSMNSKNSSKNGNPEHIAAQTFSFRELATATRNFRAECLLGEGGFGRVYKGRLENINQI 102
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+EDH
Sbjct: 103 VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLEDH 162
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
LHD+SPGKK LDWNTRMKIAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKLSD
Sbjct: 163 LHDISPGKKRLDWNTRMKIAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 222
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D
Sbjct: 223 FGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 282
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
SKAA EQ+LVAWARPLF+DR + S +ADP LQGQYPPRG +QALAVAAMCV EQ +MRP
Sbjct: 283 NSKAAGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLFQALAVAAMCVQEQANMRP 342
Query: 302 VIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 339
VIADVVTAL+YLASQKY+ + + +QS L PGTP R+K
Sbjct: 343 VIADVVTALSYLASQKYDPNTQTLQSSRLAPGTPPRSK 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568454|ref|XP_002525201.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535498|gb|EEF37167.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1484), Expect = e-162, Method: Compositional matrix adjust.
Identities = 273/343 (79%), Positives = 301/343 (87%), Gaps = 1/343 (0%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
+S VK A + G SD ITAQT TF EL A KNFR+E LGEGGFGRVYKGYLES NQ
Sbjct: 43 HSRTSVKAAPKHGGSDNITAQTFTFSELVTAAKNFRAECFLGEGGFGRVYKGYLESTNQV 102
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VAIKQL+RNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDH
Sbjct: 103 VAIKQLNRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDH 162
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
L+++SPG K LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL +GYHPKLSD
Sbjct: 163 LYEISPGVKTLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGQGYHPKLSD 222
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYS GVVLLEI++GR+A+D
Sbjct: 223 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSLGVVLLEIITGRRAID 282
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
SKA EQ+LVAWARPLF+DR + L+ADP LQGQYPPRG YQALA+AAMCV EQP++RP
Sbjct: 283 NSKATGEQNLVAWARPLFKDRKKFKLMADPMLQGQYPPRGLYQALAIAAMCVQEQPNLRP 342
Query: 302 VIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKER 344
VIADVVTAL+YLASQKY+ + + QSP PGTP RTK + +R
Sbjct: 343 VIADVVTALSYLASQKYDPEVQTAQSPRWTPGTP-RTKREAKR 384
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069304|ref|XP_002326325.1| predicted protein [Populus trichocarpa] gi|222833518|gb|EEE71995.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 574 bits (1479), Expect = e-161, Method: Compositional matrix adjust.
Identities = 276/331 (83%), Positives = 295/331 (89%)
Query: 5 LRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAI 64
LRVK S++G SD TAQT TFRELA ATKNFR+E LLGEGGFGRVYKGYLES NQ VAI
Sbjct: 51 LRVKGESKNGGSDSTTAQTFTFRELAFATKNFRAECLLGEGGFGRVYKGYLESTNQVVAI 110
Query: 65 KQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 124
KQL+RNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLH+
Sbjct: 111 KQLNRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHE 170
Query: 125 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184
+ PGK LDWNTRMKIAAGAA+GLE+LHDKA PPVIYRDLKCSNILLD YHPKLSDFGL
Sbjct: 171 VPPGKNWLDWNTRMKIAAGAAKGLEHLHDKASPPVIYRDLKCSNILLDESYHPKLSDFGL 230
Query: 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 244
AKLGPVGDNTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK
Sbjct: 231 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSK 290
Query: 245 AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA 304
A EQ+LVAWARPLF+DR + S IADP LQGQYPPRG YQALAVAAMCV EQP+MRPVIA
Sbjct: 291 ATGEQNLVAWARPLFKDRKKFSDIADPMLQGQYPPRGLYQALAVAAMCVQEQPNMRPVIA 350
Query: 305 DVVTALAYLASQKYESDAEKVQSPCLDPGTP 335
DVVTAL YLASQKY+ DAE Q P +P
Sbjct: 351 DVVTALTYLASQKYDPDAETGQRSRYPPASP 381
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510543|ref|XP_003625560.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] gi|355500575|gb|AES81778.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 274/338 (81%), Positives = 302/338 (89%), Gaps = 2/338 (0%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
NSS K+ S++G+++ I AQT +FRELA AT+NFR+E LLGEGGFGRVYKG+LESINQ
Sbjct: 39 NSSTNSKDTSKNGSTEHIAAQTFSFRELATATRNFRAECLLGEGGFGRVYKGHLESINQV 98
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDH
Sbjct: 99 VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDH 158
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
LHD+SP KK LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSD
Sbjct: 159 LHDISPAKKRLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 218
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D
Sbjct: 219 FGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 278
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
SK+AAEQ+LVAWARPLF+DR + S +ADP LQGQYP RG YQALAVAAMCV EQ +MRP
Sbjct: 279 YSKSAAEQNLVAWARPLFKDRRKFSQMADPMLQGQYPSRGLYQALAVAAMCVQEQANMRP 338
Query: 302 VIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 339
VIADVVTAL+YLA QK+ D VQ+ L P TPTRT+
Sbjct: 339 VIADVVTALSYLALQKH--DPNTVQNSRLAPSTPTRTR 374
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505176|ref|XP_003521368.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 272/338 (80%), Positives = 298/338 (88%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
NSS + K+ S++G D I AQT FRELA AT+NFR++ LLGEGGFGRVYKG LESINQ
Sbjct: 39 NSSTKSKDTSKNGNPDHIAAQTFAFRELATATRNFRNDCLLGEGGFGRVYKGRLESINQV 98
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDH
Sbjct: 99 VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDH 158
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
LHD+ PGKK LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSD
Sbjct: 159 LHDIPPGKKRLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 218
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D
Sbjct: 219 FGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 278
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
SK+A EQ+LVAWARPLF+DR + S +ADP L GQYPPRG YQALAVAAMCV EQ ++RP
Sbjct: 279 NSKSAGEQNLVAWARPLFKDRRKFSQMADPTLHGQYPPRGLYQALAVAAMCVQEQANLRP 338
Query: 302 VIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 339
VIADVVTAL+YLASQKY+ + VQS P TP RT+
Sbjct: 339 VIADVVTALSYLASQKYDPNTHTVQSSRHAPSTPPRTR 376
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440049|ref|XP_004137797.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] gi|449519164|ref|XP_004166605.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1472), Expect = e-160, Method: Compositional matrix adjust.
Identities = 276/355 (77%), Positives = 309/355 (87%), Gaps = 6/355 (1%)
Query: 9 EASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD 68
E S+ G S+ I AQ +FRELAAAT+NFR++ LLGEGGFGRVYKG LESINQ VAIKQLD
Sbjct: 44 ETSKGGGSEPIKAQIFSFRELAAATRNFRADCLLGEGGFGRVYKGKLESINQVVAIKQLD 103
Query: 69 RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 128
RNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL+YEYMPLGS++DHLHD+SPG
Sbjct: 104 RNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLIYEYMPLGSLDDHLHDISPG 163
Query: 129 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188
K +DWNTRM+IAAGAARGLEYLHDKA PPVIYRDLK SNILLD+GYHPKLSDFGLAKLG
Sbjct: 164 TKFIDWNTRMRIAAGAARGLEYLHDKASPPVIYRDLKSSNILLDKGYHPKLSDFGLAKLG 223
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248
PVGDNTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA E
Sbjct: 224 PVGDNTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDDSKAAGE 283
Query: 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308
Q+LV+WARPLF+DR R + +ADP L+GQYP RG YQALA+AAMCV EQP+MRPVIADVVT
Sbjct: 284 QNLVSWARPLFKDRLRFAQMADPMLRGQYPSRGLYQALAIAAMCVQEQPNMRPVIADVVT 343
Query: 309 ALAYLASQKYESDAEKVQSPCLDPG---TPTRTKGDKERKLNGGRGSERERTRKL 360
AL+YLASQ+Y+ + P PG TP R D +RKLNGGR +R T++L
Sbjct: 344 ALSYLASQRYD---PGIILPNDSPGSAYTPPRANRDSDRKLNGGRRYDRNPTKRL 395
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572387|ref|XP_003554350.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1468), Expect = e-160, Method: Compositional matrix adjust.
Identities = 271/339 (79%), Positives = 299/339 (88%), Gaps = 1/339 (0%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
NSS + K+ S++G D I AQT +FRELA AT+NFR+E LLGEGGFGRVYKG LESINQ
Sbjct: 39 NSSTKSKDTSKNGNPDHIAAQTFSFRELATATRNFRAECLLGEGGFGRVYKGRLESINQV 98
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDH
Sbjct: 99 VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDH 158
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
LHD+ PGKK LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSD
Sbjct: 159 LHDIPPGKKQLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 218
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D
Sbjct: 219 FGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 278
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
SK+A EQ+LVAWARPLF+DR + S +ADP LQGQYPPRG YQ +AVAAMCV EQ +MRP
Sbjct: 279 NSKSAGEQNLVAWARPLFKDRRKFSQMADPTLQGQYPPRGLYQVIAVAAMCVQEQANMRP 338
Query: 302 VIADVVTALAYLASQKYESDAEKV-QSPCLDPGTPTRTK 339
VIADVVTAL+YLASQ+Y+ + + QS PGTP R +
Sbjct: 339 VIADVVTALSYLASQRYDPNTQHTGQSSRHAPGTPPRNR 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074768|gb|ACJ85744.1| unknown [Medicago truncatula] gi|388509798|gb|AFK42965.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1460), Expect = e-159, Method: Compositional matrix adjust.
Identities = 269/326 (82%), Positives = 295/326 (90%)
Query: 14 GASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ 73
G S+ I AQT FRELA AT+NFR++ LLGEGGFGRVYKG+LES NQ VAIKQLDRNG+Q
Sbjct: 52 GDSEHIAAQTFPFRELATATRNFRADCLLGEGGFGRVYKGHLESSNQTVAIKQLDRNGLQ 111
Query: 74 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 133
GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHD+SPGKK LD
Sbjct: 112 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKKRLD 171
Query: 134 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193
W+TRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAK+GPVG+N
Sbjct: 172 WSTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKVGPVGEN 231
Query: 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253
THVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK AAEQ+LVA
Sbjct: 232 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKCAAEQNLVA 291
Query: 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313
WARPLF+DR + + +ADP LQGQYP RG YQALAVAAMCV EQ +MRPVIADVVTAL+YL
Sbjct: 292 WARPLFKDRRKFTQMADPMLQGQYPSRGIYQALAVAAMCVQEQANMRPVIADVVTALSYL 351
Query: 314 ASQKYESDAEKVQSPCLDPGTPTRTK 339
ASQ+YE + + VQS L PGTP RT+
Sbjct: 352 ASQRYEPNTQTVQSSRLGPGTPPRTR 377
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | ||||||
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.911 | 0.870 | 0.796 | 4.8e-142 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.939 | 0.660 | 0.747 | 6.6e-136 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.930 | 0.736 | 0.697 | 1.6e-125 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.919 | 0.783 | 0.674 | 3.2e-120 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.855 | 0.851 | 0.708 | 5.4e-118 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.853 | 0.797 | 0.699 | 5.6e-116 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.853 | 0.743 | 0.673 | 9.7e-112 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.875 | 0.829 | 0.654 | 8.7e-111 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.889 | 0.825 | 0.617 | 6.3e-108 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.853 | 0.791 | 0.623 | 1.4e-103 |
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1389 (494.0 bits), Expect = 4.8e-142, P = 4.8e-142
Identities = 262/329 (79%), Positives = 290/329 (88%)
Query: 11 SEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN 70
S+ SD I AQT TF ELA AT+NFR E L+GEGGFGRVYKGYL S +Q AIKQLD N
Sbjct: 48 SKSKGSDHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHN 107
Query: 71 GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 130
G+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHD+SPGK+
Sbjct: 108 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQ 167
Query: 131 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190
PLDWNTRMKIAAGAA+GLEYLHDK PPVIYRDLKCSNILLD Y PKLSDFGLAKLGPV
Sbjct: 168 PLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPV 227
Query: 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 250
GD +HVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D+S++ EQ+
Sbjct: 228 GDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQN 287
Query: 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
LVAWARPLF+DR + S +ADP LQGQYPPRG YQALAVAAMCV EQP++RP+IADVVTAL
Sbjct: 288 LVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTAL 347
Query: 311 AYLASQKYESDAEKVQSPCLDPGTPTRTK 339
+YLASQK++ A+ VQ PGTP R+K
Sbjct: 348 SYLASQKFDPLAQPVQGSLFAPGTPPRSK 376
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 6.6e-136, Sum P(2) = 6.6e-136
Identities = 255/341 (74%), Positives = 284/341 (83%)
Query: 10 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 69
A ++G + I AQT TFRELAAATKNFR E LLGEGGFGRVYKG LE+ Q VA+KQLDR
Sbjct: 57 APKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDR 116
Query: 70 NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 129
NG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHDL P K
Sbjct: 117 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK 176
Query: 130 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189
+PLDW+TRM IAAGAA+GLEYLHDKA PPVIYRDLK SNILL GYHPKLSDFGLAKLGP
Sbjct: 177 EPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGP 236
Query: 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249
VGD THVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVV LE+++GRKA+D ++A E
Sbjct: 237 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEH 296
Query: 250 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309
+LVAWARPLF+DR + +ADP LQG+YP RG YQALAVAAMC+ EQ RP+I DVVTA
Sbjct: 297 NLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 356
Query: 310 LAYLASQKYESDAEKVQSPCLDPGTP-TRTKGDKERKLNGG 349
L YLASQ ++ +A Q+ G P RT+ D+ R L G
Sbjct: 357 LTYLASQTFDPNAPSGQNSRSGSGPPFIRTRDDR-RSLGDG 396
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 1.6e-125, P = 1.6e-125
Identities = 238/341 (69%), Positives = 273/341 (80%)
Query: 13 DGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV 72
DG QI A T FRELAAAT NF ++ LGEGGFGRVYKG L+S Q VA+KQLDRNG+
Sbjct: 64 DGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGL 122
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGS+EDHLHDL P K+ L
Sbjct: 123 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL 182
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
DWN RMKIAAGAA+GLE+LHDKA PPVIYRD K SNILLD G+HPKLSDFGLAKLGP GD
Sbjct: 183 DWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGD 242
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
+HVSTRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GRKA+D+ EQ+LV
Sbjct: 243 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLV 302
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
AWARPLF DR + +ADP L+G++P R YQALAVA+MC+ EQ RP+IADVVTAL+Y
Sbjct: 303 AWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSY 362
Query: 313 LASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 353
LA+Q Y+ + + + G T+ D GG GS+
Sbjct: 363 LANQAYDPSKDDSRRNRDERGARLITRNDD----GGGSGSK 399
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1183 (421.5 bits), Expect = 3.2e-120, P = 3.2e-120
Identities = 230/341 (67%), Positives = 264/341 (77%)
Query: 9 EASEDGASDQIT---AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIK 65
+A + D++ AQT TF EL+ +T NF+S+ LGEGGFG+VYKG++E INQ VAIK
Sbjct: 68 DAKDTNVEDEVIVKKAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIK 127
Query: 66 QLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 125
QLDRNG QG REF+VEVL LSL HPNLV LIG+CA+G QRLLVYEYMPLGS+++HLHDL
Sbjct: 128 QLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDL 187
Query: 126 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185
GK PL WNTRMKIAAGAARGLEYLHD KPPVIYRDLKCSNIL+D GYH KLSDFGLA
Sbjct: 188 PSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLA 247
Query: 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 245
K+GP G THVSTRVMGTYGYCAP+YA TGQLT KSDVYSFGVVLLE+++GRKA D ++
Sbjct: 248 KVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRT 307
Query: 246 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305
QSLV WA PLF+DR + DP L+G YP RG YQALA+AAMCV EQP MRPVIAD
Sbjct: 308 RNHQSLVEWANPLFKDRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIAD 367
Query: 306 VVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKL 346
VV AL +LAS KY+ + Q T TK D+E+ L
Sbjct: 368 VVMALDHLASSKYDRSHRQKQD------NVTETKVDEEKTL 402
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1162 (414.1 bits), Expect = 5.4e-118, P = 5.4e-118
Identities = 219/309 (70%), Positives = 260/309 (84%)
Query: 13 DGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV 72
+G S+ + A+ TFRELA ATKNFR E L+GEGGFGRVYKG LE+ Q VA+KQLDRNG+
Sbjct: 24 NGPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGL 83
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
QG REFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEYMPLGS+EDHL DL PG+KPL
Sbjct: 84 QGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPL 143
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
DWNTR+KIA GAA+G+EYLHD+A PPVIYRDLK SNILLD Y KLSDFGLAKLGPVGD
Sbjct: 144 DWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGD 203
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
HVS+RVMGTYGYCAPEY +TG LT KSDVYSFGVVLLE++SGR+ +DT + + EQ+LV
Sbjct: 204 TLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLV 263
Query: 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
WA P+F+D TR+ +ADP L+G YP + QA+AVAAMC+HE+P +RP+++DV+TAL++
Sbjct: 264 TWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSF 323
Query: 313 LASQKYESD 321
L + S+
Sbjct: 324 LGASSNSSN 332
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1143 (407.4 bits), Expect = 5.6e-116, P = 5.6e-116
Identities = 216/309 (69%), Positives = 256/309 (82%)
Query: 19 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF 78
I+A TFREL ATKNF ++ LGEGGFGRVYKG +E+ Q VA+KQLDRNG QGNREF
Sbjct: 65 ISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREF 124
Query: 79 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-PLDWNTR 137
LVEV+MLSLLHH NLVNL+GYCADGDQR+LVYEYM GS+EDHL +L+ KK PLDW+TR
Sbjct: 125 LVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTR 184
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
MK+AAGAARGLEYLH+ A PPVIYRD K SNILLD ++PKLSDFGLAK+GP G THVS
Sbjct: 185 MKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVS 244
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257
TRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GR+ +DT+K EQ+LV WA P
Sbjct: 245 TRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASP 304
Query: 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317
LF+DR + +L+ADP L+G+YP +G YQALAVAAMC+ E+ RP+++DVVTAL YLA K
Sbjct: 305 LFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVTK 364
Query: 318 YESDAEKVQ 326
E D + V+
Sbjct: 365 TEEDGQTVE 373
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
Identities = 208/309 (67%), Positives = 254/309 (82%)
Query: 8 KEASEDG-ASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQ 66
K ED ++ I AQT +FRELA ATKNFR E L+GEGGFGRVYKG LE VA+KQ
Sbjct: 50 KNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQ 109
Query: 67 LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 126
LDRNG+QGN+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDHL DL+
Sbjct: 110 LDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLT 169
Query: 127 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186
P + PLDW+TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSDFGLAK
Sbjct: 170 PDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAK 229
Query: 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 246
LGPVGD HVS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +DT++
Sbjct: 230 LGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPK 289
Query: 247 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
EQ+LV WA+P+F++ +R +ADP L+G +P + QA+AVAAMC+ E+ +RP+++DV
Sbjct: 290 DEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDV 349
Query: 307 VTALAYLAS 315
VTAL +L +
Sbjct: 350 VTALGFLGT 358
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 8.7e-111, P = 8.7e-111
Identities = 208/318 (65%), Positives = 252/318 (79%)
Query: 21 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV 80
A++ TF+ELAAAT+NFR +LLGEGGFGRVYKG L+S Q VAIKQL+ +G+QGNREF+V
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIV 121
Query: 81 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 140
EVLMLSLLHHPNLV LIGYC GDQRLLVYEYMP+GS+EDHL DL ++PL WNTRMKI
Sbjct: 122 EVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKI 181
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
A GAARG+EYLH A PPVIYRDLK +NILLD+ + PKLSDFGLAKLGPVGD THVSTRV
Sbjct: 182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRV 241
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260
MGTYGYCAPEYA +G+LT+KSD+Y FGVVLLE+++GRKA+D + EQ+LV W+RP +
Sbjct: 242 MGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLK 301
Query: 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 320
D+ + + DP L+G+YP R A+A+ AMC++E+ RP I D+V AL YLA+Q
Sbjct: 302 DQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSH 361
Query: 321 DAEKVQSPCLDPG-TPTR 337
+A V SP + TP R
Sbjct: 362 EARNVSSPSPEISRTPRR 379
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 200/324 (61%), Positives = 260/324 (80%)
Query: 19 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF 78
I A++ FRELA AT +FR E L+GEGGFGRVYKG +E Q VA+KQLDRNG+QGNREF
Sbjct: 54 IKAKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREF 113
Query: 79 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 138
LVE+ LSLLHHPNL NLIGYC DGDQRLLV+E+MPLGS+EDHL D+ G++PLDWN+R+
Sbjct: 114 LVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRI 173
Query: 139 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198
+IA GAA+GLEYLH+KA PPVIYRD K SNILL+ + KLSDFGLAKLG VGD +VS+
Sbjct: 174 RIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSS 233
Query: 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258
RV+GTYGYCAPEY KTGQLT+KSDVYSFGVVLLE+++G++ +DT++ EQ+LV WA+P+
Sbjct: 234 RVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPI 293
Query: 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 318
F++ R +ADP LQG++P + QA+A+AAMC+ E+P +RP+I+DVVTAL++++++
Sbjct: 294 FREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTET- 352
Query: 319 ESDAEKVQSPCLDPGTPTRTKGDK 342
+ L+P +P +T D+
Sbjct: 353 -GSPSGLTGTALNPLSP-KTVEDQ 374
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 1.4e-103, P = 1.4e-103
Identities = 195/313 (62%), Positives = 237/313 (75%)
Query: 26 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML 85
F+EL AAT NF + ++GEGGFGRVYKG+L S+NQ VA+K+LDRNG+QG REF EV++L
Sbjct: 75 FKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAEVMVL 134
Query: 86 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
SL HPNLVNLIGYC + +QR+LVYE+MP GS+EDHL DL G LDW TRM+I GAA
Sbjct: 135 SLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHGAA 194
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
+GLEYLHD A PPVIYRD K SNILL ++ KLSDFGLA+LGP HVSTRVMGTYG
Sbjct: 195 KGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMGTYG 254
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265
YCAPEYA TGQLT KSDVYSFGVVLLEI+SGR+A+D + EQ+L++WA PL +DR
Sbjct: 255 YCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDRRMF 314
Query: 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKV 325
+ I DP L G YP +G +QALA+AAMC+ E+ + RP++ DVVTAL +LA E V
Sbjct: 315 AQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLAKP-----IEVV 369
Query: 326 QSPCLDPGTPTRT 338
+ P +PT+T
Sbjct: 370 DNTNTTPASPTQT 382
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 361 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-59 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-56 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 5e-59
Identities = 74/195 (37%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYC 100
LGEGGFG VY + + VAIK + + E L E+ +L L+HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
D + LV EY GS++D L + + L + ++I GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 161 YRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLT 218
+RDLK NILLD KL+DFGL+KL + + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 219 LKSDVYSFGVVLLEI 233
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 3e-56
Identities = 78/202 (38%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 39 ESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNL 93
LGEG FG VYKG L+ +VA+K L + Q EFL E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L+G C + + ++V EYMP G + D+L P K L + + A ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES 121
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
K I+RDL N L+ K+SDFGL++ D V + APE K
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLK 177
Query: 214 TGQLTLKSDVYSFGVVLLEILS 235
G+ T KSDV+SFGV+L EI +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-56
Identities = 75/200 (37%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 42 LGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNL 96
LGEG FG VYKG L E VA+K L + R EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
+G C G+ +V EYMP G + D L + L +++A A+G+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
++RDL N L+ K+SDFGL++ D + APE K G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 217 LTLKSDVYSFGVVLLEILSG 236
T KSDV+SFGV+L EI +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 7e-56
Identities = 72/202 (35%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 39 ESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNL 93
LGEG FG VYKG L+ +VA+K L + + EFL E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L+G C + + +V EYM G + +L + L + + A ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLES 120
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
K I+RDL N L+ K+SDFGL++ D + APE K
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLK 176
Query: 214 TGQLTLKSDVYSFGVVLLEILS 235
G+ T KSDV+SFGV+L EI +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-53
Identities = 78/205 (38%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNL 93
+ LG G FG VYK + + VA+K L + ++ E+ +L L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V LI D D LV EY G L D PL + KIA RGLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
+I+RDLK NILLD K++DFGLAK + ++ ++T V GT Y APE
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLL 171
Query: 214 TGQL-TLKSDVYSFGVVLLEILSGR 237
G K DV+S GV+L E+L+G+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 89/286 (31%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 42 LGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 97
LGEG FG VYKG L+ + +VA+K L + + R +FL E ++ L HPN+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHL-----HDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
G C + + LV EYM G + D+L SP K L + A A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
K ++RDL N L+ K+SDFGL++ D T + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 213 KTGQLTLKSDVYSFGVVLLEILS-------GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265
K G T KSDV+SFGV+L EI + G + + + R
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-------------LRKGYR- 225
Query: 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311
+ PE Y P Y+ + C P+ RP +++V L
Sbjct: 226 --LPKPE----YCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 5e-53
Identities = 78/277 (28%), Positives = 118/277 (42%), Gaps = 35/277 (12%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLV 94
+ LGEG FG+VY + + VAIK + + ++ +RE L E+ +L L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
L D D+ LV EY G + D L + L + LEYLH K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214
+++RDLK NILLD H KL+DFGLA+ + ++T V GT Y APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 215 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274
D++S GV+L E+L+G +P F + + +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTG-------------------KPPFPGDDQLLELFKKIGK 211
Query: 275 GQYPPRGFYQALAVAAM-----CVHEQPDMRPVIADV 306
+ P ++ A + + P+ R +
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL-----MLSLLHHPNLVN 95
LLG G FG VY + + +A+K ++ + G+ E +E L +LS L HPN+V
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 96 LIGYC--ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----TRMKIAAGAARGL 148
G + + + EY+ GS+ L L TR + GL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQIL-----EGL 114
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
YLH +++RD+K +NIL+D KL+DFG AK + + V GT + A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
PE + + +D++S G ++E+ +G+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 95
F +G+GGFG VYK + ++VAIK + + + + E+ +L HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
G D+ +V E+ GS++D L + L + + +GLEYLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
+I+RD+K +NILL KL DFGL+ +T ++GT + APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 216 QLTLKSDVYSFGVVLLEILSGR 237
K+D++S G+ +E+ G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 69/227 (30%), Positives = 114/227 (50%), Gaps = 21/227 (9%)
Query: 36 FRSESLLGEGGFGRVYKGY----LESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHH 90
+LG G FG VYKG E + VAIK L + + N+E L E +++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAAR 146
P++V L+G C Q L+ + MPLG + D++ + + + L+W ++ A+
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWCVQI------AK 120
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
G+ YL +K +++RDL N+L+ H K++DFGLAKL V + + + +
Sbjct: 121 GMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 252
A E T KSDV+S+GV + E+++ G K + A L+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 92/287 (32%), Positives = 133/287 (46%), Gaps = 37/287 (12%)
Query: 42 LGEGGFGRVYKGYLESIN-----QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVN 95
LGEG FG+VYKG L N VAIK L N + +EF E ++S L HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAG 143
L+G C +++EY+ G + + L SP K LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
A G+EYL + ++RDL N L+ G K+SDFGL++ D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263
+ PE G+ T +SD++SFGVVL EI S + + Q ++ R+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS--YGLQPYYGFSNQEVI------EMIRS 241
Query: 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
R L+ PE P R + A+ C +E P RP D+ T L
Sbjct: 242 RQ-LLPCPE---DCPARVY----ALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 82/215 (38%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLML-SLLHH 90
++R LGEG FG VY + VA+K L + ++E FL E+ +L SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
PN+V L + D LV EY+ GS+ED L K PL + + I A LEY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEY 116
Query: 151 LHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL----GPVGDNTHVSTRVMGTYG 205
LH K +I+RD+K NILLDR G KL DFGLAKL G + + +GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 206 YCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGR 237
Y APE + SD++S G+ L E+L+G
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVN 95
LGEG FG+V + D VA+K L+ +G Q +F E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYD-PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 96 LIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
G C R L+ EY+P GS+ D+L ++ + ++ +G++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS 127
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST--RVMGTYGYCAPEY 211
+ I+RDL NIL++ K+SDFGLAK+ P + + + Y APE
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 212 AKTGQLTLKSDVYSFGVVLLEILS 235
+T + + SDV+SFGV L E+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-33
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 99
+ +G+G FG V G Q VA+K L + + FL E +++ L HPNLV L+G
Sbjct: 12 ATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
G+ +V EYM GS+ D+L S G+ + ++ A G+EYL +K
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEKN---F 123
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 219
++RDL N+L+ K+SDFGLAK G S ++ + APE + + +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAPEALREKKFST 178
Query: 220 KSDVYSFGVVLLEILS-GR 237
KSDV+SFG++L EI S GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 8/202 (3%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
+ F E LG G FG V++G L VAIK L + + ++F EV L L H +L
Sbjct: 6 EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
++L C+ G+ ++ E M GS+ L SP + L + + +A A G+ YL +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLR--SPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
+ I+RDL NIL+ K++DFGLA+L + ++ ++S+ Y + APE A
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 214 TGQLTLKSDVYSFGVVLLEILS 235
G + KSDV+SFG++L E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V+ G VA+K L + G FL E ++ L H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNG-TTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ + +V EYM GS+ D L K L + +AA A G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL NIL+ K++DFGLA+L + D+ + + G + APE A G+ T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFT 182
Query: 219 LKSDVYSFGVVLLEILS-GR 237
+KSDV+SFG++L EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVN 95
LGEG FG+V+ G + + VA+K L R+ F E +L+ H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGAA 145
G C +GD ++V+EYM G + L P L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
G+ YL A ++RDL N L+ K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ PE + T +SDV+SFGVVL EI +
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 71/201 (35%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 98
LG+G FG+V + + A+K L + + +E L E +LS ++HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 99 YCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
+ A + LV EY P G + HL G+ + R AA LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEER-ARF-YAAEIVLALEYLHSLG- 113
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
+IYRDLK NILLD H KL+DFGLAK + + +T GT Y APE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 217 LTLKSDVYSFGVVLLEILSGR 237
D +S GV+L E+L+G+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 41 LLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNL 96
LG+G FG V +G + VA+K L + + +FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD--WNTRMKIAAGAARGLEYLHDK 154
G ++V E PLGS+ D L + G + + ++IA G + YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLESK 116
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST---RVMGTYGYCAPEY 211
I+RDL NILL K+ DFGL + P ++ +V +V + +CAPE
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 212 AKTGQLTLKSDVYSFGVVLLEILS 235
+T + SDV+ FGV L E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 64/253 (25%), Positives = 106/253 (41%), Gaps = 39/253 (15%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPN 92
+ +G+G FG+VY +S + +K++D N + RE + EV +L L+HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
++ + + +V EY G + + KP + L+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-- 210
+ +++RD+K NI L KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 211 ----YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266
Y KSD++S G VL E+ + + F+
Sbjct: 176 QNKPYNY------KSDIWSLGCVLYELCTLKHP-------------------FEGENLLE 210
Query: 267 LIADPELQGQYPP 279
L L+GQYPP
Sbjct: 211 LA-LKILKGQYPP 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 8/197 (4%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGY 99
+G+G FG VYKG L+ N +VA+K + FL E +L HPN+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
C +V E +P GS+ L K L ++++ AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 219
I+RDL N L+ K+SDFG+++ G T + APE G+ T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 220 KSDVYSFGVVLLEILSG 236
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIG 98
L+G G FG VYKG VAIKQ+ ++ + + E+ +L L HPN+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
D ++ EY GS+ + P + L ++ +GL YLH++
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLHEQG--- 119
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 218
VI+RD+K +NIL + KL+DFG+A + D + V+GT + APE + +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 219 LKSDVYSFGVVLLEILSGR 237
SD++S G ++E+L+G
Sbjct: 178 TASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 82/281 (29%), Positives = 135/281 (48%), Gaps = 41/281 (14%)
Query: 41 LLGEGGFGRVYKGYL---ESINQDVAIKQLDR-NGVQGNREFLVEVLMLSLLHHPNLVNL 96
++G+G FG VY G L + A+K L+R ++ +FL E +++ HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 97 IGYCADGD-QRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHD 153
+G C + L+V YM G + + + + P K L + A+G+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL-- 114
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK------LGPVGDNTHVSTRVMGTYGYC 207
A ++RDL N +LD + K++DFGLA+ V ++T V +
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267
A E +T + T KSDV+SFGV+L E++ T A + ++ D T + L
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELM-------TRGAPPYPDVDSF------DITVYLL 216
Query: 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308
LQ +Y P Y+ V C H +P+MRP +++V+
Sbjct: 217 QGRRLLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-----FLVEVLMLSLL 88
+F+ ++GEG F V + N++ AIK LD+ Q +E +E +L+ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58
Query: 89 -HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
HP ++ L D + V EY P G + ++ LD AA
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLA 114
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVM----- 201
LEYLH K +I+RDLK NILLD+ H K++DFG AK L P
Sbjct: 115 LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 202 ------------GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
GT Y +PE SD+++ G ++ ++L+G+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHP 91
+ +++ +GEG G VYK + ++VAIK++ + N+E ++ E+L++ HP
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHP 75
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMK---IAAGAA-- 145
N+V+ GD+ +V EYM GS L D+ + N RM IA
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGS----LTDI------ITQNFVRMNEPQIAYVCREV 125
Query: 146 -RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--VMG 202
+GLEYLH + VI+RD+K NILL + KL+DFG A S R V+G
Sbjct: 126 LQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVG 178
Query: 203 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
T + APE K K D++S G++ +E+ G
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 34/212 (16%)
Query: 41 LLGEGGFGRVYKGYLESINQD----VAIKQ--LDRNGVQGN---REFLVEVLMLSLLHHP 91
LLG G FG VY+G +N D A+K+ L +G G ++ E+ +LS L HP
Sbjct: 7 LLGSGSFGSVYEG----LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N+V +G + D + E +P GS+ L +P+ +I G LEYL
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYL 118
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-----GTYGY 206
HD+ ++RD+K +NIL+D KL+DFG+AK V G+ +
Sbjct: 119 HDRN---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYW 167
Query: 207 CAPEY-AKTGQLTLKSDVYSFGVVLLEILSGR 237
APE A+ G L +D++S G +LE+ +G+
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 82/266 (30%), Positives = 122/266 (45%), Gaps = 37/266 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V+ GY + VAIK L + G FL E ++ L HP LV L
Sbjct: 14 LGAGQFGEVWMGYYNG-HTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ ++ EYM GS+ D L +P L N + +AA A G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 220
RDL+ +NIL+ K++DFGLA+L + DN + + + APE G T+K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 221 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-- 278
SDV+SFG++L EI V + R + T +I + E + P
Sbjct: 184 SDVWSFGILLTEI------------------VTYGRIPYPGMTNPEVIQNLERGYRMPRP 225
Query: 279 ---PRGFYQALAVAAMCVHEQPDMRP 301
P Y+ + +C E+P+ RP
Sbjct: 226 DNCPEELYE---LMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 92/301 (30%), Positives = 135/301 (44%), Gaps = 39/301 (12%)
Query: 28 ELAAATKNFRSESLLGEGGFGRVYKG--YLESIN--QDVAIKQL-DRNGVQGNREFLVEV 82
EL + F E LGE FG++YKG YL ++ Q VAIK L D N Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 83 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------------K 129
+++ LHHPN+V L+G +++EY+ G + + L SP K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 130 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189
LD + IA A G+EYL + +++DL NIL+ H K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249
D V + + + PE G+ + SD++SFGVVL EI S + + Q
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPYYGFSNQ 233
Query: 250 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309
++ R + L+ E PPR + ++ C E P RP D+ T
Sbjct: 234 EVIEMVR-------KRQLLPCSE---DCPPRMY----SLMTECWQEGPSRRPRFKDIHTR 279
Query: 310 L 310
L
Sbjct: 280 L 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 82/283 (28%), Positives = 129/283 (45%), Gaps = 36/283 (12%)
Query: 37 RSESLLGEGGFGRVYKGYLESINQDV--AIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 93
+ E+++ G G YKG +SI + +K++ D N + + E+ + L HPN+
Sbjct: 693 KEENVISRGKKGASYKG--KSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNI 745
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V LIG C L++EY+ ++ + L +LS W R KIA G A+ L +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS-------WERRRKIAIGIAKALRFLHC 798
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG----DNTHVSTRVMGTYGYCAP 209
+ P V+ +L I++D P L +L G D + Y AP
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-----AYVAP 847
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269
E +T +T KSD+Y FG++L+E+L+G+ D S+V WAR + D I
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWI- 905
Query: 270 DPELQGQYP--PRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
DP ++G + + +A C P RP DV+ L
Sbjct: 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
LG+G FG VY+G + + + VAIK ++ N R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLE 149
L+G + G L+V E M G ++ +L + +PG P +++AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YL K ++RDL N ++ K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E K G T KSDV+SFGVVL E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V++G L + VA+K L + G ++FL E ++ L HP L+ L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ +V E M GS+ ++L + L + +AA A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL N+L+ K++DFGLA++ + ++ + + G + APE A + +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARV--IKEDIYEARE--GAKFPIKWTAPEAALYNRFS 182
Query: 219 LKSDVYSFGVVLLEILS-GR 237
+KSDV+SFG++L EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 42 LGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNL 96
LGEG FG+V + N VA+K L R Q N + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 97 IGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
G C++ + L+ EY+PLGS+ D+L K L+ + A G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAK 213
I+RDL N+LLD K+ DFGLAK P G + V + A E K
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 214 TGQLTLKSDVYSFGVVLLEILS 235
+ + SDV+SFGV L E+L+
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+G G VY N+ VAIK++D Q + + L EV +S +HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKP 157
GD+ LV Y+ GS L D+ P IA +GLEYLH +
Sbjct: 69 VVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG 215
I+RD+K NILL K++DFG+ A L GD T V +GT + APE +
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 216 Q-LTLKSDVYSFGVVLLEILSGR 237
K+D++SFG+ +E+ +G
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 32/272 (11%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPN 92
+F + +G+G FG V+K ++ + A+KQ+D + + E + E +L+ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
++ D + +V EY G + L +PL + + GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
K +++RD+K N+ LD + K+ D G+AKL + DNT+ + ++GT Y +PE
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELC 173
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272
+ KSDV++ GVVL E +G+ D + A +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKI-------------- 213
Query: 273 LQGQYPP--RGFYQALA-VAAMCVHEQPDMRP 301
++G +PP + + Q LA + C+ + RP
Sbjct: 214 IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 42 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLI 97
LG G FG V KG + +VA+K L + G +EFL E +++ L HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
G C G+ +LV E PLG + +L P + ++ A G+ YL K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYA 212
++RDL N+LL + K+SDFG+++ LG + + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170
Query: 213 KTGQLTLKSDVYSFGVVLLEILS 235
G+ + KSDV+S+GV L E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 40 SLLGEGGFGRV----YKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 95
LG+G FG V Y ++ + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 96 LIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
G C +R LV EY+P GS+ D+L ++ LD + A+ +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAPE 210
K ++RDL NIL++ K+ DFGL K+ P D + R G + Y APE
Sbjct: 127 KR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APE 181
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILS 235
+ ++ SDV+SFGVVL E+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 93
+ +LG+G G VYK + + A+K++ +G + R+ L+ E+ L P +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 94 VNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAARGLEY 150
V G + +G+ + V EYM GS+ D L KK + IA +GL+Y
Sbjct: 62 VKCYGAFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDY 114
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAP 209
LH K +I+RD+K SN+L++ K++DFG++K L D + T V GT Y +P
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSP 169
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGR 237
E + + +D++S G+ LLE G+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-25
Identities = 60/192 (31%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
++ E+M G++ D+L + ++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 221
RDL N L+ + K++DFGL++L GD + APE + ++KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 222 DVYSFGVVLLEI 233
DV++FGV+L EI
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 78/277 (28%), Positives = 128/277 (46%), Gaps = 32/277 (11%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPN 92
+F+ LG+G +G VYK S NQ A+K++D + Q RE V E+ +L+ ++HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+++ DG++ +V EY P G + + +K + +I RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
++ +++RDLK +NILL K+ D G++K V T +GT Y APE
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKT-QIGTPHYMAPEVW 173
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272
K + KSD++S G +L E+ + P F+ R+ L
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATF-------------------APPFEARSMQDL-RYKV 213
Query: 273 LQGQYP--PRGFYQALAVAAM-CVHEQPDMRPVIADV 306
+G+YP P + Q L + +P +RP +
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-24
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 95
F LGEG +G VYK + Q VAIK + +E + E+ +L P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLH 152
G +V EY GSV D + + K L T +IAA +GLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTL---TEEEIAAILYQTLKGLEYLH 116
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
K I+RD+K NILL+ KL+DFG++ G + D V+GT + APE
Sbjct: 117 SNKK---IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGR 237
+ K+D++S G+ +E+ G+
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 6e-24
Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 90
+F LG G FGRV + + A+K L + + ++ L E +L + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P LVNL G D LV EY+P G + HL G+ P R AA LEY
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARF-YAAQVVLALEY 116
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH ++YRDLK N+LLD + K++DFG AK V T+ + GT Y APE
Sbjct: 117 LHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPE 168
Query: 211 ------YAKTGQLTLKSDVYSFGVVLLEILSG 236
Y K D ++ G+++ E+L+G
Sbjct: 169 IILSKGYGKA------VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 7e-24
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNLI 97
+GEG +G+VYK + + VA+K++ F + E+ +L L HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 98 GYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------G 147
+ +V+EYM HDL+ G L + +K + G
Sbjct: 65 EIVTSKGKGSIYMVFEYMD--------HDLT-G---LLDSPEVKFTESQIKCYMKQLLEG 112
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
L+YLH +++RD+K SNIL++ KL+DFGLA+ N+ T + T Y
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYR 168
Query: 208 APE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
PE Y + D++S G +L E+ G+
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 45 GGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCA 101
G +GRV+ +S AIK + + + + L E +LS P +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 102 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
G + L LV EY+P G + L ++ LD + A LEYLH +I
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS------TRVMGTYGYCAPEYAKT 214
+RDLK NIL+D H KL+DFGL+K+G V +++ R++GT Y APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 215 GQLTLKSDVYSFGVVLLEILSG 236
+ D +S G +L E L G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYC 100
LG G G V K + +A+K + ++ L E+ +L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
+ + EYM GS++ L + + KIA +GL YLH+K K +I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM--------GTYGYCAPEYA 212
+RD+K SNIL++ KL DFG VS +++ GT Y APE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPERI 171
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGR 237
+ ++KSD++S G+ L+E+ +GR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-23
Identities = 69/212 (32%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSL 87
R LLG G FG V+KG +SI VAIK + DR+G Q +E +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH----DLSPGKKPLDWNTRMKIAAG 143
L H +V L+G C G LV + PLGS+ DH+ L P ++ L+W ++
Sbjct: 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQI----- 118
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
A+G+ YL + +++R+L NILL +++DFG+A L D + +
Sbjct: 119 -AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ A E G+ T +SDV+S+GV + E++S
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-23
Identities = 69/200 (34%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V+ G DVAIK + R G +F+ E ++ L HPNLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRG-KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+V EYM G + ++L + GK +W M + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIH 123
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL N L+ K+SDFGLA+ V D+ + S+ GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179
Query: 219 LKSDVYSFGVVLLEILSGRK 238
KSDV+SFGV++ E+ S K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 68/203 (33%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIG 98
LG GGFGRV ++S N+ A+K + + + + E +L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 99 YCADGDQRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
Y D++ +Y EY G + L D G ++ R A EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRDR--GLFD-EYTARF-YIACVVLAFEYLHNRG 113
Query: 156 KPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214
+IYRDLK N+LLD GY KL DFG AK G T GT Y APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILN 166
Query: 215 GQLTLKSDVYSFGVVLLEILSGR 237
D +S G++L E+L+GR
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-23
Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLV 94
F +G+G FG VYK + NQ VAIK +D + E + E+ LS P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
G G + ++ EY GS L L PG LD I GLEYLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC---LDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214
K I+RD+K +NILL KL+DFG++ G + +GT + APE K
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 215 GQLTLKSDVYSFGVVLLEILSG 236
K+D++S G+ +E+ G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 39 ESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL 93
E ++G G FG V +G L+ + DVAIK L + G +FL E ++ HPN+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
+ L G +++ EYM GS++ L +D GK + + G A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREND---GK--FTVGQLVGMLRGIASGMKYL 122
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 206
+ ++RDL NIL++ K+SDFG L +++ + G G +
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIPIRW 174
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
APE + T SDV+SFG+V+ E++S
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-23
Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 40/283 (14%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGY 99
+GEG +G VYK + + VAIK++ + L E+ +L L+HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
LV+E+M D + ++ L + +GL + H +
Sbjct: 67 FRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT-G 215
++RDLK N+L++ KL+DFGLA+ PV TH V TR Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 216 QLTLKSDVYSFGVVLLEILSGR-------------KAVDTSKAAAEQSLVAWARPLFQDR 262
+ D++S G + E+LS R K T + P F
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW-----PKFTSL 229
Query: 263 TRHSLIADPELQGQYPPRGF----YQALAVAAMCVHEQPDMRP 301
R+ + P+ G P+ F QAL + + +H P R
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-22
Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+GEG FG V +G E Q VA+K + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ +V E M G++ + L + G+ + ++ + A G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVG-DNTHVSTRVMGTYGYCAPEYAKTGQLTLK 220
RDL NIL+ K+SDFGLA++G +G DN+ + + + APE K + + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 221 SDVYSFGVVLLEILS-GR 237
SDV+S+GV+L E+ S GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LGEG FG+V+ ++ + VA+K L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-----------PLDWNTRMKIAAGAA 145
G C +G L+V+EYM G + L P K L + IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
G+ YL A ++RDL N L+ +G K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ PE + T +SD++SFGVVL EI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 65/208 (31%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQ-LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
S LGEG G V K L++ A+K ++ L E+ + P +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 99 YCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRM------KIAAGAARGLEY 150
D + EY GS++ S KK R+ KIA +GL Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLD------SIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAP 209
LH + +I+RD+K SNILL R KL DFG++ +L T GT Y AP
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAP 172
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGR 237
E + ++ SDV+S G+ LLE+ R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 44/221 (19%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHP 91
+ LGEG +G VYK + + VA+K++ + G+ L E+ +L L HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------ 145
N+V L+ + LV+EY DL KK LD ++
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCD--------MDL---KKYLD-KRPGPLSPNLIKSIMYQ 106
Query: 146 --RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
RGL Y H +++RDLK NIL++R KL+DFGLA+ + T+ + V+ T
Sbjct: 107 LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-T 161
Query: 204 YGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 237
Y APE + L S D++S G + E+++G+
Sbjct: 162 LWYRAPE------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQG---NREFLV----EVLMLSLLHH 90
+L+G G FG VY G S + +A+KQ L R L E+ +L L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
N+V +G D D + EY+P GSV L++ ++ L N +I +GL Y
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNY 121
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-----LGPVGDNTHVSTRVMGTYG 205
LH++ +I+RD+K +NIL+D K+SDFG++K N + + G+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVF 177
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ APE K T K+D++S G +++E+L+G+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNL 96
+LG+G FG+V L+ + A+K L ++ V + + +VE +L+L +P L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
+ V E++ G + H+ D K D AA GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
+IYRDLK N++LDR H K++DFG+ K GDN ++ GT Y APE + +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 217 LTLKSDVYSFGVVLLEILSGR 237
T D +SFGV+L E+L G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLE-KRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ LV+E+M G + D+L + T + + G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL N L+ K+SDFG+ + V D+ + S+ GT + +PE + +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKYS 179
Query: 219 LKSDVYSFGVVLLEILS 235
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPN 92
+ ++G G FG V+ ++ + V IKQ+ + + E +L LL HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGL 148
++ + ++V EY P G++ +++ L L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
++H K +++RDLK NILLD+ K+ DFG++K+ + + T V+GT Y
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247
+PE + KSD+++ G VL E+ S ++A + + A
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 42 LGEGGFGRVY------------KGYLESINQD----VAIKQLDRNGVQGNR-EFLVEVLM 84
LGEG FG V+ K + E+ N D VA+K L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 85 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------DLSPGKKPLDWNTR 137
LS L PN+ L+G C ++ EYM G + L L+ K L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
+ +A A G+ YL ++RDL N L+ + Y K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
R + A E G+ T KSDV++FGV L EIL+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 41 LLGEGGFGRVYKGYLESINQD------VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNL 93
LG G FG VY+G I VA+K L + Q +EFL E ++S +HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP---LDWNTRMKIAAGAARGLEY 150
V L+G C + + ++ E M G + +L D + L + I A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 151 LHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
L I+RDL N L+ D K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE G+ T +SDV+SFGV++ EIL+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 5e-22
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSL-LHHPNLVNL 96
+LG+G FG+V L+ N+ AIK L ++ V + + +VE +L+L HP L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 97 IGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
+C + V EY+ G + H+ D AA GL++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214
+IYRDLK N+LLD+ H K++DFG+ K G+ ++ GT Y APE K
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 215 GQLTLKSDVYSFGVVLLEILSGR 237
+ D +SFGV+L E+L G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-22
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 39/231 (16%)
Query: 35 NFRSESLLGEGGFGRVYK----GYLESINQD-VAIKQL-DRNGVQGNREFLVEVLMLSLL 88
N +G+G FGRV++ G L VA+K L + +F E +++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------------GKK 130
HPN+V L+G CA G L++EYM G + + L SP
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 131 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190
PL ++ IA A G+ YL ++ ++RDL N L+ K++DFGL++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 191 GD------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
D N + R M PE + T +SDV+++GVVL EI S
Sbjct: 183 ADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIG 98
LG+GGFG V +++ + A K+LD+ + +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
D LV M G ++ H++++ G+ + AA GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 218
++YRDLK N+LLD + ++SD GLA G GT GY APE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYD 172
Query: 219 LKSDVYSFGVVLLEILSGR 237
D ++ G L E+++GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 71/213 (33%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM--------LSL 87
FR ++LG G FG+V + + AIK L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 88 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 145
HP LVNL C + + V EY G + H+H + R AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVV 111
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGT 203
GL+YLH+ ++YRDLK N+LLD K++DFGL K +G GD T ST GT
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGT 164
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
+ APE T D + GV++ E+L G
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 71/203 (34%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNL 96
+LG+G FG+V+ L+ NQ AIK L ++ V + + +VE +LSL HP L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 97 IGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
YC + V EY+ G + H+ D AA GL++LH K
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK 115
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214
++YRDLK NILLD H K++DFG+ K +GD + GT Y APE
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLG 170
Query: 215 GQLTLKSDVYSFGVVLLEILSGR 237
+ D +SFGV+L E+L G+
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-H 89
++ + E ++GEG FG+V + + + + + AIK L + + R+F E+ +L L H
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTR 137
HPN++NL+G C + + EY P G++ D L + P L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
++ A+ A G++YL +K I+RDL N+L+ K++DFGL++ G+ +V
Sbjct: 122 LQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK 174
Query: 198 TRVMGTYG--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ MG + A E T KSDV+SFGV+L EI+S
Sbjct: 175 -KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 89
N+R LLG+G FGRVY Y +++A+KQ+ D + + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 90 HPNLVNLIGYCADGDQRLLVY-EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
H +V G C D+ L ++ EYMP GSV+D L L K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGV 117
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 207
EYLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS 235
+PE K+DV+S G ++E+L+
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 6e-21
Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 45/303 (14%)
Query: 42 LGEGGFGRVYKGYLESINQD-----------------VAIKQLDRNGVQGNR-EFLVEVL 83
LGEG FG V+ + + QD VA+K L + + R +FL EV
Sbjct: 13 LGEGQFGEVHLCEVVN-PQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 84 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKP---------- 131
+LS L PN++ L+G C D D ++ EYM G + L H L ++
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 132 ---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188
+ +++ + +A A G++YL + ++RDL N L+ K++DFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248
GD + R + + A E G+ T SDV++FGV L EIL K + E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308
Q ++ A F+D+ R + P P+G Y+ + C RP +D+
Sbjct: 249 Q-VIENAGEFFRDQGRQVYLFRPPP----CPQGLYELM---LQCWSRDCRERPSFSDIHA 300
Query: 309 ALA 311
L
Sbjct: 301 FLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-21
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 42 LGEGGFGRVY--KGYLESINQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LGEG FG+V+ + Y S +D VA+K L + ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGA 144
G C DGD ++V+EYM G + L P K L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
A G+ YL A ++RDL N L+ K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ PE + T +SDV+SFGV+L EI +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-21
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 41 LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNL 96
++GEG FG+V K + + + D AIK++ + + R+F E+ +L L HHPN++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTRMKIAAGA 144
+G C L EY P G++ D L + P L + AA
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
ARG++YL K I+RDL NIL+ Y K++DFGL++ G +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 173
Query: 205 G--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ A E T SDV+S+GV+L EI+S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-21
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVN 95
LG G FG VY+G + D VA+K L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK---PLDWNTRMKIAAGAARGLEYLH 152
LIG + R ++ E M G ++ L + P + L + A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 153 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+ I+RD+ N LL G K++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E G T K+DV+SFGV+L EI S
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 77/204 (37%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 98
+G G FG VY N+ VAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
LV EY LGS D L KKPL I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPEY---AKT 214
I+RD+K NILL KL+DFG A L P N+ V GT + APE
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDE 188
Query: 215 GQLTLKSDVYSFGVVLLEILSGRK 238
GQ K DV+S G+ +E L+ RK
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 37/275 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V G DVAIK + + G EF+ E ++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+V EYM G + ++L + +P +++ G+ YL K I+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIH 123
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL N L+D K+SDFGL++ V D+ + S+ +G+ + PE + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 219 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ-- 276
KSDV++FGV++ E+ S K + +R +S + QG
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK-------------------MPYERFNNSETVEKVSQGLRL 220
Query: 277 YPPRGFYQAL-AVAAMCVHEQPDMRPVIADVVTAL 310
Y P + + A+ C HE+ + RP +++++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLI-GYC 100
LG+G FG+VYK + A K + + +F+VE+ +LS HPN+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
+ +L+ E+ G+++ + +L ++ L + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-----KTG 215
+RDLK NILL KL+DFG++ + +GT + APE K
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 216 QLTLKSDVYSFGVVLLEILSGR 237
K+D++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLV 94
LG G FG+V + +++ VA+K L RE L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
NL+G C G L++ EY G + + L + L + + A+G+ +L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEY 211
I+RDL N+LL G K+ DFGLA+ + D+ +V + R+ + APE
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 212 AKTGQLTLKSDVYSFGVVLLEILS 235
T +SDV+S+G++L EI S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 27/255 (10%)
Query: 42 LGEGGFGRVY----KGYLESINQD----------VAIKQLDRNGVQGNR-EFLVEVLMLS 86
LGEG FG V+ +G E + + VA+K L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 87 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------LSPGKKPLDWNTRM 138
L +PN++ L+G C D ++ EYM G + L + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 139 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198
+A A G++YL A ++RDL N L+ Y K++DFG+++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258
R + + A E G+ T SDV++FGV L E+ + K S + EQ ++
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIENTGEF 248
Query: 259 FQDRTRHSLIADPEL 273
F+++ R ++ L
Sbjct: 249 FRNQGRQIYLSQTPL 263
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 78/269 (28%), Positives = 120/269 (44%), Gaps = 32/269 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+G+G FG VYKG + VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
G + ++ EY+ GS D L PG PL+ I +GL+YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYLHSERK---I 123
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 220
+RD+K +N+LL KL+DFG+A G + D +GT + APE K K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 221 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY--P 278
+D++S G+ +E+ G L+ P P L+GQY P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQYSKP 228
Query: 279 PRGFYQALAVAAMCVHEQPDMRPVIADVV 307
+ F +A C+++ P RP +++
Sbjct: 229 FKEFVEA------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 68/196 (34%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGY 99
LLG+G FG V+KG L+ VA+K + Q + +FL E +L HPN+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
C QR +Y M L D L L K L +K A AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 219
I+RDL N L+ K+SDFG+++ G + + + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 220 KSDVYSFGVVLLEILS 235
+SDV+S+G++L E S
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 99
+G G FG+VY + +A+K+ + N + +E E+ +L LL HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
++ + EY G++E+ L + LD + GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM----GTYGYCAPEYAKTG 215
++RD+K +NI LD KL DFG A + +NT + GT Y APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 216 QLTLK---SDVYSFGVVLLEILSGRK 238
+ +D++S G V+LE+ +G++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQL-DRNGVQGNREFLVE 81
E+ +T F E LGE FG+VYKG+L Q VAIK L D+ EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 82 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------K 129
+M S L HPN+V L+G +++ Y + + L SP K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 130 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189
L+ + I A G+E+L + V+++DL N+L+ + K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
D + + + +PE G+ ++ SD++S+GVVL E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V+ GY + + VA+K L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ ++ EYM GS+ D L GK L + +A A G+ Y+ K I+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 126
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 220
RDL+ +N+L+ K++DFGLA++ + DN + + + APE G T+K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 221 SDVYSFGVVLLEILS 235
SDV+SFG++L EI++
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 71/198 (35%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V+ G N VA+K L + G FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNG-NTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ + +V EYM GS+ D L D G+ L + +AA A G+ Y+ + I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD-GEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 220
RDL+ +NIL+ G K++DFGLA+L + DN + + + + APE A G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 221 SDVYSFGVVLLEILS-GR 237
SDV+SFG++L E+++ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGN-REFLVEVLMLSLL 88
N LGEG FG+V K + VA+K L N R+ L E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--------------------HDLSPG 128
+HP+++ L G C+ LL+ EY GS+ L + +P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 129 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188
++ L + A +RG++YL A+ +++RDL N+L+ G K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
D+ ++ + A E T +SDV+SFGV+L EI++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 41 LLGEGGFGRVYKGYL----ESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVN 95
+LG G FG VYKG E++ VAIK L+ G + N EF+ E L+++ + HP+LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
L+G C + LV + MP G + D++H D + L+W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
++ +++RDL N+L+ H K++DFGLA+L + + + + A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 213 KTGQLTLKSDVYSFGVVLLEILS-GRKAVD 241
+ T +SDV+S+GV + E+++ G K D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLL-HHPNLV 94
+LG+G FG+V L+ ++ A+K L ++ + + + VE M L+L HP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 95 NLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLH 152
L C RL V EY+ G + H+ +P R + AA GL++LH
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLH 113
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
++ +IYRDLK N+LLD H K++DFG+ K G +G T ++ GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGR 237
D ++ GV+L E+L+G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 8e-20
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 35 NFRSESLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HH 90
+ + + ++GEG FG+V K + + + D AIK++ + + R+F E+ +L L HH
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTRM 138
PN++NL+G C L EY P G++ D L + P L +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 139 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198
AA ARG++YL K I+RDL NIL+ Y K++DFGL++ G +V
Sbjct: 128 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179
Query: 199 RVMGTYG--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ MG + A E T SDV+S+GV+L EI+S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 27/270 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V+ G + + VAIK + G +F+ E ++ L HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+V E+M G + L+ L + L + + + G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 220
RDL N L+ K+SDFG+ + V D+ + S+ + PE + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 221 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 280
SDV+SFGV++ E+ + K K+ E + + +R + P+L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYE---------VVEMISRGFRLYRPKLASMT--- 229
Query: 281 GFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
Y+ V C HE+P+ RP A+++ A+
Sbjct: 230 -VYE---VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHP 91
+F ++G+G FG+V + A+K +++ R L E +L L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 150
LVNL D + LV + + G + HL + ++K LEY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEY 115
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH K +I+RD+K NILLD H ++DF +A T T GT GY APE
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPE 169
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRK 238
++ D +S GV E L G++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 32/214 (14%)
Query: 41 LLGEGGFGRVYKGYLESINQDV------AIKQLD--RNGVQGNREFLVEVL-----MLSL 87
LG G F Y+ +DV A+KQ+ RN +E +VE L +++
Sbjct: 7 QLGTGAFSSCYQA------RDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMAR 59
Query: 88 LHHPNLVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 146
L+HP+++ ++G C D L V E+M GSV L K+ + N ++ R
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----R 114
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLA-KLGPVGDNT-HVSTRVMGT 203
GL YLH+ +I+RD+K +N+L+D G +++DFG A +L G +++GT
Sbjct: 115 GLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ APE + Q DV+S G V++E+ + +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 66/197 (33%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 100
+G G FG V+ G L + N VA+K + +FL E +L HPN+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
Q+ +Y M L D L L L +++ AA G+EYL K I
Sbjct: 63 T---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYAKTGQLT 218
+RDL N L+ K+SDFG+++ D + ST M + APE G+ +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 219 LKSDVYSFGVVLLEILS 235
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 35/293 (11%)
Query: 42 LGEGGFGRVY----KGYLESINQD------------VAIKQLDRNGVQGNR-EFLVEVLM 84
LGEG FG V+ +G + +++D VA+K L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 85 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD-------WNTR 137
+S L PN++ L+ C D ++ EYM G + L P + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
+ +A A G++YL + ++RDL N L+ + Y K++DFG+++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257
R + + + E G+ T SDV++FGV L EIL+ K S+ + EQ ++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGE 248
Query: 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
F+D+ R + P L P Y+ + C RP ++ L
Sbjct: 249 FFRDQGRQVYLPKPAL----CPDSLYK---LMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 99
+G+G FG V K +S + + K++D N + ++ LV EV +L L HPN+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 100 CADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKA 155
D + L V EY G + + +K ++ +I L H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
V++RDLK +NI LD + KL DFGLAK+ +G ++ + +GT Y +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQLNHM 185
Query: 216 QLTLKSDVYSFGVVLLEILSGR 237
KSD++S G ++ E+ +
Sbjct: 186 SYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 32/269 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+G+G FG V+KG + VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
+ ++ EY+ GS D L PG PLD I +GL+YLH + K I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLE---PG--PLDETQIATILREILKGLDYLHSEKK---I 123
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 220
+RD+K +N+LL KL+DFG+A G + D +GT + APE K K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 221 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY--P 278
+D++S G+ +E+ G L+ P P L+G Y P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 228
Query: 279 PRGFYQALAVAAMCVHEQPDMRPVIADVV 307
+ F +A C++++P RP +++
Sbjct: 229 LKEFVEA------CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-19
Identities = 69/228 (30%), Positives = 111/228 (48%), Gaps = 26/228 (11%)
Query: 17 DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR 76
++I + T + K + +G+G G VY + Q+VAIKQ++ Q +
Sbjct: 2 EEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKK 60
Query: 77 EFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 135
E ++ E+L++ HPN+VN + GD+ +V EY+ GS+ D + +
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------- 109
Query: 136 TRMKIAAGAA------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLG 188
T M AA + LE+LH VI+RD+K NILL KL+DFG A++
Sbjct: 110 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
P + + ST V GT + APE K D++S G++ +E++ G
Sbjct: 167 P--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 41 LLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNL 93
LGEG FG+V K ++ VA+K L + + + + + E+ M+ ++ H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----GKKPLDWNTRMKI--------A 141
+NL+G C +V EY G++ D L P + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 201
ARG+E+L K I+RDL N+L+ + K++DFGLA+ + +
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTN 193
Query: 202 G--TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
G + APE T +SDV+SFGV+L EI +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-19
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
LG+G FG VY+G + + +D VAIK ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIAAGAARGLE 149
L+G + G L++ E M G ++ +L L +P + P +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YL+ ++RDL N ++ + K+ DFG+ + D + + + +P
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEI 233
E K G T SDV+SFGVVL EI
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 98
+G G FG VY N+ VA+K++ +G Q N ++ + EV L L HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
LV EY LGS D L KKPL I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHNM-- 142
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 215
I+RD+K NILL KL+DFG A ++ +GT + APE G
Sbjct: 143 -IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 216 QLTLKSDVYSFGVVLLEILSGRK 238
Q K DV+S G+ +E L+ RK
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 41 LLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVN 95
+LGEG FG V +G L + VA+K + + + EFL E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 96 LIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAARG 147
LIG C + +++ +M G + L G P + K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRVMGTY 204
+EYL ++ I+RDL N +L ++DFGL+K GD ++ +
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ A E T KSDV++FGV + EI +
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
++ R E LG+G FG V+ G + VAIK L + G FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L ++ + +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVE- 119
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 212
+ ++RDL+ +NIL+ K++DFGLA+L + DN + + + + APE A
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 213 KTGQLTLKSDVYSFGVVLLEI 233
G+ T+KSDV+SFG++L E+
Sbjct: 176 LYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 36 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHH 90
F+ +LG G FG VYKG E + VAIK+L + + N+E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARG 147
P++ L+G C +L + + MP G + D++ D + L+W ++ A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
+ YL ++ +++RDL N+L+ H K++DFGLAKL + + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVD 241
A E T +SDV+S+GV + E+++ G K D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 42 LGEGGFGRVY--KGYLESINQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LGEG FG+V+ + Y QD VA+K L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GKKP--LDWNTRMKIAAGAARG 147
G C +GD ++V+EYM G + L P G +P L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
+ YL A ++RDL N L+ K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS 235
PE + T +SDV+S GVVL EI +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 8e-19
Identities = 70/217 (32%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIG- 98
++GEG +G+VYK + Q VAIK +D + E E +L +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 99 -----YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARG 147
+ DQ LV E GSV D + K R+K I RG
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRG 125
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTY 204
L YLH+ VI+RD+K NILL + KL DFG+ A+L D+T + R +GT
Sbjct: 126 LAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DST-LGRRNTFIGTP 177
Query: 205 GYCAPE-----YAKTGQLTLKSDVYSFGVVLLEILSG 236
+ APE +SDV+S G+ +E+ G
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH 89
A K + +G+G FG V G + VA+K + + + FL E +++ L
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLR 57
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
H NLV L+G + L +V EYM GS+ D+L S G+ L + +K + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAM 115
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 207
EYL ++RDL N+L+ K+SDFGL K D + + +
Sbjct: 116 EYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT 166
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS-GR 237
APE + + + KSDV+SFG++L EI S GR
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQL-------DRNGVQGNREFLVEVLMLSLLHHP 91
LGEG + VYK + + VAIK++ ++G+ N L E+ +L L HP
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHP 62
Query: 92 NLVNLIG-YCADGDQRL-LVYEYMPLGSVEDHLHD----LSPG-KKPLDWNTRMKIAAGA 144
N++ L+ + + LV+E+M +E + D L+P K T
Sbjct: 63 NIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT-------- 111
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-NTHVSTRVMGT 203
RGLEYLH +++RDLK +N+L+ KL+DFGLA+ G N ++ +V+ T
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV-T 165
Query: 204 YGYCAPEY---AKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE A+ + D++S G + E+L
Sbjct: 166 RWYRAPELLFGAR--HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 70/282 (24%), Positives = 124/282 (43%), Gaps = 32/282 (11%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLH 89
NF+ E +G+G F VYK + VA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
HPN++ + + ++ +V E G + + K+ + T K LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
++H K +++RD+K +N+ + KL D GL + T + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR-HSLI 268
E KSD++S G +L E+ AA QS P + D+ +SL
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLYSLC 217
Query: 269 ADPELQGQYPP---RGFYQAL-AVAAMCVHEQPDMRPVIADV 306
E + YPP + + L + + C++ P+ RP I+ V
Sbjct: 218 KKIE-KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQGN----REFLVEVLMLSLLHHPNLV 94
+LG+G +G VY G L + Q +A+KQ LD + V + EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
+G C D + + E++P GS+ L+ P +P+ +I G A YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----LGPVGDNTHVSTRVMGTYGYCAPE 210
V++RD+K +N++L KL DFG A+ +G G ++++ + GT + APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
KSD++S G + E+ +G+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 36/288 (12%)
Query: 36 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHH 90
+ +LG G FG VYKG E++ VAIK L N + N+E L E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARG 147
P + L+G C +L V + MP G + D++ D + L+W ++ A+G
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
+ YL + +++RDL N+L+ H K++DFGLA+L + + + + +
Sbjct: 122 MSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266
A E + T +SDV+S+GV + E+++ G K D R
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG----------------IPAREIPD 222
Query: 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314
L+ E Q PP + C + RP ++V + +A
Sbjct: 223 LLEKGERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE----------FLVEVLMLSLLHH 90
L+G+G +GRVY + + +A+KQ++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
N+V +G+ + + EY+P GS+ L ++ L ++ GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAY 123
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM---GTYGYC 207
LH K +++RDLK N+L+D K+SDFG++K D+ + + + M G+ +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSMQGSVFWM 177
Query: 208 APEYAKTGQ--LTLKSDVYSFGVVLLEILSGRK 238
APE + + K D++S G V+LE+ +GR+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL------DRNGVQGNREFLVEVLMLSLLHHPNLVN 95
+G G +G VYK + + VAIK + D +Q E+ ML HPN+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ------EISMLKECRHPNIVA 64
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLEYLH 152
G D+ +V EY GS++D + PL + ++IA +GL YLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGPL---SELQIAYVCRETLKGLAYLH 118
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 209
+ K I+RD+K +NILL KL+DFG+ A+L T ++ R +GT + AP
Sbjct: 119 ETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL----TAT-IAKRKSFIGTPYWMAP 170
Query: 210 EYA---KTGQLTLKSDVYSFGVVLLE 232
E A + G K D+++ G+ +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-18
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
++ R + LG+G FG V+ G + VAIK L + G FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L ++ + +V E+M GS+ D L + K L + +AA A G+ Y+
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE- 119
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 212
+ I+RDL+ +NIL+ K++DFGLA+L + DN + + + + APE A
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 213 KTGQLTLKSDVYSFGVVLLEILS 235
G+ T+KSDV+SFG++L E+++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH-HPNLVNL 96
+LG+G FG+V L+ + A+K L ++ + + + + E +LSL HP L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 97 IGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
C RL V E++ G + H+ + D AA L +LHDK
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG 116
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
+IYRDLK N+LLD H KL+DFG+ K G + + ST GT Y APE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 216 QLTLKSDVYSFGVVLLEILSG 236
D ++ GV+L E+L G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 60/198 (30%), Positives = 84/198 (42%), Gaps = 21/198 (10%)
Query: 45 GGFGRVYKGYLESINQDVAIKQLDR------NGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
G FG VY S AIK L + N V + +M+ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK--AERAIMMIQGESPYVAKLYY 64
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
D LV EY+ G + L G P DW + A G+E LH +
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAK--QYIAEVVLGVEDLHQRG--- 117
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 218
+I+RD+K N+L+D+ H KL+DFGL++ G + + +GT Y APE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDD 171
Query: 219 LKSDVYSFGVVLLEILSG 236
SD +S G V+ E L G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
+F +LG+G FG+V + ++ AIK L ++ + + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 92 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
+ + C RL V EY+ G + H+ + K+P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFF 116
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 209
LH K +IYRDLK N++LD H K++DFG+ K G T TR GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAP 170
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
E D ++FGV+L E+L+G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
L+GEG +G V K + Q VAIK+ D V + + E+ ML L H NLVNL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV--KKIAMREIRMLKQLRHENLVNL 65
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
I + LV+E++ DH L DL LD + K RG+E+ H
Sbjct: 66 IEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY-- 211
+I+RD+K NIL+ + KL DFG A+ L G+ V T + T Y APE
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLV 173
Query: 212 --AKTGQLTLKSDVYSFGVVLLEILSG 236
K G+ D+++ G ++ E+L+G
Sbjct: 174 GDTKYGRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-18
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 14/222 (6%)
Query: 17 DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR 76
++I + T + K + +G+G G V+ + Q+VAIKQ++ Q +
Sbjct: 2 EEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKK 60
Query: 77 EFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 135
E ++ E+L++ L +PN+VN + GD+ +V EY+ GS+ D + + +D
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-----MDEA 115
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNT 194
+ + LE+LH VI+RD+K N+LL KL+DFG A++ P + +
Sbjct: 116 QIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQS 170
Query: 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
ST V GT + APE K D++S G++ +E++ G
Sbjct: 171 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
+F +LG+G FG+V + ++ AIK L ++ V + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 92 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
+ + C RL V EY+ G + H+ + K+P + AA + GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFF 116
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 209
LH + +IYRDLK N++LD H K++DFG+ K V V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAP 170
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
E D +++GV+L E+L+G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 41 LLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLV 94
LG G FG V+ E V +K L + + EF E+ M L H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHL-----HDLSPGKKPLDWNTRMKIAAGAARGLE 149
L+G C + + ++ EY LG ++ L D PL ++ + A G++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+L + ++RDL N L+ K+S L+K + + + AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAP 187
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E + + KSDV+SFGV++ E+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSLLHHPNLVN 95
+GEG +G V+K Q VAIK+ V+ + ++ E+ ML L HPNLVN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
LI + LV+EY DH L++L + + + KI + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNT-HVSTRVMGTYGYCAPE 210
K I+RD+K NIL+ + KL DFG A++ GP D T +V+TR Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170
Query: 211 YAKTGQLTLKS--DVYSFGVVLLEILSG 236
G DV++ G V E+L+G
Sbjct: 171 LL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIG 98
LG G FGRV + + AIK L + + ++ E +L L HP +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKP 157
D ++ + E++ G + HL G+ P N K A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR--KAGRFP---NDVAKFYHAELVLAFEYLHSKD-- 138
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
+IYRDLK N+LLD H K++DFG AK V D T + GT Y APE ++
Sbjct: 139 -IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAPEVIQSKGH 192
Query: 218 TLKSDVYSFGVVLLEILSG 236
D ++ GV+L E ++G
Sbjct: 193 GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVN 95
++GEG +G V K ++ + VAIK+ D V+ + L EV +L L H N+VN
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK--KTALREVKVLRQLRHENIVN 64
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
L + LV+EY+ L L L + + + Y H
Sbjct: 65 LKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
+I+RD+K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE----- 171
Query: 216 QLTLKS-------DVYSFGVVLLEILSGR 237
L + DV++ G ++ E+L G
Sbjct: 172 -LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 42 LGEGGFGRVYKGY--LESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIG 98
LG G FG V KG + DVAIK L + R E + E ++ L +P +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKP 157
C + + +LV E G L+ GKK + + +++ + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAKT 214
++RDL N+LL ++ K+SDFGL+K LG D+++ R G + + APE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINF 172
Query: 215 GQLTLKSDVYSFGVVLLEILS-GRK 238
+ + +SDV+S+G+ + E S G+K
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-18
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNL 96
+GEG FG VY+G S + VA+K RE FL E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
IG + + +V E PLG + +L K LD + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTG 215
++RD+ N+L+ KL DFGL++ + D ++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 216 QLTLKSDVYSFGVVLLEILS 235
+ T SDV+ FGV + EIL
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-18
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 92
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+VNL D LV M G ++ H++++ G + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ +YRDLK NILLD H ++SD GLA P G++ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGR 237
+ TL D + G ++ E++ G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 39 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLV 94
+ ++G G FG V++G L+ + VAIK L + R +FL E ++ H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
L G +++ EYM G+++ +L D ++ G A G++YL D
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM 126
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAK 213
++RDL NIL++ K+SDFGL++ L + T+ ++ + APE
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 214 TGQLTLKSDVYSFGVVLLEILS 235
+ T SDV+SFG+V+ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-18
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 39 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNL 93
E ++G G FG V +G L+ + VAIK L ++G + R+FL E ++ HPN+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
++L G +++ E+M G+++ L + G+ + M G A G++YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGM--LRGIAAGMKYLSE 124
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCA 208
++RDL NIL++ K+SDFGL++ + D+T T G + A
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILS 235
PE + T SDV+S+G+V+ E++S
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-18
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 92
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V+L D LV M G ++ H++++ D + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ ++YRDLK NILLD H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV 173
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGR 237
K + T D + G ++ E++ G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 1e-17
Identities = 72/203 (35%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 98
+G G FG VY N+ VAIK++ +G Q N ++ + EV L + HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
LV EY LGS D L KKPL I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 215
+I+RD+K NILL KL+DFG A + ++ +GT + APE G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 216 QLTLKSDVYSFGVVLLEILSGRK 238
Q K DV+S G+ +E L+ RK
Sbjct: 200 QYDGKVDVWSLGITCIE-LAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 42 LGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
LG+G FG VY+G I VA+K ++ + R EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIAAGAARGLE 149
L+G + G L+V E M G ++ +L L +PG+ P +++AA A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YL+ K ++RDL N ++ + K+ DFG+ + D + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E K G T SD++SFGVVL EI S
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
++ + E LG G FG V+ + VA+K + + G FL E ++ L H L
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 63
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L + ++ E+M GS+ D L K+PL + +A A G+ ++
Sbjct: 64 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 120
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 212
+ I+RDL+ +NIL+ K++DFGLA++ + DN + + + APE
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 213 KTGQLTLKSDVYSFGVVLLEILS-GR 237
G T+KSDV+SFG++L+EI++ GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV--EVLMLSLLHHP 91
+ +G G FGRV+ A+K + ++ +E V E +L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 92 NLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
++ L + + DQR L + EY+P G + +L + G+ +T + A+ LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR--NSGR--FSNSTGLFYASEIVCALE 115
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YLH K ++YRDLK NILLD+ H KL+DFG AK + D T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLAP 167
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSG 236
E ++ D ++ G+++ E+L G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 89
N+R LLG+G FGRVY Y +++A+KQ+ D + ++E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 90 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
H +V G D +R L E+MP GS++D L L N K G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEG 118
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 206
+ YLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+PE K+D++S G ++E+L+ +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIG 98
LG+GGFG V +++ + A K+LD+ ++ G + L+E +L ++ P +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 99 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
Y + L LV M G ++ H++++ G++ L+ + +A G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
++YRD+K N+LLD + +LSD GLA G T+ GT GY APE K
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 218 TLKSDVYSFGVVLLEILSGR 237
+ D ++ G + E+++GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 68/198 (34%), Positives = 91/198 (45%), Gaps = 19/198 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 98
+G G FG VY ++ VAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
LV EY LGS D L KKPL + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 215
+I+RD+K NILL KL DFG A + + +GT + APE G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 216 QLTLKSDVYSFGVVLLEI 233
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 99
LG+G FG + V K+++ R + R+ L E+++LSLL HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
D + L+ EY G++ D + + + + + + Y+H K +
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 219
++RD+K NI L + KL DFG++K+ +G ++ V+GT Y +PE + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 220 KSDVYSFGVVLLEILSGRKAVDTS 243
KSD+++ G VL E+L+ ++ D +
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 36 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH 89
LL EG FGR++ G L ++V +K + + +Q L E +L L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLS 66
Query: 90 HPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHD--LSPGKKPLDWNTR--MKIAAGA 144
H N++ ++ C DG+ ++Y YM G+++ L L P +T+ + +A
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGP-----VGDNTHVST 198
A G+ YLH + VI++D+ N ++D K++D L++ L P +GDN +
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ M A E + + SDV+SFGV+L E+++
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 99
+GEG G V+K + VA+K++ ++G + L E+ L HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
G +LV EYMP + + L D +PL +G+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---I 120
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAKTGQL 217
++RDLK +N+L+ K++DFGLA+L + S +V T Y APE Y +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR-KY 178
Query: 218 TLKSDVYSFGVVLLEILSGR 237
D+++ G + E+L+G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 92
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V+L D LV M G ++ H++ + G+ + + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ ++YRDLK NILLD H ++SD GLA P G + RV GT GY APE
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 244
K + T D ++ G +L E+++G+ K
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHP 91
NF+ E +G G F VY+ + VA+K++ + + ++ + E+ +L L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N++ + + ++ +V E G + + K+ + T K +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271
KSD++S G +L E+ AA QS P + D+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLFSLCQK 219
Query: 272 ELQGQYPP---RGFYQAL-AVAAMCVHEQPDMRPVIADV 306
Q YPP + + L + +MC++ PD RP I V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 50/218 (22%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF--------LVEVLML-SLLHHPN 92
LG+G FG VY + + VAIK++ ++F L EV L L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEY 150
+V L + D+ V+EYM E +L+ L KP + I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN----THVSTRVMGTYGY 206
+H K +RDLK N+L+ K++DFGLA+ + +VSTR Y
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WY 164
Query: 207 CAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 237
APE + L+S D+++ G ++ E+ + R
Sbjct: 165 RAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 8e-17
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 89
N+R LLG+G FGRVY Y +++A KQ+ D + ++E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 90 HPNLVNLIGYCADGDQRLLV--YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
H +V G D ++ L EYMP GSV+D L L + K G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEG 118
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 206
+ YLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+PE K+DV+S G ++E+L+ +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPN 92
+ +GEG FG++Y +S ++ IK++D + V+ EV++L+ + HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGL 148
+V + + +V EY G + ++ L + L W ++ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
+++HD+ +++RD+K NI L + G KL DFG+A+ + D+ ++ +GT Y
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYL 169
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEI 233
+PE + K+D++S G VL E+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+G+G FG V+KG Q VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
G + ++ EY+ GS D L P D + +GL+YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 220
+RD+K +N+LL KL+DFG+A G + D +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 221 SDVYSFGVVLLEILSG 236
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSL-LHHPNLVNL 96
+LG+G FG+V L+ ++ AIK L ++ + + + + E +L+L HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
D+ V EY+ G D + + +K D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
VIYRDLK NILLD H KL+DFG+ K G + T +T GT Y APE + +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 217 LTLKSDVYSFGVVLLEILSGR 237
D ++ GV++ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 38/278 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-LSLLHH---PNLVNLI 97
LG G G V K +A K + + ++L L ++H P +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 98 G-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
G + + + + E+M GS++ P + KIA GL YL++ +
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAKT 214
+++RD+K SNIL++ KL DFG++ G+ N+ T V GT Y +PE +
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFV-GTSTYMSPERIQG 176
Query: 215 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274
G+ T+KSDV+S G+ ++E+ G+ A + P+ ++ +P +
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPF----AFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232
Query: 275 ---GQYPP--RGFYQALAVAAMCVHEQPDMRPVIADVV 307
+P R F A C+ + P RP +
Sbjct: 233 LPSSDFPEDLRDFVDA------CLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 92
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V+L D LV M G ++ H++++ G D + AA GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ ++YRDLK NILLD H ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGR 237
+ T D + G ++ E++ G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLD-----RNGVQGNREFLVEVLMLSLLHHP 91
LGEG FG V +G L NQD VA+K + R+ ++ +FL E + + HP
Sbjct: 7 LGEGEFGSVMEGQL---NQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHP 60
Query: 92 NLVNLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAG 143
N++ LIG C + +++ +M G + L G P T+M K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
A G+EYL K+ I+RDL N +L+ + ++DFGL+K GD
Sbjct: 121 IASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 233
+ A E T KSDV+SFGV + EI
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 60 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-VYEYMPL 115
+VAIK L + + + F E + + L+HPN+V L+ L V+EY+P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---D 172
++ + L L ++ L H++ +++RDLK NI++
Sbjct: 64 RTLREVLA----ADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 173 RGYHPKLSDFGLAKLGP-VGDNTHV----STRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 227
H K+ DFG+ L P V D +T V+GT YCAPE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 228 VVLLEILSGRKAV 240
++ LE L+G++ V
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHH 90
+ E ++G G FG V G L+ + VAIK L + R +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGL 148
PN+++L G ++V EYM GS++ L HD L + + G A G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGM 119
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG---TYG 205
+YL D ++RDL NIL++ K+SDFGL+++ + D+ + G
Sbjct: 120 KYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIR 174
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE + T SDV+S+G+V+ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 24/202 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+GEG G V +S + VA+K++D Q RE L EV+++ HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM---KIAA---GAARGLEYLHDK 154
GD+ +V E++ G++ D + +TRM +IA + L +LH +
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 215 GQLTLKSDVYSFGVVLLEILSG 236
+ D++S G++++E++ G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 42 LGEGGFGRVYKGYLE--SINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
LG G FG V KG + + VA+K L D N E L E ++ L +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
G C + + +LV E LG L+ K + ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAKT 214
++RDL N+LL ++ K+SDFGL+K LG D + + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 215 GQLTLKSDVYSFGVVLLEILS 235
+ + KSDV+SFGV++ E S
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 89
N+R LLG G FG VY Y +++A+KQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 90 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
H +V G D +++ L EYMP GS++D L L N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQG 118
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 206
+ YLH +++RD+K +NIL D + KL DFG +K + + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+PE K+DV+S ++E+L+
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 42 LGEGGFGRVYKGYLESINQD----------VAIKQLDRNGVQGNREFLVEVLMLSLLHHP 91
LG+G F +YKG L + V +K L + + F ++S L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
+LV L G C D+ ++V EY+ G ++ LH L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYL 117
Query: 152 HDKAKPPVIYRDLKCSNILLDR-----GYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTY 204
DK +++ ++ NIL+ R GY P KLSD G+ V R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 205 GYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249
+ APE + GQ LT+ +D +SFG LLEI S + ++ +++E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 4e-16
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+G+G G VY + Q+VAI+Q++ Q +E ++ E+L++ +PN+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
GD+ +V EY+ GS+ D + + +D + + LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VI 138
Query: 161 YRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 219
+RD+K NILL KL+DFG A++ P + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 220 KSDVYSFGVVLLEILSG 236
K D++S G++ +E++ G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLH 89
F + +GEG +G VY+ + + VA+K++ +R+G+ + L E+ +L L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLR 64
Query: 90 HPNLVNLIGYCADGDQR---LLVYEY--MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 144
HPN+V L G LV EY L S+ D++ P + +
Sbjct: 65 HPNIVELKEVVV-GKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQL 117
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
RGL+YLH+ +I+RDLK SN+LL K++DFGLA+ G T + T
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTL 172
Query: 205 GYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE T T D+++ G +L E+L+ +
Sbjct: 173 WYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 42 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 92
LGEG FG+V I++D VA+K L + + + LV E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 140
++NL+G C ++ EY G++ ++L P + + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
ARG+EYL A I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE T +SDV+SFGV++ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 5e-16
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+G+G G VY + Q+VAIKQ++ Q +E ++ E+L++ +PN+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
GD+ +V EY+ GS+ D + + +D + + L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALDFLHSNQ---VI 137
Query: 161 YRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 219
+RD+K NILL KL+DFG A++ P + + ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 220 KSDVYSFGVVLLEILSG 236
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 45/223 (20%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLV----EVLMLSLLHHPNLV 94
+GEG +G+VYK + + VA+K++ + +E F + E+ +L L+H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 95 NLIGYCADGDQRL----------LVYEYMP---LGSVEDHL------HDLSPGKKPLDWN 135
NL D L LV+EYM +G +E L H S K+ L+
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE-- 127
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195
GL Y H K ++RD+KCSNILL+ KL+DFGLA+L ++
Sbjct: 128 -----------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 196 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 237
+ +V+ T Y PE + + DV+S G +L E+ + +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 42 LGEGGFGRV----YKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LGEG FG+V Y ++ + VA+K L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 97 IGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
G C + L+ E++P GS++++L K ++ ++K A +G++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST----RVMGTYGYCAPE 210
++RDL N+L++ + K+ DFGL K + + T + Y APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILS 235
+ + SDV+SFGV L E+L+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 70/282 (24%), Positives = 109/282 (38%), Gaps = 26/282 (9%)
Query: 42 LGEGGFGRVYKGYLESINQD--VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
+G G FG+V G V +K+L FL EV L+HPN++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGLEYLHDKAKP 157
C + LLV E+ PLG ++++L + + ++A A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----- 212
I+ DL N L K+ D+GLA D + APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 213 --KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270
T KS+++S GV + E L + EQ L R + +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLSDEQVLKQVV------REQDIKLPK 232
Query: 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
P+L +Y R +Y+ + + P+ RP +V L Y
Sbjct: 233 PQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM---LSLLHH 90
+ + +G G G+VYK + +A+KQ+ R G N+E +LM + L H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSH 71
Query: 91 --PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
P +V GY + E M + D L L + P+ + K+ + L
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELM--STCLDKL--LKRIQGPIPEDILGKMTVAIVKAL 127
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
YL K K VI+RD+K SNILLD + KL DFG++ G + D + TR G Y A
Sbjct: 128 HYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMA 182
Query: 209 PEY----AKTGQLTLKSDVYSFGVVLLEILSGR 237
PE + +++DV+S G+ L+E+ +G+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQ----LDRNGVQGN--REFLVEVL-MLSLLHHPN 92
+ +GEG +G VYK + + VA+K+ L G+ + RE + +L L HPN
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPN 62
Query: 93 LVNLIGYCA--DGDQRL---LVYEYMPLGSVEDHLHDL-----SPGKKPLDWNTRMKIAA 142
+V L+ C D+ L LV+E+ V+ L PG L T +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPG---LPPETIKDLMR 114
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 202
RG+++LH +++RDLK NIL+ K++DFGLA+ + T V+
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVV 168
Query: 203 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEI 233
T Y APE YA D++S G + E+
Sbjct: 169 TLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 32/280 (11%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHP 91
NFR E +G G F VY+ VA+K++ D + + + E+ +L L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N++ + ++ +V E G + + K+ + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR-HSLIAD 270
KSD++S G +L E+ AA QS P + D+ +SL
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLYSLCKK 219
Query: 271 PELQGQYPP---RGFYQAL-AVAAMCVHEQPDMRPVIADV 306
E Q YPP + + L + MC++ P+ RP I V
Sbjct: 220 IE-QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 51/155 (32%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 139 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198
KIA + LEYLH K VI+RD+K SN+L++R KL DFG++ G + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 199 RVMGTYGYCAPEY----AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLV 252
G Y APE +KSDV+S G+ ++E+ +GR D+ K +Q +V
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 253 AWARPL---------FQDRTRHSLIADPELQGQYP 278
P FQD L + + + YP
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
+F +LG+G FG+V + ++ AIK L ++ V + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 92 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
+ + C RL V EY+ G + + + K+P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFF 116
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVM-GTYGYC 207
LH K +IYRDLK N++LD H K++DFG+ K +N V+T+ GT Y
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYI 168
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
APE D ++FGV+L E+L+G+ +
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 42 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 92
LGEG FG+V I++D VA+K L + + LV E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 140
++NL+G C ++ EY G++ ++L P ++ L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
A ARG+EYL A I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE T +SDV+SFGV+L EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 42 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 92
LGEG FG+V + I++ VA+K L N + L+ E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------DLSPG-----KKPLDWNTRMKI 140
++NL+G C ++ EY G++ + L D + ++ L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
A ARG+EYL + I+RDL N+L+ K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE T +SDV+SFG+++ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 41/275 (14%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHH 90
++ L+G G +G VY+G + VA+K ++ + + V EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQ 58
Query: 91 ---PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
PN+ G G + ++ EY GSV + +K + R + A
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA----- 113
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
L+Y+H K VI+RD+K +NIL+ + KL DFG+A L + N+ + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 208 APEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266
APE G+ K+D++S G+ + E+ +G A L+ ++P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--------- 219
Query: 267 LIADPELQGQYPPRGFYQALA-VAAMCVHEQPDMR 300
P L+ G+ + L A C+ E+P R
Sbjct: 220 ----PRLED----NGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG+G FG+VYK + A K +D + +++VE+ +L+ HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ ++ E+ G+V+ + +L ++PL + L YLH+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEY-----AK 213
RDLK NIL KL+DFG++ NT R +GT + APE +K
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 214 TGQLTLKSDVYSFGVVLLEI 233
K+DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLV 94
++G GGFG VY + A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHD 153
+ D+ + + M G + HL + + M+ AA GLE++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAP 209
+ V+YRDLK +NILLD H ++SD GLA K P H S +GT+GY AP
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAP 164
Query: 210 EYAKTGQLTLKS-DVYSFGVVLLEILSG 236
E + G S D +S G +L ++L G
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 42 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPN 92
LGEG FG+V ++++ VA+K L + + + + + E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHL---------HDLSPGKKP---LDWNTRMKI 140
++NL+G C ++ EY G++ ++L + +P + P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
A ARG+EYL K I+RDL N+L+ K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 201 MGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
T G + APE T +SDV+SFGV+L EI +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----REFLVEVLMLSLLHHPNLVNL 96
L+G+GG G VY Y ++ VA+K++ R + N + FL E + + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 97 IGYCADGDQRLLVYEYMP------LGSVEDHLHDLSPGKKPLDWNTRMK----IAAGAAR 146
C+DGD VY MP L S+ + K L T + I
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL----------------GPV 190
+EY+H K V++RDLK NILL + D+G A
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ + +++GT Y APE + +D+Y+ GV+L ++L+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLV 94
++G GGFG VY + A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+ D+ + + M G + HL H + K+ + T + + GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCA 208
++ V+YRDLK +NILLD H ++SD GLA K P H S +GT+GY A
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMA 163
Query: 209 PEYAKTGQLTLKS-DVYSFGVVLLEILSG 236
PE + G S D +S G +L ++L G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-15
Identities = 77/283 (27%), Positives = 115/283 (40%), Gaps = 32/283 (11%)
Query: 41 LLGEGGFGRVYKGYLESIN---QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVN 95
+LG+G FG V + L+S + Q VA+K L D EFL E + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 96 LIGYC--ADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARG 147
LIG + RL ++ +M G + L G++P L T ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
+EYL K I+RDL N +L+ ++DFGL+K GD +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267
A E T SDV++FGV + EI++ + T A E S + + L
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQ---TPYAGVENSEI-----------YNYL 228
Query: 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
I L + PP + C +P RP + L
Sbjct: 229 IKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-15
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVN- 95
++GEG FGR + +Q A+K++ + V+ +R+ E ++L+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 96 ------------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
++ YC GD + ++ L P L W +M +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDTILQWFVQMCL--- 111
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVM 201
G++++H+K V++RD+K NI L + KL DFG A+L P + T V
Sbjct: 112 ---GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV- 161
Query: 202 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 233
GT Y PE + KSD++S G +L E+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-15
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLD------RNGVQGNREFLVEVLMLSLLHHPNLVN 95
LG+GGFG V + + + A K+L+ R G +G +VE +L+ +H +V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVHSRFIVS 57
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
L LV M G + H++++ A GLE+LH +
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
+IYRDLK N+LLD + ++SD GLA + D + GT G+ APE +
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 216 QLTLKSDVYSFGVVLLEILSGR 237
+ D ++ GV L E+++ R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-15
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 93
NF+ LGEG + VYKG + + VA+K++ + +G + E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L ++ +LV+EYM ++ ++ D + LD NT +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
V++RDLK N+L+++ KL+DFGLA+ + NT + V T Y AP+
Sbjct: 119 NR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPD-VL 172
Query: 214 TGQLTLKS--DVYSFGVVLLEILSGR 237
G T + D++S G ++ E+++GR
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 42/213 (19%)
Query: 44 EGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREF----LVEVLMLSLLHHPNLVNL- 96
EG +G VY+ + + VA+K+L ++ +G F L E+ +L L HPN+V +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEK-EG---FPITSLREINILLKLQHPNIVTVK 70
Query: 97 -IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA---------- 145
+ ++ D+ +V EY+ HDL K ++ MK +
Sbjct: 71 EVVVGSNLDKIYMVMEYVE--------HDL---KSLME---TMKQPFLQSEVKCLMLQLL 116
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
G+ +LHD +++RDLK SN+LL+ K+ DFGLA+ G T+++ T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 206 YCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE + + D++S G + E+L+ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 100
+LG+G +G VY S +AIK++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGK-KPLDWNTRMKIAAGAA--RGLEYLHDKAKP 157
++ + E +P GS L L K PL N + I GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGS----LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-- 128
Query: 158 PVIYRDLKCSNILLDRGYHP--KLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
+++RD+K N+L++ Y K+SDFG LA + P + GT Y APE
Sbjct: 129 -IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTET------FTGTLQYMAPEV 180
Query: 212 AKTGQ--LTLKSDVYSFGVVLLEILSGR 237
G +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YC 100
LG+G FG+VYK + A K ++ + +++VE+ +L+ +HP +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
DG +++ E+ P G+V+ + +L G I L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSMK---II 132
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYA----- 212
+RDLK N+LL KL+DFG++ N R +GT + APE
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 213 KTGQLTLKSDVYSFGVVLLEI 233
K K+D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 42 LGEGGFGRVYKG-------YLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
LG+G F +++KG Y E +V +K LD++ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
G C GD+ ++V EY+ GS++ +L + + W ++++A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYA 212
+ + ++ N+LL R K + KL G + V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 213 KTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271
+ Q L+L +D +SFG L EI SG D +A + + L RH
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG---GDKPLSALDS-----QKKLQFYEDRH------ 222
Query: 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
Q P + + + C+ +PD RP
Sbjct: 223 ----QLPAPKWTELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 73/230 (31%), Positives = 105/230 (45%), Gaps = 68/230 (29%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL-D--RNGVQGNREFLVEVLMLS-LLHHPNLVNLI 97
LG+G +G V+K + VA+K++ D RN R F E++ L L HPN+V L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 98 G-YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA----------- 144
A+ D+ + LV+EYM E LH + I A
Sbjct: 74 NVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANILEDVHKRYIMY 114
Query: 145 --ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNT------- 194
+ L+Y+H VI+RDLK SNILL+ KL+DFGLA+ L + +N
Sbjct: 115 QLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 237
+V+TR Y APE + L S Y+ GV +L E+L G+
Sbjct: 172 YVATR-----WYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
+G G +G V + + VAIK++ + + R L E+ +L L H N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHENIIGL 64
Query: 97 IGYCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGAARGLEY 150
+ +V E M E LH + +PL + ++ RGL+Y
Sbjct: 65 LDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQILRGLKY 118
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY----GY 206
LH A VI+RDLK SNIL++ K+ DFGLA+ D + Y Y
Sbjct: 119 LH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWY 172
Query: 207 CAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE Y T D++S G + E+L+ +
Sbjct: 173 RAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL---VEVLMLSLLHHPNLVN 95
+G G FG V K + +A+K++ + ++ L ++V+M S P +V
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVK 67
Query: 96 LIGYC-ADGDQRLLVYEYMPLGSVED-----HLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
G +GD + E M + S++ + K + KIA + L
Sbjct: 68 FYGALFREGDC-WICMELMDI-SLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALN 121
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCA 208
YL ++ K +I+RD+K SNILLDR + KL DFG++ +L ++ TR G Y A
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMA 175
Query: 209 PEYAKTGQLT---LKSDVYSFGVVLLEILSGR 237
PE ++SDV+S G+ L E+ +G+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 41 LLGEGGFGRVY---KGYLESINQDVAIKQL--------DRNGVQGNREFLVEVLMLSLLH 89
+LG+G FG+V+ K Q A+K L DR + R+ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 147
HP +V L Y + +L L+ +++ G + L K+ + +K A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALA 110
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
L++LH +IYRDLK NILLD H KL+DFGL+K + S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSG 236
APE T +D +SFGV++ E+L+G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+GEG +G VYKG + Q VA+K++ + GV + E+ +L L HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
+ L++E++ + ++ +L D P + +D +G+ + H +
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
V++RDLK N+L+D KL+DFGLA+ G V T + T Y APE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 218 -TLKSDVYSFGVVLLEILSGR 237
+ D++S G + E+ + +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
HP LV L C + RL V E++ G + H+ +K + + R +A + L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQR---QRKLPEEHARF-YSAEISLAL 109
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 206
+LH++ +IYRDLK N+LLD H KL+D+G+ K + P GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT---STFCGTPNY 162
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
APE + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 64/200 (32%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVE-VLMLSLLHHPNLVNLI 97
+G+G FG+V ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 156
D+ V +Y+ G + HL +P R + AA A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN- 116
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
+IYRDLK NILLD H L+DFGL K G T ++ GT Y APE +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 217 LTLKSDVYSFGVVLLEILSG 236
D + G VL E+L G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 49/237 (20%)
Query: 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREF----LVEVL 83
+++ LGEG FG VYK + VA+K++ +++G F L E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------FPITALREIK 59
Query: 84 MLSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 138
+L L HPN+V LI + +R VY P HDLS L N +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDLSG----LLENPSV 110
Query: 139 KIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--- 187
K+ + G+ YLH+ +++RD+K +NIL+D K++DFGLA+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 188 ------GPVGDNTHVSTRVMGTYGYCAPEY-AKTGQLTLKSDVYSFGVVLLEILSGR 237
G G T T ++ T Y PE + T D++ G V E+ + R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 72/238 (30%), Positives = 94/238 (39%), Gaps = 43/238 (18%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL----MLSLLH 89
K+F+ LLG+G GRV+ L+ + A+K LD+ + R + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLD 59
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAAR 146
HP L L LV +Y P G L L PGK + R AA
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGE----LFRLLQRQPGKCLSEEVARF-YAAEVLL 114
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---------- 196
LEYLH ++YRDLK NILL H LSDF L+K V
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 197 --------------STRVM---GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
S R GT Y APE D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 37/217 (17%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVA-------IKQLDRNGVQGNREFLVEVLMLSL 87
+F LG G G V K +A IK RN Q RE L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 88 LHHPNLVNLIGY----CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
LH N ++G+ +DG+ + + E+M GS++ L G+ P + ++ IA
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPENILGKISIAV- 108
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRV 200
RGL YL +K K +++RD+K SNIL++ KL DFG++ G + D N+ V TR
Sbjct: 109 -LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVGTR- 162
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y +PE + T++SD++S G+ L+E+ GR
Sbjct: 163 ----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 54/155 (34%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
+P LV L C RL LV EY+ G + H+ ++ L AA L
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIAL 109
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 206
+LH++ +IYRDLK N+LLD H KL+D+G+ K LGP GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNY 162
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
APE + + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 97
LLG+G FG+V ++ + A+K L + + E L E +L HP L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
D+ V EY+ G + HL S + + TR A L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRF-YGAEIVSALDYLHSGK-- 115
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
++YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 218 TLKSDVYSFGVVLLEILSGR 237
D + GVV+ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHPNLVNL 96
++G G + +V L+ + A+K + + V + + + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 97 IGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
C + RL V EY+ G + H+ ++ L +A + L YLH++
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG 116
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGYCAPEYAKT 214
+IYRDLK N+LLD H KL+D+G+ K G GD T + GT Y APE +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG 170
Query: 215 GQLTLKSDVYSFGVVLLEILSGRKAVD 241
D ++ GV++ E+++GR D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 97
LLG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 156
D+ V EY G + HL ++ + R + A L+YLH ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLH--SE 114
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 217 LTLKSDVYSFGVVLLEILSGR 237
D + GVV+ E++ GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+GEG G V + + VA+K++D Q EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKA 155
GD+ +V E++ G++ D + +TRM + R L YLH++
Sbjct: 90 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIATVCLSVLRALSYLHNQG 138
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRL 193
Query: 216 QLTLKSDVYSFGVVLLEILSG 236
+ D++S G++++E++ G
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 97
LLG+G FG+V ++ + A+K L + + E + E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 156
D+ V EY G + HL ++ + R + A LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
V+YRD+K N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 217 LTLKSDVYSFGVVLLEILSGR 237
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 92
+++ S +G G +G+V + + VAIK+L R + + R + E+ +L + H N
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHEN 75
Query: 93 LVNLIG-YCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
++ L+ + VY L + L+++ +K D + + + RGL+
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGAD--LNNIVKCQKLSDDHIQF-LVYQILRGLK 132
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
Y+H +I+RDLK SNI ++ K+ DFGLA+ +V+TR Y AP
Sbjct: 133 YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 184
Query: 210 E-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
E Y +T D++S G ++ E+L+G+
Sbjct: 185 EIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-13
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPNLVNLIG 98
+G G +G VYK + + AIK + ++ +F V E++M+ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
D+ + E+ GS++D H P L + ++ +GL YLH K K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---KTG 215
++RD+K +NILL H KL+DFG++ + +GT + APE A + G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 216 QLTLKSDVYSFGVVLLEI 233
D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 99
+GEG FG+ + + IK+++ + + E EV +LS + HPN+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
+ +V +Y G + ++ L P + LDW ++ +A L+++HD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK 121
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
+++RD+K NI L + KL DFG+A++ + ++ +GT Y +PE +
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 216 QLTLKSDVYSFGVVLLEILSGRKA 239
KSD+++ G VL E+ + + A
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 64/213 (30%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLV 94
F L+G G +G+VYKG Q AIK +D G + E E+ ML HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 95 NLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
G DQ LV E+ GSV D + + +W I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
+LH VI+RD+K N+LL KL DFG++ + +GT + A
Sbjct: 125 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMA 179
Query: 209 PEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 236
PE + KSD++S G+ +E+ G
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 59/235 (25%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLD----RNGVQGNREF----------LVEVLMLSL 87
LGEG +G+V K Y + VAIK++ N V +R+ L E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IA 141
+ H N++ L+ +GD LV + M DL KK +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDL---KKVVDRKIRLTESQVKCIL 125
Query: 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-------LGPVGDNT 194
GL LH K ++RDL +NI ++ K++DFGLA+ + +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 195 HVSTRVMGTYG-----YCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 237
+ R T Y APE L + + D++S G + E+L+G+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPE------LLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 41 LLGEGGFGRVYKGYLESINQD-VAIKQLD-RNGVQGN---------REFLVEVLML-SLL 88
LG G FG VYK ++ Q+ +A+K+++ N G + + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD----WNTRMKIAAGA 144
HPN+V + D+ +V + + + +H + L K+ WN +++
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
L YLH + + +++RDL +NI+L ++DFGLAK + + T V+GT
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTI 177
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEI 233
Y PE K K+DV++FG +L ++
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 42 LGEGGFGRVYKGYLES--INQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIG 98
+G G FG+V G + S V +K+L + VQ +FL E L H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
C + LLV E+ PLG ++ +L ++P D T ++A A GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-----DPTTLQRMACEIALGLLHLH 117
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
K I+ DL N LL K+ D+GL+ D ++ + APE
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 213 KT--GQL-----TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265
G L T +S+V+S GV + E+ + +++ ++ + R +
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLT-----YTVREQQ 227
Query: 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312
+ P L+ R +Y+ + + QP+ RP +V L+Y
Sbjct: 228 LKLPKPRLKLPLSDR-WYEVMQFCWL----QPEQRPSAEEVHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
+G G FG V + Q+VAIK++ + V R + E+ +L L H N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 99 -YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
+ + + V E + LH L + PL+ RGL+Y+H
Sbjct: 77 IFISPLEDIYFVTELL-----GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG-- 128
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ- 216
V++RDLK SNIL++ K+ DFGLA++ +VSTR Y APE T Q
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQK 182
Query: 217 LTLKSDVYSFGVVLLEILSGR 237
++ D++S G + E+L G+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 96
++G+G FG+V +S A+K L + + +E + E ++L L HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 155
++ V +Y+ G + HL +P R + AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN 116
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
+IYRDLK NILLD H L+DFGL K G + T ++ GT Y APE +
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 216 QLTLKSDVYSFGVVLLEILSG 236
D + G VL E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD---------RNGVQGNREFLVEVLM 84
+++ S +GEG +G V + VAIK++ R L E+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT--------LREIKI 56
Query: 85 LSLLHHPNLVNL------IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 138
L H N++ + + + D +V E M E L+ L + + + +
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLYKLIKTQHLSNDHIQY 110
Query: 139 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVS 197
+ RGL+Y+H V++RDLK SN+LL+ K+ DFGLA++ P D+T
Sbjct: 111 FLYQ-ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 237
T + T Y APE + K+ D++S G +L E+LS R
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 63/200 (31%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 97
LLG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
D+ V EY G + HL + R A L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIVSALGYLHSCD-- 115
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 218 TLKSDVYSFGVVLLEILSGR 237
D + GVV+ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 96
++G+G FG+V + + A+K L + V +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 155
++ V +++ G + HL +P R + AA A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSIN 116
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
++YRDLK NILLD H L+DFGL K G +T +T GT Y APE +
Sbjct: 117 ---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQ 171
Query: 216 QLTLKSDVYSFGVVLLEILSG 236
D + G VL E+L G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLH---HPNL 93
+G G +G VYK VA+K + VQ N + L EV +L L HPN+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 94 VNLIGYCADG--DQRL---LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
V L+ CA D+ LV+E++ + +L + P P + T + RGL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGL 121
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYC 207
++LH +++RDLK NIL+ G KL+DFGLA++ + ++ T V+ T Y
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYR 174
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249
APE D++S G + E+ RK + + A+Q
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 45/229 (19%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD------RNGVQGNREFLVEVLMLSLL 88
+F + L+ G +G VY + Q A+K+++ RN +Q + VE +L+
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQ---QVFVERDILTFA 58
Query: 89 HHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 146
+P +V++ +C+ +R L V EY+ G L ++ P+D RM A
Sbjct: 59 ENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDM-ARMYFAE-TVL 112
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-------STR 199
LEYLH+ +++RDLK N+L+ H KL+DFGL+K+G + T++ TR
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 200 ------VMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 236
V GT Y APE Y K D ++ G++L E L G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 46/204 (22%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL- 96
+GEG +G VYK + + VA+K++ + GV + E+ +L L+HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 97 -IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKK-----PLDWNTRMKIAA---GAAR 146
+ + + +L LV+E++ L DL KK PL I + +
Sbjct: 65 DVVHS---ENKLYLVFEFLDL--------DL---KKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG-PVGDNTHVSTRVMGTY 204
G+ Y H V++RDLK N+L+DR KL+DFGLA+ G PV TH V+ T
Sbjct: 111 GIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TL 163
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGV 228
Y APE + L S YS V
Sbjct: 164 WYRAPE------ILLGSRQYSTPV 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 68/236 (28%), Positives = 94/236 (39%), Gaps = 43/236 (18%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE----FLVEVLMLSLLH 89
+F ++G G FG V+ + Q A+K L R R E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADAD 59
Query: 90 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
P +V L Y + D+ L V EYMP G + + L P + R IA
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEET-ARFYIAELVL-A 113
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----------------LGPVG 191
L+ +H I+RD+K NIL+D H KL+DFGL K
Sbjct: 114 LDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 192 DNTHVSTR-----------VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
DN V R +GT Y APE + L+ D +S GV+L E+L G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGN--REFLVEVLMLSLL 88
K+ + E +LG G FG + +G L+ ++ VAI L R G R FL E L L
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQF 63
Query: 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HD--LSPGKKPLDWNTRMKIAAGA 144
H N+V L G G+ ++V EYM G+++ L H+ L G+ M + G
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ-------LMGMLPGL 116
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
A G++YL + +++ L +L++ K+S F + + T + G
Sbjct: 117 ASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS 170
Query: 205 G--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE + + SDV+SFG+V+ E++S
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+GEG G V ++S + VA+K++D Q EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKA 155
GD+ +V E++ G++ D + +TRM + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 216 QLTLKSDVYSFGVVLLEILSG 236
+ D++S G++++E++ G
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQ----LDRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
LG+G +G VYK +A+K+ LD + + ++E+ +L P +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFY 65
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
G + EYM GS+ D L+ + + + +I +GL++L ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKTG 215
+I+RD+K +N+L++ KL DFG V N ++ +G Y APE K+G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 216 QL------TLKSDVYSFGVVLLEILSGR 237
T++SDV+S G+ +LE+ GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---------GNREFLVEVLMLSLLHHPN 92
+G+G FG+VY+ + + A+K L + + G R LV L+ P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE---SPF 57
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V L LV +YM G + HL G+ D + IA LE+LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGRFSED-RAKFYIAE-LVLALEHLH 113
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-Y 211
K ++YRDLK NILLD H L DFGL+K + T + GT Y APE
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVL 168
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSG 236
T D +S GV++ E+ G
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
L++LH + +IYRD+K NILLD H L+DFGL+K + + + GT Y
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173
Query: 208 APEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253
APE + G D +S GV+ E+L+G QS ++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHH 90
NF+ +GEG +G VYK + + VA+K++ + GV + E+ +L L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNH 58
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR---- 146
PN+V L+ ++ LV+E++ DL KK +D + I +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH--------QDL---KKFMDASPLSGIPLPLIKSYLF 107
Query: 147 ----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG-PVGDNTHVSTRV 200
GL + H V++RDLK N+L++ KL+DFGLA+ G PV TH V
Sbjct: 108 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EV 161
Query: 201 MGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAV 240
+ T Y APE + D++S G + E+++ R+A+
Sbjct: 162 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 74/236 (31%), Positives = 106/236 (44%), Gaps = 29/236 (12%)
Query: 18 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
+ L L T + +G+G +G+VYK + A+K LD + E
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEE 64
Query: 78 FLVEVLML-SLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKP 131
E +L SL +HPN+V G Y AD G Q LV E GSV + + L +
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 132 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPV 190
LD I GA GL++LH+ +I+RD+K +NILL KL DFG+ A+L
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL--- 178
Query: 191 GDNTHVSTRV-----MGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 236
STR+ +GT + APE Q + DV+S G+ +E+ G
Sbjct: 179 -----TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 75/260 (28%), Positives = 112/260 (43%), Gaps = 28/260 (10%)
Query: 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 83
+L ++F ++G G FG V +S Q A+K L + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 84 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 141
+++ + +V L + A D + L V EYMP G D ++ +S P W R A
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKW-ARFYTA 149
Query: 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRV 200
L+ +H I+RD+K N+LLD+ H KL+DFG K+ G T V
Sbjct: 150 E-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV 204
Query: 201 MGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 256
GT Y +PE K+ G + D +S GV L E+L G DT A SLV
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYA--DSLVGTYS 257
Query: 257 PLFQDRTRHSLIADPELQGQ 276
+ + + D E+ Q
Sbjct: 258 KIMDHKNSLTFPDDIEISKQ 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLI 97
+GEG F V K + AIK + ++ Q N L E+ + L HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 98 GYCADGDQ-RL-LVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDK 154
D RL LV+E M + +L++L G+K PL + L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH------VSTRVMGTYGYCA 208
+ +RD+K NIL+ KL+DFG + G + +STR Y A
Sbjct: 120 G---IFHRDIKPENILIK-DDILKLADFGSCR----GIYSKPPYTEYISTR-----WYRA 166
Query: 209 PEYAKT-GQLTLKSDVYSFGVVLLEILS 235
PE T G K D+++ G V EILS
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLV 94
F ++G G +G+VYKG Q AIK +D + E +E+ ML HH N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 95 NLIGY------CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
G DQ LV E+ GSV D + + DW I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 205
+LH VI+RD+K N+LL KL DFG+ A+L D T V R +GT
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPY 186
Query: 206 YCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 236
+ APE + +SD++S G+ +E+ G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVN---- 95
+G G +G V + VAIK++ + + L E+ +L H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
L AD +V + M E LH + +PL RGL+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN 127
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYA 212
VI+RDLK SN+L++ ++ DFG+A+ P ++ + T + T Y APE
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVATRWYRAPELL 183
Query: 213 KT-GQLTLKSDVYSFGVVLLEILSGRKAV 240
+ + T D++S G + E+L GR+ +
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDV-AIKQLDRNGVQGNRE---FLVEVLMLSLLH 89
K+F +SL+G G FG V + E D+ A+K + ++ + F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
P + L D D LV EY P G D L L+ + D + A +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCA 208
+H ++RD+K N+L+DR H KL+DFG A+L + S +GT Y A
Sbjct: 117 SVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIA 171
Query: 209 PEYAKT------GQLTLKSDVYSFGVVLLEILSGR 237
PE T G ++ D +S GV+ E++ GR
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 34/211 (16%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL- 96
+GEG +G VYK N+ +A+K++ + GV + E+ +L + H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRLQ 67
Query: 97 -IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG----AARGLEY 150
+ + ++RL LV+EY+ L ++ H+ D SP D+ ++ RG+ Y
Sbjct: 68 DVVHS---EKRLYLVFEYLDL-DLKKHM-DSSP-----DFAKNPRLIKTYLYQILRGIAY 117
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYC 207
H V++RDLK N+L+DR + KL+DFGLA+ G PV TH T Y
Sbjct: 118 CHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYR 170
Query: 208 APE-YAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE + + D++S G + E+++ +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 96
++G+G FG+V ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 155
D+ V +Y+ G + HL +P R + AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN 116
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
++YRDLK NILLD H L+DFGL K + N ST GT Y APE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FCGTPEYLAPEVLHKQ 171
Query: 216 QLTLKSDVYSFGVVLLEILSG 236
D + G VL E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 40 SLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNRE----FLVEVLMLSLLHHPN 92
+LG+GG+G+V+ K + A+K L + + N++ E +L + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V+LI G + L+ EY+ G + HL + +T + + LE+LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLH 117
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEY 211
+ +IYRDLK NILLD H KL+DFGL K TH GT Y APE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSG 236
D +S G ++ ++L+G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 61/193 (31%), Positives = 88/193 (45%), Gaps = 43/193 (22%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQ-LDRNGVQGNREF----LVEVLMLSLLHHPNLVNL 96
+G+G FG V+K + Q VA+K+ L N +G F L E+ +L LL H N+VNL
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNL 76
Query: 97 IGYC---ADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-- 146
I C A R LV+E+ HDL+ L N +K +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCE--------HDLAG----LLSNKNVKFTLSEIKKV 124
Query: 147 ------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---LGPVGDNTHVS 197
GL Y+H +++RD+K +NIL+ + KL+DFGLA+ L +
Sbjct: 125 MKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 198 TRVMGTYGYCAPE 210
RV+ T Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFL-VEVLMLSLLHHPNLVN---- 95
+G+G +G V + + IK+L+ RN + R+ E +LS L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 96 ----------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
++G+C GD +Y +++ L P + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
L+YLH+K +++RDLK N+ L R K+ D G+A++ + + +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 239
Y +PE KSDV++ G + E+ + + A
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIK--QLDRNGVQGNREFLVEVLMLSLLHHP 91
++ + + +LG G G VYK Y + +A+K LD V+ ++ + E+ +L P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSP 59
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
++ G ++ + E+M GS++ + K P R IA +GL YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGR--IAVAVVKGLTYL 111
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
+++RD+K SN+L++ KL DFG++ ++ +GT Y APE
Sbjct: 112 WSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPER 164
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGR 237
Q + SDV+S G+ +E+ GR
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 35/250 (14%)
Query: 10 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 69
A ED +++ + + K+++ +++G G FG VY+ ++ VAIK++ +
Sbjct: 46 AGEDEDEEKMIDNDIN----RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 70 NGVQGNREFLVEVLMLSLLHHPNLVNLIGY----CADGDQRLL----VYEYMPLGSVEDH 121
+ NRE L+ + L+H N++ L Y C +++ + V E++P +V +
Sbjct: 102 DPQYKNRELLI----MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKY 156
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLS 180
+ + L + R L Y+H K + +RDLK N+L+D H KL
Sbjct: 157 MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213
Query: 181 DFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLE----- 232
DFG AK L +++ +R Y APE T D++S G ++ E
Sbjct: 214 DFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268
Query: 233 -ILSGRKAVD 241
I SG+ +VD
Sbjct: 269 PIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 42 LGEGGFGRVY--------KGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPN 92
LG+G FG VY + +++ + +L+ N VQ N E +LS L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V + D ++ EY ++ L +L K L N + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ +++RDLK NI L + K+ DFG+++L + + ++T GT Y +PE
Sbjct: 124 QRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 213 KTGQLTLKSDVYSFGVVLLEI 233
K KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 42 LGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREFL-------VEVL-MLSLLHHPN 92
+GEG +G+V+K L++ + VA+K R VQ E + V VL L HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 93 LVNLIGYCA----DGDQRL-LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
+V L C D + +L LV+E++ L + D + + PG T +
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPT---ETIKDMMFQLL 120
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
RGL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE D++S G + E+ +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 64/237 (27%)
Query: 36 FRSESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGN-------REFLVEVLMLS 86
+ E +G G +GRVYK + ++ AIK+ + Q RE + +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLR 57
Query: 87 LLHHPNLVNLIGYC-ADGDQRL-LVYEYMPLGSVEDHLHDL--------SPGKKPLDWNT 136
L H N+V+L+ D+ + L+++Y HDL + + +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIPPSM 109
Query: 137 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAKL---- 187
+ G+ YLH V++RDLK +NIL+ +RG K+ D GLA+L
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG-VVKIGDLGLARLFNAP 165
Query: 188 --GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILS 235
+ V+ T Y APE L L + D+++ G + E+L+
Sbjct: 166 LKPLADLD-----PVVVTIWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREF---LVEV 82
R+ ++F LG G FGRV ++ + VAIK+ +++ + ++ E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 83 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 142
+L+ ++HP VNL G D LV E++ G L K + AA
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAA 138
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--- 199
EYL ++YRDLK N+LLD+ K++DFG AK+ V TR
Sbjct: 139 QIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYT 187
Query: 200 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
+ GT Y APE +D ++ G+ + EIL G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 49 RVYKGYLESINQDVAIKQL--DRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105
+YKG N++V I+ G + E+ L + N++ + G+ D
Sbjct: 35 SIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 106 RL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
L L+ EY G + + L +K L + T++ +A +GL L+ P Y
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 221
++L + L+ Y K+ GL K+ +V+ V +Y +++ T+K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSE---YTIKD 203
Query: 222 DVYSFGVVLLEILSGR 237
D+YS GVVL EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHH 90
K+F+ + +G+GG+G+V+ + + VA+K++ ++ + R L E +L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN------TRMKIAAGA 144
LV L+ D + L EY+P G L++L L + M A A
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDA 116
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
L Y+H RDLK N L+D H KL+DFGL+K N+ V+G+
Sbjct: 117 LHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSP 162
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
Y APE + D +S G +L E L G
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-----REFLVEVLMLSLLHHPNLVNL 96
LGEG + VYKG + Q VA+K++ +G RE +L L H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIVTL 68
Query: 97 IGYCADGDQRLLVYEYM--PLGS-VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
LV+EY+ L ++D LS N R+ + RGL Y H
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAYCHQ 121
Query: 154 KAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP--- 209
+ V++RDLK N+L+ +RG KL+DFGLA+ V T+ + V T Y P
Sbjct: 122 RR---VLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVL 175
Query: 210 ----EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249
EY + L D++ G + E+ +GR S +Q
Sbjct: 176 LGSTEY--STSL----DMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 19/198 (9%)
Query: 85 LSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 140
L +LH N ++G+ +DG+ + + E+M GS++ L + K + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE----AKRIPEEILGKV 108
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
+ RGL YL +K + +++RD+K SNIL++ KL DFG++ G + D+ ++
Sbjct: 109 SIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF- 259
+GT Y +PE + +++SD++S G+ L+E+ GR + A +++ + RP+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGRPVVD 220
Query: 260 -QDRTRHSLIADPELQGQ 276
++ HS+ P G+
Sbjct: 221 GEEGEPHSISPRPRPPGR 238
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 29/235 (12%)
Query: 19 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR-NGVQGNRE 77
++ +T+ F + + +G+G +G+V+K + A+K LD + + E
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE 62
Query: 78 FLVEVLMLSLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
+L +L HPN+V G Y D GDQ LV E GSV D + K L
Sbjct: 63 AEYNILK-ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV------KGFL 115
Query: 133 DWNTRMK------IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186
RM+ I A GL++LH I+RD+K +NILL KL DFG++
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS- 171
Query: 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 236
+ +GT + APE Q + DV+S G+ +E+ G
Sbjct: 172 -AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 87/343 (25%), Positives = 142/343 (41%), Gaps = 68/343 (19%)
Query: 35 NFRSESLLGEGGFGRVY-----------KGYLESINQDVAIKQLDRNGVQGNREFLVEVL 83
NF +LG G +G+V+ K Y + Q A+ Q + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTE------ 54
Query: 84 MLSLLHH----PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 138
++L H P LV L Y + +L L+ +Y+ G + HL+ + +
Sbjct: 55 -RNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEV 107
Query: 139 KIAAGAA-RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTH 195
+ +G LE+LH K ++YRD+K NILLD H L+DFGL+K L + T+
Sbjct: 108 RFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 196 VSTRVMGTYGYCAPEY--AKTGQLTLKSDVYSFGVVLLEILSG------------RKAVD 241
GT Y APE K G D +S G+++ E+L+G + V
Sbjct: 165 ---SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG--------FYQALAVAAMCV 293
+ ++ P QD L DP+ + P+G F++ L A+ +
Sbjct: 221 RRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL 280
Query: 294 HE-QPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTP 335
+ P RP I + + + ++++ ++ E V SP GTP
Sbjct: 281 RKVNPPFRPSIRNELDVGNF--AEEF-TNLEPVYSP---AGTP 317
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYC 100
LGEG + VYKG Q VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 101 ADGDQRLLVYEYMPLGSVE---DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
+ V+EYM + H L P +N R+ + RGL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRLFMFQ-LLRGLAYIHGQH-- 123
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
+++RDLK N+L+ KL+DFGLA+ + T+ S V T Y P+ G
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 218 TLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254
S D++ G + +E+L G+ A EQ W
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
+GEG G V + + VA+K +D Q RE L EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
G++ ++ E++ G++ D + L+ + + L YLH + VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 220
+RD+K +ILL KLSDFG + + ++GT + APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 221 SDVYSFGVVLLEILSG 236
D++S G++++E++ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 98
+G+G FG+V + + A+K + + + E L E +L+ ++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKP 157
++ LV ++ G + HL G+ L +R + A LE LH K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ--REGRFDL---SRARFYTAELLCALENLH---KF 112
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
VIYRDLK NILLD H L DFGL KL D+ + GT Y APE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 218 TLKSDVYSFGVVLLEILSG 236
T D ++ GV+L E+L+G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 49/157 (31%), Positives = 88/157 (56%), Gaps = 15/157 (9%)
Query: 85 LSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 140
L +LH N ++G+ +DG+ + + E+M GS++ L G+ P ++ I
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPEQILGKVSI 110
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
A +GL YL +K K +++RD+K SNIL++ KL DFG++ G + D+ ++
Sbjct: 111 AV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+GT Y +PE + +++SD++S G+ L+E+ GR
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 83
R+L +++ ++G G FG V +S + A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 84 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 141
+++ + P +V L +CA D + L V EYMP G D ++ +S P W
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWAKFY--T 148
Query: 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRV 200
A L+ +H +I+RD+K N+LLD+ H KL+DFG K+ G T V
Sbjct: 149 AEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV 204
Query: 201 MGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 236
GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 100
LGEG + V+KG + VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
LV+EY+ ++ ++ D G N ++ + RGL Y H + V+
Sbjct: 74 HTDKSLTLVFEYLD-KDLKQYMDDC--GNIMSMHNVKIFLYQ-ILRGLAYCH---RRKVL 126
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 219
+RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 220 KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
+ D++ G + E+ SGR S E L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNL 93
++ + ++G+G +G V + VAIK+++ V L E+ +L LL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 94 VNLIGYCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
V + +R +V+E M E LH + L R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYC 207
+Y+H V +RDLK NIL + K+ DFGLA++ T + T + T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 208 APEYAKT--GQLTLKSDVYSFGVVLLEILSGR 237
APE + + T D++S G + E+L+G+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 68/265 (25%), Positives = 102/265 (38%), Gaps = 70/265 (26%)
Query: 37 RSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGN--REFLVEV-LMLSLL 88
+ LG G FG+V + I + VA+K L + G + + + E+ +++ +
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIG 68
Query: 89 HHPNLVNLIGYCADGDQRLLV-YEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAG 143
HH N+VNL+G C L+V EY G++ ++L SP + MK G
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEG 128
Query: 144 AARGL--------------------------EYLHDKAKPPV------------------ 159
+ L E + K P+
Sbjct: 129 KKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188
Query: 160 ------IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPE 210
I+RDL NILL K+ DFGLA+ D +V R+ + APE
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPE 245
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILS 235
T +SDV+SFGV+L EI S
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 83
R+L +++ ++G G FG V +S + A+K L + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 84 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-PGKKPLDWNTRMKIAA 142
+++ + P +V L D +V EYMP G + + + + P K + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG----LAKLGPVGDNTHVST 198
A + ++H RD+K N+LLD+ H KL+DFG + K G V +T V
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 199 RVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 236
GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGY 99
+G G +G VYK + A+K + G+ L+ E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLEYLHDKAK 156
++ + EY GS++D H P + ++IA +GL YLH K K
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---K 213
++RD+K +NILL KL+DFG+A + +GT + APE A K
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 214 TGQLTLKSDVYSFGVVLLEI 233
G D+++ G+ +E+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+GEG +G V+K ++ VA+K++ D GV + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 149
+ LV+EY DL KK D + I +GL
Sbjct: 66 DVLHSDKKLTLVFEYCD--------QDL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186
+ H V++RDLK N+L+++ KL+DFGLA+
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGL 148
PN+V L Y D LV ++ G + H+ P + W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYC 207
+ LH + ++ RDL +NILLD H +L+ F +++ D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267
APE + T D +S G +L E+L+G K + + + P + SL
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEARSL 208
Query: 268 I 268
+
Sbjct: 209 L 209
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 73/287 (25%), Positives = 114/287 (39%), Gaps = 48/287 (16%)
Query: 35 NFRSESLLGEGGFGRVY-----------KGYLESINQDVAIKQLDRNGVQGNREFLVEVL 83
NF +LG G +G+V+ K Y + + I Q + E V
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV--- 57
Query: 84 MLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 142
+ + P LV L Y D +L L+ +Y+ G + HL K+ ++I +
Sbjct: 58 LEHIRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYS 111
Query: 143 GA-ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 201
G LE+LH K +IYRD+K NILLD H L+DFGL+K D +
Sbjct: 112 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFC 167
Query: 202 GTYGYCAPEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW----- 254
GT Y AP+ + G D +S GV++ E+L+G Q+ ++
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227
Query: 255 -------ARPLFQDRTRHSLIADPELQGQYPPRG--------FYQAL 286
L +D + L+ DP+ + P F+Q +
Sbjct: 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 38/240 (15%)
Query: 10 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 69
+S AS + + EL + +G G G VYK + A+K +
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYALKVI-- 107
Query: 70 NGVQGNREFLV------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH 123
GN E V E+ +L ++HPN+V + ++ E+M GS+E
Sbjct: 108 ---YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE---- 160
Query: 124 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183
G D +A G+ YLH + +++RD+K SN+L++ + K++DFG
Sbjct: 161 ----GTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 184 LAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKT----GQLT-LKSDVYSFGVVLLEILSGR 237
+++ L D + S +GT Y +PE T G D++S GV +LE GR
Sbjct: 214 VSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH 89
A+ + L G GRV+ V +K G +G L+E ++L ++
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVN 115
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
HP+++ + G +V + D L+ +PL + + I GL
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYS----SDLYTYLTKRSRPLPIDQALIIEKQILEGLR 171
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YLH + +I+RD+K NI ++ + D G A+ PV + + GT AP
Sbjct: 172 YLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAP 225
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E + K+D++S G+VL E+L+
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 45 GGFGRVYKGYLESINQDVAIK------QLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
G FG+VY G ++ ++ A+K +++N V + E L+L P +V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLYY 71
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
+ LV EY+ G V+ LH D +K + A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRHG--- 124
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 187
+I+RDLK N+L+ H KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 100
LGEG + VYKG + + VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
LV+EY+ ++ +L D G N ++ + RGL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQ-LLRGLNYCHRRK---VL 126
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 219
+RDLK N+L++ KL+DFGLA+ + T+ + V T Y P+ + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 220 KSDVYSFGVVLLEILSGR 237
+ D++ G + E+ +GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 100
LGEG + V+KG + VA+K++ +G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 101 ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
LV+EY+ L D+ +L + + RGL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQL 217
+++RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 218 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252
+ D++ G +L E+ +GR S E L+
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 100
LGEG + VYKG + + VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
+ LV+EY+ + D PG + N ++ + RGL Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPE-NVKLFLFQ-LLRGLSYIHQRY---IL 125
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 219
+RDLK N+L+ KL+DFGLA+ V +T+ + V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 220 KSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249
D++ G + +E++ G A K +Q
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169
Y+ V++ L D G + L + ARG+E+L K ++RDL N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268
Query: 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 228
LL +G K+ DFGLA+ + D+ +VS + APE T SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 229 VLLEILS 235
+L EI S
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHP 91
F ++GEG +G V K + + VAIK+ + + N E L E+ ML L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQE 60
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N+V L + LV+EY+ +E L + P P + K+ + + ++ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAI 113
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H K +++RD+K N+L+ KL DFG A+ G N + T + T Y +PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGR 237
D++S G +L E+ G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
+G G +G V N+ VAIK++ N + R L E+ +L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 99 YCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
+ +VYE M + LH + + L + RGL+Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
V++RDLK SN+LL+ K+ DFGLA+ + T + T Y APE
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE--- 178
Query: 214 TGQLTLKS-------DVYSFGVVLLEILSGRK 238
L L DV+S G + E+L GRK
Sbjct: 179 ---LLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGY 99
+G G +G V Y + Q VA+K+L R + R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 100 ---CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
+ VY L + L+++ +K D + + I RGL+Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGAD--LNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSAG- 138
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------ 210
+I+RDLK SN+ ++ ++ DFGLA+ +V+TR Y APE
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWM 191
Query: 211 -YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y +T D++S G ++ E+L G+
Sbjct: 192 HYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 13/203 (6%)
Query: 42 LGEGGFGRVYKG--YLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIG 98
+G G FG+V Y ++ V +K+L N + EFL + +L HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
C + LLV+EY LG ++ +L ++ ++A A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK----- 213
++ DL N L K+ D+G+ D + APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 214 --TGQLTLKSDVYSFGVVLLEIL 234
T + T S+V++ GV L E+
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
RGL+YLH +++RD+K N+L++ K+ DFGLA++ ++ H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 206 YCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 237
Y APE G T D++S G + E+L R
Sbjct: 170 YRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 68/270 (25%), Positives = 103/270 (38%), Gaps = 61/270 (22%)
Query: 3 SSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVY----KGYLE-- 56
S L EA D A AQ + FR L G FG+++ + E
Sbjct: 118 SHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAH-FRVIDDLPAGAFGKIFICALRASTEEA 176
Query: 57 -------SINQDVA-----IKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104
S NQ I + + G + + E+L L L+H N++ +
Sbjct: 177 EARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI-------- 228
Query: 105 QRLLVYE---YMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
+ +L E YM + L+ +PL TR I +EY+HDK
Sbjct: 229 EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK 287
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLA----------KLGPVGDNTHVSTRVMGTYG 205
+I+RD+K NI L+ L DFG A G VG S ++ G
Sbjct: 288 ---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG 344
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
YC ++T D++S G++LL++LS
Sbjct: 345 YC--------EIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 69/262 (26%), Positives = 101/262 (38%), Gaps = 71/262 (27%)
Query: 41 LLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLH---HPN 92
+LG G FG+V + I++ VA+K L + L+ L + L+H H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI-LIHIGNHLN 72
Query: 93 LVNLIGYCADGDQRLLV-YEYMPLGSVEDHLH----------DLSPGKKPLDWNT----- 136
+VNL+G C + L+V E+ G++ + L + SP ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 137 -RMKIAAGAARGLEYLHDKAK-----PP-------------------------------- 158
+I AG A L + PP
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 159 --VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAK 213
I+RDL NILL K+ DFGLA+ D +V S R+ + APE
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIF 249
Query: 214 TGQLTLKSDVYSFGVVLLEILS 235
T +SDV+SFGV+L EI S
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 60/239 (25%), Positives = 90/239 (37%), Gaps = 29/239 (12%)
Query: 8 KEASEDGASDQITAQT----LTFRELAAATKNFRSE--SLLGEGGFGRVY--KGYLESIN 59
+A E+ S Q T A+ + S L G G V+ + +
Sbjct: 60 YDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQR 119
Query: 60 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 119
+ V +K V G + E+ +L + H ++NLI +V MP
Sbjct: 120 KKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MP----- 166
Query: 120 DHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176
+ DL PL + I L YLH + +I+RD+K NI LD +
Sbjct: 167 KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPEN 223
Query: 177 PKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 234
L DFG A KL +T GT +PE K+D++S G+VL E+
Sbjct: 224 AVLGDFGAACKLD-AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 90
K +++ +G G G V Y Q+VAIK+L R N R + VLM L++H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNH 74
Query: 91 PNLVNLIGYCADGDQRLL-----VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
N++ L+ Q+ L VY M L ++ +L + + LD +
Sbjct: 75 KNIIGLLN--VFTPQKSLEEFQDVYLVMEL--MDANLCQVI--QMDLDHERMSYLLYQML 128
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++ V+ Y
Sbjct: 129 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY- 182
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE D++S G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 37/113 (32%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 127 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186
PLD + ++ ++ A+G+++L K I+RD+ N+LL G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 187 LGPVGDNTHVSTRVMGT----YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ D+ +V V G + APE T++SDV+S+G++L EI S
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
A+G+ +L K I+RDL NILL G K+ DFGLA+ N V
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE T +SDV+S+G++L EI S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 42 LGEGGFGRVYKG-YLESINQD-VAIKQLDR--NGVQGNREFLVEV-LMLSLLHHPNLVNL 96
LG+G +G V E+ ++ VAIK++ + + L E+ L+ H N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 97 IGY-CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
+Y Y L +E LH + +PL GL+Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEEL--MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN 125
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---LGPVGDNTHVSTRVMGTYGYCAPEYA 212
V++RDLK N+L++ K+ DFGLA+ P G+N T + T Y APE
Sbjct: 126 ---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVATRWYRAPEIM 181
Query: 213 KTGQLTLKS-DVYSFGVVLLEILSGRKAV 240
+ Q K+ DV+S G +L E+L GRK V
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIK----QLDRNGVQGNREFLVEV-LMLSLLHHPNLVNL 96
+GEG +G+VYK ++ + VA+K ++D G+ L E+ L+ L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 97 IGY----CADGDQRL-LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
+ +G L LV+EY+ L D + PG +PL T +G+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPG-RPLPAKTIKSFMYQLLKGVA 124
Query: 150 YLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLG--PVGDNTHVSTRVMGTYGY 206
+ H K V++RDLK N+L+D+ K++D GL + PV TH + T Y
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 207 CAPEYAKTG-QLTLKSDVYSFGVVLLEILSG 236
APE + D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 30/83 (36%), Positives = 47/83 (56%)
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 218
+I+RD+K +NILL KL DFG +K+ + V GT Y APE + +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 219 LKSDVYSFGVVLLEILSGRKAVD 241
K+D++S GV+L E+L+ ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 45/221 (20%)
Query: 42 LGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 98
+G G +G VYK + ++D A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 66
Query: 99 YCADGDQRL-LVYEYMPLGSVEDHLHDL----------SPGKKPLDWNTRM--KIAAGAA 145
+ + D+++ L+++Y HDL KKP+ M +
Sbjct: 67 FLSHADRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTH 195
G+ YLH V++RDLK +NIL+ +RG K++D G A+ L P+ D
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD--- 171
Query: 196 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILS 235
V+ T+ Y APE + K+ D+++ G + E+L+
Sbjct: 172 -LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---------NGVQGNREFLV--EV 82
++F ++G G FG V L++ ++ A+K L++ + R+ LV +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 83 LMLSLLHHP-----NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 137
++ LH+ NL ++ Y GD L+ ++ ED L P +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAE 110
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
M IA + L Y+H RD+K NIL+D H +L+DFG + L + D T S
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 198 TRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSG 236
+ +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 37/154 (24%), Positives = 55/154 (35%), Gaps = 17/154 (11%)
Query: 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLV-N 95
S LL G RVY L + ++D +K +RE EV +L LL V
Sbjct: 2 SIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPK 57
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
++ L+ E++ G D + + A L LH
Sbjct: 58 VLASGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQ----------LAELLAKLHQLP 106
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189
+ + DL NIL+D G + D+ A GP
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 63/258 (24%), Positives = 97/258 (37%), Gaps = 78/258 (30%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---------VQGNREFLVEVLM 84
+F S ++G G FG V + A+K+L ++ V+ R+ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 85 LSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSV------EDHL-HDLSPGKKPLDWN 135
+P +V L Y + D + L+ EY+P G + +D +
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---------- 102
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--------- 186
TR IA ++ +H K I+RD+K N+LLD H KLSDFGL
Sbjct: 103 TRFYIAE-TILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158
Query: 187 --------LGPVGDNTHVSTR-------------------VMGTYGYCAPE-YAKTGQLT 218
L + +GT Y APE + +TG
Sbjct: 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YN 217
Query: 219 LKSDVYSFGVVLLEILSG 236
+ D +S GV++ E+L G
Sbjct: 218 KECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 90
+ + S +G G +G V + + VAIK+L R + + R + E+ +L + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQH 73
Query: 91 PNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGK-KPLDWNTRMKIAAG 143
N++ L+ D Q LV YM + H LS K + L +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM------- 126
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 127 -LCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 178
Query: 204 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE Y +T D++S G ++ E+L+G+
Sbjct: 179 -WYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 8e-07
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 27/230 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 90
K +++ +G G G V Y ++++VAIK+L R N R + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 91 PNLVNLIGYCADGDQRLL-----VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
N+++L+ Q+ L VY M L ++ +L + + LD +
Sbjct: 76 KNIISLLNVFTP--QKSLEEFQDVYLVMEL--MDANLCQVI--QMELDHERMSYLLYQML 129
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++ V+ Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY- 183
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS------GRKAVDTSKAAAEQ 249
Y APE D++S G ++ E++ GR +D EQ
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 92
+++ S +G G +G V + VA+K+L R + + R + E+ +L + H N
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 77
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVED-------------HLHDLSPGKKPLDWNTRMK 139
++ L+ + P S+E+ L+++ +K D + +
Sbjct: 78 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 140 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 199
I RGL+Y+H +I+RDLK SN+ ++ K+ DFGLA+ +V+TR
Sbjct: 126 IYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 200 VMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 237
Y APE D++S G ++ E+L+GR
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 59/190 (31%), Positives = 82/190 (43%), Gaps = 28/190 (14%)
Query: 129 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188
KK L + + A+G+E+L A I+RDL NILL K+ DFGLA+
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-D 228
Query: 189 PVGDNTHV---STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 244
D +V R+ + APE T++SDV+SFGV+L EI S G K
Sbjct: 229 IYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286
Query: 245 AAAEQSLVAWARPLFQ-DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303
E + R L + R R PE+ YQ + C H +P RP
Sbjct: 287 IDEE-----FCRRLKEGTRMRAPDYTTPEM---------YQTM---LDCWHGEPSQRPTF 329
Query: 304 ADVVTALAYL 313
+++V L L
Sbjct: 330 SELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 45/221 (20%)
Query: 42 LGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 98
+G G +G VYK + ++ A+KQ++ G+ + E+ +L L HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKV 66
Query: 99 YCADGDQRL-LVYEYMPLGSVEDHLHDL----------SPGKKPLDWNTRM--KIAAGAA 145
+ + D+++ L+++Y HDL KKP+ M +
Sbjct: 67 FLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTH 195
G+ YLH V++RDLK +NIL+ +RG K++D G A+ L P+ D
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD--- 171
Query: 196 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILS 235
V+ T+ Y APE + K+ D+++ G + E+L+
Sbjct: 172 -LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 90
K +++ +G G G V Y + ++VAIK+L R N R + E++++ ++H
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----------TRMK 139
N++ L+ + P S+E+ D+ + +D N RM
Sbjct: 83 KNIIGLLNV------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 140 -IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198
+ G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
V+ Y Y APE D++S G ++ E++ G
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195
M +A + L Y+H RD+K N+LLD+ H +L+DFG + L + D T
Sbjct: 109 AEMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTV 158
Query: 196 VSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG 236
S +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 28/77 (36%), Positives = 45/77 (58%)
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 218
+++RDLK +NI L KL DFG +K + V++ GT Y APE + + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 219 LKSDVYSFGVVLLEILS 235
K+D++S GV+L E+L+
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 21/184 (11%)
Query: 60 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 119
+ V IK R G E +L ++HP+++ L G L+ L +
Sbjct: 118 EHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYK 166
Query: 120 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK- 178
L+ K+ + + I R ++YLH+ +I+RD+K NI ++ HP
Sbjct: 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGD 220
Query: 179 --LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
L DFG A PV N + GT APE D++S G+VL E+ +
Sbjct: 221 VCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 237 RKAV 240
++
Sbjct: 280 HDSL 283
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 84 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
++S + H +L + G C G + ++V E++ G ++ L G+ P+ W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAW--KITVAQQ 125
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHP--KLSDFGLAKLGPVGDNTHV 196
A L YL DK +++ ++ NILL R G P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 197 STRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEI 233
R+ + APE G L+ +D +SFG LLEI
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 38 SESLLGEGGFGR--VYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPN 92
+L+G+ V+ + N VA+K+++ + + + E++ L HPN
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPN 60
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLE 149
++ + + +V M GS ED L P P + IA L+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALD 115
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA--------KLGPVGDNTHVSTRVM 201
Y+H K I+R +K S+ILL LS + + V D S + +
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 202 GTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSG 236
+ +PE + KSD+YS G+ E+ +G
Sbjct: 173 P---WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 90
K ++ +G G G V + + +VA+K+L R N R + E+++L ++H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 79
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----------TRMK 139
N+++L+ + P S+E+ D+ + +D N RM
Sbjct: 80 KNIISLLNV------------FTPQKSLEE-FQDVYLVMELMDANLCQVIHMELDHERMS 126
Query: 140 -IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198
+ G+++LH +I+RDLK SNI++ K+ DFGLA+ N ++
Sbjct: 127 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTP 181
Query: 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
V+ Y Y APE D++S G ++ E++ G
Sbjct: 182 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT----- 214
++RD+K N+LLD H +L+DFG + L D T S+ +GT Y +PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 215 GQLTLKSDVYSFGVVLLEILSG 236
G+ + D +S GV + E+L G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGT 203
A G+E+L K ++RDL N+L+ G K+ DFGLA+ + D+ ++S
Sbjct: 249 ANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE T SDV+SFG++L EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 72/275 (26%), Positives = 102/275 (37%), Gaps = 66/275 (24%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLD------RNG---VQGNREFLVEVLMLS 86
F +G G FG V N A+K L RN V+ R+ L E
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA---- 58
Query: 87 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 146
+ +V L D D V +Y+P G + L L ++ L R IA
Sbjct: 59 --DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTC 112
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL---------------------- 184
+E +H K I+RD+K NIL+DR H KL+DFGL
Sbjct: 113 AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 185 -------------AKLGPVGD-NTHVSTRVM-----GTYGYCAPE-YAKTGQLTLKSDVY 224
+L P+ R + GT Y APE +TG L D +
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWW 228
Query: 225 SFGVVLLEILSGRKA-VDTSKAAAEQSLVAWARPL 258
S GV+L E+L G+ + + A + ++ W L
Sbjct: 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 34/166 (20%)
Query: 35 NFRSESLLGEGGFGRVY--------KGY-LESINQDVAIKQLDRNGVQGNREFLVEVLML 85
+F + ++G+G FG V K Y ++++ + K+ V+ R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES--- 58
Query: 86 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN------TRMK 139
P +V+L D L+ E++P G + L + ++ TR
Sbjct: 59 ---DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFY 106
Query: 140 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185
+A +E +H K I+RD+K NIL+DRG H KLSDFGL+
Sbjct: 107 MAE-CVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 7/82 (8%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLV 94
LG G FG+V + + ++ VA+K L + RE L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 95 NLIGYCADGDQRLLVYEYMPLG 116
NL+G C G L++ EY G
Sbjct: 106 NLLGACTHGGPVLVITEYCCYG 127
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G G V+ ++ VA+K++ Q + L E+ ++ L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 102 DGDQRL--------------LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
L +V EYM L +V + PL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--------GPLSEEHARLFMYQLL 124
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGT 203
RGL+Y+H V++RDLK +N+ ++ K+ DFGLA+ + P + + + T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 204 YGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGR 237
Y +P T D+++ G + E+L+G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 48/244 (19%)
Query: 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL 87
++ +T+ F+ SLLGEG FG+V + + + A+K + RN + R+ +E+ +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVK-IVRNVPKYTRDAKIEIQFMEK 181
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-------PGKKP--LDW---- 134
+ AD R PL ++ + + + P P LDW
Sbjct: 182 VRQ----------ADPADRF------PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH 225
Query: 135 ---NTR--MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-----------RGYHPK 178
+ R +I L+Y H + +++ DLK NIL++ R P
Sbjct: 226 GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 238
+ LG D H T ++ T Y +PE +D++S G ++ E+ +G+
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 239 AVDT 242
DT
Sbjct: 344 LYDT 347
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVL--MLSLLHHPNLV 94
LG G FGRV + ++ VA+K L ++ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLH 123
NL+G C G ++ EY G + D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 92
+R +G G +G V VAIK+L R + + R + E+ +L + H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 93 LVNLIG-YCADG--DQRLLVYEYMP-----LGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 144
++ L+ + D D+ Y MP LG + H + L + +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQM 127
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
+GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179
Query: 205 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 237
Y APE T D++S G ++ E+L+G+
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 77 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 136
E +V LM +PN + L +L+ +Y+ G L DL + L
Sbjct: 58 EPMVHQLMK---DNPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAE 110
Query: 137 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTH 195
KI L LH K +I+ D+K N+L DR L D+GL K
Sbjct: 111 VKKIIRQLVEALNDLH-KHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCK--------I 159
Query: 196 VSTRVM--GTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSG 236
+ T GT Y +PE K G S D ++ GV+ E+L+G
Sbjct: 160 IGTPSCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 34 KNFRSESLLGEGGFGRV-----YKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSL 87
LG G FG+V Y + VA+K L + RE L+ E+ +LS
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 88 L-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL 122
L +H N+VNL+G C G L++ EY G + + L
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 81 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 140
EV++ HPN++ G ++ +M GS L P + + I
Sbjct: 49 EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEALIGNI 106
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD----FGLAKLGP----VGD 192
GA RGL YLH I+R++K S+IL+ LS + L + G V D
Sbjct: 107 LFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163
Query: 193 NTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 237
ST V+ + +PE + +KSD+YS G+ E+ +GR
Sbjct: 164 FPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR--EFLVEVLMLSLLHHPNLVNLIG- 98
+G G FG V+ + + K + G++ + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 99 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
+ +Q+L ++ E+ G + ++ ++ + + I L Y H+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 158 P----VIYRDLKCSNILLDRGYH-----------------PKLSDFGLAKLGPVGDNTHV 196
P V++RDLK NI L G K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 197 STRVMGTYGYCAPEYA--KTGQLTLKSDVYSFGVVLLEILSGR 237
+GT Y +PE +T KSD+++ G ++ E+ SG+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVL--MLSLLHHPNL 93
+LG G FG+V +G +++ VA+K L ++ L+ L M L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLH 123
VNL+G C ++ EY G + ++LH
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 67/272 (24%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEVLMLSLLHHPN 92
LG G FG V A+K L + V + R+ L E +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V L D D V +Y+P G + L + G P D R IA +E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDL-ARFYIAELTC-AVESVH 118
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL---------AKLGPVGDNTH-------- 195
K I+RD+K NIL+DR H KL+DFGL +K GD+
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 196 ----------------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 227
++ ++GT Y APE T D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 228 VVLLEILSGRKA-VDTSKAAAEQSLVAWARPL 258
V+L E+L G+ + + + ++ W L
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 60/246 (24%), Positives = 93/246 (37%), Gaps = 57/246 (23%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---------NGVQGNREFLVEVLM 84
++F S ++G G FG V + A+K L + ++ R+ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 85 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 144
L + V + D L+ E++P G D + L + T+ IA
Sbjct: 61 LWV------VKMFYSFQDKLNLYLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAE-T 110
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT---------- 194
++ +H I+RD+K N+LLD H KLSDFGL T
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 195 -----------------------HVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVL 230
++ +GT Y APE + +TG L D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIM 226
Query: 231 LEILSG 236
E+L G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.74 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.5 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.49 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.08 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.95 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| PLN02236 | 344 | choline kinase | 97.54 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.47 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.36 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.28 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.15 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.13 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.04 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.03 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.88 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.86 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.57 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.48 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.46 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.39 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.28 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.06 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.98 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=376.64 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=218.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.+|...++||+|+|+.||.+++..+|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999999999999999999764 3345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|.|..++|..++.. .+++++.++..++.||+.||.|||+++ |+|||||..|+|++++.++||+|||+|.. .
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~--l 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQ--L 168 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeee--e
Confidence 99999999999986 678999999999999999999999999 99999999999999999999999999986 3
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
..........+||+.|+|||++.....+..+||||+||+||.||.|++||+...-......+....
T Consensus 169 e~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-------------- 234 (592)
T KOG0575|consen 169 EYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-------------- 234 (592)
T ss_pred cCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--------------
Confidence 334455677899999999999999999999999999999999999999998764433332221111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
-..|...+.++.+||.++|+.||.+|||+.+|+..
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12233455588899999999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-52 Score=348.09 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=213.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeee-EEEcCC-eeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGD-QRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~-~~~lv 109 (361)
.+|+|++.||.|.||.||+++...+|..||.|.++-. +....+....|+.+|++|+||||+++++ .+.++. .++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 5688999999999999999999999999999998632 3334567889999999999999999998 454444 48999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||+|++|+|...++.++..+..+++..+|.++.|++.||..+|++- ++.|+||||||.|||++.+|.+||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999988888899999999999999999999999831 234999999999999999999999999999863
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. ........+||+.||+||.+.+..|+.+|||||+||++|||+.-++||.+.........+...
T Consensus 179 ~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg------------- 243 (375)
T KOG0591|consen 179 SS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG------------- 243 (375)
T ss_pred cc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-------------
Confidence 32 233344578999999999999999999999999999999999999999876332222111100
Q ss_pred cCccccCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 269 ADPELQGQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 269 ~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
-...+| ...+.++.+||..|+..||+.||+...+++.+.
T Consensus 244 ----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 ----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 001123 456778999999999999999999665555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=354.20 Aligned_cols=206 Identities=30% Similarity=0.457 Sum_probs=187.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
..+|.+.+.||.|+|++||+|+++.++..||||.+... .....+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999999876 4445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC------CceeEecccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG------YHPKLSDFGL 184 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~------~~~~L~Dfg~ 184 (361)
|||+||+|.++++. .+.+++..+..++.||+.||++||+++ |+||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998 668999999999999999999999999 9999999999999865 4589999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 248 (361)
++... ........+|++.|||||++....|+.|+|+||+|+++|++++|..||+.....+.
T Consensus 162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 99643 45556678899999999999999999999999999999999999999986554433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=343.33 Aligned_cols=266 Identities=25% Similarity=0.291 Sum_probs=216.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
+.|+.+..+|+|+||.||+++++.+|+.||||+|..+.. ...+...+|+.+|++|+|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468889999999999999999999999999999965533 334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
||+. ++.+.++. ....++...+.++++|++.|+.|+|+++ ++||||||+||||+.+|.+||||||+|+...
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~-- 152 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS-- 152 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc--
Confidence 9984 44444443 2567999999999999999999999999 9999999999999999999999999998633
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh--------hhhhhccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW--------ARPLFQDR 262 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~--------~~~~~~~~ 262 (361)
......+..+.|.+|+|||.+.+ ..|...+||||+||++.||++|.+.|++....+..-.+.. ....|...
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 23444556788999999999877 6899999999999999999999999998876655533322 22334433
Q ss_pred cccccccCccc-----cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSLIADPEL-----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+..|.. .....+....-+.+++..||.+||++|++.++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 33333333332 22233445667889999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=348.80 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=210.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEcCC-eeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 111 (361)
.+.+.++.||+|..|+||+++|+.++..+|+|++... .....+++.+|+++++..+||+||.+|+.|..+. ..+|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 4666788999999999999999999999999999544 3345578999999999999999999999999888 5999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||++|+|.+++.. .+.+++.....++.+|++||.|||+ ++ |+||||||+||||+..|.+||||||.+....
T Consensus 159 YMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lv- 230 (364)
T KOG0581|consen 159 YMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILV- 230 (364)
T ss_pred hcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhh-
Confidence 9999999999987 4779999999999999999999996 78 9999999999999999999999999987522
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchH--HHhhhHHHhhhhhhccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA--AAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
+. .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||..... .....+...+ ...
T Consensus 231 --nS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~------- 297 (364)
T KOG0581|consen 231 --NS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDE------- 297 (364)
T ss_pred --hh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcC-------
Confidence 12 44567899999999999999999999999999999999999999976511 1111121111 110
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
..|.+... ..+.++..++..||++||.+||++.++++.--
T Consensus 298 ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 298 PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 01111111 14458889999999999999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=355.09 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=213.3
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-------chHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-------GNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
+.++..|.+.+.||+|+||.|-+|..+.+|+.||||++++.... ......+|+++|++|+||||++++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 34778899999999999999999999999999999999753221 22335799999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC---CceeE
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKL 179 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~---~~~~L 179 (361)
....|+||||++||.|.+.+-. ++.+.+.....++.||+.|+.|||++| |+||||||+|||+..+ ..+||
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999987 778999999999999999999999999 9999999999999766 67999
Q ss_pred ecccccccCCCCCCcceeeccccCcCcCCchhhccCC---CCccCceehhhHHHHHHhhCCCccccchHHH-hhhHHHhh
Q 018100 180 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWA 255 (361)
Q Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~-~~~~~~~~ 255 (361)
+|||+++... ........+||+.|.|||++.+.. +..++|+|||||++|-+|+|.+||....... ....+..
T Consensus 321 tDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~- 396 (475)
T KOG0615|consen 321 TDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK- 396 (475)
T ss_pred cccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-
Confidence 9999999633 445566788999999999997654 3358899999999999999999998654433 1111100
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
... .+..........+..+||.+||..||++|||+.++++.-
T Consensus 397 ---------G~y----~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 397 ---------GRY----AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred ---------Ccc----cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 000 111223445677899999999999999999999999743
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=355.08 Aligned_cols=290 Identities=56% Similarity=0.949 Sum_probs=247.9
Q ss_pred cCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeE
Q 018100 20 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 99 (361)
Q Consensus 20 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 99 (361)
....|++.+++.++++|...+.||+|+||.||+|.... +..||||.+..........|.+|+.++.+++|||+++++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 67889999999999999999999999999999999986 58999998876544314459999999999999999999999
Q ss_pred EEcCC-eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 100 CADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 100 ~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
|.+.+ ..+||+||+..|+|.++++..... +++|..+++|+.++|+||+|||....++|+|||||++|||+|++.+.|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99888 599999999999999999873321 899999999999999999999998888899999999999999999999
Q ss_pred EecccccccCCCCCCcceeecc-ccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRV-MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
|+|||++...+.. ....... .||..|+|||....+..+.++||||||+++.||++|+.+.+.........+..|..+
T Consensus 218 lsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999999754331 1111112 699999999999889999999999999999999999998886654445557788766
Q ss_pred hhccccccccccCcccc-CCCCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 258 LFQDRTRHSLIADPELQ-GQYPP-RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
...+. ....+.|+.+. ..+++ .....+..+..+|++.+|..||++.+|++.|+.+..
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 66655 77788888876 55554 567778889999999999999999999999965544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=347.42 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=211.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..++|++++.||+|+||+||.++.+++++.+|+|++++... ...+....|..+|..++||+|+.++-.|.+...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35889999999999999999999999999999999976533 234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|++|+.||.|...++. .+.+++..+..++.+|+.||.|||++| |+||||||+|||+|..|.++|+|||+|...
T Consensus 103 Vld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999987 778999999999999999999999999 999999999999999999999999999852
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. ........+||+.|||||++.+..++..+|+||||+++|+|++|.+||...........+....
T Consensus 176 ~~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------ 241 (357)
T KOG0598|consen 176 LK--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------ 241 (357)
T ss_pred cc--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------------
Confidence 22 2223344789999999999999999999999999999999999999998765443332221111
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCC----CHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP----VIADVV 307 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~~ll 307 (361)
....+...+.+..+++.++|..||++|. ++.+|.
T Consensus 242 -----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 0111222345788999999999999995 455543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=344.41 Aligned_cols=263 Identities=35% Similarity=0.542 Sum_probs=213.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeE-EEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcCC-ee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQD-VAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD-QR 106 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~-v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 106 (361)
....+..+.+.||.|+||+||+|.+++ .. ||+|++....... .+.|.+|+.+|.+++||||+.+++++.+.. .+
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 334555666779999999999999994 55 9999997653332 458999999999999999999999998887 79
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEeccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLA 185 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~ 185 (361)
++||||+++|+|..+++.. .+..++...++.++.||++|+.|||+++. ||||||||+||||+.++ ++||+|||++
T Consensus 116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccc
Confidence 9999999999999999864 25789999999999999999999999974 89999999999999998 9999999999
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhc--cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAK--TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
+...... .......||..|||||++. ...++.++||||||+++|||+||..||...........+.
T Consensus 192 r~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~---------- 259 (362)
T KOG0192|consen 192 REKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV---------- 259 (362)
T ss_pred eeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----------
Confidence 7532211 2223357999999999999 5699999999999999999999999998765522111110
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
....+...+..++..+..++..||..||..||++.+++..|+.+....
T Consensus 260 ------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 260 ------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 001111222235558888999999999999999999999999887643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=349.03 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=213.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCe
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 105 (361)
+.--.+|.+++.||.|+|++|++|+.+.++..+|||++.+... ...+.+..|-.+|..| .||.|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4556799999999999999999999999999999999875422 2234577788899999 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
+|+|+||+++|+|.++|.. .+.+++.....++.||+.||+|||++| ||||||||+|||++++|+++|+|||.+
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999998 678999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCc---------ce--eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh
Q 018100 186 KLGPVGDNT---------HV--STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 186 ~~~~~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 254 (361)
......... .. ....+||..|.+||++.+...+..+|||+|||++|+|+.|.+||....+--.-..+.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~- 300 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ- 300 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH-
Confidence 763322111 11 144789999999999999999999999999999999999999998765422211111
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.-.+++.-+..+.+||.++|..||.+|+++.+|-+.
T Consensus 301 -----------------~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 -----------------ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----------------HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11123344444588899999999999999999887653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=349.14 Aligned_cols=271 Identities=23% Similarity=0.274 Sum_probs=218.6
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchH-HHHHHHHHHhcCC-CCccceeeeEEEcCC-eeE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLH-HPNLVNLIGYCADGD-QRL 107 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~-~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~ 107 (361)
.+-++|.+++.||.|+||.||+|+.+.+|..||||.+........+ .-.+|+..|++|+ ||||+++.+++.+.. .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4568999999999999999999999999999999998754333222 2457999999998 999999999998877 999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|||||+ .+|.+++..+ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+-
T Consensus 87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999997 9999999874 578999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCcceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhh--ccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF--QDRTR 264 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 264 (361)
.. .....+..+.|.+|+|||++. ...|+.+.|+||+||+++|+.+-++.|.+..+.+....+..+-.-- .....
T Consensus 160 v~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 32 233345567899999999874 5789999999999999999999999999988877765544432111 10000
Q ss_pred ------cccccCccc----cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 265 ------HSLIADPEL----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 265 ------~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
...+.-|.. .....+..+.++.+||.+||+.||.+||||.++++.--
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 000000110 11222346778999999999999999999999998654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=313.63 Aligned_cols=268 Identities=26% Similarity=0.342 Sum_probs=215.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.+|..++.||+|.||.||+|++..+|+.||||++......+ .....+|+..|+.++|+||+.++|+|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57888999999999999999999999999999997653332 2457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++ .+|...+.+ ....++..++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 997 899999976 3467999999999999999999999999 999999999999999999999999999975443
Q ss_pred CCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh--hhhhccccccc--
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA--RPLFQDRTRHS-- 266 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~-- 266 (361)
... ....+.|.+|+|||.+.|. .|...+|+||.||++.||+.|.+-|.+....+....+-.. .+.-..-....
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 322 2333789999999998775 6899999999999999999999988887665555433211 11111101111
Q ss_pred -------cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 267 -------LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 267 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
....+.... .-+....++.+|+.+||..||.+|+++.++++.-.
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 111111111 22345567799999999999999999999997644
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=342.70 Aligned_cols=258 Identities=31% Similarity=0.453 Sum_probs=217.6
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
+.+.+++.||+|.||.||.|.++. ...|++|.+... ....+.|.+|+.+|++|+|++||+++++|..+..+||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 445567899999999999999996 458999998654 334477889999999999999999999999988999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+.|+|.+++.. ..+..++..+.+.++.||++|++||++++ +|||||.+.||||++++.+||+|||+++.... +.
T Consensus 284 ~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~ 357 (468)
T KOG0197|consen 284 PKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD-DE 357 (468)
T ss_pred ccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC-Cc
Confidence 99999999987 33678999999999999999999999999 99999999999999999999999999994222 22
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
........-...|.|||.+....++.+|||||||++||||+| |+.|+......+....+. ..
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-----------------~G 420 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-----------------RG 420 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-----------------cc
Confidence 222222334568999999999999999999999999999999 999988766554443332 23
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.+-..|..++..+.+++..||..+|++|||++.+...|+.+...
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 33455667777999999999999999999999999999877653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=332.22 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=215.7
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
...++|++...||.|..++||+|+...+++.||||+++...... .+.+.+|+..|..++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 44589999999999999999999999999999999997654333 47899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC-
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG- 188 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~- 188 (361)
|+||.+|++.+.+..+. ...+++..|..+++++++||.|||.+| .+|||||+.||||+.+|.|+|+|||.+...
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998866 445999999999999999999999999 999999999999999999999999976442
Q ss_pred CCCCCccee-eccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 189 PVGDNTHVS-TRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
..+...... ...+|+++|||||++.. ..|+.|+||||||++..||.+|+.||.........-+.....++...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---- 253 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---- 253 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc----
Confidence 222222222 55689999999999643 47999999999999999999999999877655443322222221111
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...+..+-.........+++..||++||++|||++++++
T Consensus 254 ----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 ----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000111111122347888999999999999999999996
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=339.66 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=215.1
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC----Cc-cchHHHHHHHHHHhcCC-CCccceeeeEEEcC
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN----GV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADG 103 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 103 (361)
....++|.+.+.||+|+||+|++|.+..++..||+|+++.. .. ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35568999999999999999999999999999999987653 12 23456778999999998 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-CceeEecc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDF 182 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-~~~~L~Df 182 (361)
...|+||||+.||+|.+++.. .+++++..+..++.||++|++|||++| |+||||||+|||++.+ +++||+||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999987 678999999999999999999999999 9999999999999999 99999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCC-CC-ccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-LT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
|++.... .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||+..........+ ..
T Consensus 166 G~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki------~~ 237 (370)
T KOG0583|consen 166 GLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI------RK 237 (370)
T ss_pred ccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH------hc
Confidence 9998653 2333445678999999999998876 76 8899999999999999999999874332221111 00
Q ss_pred cccccccccCccccCCCChHH-HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 261 DRTRHSLIADPELQGQYPPRG-FYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
. . -.+|... +.++..|+.+||..||.+|+++.+++ .-..+..
T Consensus 238 ~-----~-------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 238 G-----E-------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred C-----C-------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 0 0 1112222 55888999999999999999999999 4444444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=331.57 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=207.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC--eeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 110 (361)
..+|...+.||+|+||.||++.+..+|...|||.+...+....+.+.+|+.+|.+++|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456888999999999999999999999999999987654444677999999999999999999999744333 689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEecccccccCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGP 189 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~~~~~ 189 (361)
||+.+|+|.+++.... + ++++..+..+..||++||.|||++| ++||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999998722 2 7999999999999999999999999 999999999999999 7999999999887643
Q ss_pred C-CCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccc-hHHHhhhHHHhhhhhhccccccc
Q 018100 190 V-GDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTS-KAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~-~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
. ...........||+.|||||++.+. ....++|||||||++.||+||..||... ...... . ......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~--~-------~ig~~~- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEAL--L-------LIGRED- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHH--H-------HHhccC-
Confidence 2 1222233446799999999999853 3446999999999999999999999863 111111 1 000000
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
..| .+|...+.++.+++.+|+..||.+||||.++++..-
T Consensus 240 --~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 --SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111 344455668899999999999999999999998654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=336.42 Aligned_cols=269 Identities=24% Similarity=0.291 Sum_probs=210.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcC--CeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 108 (361)
...|+.++.||+|+||.||+|++..+|..||+|++...... .-.-..+||.+|++|.||||+++.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45688899999999999999999999999999999765432 234567899999999999999999998765 68999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|+|||+ -+|.-++.. .+-.|++.++..++.||+.||+|||++| |+|||||.+|||||.+|.+||+|||+++++
T Consensus 196 VFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999997 788877765 2347999999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hhhhccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 266 (361)
....... .+..+-|.+|+|||++.|. .|+.++|+||+||||.||++|++.|.+....+....+-.. ...........
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 4433222 4456789999999999875 7999999999999999999999999988776665433221 10000000000
Q ss_pred cccC---ccccCCCC-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 LIAD---PELQGQYP-------PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~~~~---~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.. ......+. ...+...++|+..+|..||.+|.|+.+++..
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0000 00000000 1124467889999999999999999998853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=346.51 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=215.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.+-|++++.||.|+.|.|-+|++..||+.+|||++.+... .....+.+|+.+|+.+.|||++.++++++++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3668999999999999999999999999999999975421 1224578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
.||++||-|.+++.. ++++++.++..++.||+.|+.|||..+ ||||||||+|+|++..++|||+|||+|..
T Consensus 91 lEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsL-- 161 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASL-- 161 (786)
T ss_pred EEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeec--
Confidence 999999999999987 889999999999999999999999999 99999999999999999999999999984
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCC-ccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
..........+|+++|.+||++.|..|+ .++||||+|+|||.||+|+.||+..+.......+....
T Consensus 162 -e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------ 228 (786)
T KOG0588|consen 162 -EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------ 228 (786)
T ss_pred -ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------------
Confidence 4445556677899999999999999887 88999999999999999999999654332222221111
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
-+.|...+.++.+||++||.+||.+|.|+++|++..-
T Consensus 229 ------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 229 ------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1123344558889999999999999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=340.39 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=216.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
...|.....||+|+.|.||.|....+++.||||.++.......+-+.+|+.+|+..+|+|||.+++.|-.++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45699999999999999999999999999999999887777778899999999999999999999999888999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
++||+|.+.+.. ..+++.++..++.+++.||+|||.+| |+|||||.+|||++.+|.+||+|||+|......
T Consensus 352 m~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~- 422 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE- 422 (550)
T ss_pred cCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc-
Confidence 999999999985 55999999999999999999999999 999999999999999999999999999763322
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......+||++|||||+.....|.+++||||||++++||+-|.+||-.........++.-. -.
T Consensus 423 -~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n---------------g~ 486 (550)
T KOG0578|consen 423 -QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---------------GT 486 (550)
T ss_pred -cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc---------------CC
Confidence 22455678999999999999999999999999999999999999999654333222222111 01
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+...+..+.+++.+||+.||.+|+++.++|+.
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1112234455688999999999999999999999973
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=311.13 Aligned_cols=270 Identities=25% Similarity=0.314 Sum_probs=221.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc-----CC
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GD 104 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 104 (361)
...+++|++.+.||+|||+.||++.+-.++..+|+|++......+.+...+|++..+.++|||+++++++... ..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4567999999999999999999999999999999999988887888899999999999999999999887643 34
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..|++++|+..|+|.+.++.....+..+++.+++.++.+|++||++||+.. +++.|+||||.||++.+.+.++|+|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 589999999999999999988777789999999999999999999999996 5699999999999999999999999999
Q ss_pred cccCCCCCCccee-------eccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh
Q 018100 185 AKLGPVGDNTHVS-------TRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 185 ~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 254 (361)
+...+........ .....|..|+|||.+. +...+.++|||||||++|+|+.|..||+.... ....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgS---- 250 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGS---- 250 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCe----
Confidence 8764443222111 1234678999999984 45788999999999999999999999975322 1100
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.........+...-....+..+.++|..||+.||.+||++.+++..++.+.
T Consensus 251 ---------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 ---------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011111222222222346779999999999999999999999999987653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=331.81 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=209.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
+...++|++++.||+|+||.||+|+.+.+|..+|+|++.++... +.+.+..|-.+|....+|.||+++-.|.+...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34578999999999999999999999999999999999876443 345677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
||||||++||++..++.. ...|++..+..++.+++.||..+|..| ++||||||+|+|||..|++||+|||+|.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999987 788999999999999999999999999 9999999999999999999999999984
Q ss_pred cCCC----------------------CCCcc----e-------------------eeccccCcCcCCchhhccCCCCccC
Q 018100 187 LGPV----------------------GDNTH----V-------------------STRVMGTYGYCAPEYAKTGQLTLKS 221 (361)
Q Consensus 187 ~~~~----------------------~~~~~----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~s 221 (361)
.... .+... . ....+||+.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3111 00000 0 0113699999999999999999999
Q ss_pred ceehhhHHHHHHhhCCCccccchHHHhh-hHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCC
Q 018100 222 DVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 300 (361)
Q Consensus 222 DiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 300 (361)
|+||||||+||||.|.+||........- .+..|... +..... .....++.+||.+||. ||.+|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-l~fP~~--------------~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-LKFPEE--------------VDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-ccCCCc--------------CcccHHHHHHHHHHhc-CHHHh
Confidence 9999999999999999999776654443 33433321 111111 1112488899999999 99999
Q ss_pred CC---HHHHHH
Q 018100 301 PV---IADVVT 308 (361)
Q Consensus 301 ps---~~~ll~ 308 (361)
.- +.||-+
T Consensus 434 LG~~G~~EIK~ 444 (550)
T KOG0605|consen 434 LGSKGAEEIKK 444 (550)
T ss_pred cCcccHHHHhc
Confidence 75 455543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=309.65 Aligned_cols=238 Identities=28% Similarity=0.349 Sum_probs=205.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
..+|+..+.||.|+||.|.+++++.+|..+|+|+++.... ...+...+|..+|+.+.||+++.+++.+.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 5679999999999999999999999999999999976533 3345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||++||.|.++++. .+++++..+..++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||++....
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999987 778999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .-..+||+.|+|||++....+..++|+||||+++|||+.|.+||-.......-..+. .
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~------~--------- 255 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL------E--------- 255 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH------h---------
Confidence 21 345689999999999999999999999999999999999999997765522221111 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCC
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMR 300 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 300 (361)
-.-.+|+.-..++.+|+.++|+.|-.+|
T Consensus 256 ---~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 ---GKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---CcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 0112344444588899999999999999
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=316.12 Aligned_cols=268 Identities=22% Similarity=0.297 Sum_probs=215.3
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEecc--CCccchHHHHHHHHHHhcCCCCccceeeeEEEc-----
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----- 102 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 102 (361)
-.+...|...+.||+|+||.|+.|.++.+|+.||||++.. ......+...+|+.+|+.++|+||+.+.+++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3455778888999999999999999999999999999873 334456778899999999999999999999854
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
-+..|+|+|+|+ .+|...++. +..+++..+..+++||++||.|+|+.+ ++||||||+|++++.+..+|++||
T Consensus 98 f~DvYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence 356799999994 899999987 566999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh----
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP---- 257 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~---- 257 (361)
|+++...........+..+.|.+|+|||++.+ ..|+.+.||||+||++.||++|++.|.+........++....+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99997543323334466788999999998754 6899999999999999999999999988776655544333211
Q ss_pred -------------hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 258 -------------LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 258 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+......... ..+..-+ +......++|+.+||..||.+|+|+++.++.
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~---~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPK---QPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCC---CCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1110000000 0111111 2445578999999999999999999999974
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=330.18 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=217.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCe-eEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 110 (361)
++|.+++.+|+|+||.+++++++.++..+++|.+..... ...+....|+.++++++||||+.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 579999999999999999999999999999999975543 344568899999999999999999999988888 89999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
+||+||++.+.+.... +.-++++.++.++.||+.|+.|||++. |+|||||+.|||++.++.|+|+|||+++....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998755 577999999999999999999999998 99999999999999999999999999997333
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. .......+||+.|+.||.+.+..|..++|||||||++|||++-+++|...+-......+.
T Consensus 159 ~--~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~----------------- 219 (426)
T KOG0589|consen 159 E--DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN----------------- 219 (426)
T ss_pred c--hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-----------------
Confidence 2 234556789999999999999999999999999999999999999998764433322111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......+.....++..+|..||+.+|..||++.+++..
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 011223455666789999999999999999999999976
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=331.23 Aligned_cols=248 Identities=30% Similarity=0.438 Sum_probs=213.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.... +.+.+.+|+++++.++||||+.++++|++..+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5799999999999999999999999999999999865443 34568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+. |+|..++.. .+.++++.+..++.|+..||.|||+++ |.|+|+||.||+++.+|.+|++|||+++.. .
T Consensus 82 ~a~-g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m--~ 151 (808)
T KOG0597|consen 82 YAV-GDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM--S 151 (808)
T ss_pred hhh-hhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc--c
Confidence 997 599999987 788999999999999999999999999 999999999999999999999999999973 3
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
..........||+.|||||+..+..|+..+|+|||||++||+++|++||-..... ..+..+..+...
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~------~Lv~~I~~d~v~------- 218 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT------QLVKSILKDPVK------- 218 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH------HHHHHHhcCCCC-------
Confidence 3455566778999999999999999999999999999999999999999543221 111111111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.|+..+.....++..+|.+||.+|.+-.+++..
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 123445577889999999999999999998863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=332.78 Aligned_cols=264 Identities=28% Similarity=0.404 Sum_probs=204.9
Q ss_pred hhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcC-C
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-D 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 104 (361)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 478999999999999999999852 3356899999865432 2345688999999999 899999999988654 4
Q ss_pred eeEEEEEecCCCCHHHHhcccCC---------------------------------------------------------
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSP--------------------------------------------------------- 127 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~--------------------------------------------------------- 127 (361)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998864211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCc
Q 018100 128 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206 (361)
Q Consensus 128 -~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y 206 (361)
...++++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++................++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235888899999999999999999999 999999999999999999999999998753222111122223456789
Q ss_pred CCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHH
Q 018100 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 285 (361)
Q Consensus 207 ~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (361)
+|||++.+..++.++|||||||++|+|++ |..||......... ... ..... ....+...+..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~~----~~~~~----------~~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQR----LKDGT----------RMRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HHH----HhcCC----------CCCCCCCCCHHH
Confidence 99999988899999999999999999997 99999764322111 000 00000 001122334578
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 286 LAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 286 ~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.+++.+||+.||++||++.++++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=338.38 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=210.4
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcC-CCCccceeeeEEEcCC
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 104 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 104 (361)
......+|.+++.||+|.||+|+++..+.+++.+|||++++... ++.+..+.|..++... +||.++.++..|.+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 34556889999999999999999999999999999999987533 4456788888888877 5999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
++|+||||+.||++..+.+ ...+++..+..++..|+.||+|||++| |++||||.+|||+|.+|.+||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccc
Confidence 9999999999999544444 367999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
|+. ...........+||+.|+|||++.+..|+.++|+||||++||+||.|..||.+...++.-+-+...
T Consensus 515 cKe--~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--------- 583 (694)
T KOG0694|consen 515 CKE--GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--------- 583 (694)
T ss_pred ccc--cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Confidence 985 222444567789999999999999999999999999999999999999999876554332211100
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
...+|...+.+..++++++|..+|++|.-.
T Consensus 584 ---------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ---------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 122355566688999999999999999855
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=308.70 Aligned_cols=268 Identities=22% Similarity=0.275 Sum_probs=209.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccch--HHHHHHHHHHhcCCCCccceeeeEEEc--CCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 108 (361)
.++|+.+..|++|+||.||+|+++.+++.||+|.++......- -...+||.+|.+.+||||+.+-++... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3567888899999999999999999999999999974422111 135689999999999999999998754 356899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|||||+ -+|.++++.+. +++...++..++.|+++|++|||.+. |+||||||+|+|+++.|.+|++|||+|+.+
T Consensus 155 VMe~~E-hDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHH-hhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999997 89999998754 68999999999999999999999998 999999999999999999999999999974
Q ss_pred CCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh-----hhccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-----LFQDR 262 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~ 262 (361)
.. .....+..+.|.+|+|||++.+. .|+.+.|+||+|||+.||+++.+.|.+....+..+.+-..-. .+...
T Consensus 228 gs--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GS--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cC--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 33 23334556789999999999875 699999999999999999999999988877665543322111 00000
Q ss_pred cc--------cccccCccccCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TR--------HSLIADPELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~--------~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. .....-..+...+... .....++|+..+|..||.+|.|+.+.|+.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 0000000112222222 34567889999999999999999999854
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=324.64 Aligned_cols=247 Identities=27% Similarity=0.340 Sum_probs=204.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
..+|++.+.||+|+||.||+|.++.+++.|++|++.... ....+.+.+|+.+++.++||||+++++.+.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 368999999999999999999999999999999986432 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999876 567899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+ ...
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~-------- 230 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI------LAG-------- 230 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH------hcC--------
Confidence 21 12346899999999999988999999999999999999999999754332111110 000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~~ 309 (361)
. ..++......+.+|+.+||+.||.+||+ +.+++..
T Consensus 231 ~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 R----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred C----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 0112223346788999999999999996 6777753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=327.69 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=207.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.................... .
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------~ 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---------R 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------C
Confidence 22335689999999999988999999999999999999999999976544332211111100000 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+.. .......+.++.+++.+||..+|++||++.++++.
T Consensus 220 ~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00001234578899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=320.28 Aligned_cols=267 Identities=22% Similarity=0.255 Sum_probs=205.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|+||.||+|+++.++..|++|++..... ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999865422 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++++.+..+... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9987766655433 456999999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh-hh-------hcccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PL-------FQDRT 263 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~-------~~~~~ 263 (361)
.. .......++..|+|||++.+..++.++|||||||++|+|++|..||................ +. +....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 11 11223468899999999988889999999999999999999999997654332221111110 00 00000
Q ss_pred ccccccCcccc------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 264 RHSLIADPELQ------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 264 ~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.......+... .......+..+.+|+.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0111223457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.63 Aligned_cols=267 Identities=25% Similarity=0.303 Sum_probs=218.8
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeE-EEc--
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGY-CAD-- 102 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~-- 102 (361)
..+.....+++|.+.|.+|||+.||+|++...|..||+|.+-..+....+.+.+|+.+|+.|+ |+|||.++|. ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 444667789999999999999999999999877999999987777777788999999999997 9999999993 211
Q ss_pred ----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 103 ----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 103 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
.-..+|+||||.||.|.+++..+.. ..|++.++++|+.|+++||.+||.. .++|+|||||-+||||+.+|++|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 1356799999999999999987553 4499999999999999999999999 47799999999999999999999
Q ss_pred EecccccccCCCCC-Ccce------eeccccCcCcCCchhh---ccCCCCccCceehhhHHHHHHhhCCCccccchHHHh
Q 018100 179 LSDFGLAKLGPVGD-NTHV------STRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248 (361)
Q Consensus 179 L~Dfg~~~~~~~~~-~~~~------~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 248 (361)
|||||.+...-... .... .-....|+.|+|||.+ .+..+++|+|||+|||+||-||....||+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999886522211 1110 1123578999999976 578899999999999999999999999986422
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
..+.+-.+...-.+.++..+.+||+.||+.||.+||++.+++..+..+...
T Consensus 264 -----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 -----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 112222222222357788999999999999999999999999999887754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=323.41 Aligned_cols=246 Identities=25% Similarity=0.293 Sum_probs=204.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999999864322 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. .. .
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~------~~--------~ 214 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL------AG--------K 214 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------C
Confidence 1 123458899999999998889999999999999999999999997654322111110 00 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~~ 309 (361)
..++......+.+++.+||+.||.+||+ +.++++.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0112223447888999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=324.83 Aligned_cols=242 Identities=27% Similarity=0.349 Sum_probs=199.7
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
+.||+|+||.||+|.++.+|..||+|++.... ......+..|+.+++.++||||+.+++.+..+...|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 223345778999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcce
Q 018100 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 196 (361)
Q Consensus 117 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~ 196 (361)
+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++..... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCc
Confidence 99998876 567999999999999999999999999 99999999999999999999999999874211 1112
Q ss_pred eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCC
Q 018100 197 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 276 (361)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (361)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||............. .. . ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~--------~----~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME--------E----IR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH------cC--------C----CC
Confidence 233568999999999999899999999999999999999999997644322211110 00 0 11
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 277 YPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
++...+.++.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2223445788999999999999999 7888885
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.86 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=203.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||.|+||.||+|.++.++..|++|++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 36799999999999999999999999999999998654322 33467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++ ++|.+++... +..+++..+..++.||+.||+|||++| ++||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 997 5898888641 345899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh-----hhccccc-
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-----LFQDRTR- 264 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~- 264 (361)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||................. .+.....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 T--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred C--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 1 11223457889999998865 5688999999999999999999999976554333221111100 0000000
Q ss_pred --cccccCcccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 --HSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 --~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
......+... ....+....++.+|+.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 0011123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=324.15 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=208.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|+++.++..+++|++..... ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4789999999999999999999999999999999875422 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999976 55689999999999999999999985 6 99999999999999999999999999865322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc-c---
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH-S--- 266 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 266 (361)
. ......++..|+|||++.+..++.++|||||||++|+|++|..||.............. +........ .
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSIS 230 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccC
Confidence 1 12234688999999999988999999999999999999999999975543322111110 000000000 0
Q ss_pred ----------------------------cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 267 ----------------------------LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 267 ----------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.+.............+.++.+|+.+||+.||++|||+.++++..-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 000000000001123457899999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=324.10 Aligned_cols=250 Identities=28% Similarity=0.389 Sum_probs=212.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
...|+..+.||+|.||.||+|.+..+++.||+|+++... .+..+.+..|+.+|.+++++||.++++.+-.+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 356888899999999999999999999999999998653 3456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
||.||++.+++.. +..+++..+..++++++.||.|||.++ .+|+|||+.||++..+|.+||+|||.+-...
T Consensus 92 y~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~-- 162 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLT-- 162 (467)
T ss_pred HhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeee--
Confidence 9999999999987 666799999999999999999999999 9999999999999999999999999986532
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.........+||+.|||||++.+..|+.++||||||++.+||.+|.+|+.......... .......|
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~PP 229 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAPP 229 (467)
T ss_pred chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCCC
Confidence 22233366789999999999998899999999999999999999999997654421111 11111122
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+.. ..+..+.+++..||.+||+.||+|.++++
T Consensus 230 ~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3333 34447889999999999999999999985
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=308.59 Aligned_cols=271 Identities=21% Similarity=0.298 Sum_probs=209.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCc-cceeeeEEEcCC-----
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPN-LVNLIGYCADGD----- 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 104 (361)
...|..++.||+|+||+||+|+.+.+|+.||+|++...... .-....+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677778899999999999999999999999999765442 2234678999999999999 999999998877
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 105 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 105 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
.+++|+||++ .+|..++.........++...+..++.||+.||+|||+++ |+||||||+||+|++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 8899999996 8999999875432246888999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
+++....... .....++|.+|+|||++.+. .|+...||||+||+++||++++..|.+.........+-..-..-...
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9986433222 23445689999999999886 79999999999999999999999998877644443221111100000
Q ss_pred cccccccCccccCCCC------------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TRHSLIADPELQGQYP------------PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......-+.....++ +....+..+++.+||+.+|.+|.|+..+++.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0011110111110111 1112477889999999999999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=317.74 Aligned_cols=252 Identities=28% Similarity=0.399 Sum_probs=202.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.++..++|++|+.+++.+.+++..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37888999999999999999999999999999864322 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999988875422 346899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh-hHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||......... .+.... .
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~---------- 218 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV----K---------- 218 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh----h----------
Confidence 1 122346899999999999999999999999999999999999999764322111 111000 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~~ 309 (361)
.....++...+..+.+|+.+||+.||.+||+ ++++++.
T Consensus 219 -~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 -EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0001122233447888999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=312.90 Aligned_cols=272 Identities=23% Similarity=0.308 Sum_probs=209.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC-----eeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 108 (361)
-.|+..+.+|.|+||.||.|....+++.||||++-.... .-.+|+++|+.+.||||+++.-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 357888999999999999999999999999999853322 2235999999999999999988875322 3458
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-CceeEeccccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKL 187 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-~~~~L~Dfg~~~~ 187 (361)
||||++ .+|...+..+...+..++...+.-+.+||++||.|||+.| ||||||||+|+|||.+ |.+||||||.|+.
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999997 9999999876666788999999999999999999999999 9999999999999976 9999999999986
Q ss_pred CCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc--c--
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD--R-- 262 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-- 262 (361)
...+. .......+..|+|||.+.| ..|+.+.||||.||++.||+.|++.|.+....+....+-.+-..... .
T Consensus 176 L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 43332 2234457889999999877 47999999999999999999999999987665554433222110000 0
Q ss_pred --cccccccCccccC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHhc
Q 018100 263 --TRHSLIADPELQG-----QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT--ALAYLASQ 316 (361)
Q Consensus 263 --~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--~l~~l~~~ 316 (361)
........+.+.. -.....+.++.+|+.++|..+|.+|.++.+++. .++.+...
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0000111111111 123345568999999999999999999999995 45555543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=328.43 Aligned_cols=270 Identities=27% Similarity=0.430 Sum_probs=217.6
Q ss_pred ceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEE
Q 018100 23 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYC 100 (361)
Q Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 100 (361)
..+.++++.-.++..+...||+|.||+||+|.|-+ .||||+++.... ...++|++|+.++++-+|.||+.+++++
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 33445666667778889999999999999999975 699999875544 3557899999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEe
Q 018100 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 180 (361)
Q Consensus 101 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~ 180 (361)
..... .||..+|+|.+|..+++... ..+.....+.|+.||++|+.|||.++ |+|+|||..|||+.++++|||+
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEe
Confidence 88877 99999999999999998743 56999999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhcc---CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
|||++..-..-.......+..|...|||||+++. ..|++.+||||||+++|||++|..||.....+...
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi-------- 602 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII-------- 602 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------
Confidence 9999876333333333445668889999999863 47899999999999999999999999833222111
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
|.- .+.....+. .....+++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 603 -fmV-GrG~l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 603 -FMV-GRGYLMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -EEe-cccccCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111 111111111 11123456689999999999999999999999998887766
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=319.27 Aligned_cols=266 Identities=27% Similarity=0.388 Sum_probs=204.6
Q ss_pred hhCcccCCeecccCceEEEEEEECC----------------CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccce
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES----------------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 95 (361)
.++|++.+.||+|+||.||+|.+.. ++..|++|++..... .....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3689999999999999999998643 345799999875432 23456889999999999999999
Q ss_pred eeeEEEcCCeeEEEEEecCCCCHHHHhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 018100 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160 (361)
Q Consensus 96 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 160 (361)
+++++.+....++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999998854211 1235788899999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh--CCC
Q 018100 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRK 238 (361)
Q Consensus 161 H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~ 238 (361)
|+||||+|||++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999875333322222233445778999999988889999999999999999987 556
Q ss_pred ccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 239 AVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 239 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
||......... ......+..... ......++.++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVI---ENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHH---HHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77654322211 111111111000 0001122334558899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=313.98 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=211.5
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchH---HHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
...+|++.+.||+|+||+|-+|.....|+.||||.+.+....+.+ .+.+|+++|..|+||||+.++++|++.+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 357899999999999999999999889999999999876555444 47789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||..+|.|.+++.. .+.+++.++..++.||.+|+.|||.++ ++|||||.+|||+|.++++||+|||++-.+
T Consensus 131 vMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999987 778999999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCC-ccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... ......+|++.|.+||++.|..|. +.+|.||||++||.|+.|..||++...... +..+. ...
T Consensus 204 ~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l---vrQIs--------~Ga 269 (668)
T KOG0611|consen 204 ADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL---VRQIS--------RGA 269 (668)
T ss_pred ccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH---HHHhh--------ccc
Confidence 332 233457899999999999998886 889999999999999999999998644322 11110 001
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
...| ..+.+..-||+.||..||++|-|+++|...-
T Consensus 270 YrEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 270 YREP--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111 1122445599999999999999999998753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=310.63 Aligned_cols=262 Identities=20% Similarity=0.322 Sum_probs=206.7
Q ss_pred ccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCccce
Q 018100 19 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~ 95 (361)
.+....+.+.|. ..-...||+|+++.||+|... |..||+|.+....... .+.+.+|+.+++.++||||++
T Consensus 10 ~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 10 NDIKCIESDDID-----KYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred CcceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 444445555552 222357999999999999984 8899999997654433 356779999999999999999
Q ss_pred eeeEEEc----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEE
Q 018100 96 LIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNIL 170 (361)
Q Consensus 96 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nil 170 (361)
+++++.+ ....++||||+++|+|.+++.. ...+++...+.++.|++.||.|||+. + ++||||||+||+
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nil 155 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFL 155 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEE
Confidence 9999866 3467899999999999999976 56789999999999999999999985 7 889999999999
Q ss_pred EcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHh
Q 018100 171 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 248 (361)
++.++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 156 l~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~ 230 (283)
T PHA02988 156 VTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230 (283)
T ss_pred ECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999999998753221 122357889999999976 6899999999999999999999999986543222
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.... .... .....+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 231 ~~~i------~~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 231 YDLI------INKN----------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHH------HhcC----------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111 0000 0011222345578899999999999999999999999987653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=336.76 Aligned_cols=255 Identities=21% Similarity=0.237 Sum_probs=208.2
Q ss_pred hCcccCCeecccCceEEEEEEECCC-CeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESI-NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
..|.+.+.||+|++|.||+|....+ +..|++|.+..........+..|+.+++.++||||+++++++..+...|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4499999999999999999998877 788999987655444455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++........++++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988654333567999999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||............. ... .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~------~~~--~------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL------YGK--Y------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC--C-------
Confidence 2222334568999999999998899999999999999999999999997654322111110 000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...+...+..+.++|.+||+.||++||++.+++.
T Consensus 289 --~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 --DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0112223447889999999999999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=319.83 Aligned_cols=243 Identities=26% Similarity=0.359 Sum_probs=199.5
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
+.||+|+||.||+|.++.++..||+|++.... ......+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcce
Q 018100 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 196 (361)
Q Consensus 117 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~ 196 (361)
+|..++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..... ....
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC--cccc
Confidence 99988875 567999999999999999999999999 99999999999999999999999999864211 1112
Q ss_pred eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCC
Q 018100 197 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 276 (361)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (361)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||............. . ... .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~--------~~~----~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------M--------EDI----K 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------c--------CCc----c
Confidence 233468999999999998899999999999999999999999997543322111110 0 001 1
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 277 YPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
++...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223345788899999999999997 88998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=318.63 Aligned_cols=240 Identities=26% Similarity=0.315 Sum_probs=196.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
||+|+||.||+|.++.++..||+|++.... ......+..|+.+++.++||||+++++.+.+....|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999986432 23345678899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999876 567999999999999999999999999 999999999999999999999999998752211 11223
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
...|+..|+|||++.+..++.++|||||||++|+|++|..||........... .... . ..++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~------~~~~--------~----~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK------ILQE--------P----LRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH------HHcC--------C----CCCC
Confidence 35689999999999998999999999999999999999999976433221111 0100 0 1122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRPV---IADVVT 308 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~ 308 (361)
...+..+.+++.+||..||.+||+ +.+++.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 233457889999999999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=312.55 Aligned_cols=260 Identities=34% Similarity=0.495 Sum_probs=208.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCC-----eEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|.....+ ..|++|.+..... .....+.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357999999999999999999986654 6799999864432 2345688999999999999999999999998899
Q ss_pred EEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC
Q 018100 107 LLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 174 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~ 174 (361)
+++|||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 999999999999999865321 1156889999999999999999999999 9999999999999999
Q ss_pred CceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHH
Q 018100 175 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 253 (361)
Q Consensus 175 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~ 253 (361)
+.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-- 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-- 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence 9999999999875333222222333456788999999988889999999999999999998 9999876443222111
Q ss_pred hhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
+.. . .....+...+.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 239 -i~~----~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -IRS----R----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHc----C----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 100 0 0011223445688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=324.44 Aligned_cols=254 Identities=26% Similarity=0.307 Sum_probs=206.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.+..++..||+|++.... ......+..|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986532 233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999875332
Q ss_pred CC---------------------------CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccc
Q 018100 191 GD---------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 243 (361)
Q Consensus 191 ~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 243 (361)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 21 001122346899999999999999999999999999999999999999765
Q ss_pred hHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 018100 244 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVTA 309 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~ll~~ 309 (361)
........+..... ....+. ....+..+.++|.+||. ||.+||+ +.++++.
T Consensus 234 ~~~~~~~~i~~~~~---------~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKE---------SLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCC---------cccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 53222111110000 000000 01134578889999997 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=307.80 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=210.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.++.++..|++|.+..... .....+.+|+.+++.++||||+++++++.+....++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 589999999999999999999999999999998764322 22346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999998754444566899999999999999999999999 99999999999999999999999998875322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ...... . ...
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~~~~~----~------~~~ 225 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-LCQKIE----Q------CDY 225 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-HHHHHh----c------CCC
Confidence 11 1112345788899999998888999999999999999999999998643321111 111110 0 000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
+. ......+..+.+++.+||..+|++||++.++++.++.+.
T Consensus 226 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 111233457889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=319.72 Aligned_cols=243 Identities=27% Similarity=0.354 Sum_probs=198.4
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
+.||+|+||.||+|.++.+|..||+|++.... ......+.+|+.+++.++||||+.+++.+......|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999986532 223345778999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcce
Q 018100 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 196 (361)
Q Consensus 117 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~ 196 (361)
+|..++.. ...+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+|||++..... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCc
Confidence 99988875 567999999999999999999999999 99999999999999999999999998864211 1111
Q ss_pred eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCC
Q 018100 197 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 276 (361)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (361)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||............. .. .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~~--------~~----~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------ME--------EI----R 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------cC--------CC----C
Confidence 223468999999999988899999999999999999999999996543322111110 00 00 1
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 277 YPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
.+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1223345788999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.39 Aligned_cols=242 Identities=30% Similarity=0.424 Sum_probs=194.1
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhc-CCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..||+|++.... ....+.+..|..++.. .+||||+++++++..+...|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999986432 2233445566666664 4799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998876 567999999999999999999999999 9999999999999999999999999987532211 2
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............. .. . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~--------~----~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL------ND--------R----P 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------C----C
Confidence 2234568999999999998889999999999999999999999997654322111110 00 0 1
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIA-DVVT 308 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~ll~ 308 (361)
..+...+.++.+++.+||+.||++||++. ++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12223345778899999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=326.34 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=204.3
Q ss_pred hhCcccCCeecccCceEEEEEEE-----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 105 (361)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... ....+.+.+|+.++..+ +||||+++++++.++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999974 3456789999986443 23345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC----------------------------------------------------------
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 127 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------------------- 127 (361)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 128 -------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 128 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1235788999999999999999999999 999999999999999999999999998753322211
Q ss_pred ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ....... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~~----~~---------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIKE----GY---------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHHh----Cc----------
Confidence 11222334567999999999999999999999999999998 8889865432211 1111110 00
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
....+...+.++.+++.+||+.||++||++.++++.|+.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001111223478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.21 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=202.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|+++.++..||||++.... ......+.+|+.++..++||||+.+++.+.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999996432 223355778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999876 567999999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcc------------------------------------eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHh
Q 018100 191 GDNTH------------------------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 234 (361)
Q Consensus 191 ~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll 234 (361)
..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 001235899999999999889999999999999999999
Q ss_pred hCCCccccchHHHhhh-HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 018100 235 SGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVTA 309 (361)
Q Consensus 235 ~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~~ 309 (361)
+|..||.......... +..+.. ....+. ....+..+.++|.+|+. +|.+|++ +.++++.
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~----------~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE----------TLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC----------ccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999997654322211 111000 000000 01123477889999996 8999997 8888863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.71 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=203.4
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCC-eEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..++|++.+.||+|+||.||+|.++.++ ..|++|++.... ....+.+.+|+.+++.++||||+++++++.++...|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4578999999999999999999976654 689999986432 223456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999976 567999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+ ....
T Consensus 181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i------~~~~----- 244 (340)
T PTZ00426 181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI------LEGI----- 244 (340)
T ss_pred cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH------hcCC-----
Confidence 3221 22346899999999999888999999999999999999999999765432211111 0000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
..++......+.+++.+||+.||.+|+ ++.++++.
T Consensus 245 -------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011222334678899999999999995 78887753
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=315.48 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=197.8
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHH---hcCCCCccceeeeEEEcCCeeEEE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
|++.+.||+|+||.||+|.++.++..|++|++.... ....+.+..|+.++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 778999999999999999999999999999986432 22334566666554 566799999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999888864 56999999999999999999999999 9999999999999999999999999886421
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. .........|+..|+|||.+.+..++.++|||||||++|+|++|..||............. ..
T Consensus 153 ~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~------~~-------- 216 (324)
T cd05589 153 G--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV------ND-------- 216 (324)
T ss_pred C--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------
Confidence 1 1122234568999999999999899999999999999999999999997654332211110 00
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
. ...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 E----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 011223345788899999999999999 5677765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=314.86 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=206.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeE----EEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..+|++.+.||+|+||.||+|.+..++.. |++|++..... ...+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 36799999999999999999998665553 89999864432 3346788899999999999999999998765 567
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++++|+++|+|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 899999999999998752 345889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..............++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~---~ 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG---E 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------CC---C
Confidence 433222211122234567999999998899999999999999999997 999997654332211111 00 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
. ...++.....+.+++.+||..||.+||++.+++..+..+....
T Consensus 229 ~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 R-------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C-------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 0112223447888999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=326.33 Aligned_cols=264 Identities=27% Similarity=0.423 Sum_probs=205.5
Q ss_pred HhhCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcCC
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 104 (361)
-.++|++.+.||+|+||.||+|.+... +..|++|++..... ...+.+.+|+.+++.+ +|+||+++++.+....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 346899999999999999999986443 35799999865432 2345688999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccC----------------------------------------------------------
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLS---------------------------------------------------------- 126 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~---------------------------------------------------------- 126 (361)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885311
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 127 --------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 127 --------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
....++++..++.++.||+.||.|||+++ ++||||||+|||+++++.++|+|||++.............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 01235788999999999999999999999 9999999999999999999999999987532222111122
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 277 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (361)
...++..|+|||++.+..++.++|||||||++|+|++ |..||........ ...... .. .....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~----~~----------~~~~~ 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVK----RG----------YQMSR 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHH----cc----------cCccC
Confidence 2334567999999988899999999999999999997 9999975432211 110000 00 00011
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 278 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
+...+.++.+++.+||+.||++||++.++++.|+.+.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1222457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=291.30 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=214.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++++.||.|.||.||+|+.+.++-.||+|++.+... ....++.+|+++-.+|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3788999999999999999999999999999999875432 2235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+||...|.|...++... ...+++...+.++.|++.||.|+|.++ ++||||||+|+|++..|.+|++|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999888533 567999999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.......+||..|.|||...+...+..+|+|++|++.||++.|.+||...........+..
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--------------- 236 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--------------- 236 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH---------------
Confidence 3334556899999999999999999999999999999999999999976543222221111
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
....+|+..+.++.++|.+|+..+|.+|....++++.-
T Consensus 237 ---~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 237 ---VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ---ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 11223455566889999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=322.69 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=214.3
Q ss_pred CCcccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccce
Q 018100 16 SDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 95 (361)
.++...|..+|++|.. ++.||.|+.|.||+|+.+ ++.||||+++.- -..+|+.|++|+|+||+.
T Consensus 113 ~qq~e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~ 176 (904)
T KOG4721|consen 113 QQQEELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIIT 176 (904)
T ss_pred hhhhhhccCCHHHhhh-------hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceee
Confidence 3455678888888874 679999999999999998 789999998532 224789999999999999
Q ss_pred eeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC
Q 018100 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175 (361)
Q Consensus 96 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~ 175 (361)
+.++|.....+|||||||..|.|...+.. +.+++......|..+||.|+.|||.+. |+|||||.-||||..+.
T Consensus 177 FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d 249 (904)
T KOG4721|consen 177 FKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDD 249 (904)
T ss_pred EeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccc
Confidence 99999999999999999999999999988 788999999999999999999999999 99999999999999999
Q ss_pred ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
.|||+|||-++..... ...-.+.||..|||||++++...+.|+||||||++|||||||..||.........
T Consensus 250 ~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------ 320 (904)
T KOG4721|consen 250 VVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------ 320 (904)
T ss_pred eEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE------
Confidence 9999999988742111 2223467999999999999999999999999999999999999998754332111
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
|.-.. -.+....|..++..+.-|+++||+..|..||++++++..|+.+.+
T Consensus 321 ---wGVGs-------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 321 ---WGVGS-------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ---EeccC-------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 11111 112223345556677789999999999999999999999976554
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=312.92 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=200.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|.++.++..||+|++...... ....+.+|+.+++.++||||+.+++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36899999999999999999999999999999998754322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 788777754 2356899999999999999999999999 999999999999999999999999998642221
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhh-h-HHHhhhhh----hccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-S-LVAWARPL----FQDRTR 264 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-~-~~~~~~~~----~~~~~~ 264 (361)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... . +....... +.....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1 11223457889999999865 45788999999999999999999999764322111 1 10000000 000000
Q ss_pred cccccCccccCCCC---------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 HSLIADPELQGQYP---------PRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 ~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.............+ ......+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000 011246778999999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.27 Aligned_cols=258 Identities=27% Similarity=0.343 Sum_probs=203.5
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--------------cchHHHHHHHHHHhcCCCCccce
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------------QGNREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~ 95 (361)
.+..++|++.+.||+|.||.|-+|.+..+++.||||++.+... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3557899999999999999999999999999999999964211 12357889999999999999999
Q ss_pred eeeEEEc--CCeeEEEEEecCCCCHHHHhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc
Q 018100 96 LIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKP-LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 172 (361)
Q Consensus 96 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~ 172 (361)
++++..+ .+.+|+|+|||..|.+...-. .++ +++.+++.++.++..||+|||.+| |+||||||+|+|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 9999865 568899999999887643222 344 999999999999999999999999 99999999999999
Q ss_pred CCCceeEecccccccCCCCC---CcceeeccccCcCcCCchhhccCC----CCccCceehhhHHHHHHhhCCCccccchH
Q 018100 173 RGYHPKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKA 245 (361)
Q Consensus 173 ~~~~~~L~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 245 (361)
++|.+||+|||.+.....+. ........+||+.|+|||...++. ...+.||||+|++||.|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999999987643321 111223368999999999886632 34788999999999999999999976543
Q ss_pred HHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 246 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
...-..+ .. ..+.-...+.....+.+||.+||++||++|.++.+|.....
T Consensus 325 ~~l~~KI------vn----------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 LELFDKI------VN----------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHH------hc----------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 2221111 11 11111111234558889999999999999999999886654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=318.31 Aligned_cols=266 Identities=22% Similarity=0.328 Sum_probs=200.0
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcC-----CeeE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 107 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 107 (361)
+|++.+.||+|+||.||+|.++.++..|++|.+.... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6899999999999999999999999999999986432 22335688899999999999999999987543 3579
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+++ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 789988875 567999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCC-cceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hhh-----
Q 018100 188 GPVGDN-THVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPL----- 258 (361)
Q Consensus 188 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~----- 258 (361)
...... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||............... ...
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322111 111233568999999999865 67899999999999999999999999765432221111000 000
Q ss_pred --hcccc------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 259 --FQDRT------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 259 --~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..... ............. .+..+..+.+++.+||+.||++||++.++++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHh-cCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0000000000000 01223467889999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.07 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=211.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+...+|++.+.||.|+||.||+|.++. +..+++|++..........+..|+.+++.++|+||+++++++.+....++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 345789999999999999999999988 8899999998766656678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.... +..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999997633 456899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........... ...
T Consensus 157 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~~------------ 219 (261)
T cd05148 157 DV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---ITA------------ 219 (261)
T ss_pred cc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HHh------------
Confidence 11 11122335667999999988889999999999999999998 8999976543221111 110
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
......+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 --GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00011123334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=308.10 Aligned_cols=256 Identities=28% Similarity=0.346 Sum_probs=209.4
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..+.|++++.||.|..|+||++..++++..+|+|++.+.....+ .....|-++|+.++||.+..+|..++.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 35678899999999999999999999999999999987654433 356679999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
+||||+||+|..+.+... ++.+++..+..++.+++.||+|||..| ||+|||||+||||.++|.|.|.||+++...
T Consensus 155 ~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999998754 678999999999999999999999999 999999999999999999999999986442
Q ss_pred CCCC-------------------------------C-c----------------------ceeeccccCcCcCCchhhcc
Q 018100 189 PVGD-------------------------------N-T----------------------HVSTRVMGTYGYCAPEYAKT 214 (361)
Q Consensus 189 ~~~~-------------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~ 214 (361)
.... . . ......+||-.|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 1100 0 0 00112568999999999999
Q ss_pred CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHccc
Q 018100 215 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 294 (361)
Q Consensus 215 ~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 294 (361)
...+.++|+|+||+++|||+.|.-||.+........-+ +.. +..+ .. .+..+..+.+||+++|.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~~------------~l~F-p~-~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VGQ------------PLKF-PE-EPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hcC------------CCcC-CC-CCcchhHHHHHHHHHhc
Confidence 99999999999999999999999999876554332111 110 0011 11 11445688999999999
Q ss_pred CCCCCCCC----HHHHHH
Q 018100 295 EQPDMRPV----IADVVT 308 (361)
Q Consensus 295 ~dP~~Rps----~~~ll~ 308 (361)
+||++|.- +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999987 666654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=335.28 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=211.0
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
.+++...++|++.+.||+|+||.||+|.+..++..||||++..... .....+.+|+..+..++|+|++++++.+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 4455667899999999999999999999999999999999865432 23456788999999999999999887764322
Q ss_pred --------eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 105 --------QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 105 --------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 367999999999999999764444567999999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 256 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 256 (361)
++|+|||++................|+..|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~---- 257 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT---- 257 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----
Confidence 9999999987543222222233456899999999999989999999999999999999999999765332211100
Q ss_pred hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 257 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... .....++..+..+.+++.+||+.||.+||++.++++.
T Consensus 258 --~~~-----------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 --LAG-----------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --hcC-----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 0011223344578899999999999999999999863
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=309.35 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=210.1
Q ss_pred hhCcccCCeecccCceEEEEEEE-----CCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..+|.+.+.||+|+||.||++.. ..++..+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 36799999999999999999985 3345679999987655555567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 108 LVYEYMPLGSVEDHLHDLS---------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
+|+||+++++|.+++.... .....+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986422 11235899999999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||............. ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~--~~ 238 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT--QG 238 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cC
Confidence 999999875322221111222335678999999988899999999999999999998 899987654322111110 00
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.. .. .+...+.++.+++.+||+.||.+||++.++++.|+.+...
T Consensus 239 --------~~---~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 --------RV---LQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --------Cc---CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00 00 0112334789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=316.87 Aligned_cols=242 Identities=28% Similarity=0.382 Sum_probs=197.5
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCC-CccceeeeEEEcCCeeEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 110 (361)
+|++.+.||+|+||.||+|.++.++..||+|++.... ....+.+..|+.++..+.| ++|+.+++.+.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999986432 2334567789999998876 56888999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999876 567899999999999999999999999 99999999999999999999999999864211
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ........|+..|+|||++.+..++.++|||||||++|+|++|..||............. ..
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~------~~--------- 216 (324)
T cd05587 154 G--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM------EH--------- 216 (324)
T ss_pred C--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC---------
Confidence 1 112233568999999999999899999999999999999999999997654322211110 00
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
...++...+..+.+++.+||..||.+|++.
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011122334578889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=317.88 Aligned_cols=243 Identities=27% Similarity=0.347 Sum_probs=198.4
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
+.||+|+||.||+|.++.++..|++|++.... ......+..|+.+++.++||||+.+++.+.+....|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999986532 223355678999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 117 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
+|..++.. ...+++..+..++.||+.||.|||+ ++ ++||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence 99988875 5679999999999999999999997 78 999999999999999999999999998642111 11
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--------------~----~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------E----I 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--------------C----C
Confidence 122346899999999999889999999999999999999999999765432222111100 0 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
.++...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11222344788899999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=306.60 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=204.8
Q ss_pred hhCcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++ ..+..|++|.+..... .....+.+|+..+..++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 568999999999999999999875 3467899999875432 233568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++... ...+++..++.++.||+.||+|||+++ ++|+||+|+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998752 346899999999999999999999999 999999999999999999999999987542
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||............ . . ...
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~----~---~~~ 226 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV---E----D---GFR 226 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH---H----C---CCC
Confidence 1111 111111234568999999988999999999999999999875 99999765433211111 0 0 000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
...+...+..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 227 -------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011233455788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.50 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=197.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..+|+..+.||+|+||.||+|.+..+++.|+||++...... ....+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 46778889999999999999999999999999998654322 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+. ...++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++......
T Consensus 153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999998542 23567888999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeccccCcCcCCchhhcc-----CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
........|+..|+|||++.. ...+.++|||||||++|+|++|..||................ ..
T Consensus 222 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~----- 291 (353)
T PLN00034 222 --MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MS----- 291 (353)
T ss_pred --cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---cc-----
Confidence 111223468999999998743 234568999999999999999999997432221111111000 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.....+...+.++.+||.+||+.||++||++.++++.-
T Consensus 292 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 292 ------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00111223445788999999999999999999999753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=316.64 Aligned_cols=238 Identities=29% Similarity=0.421 Sum_probs=194.3
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..||+|++... .....+.+..|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998643 223345667788888776 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..... ...
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCC
Confidence 999998876 567999999999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~------------~ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDE------------V 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hcCC------------C
Confidence 223356899999999999889999999999999999999999999765433221111 0000 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIA 304 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 304 (361)
..+...+.++.+++.+||+.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 11222345788999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=317.43 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=205.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|.++.++..+++|.+..... .....+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4789999999999999999999999999999998865422 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ + ++|+||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999976 45689999999999999999999974 7 99999999999999999999999999864321
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh-hhhc---cccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQ---DRTRHS 266 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~---~~~~~~ 266 (361)
. ......++..|+|||++.+..++.++|||||||++|+|++|..||................ .... ......
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 1 1223458889999999998889999999999999999999999997654322211110000 0000 000000
Q ss_pred c------ccCcc-----------------ccCCC-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 L------IADPE-----------------LQGQY-PPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~------~~~~~-----------------~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ...+. ..... ......++.+|+.+||+.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 00000 00000 01123467889999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.88 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=207.3
Q ss_pred hhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
..+|.+.+.||+|+||.||+|.+.. ++..|++|.+...... ..+.+.+|+.+++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3678999999999999999998753 3578999998765444 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 107 LLVYEYMPLGSVEDHLHDLS----------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
++||||+++++|.+++.... .....+++..+..++.||+.||.+||+++ ++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999987531 12345889999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 255 (361)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.............
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-- 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence 99999999864322221111223345678999999999999999999999999999998 999986554332211110
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
. ... ...+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 239 -----~---~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 -----Q---GRL-------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -----c---CCc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 000 0111223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.65 Aligned_cols=241 Identities=29% Similarity=0.444 Sum_probs=194.8
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..||+|++.... ....+.+..|..++..+ +||||+++++.+.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999986532 22344566777777654 899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||++| ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence 999998876 567899999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............. .. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~------~~--------~~---- 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR------VD--------TP---- 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------CC----
Confidence 2234568999999999999899999999999999999999999997654322111110 00 01
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIA-DVV 307 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~ll 307 (361)
..+.....++.+++.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11222345788899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=322.14 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=200.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.++.++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986432 223356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999876 567899999999999999999999999 99999999999999999999999999853211
Q ss_pred CCCc---------------------------------------------ceeeccccCcCcCCchhhccCCCCccCceeh
Q 018100 191 GDNT---------------------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 225 (361)
Q Consensus 191 ~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 225 (361)
.... .......|+..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001235899999999999889999999999
Q ss_pred hhHHHHHHhhCCCccccchHHHhhh-HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCC---C
Q 018100 226 FGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR---P 301 (361)
Q Consensus 226 lG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---p 301 (361)
|||++|+|++|..||.......... +..+.. . +..+. ....+.++.++|.+||. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------~--~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE--------T--LYFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC--------c--cCCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999997654322111 111100 0 00000 01223477889999997 67665 5
Q ss_pred CHHHHHHH
Q 018100 302 VIADVVTA 309 (361)
Q Consensus 302 s~~~ll~~ 309 (361)
++.++++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=335.05 Aligned_cols=263 Identities=31% Similarity=0.464 Sum_probs=223.7
Q ss_pred hCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.+....+.||+|.||+||+|+--+ ....||||.++..... ...+|.+|++++..|+|||||+++++|.+++-.|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 556678899999999999998643 3567999999876665 6678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCC------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 108 LVYEYMPLGSVEDHLHDLSP------G----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~------~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
+|+|||+.|+|.+++..... . ..+++..+.+.|+.|||.|++||-++. +|||||...|+||+++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999964321 1 234899999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhh
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 256 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 256 (361)
||+|||+++.....++........-...|||||.+...+|+.+|||||+|++|||+++ |..||.+....+....+..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-- 720 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-- 720 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc--
Confidence 9999999987555555555444556789999999999999999999999999999999 9999977655544433321
Q ss_pred hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 257 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
-.+ ..+|.+++.++.+|+..||+.+|++||++.||-.+|......
T Consensus 721 --------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 721 --------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 111 456677788999999999999999999999999999877654
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=308.99 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=211.0
Q ss_pred hhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.+........+.+.+|+.+++.++|+||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 4678999999999999999998643 35668999887655555567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC
Q 018100 108 LVYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~ 175 (361)
+||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 9999999999999986522 11245899999999999999999999999 99999999999999999
Q ss_pred ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHh
Q 018100 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 254 (361)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--- 237 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC--- 237 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999999999875332222222233446778999999988899999999999999999998 9999865443222111
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.. .. .. ...+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 238 ~~----~~-~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 IT----QG-RV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred Hh----CC-CC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 10 00 00 001122345788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=320.55 Aligned_cols=253 Identities=25% Similarity=0.261 Sum_probs=200.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.|++++.||+|+||.||+|.++.++..||+|++..... ...+.+..|+.+++.++|+||+++++.+.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68899999999999999999999999999999865322 233568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999876 567999999999999999999999999 999999999999999999999999987532100
Q ss_pred CC---------------------------------------------cceeeccccCcCcCCchhhccCCCCccCceehh
Q 018100 192 DN---------------------------------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 226 (361)
Q Consensus 192 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 226 (361)
.. ........||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000112468999999999988889999999999
Q ss_pred hHHHHHHhhCCCccccchHHHhhh-HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcc--cCCCCCCCCH
Q 018100 227 GVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV--HEQPDMRPVI 303 (361)
Q Consensus 227 G~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dP~~Rps~ 303 (361)
||++|+|++|..||.......... +..+... . ........+.++.++|.+|+ ..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------~-----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT----------L-----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc----------c-----CCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 999999999999997654322211 1110000 0 00001122347788998844 5566679999
Q ss_pred HHHHHH
Q 018100 304 ADVVTA 309 (361)
Q Consensus 304 ~~ll~~ 309 (361)
.+++..
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=319.66 Aligned_cols=255 Identities=23% Similarity=0.244 Sum_probs=199.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.++.++..||+|++.... ......+..|+.++..++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986532 223356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc---------------------------------ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCC
Q 018100 191 GDNT---------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237 (361)
Q Consensus 191 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 237 (361)
.... .......||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1000 0012346899999999999989999999999999999999999
Q ss_pred CccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 018100 238 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH--EQPDMRPVIADVVTA 309 (361)
Q Consensus 238 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dP~~Rps~~~ll~~ 309 (361)
.||...........+.... .....+. . ...+..+.++|.+++. .++..||++++|++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~---------~~~~~p~---~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK---------ETLIFPP---E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc---------CcccCCC---c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9997654332211111000 0000000 0 0123467778887654 233356899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=313.98 Aligned_cols=243 Identities=28% Similarity=0.387 Sum_probs=197.3
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.+++.||+|++.... ....+.+..|..++..+ +||||+.+++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999986532 22334567788888766 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999988876 567899999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i------~~~~------------~ 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI------LHDD------------V 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH------HcCC------------C
Confidence 223346899999999999889999999999999999999999999765433221111 0000 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRP-------VIADVVTA 309 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~~ll~~ 309 (361)
..+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11222345788899999999999999 77777753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=311.34 Aligned_cols=244 Identities=27% Similarity=0.365 Sum_probs=197.2
Q ss_pred CCeecccCceEEEEEEEC---CCCeEEEEEEeccCC----ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 39 ESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++.||+|+||.||++... .++..||+|++.... ......+..|+.+++.++||||+++++.+.++...|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 468899999986432 1223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999999876 567899999999999999999999999 999999999999999999999999998642111
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........|+..|+|||++.+..++.++|||||||++|+|++|..||............ ... .
T Consensus 154 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~------~~~--------~- 216 (323)
T cd05584 154 --GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI------LKG--------K- 216 (323)
T ss_pred --CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH------HcC--------C-
Confidence 11223346899999999998888999999999999999999999999765432211111 000 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
...++..+..+.+++.+||+.||++|| ++.++++.
T Consensus 217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111223344788999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.33 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=208.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
..+|++.+.||+|++|.||+|.++.++..|++|.+... ......+.+|+.+++.++|+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 35688999999999999999999988999999998643 33356788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999986522 356899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. ........+..|+|||.+.+..++.++|||||||++|+|++ |..||............. .
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~-------------- 220 (263)
T cd05052 159 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---K-------------- 220 (263)
T ss_pred e-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C--------------
Confidence 1 11111223567999999988899999999999999999998 999987643322211110 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
......+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 001112233445888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.72 Aligned_cols=254 Identities=24% Similarity=0.220 Sum_probs=201.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.+|++++.||+|+||.||+|+++.++..||+|++.... ......+.+|+.+++.++|+||+++++.+.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 123456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999998742210
Q ss_pred CCC-----------------------------------------cceeeccccCcCcCCchhhccCCCCccCceehhhHH
Q 018100 191 GDN-----------------------------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 229 (361)
Q Consensus 191 ~~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~ 229 (361)
... ........|+..|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 000112468999999999999899999999999999
Q ss_pred HHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC---CHHHH
Q 018100 230 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP---VIADV 306 (361)
Q Consensus 230 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~l 306 (361)
+|+|++|..||................. .. ........+..+.++|.+|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~---------~~-----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWET---------TL-----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCc---------cc-----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 9999999999976544322111110000 00 00001122346777888876 5999999 88999
Q ss_pred HHH
Q 018100 307 VTA 309 (361)
Q Consensus 307 l~~ 309 (361)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=308.30 Aligned_cols=266 Identities=22% Similarity=0.294 Sum_probs=197.0
Q ss_pred hCcccCCeecccCceEEEEEEECC-CCeEEEEEEeccCCcc--chHHHHHHHHHHhcC---CCCccceeeeEEE-----c
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCA-----D 102 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~-~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 102 (361)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 4688999998643322 223456677776655 6999999999885 3
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
....++||||++ ++|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 79999886533 346899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhhhhhcc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQD 261 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 261 (361)
|++...... .......++..|+|||++.+..++.++|||||||++|+|++|..||.......... +..........
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 998753222 22233458899999999988889999999999999999999999997654432221 11111000000
Q ss_pred cccc-ccccC-------ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 RTRH-SLIAD-------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 ~~~~-~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.... ..... +.......+..+..+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000 00000111233457788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=308.08 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=197.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
||+|+||.||+|.++.++..|++|.+...... ..+.+..|+.+++.++|+||+.+.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998643222 224567899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.........+++..++.++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9887554334567999999999999999999999999 9999999999999999999999999986532221 1122
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
...|+..|+|||.+.+..++.++|||||||++|+|++|..||............ ...... . ....+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~---------~---~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILN---------D---SVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhcc---------c---CCCCc
Confidence 346889999999999999999999999999999999999999754321111000 000000 0 01122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
...+..+.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 33445788999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=308.70 Aligned_cols=266 Identities=28% Similarity=0.406 Sum_probs=210.2
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEE
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCA 101 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 101 (361)
+....++|++.+.||+|+||.||+|.+... ...+++|.+..... .....+.+|+.++..+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 345567899999999999999999998643 37899999865322 2335688899999999 7999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
.+...+++|||+++++|..++.... .....+++..++.++.||+.||.|||+++ ++|+||+|+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 9999999999999999999986421 22457899999999999999999999999 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHh
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 248 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~ 248 (361)
+++.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999875333221111222234567999999988899999999999999999997 9999876543322
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
..... ... ....+...+..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 244 ~~~~~-------~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLK-------EGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHH-------cCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 21110 000 01112233457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=312.85 Aligned_cols=242 Identities=31% Similarity=0.446 Sum_probs=194.7
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhc-CCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..||+|++.... ....+....|..++.. ++||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999986532 2233456667777775 4899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999876 467899999999999999999999999 9999999999999999999999999986422211 1
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--------------~~---- 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--------------NP---- 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CC----
Confidence 223346899999999999889999999999999999999999999765432221111100 01
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIA-DVVT 308 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~ll~ 308 (361)
.++......+.+++.+||+.||++||++. ++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11122334778899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=305.22 Aligned_cols=255 Identities=23% Similarity=0.293 Sum_probs=204.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.++.++..|++|++..........+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 46899999999999999999999988999999998755444556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999875 567899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.......++..|+|||.+. ...++.++|+|||||++|+|++|..||.......... .. ......
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------~~--~~~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------LM--SKSNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------ee--ecCCCC
Confidence 1122345788899999874 3457889999999999999999999985432211100 00 000000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.. ......+..+.+++.+||+.+|++||+++++++.
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 228 PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0111 0011234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=328.25 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=199.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcC--------C
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------D 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~ 104 (361)
.++|++.+.||+|+||.||+|.+..++..||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 468999999999999999999999999999999885432 2345799999999999999998876432 2
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEeccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFG 183 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg 183 (361)
.+++||||++ ++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999997 6888877654444678999999999999999999999999 99999999999999665 69999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhhhhcc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQD 261 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~ 261 (361)
++....... ......++..|+|||++.+. .++.++|||||||++|+|++|.+||........... ..........
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 997532221 12234678999999998664 689999999999999999999999976543322211 1110000000
Q ss_pred c----------cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 R----------TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ..........+...++...+.++.+||.+||..||.+|||+.++++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00000001111122233345688999999999999999999999964
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.10 Aligned_cols=242 Identities=28% Similarity=0.427 Sum_probs=197.2
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..||+|++.... ......+..|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 23345677888888877 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GV 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CC
Confidence 999998876 557999999999999999999999999 999999999999999999999999988642111 11
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............ ... . .
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i------~~~--------~----~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI------LED--------E----V 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcC--------C----C
Confidence 122345889999999999999999999999999999999999999765432211111 000 0 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVI-----ADVVT 308 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~ll~ 308 (361)
..+...+..+.++|.+||+.||.+||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1122334578899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=314.88 Aligned_cols=242 Identities=28% Similarity=0.369 Sum_probs=196.9
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+|++.+.||+|+||.||+|.++.++..||+|++..... ...+.+..|..++..+ +|++|+.+++.+.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999875322 2234466677777776 5899999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998876 567999999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------~~--------- 216 (323)
T cd05616 154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EH--------- 216 (323)
T ss_pred C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH------hC---------
Confidence 1 112233568999999999999999999999999999999999999997654332211110 00
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
...++...+.++.+++.+||+.||++|++.
T Consensus 217 ---~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 ---NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011222344578899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.79 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=211.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|++|.||+|.+..+|..|++|.+.... ......+.+|+.+++.++|+|++++++.+......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999889999999886422 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++......+..+++..++.++.||+.||.|||+.| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998765444567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..... ..
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~----~~--------- 222 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKI----EK--------- 222 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-HHhhh----hc---------
Confidence 21 1122235788899999998888999999999999999999999998644311110 00000 00
Q ss_pred ccccCCCCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 271 PELQGQYPP-RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 271 ~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
......+. ..+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 223 -~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 -CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00011111 34457888999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.33 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=198.7
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
+.||+|+||.||+|.++.++..+++|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 468999999999999998899999998764332 2345688999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.. .+..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999864 1346899999999999999999999999 9999999999999999999999999987432211111111
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 277 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (361)
....+..|+|||.+.+..++.++||||||+++|+|++ |..||.............. . .....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------~----------~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------G----------VRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-------C----------CCCCC
Confidence 1123456999999988889999999999999999998 8888865433221111110 0 00111
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 278 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.34 Aligned_cols=253 Identities=25% Similarity=0.295 Sum_probs=203.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|.+.+.||+|+||.||+|.++.++..||+|++..... ...+.+.+|+.+++.++|+||+.+++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999875322 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999762 257999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhc------cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAK------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
... .......++..|+|||++. +..++.++|||||||++|+|++|..||...........+ .... .
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~-~ 226 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------MNFQ-R 226 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH------HcCC-C
Confidence 211 1223346899999999986 456789999999999999999999999765432221111 0000 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. . .....+..+..+.+|+..||. +|++||++.++++
T Consensus 227 ~--~-----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 F--L-----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred c--c-----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0 000112234578889999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=307.34 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=202.8
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.|++.+.||+|+||.||++.+..++..||+|++...... ....+.+|+.+++.++||||+++++.+.++...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999999988999999998653221 22456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998876422 356999999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. ......|+..|+|||++.+..++.++||||+||++|+|++|..||............. .....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~~~~~----------- 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKE----------- 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--HHhhh-----------
Confidence 1 1123468899999999988889999999999999999999999997643321111100 00000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
....++...+..+.+++.+||..||++|| ++.++++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00112223444778899999999999999 78888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=320.47 Aligned_cols=251 Identities=25% Similarity=0.273 Sum_probs=198.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
+|++++.||+|+||.||+|+++.++..||+|++..... .....+.+|+.+++.++|+||+++++.+.++...|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999865322 233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999876 456899999999999999999999999 999999999999999999999999987431100
Q ss_pred C---------------------------------------------CcceeeccccCcCcCCchhhccCCCCccCceehh
Q 018100 192 D---------------------------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 226 (361)
Q Consensus 192 ~---------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 226 (361)
. .........|+..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000112468999999999998899999999999
Q ss_pred hHHHHHHhhCCCccccchHHHhhh-HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC---
Q 018100 227 GVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV--- 302 (361)
Q Consensus 227 G~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 302 (361)
||++|+|++|..||.......... +..+.. ....+ .....+.++.++|.+|+ .+|.+|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------~~~~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQT----------SLHIP-----PQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCC----------CcCCC-----CcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 999999999999997654322211 111000 00000 01122346778888876 59999987
Q ss_pred HHHHHH
Q 018100 303 IADVVT 308 (361)
Q Consensus 303 ~~~ll~ 308 (361)
+.++++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 777775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=300.95 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=205.8
Q ss_pred hCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
++|++.+.||+|+||.||+|.++.+ ...|++|.+...... ....+..|+.+++.++||||+++++++.+....+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 6799999999999999999998654 457999988654322 335688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998652 246899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~~~~-------~- 226 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK---AVEDGY-------R- 226 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH---HHHcCC-------C-
Confidence 2222211222334568999999988889999999999999999998 999986543222111 110000 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 227 ------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=315.25 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=196.2
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..||+|++.... ....+.+..|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997532 22335577899999888 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCC
Confidence 999988865 567999999999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH--hhhHHHhhhhhhccccccccccCccc
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--EQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||+...... ......+....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------~ 220 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-----------K 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------C
Confidence 2233568999999999999899999999999999999999999996422111 00000000000000 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPV------IADVVT 308 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~ll~ 308 (361)
....+...+..+.+++.+||+.||.+|++ +.++++
T Consensus 221 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 221 QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 01122233457888999999999999997 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.90 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=205.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
+|++.+.||+|+||.||++.++.++..+++|.+.... ....+.+..|+.+++.++|+|++++++.+.++...++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999999999999999986432 234466888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++.... ...+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 9999999886422 456899999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
........++..|+|||++.+..++.++|+||||+++|+|++|..||............. .. ..
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~------~~--~~-------- 217 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC------QG--SY-------- 217 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh------cC--CC--------
Confidence 112233457888999999988889999999999999999999999997643322111110 00 00
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+..+.+++.+||+.||++||++.+++.+
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122234467889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=295.76 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=209.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+.+.|++-+.||+|.|+.|+++.+..+|+.+++|+++.. .....+.+.+|+.+.+.|+||||+.+.+.+......|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3557899999999999999999999999999999998643 33356789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEeccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLA 185 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Dfg~~ 185 (361)
|+|+++|++|-.-+.. ...+++..+-.++.||++||.|+|.++ |||||+||+|+++-. .--+||+|||++
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999766654 355789999999999999999999999 999999999999954 345999999999
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
.... .........|++.|+|||+++..+++..+|||+.|++||-|+.|++||.+........-+ .. .
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I------~~----g 227 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI------KA----G 227 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH------hc----c
Confidence 8643 333344567999999999999999999999999999999999999999774332211100 00 1
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
+-.+.....+...++..+|+++||..||.+|.|+.|.|.
T Consensus 228 ----~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 ----AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 112223334556668999999999999999999998874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.75 Aligned_cols=240 Identities=26% Similarity=0.327 Sum_probs=193.8
Q ss_pred CCeecccCceEEEEEEE---CCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 39 ESLLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~---~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++.||+|+||.||++.+ +.+|..|++|++..... .....+..|+.+++.++||||+++++++.++...|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999876 35689999999875322 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 151 (318)
T cd05582 81 RGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 151 (318)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence 99999999865 567999999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
........|+..|+|||.+.+..++.++|||||||++|+|++|..||............ ....
T Consensus 152 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i------~~~~----------- 214 (318)
T cd05582 152 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI------LKAK----------- 214 (318)
T ss_pred CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH------HcCC-----------
Confidence 11223356889999999998888999999999999999999999999765432221111 0000
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 305 (361)
...+...+..+.+++.+||+.||++||++.+
T Consensus 215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0112223447788999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=321.08 Aligned_cols=262 Identities=18% Similarity=0.185 Sum_probs=199.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
..+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999999999999999753 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 788888865 456899999999999999999999999 9999999999999999999999999986421111
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHH-------Hhh-hHHHhhhh---hhcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA-------AEQ-SLVAWARP---LFQD 261 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~-------~~~-~~~~~~~~---~~~~ 261 (361)
........||..|+|||++.+..++.++|||||||++|+|++|..||-..... ... .+...... .+..
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 11122346899999999998889999999999999999999999876432110 000 00000000 0000
Q ss_pred c-----------cccccccCccccCC--CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 R-----------TRHSLIADPELQGQ--YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~-----------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ........+..... .....+.++.+||.+||+.||.+|||+.++++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00000000000000 001235578899999999999999999999964
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.03 Aligned_cols=254 Identities=23% Similarity=0.262 Sum_probs=203.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.++..||+|++.... ......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 578999999999999999999999999999999986431 22334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999865 45899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccC----CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
... ........|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+ .....
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~~-- 264 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------MDHKN-- 264 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH------HcCCC--
Confidence 211 1112234689999999998653 4789999999999999999999999765432211111 00000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~ll~~ 309 (361)
....+ .....+..+.++|.+||..+|++ |+++.++++.
T Consensus 265 -~~~~~-----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -SLTFP-----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -cCCCC-----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00000 01123458889999999999988 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=306.42 Aligned_cols=251 Identities=35% Similarity=0.539 Sum_probs=195.9
Q ss_pred cCCeecccCceEEEEEEEC----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 38 SESLLGEGGFGRVYKGYLE----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+.+.||.|.||.||+|.+. ..+..|+||.+..... ...+.+.+|+..++.++||||+++++++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999998 4467899999965333 2367899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++|+|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999998731 367999999999999999999999999 9999999999999999999999999987642222
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.............|+|||.+.+..++.++||||||+++|||++ |..||............ .. .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~---~~----~--------- 221 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL---KQ----G--------- 221 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH---HT----T---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc----c---------
Confidence 2222333456778999999988889999999999999999999 77898765332211111 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.....+...+..+.+++.+||+.||++||++.++++.|
T Consensus 222 -~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 -QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00111223445788899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.07 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=210.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.+|++.+.||+|++|.||+|.++.++..+++|.+..... .....+.+|+.+++.++|+||+++++.+..+...++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 578999999999999999999998899999998765332 23356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754434567899999999999999999999999 99999999999999999999999998875322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ...... ....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----------~~~~ 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKIE----------QCDY 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hhhhhh----------cCCC
Confidence 21 1112345788999999998888999999999999999999999999643221111 000000 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
+.. .+...+..+.+++.+||..||++|||+.+|++.++++.
T Consensus 226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 100 11234457889999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=305.74 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=204.4
Q ss_pred HHhhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
...++|++.+.||+|+||.||.|.++. ++..|++|++..... .....+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356889999999999999999998753 356799998854322 23456888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 999999999999999998653211 234678889999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||............. ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM--EG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--cC
Confidence 999999875332222111122345678999999988889999999999999999998 788987654332221110 00
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.. + ..+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 238 ------~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 ------GL-----L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ------Cc-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 0 111223347888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.24 Aligned_cols=238 Identities=27% Similarity=0.358 Sum_probs=191.0
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHH-HHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.+|+.|++|++..... .....+..|.. +++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999864321 12234444544 56778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||++| ++||||||+|||++.++.++|+|||++..... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCC
Confidence 999998876 567999999999999999999999999 99999999999999999999999999864211 112
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............ ... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~--------~~---- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI------LNK--------PL---- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH------HcC--------CC----
Confidence 223346899999999999989999999999999999999999999764332211110 000 00
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIA 304 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 304 (361)
..++..+..+.+++.+||+.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11122344788899999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=314.12 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=192.3
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..||+|++.... ......+..|+.++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999987532 22334577888888776 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999988865 567999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh--hhHHHhhhhhhccccccccccCccc
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE--QSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||........ .....+....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----------~ 220 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------K 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----------C
Confidence 12335689999999999999999999999999999999999999953211100 0000000000000 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
....+...+..+.+++.+||+.||++||++
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 011233344577889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=292.11 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=216.3
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc----c----hHHHHHHHHHHhcC-CCCccceee
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----G----NREFLVEVLMLSLL-HHPNLVNLI 97 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~----~~~~~~e~~~l~~l-~h~~i~~~~ 97 (361)
...+.+...|.-.+.||.|..+.|.++.++.+|..+++|++...... . .++-..|+.+|+++ .||+|+.+.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 34467788999999999999999999999999999999998643211 1 13455699999988 599999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
|+++.+...++|++.|+.|.|.+++.. .-.+++.....++.|+++|++|||.++ ||||||||+|||++++.++
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence 999999999999999999999999987 678999999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhcc------CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 251 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 251 (361)
+|+|||++.... .+......+||+.|+|||.+.. ..|+..+|+|++|+++|.|+.|++||-...+.....+
T Consensus 163 ~isDFGFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ 239 (411)
T KOG0599|consen 163 KISDFGFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRM 239 (411)
T ss_pred EEeccceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHH
Confidence 999999998533 3333455789999999998853 4688999999999999999999999977655444433
Q ss_pred HHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 252 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+....- .+...-..+.+....+||.+||+.||.+|.|+.++|+.
T Consensus 240 ImeGky--------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKY--------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhccc--------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 322211 12223344556678899999999999999999999973
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=301.79 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=203.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCe----EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~----~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+|++.+.||+|+||.||+|.+..++. .+++|.+..... .....+..|+..+..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 678899999999999999999977665 477777753322 223567778888999999999999998754 45778
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
++||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999752 356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.............++..|+|||.+.+..++.++||||||+++|+|++ |..||..........+.. . ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~---~~~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------K---GER 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------C---CCc
Confidence 32222222233446678999999988889999999999999999998 999997654322221111 0 000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
... +..++..+.+++.+||..||++||++.++++.|..+...
T Consensus 230 ~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 001 111234678899999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=299.62 Aligned_cols=253 Identities=28% Similarity=0.368 Sum_probs=204.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
++|.+.+.||+|++|.||.|.+..++..|++|.+...... ....+.+|+.+++.++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999988999999998643221 23467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999876 456899999999999999999999999 999999999999999999999999998653
Q ss_pred CCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~----~------- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF--KIA----T------- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH--HHh----c-------
Confidence 2211111 1123457788999999998889999999999999999999999996543221110 000 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......+...+..+.+++.+||..+|.+||++.++++.
T Consensus 222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ---QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000112223344578889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=302.71 Aligned_cols=252 Identities=31% Similarity=0.488 Sum_probs=205.0
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchH--HHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
|++.+.||+|+||.||+|.+..++..+|+|++......... ....|+.+++.++||||+++++++.++...++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78899999999999999999999999999999876544332 2456999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++.. ...+++..++.++.||++||.+||+++ ++|+||+|+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 98899999984 567899999999999999999999999 999999999999999999999999998753 222
Q ss_pred cceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh-hhhccccccccccCc
Q 018100 194 THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQDRTRHSLIADP 271 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 271 (361)
........++..|+|||++. +..++.++||||||+++|+|++|..||................ ......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS--------- 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------
Confidence 23334456888999999998 7889999999999999999999999998763222222211111 000000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..........+.+++.+||+.||++||++.++++
T Consensus 223 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 ---SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011258889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.95 Aligned_cols=255 Identities=26% Similarity=0.282 Sum_probs=218.6
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCC-CCccceeeeEEEcCCe
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 105 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 105 (361)
..+...|++.+.||.|.||.||.++.+.+|..+|+|++.+.... ..+.+.+|+.+|+++. ||||+.+++++++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 45567899999999999999999999999999999999765443 3458999999999998 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC----CceeEec
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLSD 181 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~----~~~~L~D 181 (361)
.++|||++.||.|.+.+... .+++.++..++.|++.|+.|||+.| ++||||||+|+|+... +.++++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999999873 3999999999999999999999999 9999999999999643 4799999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...........+...
T Consensus 183 FGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~------ 253 (382)
T KOG0032|consen 183 FGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG------ 253 (382)
T ss_pred CCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC------
Confidence 999986433 44556678999999999999899999999999999999999999999876654333211111
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+..+.....+.....+.++|+.|+..||.+|+++.++++.
T Consensus 254 --------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 --------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1133334445567788999999999999999999999983
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=300.58 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=205.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|++|.||+|.... +..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4689999999999999999999765 6779999876432 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.... ...++...++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999986532 456889999999999999999999999 9999999999999999999999999997643221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........... ....+ ..
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~~~~----------~~ 223 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA---LQRGY----------RM 223 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH---HHcCC----------CC
Confidence 1 11122335667999999988889999999999999999998 9999975433221111 10000 00
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
......+..+.+++.+||..+|++||++.++++.|+.
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111233478889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=313.16 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=198.2
Q ss_pred CcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCC----ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCee
Q 018100 35 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNG----VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 106 (361)
+|++.+.||+|+||.||+|... .++..|++|++.... ....+.+..|+.++..+ +|++|+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999998864 468899999986432 12235577899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999876 567999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
....... .......|+..|+|||++.+. .++.++|||||||++|+|++|..||............ ......
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~----- 225 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK----- 225 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-----
Confidence 5322211 112234689999999999765 4788999999999999999999999643221111000 000000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
.++. .+...+..+.+++.+||+.||++|| ++.++++
T Consensus 226 ---~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0111 1223344788899999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.12 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=208.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
...+|++.+.||+|++|.||+|.+..++..|++|.+........+.+.+|+.+++.+.|+|++++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 35789999999999999999999998999999999977666666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.. ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999864 45899999999999999999999999 999999999999999999999999988753221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. .......++..|+|||.+.+..++.++|||||||++|+|++|..||......... ..... . .. +
T Consensus 170 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~----~--~~-----~ 234 (296)
T cd06654 170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIAT----N--GT-----P 234 (296)
T ss_pred c--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhc----C--CC-----C
Confidence 1 1122345788999999998888999999999999999999999999754432111 10000 0 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ...+...+..+.+++.+||..||++||++.++++.
T Consensus 235 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 E--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred C--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 01122334578889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=310.82 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=216.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
++.+=|.+.+.||+|.|+.|-+|++--+|+.||||++++...+. ...++.|+..|+..+||||+++|++..++..+||
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 34567999999999999999999999999999999998765554 3578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE-cCCCceeEeccccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv-~~~~~~~L~Dfg~~~~ 187 (361)
|+|.-++|+|.++|... ...+++..+.+++.||+.|+.|+|... +|||||||+||.+ ..-|-+||.|||++-.
T Consensus 95 iLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecccccc
Confidence 99999999999999763 467999999999999999999999999 9999999999866 5678999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCC-ccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
+.. +......+|+..|.|||++.|..|+ +++||||||++||.|++|++||...+..+...++
T Consensus 169 f~P---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI-------------- 231 (864)
T KOG4717|consen 169 FQP---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI-------------- 231 (864)
T ss_pred CCC---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--------------
Confidence 433 3334556899999999999999887 7899999999999999999999876554333222
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......|.....++.+||..||..||++|-+.++|...
T Consensus 232 ----mDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 ----MDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----hcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 122234567788899999999999999999999888753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.28 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=206.1
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|.+.+.||+|++|.||+|.++.++..|++|.+.... ......+.+|+.+++.++|||++++++.+.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5888999999999999999999999999999986432 33456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.... +..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~- 154 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN- 154 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc-
Confidence 99999999997632 457999999999999999999999999 999999999999999999999999988753322
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
........++..|+|||++.+..++.++|+||||+++|+|++|..||............ ...
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~--------------- 216 (256)
T cd08529 155 -TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRG--------------- 216 (256)
T ss_pred -cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcC---------------
Confidence 11122345788899999998888999999999999999999999999765432211100 000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011111334578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.30 Aligned_cols=256 Identities=22% Similarity=0.270 Sum_probs=201.6
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
...++|++.+.||+|+||.||+|.++.++..+|+|++.... ......+.+|+.+++.++||||+++++.+.++...|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 33578999999999999999999999999999999986421 223345778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999864 45899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccC----CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
..... ........|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+ .....
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i------~~~~~ 264 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI------MDHKN 264 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCc
Confidence 32211 1112345689999999998653 3788999999999999999999999765432211110 00000
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 309 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~ll~~ 309 (361)
....+ .....+..+.+++..||..++.+ |+++.++++.
T Consensus 265 ---~~~~p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ---SLNFP-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---ccCCC-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00000 01122446778999999865543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.05 Aligned_cols=271 Identities=28% Similarity=0.424 Sum_probs=204.1
Q ss_pred hCc-ccCCeecccCceEEEEEEE----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEc--CCe
Q 018100 34 KNF-RSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQ 105 (361)
Q Consensus 34 ~~y-~~~~~lg~G~~g~v~~~~~----~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 105 (361)
++| ++.+.||+|+||.||++.. ..++..|++|.+..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 8999999999999988653 34578899999875432 234668889999999999999999998765 346
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 7899999999999999975 45999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 186 KLGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 186 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~-~~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMT-VVR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccc-hhh
Confidence 7543322111 1122235667999999988889999999999999999999999986543211100 000000000 000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.....+.......+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000111111223344568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=317.42 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=207.2
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhcCC-CCccceeeeEEEcC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADG 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 103 (361)
.-.++|++.+.||+|+||.||+|.+... +..||+|++...... ..+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 3367899999999999999999987432 357999998654332 3456889999999996 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC--------------------------------------------------------
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSP-------------------------------------------------------- 127 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------------------------- 127 (361)
...|+||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998754210
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 128 ------------------------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 128 ------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
....+++..++.++.||+.||.|||+++ ++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 1235788899999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhh
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 250 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 250 (361)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~- 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF- 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-
Confidence 9999999999999875322222222223346678999999988889999999999999999997 99998754322111
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
..... .. .....+...+..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus 350 -~~~~~----~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 -YNKIK----SG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHHh----cC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00000 00 001112234457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=305.22 Aligned_cols=259 Identities=28% Similarity=0.389 Sum_probs=204.3
Q ss_pred hCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.+|++.+.||+|+||.||+|.+..+ +..|++|++...... ..+.+..|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4688899999999999999987543 578999998754322 2356888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC
Q 018100 108 LVYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~ 175 (361)
++++|+.+++|.+++.... .....+++..++.++.|++.||.|||+++ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985311 11245888999999999999999999999 99999999999999999
Q ss_pred ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHh
Q 018100 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 254 (361)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI-- 239 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999875332222222233345678999999988889999999999999999998 88888654332211111
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
. ... ....+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 240 -~---~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 -R---NRQ-----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -H---cCC-----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 000 011223344578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=303.43 Aligned_cols=265 Identities=23% Similarity=0.294 Sum_probs=197.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcC---CCCccceeeeEEEc-----CC
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCAD-----GD 104 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 104 (361)
+|++.+.||+|+||.||+|.++.++..|++|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999999999999999998653222 223456677777655 69999999998754 34
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++++||+. ++|.+++.... ...+++..+..++.||+.||.|||++| ++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 68888886532 345899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhhh----hh
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARP----LF 259 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~----~~ 259 (361)
+...... .......++..|+|||++.+..++.++|||||||++|+|++|.+||.......... +...... .+
T Consensus 155 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 8753221 11223457889999999988899999999999999999999999997654432221 1111100 00
Q ss_pred ccccc----cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 260 QDRTR----HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 260 ~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..... ......+.......+.....+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 00000000001111233457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.79 Aligned_cols=240 Identities=27% Similarity=0.341 Sum_probs=191.5
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHH-HHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..|++|++..... .....+..|. .+++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999864321 1222334444 456788999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|.+++.. ...+++..+..++.||+.||.|||++| ++||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999999876 567889999999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............ ... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~~----~--------~ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LNK----P--------L 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH------HhC----C--------c
Confidence 223456899999999999989999999999999999999999999765432221111 000 0 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 306 (361)
..++..+..+.+++.+||+.||.+||++.+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 1122334478889999999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=303.60 Aligned_cols=259 Identities=31% Similarity=0.431 Sum_probs=203.6
Q ss_pred hCcccCCeecccCceEEEEEEEC----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLE----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+|++.+.||+|+||.||+|.+. .++..|++|.+...... ....+.+|+.+++.++||||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 57889999999999999999853 34678999998643332 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC
Q 018100 109 VYEYMPLGSVEDHLHDLSP-------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~ 175 (361)
+|||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853110 1235889999999999999999999999 99999999999999999
Q ss_pred ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHh
Q 018100 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 254 (361)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||..............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999875332222222223345667999999988889999999999999999998 9899865433221111110
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
. .. . ..+...+..+.+++.+||+.||++||++.++++.|..
T Consensus 242 ~----------~~---~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 R----------QL---L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred C----------Cc---C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0 00 0 1112233478889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.71 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=204.5
Q ss_pred hhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|.+.+.||+|++|.||+|.+.. ++..|++|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4779999999999999999999987 6788999988644322 235688899999999999999999999988899
Q ss_pred EEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC---ceeEe
Q 018100 107 LLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLS 180 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~---~~~L~ 180 (361)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999875321 1235899999999999999999999999 99999999999998765 58999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhh
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------ 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence 9999875322111111112233567999999988889999999999999999997 999997654332221111
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.... ...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 236 -~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0000 1112233457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=313.11 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=204.3
Q ss_pred hhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEc-CC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-GD 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 104 (361)
.++|++.+.||+|+||.||+|.... +++.|++|++..... ...+.+..|+.++..+ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4689999999999999999997543 357899999875432 2235677899999999 79999999998754 45
Q ss_pred eeEEEEEecCCCCHHHHhcccCCC--------------------------------------------------------
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPG-------------------------------------------------------- 128 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~-------------------------------------------------------- 128 (361)
..++++||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988542110
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcC
Q 018100 129 -KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207 (361)
Q Consensus 129 -~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 207 (361)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999999 9999999999999999999999999987532222111222334567899
Q ss_pred CchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHH
Q 018100 208 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 286 (361)
Q Consensus 208 aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (361)
|||++.+..++.++|||||||++|+|++ |..||........ +... ...... ...+.....++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~----~~~~~~----------~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRR----LKEGTR----------MRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHH----HhccCC----------CCCCccCCHHHH
Confidence 9999999999999999999999999998 9999965322111 0000 000000 011222345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 287 AVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 287 ~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
+++.+||+.+|++||++.++++.|+.+.+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.51 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=202.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||+|+||.||+|.++.++..|++|.+...... ....+.+|+.+++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 6799999999999999999999999999999998654322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
++ ++|.+++... +..++...+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 97 5888877542 345899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hh----hhccccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RP----LFQDRTRHS 266 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~----~~~~~~~~~ 266 (361)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||............... .. .+.......
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11223357889999998865 46889999999999999999999999765543332211110 00 000000000
Q ss_pred c---ccCcccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 L---IADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~---~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ...+... ....+..+.++.+++.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0 0000000 00112234577899999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=302.78 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=205.9
Q ss_pred hhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|.+.+.||+|+||.||+|... .++..+++|.+..........+.+|+.+++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 468899999999999999999743 346789999887665555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 108 LVYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
+++||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||+|+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999875321 1135889999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 255 (361)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...............
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999865322221111222334678999999988899999999999999999998 89998654332221111000
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
. .. ..+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 241 ----------~---~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 ----------R---EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----------c---cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 00 111223347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=298.41 Aligned_cols=256 Identities=28% Similarity=0.413 Sum_probs=205.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|++|.||+|.+.. +..|++|.+.... ...+.+.+|+.+++.++|+||+++++++......+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34679999999999999999999765 5789999986543 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... +..+++..+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999987532 356899999999999999999999999 999999999999999999999999998764321
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||........... ... . .
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~~----~--~----- 221 (261)
T cd05068 157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ---VDQ----G--Y----- 221 (261)
T ss_pred ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HHc----C--C-----
Confidence 111 1111122457999999988899999999999999999999 9999976433221111 100 0 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 ---RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 001122334578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=305.48 Aligned_cols=262 Identities=29% Similarity=0.436 Sum_probs=204.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeE--EEEEEeccCC-ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~--v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++.++.. +++|.+.... ......+.+|+.++..+ +|+||+++++++.++...++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46899999999999999999998877654 5777665432 22345688899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 109 VYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
|+||+++++|.+++.... .....+++..++.++.||+.||+|||++| ++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986422 11246899999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 255 (361)
++|+|||++..... .........+..|+|||.+.+..++.++|||||||++|+|++ |..||........... .
T Consensus 163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~ 236 (303)
T cd05088 163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---L 236 (303)
T ss_pred EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH---H
Confidence 99999999863111 111111223567999999988889999999999999999998 9999965433221111 0
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.. . .....+...+..+.+++.+||+.+|++||++.++++.|..+....
T Consensus 237 ~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 PQ----G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred hc----C----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 0 000111122347788999999999999999999999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=297.48 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=201.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
.+|++.+.||+|+||.||+|.++. +..+++|.+... ....+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 568899999999999999998875 568999987643 333467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998752 245899999999999999999999999 99999999999999999999999998875322111
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||............. . ......
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~---~-------~~~~~~-- 222 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS---R-------GFRLYR-- 222 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C-------CCCCCC--
Confidence 1 1112234567999999988889999999999999999999 899997654322211110 0 000001
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 -----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 -----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111234788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.38 Aligned_cols=263 Identities=31% Similarity=0.450 Sum_probs=215.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe---E-EEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ---D-VAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~-v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
.++-.+.+.||+|+||.||+|..+..+. . ||+|..... .......+.+|+++|++++||||++++|++..+.-
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4555667899999999999999876422 3 899988753 24455779999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
+++|||+|+||+|.+++... +..++..+...++.+.|+||+|||+++ ++||||...|+|++.++.+||+|||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999872 235999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceee-ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 186 KLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 186 ~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
+... ...... ...-...|+|||.+....++.++||||||+++||+++ |..||.+.........+.
T Consensus 310 ~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---------- 376 (474)
T KOG0194|consen 310 RAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---------- 376 (474)
T ss_pred cCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH----------
Confidence 7422 111111 2235678999999999999999999999999999999 888998765543322220
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccCCC
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYES 320 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~~~ 320 (361)
....+...+...+..+..++.+||..||++||++.++.+.++.+.......
T Consensus 377 ------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 377 ------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 011122233455668888999999999999999999999999988776543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=299.04 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=201.8
Q ss_pred cccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCe-----
Q 018100 36 FRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 105 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 105 (361)
|.+.+.||+|+||.||.|....+ +..|++|.+..... .....+..|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999997653 47899999875432 233568899999999999999999998865444
Q ss_pred -eEEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 106 -RLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 106 -~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
.++++||+++++|..++.... .....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999885422 12346899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~---~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY---DYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----
Confidence 99876433322211222234567999999988889999999999999999999 88998654332211 11100
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
.. . ...+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 231 ---~~---~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 ---GN---R----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---CC---C----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 011223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=302.75 Aligned_cols=261 Identities=28% Similarity=0.415 Sum_probs=205.6
Q ss_pred CcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
+|++.+.||+|+||.||+|.... ....+++|.+..... .....+.+|+.+++.++||||+++++.+..+...++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 235688888764432 234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 109 VYEYMPLGSVEDHLHDLS--------------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
++||+.+++|.+++.... .....+++..++.++.|++.||.|||+++ ++||||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 11245889999999999999999999999 9999999999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHH
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 247 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~ 247 (361)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875322221111222345678999999988889999999999999999998 999997654322
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.... .... .....+...+.++.+++..||+.+|++||++.++++.|+.+-.
T Consensus 238 ~~~~---~~~~--------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNL---LKTG--------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHH---HhCC--------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2111 1100 0011122334578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=301.16 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=205.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe----EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..+|++.+.||+|+||.||+|.+..++. .|++|++..... .....+.+|+.+++.++|+||+.+++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3678999999999999999999877665 489999865432 2345688899999999999999999998754 567
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++++|+++|+|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 899999999999998652 346899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..............++..|+|||.+.+..++.++|||||||++|+|++ |..||............. . . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~----~---~ 228 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---K----G---E 228 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C----C---C
Confidence 432222111112234567999999988889999999999999999998 899997644322211111 0 0 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
. ...+...+..+.+++.+||+.||++||++.++++.|..+....
T Consensus 229 ~-------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 R-------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred c-------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 0111223447888999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.79 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=207.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-C-----CccceeeeEEEcCCeeE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-H-----PNLVNLIGYCADGDQRL 107 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~ 107 (361)
-+|+|.+.||+|+||.|.+|.+..+++.||||+++. ...-.++...|+.+|..|+ | -|+|+++++|...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 389999999999999999999999999999999864 3444566778999999987 4 39999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC--CceeEeccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLA 185 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~--~~~~L~Dfg~~ 185 (361)
||+|.+. .+|.+++.... ..+++...+..++.||+.||.+||..+ |||+||||+|||+... ..||++|||.+
T Consensus 265 iVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999984 99999998744 557999999999999999999999999 9999999999999754 47999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh--------
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-------- 257 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 257 (361)
......-. ....+..|+|||++.|..|+.+.||||||||+.||++|.+.|.+....+....+.....
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 75322222 44578889999999999999999999999999999999999988877655533222110
Q ss_pred -------hhcc-c------cccc-------------------cccCc----cccCCCChHHHHHHHHHHHHcccCCCCCC
Q 018100 258 -------LFQD-R------TRHS-------------------LIADP----ELQGQYPPRGFYQALAVAAMCVHEQPDMR 300 (361)
Q Consensus 258 -------~~~~-~------~~~~-------------------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~R 300 (361)
.+.. . .... ....| .+........-..+.+++.+||..||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 1111 0 0000 00000 00111111334567889999999999999
Q ss_pred CCHHHHHHH
Q 018100 301 PVIADVVTA 309 (361)
Q Consensus 301 ps~~~ll~~ 309 (361)
+|+.+.++.
T Consensus 494 ~tp~qal~H 502 (586)
T KOG0667|consen 494 ITPAQALNH 502 (586)
T ss_pred CCHHHHhcC
Confidence 999999963
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=304.21 Aligned_cols=266 Identities=28% Similarity=0.416 Sum_probs=206.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCC----------------eEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccce
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESIN----------------QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~----------------~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 95 (361)
..+|++.+.||+|+||.||+|.+...+ ..|++|.+..... ...+.+.+|+.+++.++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 368999999999999999999876543 5689999875433 23467888999999999999999
Q ss_pred eeeEEEcCCeeEEEEEecCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 96 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
+++++..+...++++||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999876321 1236899999999999999999999999 9999999999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh--CCCccccchHH
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAA 246 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~ 246 (361)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875333222222233445678999999988889999999999999999998 67787654322
Q ss_pred HhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 247 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.. .......+..... ......++..+.++.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV---IENAGHFFRDDGR-------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHhccccccc-------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 1111111111100 0011112233458899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=308.90 Aligned_cols=242 Identities=27% Similarity=0.372 Sum_probs=196.3
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+|++.+.||+|+||.||+|.++.++..||+|++.... ....+.+..|..++..+. |++|+.+++.+.+....|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999999999999999986432 223355777888888875 578888999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999876 567999999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ........|+..|+|||++.+..++.++|||||||++|+|++|..||............ ....
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~~~-------- 217 (323)
T cd05615 154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI------MEHN-------- 217 (323)
T ss_pred C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC--------
Confidence 1 11223345899999999999888999999999999999999999999765432211111 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
...+...+..+.+++.+||+.+|.+|++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11122334478889999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=300.60 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=203.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.+..++..|++|++..........+.+|+.+++.++||||+++++.+..+...++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46889999999999999999999999999999998765545556688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. .+.+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~-- 158 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA-- 158 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC--
Confidence 999999999876 567999999999999999999999999 99999999999999999999999999865322
Q ss_pred CcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.........++..|+|||.+. ...++.++|+|||||++|+|++|..||............ ... ...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~---------~~~ 227 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKS---------NFQ 227 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hcc---------CCC
Confidence 111223346888999999874 456889999999999999999999998543321111000 000 000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+.... ....+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000 0112346788999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=306.77 Aligned_cols=238 Identities=27% Similarity=0.353 Sum_probs=190.5
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHH-HHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..|++|++..... .....+..|. .+++.++||||+++++.+.+....|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999864321 1223444554 457888999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|...+.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCC
Confidence 999888865 567899999999999999999999999 99999999999999999999999999874211 111
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............ ... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~~------------~~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI------LHK------------PL 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH------hcC------------CC
Confidence 223346899999999998888999999999999999999999999765332211110 000 01
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIA 304 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 304 (361)
..++.....+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12223345788899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=301.56 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=206.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|.++.. +..|++|.+..... .....+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 47899999999999999999998653 37899999864432 2345688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEe
Q 018100 107 LLVYEYMPLGSVEDHLHDLSP------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 180 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~ 180 (361)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865332 1234788999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhh
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.............
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 9999875332222222233446778999999988889999999999999999998 999996543322221111
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.. . .. ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 -~~-~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DG-G-----HL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cC-C-----CC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00 0 00 111222457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=312.34 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=200.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCC----
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 104 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 104 (361)
...++|++.+.||+|+||.||+|.+..+|..|++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45689999999999999999999999999999999986432 223456788999999999999999999886443
Q ss_pred --eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 105 --QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 105 --~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
..|+||||++ ++|...+. ..++...+..++.||+.||.|||++| ++||||||+|||++.++.++|+||
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 4699999997 56766664 24888999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HH--------
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VA-------- 253 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~-------- 253 (361)
|++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||........... ..
T Consensus 168 g~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 168 GLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred CCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 99874221 1122334678899999999999999999999999999999999999976543221100 00
Q ss_pred -------hhhhhhccccccccccCccc--------cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 254 -------WARPLFQDRTRHSLIADPEL--------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 254 -------~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
................-... ...........+.+||.+||+.||++|||+.++++.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000000000000000 0001112234678999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=300.79 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=194.7
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
||+|+||.||++..+.+|..+++|.+...... ....+..|+.+++.++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998643221 223456799999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.... ...+++..++.++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 98886422 345899999999999999999999999 999999999999999999999999998753221 1223
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
...++..|+|||++.+..++.++|||||||++|+|++|..||.......... .......... .... .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~--------~~~~---~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDE--------VKFE---H 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhccc--------cccc---c
Confidence 3468889999999988889999999999999999999999996543211110 0000000000 0000 0
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
...+.++.+++.+||+.||++||++.++++.+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12334788999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=305.46 Aligned_cols=266 Identities=25% Similarity=0.374 Sum_probs=203.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCC--------------CeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI--------------NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLI 97 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~--------------~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 97 (361)
.++|++.+.||+|+||.||+|.+..+ ...|++|.+..... ...+.+.+|+.+++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 36899999999999999999987543 23589999865422 2345688999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
+++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999864210 1124788999999999999999999999 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh--CCCccccchHHH
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAA 247 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~~ 247 (361)
+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875332222222222345678999999988889999999999999999988 567776543322
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
... .....+........ ...++..+..+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIE---NTGEFFRNQGRQIY-------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHH---HHHHhhhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 11111111100000 1112223458899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=313.45 Aligned_cols=262 Identities=23% Similarity=0.273 Sum_probs=204.5
Q ss_pred HHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 26 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
+..+....++|++.+.||+|+||.||+|.++.++..+|+|++.... ......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344555789999999999999999999999999999999986422 1223457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
+...|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999865 45899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccC----CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
|++....... ........|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------ 259 (371)
T cd05622 187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------ 259 (371)
T ss_pred CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH------
Confidence 9987532211 1112345689999999998653 3789999999999999999999999765432211111
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTAL 310 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~ll~~l 310 (361)
.... .. +........+..+.++|..||..++.+ |+++.++++..
T Consensus 260 ~~~~-~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHK-NS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCC-Cc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000 00 000011233457788999999844433 77999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.90 Aligned_cols=252 Identities=33% Similarity=0.488 Sum_probs=205.6
Q ss_pred CeecccCceEEEEEEECCC---CeEEEEEEeccCCccc-hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.+... +..|++|.+....... .+.+..|+..+..++|+|++++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999876 8899999987654433 57788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 116 GSVEDHLHDLSPG-----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 116 ~~L~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999874211 367999999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||............ .. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~-------~---- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---RK-------G---- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-------C----
Confidence 322222333456788999999988889999999999999999999 69999766332211111 00 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.....+...+..+.+++.+||..+|++||++.++++.|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122233558889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=314.46 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=199.6
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.++.++..||+|++.... ......+..|+.++..++|++|+++++.+.++...|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999999999999999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||++| ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999876 567999999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCc---------------------------------ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCC
Q 018100 191 GDNT---------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237 (361)
Q Consensus 191 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 237 (361)
.... .......||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1000 0011246899999999999999999999999999999999999
Q ss_pred CccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 018100 238 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVT 308 (361)
Q Consensus 238 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~ 308 (361)
.||...........+.... .....+ .. ......+.++|.+|+ .||.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~---------~~~~~p---~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQETYRKVMNWK---------ETLVFP---PE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHHHHHHHcCC---------CceecC---CC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9997654432211111000 000000 00 112346778888876 49999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=333.95 Aligned_cols=265 Identities=32% Similarity=0.456 Sum_probs=216.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe-----EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ-----DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
....+..+.||+|.||.||.|....... .|++|.+..... .....|.+|+.+|+.++||||+++++++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456678899999999999999865433 389999876533 3456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
+|++|||+||+|..++..... ....++..+.+.++.|||+|+.||++++ +|||||...|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999986311 1457899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
+|+.....++........-...|||||.+.+..++.++||||||+++||+++ |..||............. .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~-------~- 919 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL-------E- 919 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-------h-
Confidence 9985333333332222234468999999999999999999999999999999 999997765543332111 0
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.-+.+.|..++..+.+++.+||+.+|++||++..|++.+..+....
T Consensus 920 ---------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 920 ---------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 0123445667778999999999999999999999999888777543
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=303.79 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=204.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCe--EEEEEEeccC-CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRN-GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~--~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 109 (361)
++|++.+.||+|+||.||+|..+.++. .+++|.+... .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 589999999999999999999877664 4688887642 223345688899999999 799999999999998999999
Q ss_pred EEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 110 YEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
+||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999864211 1235889999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhh
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 256 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 256 (361)
+|+|||++..... .........+..|+|||.+.+..++.++|||||||++|+|++ |..||............
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~---- 231 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL---- 231 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999863211 111111123456999999988889999999999999999997 99999765432211110
Q ss_pred hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 257 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.. ......+...+..+.+++.+||+.+|.+||+++++++.|..+....
T Consensus 232 ---~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 ---PQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---hc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 0001112223457889999999999999999999999998777543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.83 Aligned_cols=239 Identities=26% Similarity=0.354 Sum_probs=191.2
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHH-HHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.+|..|++|++.... ......+..|.. +++.++||||+++++.+......|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999986432 122234455554 56778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||++| ++||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCC
Confidence 999988875 567999999999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............ .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~------~~----~~~-------- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI------LH----KPL-------- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH------Hc----CCc--------
Confidence 223456899999999999989999999999999999999999999765432211110 00 000
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 305 (361)
..++..+..+.+++.+||+.||.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 111223447788999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=302.47 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=202.0
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.|++.+.||+|+||.||+|.++.++..|++|.+....... ...+..|+.+++.++|++++.+++.+.+....++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4778899999999999999999999999999986543222 2456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+.+++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999886422 346899999999999999999999999 999999999999999999999999998653222
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 270 (361)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... .......
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------- 219 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------- 219 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-------------
Confidence 11 123468899999999998899999999999999999999999997543211110 0000000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~~ 309 (361)
.....+...+.++.+|+.+||+.||.+||+ +.++++.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 --VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 000112223447888999999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.92 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=207.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||.|++|.||+|.+..++..+++|++........+.+.+|+.+++.++||||+++++.+.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67999999999999999999999889999999998665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
.+++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 154 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-- 154 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence 999999988762 257999999999999999999999999 999999999999999999999999988753221
Q ss_pred cceeeccccCcCcCCchhhccC---CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 194 THVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
........++..|+|||.+.+. .++.++|+||||+++|+|++|..||............. ...+ ..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~---------~~ 223 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNF---------PP 223 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccC---------CC
Confidence 1112234577889999998776 78999999999999999999999997644322211110 0000 00
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
+ ........+.++.+++.+||..+|.+||++.+++.
T Consensus 224 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 P--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 01122344567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=314.32 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=201.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCC-----eeE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 107 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 107 (361)
+|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999899999999986432 223456889999999999999999999998766 789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 788887765 567999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-h-hhhcc---
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-R-PLFQD--- 261 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~-~~~~~--- 261 (361)
...... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+... . +....
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 322211 112234578899999998774 4789999999999999999999999765543222211100 0 00000
Q ss_pred -------ccccccccCccc--cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 -------RTRHSLIADPEL--QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 -------~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.........+.. ..........++.+|+.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 001112234578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.47 Aligned_cols=250 Identities=27% Similarity=0.419 Sum_probs=203.3
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---------hHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
+|.+.+.||+|++|.||+|.+..++..+++|.+....... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999998889999999886543322 1457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.++++||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976 466899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 186 KLGPVGDN----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 186 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
........ ........++..|+|||.+.+..++.++|+|||||++|+|++|..||......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~----- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI--FKIGE----- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH--HHHhc-----
Confidence 76432111 11112234778899999998888999999999999999999999999764332111 00000
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
... ...+...+..+.+++.+||+.||.+||++.++++
T Consensus 227 ------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ------NAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001 1122334457888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=303.53 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=208.1
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
...++|++.+.||+|++|.||+|.+..++..|++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 44689999999999999999999999889999999997665556677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999864 45899999999999999999999999 99999999999999999999999998865322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ... . .
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~--~-----~ 232 (297)
T cd06656 168 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN--G-----T 232 (297)
T ss_pred Cc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccC--C-----C
Confidence 21 1122345788899999998888999999999999999999999999654321110000 000 0 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+. ...+...+..+.+++.+||..+|++||++.++++.
T Consensus 233 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 11122334467889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.89 Aligned_cols=268 Identities=25% Similarity=0.375 Sum_probs=210.3
Q ss_pred HHHhhCcccCCeecccCceEEEEEEEC-------CCCeEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCccceeeeEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYC 100 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 100 (361)
.....+|.+.+.||+|+||.||+|.+. ..+..|++|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 344688999999999999999999753 234579999886432 23346788999999999 799999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 101 ADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 101 ~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
......+++|||+.+++|.+++..... ....+++..++.++.||+.||.|||++| ++|+||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 999999999999999999999875321 1235788899999999999999999999 9999999999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHH
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 247 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~ 247 (361)
|+++.++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999999875433222222222335567999999988889999999999999999998 788886543322
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
...... ... ....+...+..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 248 ~~~~~~-------~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 LFKLLK-------EGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHH-------cCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 211110 000 00112234557888999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=308.31 Aligned_cols=244 Identities=25% Similarity=0.350 Sum_probs=193.0
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++..|++|++..... ...+.+..|+.++..+ +||+|+.+++.+.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999975422 2335577899998888 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCC
Confidence 999988875 467999999999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
......|+..|+|||++.+..++.++|||||||++|+|++|..||..................... . ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~--------~~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---K--------PI 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---C--------CC
Confidence 223456899999999999999999999999999999999999999643221111111000000000 0 01
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
..+...+..+.+++.+||+.||++|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1222334477889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=304.48 Aligned_cols=264 Identities=27% Similarity=0.389 Sum_probs=207.0
Q ss_pred hhCcccCCeecccCceEEEEEEECC-------CCeEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
.++|.+.+.||+|+||.||+|.+.. +...+++|.+.... ......+..|+.+++.+ +|+||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4789999999999999999998643 23569999987542 22345688899999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
...++||||+.+++|.+++..... ....+++..++.++.|++.||+|||++| ++|+||+|+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975321 1235889999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhh
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 250 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 250 (361)
+.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999875322211111111223467999999988889999999999999999998 888986543322111
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
... .. . ....+...+..+.+++.+||..+|++||++.++++.|+.+...
T Consensus 254 ~~~-------~~---~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 LLK-------EG---H-------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHH-------cC---C-------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 110 00 0 0111223345888899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=304.83 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=206.5
Q ss_pred HHhhCcccCCeecccCceEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
-..++|.+.+.||+|+||.||+|.+ ..++..|++|.+..... ...+.+.+|+.+++.+ +||||+++++.+...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3346899999999999999999975 33456899998865432 2345688999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
...+++|||+.+++|.+++.... ...+++.++..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999987522 234899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~~~~---- 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLIKEG---- 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHHHcC----
Confidence 9875332222112222345678999999988889999999999999999998 99998654332111 1100000
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
.....+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 261 ----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ----------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011122334788899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=302.29 Aligned_cols=269 Identities=24% Similarity=0.327 Sum_probs=210.3
Q ss_pred cCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeee
Q 018100 20 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIG 98 (361)
Q Consensus 20 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 98 (361)
+..+..++.+..+.++|++.+.||+|+||.||+|.++.++..+++|++.... .....+.+|+.+++.+ +|+|++++++
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred CCceEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 3445666777888999999999999999999999999999999999876432 2235677899999999 6999999999
Q ss_pred EEE-----cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC
Q 018100 99 YCA-----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 173 (361)
Q Consensus 99 ~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~ 173 (361)
++. .+...++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||+|+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~ 159 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTT 159 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECC
Confidence 873 445789999999999999988654333567899999999999999999999999 999999999999999
Q ss_pred CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc-----CCCCccCceehhhHHHHHHhhCCCccccchHHHh
Q 018100 174 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248 (361)
Q Consensus 174 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 248 (361)
++.++|+|||++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred CCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 9999999999987532211 11223458889999998753 4578899999999999999999999875432211
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .... . ...... ..+......+.+++.+||+.||++||++.++++.
T Consensus 238 ~--~~~~-----~-~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 L--FKIP-----R-NPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred H--hhcc-----c-cCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1 0000 0 000000 0111223468889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.47 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=208.7
Q ss_pred HhhCcccCCeecccCceEEEEEEECC----CCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEc-CCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 105 (361)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999876 35789999876432 2234568889999999999999999998765 567
Q ss_pred eEEEEEecCCCCHHHHhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPG----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
.+++++|+.+++|.+++...... +..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998764322 156899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
||+++...............++..|+|||.+.+..++.++|||||||++|++++ |..||........ ..+.....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~- 236 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAYLKDGY- 236 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHHHHcCC-
Confidence 999875433222212222345677999999988889999999999999999998 9999976533221 11111100
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
. ...+...+..+.+++.+||..||++||++.++++.|..+..
T Consensus 237 ------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 ------R-------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ------C-------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00112233478899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.78 Aligned_cols=267 Identities=21% Similarity=0.307 Sum_probs=202.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||.|+||.||+|.++.++..|++|.+..... .....+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 3679999999999999999999999999999999864432 223467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++ ++|.+++... ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 6888887652 346899999999999999999999999 999999999999999999999999998653221
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hh----hhcc---c
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RP----LFQD---R 262 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~----~~~~---~ 262 (361)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... .. .+.. .
T Consensus 158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 T--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred C--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1 11122346788999998865 45788999999999999999999999765443222111100 00 0000 0
Q ss_pred cccccccCccccC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSLIADPELQG----QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........+.... ...+..+..+.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000011100 011223447788999999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=333.07 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=202.3
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEc--CCe
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQ 105 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 105 (361)
.....+|++++.||+|+||.||+|.++.++..|++|++..... .....+..|+.+++.++||||+.++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3456899999999999999999999999999999999865432 234568899999999999999999998854 457
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeeecCCCCCcEEEcC--------
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK----PPVIYRDLKCSNILLDR-------- 173 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~i~H~dl~p~Nilv~~-------- 173 (361)
+|+||||+++++|.+++.........+++..++.|+.||+.||.|||+.+. ..|+|+||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997644334679999999999999999999998431 22999999999999964
Q ss_pred ---------CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCcccc
Q 018100 174 ---------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDT 242 (361)
Q Consensus 174 ---------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~ 242 (361)
.+.++|+|||++...... .......|++.|+|||++.+ ..++.++|||||||+||+|++|..||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 345899999998753221 12233468999999999854 4588999999999999999999999975
Q ss_pred chHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 243 SKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...... +..... . . +.+. ....+..+.+||..||+.+|.+||++.+++.
T Consensus 246 ~~~~~q--li~~lk----~---~-----p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFSQ--LISELK----R---G-----PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHHH--HHHHHh----c---C-----CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 432211 111000 0 0 0000 0112347889999999999999999999995
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=297.28 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=199.2
Q ss_pred cccCCeecccCceEEEEEEECCCCe--EEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcC------Ce
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQ 105 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~--~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 105 (361)
|.+.+.||+|+||.||+|.+..++. .+++|.+.... ....+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999887664 68999876532 23346688899999999999999999987432 24
Q ss_pred eEEEEEecCCCCHHHHhccc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
.++++||+.+++|.+++... ......+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887421 112346899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
++................++..|+|||.+.+..++.++|||||||++|+|++ |..||............ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-------~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL-------RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HcC
Confidence 9876433221111122345678999999988889999999999999999999 88999754332211111 000
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
. . ...++..+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 231 ~---~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 N---R-------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---C-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0 011122344788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.68 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=201.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||+|++|.||.|.+.. +..+++|.+.... ...+.+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 578999999999999999998865 4569999886443 33467889999999999999999999999888899999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
.+++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998752 236899999999999999999999999 99999999999999999999999998875322211
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||............... . ..
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-------~---~~---- 220 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-------L---RL---- 220 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-------C---CC----
Confidence 11112234567999999988889999999999999999998 99999755432221111000 0 00
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
..+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 00111235788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.27 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=204.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.+.|++.+.||.|+||.||+|.+..++..+++|.+........+.+..|+.+++.++|+|++++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 46799999999999999999999999999999999776655667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|..++... ...+++..++.++.||+.+|.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 9999998877542 346899999999999999999999999 999999999999999999999999988642111
Q ss_pred CcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
........++..|+|||++. +..++.++|+|||||++|+|++|..||......... ...... .
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~------~--- 231 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIAKS------E--- 231 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HHHhcC------C---
Confidence 11122345778899999884 345788999999999999999999999654322111 110000 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+. ...+...+..+.+++.+||..||++||++.++++.
T Consensus 232 --~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 --PPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --Ccc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 01122334478889999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=302.83 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=207.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||.|++|.||+|.+..+++.|++|.+........+.+.+|+.+++.++|||++.+++++..+...++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35699999999999999999999999999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|..++.. ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998864 46899999999999999999999999 9999999999999999999999999886532221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
. ......++..|+|||.+.+..++.++|||||||++|+|++|..||............. .. ....
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~------~~--~~~~----- 234 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TN--GTPE----- 234 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hc--CCcc-----
Confidence 1 1123457889999999988889999999999999999999999997654432211110 00 0000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+..+.++|.+||..||++||++.++++.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01112233478889999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=302.93 Aligned_cols=265 Identities=26% Similarity=0.399 Sum_probs=207.5
Q ss_pred hhCcccCCeecccCceEEEEEEECC-------CCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
.++|.+.+.||+|+||.||+|.+.. ....+++|.+..... .....+..|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4688999999999999999998632 345789998864322 2345678899999999 699999999999998
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
...++++||+++++|.+++..... ....+++..+..++.||+.||.|||++| ++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 899999999999999999965321 1246899999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhh
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 250 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 250 (361)
+.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999975332221111112223457999999988889999999999999999999 889986543322211
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
... .. . ....+...+..+.+++.+||..+|++||++.++++.|..+....
T Consensus 248 ~~~-------~~---~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 248 LLR-------EG---H-------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHH-------cC---C-------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 110 00 0 01112233457889999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.10 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=202.9
Q ss_pred hCcccCCeecccCceEEEEEEECC----------------CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCcccee
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLES----------------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNL 96 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~ 96 (361)
++|++.+.||+|+||.||++.+.. ++..+++|++..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 679999999999999999986542 345789999865432 234678899999999999999999
Q ss_pred eeEEEcCCeeEEEEEecCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 97 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
++++.++...+++|||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999875321 1234788899999999999999999999 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh--CCCccccchHHH
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAA 247 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~~ 247 (361)
+++.++.++|+|||++................++..|++||...+..++.++|||||||++|+|++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875322222122222334678999999888889999999999999999998 678886543222
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.. ......+........ ...+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 242 ~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VI---ENTGEFFRDQGRQVY-------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 111111111100000 0112223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=311.35 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=201.5
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcC-----
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 103 (361)
...++|++.+.||+|+||.||+|.+..++..|++|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 456899999999999999999999999999999999875422 2345677899999999999999999988543
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 104 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 104 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
...|+||||++ ++|.+.+.. .++...+..++.||++||.|||++| ++||||||+||+++.++.++|+||
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 35699999997 567666642 4889999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHh-------
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAW------- 254 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~------- 254 (361)
|++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||........... ...
T Consensus 164 g~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99975322 1122334688999999999998999999999999999999999999976543222110 000
Q ss_pred --------hhhhhccccccccccCccc--------cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 255 --------ARPLFQDRTRHSLIADPEL--------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 255 --------~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
................+.. ...........+.++|.+||+.||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000000000 001112224567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.16 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=202.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|++|.||+|.++. +..+++|.+..... ..+.+.+|+.+++.++|+|++++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4689999999999999999998775 66799999865433 34678899999999999999999998854 567899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999987522 346899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........... ... .
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~---~~~----~--------- 219 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ---VER----G--------- 219 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HHc----C---------
Confidence 11 1112234567999999988889999999999999999999 8899976433221111 100 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.....+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011122334578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=294.64 Aligned_cols=255 Identities=30% Similarity=0.418 Sum_probs=202.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.+..+ ..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+.. ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 46799999999999999999998765 469999986533 234678899999999999999999998754 567899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.... +..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997522 346899999999999999999999999 9999999999999999999999999987533222
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.. ......++..|+|||...+..++.++|||||||++|+|++ |..||............. .. .
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~--~------ 220 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RG--Y------ 220 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------cC--C------
Confidence 11 1122345677999999988889999999999999999999 888887543322111100 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011223445788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.72 Aligned_cols=251 Identities=28% Similarity=0.416 Sum_probs=200.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
.+|++.+.||+|+||.||+|.++. +..+++|++..... ....+.+|+.+++.++|+||+++++++......++|+||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 568899999999999999999874 66899999864432 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998652 246899999999999999999999999 99999999999999999999999998875322111
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ...
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~-------------- 217 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV---SAG-------------- 217 (256)
T ss_pred -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH---HcC--------------
Confidence 11111123457999999988899999999999999999998 89999754332211110 000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.....+...+..+.+++.+||..+|++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111223455888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.38 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=203.6
Q ss_pred hCcccCCeecccCceEEEEEEECCCCe---EEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~---~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.+|++.+.||+|+||.||+|.++.++. .|++|.+... .......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 568999999999999999999887654 5999998654 223346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998752 346899999999999999999999999 9999999999999999999999999886532
Q ss_pred CCCCcceee-ccc--cCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 190 VGDNTHVST-RVM--GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 190 ~~~~~~~~~-~~~--~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
......... ... .+..|+|||.+.+..++.++|||||||++|+|++ |..||......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~---~~i~~~~~----- 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---NAIEQDYR----- 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH---HHHHcCCc-----
Confidence 221111111 111 1346999999988889999999999999999886 99999654332211 11110000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122344778899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=298.61 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=202.2
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 78889999999999999999999999999998766555566788899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence 999888754 1356899999999999999999999999 999999999999999999999999998653221 11
Q ss_pred eeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 196 VSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
......++..|+|||++. +..++.++|||||||++|+|++|..||......... ...... ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~------~~~~--- 227 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAKS------EPPT--- 227 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhhc------CCCC---
Confidence 122345788999999873 345788999999999999999999999754322111 110000 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+..+.+++.+||+.||.+||++.++++.
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 ----LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122234578899999999999999999998854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.57 Aligned_cols=268 Identities=22% Similarity=0.278 Sum_probs=205.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||+|+||.||+|.+..++..+++|.+..... .....+.+|+.+++.++||||+++++.+.++...++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 379999999999999999999999999999999865422 2235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999976 4678999999999999999999997 57 999999999999999999999999988642211
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc-----c
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH-----S 266 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 266 (361)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||......................... .
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1223467889999999988889999999999999999999999996544222211111000000000000 0
Q ss_pred cccC--------------ccccCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 267 LIAD--------------PELQGQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 267 ~~~~--------------~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.... .......+ ...+.++.+++.+||..||++||++.++++..-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0000 00000000 1134468899999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=296.05 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=206.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe----EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..+|++.+.||+|+||.||+|.++.++. .+++|....... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3689999999999999999999876654 589998765533 234568889999999999999999999987 7889
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|+||+.+++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999998752 345899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..............++..|+|||.+.+..++.++|+||||+++|+|++ |..||............. . ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~---~~ 228 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------K---GE 228 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------C---CC
Confidence 432222111111223567999999988889999999999999999998 999997654332211111 0 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
. ...+......+.+++.+||..||+.||++.++++.|..+...
T Consensus 229 ~-------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 R-------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred C-------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 011222334778899999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=300.43 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=205.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||.|++|.||+|.+..++..+++|.+........+.+..|+.+++.++|+|++++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 36799999999999999999999888999999998766555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 9999999998652 356999999999999999999999999 999999999999999999999999987653221
Q ss_pred CcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
........++..|+|||.+. +..++.++|+||||+++|+|++|..||......... .... .. ..
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~~----~~--~~-- 225 (280)
T cd06611 157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKIL----KS--EP-- 225 (280)
T ss_pred -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHHh----cC--CC--
Confidence 11122345788899999874 345778999999999999999999999765332211 1100 00 00
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+ ....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 226 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---P--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---C--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 001122334478889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=304.20 Aligned_cols=256 Identities=21% Similarity=0.234 Sum_probs=199.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||++.++.++..||+|++... .....+.+.+|+.++..++|+||+.+++.+.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999999999999999998642 1223355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998641 356899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCcceeeccccCcCcCCchhhcc-----CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||............ ......
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i------~~~~~~- 226 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKEH- 226 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH------HcCCCc-
Confidence 111 11222458999999999863 45788999999999999999999999764332211111 000000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPD--MRPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~--~Rps~~~ll~~ 309 (361)
...+. .....+..+.+++.+||..+++ .|+++.++++.
T Consensus 227 --~~~~~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 --FQFPP----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --ccCCC----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00001 1112345778899998865444 37899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.55 Aligned_cols=250 Identities=31% Similarity=0.475 Sum_probs=205.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||.|++|.||+|... |+.|++|.+..... ..+.+.+|+.+++.++|+||+++++++.++...++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 468999999999999999999876 78899999976544 456789999999999999999999999989999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997622 236899999999999999999999999 9999999999999999999999999987532111
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.....+..|+|||.+.+..++.++||||||+++|+|++ |..||............ .. .
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~----~--------- 215 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV---EK----G--------- 215 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---hc----C---------
Confidence 12234567999999988889999999999999999997 99998655332211111 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.....+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0001122234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.52 Aligned_cols=266 Identities=21% Similarity=0.269 Sum_probs=201.0
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcC-----
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 103 (361)
...++|++.+.||+|+||.||.|.+..++..|+||++.... ......+.+|+.+++.++||||+.+++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34689999999999999999999999999999999986532 22345678899999999999999999987543
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 104 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 104 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999996 677777642 4788999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhh-----
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR----- 256 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~----- 256 (361)
|++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||...........+ ....
T Consensus 171 G~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 171 GLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99975322 11223346889999999999999999999999999999999999999765432221111 0000
Q ss_pred ----------hhhcccccccccc----Ccc----ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 257 ----------PLFQDRTRHSLIA----DPE----LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 257 ----------~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
............. .+. ............+.+||.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000 000 0001111123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.68 Aligned_cols=250 Identities=28% Similarity=0.393 Sum_probs=205.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||.|++|.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999999999999999987543 33345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999875 37899999999999999999999999 9999999999999999999999999987643221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||............. .. ..+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------~~------~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-------KN------NPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------hc------CCCC
Confidence 12233457788999999988889999999999999999999999997544221111000 00 0001
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.... ..+..+.+++.+||..+|++||+++++++.
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1000 034478889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=298.81 Aligned_cols=266 Identities=21% Similarity=0.265 Sum_probs=201.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|++|.||+|.++.++..|++|++...... ....+.+|+.+++.++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999999989999999998654322 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+. ++|.+++..... +..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 788888865332 357899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhh----hhcccc---
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARP----LFQDRT--- 263 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~----~~~~~~--- 263 (361)
.......++..|+|||.+.+. .++.++|||||||++|+|++|+.||........... ...... .+....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 111223467889999988654 578899999999999999999999976543222111 000000 000000
Q ss_pred c----cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 264 R----HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 264 ~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ....... .........+.++.++|.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000 000111123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=297.75 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=200.8
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.|++.+.||+|+||.||.|.+..++..+++|.+...... ....+.+|+.+++.++|+|++.+.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999999999999999998654222 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999998886522 346999999999999999999999999 999999999999999999999999988653221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.............. ..... ..
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~~~~--------~~ 222 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RVLET--------EE 222 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hhhcc--------cc
Confidence 1 11234688999999999888899999999999999999999999976433221111110 00000 00
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
.++...+..+.+|+..||+.||++||+ +.+++.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111223346788999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.28 Aligned_cols=250 Identities=27% Similarity=0.370 Sum_probs=206.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||+|++|.||+|.++.++..+++|.+..... .+.+.+|+.+++.++|+|++++++.+.++...|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 679999999999999999999998899999999865432 578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999864 2356899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||............. . ....
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~-------~--------~~~~ 217 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP-------N--------KPPP 217 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc-------c--------CCCC
Confidence 12223457888999999988899999999999999999999999997543322111000 0 0000
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
....+......+.+++.+||+.||++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11112234457889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=294.04 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=204.0
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
...++|++.+.||+|+||.||+|..+. +..|++|.+.... .....+.+|+.+++.++|+|++++++++. ....++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 345789999999999999999998765 6789999987543 33467889999999999999999999874 45689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+.+++|.+++.... +..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999886522 457899999999999999999999999 99999999999999999999999999865332
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||............ . ...
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~----~~~------ 220 (260)
T cd05067 155 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---E----RGY------ 220 (260)
T ss_pred CCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---H----cCC------
Confidence 111 11112234668999999988889999999999999999998 99999754432221111 0 000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
....+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 ----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001122234478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=299.00 Aligned_cols=264 Identities=28% Similarity=0.427 Sum_probs=205.2
Q ss_pred HHhhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
...++|++.+.||+|+||.||+|..+. .+..|++|.+..... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346889999999999999999997653 255899998764432 22345778999999999999999999999989
Q ss_pred eeEEEEEecCCCCHHHHhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSP------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
..++||||+++++|.+++..... ....++...+..++.||+.||.|||+++ ++||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 1234577889999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
|+|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||.............
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---- 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM---- 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 999999875322222111222334677999999988889999999999999999998 788986543322211110
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.... .. .+...+..+.+++.+||+.||++||++.++++.|+...
T Consensus 236 ---~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 ---DGGY------LD----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---cCCC------CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0000 00 11122347889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=296.89 Aligned_cols=266 Identities=26% Similarity=0.319 Sum_probs=203.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|++|.||+|.++.++..|++|++..... ...+.+.+|+.+++.++|+|++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999998899999999864422 233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|..++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9998888877654 456999999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH-hhhhh-------hccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WARPL-------FQDR 262 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~~-------~~~~ 262 (361)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............. ..... +...
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 11 1223356788999999866 567899999999999999999999997654432221111 00000 0000
Q ss_pred cccccccCccccCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSLIADPELQGQ-----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........+..... ..+..+..+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000110000 01123457889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.10 Aligned_cols=273 Identities=26% Similarity=0.380 Sum_probs=203.1
Q ss_pred hCcccCCeecccCceEEEEEEE----CCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc--CCeeE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRL 107 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 107 (361)
.+|++.+.||+|+||.||.|.. ..++..|++|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5789999999999999999984 44688999999876655556778999999999999999999998643 45678
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|+||+++++|.+++... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998652 245899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCcce-eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|..++..................... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV-YHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch-HHHH
Confidence 433221111 11122345699999998888999999999999999999988776433211100000000000000 0000
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
...........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000111223445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.68 Aligned_cols=254 Identities=27% Similarity=0.377 Sum_probs=201.3
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcC------
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG------ 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------ 103 (361)
.+.+.|++.+.||+|+||.||+|.+..+++.|++|.+.... .....+..|+.++..+ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45688999999999999999999999999999999986543 3445788899999988 699999999998652
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
...|++|||+.+++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 46799999999999999987522 356899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
++...... ........|+..|+|||++. +..++.++|||||||++|+|++|..||.............
T Consensus 157 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~----- 229 (272)
T cd06637 157 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP----- 229 (272)
T ss_pred Cceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-----
Confidence 98753221 11223345788999999985 3467889999999999999999999996543221111100
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.. . .+. ......+..+.+++.+||..||.+||++.++++
T Consensus 230 -~~--~-----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 -RN--P-----APR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -cC--C-----CCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0 000 011123347889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=293.97 Aligned_cols=256 Identities=30% Similarity=0.448 Sum_probs=205.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|++|.||+|.++. +..+++|.+.... ...+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45789999999999999999999875 5789999987543 345678899999999999999999999998889999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... +..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999997622 356899999999999999999999999 999999999999999999999999998753321
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. .........+..|+|||.+.+..++.++|+||||+++|+|++ |..||........... ....+
T Consensus 157 ~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---~~~~~----------- 221 (261)
T cd05034 157 E-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ---VERGY----------- 221 (261)
T ss_pred h-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCC-----------
Confidence 1 111112234567999999988889999999999999999998 9999965433221111 10000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111224478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.22 Aligned_cols=247 Identities=29% Similarity=0.418 Sum_probs=195.8
Q ss_pred eecccCceEEEEEEE--CCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 41 LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~--~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
.||+|+||.||+|.+ +.++..+++|++...... ..+.+..|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999975 456789999998644322 34568889999999999999999998854 4678999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcce
Q 018100 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 196 (361)
Q Consensus 117 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~ 196 (361)
+|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999875 456899999999999999999999999 99999999999999999999999999875332221111
Q ss_pred -eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcccc
Q 018100 197 -STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274 (361)
Q Consensus 197 -~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (361)
.....++..|+|||.+.+..++.++|+|||||++|+|++ |..||............. ... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~----------~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGE----------R 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCC----------C
Confidence 111233568999999988889999999999999999998 999997654332211111 000 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 275 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
...+...+.++.++|.+||+.||++||++.+|.+.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11222344578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.22 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=199.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 47889999999999999999999999999999986542 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|..+ ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999998654 23788899999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 271 (361)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ............ .+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PP 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------CC
Confidence 1223468889999999988889999999999999999999999996532211100 000000000000 00
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. .....+.++.+++.+||+.||++||++.++++.
T Consensus 219 ~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 011223478889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=291.78 Aligned_cols=249 Identities=31% Similarity=0.465 Sum_probs=197.9
Q ss_pred CeecccCceEEEEEEECCCC---eEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~---~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.+...+ ..+++|.+...... ..+.+..|+.+++.+.|+|++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876654 78999998755442 3457889999999999999999999876 4567999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999976 457899999999999999999999999 9999999999999999999999999987543222111
Q ss_pred e-eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 196 V-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 196 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ....... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~---~~~~~~~-------~------ 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI---AMLESGE-------R------ 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHHcCC-------c------
Confidence 1 111123457999999988899999999999999999998 99999765432211 1111100 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
...+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=298.29 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=203.7
Q ss_pred hhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|.+.. ++..|++|++..... .....+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4689999999999999999998753 578899999865433 2345688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 107 LLVYEYMPLGSVEDHLHDLS------------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
++++||+++++|.+++.... .....+++..++.++.||+.||.|||+++ ++|+||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 11235788999999999999999999999 9999999999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHH
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 247 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~ 247 (361)
|+++.++.++|+|||.+.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998864322221111222234567999999988899999999999999999997 888886443322
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.... . .. ... ...+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 241 ~~~~---~----~~-~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VIYY---V----RD-GNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHH---H----hc-CCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111 0 00 000 0112223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.55 Aligned_cols=268 Identities=19% Similarity=0.259 Sum_probs=196.1
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC------CCccceeeeEEE
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH------HPNLVNLIGYCA 101 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 101 (361)
++....++|++.+.||+|+||.||+|.+..++..||||++.... ...+....|+.+++.++ |.+++.+++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445689999999999999999999999999999999986432 22334555676666654 456888888886
Q ss_pred cC-CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCC----
Q 018100 102 DG-DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGY---- 175 (361)
Q Consensus 102 ~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~---- 175 (361)
.+ ...|+||+++ +++|.+++.. ...+++..+..++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 54 5788999988 6889888875 4679999999999999999999998 58 99999999999998765
Q ss_pred ------------ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccc
Q 018100 176 ------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 243 (361)
Q Consensus 176 ------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 243 (361)
.+||+|||.+.... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999875321 1123456899999999999999999999999999999999999999765
Q ss_pred hHHHhhhHHHhhhh-----------------hhccccccccccCccc----cCCC---ChHHHHHHHHHHHHcccCCCCC
Q 018100 244 KAAAEQSLVAWARP-----------------LFQDRTRHSLIADPEL----QGQY---PPRGFYQALAVAAMCVHEQPDM 299 (361)
Q Consensus 244 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~----~~~~---~~~~~~~l~~li~~~l~~dP~~ 299 (361)
.............. .+..........++.. .... .......+.+||.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 54332222111100 0000000000000000 0000 0011235678999999999999
Q ss_pred CCCHHHHHHH
Q 018100 300 RPVIADVVTA 309 (361)
Q Consensus 300 Rps~~~ll~~ 309 (361)
|||+.++++.
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999973
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=291.81 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=202.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEc-CCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 111 (361)
+|++.+.||.|++|.||++.++.+++.|++|.+..... ...+.+.+|+.+++.++|+|++++++.+.. +...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58999999999999999999999899999999865332 334568889999999999999999998764 446789999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... ...+++.+++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987522 456899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........++..|+|||++.+..++.++||||||+++|+|++|..||.......... ......
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~--~~~~~~------------- 218 (257)
T cd08223 156 --CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY--RIIEGK------------- 218 (257)
T ss_pred --CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHhcC-------------
Confidence 112233457889999999998889999999999999999999999997543322111 000000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....+...+..+.+++.+||+.||++||++.++++.
T Consensus 219 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 --LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001122344578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=302.32 Aligned_cols=267 Identities=27% Similarity=0.393 Sum_probs=208.1
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCC-------CeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESI-------NQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCA 101 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~-------~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 101 (361)
....+|++.+.||+|+||.||.|.+... +..|++|.+..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 3446799999999999999999986432 34689998764322 2346788999999999 7999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
.+...++++||+.+++|.+++..... ....+++..++.++.||+.||.|||++| ++|+||+|+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 99999999999999999999875321 1235788999999999999999999999 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHh
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 248 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~ 248 (361)
+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999875332221111122233467999999988899999999999999999998 8889876543222
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
..... .. . ....+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 246 ~~~~~-------~~---~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 FKLLK-------EG---H-------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHH-------cC---C-------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11110 00 0 00112233457889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=291.73 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=199.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEE-EcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e 111 (361)
..+|++.+.||+|+||.||++... +..+++|.+... ...+.+.+|+.+++.++|+|++++++++ ..+...++++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 368999999999999999999876 778999988543 2346788999999999999999999875 45567899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999987522 345899999999999999999999999 999999999999999999999999998742221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ..... .
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~~~----~-------- 215 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEK----G-------- 215 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhc----C--------
Confidence 1 12234567999999988889999999999999999997 99998654322111 11100 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.....++..+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 --YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0011122334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=327.83 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=206.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999998653222 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 111 EYMPLGSVEDHLHDLSP-------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
||++|++|.+++..... ....++...++.++.||++||+|||++| ++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 1234667788999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCC----------------cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH
Q 018100 184 LAKLGPVGDN----------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247 (361)
Q Consensus 184 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 247 (361)
++........ ........||..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9875311100 001122468999999999999999999999999999999999999997532211
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHhc
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLASQ 316 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~ll~~l~~l~~~ 316 (361)
..... ....+.... .....+..+.+++.+||+.||++|| ++.++++.|+.....
T Consensus 239 i~~~~--------------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRD--------------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhh--------------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11000 000000000 0012334678899999999999996 566777888766543
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=293.52 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=204.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCC---eEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..+|++.+.||+|+||.||+|.++.++ ..+++|.+..... ...+.+.+|+.+++.++||||+++++++.++...++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 368999999999999999999986443 3799998865432 234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++... ...+++.+++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999998752 246899999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCCccee-eccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDNTHVS-TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
......... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.......... ...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~---~~~~~~----~-- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK---AIEEGY----R-- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH---HHhCCC----c--
Confidence 322211111 11123457999999988889999999999999999886 999996543322111 111000 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122344788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=306.61 Aligned_cols=193 Identities=24% Similarity=0.373 Sum_probs=166.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
...+|++.+.||+|+||.||+|.+..++..|++|+.... ....|+.+++.++|+||+++++++......++|++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 346799999999999999999999999999999985432 23468999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
++. ++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 788887754 2457999999999999999999999999 999999999999999999999999998742211
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCcc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 240 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf 240 (361)
.......|+..|+|||++.+..++.++|||||||++|+|+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1122345889999999999889999999999999999999855443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=290.14 Aligned_cols=248 Identities=30% Similarity=0.449 Sum_probs=199.7
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
+.||+|++|.||+|.+.. +..|++|.+...... ....+.+|+.+++.++|+||+.+++++.+....++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999988 999999998765443 456788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++... ...++...++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9998652 346899999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 277 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (361)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||............... . ....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~---~--------------~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG---Y--------------RMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC---C--------------CCCC
Confidence 1223567999999988889999999999999999998 88898765432222111100 0 0011
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 278 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
+...+..+.+++.+||..+|++||++.++++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=294.41 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=205.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
..|+..+.||.|+||.||.|.++.++..|++|++..... .....+.+|+.+++.+.|+||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 568889999999999999999998899999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. .++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998864 46899999999999999999999999 9999999999999999999999999986532221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ...
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------~~~ 216 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----------------PKN 216 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----------------hcC
Confidence 1122235778899999998888999999999999999999999999754322111100 000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.....+...+..+.+++.+||+.+|++||++.+++..-
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 01122334566888999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=291.00 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=206.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|+||.||.+....++..+++|.+.... ......+.+|+.+++.++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999999999999999986543 33446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987632 356899999999999999999999999 9999999999999999999999999987532222
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ... ..
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~~------~~------- 218 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--VQG------NY------- 218 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HcC------CC-------
Confidence 1 223345788999999998888899999999999999999999999764332211111 000 00
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 --TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00112334578889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.07 Aligned_cols=266 Identities=21% Similarity=0.230 Sum_probs=200.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECC--CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
...+|++.+.||+|+||.||+|.... ++..|++|.+... ....+|+.+++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 35689999999999999999998643 4678999987543 2356799999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|+++. ++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 788888854 567999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh-hhHHHhhhhh------hccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPL------FQDR 262 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~------~~~~ 262 (361)
............|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+....... +...
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 33222223345689999999999988999999999999999999999999965432111 1111100000 0000
Q ss_pred cccc-----cccCccccCCCC-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 263 TRHS-----LIADPELQGQYP-------PRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 263 ~~~~-----~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.... ..........+. .....++.++|.+||..||++||++.+++..-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000 000000000000 01234677899999999999999999999753
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=293.13 Aligned_cols=252 Identities=31% Similarity=0.448 Sum_probs=196.7
Q ss_pred CeecccCceEEEEEEECCCCe--EEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~--~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++.++. .+++|.+.... ....+.+.+|+.++..+ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 46888876432 23345788899999999 799999999999999999999999999
Q ss_pred CCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 116 GSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 116 ~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865221 1235889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
++..... .........+..|+|||++.+..++.++||||||+++|+|++ |..||........... ... .
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~~----~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LPQ----G 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH---HhC----C
Confidence 8853111 111111223557999999988889999999999999999997 9999965433221111 100 0
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.....+...+..+.+++.+||..||.+||++.++++.|..+.
T Consensus 228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111123347889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=292.69 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=203.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe---EEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..+|+..+.||+|+||.||+|..+.++. .+++|.+.... ....+.+..|+.+++.++|+|++++.+++.+....++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578899999999999999999876554 79999886542 2334668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999865 2356899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCccee-eccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDNTHVS-TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
......... .....+..|+|||.+.+..++.++|||||||++|+|++ |..||........... .. .. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~---i~----~~---~ 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA---IN----DG---F 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH---Hh----cC---C
Confidence 322211111 11123456999999988889999999999999999997 9999965433211111 10 00 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
. ...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 228 ~-------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 R-------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 001112334788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=304.90 Aligned_cols=264 Identities=20% Similarity=0.303 Sum_probs=199.0
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcC-----
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 103 (361)
...++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 346899999999999999999999999999999999865322 2335577899999999999999999887543
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 104 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 104 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 6899888763 56999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhh---
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARP--- 257 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~--- 257 (361)
|++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||............ .....
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 998753221 223468899999999876 56889999999999999999999999764432221111 00000
Q ss_pred -hhcccc---------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 258 -LFQDRT---------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 258 -~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...... .........+. .........+.+|+.+||..||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000000000 0000112357789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=290.07 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=195.7
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCC
Q 018100 41 LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 117 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~--~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 117 (361)
.||+|+||.||+|.+. ..+..|++|++..... ...+.+.+|+.+++.++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999875 3456799999865432 234568899999999999999999998854 57899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcce-
Q 018100 118 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV- 196 (361)
Q Consensus 118 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~- 196 (361)
|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988641 356899999999999999999999999 99999999999999999999999999875322221111
Q ss_pred eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 197 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||............... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----------------~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-----------------KRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----------------CCC
Confidence 111223467999999988889999999999999999996 99999765433221111100 001
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
..+...+.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12333455888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.80 Aligned_cols=241 Identities=24% Similarity=0.295 Sum_probs=188.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcC---CCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
||+|+||.||+|.++.++..||+|++...... .......|..++... .||||+.+++.+.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998643221 223344566666554 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|..++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NK 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CC
Confidence 999988875 567999999999999999999999999 999999999999999999999999998642211 11
Q ss_pred eeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcccc
Q 018100 196 VSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (361)
......|+..|+|||++.+. .++.++|||||||++|+|++|..||............... .. .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~---------~~-----~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG---------KV-----RFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC---------CC-----CCC
Confidence 22335689999999998754 4789999999999999999999999765432221111000 00 000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 018100 275 GQYPPRGFYQALAVAAMCVHEQPDMRP----VIADVVT 308 (361)
Q Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~~ll~ 308 (361)
. ...+..+.+++.+||+.||++|| ++.++++
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 01234678899999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=310.59 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=205.7
Q ss_pred HHhhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCC-CCccceeeeEEEcC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADG 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 103 (361)
...++|.+.+.||+|+||.||+|.+.. ++..||+|++...... ..+.+..|+.++..+. ||||+++++.+...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 334578889999999999999999643 4568999999754332 2346889999999997 99999999999998
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC--------------------------------------------------------
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSP-------------------------------------------------------- 127 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------------------------- 127 (361)
...++|+||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 899999999999999999864211
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 128 --------------------------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 128 --------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
....+++..++.++.||+.||.|||+++ ++|+||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1134678889999999999999999999 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHh
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 248 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~ 248 (361)
+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999875322211111222346778999999988889999999999999999998 8899865432211
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
. ...... . .....+...+..+.+++.+||..+|.+||++.+|++.|+.+
T Consensus 351 ~--~~~~~~----~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 F--YNAIKR----G----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H--HHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 000000 0 00111223445888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=297.18 Aligned_cols=267 Identities=25% Similarity=0.340 Sum_probs=205.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|++|.||+|.++.+++.|++|++.... ....+.+.+|+.+++.++|+||+++++++..+...++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999999999999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++++.+..+... ...+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9987666655543 456899999999999999999999999 999999999999999999999999998764332
Q ss_pred CCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh-h-------hhccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-P-------LFQDR 262 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~-------~~~~~ 262 (361)
... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||................ . .+...
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 211 12234577889999999877 88999999999999999999999997654432221111100 0 00000
Q ss_pred ccccc--ccCc----cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSL--IADP----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~--~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..... .... .....++...+..+.+++.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000 0011122223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=295.12 Aligned_cols=257 Identities=28% Similarity=0.364 Sum_probs=203.3
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCC-----
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD----- 104 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~----- 104 (361)
...++|++.+.||+|++|.||+|.++.++..+++|++..... ..+.+.+|+.+++.+ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356899999999999999999999998899999999865433 346788999999998 6999999999986543
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 105 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 105 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
..++||||+++++|.+++......+..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 589999999999999998764433567999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhcc-----CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
.+...... ........++..|+|||.+.. ..++.++||||||+++|+|++|..||......... ....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~--- 231 (275)
T cd06608 159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--FKIP--- 231 (275)
T ss_pred cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--HHhh---
Confidence 88653221 122233457889999998753 35678999999999999999999999654322111 1000
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.. .......+...+..+.+++.+||..||++|||+.++++
T Consensus 232 -~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RN---------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cc---------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00001111223457889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=292.54 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=202.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc----------chHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
+|.+.+.||+|++|.||+|....++..+++|.+...... ..+.+..|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999988999999987532111 1245778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999876 467899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCC--CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
+................++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~----~~- 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FKLG----NK- 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HHhh----cc-
Confidence 87533222222223345788999999987654 789999999999999999999999643322111 0000 00
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. .+.+........+..+.+++.+||..+|++||++.++++.
T Consensus 228 -~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 -RS----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cc----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 0111111122334588899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=296.49 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=201.8
Q ss_pred hCcccCCeecccCceEEEEEEE----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcC--Cee
Q 018100 34 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 106 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~----~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 106 (361)
+-|++.+.||+|+||.||+|.. +.++..|++|.+.... ......+.+|+.+++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578999999999999999984 4568899999986443 23346788999999999999999999998765 567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++... ...+++..++.++.||+.||.|||++| ++||||+|+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998651 245899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh---------hhHHHhhh
Q 018100 187 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE---------QSLVAWAR 256 (361)
Q Consensus 187 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~---------~~~~~~~~ 256 (361)
........ .......++..|+|||.+.+..++.++|||||||++|+|++++.|+........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 54322211 112234566789999999888899999999999999999998766432111000 00000000
Q ss_pred hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 257 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
.... ......+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 238 -~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VLEE----------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHc----------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 000111223455889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.70 Aligned_cols=253 Identities=29% Similarity=0.408 Sum_probs=201.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||+|++|.||+|.+..+ ..+++|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 6799999999999999999998764 468999876433 334678889999999999999999988754 5678999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
.+++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999997532 345899999999999999999999999 99999999999999999999999999875322211
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||...+..++.++||||||+++|+|++ |..||.......... .... . .
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~----~---~------ 220 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---QVER----G---Y------ 220 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc----C---C------
Confidence 11112235677999999988889999999999999999999 899997643322111 1100 0 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
....+...+..+.+++.+||..||++||++.++++.|+.
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001122334578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=293.16 Aligned_cols=252 Identities=30% Similarity=0.436 Sum_probs=199.0
Q ss_pred CeecccCceEEEEEEECCCC------eEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 40 SLLGEGGFGRVYKGYLESIN------QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~------~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+.||+|+||.||+|.++... ..+++|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46899999999999986543 6799998765432 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-----ceeEecccc
Q 018100 113 MPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-----HPKLSDFGL 184 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-----~~~L~Dfg~ 184 (361)
+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999865221 1245889999999999999999999999 99999999999999887 899999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
+................++..|+|||.+.+..++.++|||||||++|+|++ |..||............ . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~---~----~-- 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV---T----A-- 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH---h----c--
Confidence 875332222222222345678999999998899999999999999999998 99999754332211111 0 0
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
. .....+...+..+.+++.+||..+|++||++.++++.|+
T Consensus 229 -~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 -G-------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -C-------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 001122334557889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=305.13 Aligned_cols=264 Identities=28% Similarity=0.414 Sum_probs=201.8
Q ss_pred hhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEc-CC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-GD 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 104 (361)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.++..+ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 368999999999999999999853 4578899999865432 2345688899999999 68999999998754 45
Q ss_pred eeEEEEEecCCCCHHHHhcccCC---------------------------------------------------------
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSP--------------------------------------------------------- 127 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~--------------------------------------------------------- 127 (361)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccc
Q 018100 128 ------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 201 (361)
Q Consensus 128 ------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~ 201 (361)
....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124788889999999999999999999 9999999999999999999999999987532221111122233
Q ss_pred cCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChH
Q 018100 202 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 280 (361)
Q Consensus 202 ~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (361)
++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ... ..... .. ..+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~----~~~~~---~~-------~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKEGT---RM-------RAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHH----HhccC---CC-------CCCCC
Confidence 5667999999988889999999999999999997 89998654321111 000 00000 00 00111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 281 GFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 281 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
....+.+++..||+.||++||++.++++.|+.+.+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23367889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=296.85 Aligned_cols=260 Identities=26% Similarity=0.357 Sum_probs=204.1
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEE--
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCA-- 101 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-- 101 (361)
+..++....+.|++.+.||.|+||.||+|.+..+++.+++|++.... .....+..|+.+++.+ +|+|++++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555566789999999999999999999999999999999986543 2345678899999988 6999999999884
Q ss_pred ----cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 102 ----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 102 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
.....+++|||+.+++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 3467899999999999999987533 356889999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 252 (361)
+|+|||++....... .......++..|+|||.+. +..++.++|+|||||++|+|++|..||............
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 999999986532111 1122345788999999875 346788999999999999999999999654322111100
Q ss_pred HhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
... ..+.. .....+..+.++|.+||..||.+||++.++++
T Consensus 239 -------~~~------~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -------PRN------PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------hhC------CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 00000 01123447889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=289.80 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=199.5
Q ss_pred CeecccCceEEEEEEECC-CC--eEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLES-IN--QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~-~~--~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|++|.||+|.+.. .+ ..|++|.+..... ...+.+..|+.+++.++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 23 3689999876655 455678999999999999999999999988 888999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 99999997632 146899999999999999999999999 9999999999999999999999999987643322111
Q ss_pred -eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 196 -VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 196 -~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||............. . . ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~---~---~~~------ 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---K---E---GER------ 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h---c---CCc------
Confidence 1122346778999999988899999999999999999998 999996543322111110 0 0 000
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111223457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=301.41 Aligned_cols=256 Identities=21% Similarity=0.222 Sum_probs=199.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||++.++.++..||+|++.... ......+.+|+.++..++|++|+.+++.+.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986421 222345778899999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhcc-----CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||............ ......
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~~- 226 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHEER- 226 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH------HcCCCc-
Confidence 111 11223468999999999865 46788999999999999999999999754332211111 000000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~ll~~ 309 (361)
..-+. .....+..+.+++.+||..++++ |++++++++.
T Consensus 227 --~~~p~----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 --FQFPS----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --ccCCC----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00011 11123457888999999876554 4678888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=291.63 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=204.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..+|.+.+.||+|+||.||+|.+... ...|++|...... ....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence 46799999999999999999987653 3468999886544 33456788999999999999999999998764 5689
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999752 235899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||............. ...
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~---- 225 (270)
T cd05056 158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------NGE---- 225 (270)
T ss_pred ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------cCC----
Confidence 22211 11112234467999999988889999999999999999986 999997654332211110 000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.. ..+...+..+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 226 --~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 1122334578889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=289.63 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=204.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|+||.+|.+....++..|++|.+.... ....+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5899999999999999999999999999999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+.+++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999886522 346899999999999999999999999 9999999999999999999999999887532221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||............ .... .
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~~~-----------~-- 218 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--IRGS-----------Y-- 218 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--hcCC-----------C--
Confidence 1122345788899999998888999999999999999999999999754332211100 0000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+.++.+++.+||+.+|++||++.++++.
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01122334478899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=291.97 Aligned_cols=251 Identities=28% Similarity=0.373 Sum_probs=198.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhcCCCCccceeeeEEEc--CCee
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 106 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 106 (361)
.+|++.+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368999999999999999999999999999998864321 123468889999999999999999998865 3677
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999976 456899999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCC-CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGD-NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... .........++..|+|||.+.+..++.++|||||||++|+|++|..||............ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~------~~----- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI------AT----- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH------hc-----
Confidence 532111 111112245788899999998888999999999999999999999999754322111000 00
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ......+......+.+++ +||..+|++||++.++++
T Consensus 224 -~----~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 -Q----PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -C----CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0 001122333344666777 688899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=290.47 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=205.5
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEE--cCCeeEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVY 110 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 110 (361)
+|++.+.||.|+||.||+|.+..++..|++|.+..... ...+.+..|+.+++.++|+|++++++.+. .+...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58899999999999999999999999999999865433 23456888999999999999999999775 345679999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
||+++++|.+++.........+++..++.++.||+.||.+|| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444578999999999999999999999 888 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .... ..
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~----~~--- 225 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SKIK----EG--- 225 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH---HHHh----cC---
Confidence 76433221 122345788999999998888999999999999999999999999765422211 1110 00
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+...+..+.+++.+||+.+|++||++.+|++.
T Consensus 226 -------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 -------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0011223344588899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=291.91 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=203.6
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
+|+..+.||+|++|.||.|.+..++..|++|++...... ..+.+..|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588899999999999999999999999999998643211 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEeccccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKL 187 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~~~ 187 (361)
|+||+.+++|.+++.. ..++++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999876 457899999999999999999999999 99999999999998776 599999999865
Q ss_pred CCCCCC--cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 188 GPVGDN--THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 188 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||............... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~------ 224 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---A------ 224 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH---h------
Confidence 332211 11122345788999999998888999999999999999999999999643221111111000 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........+......+.+++.+||..+|++||++.+++.
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 ----SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000112233345568889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.85 Aligned_cols=254 Identities=29% Similarity=0.346 Sum_probs=204.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|++|.||+|.+..++..|++|.+...... ..+.+..|+.+++.++|+||+++++.+.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4789999999999999999999999999999999765433 3356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+.+++|.+++.... +..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987522 457999999999999999999999999 99999999999999999999999998765322
Q ss_pred CCCc---------------------------ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccc
Q 018100 191 GDNT---------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 243 (361)
Q Consensus 191 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 243 (361)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111235788899999999888999999999999999999999999765
Q ss_pred hHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 018100 244 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV----IADVVT 308 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~~ll~ 308 (361)
....... ... ... ... ......+..+.+++.+||+.||++||+ +.+++.
T Consensus 236 ~~~~~~~--~~~----~~~--------~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFS--NIL----KKE--------VTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHH--HHh----cCC--------ccC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4322111 000 000 000 001113558899999999999999999 767665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=296.53 Aligned_cols=264 Identities=28% Similarity=0.465 Sum_probs=205.5
Q ss_pred hCcccCCeecccCceEEEEEEECC----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEc--CCee
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 106 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 106 (361)
++|++.+.||+|+||.||+|.+.. ++..+++|++...... ..+.+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 578889999999999999999653 4789999998765443 45678999999999999999999999877 5678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+++|||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999752 235999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh--------hHHHhhhh
Q 018100 187 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--------SLVAWARP 257 (361)
Q Consensus 187 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~--------~~~~~~~~ 257 (361)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 64322111 1111223456799999998888999999999999999999999998654322110 00000000
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
.... ......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 238 ~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKE----------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHc----------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 000111223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.84 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=203.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|++|.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5899999999999999999999999999999987543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEecccccccCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVG 191 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~~~~~~~ 191 (361)
+++++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 346899999999999999999999999 99999999999998654 5799999998753222
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||............ ...
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--~~~-------------- 216 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI--MSG-------------- 216 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH--Hhc--------------
Confidence 1 112245788999999998888899999999999999999999999765332211100 000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 217 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 -TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0011122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.58 Aligned_cols=252 Identities=33% Similarity=0.479 Sum_probs=202.7
Q ss_pred cccCCeecccCceEEEEEEECCCC----eEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~----~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+++.+.||.|+||.||+|.+...+ ..|++|.+...... ..+.+..|+..++.++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467889999999999999998766 89999998655433 4567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.... ...+++..+..++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997622 122899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
...... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.............. ...
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------~~~-- 222 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------GYR-- 222 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----------CCC--
Confidence 311111 12236678999999988889999999999999999998 8888875433222111100 000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
...+...+..+.+++.+||..||++|||+.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011122445788899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.04 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=202.9
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+|+..+.||+|++|.||+|....++..|++|.+..... ...+.+.+|+.+++.++|+|++++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999998899999999865432 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999976 456899999999999999999999999 9999999999999999999999999887532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCC-CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......... ..... . .
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~-----~--~--- 218 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FKIGR-----S--K--- 218 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HHHHh-----c--c---
Confidence 221 223345788899999987766 899999999999999999999999765421111 10000 0 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+......+.+++.+||+.+|++||++.+++.
T Consensus 219 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 001122233457888999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.21 Aligned_cols=256 Identities=21% Similarity=0.229 Sum_probs=199.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||++.++.++..+++|++.... ......+..|+.++..++|++|+.+++.+.+....|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986421 122345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
. .........|+..|+|||++. ...++.++|||||||++|+|++|..||...........+ .....
T Consensus 155 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~-- 225 (332)
T cd05623 155 D-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKE-- 225 (332)
T ss_pred C-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH------hCCCc--
Confidence 1 111222346899999999986 346789999999999999999999999765432221111 00000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~ll~~ 309 (361)
....+. .....+..+.+++.+|+..++++ |+++.++++.
T Consensus 226 -~~~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 -RFQFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cccCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000011 11223457888999998765554 6889999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=297.59 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=202.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
+.|.....||+|+||.||++.+..++..|+||.+........+.+.+|+.+++.++|+|++++++.+..+...++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44555677999999999999999889999999987655555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++.. ..+++..++.++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 99999998854 45899999999999999999999999 9999999999999999999999999886432211
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||............ .... .+..
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~----------~~~~ 238 (292)
T cd06658 173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNL----------PPRV 238 (292)
T ss_pred -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcC----------CCcc
Confidence 1122345788999999998888999999999999999999999999754332211111 0000 0000
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .....+..+.+++.+||..||.+||++.++++.
T Consensus 239 ~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 K--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 011223367789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=295.52 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=202.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+.|++.+.||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45778889999999999999999889999999986443 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT- 154 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc-
Confidence 999999998864 56899999999999999999999999 999999999999999999999999998653221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... .. ... ..+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~----~~~------~~~- 219 (277)
T cd06642 155 -QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---LI----PKN------SPP- 219 (277)
T ss_pred -chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---hh----hcC------CCC-
Confidence 111222457888999999988889999999999999999999999986432211110 00 000 001
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122334578899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.38 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=203.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|+||.||+|.+.. +..+++|.+... ....+.+.+|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45789999999999999999998664 567999987643 2334678889999999999999999999887 67899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... +..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999997532 456888999999999999999999999 999999999999999999999999988753222
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........... ....+
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~~~~----------- 220 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERGY----------- 220 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HhCCC-----------
Confidence 11 11122234567999999988889999999999999999998 9999976433221111 10000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112334578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.68 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=203.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe----EEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|++.+.||+|+||.||+|.+..++. .|++|.+...... ....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4678899999999999999999877665 4688887644322 234678899999999999999999998654 467
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++++|+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 89999999999999875 1346899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..............++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~---~ 228 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KG---E 228 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CC---C
Confidence 432222111222335678999999988889999999999999999997 899997653322221111 00 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.. ..++..+..+.+++..||..+|++||++.++++.|..+...
T Consensus 229 ~~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 RL-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01122334788899999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=294.94 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=208.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++||||+++++.+......++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 468999999999999999999999999999999886543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+ ++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999998876 4578999999999999999999997 57 99999999999999999999999998764211
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH-----hhhHHHhhhhhhcccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-----EQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~ 265 (361)
. ......++..|+|||++.+..++.++|+|||||++|+|++|..||....... ...+...........
T Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 229 (284)
T cd06620 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--- 229 (284)
T ss_pred h----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence 1 1123468899999999988889999999999999999999999997544321 111111111111100
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.+.+. ....+..+.+++.+||+.||++||++.++++....+.
T Consensus 230 ----~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 ----PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ----CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00000 0113447889999999999999999999998755444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=311.62 Aligned_cols=264 Identities=20% Similarity=0.217 Sum_probs=196.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
...|.+.+.||+|+||.||+|.+..++..|+||... ...+.+|+.+++.++|+||+++++++..+...++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346999999999999999999999999999999642 23356899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+. ++|..++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 7888887641 346999999999999999999999999 9999999999999999999999999987533222
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccch-H-------HHhhhHHHhhhhh---hcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK-A-------AAEQSLVAWARPL---FQD 261 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~-~-------~~~~~~~~~~~~~---~~~ 261 (361)
.........|+..|+|||++.+..++.++|||||||++|+|++|..|+-... . .....++...... +..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2222233568999999999999899999999999999999999876542211 1 1111111111000 000
Q ss_pred cc----------ccccccCccccCCCC---hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 RT----------RHSLIADPELQGQYP---PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~~----------~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. .......+....... ......+.+||.+||+.||.+|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000000000000 0112367889999999999999999999974
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=291.18 Aligned_cols=251 Identities=27% Similarity=0.350 Sum_probs=199.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhcCCCCccceeeeEEEc--CCee
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 106 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 106 (361)
.+|++.+.||+|+||.||.|.+..++..|++|.+..... ...+.+.+|+.+++.++||||+++++.+.+ ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998753211 123567889999999999999999998865 3567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999875 456899999999999999999999999 9999999999999999999999999887
Q ss_pred cCCCCCC-cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
....... ........++..|+|||++.+..++.++|||||||++|+|++|..||......... .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~~----~----- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI--FKIA----T----- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--HHHh----c-----
Confidence 5321111 11122245788999999998888999999999999999999999999754322111 0000 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.......+......+.+++.+||. +|++||+++++++
T Consensus 224 -----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 -----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000112234445577889999995 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=295.99 Aligned_cols=265 Identities=26% Similarity=0.316 Sum_probs=206.5
Q ss_pred eeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEc
Q 018100 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD 102 (361)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 102 (361)
++...+..+.++|++.+.||+|+||.||+|..+.++..+++|++.... .....+..|+.++..+ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344566677899999999999999999999999999999999986432 2235677899999988 79999999999864
Q ss_pred C-----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 103 G-----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 103 ~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
. ...++|+||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999988654334567899999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhccC-----CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 252 (361)
+|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|..||......... .
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--F 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--H
Confidence 9999999875322111 11223578889999987543 3689999999999999999999999754332111 1
Q ss_pred HhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..... . .... ..+......+.+++.+||+.+|++||++.++++.
T Consensus 244 ~~~~~----~--~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPRN----P--PPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhcC----C--CCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10000 0 0000 0112233468889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.05 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=208.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.+|++.+.||+|++|.||+|.++.++..|++|++..... .....+.+|+..+..++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368899999999999999999999999999999876544 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
+++++|.+++.. ...+++..++.++.||++||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999976 4679999999999999999999999 99 999999999999999999999999988753322
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||................ .. ..+
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~-------~~~ 221 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DG-------PPP 221 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cC-------CCC
Confidence 21 1123457888999999988889999999999999999999999997654211111111110 00 001
Q ss_pred cccCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..+.. .+..+.+++.+||..+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122 44588899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=306.87 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=206.0
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEecc--CCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCe
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 105 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 105 (361)
|....+.|+++++||.||.+.||++...+. ..+++|.+.. .+.....-+.+|+..|.+|+ |.+|+.++|+-..++.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 455678899999999999999999998764 4566666543 23344567999999999995 8999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
+|+||||-+ .+|..++.... ..++...+..++.||+.|+.++|.+| |||.||||.|||+-. |.+||+|||++
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA 506 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIA 506 (677)
T ss_pred EEEEeeccc-ccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechh
Confidence 999999864 89999998722 33444589999999999999999999 999999999998864 68999999999
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccC-----------CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 254 (361)
.........-.....+||..||+||.+... ..+.++|||||||+||+|+.|+.||.....
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------- 577 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------- 577 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------
Confidence 987777777777778999999999988532 266889999999999999999999975321
Q ss_pred hhhhhccccccccccCccccCCCChHHHH-HHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFY-QALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...+...+.+|.-..+++..... +++++++.||+.||++||++.++|+
T Consensus 578 ------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 ------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11223344455443444433222 3899999999999999999999996
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=296.67 Aligned_cols=266 Identities=26% Similarity=0.337 Sum_probs=202.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|+||.||+|.++.++..|++|.+...... ..+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4789999999999999999999988999999998654322 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|..+... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9998888877654 456899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhh--------ccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF--------QDR 262 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~ 262 (361)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..................+ ...
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 1 11223457888999998865 457789999999999999999999997544322111111000000 000
Q ss_pred cccccccCcccc-----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSLIADPELQ-----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........+... ....+..+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 0111234567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.22 Aligned_cols=245 Identities=27% Similarity=0.348 Sum_probs=202.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999999999999999864322 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. .....++..|+|||.+.+...+.++||||||+++|+|++|..||............. .. .
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~--------~ 214 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL------EG--------K 214 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------cC--------C
Confidence 2 223457889999999988888999999999999999999999997654221111110 00 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
. ..+......+.+++.+||..||.+|+ +++++++
T Consensus 215 ~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 11222244778899999999999998 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=289.83 Aligned_cols=273 Identities=26% Similarity=0.342 Sum_probs=217.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchH---HHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
--++|..++.||+|.||+|.+++.+.++..+|+|++.+.-....+ .-..|-.+|+..+||.+..+.-.|..++.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 357899999999999999999999999999999999765443333 34567889999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+.||.|.-.+.. ...+++.....+...|..||.|||+++ ||.||||.+|.|+|.+|.+||+|||+|.-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE- 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE- 317 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh-
Confidence 9999999999877765 677999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
...........+||+.|+|||++.+..|..++|+|.+|+++|+|++|+.||-.......-.++.
T Consensus 318 -~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--------------- 381 (516)
T KOG0690|consen 318 -EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--------------- 381 (516)
T ss_pred -cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------------
Confidence 3334445567889999999999999999999999999999999999999996543322221111
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHHHHhccCCCccccCCCCCCCC
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTALAYLASQKYESDAEKVQSPCLDP 332 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~l~~l~~~~~~~~~~~~~~~~~~~ 332 (361)
.....+|.....+...|+..+|.+||.+|. ++.+|.+ -.++....+........+|+..|
T Consensus 382 ---~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~-h~FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 382 ---MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR-HRFFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred ---hhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh-hhhhccCCHHHHHHhccCCCCCC
Confidence 001234445555888899999999999994 3444443 23444444444444444444333
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.92 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=201.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.+|++.+.||+|+||.||++.++.++..|++|.+..... .....+.+|+.+++.++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 478999999999999999999999999999999875432 22356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||++|++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999976 467899999999999999999999999 99999999999999999999999998763111
Q ss_pred CCC-------------cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh
Q 018100 191 GDN-------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 191 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||............ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~--~~- 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--IS- 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh-
Confidence 100 00111234677899999998888999999999999999999999999754322111110 00
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
. ....+.. ....+..+.+++.+||+.||++||++.++.+.|+
T Consensus 231 ---~-----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 231 ---D-----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---c-----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0 0000111 1123447889999999999999999655555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.94 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=203.6
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|++|.||+|.+..+|..|++|++..... .....+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999998899999999876542 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+ +++|.+++... ...+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998652 256999999999999999999999999 9999999999999999999999999987643322
Q ss_pred CcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhh-------hhhcccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWAR-------PLFQDRT 263 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~-------~~~~~~~ 263 (361)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||........... ..... +.+....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 112234578899999988654 468999999999999999999888865443222111 10000 0000000
Q ss_pred ccccccCcc----ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 264 RHSLIADPE----LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 264 ~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......+. ......+.....+.+++.+||..||.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0001112234688899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.51 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=201.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||+|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4789999999999999999999989999999988643 222345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
+++++|..++.... ....+++..+..++.||+.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999998887522 13478999999999999999999996 58 999999999999999999999999998643211
Q ss_pred CCcceeeccccCcCcCCchhhccC------CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
......++..|+|||.+.+. .++.++|+|||||++|+|++|..||............. ....
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~----- 224 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AIVD----- 224 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---HHhh-----
Confidence 11223577889999998543 35789999999999999999999996543211111100 0000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......++..+.++.+++.+||+.+|++||++.+++..
T Consensus 225 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 225 ------GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00012233355578899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=295.48 Aligned_cols=265 Identities=18% Similarity=0.222 Sum_probs=197.8
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|++|.||+|.++.+|..|++|.+...... ....+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999999999999999998643222 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
++ ++|.+++... ...+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 6888777541 356999999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCcccc-chHHHhhhHH-Hhhhh-------hhccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDT-SKAAAEQSLV-AWARP-------LFQDR 262 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~-~~~~~~~~~~-~~~~~-------~~~~~ 262 (361)
.......++..|+|||.+.+. .++.++|||||||++|+|++|..||.. .......... ..... .....
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 111223567889999998764 478999999999999999999888533 2221111100 00000 00000
Q ss_pred cccccccCc---cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSLIADP---ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
......... .......+..+..+.+++.+||+.||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000 0001112234557889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.76 Aligned_cols=266 Identities=25% Similarity=0.278 Sum_probs=201.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+|++.+.||+|++|.||+|.+..++..|++|.+...... ....+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588899999999999999999988999999999755332 234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+ +++|.+++... ...+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999999751 136999999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhh----hhcccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARP----LFQDRT 263 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~----~~~~~~ 263 (361)
... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||............ ..... .+....
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 221 11122345778999998855 46789999999999999999998888654432211111 00000 000000
Q ss_pred cccccc-----CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 264 RHSLIA-----DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 264 ~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...... .+..........+..+.+++.+||+.||++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000011112335678899999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.33 Aligned_cols=247 Identities=31% Similarity=0.441 Sum_probs=196.4
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999876 4788999998654332 234688899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 152 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSG 152 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCC
Confidence 9988642 345899999999999999999999999 99999999999999999999999999864222111 1111
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 277 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (361)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||............. . . .....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~----~----------~~~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K----G----------YRMSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----C----------CCCCC
Confidence 1234567999999988889999999999999999998 999997553322211110 0 0 00111
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 278 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2233457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.03 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=200.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
+|++.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999875 5889999988643211 12457889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999975 456899999999999999999999999 999999999999999999999999988653
Q ss_pred CCC----CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 189 PVG----DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 189 ~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
... ..........++..|+|||.+.+..++.++|+||||+++|+|++|..||............. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~-------- 222 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG--A-------- 222 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh--h--------
Confidence 211 11111223457889999999988889999999999999999999999997543322111000 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ....+ ..+...+..+.+++.+||+.+|++||++.++++
T Consensus 223 ~-~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 H-RGLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred c-cCCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00011 112234457889999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.01 Aligned_cols=265 Identities=18% Similarity=0.223 Sum_probs=196.2
Q ss_pred cCCeeccc--CceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 38 SESLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 38 ~~~~lg~G--~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
+++.||+| +|++||++.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 689999999999999999999875432 23356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC-CC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV-GD 192 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~-~~ 192 (361)
++++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++++||+.+..... +.
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986522 345899999999999999999999999 99999999999999999999999986533111 00
Q ss_pred C----cceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc-
Q 018100 193 N----THVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH- 265 (361)
Q Consensus 193 ~----~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 265 (361)
. ........++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCcccccccc
Confidence 0 001112345677999999875 46889999999999999999999999754322111 00000000000000
Q ss_pred ------------ccccC-------------c----cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 266 ------------SLIAD-------------P----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 266 ------------~~~~~-------------~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....+ + .............+.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 0 00000111234578899999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=288.90 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=206.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||.|++|.||+|....++..+++|++..... .....+.+|+.+++.++|+|++++++.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 479999999999999999999988899999999865432 2456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++..... ...+++..+..++.||+.||.+||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976321 246899999999999999999999999 9999999999999999999999999886643322
Q ss_pred Cc--ceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 193 NT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 193 ~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .......++..|+|||.+... .++.++|+||||+++|+|++|..||......... ...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~~-----------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQN-----------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhcC-----------C
Confidence 22 122334578899999998766 7899999999999999999999999754332111 100000 0
Q ss_pred CccccCCC-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 270 DPELQGQY-PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+...... ....+..+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00010000 1233457889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.60 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=200.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.........||+|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 34455556899999999999999988999999998766655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEecccccccCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPL--DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGP 189 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~~~~~ 189 (361)
+++++|.+++... ...+ ++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||.+....
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 87 VPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred CCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999998752 1334 88889999999999999999999 999999999999976 6799999999886532
Q ss_pred CCCCcceeeccccCcCcCCchhhccC--CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... .....
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~---~~~~~-------- 227 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---KVGMF-------- 227 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---hhhhh--------
Confidence 211 112223578899999998654 378999999999999999999999965322111100 00000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......+......+.+++.+||+.+|++||++.++++.
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111223344578899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.93 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=203.5
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|.+.+.||+|++|.||+|.+..++..|++|.+...... ..+.+..|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 689999999999999999999988999999998765443 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. +..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999976 556899999999999999999999999 9999999999999999999999999987643322
Q ss_pred Ccce--eeccccCcCcCCchhhccCC---CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 193 NTHV--STRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......... ...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~--~~~~~~-------~-- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--MFHVGA-------G-- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH--HHHHhc-------C--
Confidence 2111 11245678999999987765 889999999999999999999999654221111 000000 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 223 -~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0112447788999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.57 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=202.8
Q ss_pred hCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
++|++.+.||.|+||.||+|..+. +...|++|.+...... ..+.+.+|+.+++.++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 689999999999999999999764 3467999987654333 3467889999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPG-----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
+||||+++++|.+++...... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999763311 126899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
|++....... ........++..|+|||.+.+...+.++||||||+++|+|++ |..||........ ...... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~~~~---~ 234 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNRLQA---G 234 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHHHHc---C
Confidence 9886422211 111222345677999999988888999999999999999998 7889865332211 111100 0
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 235 ----------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 ----------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000111223447889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.91 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=205.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|.+.+.||+|+||.||++....++..|++|.+........+.+.+|+.+++.++|||++++++.+......|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 47899999999999999999999888999999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999864 45889999999999999999999999 9999999999999999999999999876432221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ .. ...
T Consensus 170 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~---------~~~ 232 (293)
T cd06647 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT---------NGT 232 (293)
T ss_pred --cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hc---------CCC
Confidence 1122235778899999998888999999999999999999999999754322111000 00 000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+...+..+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122234478889999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.33 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=196.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHH-HhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|+||.||+|.++.+|..||+|.+..... .....+..|+.. ++.++|||++++++++..+...|+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 478999999999999999999999999999999875432 223345556554 566789999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|++ ++|.+++.........+++..++.++.||+.||.|||++ + ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 788888765443456799999999999999999999997 8 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhcc----CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ .+......
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~--------- 223 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQVVEE--------- 223 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHHHhc---------
Confidence 1 11222457888999998865 4568899999999999999999999964321110 01000000
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..+.+. ....+.++.+++.+||..+|++||++.++++.
T Consensus 224 --~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 --PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 01234578899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=290.40 Aligned_cols=248 Identities=27% Similarity=0.348 Sum_probs=204.0
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
+|++.+.||.|+||.||+|.++.++..|++|++..... ...+.+.+|+.+++.++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58899999999999999999998999999999875432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+.+++|..++.. ..++++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999976 457999999999999999999999999 999999999999999999999999988753322
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.................
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-------------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------------
Confidence 1 12234578889999999888899999999999999999999999976543211111111000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI--ADVV 307 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~~ll 307 (361)
.....+...+..+.++|.+||+.||.+||++ .+++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111222334688899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.80 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=203.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecC
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 114 (361)
.|.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.++..++|||++++++.+..+...++++||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 34556689999999999999998899999999876555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
+++|..++.. ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-- 171 (297)
T cd06659 102 GGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-- 171 (297)
T ss_pred CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--
Confidence 9999987754 56899999999999999999999999 9999999999999999999999999886432211
Q ss_pred ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (361)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||............. . . +...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~---~---------~~~~ 236 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---D---S---------PPPK 236 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---c---c---------CCCC
Confidence 11223457889999999988889999999999999999999999997543322211110 0 0 0000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 275 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.......+..+.+++.+||+.+|++||++.++++.-
T Consensus 237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 001112234678899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=288.70 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=203.1
Q ss_pred CcccCCeecccCceEEEEEEECC-CCeEEEEEEeccCCc----------cchHHHHHHHHHHhc-CCCCccceeeeEEEc
Q 018100 35 NFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGV----------QGNREFLVEVLMLSL-LHHPNLVNLIGYCAD 102 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~-~~~~v~iK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 102 (361)
.|++.+.||+|+||.||+|.++. .+..+++|.+..... .....+..|+.++.. ++||||+.+++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 678899998753221 122456778887765 789999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
+...+++|||+++++|.+++.........+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886544445679999999999999999999996 67 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ .....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~-- 230 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI--VEAVY-- 230 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH--hhccC--
Confidence 99987533221 223445788999999998888999999999999999999999999654332211111 00000
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.+.. ....+..+.+++.+||+.||++||++.++.+++.
T Consensus 231 --------~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 --------EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000 0122347889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=292.34 Aligned_cols=240 Identities=28% Similarity=0.472 Sum_probs=190.8
Q ss_pred CeecccCceEEEEEEECCCCe-------EEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 40 SLLGEGGFGRVYKGYLESINQ-------DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~-------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+.||.|+||.||+|.++..+. .+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999999866544 3888887655444456788899999999999999999999998899999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc--------eeEecccc
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------PKLSDFGL 184 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~--------~~L~Dfg~ 184 (361)
+++++|.+++... +..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998752 236899999999999999999999999 999999999999987765 69999998
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCC-CccccchHHHhhhHHHhhhhhhccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
+..... .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||............ ..
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~- 220 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------ED- 220 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------Hc-
Confidence 764221 122357788999999976 45789999999999999999985 565543322211110 00
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
....+...+..+.+++.+||+.||++||+++++++.|
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0112223345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=288.08 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=189.2
Q ss_pred CeecccCceEEEEEEECCC------------CeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 40 SLLGEGGFGRVYKGYLESI------------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~------------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
+.||+|+||.||+|..... ...|++|++..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986432 3368999876655445567888999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc-------eeEe
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-------PKLS 180 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~-------~~L~ 180 (361)
+||||+++++|..++.. ....+++..++.++.||+.||+|||+++ ++|+||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999888764 1356899999999999999999999999 999999999999987664 8999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHh-hCCCccccchHHHhhhHHHhhhhh
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
|||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||............ ...
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~ 225 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQ 225 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcC
Confidence 9998864211 12234678899999886 467889999999999999998 488888654322211110 000
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.. .......++.+|+.+||+.||.+||++.+|++.+
T Consensus 226 -------~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 -------CM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------cc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0111234778899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=286.59 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=192.2
Q ss_pred CeecccCceEEEEEEECC--CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 40 SLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
+.||+|+||.||+|.... ++..+++|.+...... ....+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998653 4567999988654332 2346888999999999999999999999988999999999999
Q ss_pred CHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 117 SVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 117 ~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
+|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999875321 1235677788899999999999999999 9999999999999999999999999986532222111
Q ss_pred eeeccccCcCcCCchhhccC-------CCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 196 VSTRVMGTYGYCAPEYAKTG-------QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~-------~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||............ .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--~~------~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--VR------EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--hh------cccCC
Confidence 12234567789999988542 35789999999999999996 99999765433221111 00 00011
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
...+.... ..+..+.+++..|| .+|++||++.+|+..|.
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11122211 12335677999998 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=291.06 Aligned_cols=267 Identities=22% Similarity=0.318 Sum_probs=198.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|++|.||+|.++.++..|++|.+...... ....+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36899999999999999999999988999999998654322 22456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+. ++|.+++... ...+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 997 5899888652 346899999999999999999999999 999999999999999999999999998643221
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHh-hh-HHHhhhh----hhccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QS-LVAWARP----LFQDRTR 264 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-~~-~~~~~~~----~~~~~~~ 264 (361)
.. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........ .. ....... .+.....
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11 1112235778999999865 4578999999999999999999999965542111 11 0000000 0000000
Q ss_pred c--------ccccCccccCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 H--------SLIADPELQGQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 ~--------~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. .......+....+ ......+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000000000 001257788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=282.11 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=206.1
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecC
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 114 (361)
+|++.+.||+|++|.||++.+..++..+++|++..........+.+|+.+++.++|++++.+++.+..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 58899999999999999999998899999999976655556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
+++|.+++... ...+++..++.++.|++.||.+||+++ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998762 257899999999999999999999999 99999999999999999999999999876433221
Q ss_pred ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (361)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ... +...
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~~ 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------NGP-----PGLR 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------cCC-----CCcC
Confidence 2334578899999999888899999999999999999999999976532221111100 000 0000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 275 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+..+.+++.+||+.||++|||+.++++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112447889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=290.65 Aligned_cols=239 Identities=24% Similarity=0.385 Sum_probs=187.7
Q ss_pred eecccCceEEEEEEECCC------------------------CeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcccee
Q 018100 41 LLGEGGFGRVYKGYLESI------------------------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 96 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~------------------------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 96 (361)
+||+|+||.||+|....+ ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999985321 24588998865544445678889999999999999999
Q ss_pred eeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-
Q 018100 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY- 175 (361)
Q Consensus 97 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~- 175 (361)
++++.++...++||||+++++|..++.. ....+++..+..++.||+.||+|||+++ ++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988864 2356899999999999999999999999 99999999999997654
Q ss_pred ------ceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHh-hCCCccccchHHH
Q 018100 176 ------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAA 247 (361)
Q Consensus 176 ------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll-~g~~pf~~~~~~~ 247 (361)
.++++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 389999998753211 112346778999998865 56899999999999999995 6899987543322
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
...... .. . ..+......+.+++.+||+.+|++||++.++++.|
T Consensus 230 ~~~~~~-------~~---~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYE-------KK---H---------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH-------hc---c---------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 211110 00 0 00111123678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=300.72 Aligned_cols=261 Identities=28% Similarity=0.403 Sum_probs=214.5
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECC----CCeEEEEEEecc-CCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDR-NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~v~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
+...+.....+.||.|.||.||.|.... ..-.||||.-+. ..++..+.|..|+.+|++++||||++++++|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3444555667899999999999999743 345688888665 3455678899999999999999999999999865
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
-.+||||.++.|.|..+++. .+..++......++.||+.||.|||+.. +|||||...||||.....+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 67899999999999999987 2456999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
++........... ...-...|||||.++-..++.+||||.||+++||++. |..||.+....+.. .
T Consensus 538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------~--- 603 (974)
T KOG4257|consen 538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------G--- 603 (974)
T ss_pred hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------E---
Confidence 9985544443332 3334678999999998999999999999999999988 99999764332211 1
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.....-+..+|+.++..+..|+.+||+.||.+||.+.++...|..+.+
T Consensus 604 ----~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 ----HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111223345677888899999999999999999999999988876655
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=284.41 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=200.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
.+|++.+.||+|+||.||+|.+.. +..+++|.+.... .....+..|+.+++.++|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 578899999999999999998864 6789999886432 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++... ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999988651 246899999999999999999999999 99999999999999999999999998865322111
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||............ .. ......
T Consensus 156 ~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~---~~~~~~-- 222 (256)
T cd05112 156 T-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-------NA---GFRLYK-- 222 (256)
T ss_pred c-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-------hC---CCCCCC--
Confidence 1 1111224567999999988889999999999999999998 99999754432211111 00 000001
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111235788899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=289.48 Aligned_cols=261 Identities=25% Similarity=0.311 Sum_probs=204.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEc--CCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 110 (361)
++|+..+.||.|++|.||+|.++.++..+++|.+..... .....+.+|+++++.++||||+++++++.+ ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468889999999999999999999999999999875433 234668899999999999999999998854 34689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.........++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987654434567899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchH--HHhhhHHHhhhhhhccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA--AAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ........+.... ....+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----PNPEL 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-----Cchhh
Confidence 11 1233567889999999888999999999999999999999999976522 1111111111110 00000
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... .......+..+.+++.+||..+|.+|||+.++++.
T Consensus 229 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 00001234578899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=293.77 Aligned_cols=199 Identities=25% Similarity=0.341 Sum_probs=161.2
Q ss_pred CCeecccCceEEEEEEECC--CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc--CCeeEEEEEecC
Q 018100 39 ESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMP 114 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 114 (361)
.+.||+|+||.||+|.++. ++..|++|.+.... ....+.+|+.+++.++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 4689999999999999763 57889999986542 23457789999999999999999998854 456789999985
Q ss_pred CCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE----cCCCceeEeccccc
Q 018100 115 LGSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 185 (361)
Q Consensus 115 ~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv----~~~~~~~L~Dfg~~ 185 (361)
++|.+++.... .....+++..+..++.||+.||.|||+++ ++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 78888775321 11235899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCC-cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccc
Q 018100 186 KLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTS 243 (361)
Q Consensus 186 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 243 (361)
........ ........++..|+|||++.+ ..++.++||||+||++|+|++|.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 75332211 111233567899999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=283.43 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=208.8
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||.|++|.||++.+..++..|++|++..... .....+..|+++++.++|+|++++.+.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58899999999999999999998899999999876543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++......+..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999874434578999999999999999999999999 9999999999999999999999999987633322
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||.+.+..++.++|+||+|+++|+|++|..||............ .. . .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~----~--~-------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LK----G--Q-------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH--hc----C--C--------
Confidence 1223346788899999998888999999999999999999999999765432211110 00 0 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....+...+..+.+++.+||..+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=291.62 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=199.5
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||.|++|.||+|.++.++..|+||.+..... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48899999999999999999999999999999864332 2335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+. ++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68988886532 456899999999999999999999999 9999999999999999999999999986532221
Q ss_pred CcceeeccccCcCcCCchhhccCC-CCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhhhhh-------cc--
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLF-------QD-- 261 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~-------~~-- 261 (361)
. ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.......... ......... ..
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 112234677899999886644 5888999999999999999999997654322111 111000000 00
Q ss_pred --ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 --RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...........+ ....+.....+.++|.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 0011123446788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.56 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=204.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||.|++|.||+|.++.+++.+++|.+..... .....+.+|+.+++.++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 468889999999999999999999999999999876533 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997622 678999999999999999999999 88 999999999999999999999999988643211
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ............ .+
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~-------~~ 222 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVNEP-------PP 222 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhcCC-------CC
Confidence 11 1145788899999998889999999999999999999999999654211110 011111100000 00
Q ss_pred cccCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .+.. .+..+.++|.+||..||++||++.+++..
T Consensus 223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 R----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 1111 34478899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=288.97 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=202.5
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecC
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 114 (361)
+|...+.||+|++|.||++.+..++..+++|++........+.+.+|+.+++.++|+|++++++++......++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 56667899999999999999988899999999875555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
+++|.+++.. ..+++..+..++.||+.||.+||+++ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 9999999875 45899999999999999999999999 9999999999999999999999999876432211
Q ss_pred ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (361)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||............... . .+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------~-----~~~~- 235 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------L-----PPKL- 235 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--------C-----CCCC-
Confidence 1122345788999999998888999999999999999999999998654332111111000 0 0000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 275 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001123347889999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=285.07 Aligned_cols=246 Identities=29% Similarity=0.456 Sum_probs=198.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||+|+||.||.+.. ++..|++|.+.... ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 6799999999999999999875 47889999986432 346788999999999999999999998765 478999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
.+++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999987532 346899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||............. ...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~--------- 214 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGY--------- 214 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCC---------
Confidence 11234567999999988889999999999999999997 999997654332211110 000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 00111233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=309.28 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=210.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
.-|.|+..||-|+||+||+|.++.++...|.|++........+.+.-||.+|....||+|+++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34778889999999999999999999999999998777777888999999999999999999999998899999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
.||-+...+-. .+..+++.++..+++|++.||.|||+++ |+|||||..|||++-+|.++|+|||.+-. ....
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKST 183 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhH
Confidence 99999887754 3578999999999999999999999999 99999999999999999999999998754 1112
Q ss_pred cceeeccccCcCcCCchhh-----ccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 194 THVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
........||++|||||+. .+.+|+.++||||||++|.+|..+.+|............+....+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP----------- 252 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP----------- 252 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC-----------
Confidence 2223456899999999986 456899999999999999999999999876554433222211111
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
|. .-.|........+++.+||.+||..||+++++++
T Consensus 253 --PT--LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 --PT--LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --Cc--ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 1124455667888999999999999999999986
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=305.34 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=206.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHH
Q 018100 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 120 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 120 (361)
.||+|+||+||-|++..+...+|||.+...+....+-+.+||.+.+.|+|.||+++++.+.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999999999999999987777777889999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc-CCCceeEecccccccCCCCCCccee
Q 018100 121 HLHDLSPGKKPL--DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVS 197 (361)
Q Consensus 121 ~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~-~~~~~~L~Dfg~~~~~~~~~~~~~~ 197 (361)
++... =+++ ++..+-.+..||++||.|||++. |||||||-+||||+ -.|.+||+|||-+++.. .-....
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 99761 2455 88899999999999999999999 99999999999996 47899999999987632 223344
Q ss_pred eccccCcCcCCchhhccC--CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 198 TRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 198 ~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
....||..|||||++..+ .|..++|||||||++.||.||++||-........-.. -.++ ....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmy------------KvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMY------------KVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcce------------ecCC
Confidence 556799999999999654 5889999999999999999999999654332211100 0011 1123
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..|...+.++..+|.+|+..||..||++.++++.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 3455667788899999999999999999999973
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=286.68 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=202.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+-|++.+.||.|+||.||+|.++.++..|++|.+..... .....+.+|+.++..++||||+++++.+..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 457788999999999999999988899999999864432 2335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. ..+++..+..++.|++.|+.+||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999999864 46899999999999999999999999 9999999999999999999999999886532211
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||............ . .. . .+
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~----~~-~-----~~- 219 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI---P----KN-N-----PP- 219 (277)
T ss_pred --hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH---h----cC-C-----CC-
Confidence 1122245778899999998888899999999999999999999999754322111110 0 00 0 01
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122334578899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=283.81 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=207.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcC--CeeEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 110 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 110 (361)
+|++.+.||+|++|.||+|.+..++..|++|++..... ...+.+.+|+..++.++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58889999999999999999998899999999875543 3456788999999999999999999999888 8999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999976 447999999999999999999999999 99999999999999999999999999876443
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
...........++..|+|||.+.+...+.++||||||+++|+|++|..||......... .. ... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~-------~~~-------~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-LY-------KIG-------S 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HH-------hcc-------c
Confidence 32211123456788999999998888999999999999999999999999765411110 00 000 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......+...+..+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011112233335688899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=285.26 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=207.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|++|.||++.++.++..+++|.+..... .....+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58899999999999999999999999999999875432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++......+..+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998764444567899999999999999999999999 999999999999999999999999998764332
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ .. .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~---------------~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV--QR---------------G 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hc---------------C
Confidence 122245788999999998888999999999999999999999999765432211111 00 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+.....++.+++.+||..+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111223445578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=285.58 Aligned_cols=238 Identities=29% Similarity=0.459 Sum_probs=190.4
Q ss_pred CeecccCceEEEEEEECCCC----------eEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 40 SLLGEGGFGRVYKGYLESIN----------QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999998766 45888887654333 5778899999999999999999999987 778999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-------ceeEecc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-------HPKLSDF 182 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-------~~~L~Df 182 (361)
+||+++++|.+++... ...++...+..++.||+.||.|||+++ ++|+||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998762 226899999999999999999999999 99999999999999888 7999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccC--CCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhh
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.............
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------ 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------ 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh------
Confidence 99875322 2223466789999998776 78899999999999999999 577776543211111100
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
. ... .+......+.+++.+||..+|.+||++.++++.|
T Consensus 221 -~---~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -D---QHR---------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -c---CCC---------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 000 0011115788899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.50 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=191.8
Q ss_pred CeecccCceEEEEEEECC---CCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEE-cCCeeEEEEEecC
Q 018100 40 SLLGEGGFGRVYKGYLES---INQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMP 114 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 114 (361)
+.||+|+||.||+|.+.. .+..|++|.+.... ....+.+.+|+.+++.++|||++++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 34679999875432 233467888999999999999999999765 4556789999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
+++|.+++... ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998752 234677888999999999999999999 999999999999999999999999998743221110
Q ss_pred --ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhC-CCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 195 --HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 195 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.......++..|+|||.+.+..++.++|||||||++|+|++| .+||......... .... . .. .+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~---~~~~---~----~~---~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT---VYLL---Q----GR---RL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHh---c----CC---CC
Confidence 111123356689999999888899999999999999999995 5666543322111 1110 0 00 00
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.. +...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 222 ~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 1112347888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.08 Aligned_cols=264 Identities=28% Similarity=0.425 Sum_probs=220.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.....+.+.||+|.||.|.++.... +..||+|.++...... .+.|..|+++|.+|+||||+.++++|..++.+++|+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4678899999999999999999876 7999999998765554 4789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++.|+|.+++..... +.+.......++.||+.|++||.+.+ +|||||.+.|+|+++++++||+|||+++-...+
T Consensus 616 YmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999987432 22455667789999999999999999 999999999999999999999999999876666
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh--CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
++.......+-...|||||.+..++++.++|+|+||+++||+++ ...||.....+ +.+......+........
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~-- 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV-- 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee--
Confidence 66666667778899999999999999999999999999999866 66787654332 222223333333332222
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
...|+.++..+.+++..||..|..+||+++++-..|..
T Consensus 766 -----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 766 -----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred -----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 33455677799999999999999999999999887764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=287.37 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=201.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCC---CCccceeeeEEEcCCeeEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.|++.+.||+|+||.||+|.+..++..|++|.+.... ......+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4788999999999999999999999999999986543 234456888999998886 999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998864 36899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............ . ...
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~------~~~ 218 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------P------KSK 218 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------c------cCC
Confidence 22 11223457888999998865 45789999999999999999999999764332111000 0 000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.+... ..+.++.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111111 134478899999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=289.43 Aligned_cols=267 Identities=21% Similarity=0.290 Sum_probs=201.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcC--CeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 108 (361)
.++|++.+.||.|++|.||+|.++.++..+++|.+....... ...+.+|+.++..++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999999889999999986543322 23467899999999999999999998777 88999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|+||++ ++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 84 v~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 84 VMEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 999997 6998888652 236899999999999999999999999 999999999999999999999999988754
Q ss_pred CCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhhh--------
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPL-------- 258 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~-------- 258 (361)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||............ ......
T Consensus 157 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 157 GSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 3321 111223467889999998654 4689999999999999999999999765433222111 100000
Q ss_pred --hccc--cccccccCccccCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 259 --FQDR--TRHSLIADPELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 259 --~~~~--~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
+... ..........+...++.. ....+.++|.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000000011111222222 3557888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=296.28 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=201.6
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcC-----
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 103 (361)
...++|++.+.||+|+||.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45689999999999999999999999999999999986432 22345677899999999999999999987543
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 104 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 104 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
...|+|+||+. ++|.+.+.. .++...+..++.||+.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 35699999996 688887754 2889999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhh------
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWA------ 255 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~------ 255 (361)
|++....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||............ ...
T Consensus 163 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 163 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9987532211 122345788899999999999999999999999999999999999755432211100 000
Q ss_pred ---------hhhhccccccc-----cc----cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 256 ---------RPLFQDRTRHS-----LI----ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 256 ---------~~~~~~~~~~~-----~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
........... .. ..+......+...+..+.+++.+||+.||++||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 00 00000011122345577899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.79 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=198.7
Q ss_pred cccCCeecccCceEEEEEEECC---CCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCC------
Q 018100 36 FRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 104 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 104 (361)
|.+.+.||+|+||.||+|.++. ++..|++|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998643 57899999986542 223456888999999999999999999885432
Q ss_pred eeEEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
..+++++|+.+++|.+++.... .....++...++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875321 11235799999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
|++................++..|++||.+.+..++.++|||||||++|+|++ |..||........... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~---~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY---LIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH---HHc----
Confidence 99875432221111222335567999999988889999999999999999999 8899865433221111 100
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
. .. ...++..+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~---~~-------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 G---NR-------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C---Cc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 001122345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=283.83 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=202.9
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|+||.||+|.++.++..+++|.+..... ...+.+.+|+.+++.++|+|++++++.+.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58899999999999999999999999999999865422 3445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc-eeEecccccccCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-PKLSDFGLAKLGPVG 191 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~-~~L~Dfg~~~~~~~~ 191 (361)
+++++|.+++.... +..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999986522 346899999999999999999999999 999999999999998864 699999988753221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........++..|+|||++.+..++.++|+||||+++|+|++|..||......... .......
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~------------- 218 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV--LKICQGY------------- 218 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHhccc-------------
Confidence 11222345788899999998888999999999999999999999999754322111 1000000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+..+..+.+++.+||..+|++||++.+++..
T Consensus 219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 --FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.27 Aligned_cols=266 Identities=24% Similarity=0.284 Sum_probs=197.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..+|++.+.||+|+||.||+|.+..++..|++|.+....... ...+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999999989999999986543322 2457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+. ++|.+++... ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 7777766431 345788899999999999999999999 999999999999999999999999988652221
Q ss_pred CCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh--hhhhcc----ccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA--RPLFQD----RTR 264 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~----~~~ 264 (361)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.............+. ...... ...
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 111223468889999998653 5788999999999999999999999754432111100000 000000 000
Q ss_pred cccccCccccCCCC----------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 HSLIADPELQGQYP----------PRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 ~~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.... .+....... ......+.+++.+|+..||.+|||+.+++.
T Consensus 235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNY-KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccc-cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 000000000 011346788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=283.27 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=189.0
Q ss_pred CeecccCceEEEEEEECC--CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 40 SLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
+.||+|+||.||+|.... ....+++|.+...... ....+.+|+..++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 3457888887544322 2346788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 117 SVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 117 ~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
+|.+++...... ....++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998763321 233567888999999999999999999 9999999999999999999999999986432221111
Q ss_pred eeeccccCcCcCCchhhcc-------CCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 196 VSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||......... ...... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~~~------~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--KQVVRE------QDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--HHHhhc------cCcc
Confidence 1222345677999998742 356889999999999999999 78888654332211 110000 0011
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
...+.. +...+..+.+++..|| .||++||++.+|++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111222 1223346667888888 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=286.79 Aligned_cols=272 Identities=25% Similarity=0.357 Sum_probs=217.1
Q ss_pred ccCCCCCcccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC
Q 018100 11 SEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH 90 (361)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h 90 (361)
++.++++-.++..-+ .-+.-.+-|.++..||+|+||.||+|.++.+|+.+|||.+.-. .+.+.+..|+.++++...
T Consensus 12 ~~~~ss~~~KLd~~s--L~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S 87 (502)
T KOG0574|consen 12 SEEGSSDGFKLDSSA--LNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKS 87 (502)
T ss_pred CCCCcccccccChhh--hcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCC
Confidence 455555555444221 1122334477889999999999999999999999999998543 356788999999999999
Q ss_pred CccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEE
Q 018100 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 170 (361)
Q Consensus 91 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nil 170 (361)
|+++++|+.+.....+++|||||..|++.+.+.. ..+++++.++..++..-++||+|||... =+|||||..|||
T Consensus 88 ~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNIL 161 (502)
T KOG0574|consen 88 KYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNIL 161 (502)
T ss_pred chhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEE
Confidence 9999999999999999999999999999999876 3578999999999999999999999998 899999999999
Q ss_pred EcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhh
Q 018100 171 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 250 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~ 250 (361)
++-+|..||+|||.+-. ..+.-.......||+.|||||++..-.|+.++||||||++..+|.-|++|+..-......
T Consensus 162 LNT~G~AKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI- 238 (502)
T KOG0574|consen 162 LNTDGIAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI- 238 (502)
T ss_pred Ecccchhhhhhccccch--hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-
Confidence 99999999999999864 222233345578999999999999999999999999999999999999999754332111
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
|... . .|...-..|...+.+..+++++||-+.|++|-++.++++.
T Consensus 239 --------FMIP----T--~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 239 --------FMIP----T--KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --------Eecc----C--CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1111 0 1111112233345567789999999999999999988864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.44 Aligned_cols=267 Identities=22% Similarity=0.336 Sum_probs=201.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
+|++.+.||.|++|.||+|.+..++..|++|++...... ....+.+|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 589999999999999999999999999999998755332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+ ++|.+++..... ...+++..+..++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 7 588888765221 346899999999999999999999999 9999999999999999999999999986532211
Q ss_pred cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhhhhhcc----cccccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQD----RTRHSL 267 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~----~~~~~~ 267 (361)
.......++..|++||.+.+. .++.++||||||+++|+|++|..||.......... ........... ......
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 111223467889999988654 56889999999999999999999997654322211 11110000000 000000
Q ss_pred ccC--c----cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 268 IAD--P----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 268 ~~~--~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
... + .......+..+..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0 0001111233557889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=288.12 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=199.8
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
|++.+.||.|++|.||+|.++.+|..|++|++..... .....+.+|+.+++.++|||++++++++.++...++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6788999999999999999998999999999865432 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+ ++|.+++.... ...+++..++.++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 78999887522 246899999999999999999999999 99999999999999999999999999865322211
Q ss_pred cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhhhhc----------c
Q 018100 194 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQ----------D 261 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~----------~ 261 (361)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||........... ......... .
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 11223457889999987654 578899999999999999999999976543222111 000000000 0
Q ss_pred -ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 -RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
....... .........+..+..+.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000001112233457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=285.62 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=207.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..+.|++.+.||+|++|.||.|.+..++..|++|++..... ..+.+.+|+..++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678899999999999999999998899999999976544 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998621 37999999999999999999999999 999999999999999999999999987642221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ... .. +
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~~~------~~-----~ 234 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--TTK------GI-----P 234 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hhc------CC-----C
Confidence 1 1112234678899999998888999999999999999999999999754332211110 000 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
. ...+...+..+.+++.+||+.+|.+||++.++++..
T Consensus 235 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 235 P--LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred C--CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0 001112345788999999999999999999999744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.09 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=205.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|++.+.||+|++|.||+|.+..++..|++|.+..... .....+.+|+.++..++|+|++++++++.++...+++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58899999999999999999998899999999976644 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. ...+++..++.++.|++.||.+||++| ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999876 467999999999999999999999999 9999999999999999999999999987643322
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.. .....++..|+|||...+..++.++||||||+++|+|++|..||......... ..... .
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~~~~-------~-------- 214 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FRIVQ-------D-------- 214 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHhc-------c--------
Confidence 21 22345788899999998878899999999999999999999999754321111 00000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+...+..+.+++.+||..+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001112233457889999999999999999999884
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=282.27 Aligned_cols=243 Identities=28% Similarity=0.364 Sum_probs=197.7
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
||.|++|.||+|.+..++..+++|++..... ...+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999999899999999875432 2345788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.. ...++...+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999976 456899999999999999999999999 9999999999999999999999999987543321 122
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||............... . ......++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~----------~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL----K----------GNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh----c----------cCCCCCCC
Confidence 345788899999998888999999999999999999999999765421111111000 0 00011222
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
...+..+.+++.+||+.+|++||+ +.++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 233558899999999999999999 777775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=281.80 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=189.5
Q ss_pred CeecccCceEEEEEEECCC--CeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 40 SLLGEGGFGRVYKGYLESI--NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~--~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
+.||+|+||.||+|..... ...+++|.+..... ...+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975432 34566777654432 33467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcce
Q 018100 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 196 (361)
Q Consensus 117 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~ 196 (361)
+|.+++.........++...++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999764322345777888999999999999999999 99999999999999999999999998754222111112
Q ss_pred eeccccCcCcCCchhhcc-------CCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 197 STRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |..||............ .. . .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~~----~--~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV--IK----D--QQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--Hh----h--ccccc
Confidence 223457788999998743 245789999999999999997 56788654332111110 00 0 00111
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.++.... .....+.+++..|| .+|++||++.++++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1222222 23346777999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=291.68 Aligned_cols=270 Identities=21% Similarity=0.269 Sum_probs=199.8
Q ss_pred CcccCCeecccCceEEEEEEECC--CCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcC--CeeE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 107 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 107 (361)
+|++.+.||+|++|.||+|.++. ++..|++|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58899999999999999999988 78999999987632 33346678899999999999999999999887 8899
Q ss_pred EEEEecCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC----CCceeEecc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDF 182 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~----~~~~~L~Df 182 (361)
+||||++ ++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 6777777543322 237899999999999999999999999 999999999999999 999999999
Q ss_pred cccccCCCCCC-cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHh-------hhHHH
Q 018100 183 GLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-------QSLVA 253 (361)
Q Consensus 183 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-------~~~~~ 253 (361)
|++........ ........++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99875332221 1112234578889999988664 578999999999999999999999975443220 00000
Q ss_pred hhhhh----------hccccccccccCccccCCCC-----------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 254 WARPL----------FQDRTRHSLIADPELQGQYP-----------PRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 254 ~~~~~----------~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..... +..........+......++ ......+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000000000 023346888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.10 Aligned_cols=262 Identities=24% Similarity=0.276 Sum_probs=195.4
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCC-CCccceeeeEEEcC--CeeEEEEE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYE 111 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 111 (361)
|++.+.||+|+||.||+|.++.++..|++|.+...... .......|+.++..+. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67889999999999999999999999999998654222 2233457888888885 99999999999887 88999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+. ++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 6787777641 356899999999999999999999999 999999999999999 99999999998753222
Q ss_pred CCcceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhh-------hhccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARP-------LFQDR 262 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~-------~~~~~ 262 (361)
.. .....++..|+|||.+. +..++.++|||||||++|+|++|..||......+..... ..... .+...
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 11 12235788999999764 455788999999999999999999999765433221111 10000 00000
Q ss_pred cccccccCcccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TRHSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ......+... ....+..+..+.++|.+||+.+|++||++.++++.
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 R-HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred c-cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 0000000000 00112345689999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=287.39 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=199.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcC--CeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 108 (361)
..+|++.+.||+|+||.||+|.++.+|..|++|.+....... ...+.+|+.+++.++|+|++++++++... ...++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999999999999999986443221 23456799999999999999999998654 56899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 6888888652 256899999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH-hhhhhhcc-----
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WARPLFQD----- 261 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~----- 261 (361)
.... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||............. ........
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 3221 11122335778999999865 467899999999999999999999997654433222111 11000000
Q ss_pred --ccc--cccccCcccc--CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 --RTR--HSLIADPELQ--GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 --~~~--~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... .......... .......+..+.++|.+||+.||++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000000000 00001124567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=292.28 Aligned_cols=269 Identities=25% Similarity=0.326 Sum_probs=201.6
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcC-CCCccceeeeEEEc--CCe
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD--GDQ 105 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 105 (361)
.+.++|++.+.||+|+||.||+|.+..++..+++|.+... .......+..|+.++..+ +|+||+++++++.. ...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3568899999999999999999999988999999988542 223345677899999999 99999999998864 346
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.++|+||++ ++|..++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 899999997 699888865 36889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCc---ceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh----
Q 018100 186 KLGPVGDNT---HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP---- 257 (361)
Q Consensus 186 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~---- 257 (361)
......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 754332211 12223457889999998754 5678999999999999999999999975543322111100000
Q ss_pred --------hhccc-c-ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 258 --------LFQDR-T-RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 258 --------~~~~~-~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..... . .......... ....+..+..+.+++.+||+.||++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 0 0000000000 01111235578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=283.86 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=194.2
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
||+|+||.||+|.++.+|..|++|.+..... .....+..|+.+++.++|||++++++.+......|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999865322 2234567899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence 99987522 246899999999999999999999999 99999999999999999999999998865322 11122
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||............. .... ......+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~------------~~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTL------------EMAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hccc------------cccccCC
Confidence 3457788999999988889999999999999999999999996543311111000 0000 0011122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
...+..+.++|.+||+.||.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23345788999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=291.95 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=202.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEE----cCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~ 106 (361)
..+|++.+.||+|++|.||+|.++.++..|++|++..... .....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3789999999999999999999999999999999875422 33456778999999999999999998875 34568
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 789888875 566999999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCC--cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh-----h
Q 018100 187 LGPVGDN--THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-----L 258 (361)
Q Consensus 187 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~ 258 (361)
....... ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||................. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 5322111 111123467889999998865 4688999999999999999999999976543322211111000 0
Q ss_pred hc----cc----cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 259 FQ----DR----TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 259 ~~----~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+. .. ........+.......+..+..+.++|.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 00 00000000000001112235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.36 Aligned_cols=199 Identities=24% Similarity=0.335 Sum_probs=160.5
Q ss_pred CCeecccCceEEEEEEECC--CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEE--cCCeeEEEEEecC
Q 018100 39 ESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMP 114 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 114 (361)
...||+|+||.||+|.++. ++..|++|.+.... ....+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999764 46789999986543 2345778999999999999999999884 4567899999986
Q ss_pred CCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE----cCCCceeEeccccc
Q 018100 115 LGSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 185 (361)
Q Consensus 115 ~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv----~~~~~~~L~Dfg~~ 185 (361)
++|.+++.... .....+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.++|+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 68877764311 11235899999999999999999999999 9999999999999 56678999999999
Q ss_pred ccCCCCCC-cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccc
Q 018100 186 KLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTS 243 (361)
Q Consensus 186 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 243 (361)
........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 75332211 111223467889999999876 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=300.01 Aligned_cols=247 Identities=32% Similarity=0.415 Sum_probs=206.6
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.|.-++.||.|+||.||.|++..+.+.||||+++-+... ..+.+..|+..|+.++|||++.+.+.|-.+..+||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3477788999999999999999999999999999755443 3457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|||- |+-.+++.- .++++-+..|..|+.+.+.||.|||+.+ .+|||||..|||+++.|.|||+|||.+.....
T Consensus 106 EYCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9995 888888875 3578999999999999999999999999 99999999999999999999999999875222
Q ss_pred CCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
...++||+.|||||++. .+.|+-++||||||++-.+|.-.++|....+.......+....
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe----------- 241 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------- 241 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-----------
Confidence 23467999999999884 4689999999999999999999999987666554443332111
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.|.+. .+..+.....++..||++-|++|||.++++..
T Consensus 242 --sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 --SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11121 23344566789999999999999999998753
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=285.83 Aligned_cols=269 Identities=20% Similarity=0.258 Sum_probs=198.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCC-CCccceeeeEEEcCCe-----
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ----- 105 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 105 (361)
++|++.+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999999765422 22356788999999995 6999999999876655
Q ss_pred eEEEEEecCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEeccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFG 183 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg 183 (361)
.|+||||++ ++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 799999997 5888887653322 356899999999999999999999999 999999999999998 8899999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhhh----
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARP---- 257 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~---- 257 (361)
++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... +......
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 98753221111 112245778999998865 457899999999999999999999997644322211 1110000
Q ss_pred hhcccccccc-----ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 258 LFQDRTRHSL-----IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 258 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+........ ...+.......+..+..+.++|.+||..||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 00000000111234557889999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=288.99 Aligned_cols=253 Identities=30% Similarity=0.411 Sum_probs=200.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.|...+.||+|+||.||+|.+..++..+++|.+...... ....+..|+.+++.++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4488899999999999999999988999999998644322 2346888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+. ++|.+.+.. ...++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9997 577776653 1456899999999999999999999999 99999999999999999999999998864322
Q ss_pred CCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.....++..|+|||.+. +..++.++|||||||++|+|++|..||............ ....
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~~~--------- 240 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNE--------- 240 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--Hhcc---------
Confidence 12235788899999873 456889999999999999999999998654322211111 0000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.+. ......+..+.+++.+||+.+|.+||++.++++.+..+..
T Consensus 241 --~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 241 --SPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred --CCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 000 0011233468889999999999999999999987655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=281.68 Aligned_cols=251 Identities=26% Similarity=0.329 Sum_probs=200.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC-----CccchHHHHHHHHHHhcCCCCccceeeeEEEcC--Cee
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 106 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 106 (361)
.+|++.+.||+|++|.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999999999999999987532 122335688899999999999999999998653 567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++++||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999875 456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~--------- 223 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FKIAT--------- 223 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HHHHc---------
Confidence 5322111 11112345788899999998888999999999999999999999999754322111 11000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.......+......+.+++.+||. +|..||++.+++.
T Consensus 224 -----~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 -----QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001112234445578889999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.62 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=198.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcC-----Cee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 106 (361)
.++|++.+.||+|++|.||+|.+..+|..|++|.+..... .....+..|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4789999999999999999999999999999999864322 2345678899999999999999999887544 357
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++++||+. ++|..++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 688877754 56999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhhhhcccc
Q 018100 187 LGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRT 263 (361)
Q Consensus 187 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~ 263 (361)
....... ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 5322111 111223457889999998754 5688999999999999999999999975433221110 000000000000
Q ss_pred -------cc---ccc-cCccc-cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 264 -------RH---SLI-ADPEL-QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 264 -------~~---~~~-~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. ... ..+.. .....+.....+.+++.+||+.||.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000 00000 000011234578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.13 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=201.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcC-----Ce
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 105 (361)
.++|.+.+.||+|+||.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999999999999999999986532 22345677899999999999999999987644 34
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.|+++||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 789888875 567999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH-hhhhhhccc-
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WARPLFQDR- 262 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~~- 262 (361)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||............. .........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7533221 12223457888999998865 468899999999999999999999997654322211111 000000000
Q ss_pred ------c------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 ------T------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ------~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .......+... ...+..+..+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00000000000 1112345578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=286.47 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=198.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCC-----
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 104 (361)
..++|++.+.||+|+||.||+|.++.++..|++|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 446899999999999999999999999999999998643222 2234667999999999999999999886543
Q ss_pred ---eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 105 ---QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 105 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
..++|+||+. ++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 4599999996 688887764 1346899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCc--ceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 182 FGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 182 fg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||..................
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9998753222211 111233567889999988664 4788999999999999999999999765543332222211110
Q ss_pred hc-----ccccccc---ccCccc-cCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 259 FQ-----DRTRHSL---IADPEL-QGQY-----PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 259 ~~-----~~~~~~~---~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.. ....... ...+.. .... +......+.++|.+||..||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0000000 000000 0000 0011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=296.98 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=210.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
...|.+.+.||+|.|+.|.+|.+..++..||||.+++..... .+.+.+|+++|+.++||||++++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467999999999999999999999999999999998765543 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+.+|.+.+++.. .+.+.+..+..++.|+.+|++|||+++ |||||||++|||++.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 99999999999987 677888999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCC-ccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
........+|++.|.|||++.+..++ +++|+||+|+++|.|+.|..||++........ .....
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-----------rvl~g--- 270 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-----------RVLRG--- 270 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-----------hheee---
Confidence 33444557899999999999987765 89999999999999999999998643211110 00000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.+ ..+--...++.++|+++|-.+|.+|++..++.+.-
T Consensus 271 --k~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 271 --KY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred --ee--cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 00 11112233667799999999999999999998643
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=285.08 Aligned_cols=267 Identities=21% Similarity=0.253 Sum_probs=198.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|++|.||+|.++.+++.|++|.+..... ...+.+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999998999999999865432 223568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~~~~~~ 190 (361)
|++ ++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 67877775422 334688899999999999999999999 999999999999985 55799999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhhhhcccc-----
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRT----- 263 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~----- 263 (361)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... ............
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 11 11122346788999998866 4578999999999999999999999976543222111 110000000000
Q ss_pred -----ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 264 -----RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 264 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...............+..+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000011223456888999999999999999999996
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=286.90 Aligned_cols=249 Identities=32% Similarity=0.410 Sum_probs=199.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.+..+++.|++|.+...... ..+.+.+|+.+++.++|||++++++++.++...++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 46699999999999999999999988999999998644332 234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+||+. +++.+++... ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 6777776532 346899999999999999999999999 9999999999999999999999999886532
Q ss_pred CCCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.. ....++..|+|||++. ...++.++||||||+++|+|++|..||.............. . .
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------~---~- 230 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------N---D- 230 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc------C---C-
Confidence 11 2235778899999874 35688999999999999999999999865433221111100 0 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.+.. .....+..+.+++.+||+.||++||++.+++...
T Consensus 231 ---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 ---SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 0112345788999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.65 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=197.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.+|...+.||+|+||.||++.+..++..+++|.+..... .....+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 356677899999999999999999999999999875432 23456888999999986 9999999999999899999999
Q ss_pred ecCCCCHHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDL-SPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|+. +++.++.... ......+++..+..++.|++.||.|||+. + ++||||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 6766654321 11246799999999999999999999975 8 9999999999999999999999999986422
Q ss_pred CCCCcceeeccccCcCcCCchhhccC---CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ .+.. ....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~----- 226 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-QLTQ----VVKG----- 226 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH-HHhh----hcCC-----
Confidence 211 11223578889999998765 688999999999999999999999975431110 0000 0000
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..+.+........+..+.+|+.+||+.||++||++.+++..
T Consensus 227 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 --DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111222345578899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=285.71 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=198.9
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
...||+|+||.||++..+.++..|++|++..........+.+|+.+++.++|+|++++++.+..+...+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999999999999999998655444556788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.. ..+++..+..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 988754 45899999999999999999999999 9999999999999999999999999876432211 1122
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..||............. .... +.+ ...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~~----------~~~--~~~ 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNLP----------PKL--KNL 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhCC----------ccc--CCc
Confidence 3457888999999988888999999999999999999999997543322211111 0000 000 001
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1223467889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.58 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=204.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCC-----eeE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 107 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 107 (361)
+|++.+.||.|++|.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999999889999999987643 334467889999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++|+|+. ++|.+++.. ...+++..++.++.||+.||.+||++| ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 688888865 458999999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCC-cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhhhhccccc
Q 018100 188 GPVGDN-THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQDRTR 264 (361)
Q Consensus 188 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~ 264 (361)
...... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+ ............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 433221 0112234578889999999877 8899999999999999999999999766543222111 100000000000
Q ss_pred -------c-----ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 265 -------H-----SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 265 -------~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .....+.......+..+..+.+++.+||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 00000000001112235578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.18 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=188.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCcc--c-hHHHHHHHHHH---hcCCCCccceeeeEEEcCCeeEEEEEecC
Q 018100 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--G-NREFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~-~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 114 (361)
.||+|+||.||++.+..++..+++|.+...... . ...+.+|..++ ...+||+++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998654222 1 12233444333 33479999999999999899999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
+++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999998875 567999999999999999999999999 999999999999999999999999998643211
Q ss_pred ceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 195 HVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
......++..|+|||.+. +..++.++||||+||++|+|++|..||............... . ..
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~------------~~ 214 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L------------TV 214 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h------------cC
Confidence 112245889999999886 456889999999999999999999999654321111111000 0 00
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
....++..+..+.++|.+||..||++|| ++.++++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112333445788999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=279.30 Aligned_cols=242 Identities=24% Similarity=0.274 Sum_probs=189.3
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHH-hcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLML-SLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||.|++|.||+|.+..++..|++|.+....... ...+..|..++ ...+|+|++++++.+..+...|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999889999999986543222 12334444443 445899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999976 467899999999999999999999999 99999999999999999999999998874221
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||............. ... .....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~--------~~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL------SRR--------INWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcc--------cCCCC
Confidence 223457788999999988888999999999999999999999997543322111110 000 00001
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
......+..+.+++.+||+.+|++||++.++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 111123457889999999999999997654444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=288.34 Aligned_cols=265 Identities=19% Similarity=0.261 Sum_probs=195.0
Q ss_pred Ceeccc--CceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G--~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
..||.| +||.||+|.+..+|..|++|++..... ...+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 899999999999999999999865432 2346688899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC-CCc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG-DNT 194 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~-~~~ 194 (361)
++|.+++.... ...+++..+..++.||+.||+|||+++ ++||||||+||+++.++.++++||+.+...... ...
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987643 345899999999999999999999999 999999999999999999999999854321111 000
Q ss_pred c----eeeccccCcCcCCchhhccC--CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc------
Q 018100 195 H----VSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR------ 262 (361)
Q Consensus 195 ~----~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 262 (361)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||......................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0 00112345679999998763 57899999999999999999999997654322111000000000000
Q ss_pred -----------------------cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 -----------------------TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 -----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......................+.+|+++||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000001111112223456678999999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=279.18 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=198.1
Q ss_pred eHHHHHHHhhCcccCCee--cccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEE
Q 018100 25 TFRELAAATKNFRSESLL--GEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCA 101 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~l--g~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 101 (361)
++.++....++|++.+.+ |+|+||.||++..+.++..+++|.+........ |+.....+ +|+|++++++.+.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence 455666777889998887 999999999999999999999999865432221 22222222 6999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEe
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLS 180 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~ 180 (361)
..+..++||||+++++|.+++.. ...+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++ .++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999976 457999999999999999999999999 99999999999999998 99999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
|||++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||........ ....+.... .
T Consensus 153 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~ 224 (267)
T PHA03390 153 DYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-Q 224 (267)
T ss_pred cCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-c
Confidence 99988753211 123578899999999888899999999999999999999999974432211 111111000 0
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVT 308 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~ll~ 308 (361)
. ....+...+..+.++|.+||+.+|.+||+ +.++++
T Consensus 225 ---~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 ---K---------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---c---------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 01112234457889999999999999996 588874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=275.58 Aligned_cols=255 Identities=23% Similarity=0.277 Sum_probs=200.3
Q ss_pred HhhCcccC-CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEc----CCe
Q 018100 32 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 105 (361)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 105 (361)
++++|.+. +.||-|-.|+|..+.++.+++.+|+|++.. .....+|++..... .|||||.+++++++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56777776 579999999999999999999999999753 24566788877666 59999999999864 346
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 182 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Df 182 (361)
+.+|||.++||.|.+.+++.. ...+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 679999999999999998844 567999999999999999999999999 999999999999965 456999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
|+++.. .........+-|+.|.|||++...+|+..+|+||+|+++|-||+|.+||-...... +.+-+...
T Consensus 209 GFAK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------ispgMk~r 278 (400)
T KOG0604|consen 209 GFAKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMKRR 278 (400)
T ss_pred cccccc---CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------CChhHHhH
Confidence 999852 22233344567999999999998999999999999999999999999994221100 00001111
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.... .-.+...-....++...++|+.+|..+|.+|.|++++++.
T Consensus 279 I~~g---qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 279 IRTG---QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhcc---CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1110 1112222234567788899999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=282.76 Aligned_cols=264 Identities=24% Similarity=0.286 Sum_probs=202.4
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
|++.+.||+|++|.||+|.+..++..+++|.+...... ....+..|+.+++.++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999988999999998754333 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+ ++|.+++... ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 7 5888877652 257899999999999999999999999 9999999999999999999999999887543322
Q ss_pred cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhhhhc----ccc---c
Q 018100 194 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQ----DRT---R 264 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~----~~~---~ 264 (361)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||............ ........ ... .
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112224577889999998776 7899999999999999999999999765443221111 10000000 000 0
Q ss_pred cccccCcc----ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 HSLIADPE----LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 ~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
......+. ......+..+..+.++|.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 001112334668899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=283.94 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=203.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 109 (361)
++|.+.+.||+|++|.||+|....++..|++|++..... ...+.+..|+.+++.++ |+||+++++++.++...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 479999999999999999999999999999999865322 22356788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
||++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999976 457999999999999999999999999 9999999999999999999999999887532
Q ss_pred CCCCc------------------ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH
Q 018100 190 VGDNT------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 251 (361)
Q Consensus 190 ~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 251 (361)
..... .......++..|+|||++.+..++.++|+||||++++++++|..||...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 22210 112234567889999999888899999999999999999999999976542211110
Q ss_pred HHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 018100 252 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI----ADVVT 308 (361)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~ll~ 308 (361)
. .. .....+...+..+.+++.+||+.+|++||++ +++++
T Consensus 234 ~------~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 I------LK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H------Hh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 00 0011122234578899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=281.58 Aligned_cols=266 Identities=22% Similarity=0.284 Sum_probs=200.7
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcC--CeeEEEEE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYE 111 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 111 (361)
|++.+.||.|++|.||+|.+..++..+++|.+.... ......+.+|+.+++.++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999999999999997653 23345688899999999999999999999887 88999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++ ++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 5888888652 257999999999999999999999999 999999999999999999999999998764332
Q ss_pred CCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhhh----hcccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPL----FQDRTRH 265 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~----~~~~~~~ 265 (361)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ ...... +......
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11222346778999998765 45789999999999999999999999765543222111 100000 0000000
Q ss_pred --------ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 266 --------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 266 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......+........+..+.+++.+||..+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000111125578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=279.34 Aligned_cols=246 Identities=28% Similarity=0.353 Sum_probs=196.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
||.|+||.||+|.+..++..+++|++..... ...+.+.+|+.+++.++|+||+++++.+..+...|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999899999999865433 3445688899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC-----
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN----- 193 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~----- 193 (361)
.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999976 347899999999999999999999999 99999999999999999999999998875322211
Q ss_pred -cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 -THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
........++..|+|||.+.+...+.++|+||||+++|+|++|..||.............. . .. ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~--~~---~~~~ 222 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------G--KI---EWPE 222 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------C--Cc---CCCc
Confidence 1122334577889999999888899999999999999999999999976543322111100 0 00 0000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
. ...+..+.+++.+||+.+|++||++..+.+.|
T Consensus 223 ~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 223 D-----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred c-----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 00245788899999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=282.93 Aligned_cols=270 Identities=25% Similarity=0.315 Sum_probs=200.2
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCC---
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--- 104 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 104 (361)
+...++|++.+.||+|++|.||+|.++.++..|++|.+..... .....+.+|+.+++.++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 3566899999999999999999999999899999999865432 22346778999999999999999999887654
Q ss_pred -------eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 105 -------QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 105 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
..++|+||++ +++..++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMD-HDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccC-ccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcE
Confidence 7899999997 4777766541 346899999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA- 255 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~- 255 (361)
+|+|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...............
T Consensus 156 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 156 KLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred EeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999875433221 11112235678999998864 45789999999999999999999999765433222111111
Q ss_pred hhh----hccccccccc--cC------ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 256 RPL----FQDRTRHSLI--AD------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 256 ~~~----~~~~~~~~~~--~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
... +......... .+ ...... ....+..+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000000000 00 000000 0112457889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=282.34 Aligned_cols=259 Identities=15% Similarity=0.172 Sum_probs=188.7
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCccch-H----------HHHHHHHHHhcCCCCcccee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGN-R----------EFLVEVLMLSLLHHPNLVNL 96 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~-~----------~~~~e~~~l~~l~h~~i~~~ 96 (361)
...++|++.+.||+|+||.||+|.+..+ +..+++|+......... + ....+...+..+.|++++.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457999999999999999999999877 66777776433222111 1 12233445566789999999
Q ss_pred eeEEEcCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc
Q 018100 97 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 172 (361)
Q Consensus 97 ~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~ 172 (361)
++.+.... ..+++++++. .++.+.+.. ....++..++.++.|++.||.|||+++ ++||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 98765433 3467788764 577776654 334678889999999999999999999 99999999999999
Q ss_pred CCCceeEecccccccCCCCCC-----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH
Q 018100 173 RGYHPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247 (361)
Q Consensus 173 ~~~~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 247 (361)
.++.++|+|||++........ ........||..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999876422111 011123468999999999999999999999999999999999999997653221
Q ss_pred hhhH---HHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 248 EQSL---VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 248 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.... ..+...... ... ..+..+..+.+++..||..+|++||++.++++.|
T Consensus 241 ~~~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHE----------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhh----------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1110 111111100 000 0112245788999999999999999999999876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=288.89 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=198.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcC---------
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------- 103 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 103 (361)
..+|++.+.||.|+||.||+|.++.++..|++|.+........+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 47899999999999999999999999999999998766666667788999999999999999998776543
Q ss_pred -----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCce
Q 018100 104 -----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHP 177 (361)
Q Consensus 104 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~ 177 (361)
...++|+||+. ++|.+++.. ..+++..++.++.||++||.|||++| ++|+||+|+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999996 688888754 46899999999999999999999999 999999999999974 5678
Q ss_pred eEecccccccCCCCCC-cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 178 KLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
+|+|||.+........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999865321111 111122356788999998754 56788999999999999999999999755432221111000
Q ss_pred hhhhcc------------ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 256 RPLFQD------------RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 256 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+.... .................+....++.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 00000000000000011123457888999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=287.62 Aligned_cols=269 Identities=21% Similarity=0.269 Sum_probs=200.4
Q ss_pred hhCccc-CCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--------------hHHHHHHHHHHhcCCCCccceee
Q 018100 33 TKNFRS-ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------------NREFLVEVLMLSLLHHPNLVNLI 97 (361)
Q Consensus 33 ~~~y~~-~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~ 97 (361)
.++|.. .+.||.|+||.||+|.++.++..|++|++....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 467765 577999999999999999899999999986543222 12467899999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
+++..+...++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999996 789988865 566999999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCC------------CcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccch
Q 018100 178 KLSDFGLAKLGPVGD------------NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSK 244 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~ 244 (361)
+|+|||++....... .........++..|+|||.+.+. .++.++|+|||||++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999887533110 00111123457789999998764 46899999999999999999999997665
Q ss_pred HHHhhhHH-Hhhhhh----hccccccc-----cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 245 AAAEQSLV-AWARPL----FQDRTRHS-----LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 245 ~~~~~~~~-~~~~~~----~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
........ ...... +....... ....+.......+..+..+.+++.+||+.+|++||++++++..
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 43222111 111000 00000000 0000000001112234578899999999999999999999963
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=277.63 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=199.7
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-----ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+|.+.+.||+|+||.||++.+...+..+++|++.... ......+..|+.+++.++|||++++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6899999999999999999998877777777765321 12233566789999999999999999999988999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988764444567999999999999999999999999 999999999999975 569999999886532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ... .
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~--~~~----~--------- 219 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL--RIV----E--------- 219 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHH----c---------
Confidence 21 122233457888999999988888999999999999999999999996543211110 000 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......+...+.++.+++.+||..+|++||++.++++.
T Consensus 220 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 --GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00011233445588899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.94 Aligned_cols=243 Identities=25% Similarity=0.305 Sum_probs=189.1
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHH---HHHhcCCCCccceeeeEEEcCCeeEEEEEecC
Q 018100 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEV---LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 114 (361)
.||+|+||.||+|.+..+++.|++|.+....... ...+..|. ..++...||+|+.+++.+......++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999889999999987543221 11233333 34445679999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
|++|..++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988865 567999999999999999999999999 9999999999999999999999999986432211
Q ss_pred ceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.....|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||................ ...
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~~--- 215 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----------TMA--- 215 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----------ccC---
Confidence 123468899999999874 468999999999999999999999997642211111110000 001
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
...+...+..+.+++.+||..+|.+|| ++.++++.
T Consensus 216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112222345888999999999999999 89999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=292.98 Aligned_cols=264 Identities=26% Similarity=0.396 Sum_probs=218.2
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
++-...+....+.||.|.||.||.|.|+.-.-.||||.+... ....+.|..|+.+|+.++|||++.++++|..+.-.||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 344446667889999999999999999999999999998644 4556889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|.|||..|+|.+++..-. ...++....+.++.||+.|++||..++ ++||||...|+||.++..+|++|||+++.+
T Consensus 341 iTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999997633 455788888999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... ........-...|.|||-+....++.++|||+||++|||+.| |-.|+.+........+..
T Consensus 416 tgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------------- 480 (1157)
T KOG4278|consen 416 TGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------------- 480 (1157)
T ss_pred cCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh--------------
Confidence 3332 222222233568999999999999999999999999999998 999998754433322221
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
..++-+-|..++..+.+|++.||+.+|.+||+++++-+.++.+-..
T Consensus 481 ---kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 481 ---KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ---ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 1112222344556899999999999999999999999999876543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=277.03 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=196.7
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcC---CCCccceeeeEEEcCCe-----
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQ----- 105 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 105 (361)
|++.+.||+|+||.||+|.++.++..|++|.+...... ....+.+|+.+++.+ .|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999999988999999998744322 123466677776655 59999999999987766
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.+++|||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 68988886522 235899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhh----hhc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARP----LFQ 260 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~----~~~ 260 (361)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||............ ..... .+.
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 7532221 112234678899999999888999999999999999999999999765433221111 10000 000
Q ss_pred cccc--ccccc--CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 261 DRTR--HSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 261 ~~~~--~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.... ..... .........+.....+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 00000 000001112234567788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=249.75 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=208.5
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
+|.-.+.||+|.||+||+|+++.+++.|++|.+.....++ -....+|+.+++.++|.||++++++.+.+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999999999999999997554332 25678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
|+ .+|..+... -++.++.+.+.+++.|+++||.|+|+++ +.|||+||+|.+|+.+|.+||+|||+++.+....
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 96 888888876 3467999999999999999999999999 9999999999999999999999999998754432
Q ss_pred CcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccc--cccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDR--TRHSLI 268 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 268 (361)
......+.|.+|.+|+++.+. -|+.+.|+||.||++.|+.. |++.|.+....+....+-+.-...... .....+
T Consensus 156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 222334578999999999875 57899999999999999988 788888876665554443332211111 112222
Q ss_pred cCccccCCCC---------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 269 ADPELQGQYP---------PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 269 ~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.|-....-++ +.....-.+++.++|.-+|.+|.++++.++.
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2222222222 2222334679999999999999999988754
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=302.41 Aligned_cols=275 Identities=20% Similarity=0.219 Sum_probs=189.1
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCe-EEEEEEec-----------------cCCccchHHHHHHHHHHhcCCCC
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQ-DVAIKQLD-----------------RNGVQGNREFLVEVLMLSLLHHP 91 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-~v~iK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~ 91 (361)
..+.++|++++.||+|+||.||+|..+.... .++.|.+. .........+.+|+.+++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456899999999999999999987654321 22222110 01112234578899999999999
Q ss_pred ccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEE
Q 018100 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 170 (361)
Q Consensus 92 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nil 170 (361)
||+++++++.+....|+|++++. ++|..++.... ..........+..++.||+.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999985 67777664311 11223456678899999999999999999 999999999999
Q ss_pred EcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCC-ccccchHHHhh
Q 018100 171 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK-AVDTSKAAAEQ 249 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~-pf~~~~~~~~~ 249 (361)
++.++.+||+|||++....... ........|+..|+|||++.+..++.++|||||||++|+|++|.. ||.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999999999997543221 111223568999999999999899999999999999999999875 44332221111
Q ss_pred hHHHhhhh------hhccccc--cccccCc---cccCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 250 SLVAWARP------LFQDRTR--HSLIADP---ELQGQYP-----PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 250 ~~~~~~~~------~~~~~~~--~~~~~~~---~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+...... .+..... ...+... ......+ ...+.++.++|.+||+.||++||++.++++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111110 0000000 0000000 0000000 0122356778999999999999999999974
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=280.72 Aligned_cols=250 Identities=30% Similarity=0.386 Sum_probs=198.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
...|...+.||+|++|.||+|.++.++..+++|.+..... .....+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 4558888999999999999999999899999999864322 2234677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+||+. ++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 6887776531 356899999999999999999999999 9999999999999999999999999886532
Q ss_pred CCCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
. .....++..|+|||.+. ...++.++|||||||++|+|++|..||............ ...
T Consensus 167 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~--------- 229 (308)
T cd06634 167 P------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQN--------- 229 (308)
T ss_pred C------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--hhc---------
Confidence 1 12235778899999874 356788999999999999999999998654332211100 000
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
. .+.. .....+..+.++|.+||+.+|.+||++.+++....
T Consensus 230 ~--~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 230 E--SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred C--CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0 0000 01233457888999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=283.60 Aligned_cols=269 Identities=23% Similarity=0.300 Sum_probs=196.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcC-------
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG------- 103 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 103 (361)
.++|++.+.||+|++|.||+|.++.++..+++|.+....... ...+.+|+.+++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999999999999999986443222 24567899999999999999999887443
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 104 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 104 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
...++|++|+. ++|...+.. ....+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 34689999996 577776654 1357999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcce---------eeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH
Q 018100 183 GLAKLGPVGDNTHV---------STRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252 (361)
Q Consensus 183 g~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 252 (361)
|++........... .....++..|+|||.+.+. .++.++|||||||++|+|++|.+||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99875322211111 1123467789999987654 5789999999999999999999999765443222211
Q ss_pred -Hhhhhh----hccccccccccCccccCCCC-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 253 -AWARPL----FQDRTRHSLIADPELQGQYP-------PRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 253 -~~~~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...... +..........+.......+ ......+.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000 00000000000000000001 112246788999999999999999999885
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=293.17 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=215.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++..+.++||+|.||.|++|.|+.. -..||||.+...... ....|.+|+.+|.+|+|+|++++|++.-+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 34455678999999999999999764 356999998755444 56789999999999999999999999987 56779
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|+|.+++|+|.+.++. .....|.......++.||+.|+.||.+++ +|||||...|+++-....|||+|||+.+..
T Consensus 188 V~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 9999999999999987 33567888999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccee-eccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDNTHVS-TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..+...+.. ....-...|+|||.++...++.++|||++|++||||++ |..||.+.........+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i-------------- 328 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI-------------- 328 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc--------------
Confidence 555544433 23445678999999999999999999999999999999 88999876554333222
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
|..-+...+..++.++.+++..||..+|++||++.+|.+.+-...
T Consensus 329 ---D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 329 ---DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ---cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 222233446678889999999999999999999999986554333
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=279.91 Aligned_cols=246 Identities=31% Similarity=0.432 Sum_probs=196.2
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.|...+.||+|+||.||+|.+..++..|++|.+...... ....+.+|+.+++.++|||++++++++.++...|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 377778899999999999999989999999998644332 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+. +++.+++.. ...++++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-- 172 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-- 172 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC--
Confidence 996 677777654 1356899999999999999999999999 9999999999999999999999999886421
Q ss_pred CCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
......++..|+|||.+. +..++.++||||||+++|+|++|..||.............. . .
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~------~--~---- 236 (313)
T cd06633 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------N--D---- 236 (313)
T ss_pred ----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------c--C----
Confidence 112345788899999974 45688999999999999999999999866533222111100 0 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.. .....+..+.+++.+||+.+|.+||++.+++..
T Consensus 237 -~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 -SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011223467889999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=285.75 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=200.0
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCC--
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-- 104 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 104 (361)
+..+.++|++.+.||+|++|.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 44567899999999999999999999999999999999854322 22356788999999999999999999886543
Q ss_pred ----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEe
Q 018100 105 ----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 180 (361)
Q Consensus 105 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~ 180 (361)
..++|++|+ +++|.+++.. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 358999998 6899888864 46899999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhh-HHHhhh--
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWAR-- 256 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~-- 256 (361)
|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... +.....
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998753221 122356788999999866 458899999999999999999999997554321111 000000
Q ss_pred -hhhccc-----cccccccCccc----cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 257 -PLFQDR-----TRHSLIADPEL----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 257 -~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..+... ........+.. .....+.....+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000000000 00111223446889999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=298.75 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=218.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCC---eEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~---~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
....|.+.||.|.||.|++|+.+..| ..||||.++.... ..+..|..|+.+|-+++||||+++-++.....-..||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34678899999999999999998765 5799999976544 4556799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
.|||+.|+|..++... .+.++..+...+++.|+.|+.||-+.+ +|||||...||||+.+..+|++|||+++...
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999873 356999999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCcceeecccc--CcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMG--TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.... ...+...| ...|.|||.+...+++.+|||||+|++|||.+. |..|+-.....+...-+
T Consensus 783 dd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-------------- 847 (996)
T KOG0196|consen 783 DDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-------------- 847 (996)
T ss_pred cCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH--------------
Confidence 3321 11222222 468999999999999999999999999999988 99998665443332211
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccC
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 318 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~ 318 (361)
...++..-|.+++..|.+|+..||++|-.+||.+.+|+..|+++..++.
T Consensus 848 ---e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 848 ---EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ---HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1223334466788899999999999999999999999999999887653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.19 Aligned_cols=272 Identities=20% Similarity=0.253 Sum_probs=208.8
Q ss_pred HHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-C-C----ccceeeeE
Q 018100 26 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-H-P----NLVNLIGY 99 (361)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~ 99 (361)
++.-..+.++|.+.+.+|+|.||.|-.+.+..++..||||++... ....++..-|+++|+++. + | -++.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 344456689999999999999999999999999999999998643 334566777999999984 2 2 34566778
Q ss_pred EEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC------
Q 018100 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR------ 173 (361)
Q Consensus 100 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~------ 173 (361)
|...++.|||+|.+ |.++.+++.. +...+++...+..+++||++++.+||+.+ ++|.||||+||++..
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 99999999999988 6799999976 33568999999999999999999999999 999999999999831
Q ss_pred --------------CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCc
Q 018100 174 --------------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 239 (361)
Q Consensus 174 --------------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p 239 (361)
+..|+++|||.++.... .....+.|..|+|||++.+-.++.++||||+||+|+|+++|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 34589999999986222 22456789999999999999999999999999999999999999
Q ss_pred cccchHHHhhhHHHhhhhhhcccccccc---------ccC----------------c---cccCCCChHHHHHHHHHHHH
Q 018100 240 VDTSKAAAEQSLVAWARPLFQDRTRHSL---------IAD----------------P---ELQGQYPPRGFYQALAVAAM 291 (361)
Q Consensus 240 f~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~----------------~---~~~~~~~~~~~~~l~~li~~ 291 (361)
|.+....+...+.+.+-+.++....... -.+ + ...-...+.....|++|+++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 9876654433332222111111000000 000 0 00111223456679999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 018100 292 CVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 292 ~l~~dP~~Rps~~~ll~~ 309 (361)
||..||.+|+|+.|+++.
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999964
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=277.04 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=201.1
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
|++.+.||+|++|.||+|.+..+++.|++|++.... ....+.+..|+.+++.++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999999999999999987653 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
. ++|.+++... ...+++..++.++.|++.||.+||+++ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 6999999762 146999999999999999999999999 99999999999999999999999999875332211
Q ss_pred cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhh----hhhc---cc--
Q 018100 194 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR----PLFQ---DR-- 262 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~----~~~~---~~-- 262 (361)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||............ .... ..+. ..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 11223456789999998766 7899999999999999999999999765433221111 0000 0000 00
Q ss_pred --cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 --TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........... ....+..+..+.+++.+||..||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 0011122557899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=279.33 Aligned_cols=257 Identities=20% Similarity=0.251 Sum_probs=190.9
Q ss_pred CceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhc
Q 018100 46 GFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH 123 (361)
Q Consensus 46 ~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 123 (361)
+++.||.++.+.++..||+|++... .....+.+..|+.+++.++|+||+++++++.++...+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4566677777778999999998754 23345678999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC-----cceee
Q 018100 124 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-----THVST 198 (361)
Q Consensus 124 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~-----~~~~~ 198 (361)
... ...+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 633 346899999999999999999999999 99999999999999999999999998764322111 11112
Q ss_pred ccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh----hhccc------cccc
Q 018100 199 RVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP----LFQDR------TRHS 266 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----~~~~~------~~~~ 266 (361)
...++..|+|||++.+ ..++.++|+|||||++|+|++|..||......... ...... .+... ....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhcCCcC
Confidence 2346678999999865 35889999999999999999999999754322111 110000 00000 0000
Q ss_pred c----ccCc----cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 L----IADP----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~----~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ..++ .............+.+++.+||+.||++||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 0000 01111223345578889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=285.17 Aligned_cols=266 Identities=22% Similarity=0.329 Sum_probs=197.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcC------C
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------D 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 104 (361)
..+|.+.+.||+|+||.||+|.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4799999999999999999999998899999999865322 2235678899999999999999999988654 2
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++|++|+. .+|..+.. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999985 57766542 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh----hhh
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR----PLF 259 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~ 259 (361)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||................ +.+
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8753221 122346788999999866 468899999999999999999999997654322211111000 000
Q ss_pred ----cccc------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHH
Q 018100 260 ----QDRT------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA--LAYLA 314 (361)
Q Consensus 260 ----~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~--l~~l~ 314 (361)
.... ........... ...+.....+.++|.+||+.||.+||++.+++.. ++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 00000000000 0011234467899999999999999999999953 55443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=307.70 Aligned_cols=257 Identities=25% Similarity=0.286 Sum_probs=207.3
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
+++-..++|+|++.||+|+||.|.+++++.++..+|+|++++- ......-|..|-.+|..-+.+=|+.++-.|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3344478999999999999999999999999999999998762 2233455778888988888999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
++|+||+|++||+|..++.. ...+++.++..++..|.-||..||+.| +|||||||+|||+|..|+++|+|||.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999987 447999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhc----c-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhh
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAK----T-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|..... ++.......+||+.|++||++. + +.|...+|+||+|+++|||+.|.-||-.......... ++
T Consensus 222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K------Im 294 (1317)
T KOG0612|consen 222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK------IM 294 (1317)
T ss_pred HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH------Hh
Confidence 976432 3344455678999999999984 2 5688999999999999999999999954433222111 11
Q ss_pred ccccccccccCccccCCCC--hHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 018100 260 QDRTRHSLIADPELQGQYP--PRGFYQALAVAAMCVHEQPDMRPV---IADVVTA 309 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~~ 309 (361)
... . . ..+| ...+....+||.+.+. +|..|.. ++++-..
T Consensus 295 ~hk-~--~-------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHK-E--S-------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chh-h--h-------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 110 0 0 1112 2356688889988775 4888877 7777653
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=276.52 Aligned_cols=264 Identities=24% Similarity=0.302 Sum_probs=198.2
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEEEEec
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
|++.+.||+|++|.||+|....++..|+||.+...... ......+|+..+..++ |+|++++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67889999999999999999988999999998654322 2234567899999998 999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+++|.+++.... +..+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 789988886522 347899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhhh----hcccccccc
Q 018100 194 THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPL----FQDRTRHSL 267 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~----~~~~~~~~~ 267 (361)
......++..|+|||.+. +..++.++|+||||+++|+|++|..||........... ....... +........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 112345788899999874 45678999999999999999999999976543322211 1100000 000000000
Q ss_pred ccCcc-------ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 268 IADPE-------LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 268 ~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..... ......+..+..+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 000111122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=281.43 Aligned_cols=265 Identities=23% Similarity=0.289 Sum_probs=200.9
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEc-CCee
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQR 106 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 106 (361)
-.+.++|++.+.||.|+||.||+|.++.++..|++|.+.... ....+.+..|+.+++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999999999999999875432 2234668889999999999999999998865 5678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++++||+ +++|..++.. .++++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 5789888864 46888999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhh--------
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWAR-------- 256 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~-------- 256 (361)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... .....
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43221 122346788999998765 5689999999999999999999999976543222111 11000
Q ss_pred hhhccccccccccCccccC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 257 PLFQDRTRHSLIADPELQG-----QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...... ............ ...+..+..+.++|.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000000 0111234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=284.33 Aligned_cols=269 Identities=21% Similarity=0.293 Sum_probs=201.4
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcC-
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG- 103 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 103 (361)
.++-.+.++|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 455667799999999999999999999999899999999986532 22345678899999999999999999987543
Q ss_pred -----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 104 -----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 104 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888877 7899888764 45899999999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWAR 256 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~ 256 (361)
|+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||............ ....
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999875321 1123457888999998866 56889999999999999999999999654332211110 0000
Q ss_pred ---h-hh---cccc------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 257 ---P-LF---QDRT------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 257 ---~-~~---~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
+ .. .... .........+ .......+..+.++|.+||+.||.+||++.+++..-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0 00 0000 0000000000 000111244678999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=309.38 Aligned_cols=256 Identities=28% Similarity=0.390 Sum_probs=194.2
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcC-----
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 103 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 103 (361)
.+...+|+.++.||+||||.||+++++-+|..+|||++.... ......+.+|+..|.+|+|||+|+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678889999999999999999999999999999997654 22345688999999999999999987443211
Q ss_pred --------------------------------------------------------------------------------
Q 018100 104 -------------------------------------------------------------------------------- 103 (361)
Q Consensus 104 -------------------------------------------------------------------------------- 103 (361)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEEecCCCCHHHHhcccCCCCCCC-CHHHHHHHHHHHHHHH
Q 018100 104 ----------------------------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGL 148 (361)
Q Consensus 104 ----------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l-~~~~~~~i~~qi~~al 148 (361)
..+||-||||+..++.+++.. +... .....|.++.+|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHH
Confidence 135888999997777777765 3322 4678999999999999
Q ss_pred HHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC------C----------CCCcceeeccccCcCcCCchhh
Q 018100 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP------V----------GDNTHVSTRVMGTYGYCAPEYA 212 (361)
Q Consensus 149 ~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~------~----------~~~~~~~~~~~~~~~y~aPE~~ 212 (361)
.|+|++| ++||||||.|||+++++.|||+|||++.... . +......+..+||..|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999 9999999999999999999999999987511 0 1111123457899999999999
Q ss_pred ccC---CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHH
Q 018100 213 KTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 289 (361)
Q Consensus 213 ~~~---~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (361)
.+. .|+.|+|+||||+++|||+. ||.+..... ...... . ...+..+ ..+.......-..+|
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa--~iL~~L-------R-~g~iP~~---~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA--SILTNL-------R-KGSIPEP---ADFFDPEHPEEASLI 851 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHH--HHHHhc-------c-cCCCCCC---cccccccchHHHHHH
Confidence 664 59999999999999999985 466543211 111100 0 1111111 223333444556799
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 018100 290 AMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 290 ~~~l~~dP~~Rps~~~ll~ 308 (361)
+.|++.||.+||||.++|.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.76 Aligned_cols=267 Identities=28% Similarity=0.516 Sum_probs=204.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
......|...+.||+|+||.||+|.++.++..||+|.+...... ...|+..+++++||||+++++++.+....++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 33456788899999999999999999888999999998643322 23468889999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++|+|.++++. +++..+..++.||++||+|||....+.++||||||+||+++.++..++. |+......
T Consensus 762 ~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 762 HEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 999999999999963 7899999999999999999994422229999999999999998887765 55443211
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||+..... ...+..|....+... ......
T Consensus 834 ~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~ 905 (968)
T PLN00113 834 T------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDC-HLDMWI 905 (968)
T ss_pred c------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCcc-chhhee
Confidence 1 11235788999999999889999999999999999999999999543221 122333332222111 111222
Q ss_pred CccccC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 270 DPELQG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 270 ~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
++.... ..+.....++.+++.+||+.||++||++.++++.|+.+...
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 333221 23445666788999999999999999999999999877653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=270.46 Aligned_cols=237 Identities=30% Similarity=0.359 Sum_probs=194.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
||+|++|.||.+.+..+++.+++|.+...... ....+..|+.+++.++|+|++++++.+..+...+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999988999999998755332 345688899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceee
Q 018100 119 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198 (361)
Q Consensus 119 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~ 198 (361)
.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999976 456899999999999999999999999 9999999999999999999999999987532221 1223
Q ss_pred ccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
...++..|+|||.+.+...+.++|+||||+++|+|++|..||............ . .. . ...+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~---~~--------~----~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI---L---KD--------P----LRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---h---cC--------C----CCCC
Confidence 345788899999998888899999999999999999999999765431111110 0 00 0 1112
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRPVIAD 305 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps~~~ 305 (361)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 222457889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=318.29 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=205.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.-+|.-...||.|.||.||.|.+..+|+..|+|-+.... ......+.+|+.++..++|||++.++++=.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 456777889999999999999999999999999875332 233456788999999999999999999998888999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|||++|+|.+++.. +.-.++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.+.....
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999986 566778888899999999999999999 99999999999999999999999999976433
Q ss_pred CC--CcceeeccccCcCcCCchhhccCC---CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 191 GD--NTHVSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 191 ~~--~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
.. -........||+.|||||++.+.. -..+.|||||||++.||+||+.||.....+-.. ...+ ...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--My~V-------~~g 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--MYHV-------AAG 1457 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--HhHH-------hcc
Confidence 21 111122357999999999997643 447899999999999999999999764332111 1111 001
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+ ...+|...+.+-.++|.+||..||++|.++.++++.
T Consensus 1458 h-------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 H-------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred C-------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 123344466688899999999999999999888764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=282.68 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=195.0
Q ss_pred CcccCCeecccCceEEEEEEECCC--CeEEEEEEeccCCc--cchHHHHHHHHHHhcC-CCCccceeeeEEEc----CCe
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESI--NQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 105 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~--~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 105 (361)
+|++.+.||+|+||.||+|.+..+ +..|++|.+..... ...+.+..|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588999999999999999999887 88999999864322 2245678899999999 59999999987532 245
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.+++++++. ++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+|||++.++.++|+|||.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899885 789888865 567999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC--cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhh------
Q 018100 186 KLGPVGDN--THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWA------ 255 (361)
Q Consensus 186 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~------ 255 (361)
........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 75322211 111223467889999998765 5688999999999999999999999976543211110 0000
Q ss_pred ------hhhhccc-cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 256 ------RPLFQDR-TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 256 ------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+..... ..........+ ....+.....+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000000 0111122457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=276.09 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=196.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 109 (361)
..++|++.+.||+|++|.||+|.++.++..|++|.+...... ....+..|+.++... .|+||+++++++.++...|++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 457899999999999999999999998999999998754332 334466677766666 499999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|||+. ++|.+++... ...+++..+..++.||+.||.|||+ ++ ++|+||+|+||++++++.++|+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99985 6777776542 2478999999999999999999997 58 999999999999999999999999998653
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCC----CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
.... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||......... +.... ...
T Consensus 166 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~----~~~-- 235 (296)
T cd06618 166 VDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKIL----QEE-- 235 (296)
T ss_pred cCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH-HHHHh----cCC--
Confidence 2211 112234677899999986543 788999999999999999999999753322111 11100 000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
. +... .....+.++.+++.+||..||++||++.++++..
T Consensus 236 ~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 P-----PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-----CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 0000 0012344788999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.85 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=204.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.+.|++-+.||+|+||.|+-++.+.+|.-+|.|.+.+..... .....+|-.+|..++.+.||.+--.|++.+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 466888899999999999999999999999999986543322 23467899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+..|+||+|.-.|.+.- +..+++..+..++.+|+.||++||+.+ ||+|||||+|||+|+.|+++|+|+|++.-..
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999987665533 468999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.+. .....+||..|||||++.+..|+...|+|||||+||+|+.|+.||.....-....-+. .....
T Consensus 339 ~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd-----------rr~~~ 404 (591)
T KOG0986|consen 339 EGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD-----------RRTLE 404 (591)
T ss_pred CCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH-----------HHHhc
Confidence 433 3334479999999999999999999999999999999999999997654322221110 00011
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA 304 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 304 (361)
+ ...++..-+.++.+|.+.+|++||.+|.-.+
T Consensus 405 ~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 D---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred c---hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 1223344455888899999999999997544
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=289.58 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=197.8
Q ss_pred ccCCeecccCceEEEEEEECCCCeEEEEEEeccC----CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCe--eEEEE
Q 018100 37 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--RLLVY 110 (361)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~ 110 (361)
+....||+|+|-+||+|.+..+|..||.-.++.. .+...+.|..|+.+|+.|+||||++++++|.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3456899999999999999999999988766422 23344789999999999999999999999977554 67899
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-CceeEecccccccCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGP 189 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-~~~~L~Dfg~~~~~~ 189 (361)
|.+..|+|..|+.. .+.++...+..|++||++||.|||++. |+|+|||||-+||||+.+ |.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999987 677999999999999999999999995 779999999999999865 899999999998632
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh--hHHHhhhhhhcccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 267 (361)
.. ......||+.|||||... ..|+..+||||||+++.||+|+.+||..-...... .+...+.|.
T Consensus 198 ~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~--------- 263 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA--------- 263 (632)
T ss_pred cc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH---------
Confidence 21 123368999999999885 79999999999999999999999999654433222 111111110
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+...- -.++.++|.+||.. ...|||+.|+|..
T Consensus 264 ----sl~kV~----dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 264 ----ALSKVK----DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----HhhccC----CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 011111 22678899999999 9999999999963
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=272.22 Aligned_cols=281 Identities=21% Similarity=0.248 Sum_probs=205.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCe----EEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEc-CC
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GD 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 104 (361)
-...|++...||+|+||.||+|..+.++. .+|||++..... -......+|+.+++.++|||++.+..++-. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34679999999999999999997766543 689999875422 123457889999999999999999998865 78
Q ss_pred eeEEEEEecCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC----CceeE
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKL 179 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~----~~~~L 179 (361)
..+++++|.+ -+|.+.++-.+. ....++...+.++++||+.|+.|||++= |+||||||.||||..+ |.+||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 8999999997 788888864222 2357999999999999999999999997 9999999999999877 99999
Q ss_pred ecccccccCCCCCCcc-eeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhH---HHh
Q 018100 180 SDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL---VAW 254 (361)
Q Consensus 180 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~---~~~ 254 (361)
+|||+++.+...-... .....+.|.+|+|||++.|. .|+.+.||||+||++.||++-.+.|.+......... .+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999998754332222 23345679999999999885 699999999999999999999998876554322210 000
Q ss_pred hhhhh-----------ccccccccccC--cccc-CCCCh-----------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 255 ARPLF-----------QDRTRHSLIAD--PELQ-GQYPP-----------RGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 255 ~~~~~-----------~~~~~~~~~~~--~~~~-~~~~~-----------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....+ ....+...... ..+. ....+ .-.....+|+.++|..||.+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 00000 00000000000 0000 00000 012236789999999999999999999987
Q ss_pred HHHHHhc
Q 018100 310 LAYLASQ 316 (361)
Q Consensus 310 l~~l~~~ 316 (361)
.-+....
T Consensus 338 ~yF~~d~ 344 (438)
T KOG0666|consen 338 PYFTEDP 344 (438)
T ss_pred cccccCC
Confidence 6655443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=286.51 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=199.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCe---
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 105 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 105 (361)
.+.++|++.+.||+|++|.||+|.+..++..|++|++.... ......+.+|+.+++.+.|+|++++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34688999999999999999999999999999999986432 2233567789999999999999999988765544
Q ss_pred ---eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 106 ---RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 106 ---~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
.++|++|+ +++|.+++.. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 6899998874 56999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhh---
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARP--- 257 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~--- 257 (361)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... ......
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 998753222 222356788999998865 4678999999999999999999999976543322111 110000
Q ss_pred hhccccc----------cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 258 LFQDRTR----------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 258 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+..... ......+.+. ......+..+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 0000000000 0011224578899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.76 Aligned_cols=206 Identities=28% Similarity=0.401 Sum_probs=177.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEcCC------ee
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QR 106 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 106 (361)
.-|...+.||+|+||.||+|+++.+|+.||||.++.. .....+...+|+++|++++|+|||++.++=++.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4456678999999999999999999999999999764 3455678899999999999999999988765543 45
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc--CCC--ceeEecc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGY--HPKLSDF 182 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~--~~~--~~~L~Df 182 (361)
.+|||||.||+|...++...+ ...+++.+++.++.++..||.|||.+| ||||||||.||++- ++| ..||+||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred eEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 799999999999999988665 456999999999999999999999999 99999999999984 334 4799999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHH
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 246 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~ 246 (361)
|.|+-.. ........+||..|++||... ...|+..+|.|||||++|+..||..||......
T Consensus 169 G~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 169 GAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9998533 333566688999999999997 488999999999999999999999999655443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=275.93 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=197.6
Q ss_pred CcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCee
Q 018100 35 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 106 (361)
+|++.+.||+|++|.||++.+. .++..|++|.+..... ...+.+.+|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4888999999999999999864 3578899999864321 2234577899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998875 456899999999999999999999999 9999999999999999999999999886
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCC--CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
....... .......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......... ..........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS--- 227 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc---
Confidence 5322211 1112235788999999987654 788999999999999999999999643211100 0000100100
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.+ ..+......+.+++.+||+.||++|||+.++.+.|+
T Consensus 228 -----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 -----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred -----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 01 112223347888999999999999999887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=268.01 Aligned_cols=267 Identities=23% Similarity=0.310 Sum_probs=206.1
Q ss_pred HHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCC
Q 018100 26 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 104 (361)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 104 (361)
|+++.+.+ .+.||+|+++.|--++...+|..+|||++.+.....+..+.+|++++.+.+ |+||+.++++|+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 45555544 358999999999999999999999999998887777788999999999985 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc---eeEec
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSD 181 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~---~~L~D 181 (361)
..|||||.+.||+|...|+. ...+++.++..+..+|+.||.|||.+| |.||||||+|||-...+. +||+|
T Consensus 150 ~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999987 667999999999999999999999999 999999999999876654 79999
Q ss_pred ccccccCCCCC-----CcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhh--
Q 018100 182 FGLAKLGPVGD-----NTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-- 249 (361)
Q Consensus 182 fg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-- 249 (361)
|.+..-..... ........+|+..|||||+.. ...|+.++|.||||+++|-||.|.+||.+.=..+-.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 98864321111 122234467889999999762 246899999999999999999999999653211000
Q ss_pred ---hHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 250 ---SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 250 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.-..-...+|........ ++...-....+.+..++++.+|..|+.+|.++..++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkY----eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKY----EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCC----cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000111111111100 1111122345667788999999999999999998886
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.42 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=195.2
Q ss_pred CcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCee
Q 018100 35 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 106 (361)
+|++.+.||+|+||.||+|... .+|..|++|++..... ...+.+.+|+.++..+ +|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 3688999999865322 2235678899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999876 567899999999999999999999999 9999999999999999999999999887
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ...........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 227 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc---
Confidence 5322111 11123457889999999865 3467899999999999999999999964221100 00001000000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
.+ .++......+.+++.+||+.||++|| ++.+++.
T Consensus 228 -----~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -----EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01 11222344778899999999999997 6666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=270.25 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=205.4
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--CCCCccceeeeEEEcC----
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG---- 103 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~---- 103 (361)
+.+.++..+.+.||+|.||.||+|.|+ |+.||||+|... +.+.+.+|.++++. |+|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 455688999999999999999999999 889999999643 34567778887765 6999999998876433
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
.+++||.+|-+.|+|.|++.. ..++....++++..+++||++|| .+|+|.|.|||||..||||..+|..-
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 478999999999999999986 67999999999999999999999 45788999999999999999999999
Q ss_pred EecccccccCCCCC--CcceeeccccCcCcCCchhhccCC----CC--ccCceehhhHHHHHHhhCC----------Ccc
Q 018100 179 LSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAKTGQ----LT--LKSDVYSFGVVLLEILSGR----------KAV 240 (361)
Q Consensus 179 L~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~----~~--~~sDiwslG~~l~~ll~g~----------~pf 240 (361)
|+|+|++....... -.......+||..|||||++.... +. ..+||||||.++||+.-.. .||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999997744332 222345578999999999995432 21 4589999999999997542 444
Q ss_pred ccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 241 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
-.....++. .. .+........+.....+..........+.+|++.||..+|..|.|+-.+-+.|.++..
T Consensus 437 yd~Vp~DPs-~e-----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPS-FE-----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCC-HH-----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 322111110 00 0111111111111111222334567788899999999999999999999999988874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.77 Aligned_cols=147 Identities=31% Similarity=0.409 Sum_probs=133.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.+..++..||||++...... ....+..|+.++..++|+||+++++.+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999998654322 235678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976 456899999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=257.77 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=196.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.++.+++..||.|+-|.||+++.+.+|...|||.+..+... +.+.+..++.++..- .+|+|++.+++|..+...++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 45566778999999999999999999999999999766443 345677777776554 4899999999999998889999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|.|. ..+..++... .+++++..+=++...+.+||.||..+.. |+|||+||+|||+|+.|++||||||++-+.
T Consensus 171 elMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrl-- 242 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRL-- 242 (391)
T ss_pred HHHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeeccccccee--
Confidence 9883 5566665542 4679999999999999999999997754 999999999999999999999999998642
Q ss_pred CCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHh-hhHHHhhhhhhccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 266 (361)
......+...|-..|||||.+. ...|+.++||||||++++||.||+.||..-..+-. ...+....+
T Consensus 243 -vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--------- 312 (391)
T KOG0983|consen 243 -VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--------- 312 (391)
T ss_pred -ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---------
Confidence 2233345567889999999884 45789999999999999999999999987432211 111110000
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
|.+.... .-+....+++..||.+|+.+||...++++.
T Consensus 313 ----P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 ----PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ----CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111000 022367789999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=263.08 Aligned_cols=220 Identities=24% Similarity=0.256 Sum_probs=177.6
Q ss_pred cCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcc
Q 018100 45 GGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 124 (361)
Q Consensus 45 G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 124 (361)
|.+|.||++.++.+++.+++|.+.... ....|...+....||||+++++++.++...+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986543 223345555556799999999999999999999999999999999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCc
Q 018100 125 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204 (361)
Q Consensus 125 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~ 204 (361)
...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 456999999999999999999999999 999999999999999999999999987542221 11223566
Q ss_pred CcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHH
Q 018100 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 284 (361)
Q Consensus 205 ~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (361)
.|+|||.+.+..++.++|+||+|+++|+|++|..||....... . .......+...+..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~----------~~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N----------THTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c----------cccccCCcccCCHH
Confidence 7999999988888999999999999999999998875321100 0 00001122334457
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 018100 285 ALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 285 l~~li~~~l~~dP~~Rps~ 303 (361)
+.+++.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8889999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=270.85 Aligned_cols=276 Identities=26% Similarity=0.355 Sum_probs=217.4
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcC-CCCccceeeeEEEcCCee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 106 (361)
.-..+|..+..||+|+||+|.+|..+.+.+.+|||++.+.-.. +.+--+.|-.+|... +-|.++.++..|.+-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 3346888999999999999999999999999999998765332 233344567777665 468899999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
|+||||+.||+|--.+++ -+.+.+..+..++.+|+-||-+||++| |+.||||.+|||++.+|.+||+|||+|.
T Consensus 426 yFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999888887 567888899999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
-. ..........+||+.|+|||++...+|..++|+||+|++||||+.|++||++...+..-.-+ .
T Consensus 499 En--i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------~------- 563 (683)
T KOG0696|consen 499 EN--IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------M------- 563 (683)
T ss_pred cc--ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------H-------
Confidence 52 22233345678999999999999999999999999999999999999999987654332111 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCC----CHHHHHHHHHHHHhccCCCccccCCCCCCCCC
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP----VIADVVTALAYLASQKYESDAEKVQSPCLDPG 333 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~~ll~~l~~l~~~~~~~~~~~~~~~~~~~~ 333 (361)
+-+-.+|...+.+..++....|.++|.+|. ..++=+.+-..++...|+........|+..|.
T Consensus 564 -----ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 564 -----EHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPK 629 (683)
T ss_pred -----HccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCc
Confidence 111244556677889999999999999994 44444444444444444444444444444443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.12 Aligned_cols=243 Identities=25% Similarity=0.309 Sum_probs=196.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+...|.+...+|.|+|+.|-.+.+..+++..++|++.....+ ..+|+.++... +||||+++.+.+.++...|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 477899999999999999999999999999999999765222 33466555544 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE-cCCCceeEecccccccCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv-~~~~~~~L~Dfg~~~~~~ 189 (361)
|.++|+-+.+.+.. ...+. ..+..|+.+|+.|+.|||++| ++||||||+|||+ +..++++|+|||.+....
T Consensus 396 e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988887765 22233 778889999999999999999 9999999999999 689999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. ....+-|..|.|||++....+++++||||||++||+||+|+.||...... ..+...+.
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~------------- 527 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQ------------- 527 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhc-------------
Confidence 22 22234678899999999999999999999999999999999999766554 11111110
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
. ..+....+....+|+.+||+.||.+||++.++...-
T Consensus 528 ~----~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 528 M----PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred C----CccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 0 111134455888999999999999999999998643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=267.92 Aligned_cols=259 Identities=27% Similarity=0.363 Sum_probs=201.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccc------hHHHHHHHHHHhcCCCCccceeeeEEE-cC
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQG------NREFLVEVLMLSLLHHPNLVNLIGYCA-DG 103 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 103 (361)
.+++|-++++||+|+|+.||+|.+....+.||+|+-..+. +.+ .+...+|..+.+.|.||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3588999999999999999999999889999999865331 111 234678999999999999999999985 45
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEe
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLS 180 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~ 180 (361)
+..|.|+|||+|.+|.-++.. ...+++.++..|+.||..||.||... +++|+|-||||.|||+.. .|.+||.
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 677899999999999999987 67899999999999999999999988 577999999999999954 5789999
Q ss_pred cccccccCCCCCCc-----ceeeccccCcCcCCchhhc----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH
Q 018100 181 DFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAK----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 251 (361)
Q Consensus 181 Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 251 (361)
|||++..+...... ....+..||.+|++||.+- ...++.++||||+|+++|.-+.|+.||.........
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-- 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-- 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--
Confidence 99999875443322 3345678999999999874 246889999999999999999999999764332111
Q ss_pred HHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 018100 252 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 307 (361)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 307 (361)
... ....+ ..+..-..-|....+..++|++||+.--+.|.+..++.
T Consensus 694 Lqe-----NTIlk-----AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQE-----NTILK-----ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hhh-----hchhc-----ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 110 00000 01111111233455778899999999999997766655
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=273.02 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=199.8
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCC
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
.+.||.|.||+||-|.++.+|+.||||++++... .....+.+|+.+|+++.||.|+.+-..|++.+..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 3789999999999999999999999999986533 344678999999999999999999999999999999999996 6
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC---CceeEecccccccCCCCCC
Q 018100 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 117 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~---~~~~L~Dfg~~~~~~~~~~ 193 (361)
+..+.+-.. .++.+++..-..++.||+.||.|||.++ |+|+||||+|||+... ..+||||||+++..+ .
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---E 719 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---E 719 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc---h
Confidence 766666442 3678999999999999999999999999 9999999999999654 469999999999633 3
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......+||+.|+|||++++..|...-|+||.|+++|-=+.|..||.......+. +.....++ .+..
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAaFMy----------Pp~P 787 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAAFMY----------PPNP 787 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhcccccc----------CCCc
Confidence 33445578999999999999999999999999999999999999999765332111 11010001 1111
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. .......++||..+|+..-.+|.++...++
T Consensus 788 W----~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 W----SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred h----hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1 223447889999999999999999987664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=279.27 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=213.2
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEE-----cC
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCA-----DG 103 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~ 103 (361)
..-...|++.+.||.|.+|.||++.++.+++.+|+|+.... .+..+.+..|.++++.+ .|||++.+++++. .+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 33456789999999999999999999999999999987654 33446678899999988 5999999999884 36
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
+++|||||||.||+..+++.... +..+.+..+..|++.++.|+.+||.+. ++|||||-.|||++.++.+||+|||
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 78999999999999999999866 788999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhcc-----CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
.+..... .........||+.|||||++.. ..|+..+|+||||++..||--|.+|+.........
T Consensus 169 vSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL--------- 237 (953)
T KOG0587|consen 169 VSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------- 237 (953)
T ss_pred eeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh---------
Confidence 8864221 2222345689999999999853 46889999999999999999999998765443221
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+|......+...+....++|..||.+|-.+||++.++++
T Consensus 238 ------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 ------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11222344444556677788899999999999999999999885
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=258.25 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=200.7
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 107 (361)
...+|++++.||+|+|++|.+++++.+.+.+|+|++++. ...+......|-.+..+. +||.++.++..|.++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 367899999999999999999999999999999998753 334456677788888776 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|.||++||+|--.++. ..+++++.+..+...|.-||.|||++| |+.||||.+|+|++..|.+||.|+|+|+-
T Consensus 328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999766665 567999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHH-HhhhHHH-hhhhhhcccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA-AEQSLVA-WARPLFQDRTRH 265 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~-~~~~~~~-~~~~~~~~~~~~ 265 (361)
...........+||+.|+|||++.+..|..++|+|+||+++++|+.|+.||+...-. ...+... ..+-.....
T Consensus 401 --~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--- 475 (593)
T KOG0695|consen 401 --GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--- 475 (593)
T ss_pred --CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---
Confidence 223344456678999999999999999999999999999999999999999743211 1111111 111111111
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 301 (361)
...|...+.....+++.-|.+||.+|.
T Consensus 476 ---------iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 ---------IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---------ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 112222333445588899999999994
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=256.69 Aligned_cols=257 Identities=25% Similarity=0.310 Sum_probs=198.0
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEec
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
.+-+..||.|.||+|++-.++.+|...|||.+..... .+..++..|.+...+- ++|||+++++.+..+..+|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 4446689999999999999999999999999987655 4456677788765554 6999999999999999999999999
Q ss_pred CCCCHHHHhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 114 PLGSVEDHLHD-LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 114 ~~~~L~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+ .+|..+... +.-.+..+++.-+-.|......||.||...-+ |+|||+||+|||++..|.+||||||+|-. ..
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGq---Lv 219 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQ---LV 219 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHh---HH
Confidence 6 888776643 22235678998888888889999999987755 99999999999999999999999999863 12
Q ss_pred CcceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.....+...|-..|+|||.+.. ..|+.+|||||||++|||+.||..|+..+...-+. +...+..... .+..
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq-l~~Vv~gdpp------~l~~ 292 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ-LCQVVIGDPP------ILLF 292 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH-HHHHHcCCCC------eecC
Confidence 2233444568889999999853 35899999999999999999999999877652221 1111111000 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..-.-..+..+..+|..||.+|-..||+..++++.
T Consensus 293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 00112245578889999999999999999999863
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.28 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=214.7
Q ss_pred cccCCeecccCceEEEEEEECCCC----eEEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~----~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.+..+.||+|+||+||+|.+-..| .+|+||++... .......+.+|+.+|..+.|||++++++++.... .-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 445679999999999999996554 46888887654 3344577999999999999999999999998765 77899
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
+|+++|+|.++++. +...+-....+.|+.||++|+.|||.++ ++||||...||||..-..+|+.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987 3467888999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
...............|+|=|.+....++.++||||+|+++||++| |..|+++....+..++...
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~--------------- 915 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK--------------- 915 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc---------------
Confidence 444433333445678999999999999999999999999999999 9999988766554443321
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
..+...|+.++.++..++.+||..|+..||+++++..++..+...
T Consensus 916 --geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 916 --GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred --cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 112455777888999999999999999999999999998776643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=262.04 Aligned_cols=273 Identities=30% Similarity=0.426 Sum_probs=201.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--CCCCccceeeeEEEcCC----ee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADGD----QR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~ 106 (361)
.....+.+.||+|.||.||+|+.. ++.||||++.. ...+.+.+|-.++.. ++|+||+.+++.-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 455667789999999999999987 68999999864 344667777777665 57999999998876555 88
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCcEEEcCCCceeEe
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------KPPVIYRDLKCSNILLDRGYHPKLS 180 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~i~H~dl~p~Nilv~~~~~~~L~ 180 (361)
+||++|.+.|+|.+++.. ..+++.....++..+++||+|||+-- +++|+|||||..||||.++++..|+
T Consensus 284 wLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 999999999999999986 66999999999999999999999653 5689999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccC-CCC-----ccCceehhhHHHHHHhhCCCcccc-ch-------HH
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLT-----LKSDVYSFGVVLLEILSGRKAVDT-SK-------AA 246 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~-----~~sDiwslG~~l~~ll~g~~pf~~-~~-------~~ 246 (361)
|||++.....+.........+||..|||||++.+. ++. .+.||||+|.++|||+++...+.. .. ..
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999886655444444457899999999999653 222 468999999999999987644421 10 00
Q ss_pred HhhhH--HHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccCC
Q 018100 247 AEQSL--VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 319 (361)
Q Consensus 247 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~~ 319 (361)
..... .+.++...........+ +...... .....+.+.+..||..||+.|.|+.=+.+++..+.-....
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~--p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKI--PDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCC--hhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 00000 00000000000001111 1111111 2345678899999999999999999999999887765443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=252.10 Aligned_cols=275 Identities=22% Similarity=0.329 Sum_probs=203.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-c-hHHHHHHHHHHhcCCCCccceeeeEEEc--------C
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-G-NREFLVEVLMLSLLHHPNLVNLIGYCAD--------G 103 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 103 (361)
+.|+-...||+|.||.||+|+.+.+|+.|++|++--.+.. . -....+|+.+|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 5577778999999999999999999999999876322111 1 1345679999999999999999887743 2
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
..+|+||.+|+ .+|.-++.+ ....++..++..++.++..||.|+|++. |+|||+||.|+||+.+|.++|+|||
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 45799999997 788888765 2367999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCc--ceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh----
Q 018100 184 LAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR---- 256 (361)
Q Consensus 184 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---- 256 (361)
+++.+...... ...+..+.|.+|++||.+.|. .++++.|||+.||++.+|++|.+.|.+........++...-
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99764333222 223345679999999988774 68999999999999999999999998766554443332211
Q ss_pred -hhhcccccccc---ccCccccC---CCChHH------HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 257 -PLFQDRTRHSL---IADPELQG---QYPPRG------FYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 257 -~~~~~~~~~~~---~~~~~~~~---~~~~~~------~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
..+........ +..+.+.. ..-.+. -.+..+|+.++|..||.+|+++.+++..--+...
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 11111111110 00000000 000111 1267789999999999999999999976554443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=250.19 Aligned_cols=239 Identities=31% Similarity=0.387 Sum_probs=193.5
Q ss_pred CceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcc
Q 018100 46 GFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 124 (361)
Q Consensus 46 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 124 (361)
+||.||+|.+..++..+++|++....... .+.+.+|+..++.++|+|++++++.+......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997665544 67899999999999999999999999998999999999998899999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCc
Q 018100 125 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204 (361)
Q Consensus 125 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~ 204 (361)
...++...++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 334899999999999999999999999 9999999999999999999999999987633321 223345788
Q ss_pred CcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHH
Q 018100 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 284 (361)
Q Consensus 205 ~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (361)
.|++||.+.+..++.++||||||+++|+|++|..||........ ........... . .......+..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~~~~~~-----------~-~~~~~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKKIGKPKPP-----------F-PPPEWKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHhccCCC-----------C-ccccccCCHH
Confidence 89999999888889999999999999999999999976321111 11111000000 0 0000003347
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 018100 285 ALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 285 l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=271.47 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=212.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
...++..+..||-|+||.|=++..+.....+|+|.+++. .....+.+..|-.+|...+.|.|+++|..|.++...|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 356778889999999999999998876666888888654 33445678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
+||-|-||.|+..+.. .+.++......++..+++|++|||++| |++|||||+|.+++.+|-+||.|||+++..
T Consensus 498 LmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999987 778999999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. ....-..+||+.|.|||++.+...+.++|.||||+++|||++|.+||....+....+++......
T Consensus 571 ~~---g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------- 637 (732)
T KOG0614|consen 571 GS---GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------- 637 (732)
T ss_pred cc---CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence 33 22334568999999999999999999999999999999999999999988776555444322111
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
..+|........+||++++..+|.+|.- +.+|-.
T Consensus 638 ------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 638 ------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 2334555667888999999999999965 555544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=240.86 Aligned_cols=274 Identities=17% Similarity=0.261 Sum_probs=203.7
Q ss_pred cCcceeHHHHHH---HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccce
Q 018100 20 TAQTLTFRELAA---ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVN 95 (361)
Q Consensus 20 ~~~~~~~~~~~~---~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~ 95 (361)
..+.+.++.... ..++|++.+.+|+|.++.||.|....+++.++||++.+. ..+.+.+|+.+|.+|. ||||++
T Consensus 21 p~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 21 PREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred chhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeee
Confidence 334445554332 257899999999999999999999999999999998643 4467899999999997 999999
Q ss_pred eeeEEEc--CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC
Q 018100 96 LIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 173 (361)
Q Consensus 96 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~ 173 (361)
++++..+ .....+|+||++..+...+... ++..++..++.++++||.|||++| |+|||+||.|+||+.
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDH 167 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeech
Confidence 9999865 4567899999998888887754 889999999999999999999999 999999999999996
Q ss_pred C-CceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHH-Hhhh
Q 018100 174 G-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA-AEQS 250 (361)
Q Consensus 174 ~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~-~~~~ 250 (361)
. ..++|+|+|++..+..+... ...+.+..|-.||.+-+ ..|+.+-|+|||||++..|+..+.||-..... +...
T Consensus 168 ~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 168 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred hhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 5 56999999999875443322 23456788999998865 46889999999999999999999998543322 2211
Q ss_pred HHHhhh---hhhccccccccccCccccC----------------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 251 LVAWAR---PLFQDRTRHSLIADPELQG----------------QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 251 ~~~~~~---~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+..+- ....-..+.....+|.+.. +-..-...++++++.++|..|-++|+|+.|....
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111100 0000000011111111110 0001123578899999999999999999998863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=278.30 Aligned_cols=266 Identities=27% Similarity=0.418 Sum_probs=208.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECC-------CCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYC 100 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 100 (361)
+...++..+.+.||+|.||.|++|.... ....||||.+..... .+.+.+..|+.+|+.+ .|+||+.+++.+
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 4444555677799999999999997542 146799999875433 3557899999999998 599999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHhcccC---C-C------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 101 ADGDQRLLVYEYMPLGSVEDHLHDLS---P-G------K--KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 101 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~-~------~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
......++|.||+..|+|.+++.... . . . ..++..+.+.++.||+.|++||++.. ++||||...|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99899999999999999999997633 0 0 0 13999999999999999999999999 9999999999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeecc-ccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHH
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV-MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 246 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~ 246 (361)
||+.++..+|++|||+++.............. .-...|||||.+....++.++||||+|+++|||++ |..|+.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999853333322211111 12445999999999999999999999999999999 88999763211
Q ss_pred HhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 247 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
... ..+. ....+...|..+..++.++++.||+.+|++||++.++.+.++...
T Consensus 529 ~~l--~~~l--------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EEL--LEFL--------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH--HHHH--------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 1111 111222334455668889999999999999999999999998743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=275.35 Aligned_cols=268 Identities=19% Similarity=0.197 Sum_probs=171.5
Q ss_pred HhhCcccCCeecccCceEEEEEEECCC----CeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeE------EE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESI----NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY------CA 101 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 101 (361)
..++|.+.+.||+|+||.||+|.+..+ +..|++|.+...... +....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999999999999999988 899999987543221 211111 1111222222211111 24
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSP----------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 165 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~ 165 (361)
.+...++|++|+.+++|.+++..... .........+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999998864210 0011223456789999999999999999 9999999
Q ss_pred CCcEEEcC-CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccC----------------------CCCccCc
Q 018100 166 CSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG----------------------QLTLKSD 222 (361)
Q Consensus 166 p~Nilv~~-~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sD 222 (361)
|+|||++. ++.+||+|||++........ .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999975322221 222345688999999976322 2345679
Q ss_pred eehhhHHHHHHhhCCCccccchHHHhhhHHHhhh--hhhccccccccccCccccC--CCChHHHHHHHHHHHHcccCCCC
Q 018100 223 VYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR--PLFQDRTRHSLIADPELQG--QYPPRGFYQALAVAAMCVHEQPD 298 (361)
Q Consensus 223 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~ 298 (361)
||||||++|+|+++..+++.....-...+..... ..+...... ...+.... ...........+||.+||+.||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP--RASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc--ccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999777654322111110000000 000000000 00000000 00011122455899999999999
Q ss_pred CCCCHHHHHHH
Q 018100 299 MRPVIADVVTA 309 (361)
Q Consensus 299 ~Rps~~~ll~~ 309 (361)
+|||+.++++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=265.38 Aligned_cols=205 Identities=28% Similarity=0.316 Sum_probs=176.6
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.-|..++.||-|+||.|.++...++...+|+|.+.+.+...+ ...+.|-.+|.....+-||+++-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 447788999999999999999999999999999876544332 34677999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
+|++||++-.++-. .+-+.+..+..++.++.+|+++.|..| ++||||||+|||||.+|.|||.|||+|+-+..
T Consensus 709 dYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999998876 567999999999999999999999999 99999999999999999999999999854211
Q ss_pred ---------CCCcce-------------------------------eeccccCcCcCCchhhccCCCCccCceehhhHHH
Q 018100 191 ---------GDNTHV-------------------------------STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 230 (361)
Q Consensus 191 ---------~~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l 230 (361)
++.... .-..+||..|+|||++....++..+|+||.|++|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 100000 0114689999999999999999999999999999
Q ss_pred HHHhhCCCccccchH
Q 018100 231 LEILSGRKAVDTSKA 245 (361)
Q Consensus 231 ~~ll~g~~pf~~~~~ 245 (361)
|+|+.|+.||.....
T Consensus 862 ~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHhhCCCCccCCCC
Confidence 999999999965443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.26 Aligned_cols=132 Identities=23% Similarity=0.333 Sum_probs=115.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC--------CCccceeeeEEE----
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA---- 101 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 101 (361)
++|.+.++||.|.|++||+|-+.++.+.||+|+++.. ....+....||.+|++++ ..+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 8999999999999999999999999999999998543 344567788999998874 248999999985
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
++.+.|+|+|+. |.+|..+|.... ...++...+..|++||+.||.|||+..+ |+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 467899999998 799999997644 5679999999999999999999998865 9999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=257.34 Aligned_cols=280 Identities=21% Similarity=0.227 Sum_probs=214.3
Q ss_pred cCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC------Ccc
Q 018100 20 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH------PNL 93 (361)
Q Consensus 20 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i 93 (361)
.+-++.+.--+....+|.|....|+|-|++|..|.+...|..||||++..+.. -.+.=..|+++|+.|+. -|.
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 34455555566778999999999999999999999999999999999975533 23445679999999962 378
Q ss_pred ceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC
Q 018100 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 173 (361)
Q Consensus 94 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~ 173 (361)
+.++..|.+.+++|+|||-+ ..+|.+++..+-. +-.|....+..++.|++-||..|...| |+|.||||+||||++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 88999999999999999988 4899999987543 456889999999999999999999999 999999999999997
Q ss_pred C-CceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH
Q 018100 174 G-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252 (361)
Q Consensus 174 ~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 252 (361)
. ..+||||||.|....... .+....+..|.|||++.|..|+...|+||+||+||||.||...|++........+.
T Consensus 572 ~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred CcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 6 458999999987532222 23334567799999999999999999999999999999999999887765554332
Q ss_pred Hhhh---------------hhhcccccccc----------------ccCc------cc--cCCCC---hHHHHHHHHHHH
Q 018100 253 AWAR---------------PLFQDRTRHSL----------------IADP------EL--QGQYP---PRGFYQALAVAA 290 (361)
Q Consensus 253 ~~~~---------------~~~~~~~~~~~----------------~~~~------~~--~~~~~---~~~~~~l~~li~ 290 (361)
--.. +.|....+... ...| .+ ...++ +.....+.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 2111 11111110000 0011 00 00122 234566788999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 018100 291 MCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 291 ~~l~~dP~~Rps~~~ll~~ 309 (361)
+||..||++|.+..+.|..
T Consensus 728 kml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHhccChhhcCCHHHHhcC
Confidence 9999999999999998853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=243.08 Aligned_cols=267 Identities=21% Similarity=0.322 Sum_probs=200.4
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcC-----CeeE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 107 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 107 (361)
+.+-.+.||-|+||.||.+.+..+|+.|++|++... +....+.+.+|+.+|.-++|.|++..+++..-. ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345568999999999999999999999999998542 233456789999999999999999988876432 2456
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++.|.+. .+|...+.. ...++.+.+..+++||++||.|||+.+ |.||||||.|.+|+.+..+||||||+++.
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 7778774 777777766 788999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh--hhhhc----
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA--RPLFQ---- 260 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~---- 260 (361)
-.... ....+.-+.|..|+|||++.|. .|+.+.||||.||++.||+..+..|..-......+++.-. .+...
T Consensus 206 ee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 33222 2223445678899999999875 6899999999999999999999888665544443332111 00000
Q ss_pred --cccccccccC----cc----ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 261 --DRTRHSLIAD----PE----LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 261 --~~~~~~~~~~----~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
+..+.+.+.. |. .....+.....+...++.++|..||++|.+.++.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0011111111 11 11122334455677789999999999999999888654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=243.53 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=215.1
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEE
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYC 100 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 100 (361)
+++..-..+++...++-+|.||.||.|.|... .+.|.+|.+... +..+...+..|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 34445567788889999999999999987643 344667766433 333456688899999999999999999987
Q ss_pred E-cCCeeEEEEEecCCCCHHHHhcc----cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC
Q 018100 101 A-DGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175 (361)
Q Consensus 101 ~-~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~ 175 (361)
. +....++++++...|+|..++.. -.+....++..+...++.|++.|++|||+++ ++|.||...|++|++.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 4 55677899999999999999972 1112356788899999999999999999999 99999999999999999
Q ss_pred ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHh
Q 018100 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 254 (361)
.+||+|=.+++.....++......-.....||+||.+.+..|+.++|+||||+++|||++ |+.|+..-+..+.....
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-- 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-- 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--
Confidence 999999999987655555554444456778999999999999999999999999999999 99998765443322111
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
....+...|-+++.+++.++.-||+.+|++||++++++.-|..+..+
T Consensus 512 ---------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 ---------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ---------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 11222344556777999999999999999999999999998877654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=226.51 Aligned_cols=211 Identities=24% Similarity=0.315 Sum_probs=176.5
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCee
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 106 (361)
++....+..-+..||+|++|.|-+.++..+|...|+|.+...-. .....+.+|+.+...- .+|+++.+++.+..+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44455666677899999999999999999999999999865433 3345677788877655 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++.||.++ .+|..+.......++.+++.-+=+++..+..||.|||++-. ++|||+||+|||++.+|.+|+||||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 99999996 89998887766668899999999999999999999999865 9999999999999999999999999986
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhc----cCCCCccCceehhhHHHHHHhhCCCccccchH
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAK----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 245 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 245 (361)
... ..-..+...|-..|+|||.+. +..|+-++||||||+++.||.+++.|++.+..
T Consensus 198 ~L~---dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLV---DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eeh---hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 421 112223345778899999874 34799999999999999999999999976544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=266.15 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=187.1
Q ss_pred cccCCeecccCce-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEEec
Q 018100 36 FRSESLLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 36 y~~~~~lg~G~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
|.-.+.+|.|+.| .||+|... |+.||||.+-... ..-..+|+..|+.- .||||+++++.=.+.+..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 3344678898876 68899987 7899999875332 23467899999887 5999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---C--CceeEecccccccC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---G--YHPKLSDFGLAKLG 188 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~--~~~~L~Dfg~~~~~ 188 (361)
. .+|.+++...............+.++.|+++||++||+.+ ||||||||+||||+. + ..++|+|||+|+..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 9999999872111111222566889999999999999999 999999999999976 2 46899999999885
Q ss_pred CCCCCcce-eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..+..... .....||..|+|||++....-+.++|||||||++|+.++ |.+||..........+.. .
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-~----------- 729 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-N----------- 729 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-c-----------
Confidence 55443322 344679999999999998888889999999999999999 589997653322211110 0
Q ss_pred cccCccccC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 018100 267 LIADPELQG-QYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 307 (361)
Q Consensus 267 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 307 (361)
..+.. ...+++ +..+||.+|+..+|..||++.+|+
T Consensus 730 ----~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 730 ----YTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ----cceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 00000 011111 778899999999999999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-31 Score=253.13 Aligned_cols=268 Identities=19% Similarity=0.215 Sum_probs=178.6
Q ss_pred HhhCcccCCeecccCceEEEEEEEC----------------CCCeEEEEEEeccCCccchHH--------------HHHH
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLE----------------SINQDVAIKQLDRNGVQGNRE--------------FLVE 81 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~----------------~~~~~v~iK~~~~~~~~~~~~--------------~~~e 81 (361)
..++|++.+.||+|+||.||+|... ..+..|+||.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999752 235679999986433222222 3346
Q ss_pred HHHHhcCCCCcc-----ceeeeEEEc--------CCeeEEEEEecCCCCHHHHhcccCC--------------------C
Q 018100 82 VLMLSLLHHPNL-----VNLIGYCAD--------GDQRLLVYEYMPLGSVEDHLHDLSP--------------------G 128 (361)
Q Consensus 82 ~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~ 128 (361)
+.++.+++|.++ +.+++++.. ....++|+||+.+++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766544 455666532 3567999999999999998864210 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCC
Q 018100 129 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208 (361)
Q Consensus 129 ~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 208 (361)
...+++..++.++.|++.+|.|||+++ ++||||||+||+++.++.++|+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123467788999999999999999999 999999999999999999999999998643222111 1111234788999
Q ss_pred chhhccCC----------------------CCccCceehhhHHHHHHhhCCC-ccccchHHHhhh-HHHhhhhhhccccc
Q 018100 209 PEYAKTGQ----------------------LTLKSDVYSFGVVLLEILSGRK-AVDTSKAAAEQS-LVAWARPLFQDRTR 264 (361)
Q Consensus 209 PE~~~~~~----------------------~~~~sDiwslG~~l~~ll~g~~-pf~~~~~~~~~~-~~~~~~~~~~~~~~ 264 (361)
||.+.... ...+.|+||+||++|+|++|.. ||.......... ........+.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875322 1134799999999999999875 665322111100 00000000000000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQP---DMRPVIADVVTA 309 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~~ll~~ 309 (361)
....-...+.......+|+.+||..+| .+|+|+.++++.
T Consensus 459 ------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 ------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000001122334578889999999866 689999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=226.07 Aligned_cols=211 Identities=36% Similarity=0.546 Sum_probs=183.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHH
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 120 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 120 (361)
||+|.+|.||++....++..+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998755432 34678899999999999999999999999899999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEecccccccCCCCCCcceeec
Q 018100 121 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTR 199 (361)
Q Consensus 121 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~~~~~~~~~~~~~~~ 199 (361)
++.... ..++...++.++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 987621 46899999999999999999999999 999999999999999 89999999999875333221 1223
Q ss_pred cccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCC
Q 018100 200 VMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP 278 (361)
Q Consensus 200 ~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (361)
..+...|++||.+... ..+.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577889999999776 888999999999999999
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 279 PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..+.+++..|++.||++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 266779999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=235.87 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=201.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcC------C
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------D 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 104 (361)
..+|.-++.+|.|.- .|..|.+...++.|++|++... +....+...+|..++..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 368889999999998 7778888888999999998654 223346678899999999999999999998544 3
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..|+|||+++ .+|...+.. .++-..+..++.|+++|+.+||+.| |+||||||+||++..++.+|+.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 4589999996 888888762 3777889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hh---------
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AW--------- 254 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~--------- 254 (361)
+.. ....-..+..+.+..|.|||++.+..+.+.+||||+||++.||++|+..|.+....+....+ ..
T Consensus 165 ar~---e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 165 ART---EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hcc---cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 985 22224556678899999999999988999999999999999999999999765433222111 00
Q ss_pred ------hhhhhcc------ccccccccCccccC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 255 ------ARPLFQD------RTRHSLIADPELQG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 255 ------~~~~~~~------~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+.-+... ......+.|..+.. +.++.....+.+++.+||-.||++|.++.++|..
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000 00111111111111 1112334567889999999999999999999964
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=224.74 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=189.6
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeE-EEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGY-CADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~l 108 (361)
.+.+.|.|.+.||+|.||.+-++.+++++..+++|.+.... ...+.|.+|..---.|. |.||+..+++ |.+.+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 45688999999999999999999999999999999987653 34577888987766664 8999988875 466677789
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc--CCCceeEecccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAK 186 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~--~~~~~~L~Dfg~~~ 186 (361)
++||++.|+|.+.+.. ..+-+.....++.|+++||.|+|+++ +||||||.+||||- +.-++||||||..+
T Consensus 100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999998875 56889999999999999999999999 99999999999994 33479999999987
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhcc---C--CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKT---G--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
..+. . -....-...|.+||.... . ...+.+|+|.||+++|..++|..||.... ........|.. +..
T Consensus 172 k~g~--t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~--w~~ 243 (378)
T KOG1345|consen 172 KVGT--T---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQ--WLK 243 (378)
T ss_pred ccCc--e---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHH--Hhc
Confidence 5211 1 111223567999997632 2 35688999999999999999999997322 22222222221 111
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 307 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 307 (361)
. .....|.....+.+ .+..+.++-|..+|++|-.+.+..
T Consensus 244 r---k~~~~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 244 R---KNPALPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred c---cCccCchhhcccCH----HHHHHHHHhcCCcccccchhHHHH
Confidence 1 11122333333433 567799999999999994444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=250.01 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=171.3
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccch--------HHHHHHHHHHhcCC---CCccceeeeE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--------REFLVEVLMLSLLH---HPNLVNLIGY 99 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--------~~~~~e~~~l~~l~---h~~i~~~~~~ 99 (361)
....+|...+.+|+|+||.|++|.++.+...|+||.+.+...-.- -.+-.|+.+|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 345679999999999999999999999999999999865422110 11345999999987 9999999999
Q ss_pred EEcCCeeEEEEEec-CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 100 CADGDQRLLVYEYM-PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 100 ~~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
|++++.+||++|.- +|.+|.+++.. ++.+++.++..|+.|++.|+++||++| |||||||-+||.++.+|-+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence 99999999999864 56789999987 788999999999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhccCCCC-ccCceehhhHHHHHHhhCCCcc
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAV 240 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf 240 (361)
|+|||.+.....+. ....+||..|.|||++.|..|- ..-|||+||++||.++....||
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99999886532222 2345799999999999988764 6789999999999999988886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=253.83 Aligned_cols=254 Identities=23% Similarity=0.289 Sum_probs=207.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
..+|+++..+|.|++|.||+++++.+++..++|+++....++..-+..|+-+++..+||||+.+++.+-....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46899999999999999999999999999999999887777778888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
|.||+|.+..+. .+++++.++..+++..++++.|||+.| =+|||||-.||++++.|.+||.|||.+-.. ..
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi--ta 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI--TA 164 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh--hh
Confidence 999999998887 789999999999999999999999999 899999999999999999999999987541 22
Q ss_pred CcceeeccccCcCcCCchhh---ccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.-.......||+.|||||+. +...|...+|||++|++..|+---++|-..........+... .. .
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----------S~-~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----------SG-F 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----------cC-C
Confidence 22233456899999999976 456799999999999999999877776433322211111110 00 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
+|.... -.......+.++++.||.++|++||+++.+++
T Consensus 233 qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111111 11233446778999999999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=222.36 Aligned_cols=199 Identities=35% Similarity=0.453 Sum_probs=174.1
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecC
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 114 (361)
|.+.+.||.|++|.||+|.+..++..+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67789999999999999999988999999999866554 56788899999999999999999999999899999999999
Q ss_pred CCCHHHHhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 115 LGSVEDHLHDLSPGKKP-LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+++|.+++.. ... +++..++.++.+++.++.+||+++ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 8899999976 233 899999999999999999999999 99999999999999999999999998876433321
Q ss_pred cceeeccccCcCcCCchhh-ccCCCCccCceehhhHHHHHHhhCCCcccc
Q 018100 194 THVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAVDT 242 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~~l~~ll~g~~pf~~ 242 (361)
.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112234567789999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=228.92 Aligned_cols=202 Identities=29% Similarity=0.367 Sum_probs=171.0
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECC---CCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCe
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 105 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 105 (361)
....+.|.+++.||+|.|++||++.... .++.|++|.+...+.. ..+.+|+++|..+. +.||+++.+.+..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3456789999999999999999999877 6889999998765544 45889999999995 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEecccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGL 184 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~ 184 (361)
..+|+||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||+||+.+. .+.-.|+|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999999876 778999999999999999999999 999999999999985 57889999999
Q ss_pred cccCCC-------------------CC-----------------------CcceeeccccCcCcCCchhhcc-CCCCccC
Q 018100 185 AKLGPV-------------------GD-----------------------NTHVSTRVMGTYGYCAPEYAKT-GQLTLKS 221 (361)
Q Consensus 185 ~~~~~~-------------------~~-----------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~s 221 (361)
+..... +. .........||++|+|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 862000 00 0001123568999999998854 5788999
Q ss_pred ceehhhHHHHHHhhCCCccccc
Q 018100 222 DVYSFGVVLLEILSGRKAVDTS 243 (361)
Q Consensus 222 DiwslG~~l~~ll~g~~pf~~~ 243 (361)
||||.|+++..+++++.||-..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeeccceeehhhccccccccC
Confidence 9999999999999999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-26 Score=208.60 Aligned_cols=263 Identities=21% Similarity=0.194 Sum_probs=197.5
Q ss_pred CcccCCeecccCceEEEEEEECCCC-eEEEEEEeccCCccchHHHHHHHHHHhcCC----CCccceeeeEE-EcCCeeEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREFLVEVLMLSLLH----HPNLVNLIGYC-ADGDQRLL 108 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 108 (361)
+|.+.+.||+|+||.||.|.+..++ ..+|+|............+..|..++..+. .+++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998764 678888876543333336778888888886 36889999998 57788999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-----CceeEeccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-----YHPKLSDFG 183 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-----~~~~L~Dfg 183 (361)
||+.+ |.+|.++..... ...++..+++.++.|++.+|.+||+.| ++||||||+|+++... ..++|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 899999886533 578999999999999999999999999 9999999999999865 469999999
Q ss_pred ccc--cCCCCCCc----c-e-eeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 184 LAK--LGPVGDNT----H-V-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 184 ~~~--~~~~~~~~----~-~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
+++ ........ . . .....||..|+++....+...+.+.|+||+++++.+++.|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 32222111 1 1 22356999999999999999999999999999999999999999655432221111100
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.. .... .. .....+..+.++...+-..+...+|....+...+......
T Consensus 253 ~~-------~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PR-------KLLT-DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hh-------hhcc-cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00 0000 00 1111223444455555558899999999999988766554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=244.75 Aligned_cols=196 Identities=17% Similarity=0.258 Sum_probs=135.4
Q ss_pred cCCC-CccceeeeEE-------EcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018100 87 LLHH-PNLVNLIGYC-------ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158 (361)
Q Consensus 87 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 158 (361)
.++| +||..+++++ .+....++++|++ +++|.+++.. ....+++..++.++.||++||.|||++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3445 5666666766 2233566778887 5899999964 1356999999999999999999999999
Q ss_pred eeecCCCCCcEEEcCCCce-------------------eEecccccccCCCCCC--------------cceeeccccCcC
Q 018100 159 VIYRDLKCSNILLDRGYHP-------------------KLSDFGLAKLGPVGDN--------------THVSTRVMGTYG 205 (361)
Q Consensus 159 i~H~dl~p~Nilv~~~~~~-------------------~L~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~ 205 (361)
|+||||||+||||+..+.+ |++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999665554 4555555432100000 000111357888
Q ss_pred cCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHH
Q 018100 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 285 (361)
Q Consensus 206 y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (361)
|+|||++.+..++.++|||||||+||||++|..|+........ .+. ... ..+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~-~~~---~~~----------~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS-SLR---HRV----------LPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH-HHH---Hhh----------cChhh-----hhcCHHH
Confidence 9999999999999999999999999999999888753221100 000 000 00000 0112245
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 018100 286 LAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 286 ~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..++.+||+.+|.+||++.++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=195.39 Aligned_cols=169 Identities=22% Similarity=0.212 Sum_probs=125.9
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
|+|.+++.. .+..+++..++.++.||+.||.|||+++ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 688888875 1356999999999999999999999886 999999999999999 9988753221
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
...|+..|+|||++.+..++.++|||||||++|+|++|..||......... +.......... .+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~--------~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMPAD--------DPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhccC--------Cccc-c
Confidence 125789999999999999999999999999999999999999654321111 11111110000 0000 0
Q ss_pred CCChHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 276 QYPPRGFY--QALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 276 ~~~~~~~~--~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
..+..... .+.+++.+||..||.+||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 01112222 58899999999999999999999998876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=204.51 Aligned_cols=183 Identities=17% Similarity=0.138 Sum_probs=137.1
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEEECC-CCeEEEEEEeccCC-----ccchHHHHHHHHHHhcCCCCccceeee
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIG 98 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~ 98 (361)
+-..+.....+|++.+.||+|+||+||+|.++. ++..++||++.... ....+.+.+|+.+|+.++|+|++..+.
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 334566778999999999999999999999876 67778999865321 112456889999999999999985332
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCcEEEcCCCce
Q 018100 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHP 177 (361)
Q Consensus 99 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl-~p~Nilv~~~~~~ 177 (361)
. ....|+||||++|++|.. +.. .. ...++.|+++||.|||++| |+|||| ||+|||++.++.+
T Consensus 89 ~---~~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 89 A---TGKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred E---cCCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence 2 245799999999999963 211 11 1467899999999999999 999999 9999999999999
Q ss_pred eEecccccccCCCCCC-cce-----eeccccCcCcCCchhhccC------CCCccCcee
Q 018100 178 KLSDFGLAKLGPVGDN-THV-----STRVMGTYGYCAPEYAKTG------QLTLKSDVY 224 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~-~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~sDiw 224 (361)
+|+|||++........ ... -....++..|+|||.+... ..+..+|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999986433211 111 1234577889999988432 234456666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=184.52 Aligned_cols=260 Identities=21% Similarity=0.231 Sum_probs=195.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC-CccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 111 (361)
.+.|++++.||.|+||.+|+|....+|+.||||+-... .....+..|..+...|++ ..|..+..+..+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 57899999999999999999999999999999985433 333567789999998874 777788888888888999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecccccccC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLG 188 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Dfg~~~~~ 188 (361)
.. |.+|.++++-- ...++..+++-++-|++.-++|+|.++ ++||||||+|+|+.- ...+.|+|||++..+
T Consensus 92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 88 79999988641 246899999999999999999999999 999999999999964 467999999999874
Q ss_pred CCCCC-----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 189 PVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 189 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
..... ........||..|.+-....+...+.+.|+-|+|.++.++.-|..||.+..+....+....+...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----- 239 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----- 239 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-----
Confidence 33321 22234467899999888877778889999999999999999999999987766555444333211
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
........+...+|. +..-.+.-|-...=++-|+..-+.+.+.
T Consensus 240 -K~s~~ie~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 240 -KMSTPIEVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred -hcCCCHHHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 111111222333333 3444555555555555565554444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-26 Score=224.85 Aligned_cols=247 Identities=23% Similarity=0.216 Sum_probs=184.8
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHH---HHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+|...+.||.+.|=+|.+|++.. |. |+||++-+.. ....+.+.+ |++ ...+++||.+++.-+...+.-.|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78889999999999999999886 54 9999986554 233344443 444 45568999999988888888889999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC--
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-- 188 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~-- 188 (361)
+|+. -+|.+.+.. .+-+...+..+|+.||+.||..+|..| |||||||.+||||+.-+-+.|+||..-+..
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9985 889998876 677889999999999999999999999 999999999999999999999999865431
Q ss_pred CCC---CCcceeeccccCcCcCCchhhcc-----------CCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHH
Q 018100 189 PVG---DNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 253 (361)
Q Consensus 189 ~~~---~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~ 253 (361)
+.. +............+|+|||.+-. ...+++.||||+||++.||++ |++||.....-.....-.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA 252 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence 111 12222233445578999998733 126789999999999999999 899997653322211100
Q ss_pred hhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....-...+.| ..+++|+..|++.||.+|.++++.|+.
T Consensus 253 -----~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 -----DDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -----cCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000000001111 156779999999999999999999976
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=221.29 Aligned_cols=262 Identities=20% Similarity=0.236 Sum_probs=192.5
Q ss_pred ccCCeecccCceEEEEEEECCCCeEEEEEEecc---CCccch---HHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 37 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.-...+|.|++|.++.+........+..|.+.. ...... ..+..|+.+-..++|+|++..+..+.+....+..|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999888887766555566665431 111111 12555777777889999988877776665555669
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|||++ +|..++.. ...++..++-.++.|++.||.|+|+.| +.|||+||+|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 99999986 457999999999999999999999999 99999999999999999999999999987555
Q ss_pred CCCc--ceeeccccCcCcCCchhhccCCCCc-cCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 191 GDNT--HVSTRVMGTYGYCAPEYAKTGQLTL-KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 191 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... .......|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+......... .....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~------~~~~~ 546 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS------DQRNI 546 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc------ccccc
Confidence 4443 4455678999999999999988885 5899999999999999999997655433321000000 00000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHh
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT--ALAYLAS 315 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--~l~~l~~ 315 (361)
. .-........+.....+|.+||+.||.+|.++.+|++ .+..+..
T Consensus 547 ~---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 547 F---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred c---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 0 0000111123445667999999999999999999996 4444443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=184.70 Aligned_cols=208 Identities=25% Similarity=0.310 Sum_probs=176.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.-.|+|.+.||+|.||.++.|.+--+++.||||.-. ......++..|....+.|. .++|..++-+...+.+..+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 357999999999999999999999999999999743 3344567888999888885 7999999888888888899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-----CceeEecccccc
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-----YHPKLSDFGLAK 186 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-----~~~~L~Dfg~~~ 186 (361)
.. |.+|.+++.- . +..++..+++.++.|++.-++++|++. +|.|||||+|+||... ..|.++|||++.
T Consensus 105 LL-GPSLEDLFD~-C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL-C--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHH-h--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88 7899888753 1 467999999999999999999999999 9999999999999753 458999999998
Q ss_pred cCCCCCC-----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh
Q 018100 187 LGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249 (361)
Q Consensus 187 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~ 249 (361)
.+..... ........||..||+-....+...+.+.|+-|||-++++.|-|..||.+.......
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK 245 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK 245 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence 7544322 22334567999999999999999999999999999999999999999887654433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-23 Score=187.25 Aligned_cols=258 Identities=33% Similarity=0.435 Sum_probs=197.0
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCC-ccceeeeEEEcCCeeEEEEE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 111 (361)
|.+.+.||.|+|+.||.+.+. ..+++|.+...... ....+.+|+..+..+.|+ +++.+.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999987 67899998755443 256788999999999987 79999999977777899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~~~~~~ 190 (361)
++.++++.+++...... ..++...+..++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777651110 37999999999999999999999999 99999999999999998 799999999875333
Q ss_pred CCCcc----eeeccccCcCcCCchhhcc---CCCCccCceehhhHHHHHHhhCCCccccchHH----HhhhHHHhhhhhh
Q 018100 191 GDNTH----VSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA----AEQSLVAWARPLF 259 (361)
Q Consensus 191 ~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~ 259 (361)
..... ......++..|++||.+.+ .......|+|++|+++++++.|..||...... .......... .
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~ 232 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP--T 232 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC--C
Confidence 22211 2355679999999999987 57889999999999999999999998665431 1111111000 0
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000002223467789999999999999998877764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=190.93 Aligned_cols=236 Identities=18% Similarity=0.250 Sum_probs=154.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCC----------CccceeeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH----------PNLVNLIGYC 100 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~ 100 (361)
..+...+.||.|+++.||.+.+..+|+.+++|++..... ...+.+.+|......+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345667899999999999999999999999999854332 234567777766555332 2333333332
Q ss_pred E---------cC---C-----eeEEEEEecCCCCHHHHhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 018100 101 A---------DG---D-----QRLLVYEYMPLGSVEDHLHD---LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160 (361)
Q Consensus 101 ~---------~~---~-----~~~lv~e~~~~~~L~~~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 160 (361)
. .. . ..+++|+-+. ++|.+++.. .......+.....+.+..|+++.+++||+.| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 2 11 1 2367888884 888887643 2221223445556788899999999999999 99
Q ss_pred ecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc--------CCCCccCceehhhHHHHH
Q 018100 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--------GQLTLKSDVYSFGVVLLE 232 (361)
Q Consensus 161 H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~~l~~ 232 (361)
|+||+|+|++++.+|.++|+||+...... . ... ....+..|.|||.... ..++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g--~--~~~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAG--T--RYR-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETT--E--EEE-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecC--c--eee-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999999998776421 1 111 1334577999997633 257889999999999999
Q ss_pred HhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCC
Q 018100 233 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 300 (361)
Q Consensus 233 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 300 (361)
|++|..||+........ ......|. +.+..+..||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~---------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADP---------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTS---------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccc---------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999764322111 10233455 777889999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=180.77 Aligned_cols=172 Identities=12% Similarity=0.108 Sum_probs=133.0
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHH---------HHHHHHHHhcCCCCccceeeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---------FLVEVLMLSLLHHPNLVNLIGYCA 101 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~ 101 (361)
...++|++.+.||.|+||.||++.. ++..+++|++.......... +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4578999999999999999999655 36689999997554433322 678999999999999999988865
Q ss_pred cC--------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC
Q 018100 102 DG--------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 173 (361)
Q Consensus 102 ~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~ 173 (361)
.. ...+++|||++|.+|.++.. +++ ....+++.+|..||+.| ++|||++|+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 32 35789999999999988732 232 24669999999999999 999999999999999
Q ss_pred CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHh
Q 018100 174 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 234 (361)
Q Consensus 174 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll 234 (361)
+| ++|+|||........... ...+....+..++|+|+||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 98 999999987642111000 00233445667999999999987664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=182.48 Aligned_cols=250 Identities=21% Similarity=0.361 Sum_probs=193.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++..+..+|.+...|..|+|+|. |..+++|++.-. .....+.|..|.-.|+-+.||||+.+++.|.....+.++..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 44556778899999999999998 556778876533 23334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEe--cccccccCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS--DFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~--Dfg~~~~~~ 189 (361)
|++.|+|...++... +-..+..++.+++.++++|++|||+... -|---.|+...++||++...+|. |--++.
T Consensus 268 ~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee---
Confidence 999999999998732 3456888999999999999999999863 23334688899999998776553 222221
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCC---CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQL---TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
......-.+.|++||.++...- -.++|+|||++++|||.|...||......+-. -
T Consensus 342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------m 399 (448)
T KOG0195|consen 342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------M 399 (448)
T ss_pred ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------h
Confidence 1111234678999999976543 36799999999999999999999875443221 1
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
.+.-..++...|+.....+..|+.-|+..||.+||.+..++-.|+++
T Consensus 400 kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 400 KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 12233455566777788889999999999999999999999888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=171.10 Aligned_cols=139 Identities=15% Similarity=0.078 Sum_probs=107.9
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--c------------------------hHHHHHHHHHHhcCCCC
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--G------------------------NREFLVEVLMLSLLHHP 91 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ 91 (361)
+...||+|++|.||+|.+. +|+.||+|++...... . ......|+..+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 3568999999999999997 7999999998654221 1 01223489999999877
Q ss_pred ccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCcEE
Q 018100 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYRDLKCSNIL 170 (361)
Q Consensus 92 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~i~H~dl~p~Nil 170 (361)
++.....+... ..++||||++|+++...... ...++...+..++.|++.+|.++ |+.| ++||||||+||+
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 66433322222 23899999988766544322 35689999999999999999999 7999 999999999999
Q ss_pred EcCCCceeEeccccccc
Q 018100 171 LDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~~ 187 (361)
++ ++.++|+|||++..
T Consensus 151 i~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 151 YH-DGKLYIIDVSQSVE 166 (190)
T ss_pred EE-CCcEEEEEcccccc
Confidence 98 47899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=177.90 Aligned_cols=195 Identities=22% Similarity=0.197 Sum_probs=140.8
Q ss_pred CCCccceeeeEEEc---------------------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHH
Q 018100 89 HHPNLVNLIGYCAD---------------------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 141 (361)
Q Consensus 89 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~ 141 (361)
+||||+.+..+|.+ ...+|+||..++ .+|..++.. ...+......++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999998876643 256799999886 899999875 447777888999
Q ss_pred HHHHHHHHHHhcCCCCCeeecCCCCCcEEEc--CC--CceeEecccccccCCCC----CCcceeeccccCcCcCCchhhc
Q 018100 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RG--YHPKLSDFGLAKLGPVG----DNTHVSTRVMGTYGYCAPEYAK 213 (361)
Q Consensus 142 ~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~--~~--~~~~L~Dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~ 213 (361)
.|+++|+.|||.+| +.|||+|.+|||+. ++ ..++++|||+|...... ..........|.-.-+|||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999993 33 35899999998652221 1122223456788899999985
Q ss_pred cCC------CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHH
Q 018100 214 TGQ------LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 287 (361)
Q Consensus 214 ~~~------~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (361)
... --.++|.|+.|.+.||+++...||-.....-. +.. ......-|.+ +..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r-----------~Yqe~qLPal----p~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTR-----------TYQESQLPAL----PSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chh-----------hhhhhhCCCC----cccCChHHHH
Confidence 421 12689999999999999999999854211100 000 0111112223 3444558889
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 018100 288 VAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 288 li~~~l~~dP~~Rps~~~ll~ 308 (361)
++..+|+.||.+|+++.-...
T Consensus 489 lV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHHHHhcCCccccCCccHHHh
Confidence 999999999999998654443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=165.07 Aligned_cols=139 Identities=16% Similarity=0.099 Sum_probs=110.2
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--------------------------hHHHHHHHHHHhcCCCC
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------------------------NREFLVEVLMLSLLHHP 91 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ 91 (361)
+...||+|++|.||+|.+. +|+.||||++....... ...+..|+..+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4578999999999999987 79999999987542210 11235788999999888
Q ss_pred ccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEE
Q 018100 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNIL 170 (361)
Q Consensus 92 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nil 170 (361)
++.....+... ..++||||++|+++...... ...++...+..++.|++.++.++|+ +| ++|+||||+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 87544443332 24899999988755433222 3457889999999999999999999 99 999999999999
Q ss_pred EcCCCceeEeccccccc
Q 018100 171 LDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~~ 187 (361)
++ ++.++|+|||++..
T Consensus 151 l~-~~~~~liDFG~a~~ 166 (190)
T cd05145 151 YH-DGKPYIIDVSQAVE 166 (190)
T ss_pred EE-CCCEEEEEccccee
Confidence 99 88999999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=192.88 Aligned_cols=201 Identities=23% Similarity=0.269 Sum_probs=160.1
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC---CCccceeeeEEEcC
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADG 103 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 103 (361)
.+++...+.|.|.+.||+|+||+||.|.... |+.||+|+-.....-+ |.--.+++.+|+ -+.|+.+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3456668899999999999999999999988 9999999876554432 111233444444 23455555555566
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-------CCc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------GYH 176 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-------~~~ 176 (361)
+..++|++|.+.|+|.++++. .+.+++..+..+..|++..|+.||..+ ||||||||+|+|+.. +-.
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 778899999999999999985 678999999999999999999999999 999999999999942 345
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCC
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 238 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~ 238 (361)
++|+|||.+..+..-.........+.|..+-=+|...|..++..+|.|+|+.+++-||.|.+
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999998864322222233344567888889999999999999999999999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=157.62 Aligned_cols=185 Identities=19% Similarity=0.140 Sum_probs=137.5
Q ss_pred ccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccch----HHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEEEE
Q 018100 37 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.+...|++|+||+|+++.. .+.+++.+.+........ ..+.+|+.+|++|. ++++..++++ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4677899999999997766 478888888765543211 24788999999995 5788888886 34689999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCcEEEcCCCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl-~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|+.|.+|...... ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999888654321 11357889999999999999 999999 79999999999999999999985332
Q ss_pred CCCcc---e--------eeccccCcCcCCchhhccC-CCC-ccCceehhhHHHHHHhhCCCccc
Q 018100 191 GDNTH---V--------STRVMGTYGYCAPEYAKTG-QLT-LKSDVYSFGVVLLEILSGRKAVD 241 (361)
Q Consensus 191 ~~~~~---~--------~~~~~~~~~y~aPE~~~~~-~~~-~~sDiwslG~~l~~ll~g~~pf~ 241 (361)
..... . ......++.|+.|+...-. ..+ ...++++.|+.+|.++|+..++-
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 21100 0 0112246677788754322 333 56788899999999999988763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-22 Score=185.21 Aligned_cols=225 Identities=26% Similarity=0.327 Sum_probs=177.9
Q ss_pred ecccCceEEEEEEE---CCCCeEEEEEEeccCCccch--HHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEEEEecCC
Q 018100 42 LGEGGFGRVYKGYL---ESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 42 lg~G~~g~v~~~~~---~~~~~~v~iK~~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+|+|+||.|+++.. ...+..+++|+......... .....|-.++...+ ||.++.+.-.+..+...+++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999997653 33477788888765433221 13455777787776 99999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
|.|...+.. ...+++.....+...++-|++++|..+ ++|+|+|++||+++.+|.+++.|||+++..-...
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999887765 567888899999999999999999999 9999999999999999999999999987421111
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 275 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (361)
..+|+..|||||++. ....++|.||+|+++|+|++|..||.... ...+ +....
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----~~~I------------------l~~~~ 204 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----MKRI------------------LKAEL 204 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----HHHH------------------hhhcc
Confidence 117899999999997 56788999999999999999999998710 0000 11112
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 276 QYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
..|......+.+++..++..+|..|.-.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3344555677789999999999999644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=157.48 Aligned_cols=137 Identities=20% Similarity=0.245 Sum_probs=108.7
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-----CCCccceeeeEEEcCC---eeE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HHPNLVNLIGYCADGD---QRL 107 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~ 107 (361)
+.-.+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999995 6666655 69998765444567799999999999 5799999999998864 323
Q ss_pred -EEEEe--cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCcEEEcC----CCceeE
Q 018100 108 -LVYEY--MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL-EYLHDKAKPPVIYRDLKCSNILLDR----GYHPKL 179 (361)
Q Consensus 108 -lv~e~--~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~i~H~dl~p~Nilv~~----~~~~~L 179 (361)
+|+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 557899999965 235555 35677888777 9999999 999999999999974 347999
Q ss_pred eccccc
Q 018100 180 SDFGLA 185 (361)
Q Consensus 180 ~Dfg~~ 185 (361)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=174.86 Aligned_cols=218 Identities=28% Similarity=0.424 Sum_probs=163.6
Q ss_pred HhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eecC
Q 018100 85 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV-IYRD 163 (361)
Q Consensus 85 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i-~H~d 163 (361)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ....+++.....++.+|+.||.|||+.. + +||.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4678999999999999999999999999999999999976 3467899999999999999999999886 5 9999
Q ss_pred CCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccC-------CCCccCceehhhHHHHHHhhC
Q 018100 164 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-------QLTLKSDVYSFGVVLLEILSG 236 (361)
Q Consensus 164 l~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~sDiwslG~~l~~ll~g 236 (361)
++..|++++....+||.|||+.................-...|.|||.+.+. ..+.+.|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998764321111112222345679999998663 256789999999999999999
Q ss_pred CCccccchHHHh-hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 237 RKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 237 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
..||+....... ..++..+.. . ......|.+...- .....+..++.+||..+|.+||++..+-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~----~--~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK----G--GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh----c--CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999976443222 222222211 0 0000111111000 122268889999999999999999999988876665
Q ss_pred c
Q 018100 316 Q 316 (361)
Q Consensus 316 ~ 316 (361)
.
T Consensus 227 ~ 227 (484)
T KOG1023|consen 227 G 227 (484)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=190.34 Aligned_cols=212 Identities=25% Similarity=0.343 Sum_probs=150.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
....+|..+++|..|++|.||+++|+.+.+.+++| +++.+...+ + ++.....|.++
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR----n---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR----N---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh----c---cccccCCccee----------------
Confidence 34578999999999999999999999999999995 443322111 1 22222333333
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|+-..++.. -++++... +.+++|||+.+ |+|+|+||+|.+|+.-|.+|+.|||+......
T Consensus 136 -----gDc~tllk~----~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKN----IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhccc----CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 444445544 34455444 78999999999 99999999999999999999999998765222
Q ss_pred CCC-------------cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh
Q 018100 191 GDN-------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 191 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
... .....+.+||+.|+|||++....|...+|+|++|+++|+.+.|+.||.+...+.....+-....
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 111 1112446899999999999999999999999999999999999999987754433221110000
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 301 (361)
.+ ++- ....+.++.+++.++|+.+|..|.
T Consensus 276 ~w-----------pE~----dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EW-----------PEE----DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cc-----------ccc----CcCCCHHHHHHHHHHHHhChHhhc
Confidence 01 111 122234888899999999999995
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=157.30 Aligned_cols=144 Identities=13% Similarity=0.102 Sum_probs=112.4
Q ss_pred hhCcccCCeecccCceEEEEEE-ECCCCeEEEEEEeccCCcc------------------------chHHHHHHHHHHhc
Q 018100 33 TKNFRSESLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQ------------------------GNREFLVEVLMLSL 87 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~-~~~~~~~v~iK~~~~~~~~------------------------~~~~~~~e~~~l~~ 87 (361)
..-|.+.+.||+|++|.||+|. +..+|..|++|++...... ....+..|+..+..
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3359999999999999999998 6677999999998754211 01235679999999
Q ss_pred CCCCc--cceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 018100 88 LHHPN--LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 165 (361)
Q Consensus 88 l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~ 165 (361)
+.+.. +..+++. . ..++||||++|.+|..+... ...+....+..++.||+.+|.+||++|. ++|+|||
T Consensus 107 L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 87532 3333332 2 35899999998887665432 3456677788999999999999998875 9999999
Q ss_pred CCcEEEcCCCceeEeccccccc
Q 018100 166 CSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 166 p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
|+||+++ ++.++|+|||.+..
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhc
Confidence 9999999 88999999998863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=149.91 Aligned_cols=134 Identities=22% Similarity=0.315 Sum_probs=112.2
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCccc--------hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|+.++..+.|+++.....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 47789999865432211 1347789999999999988777777767778899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
|++|++|.+++.. .. . ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865 11 1 78899999999999999999 99999999999999 78999999998763
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-20 Score=168.35 Aligned_cols=174 Identities=25% Similarity=0.363 Sum_probs=129.9
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
.+||.|++|...+|.+|+.... .....+....+.++.|++.|++| ++ .+|+|+||.||++..+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997433 24567888999999999999999 88 99999999999999999999999999
Q ss_pred cccCCCCC----CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhh
Q 018100 185 AKLGPVGD----NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 185 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
........ .....+...||..||+||++.+..|+.++||||||++++||+. -.-+|.......+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d----------- 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD----------- 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh-----------
Confidence 87543332 2334556789999999999999999999999999999999997 2333322111100
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 305 (361)
.......|.+..++| .-..|+.+++...|.+||++.+
T Consensus 472 ----~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 472 ----IRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ----hhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 011111222222222 2345999999999999994433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-18 Score=144.51 Aligned_cols=145 Identities=16% Similarity=0.057 Sum_probs=112.5
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc----------------------chHHHHHHH
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------------------GNREFLVEV 82 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------------------~~~~~~~e~ 82 (361)
..+++.....-|.+.+.||+|+||.||+|.+. +|+.|+||++...... .......|+
T Consensus 6 ~~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 84 (198)
T cd05144 6 ALHTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF 84 (198)
T ss_pred HHHHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence 34555665566999999999999999999886 6999999987643210 011356788
Q ss_pred HHHhcCCCCc--cceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 018100 83 LMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160 (361)
Q Consensus 83 ~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 160 (361)
.++..+.+++ +...++ ....++||||++|++|..+... .....++.+++.++.++|+.+ ++
T Consensus 85 ~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~ 147 (198)
T cd05144 85 AALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---II 147 (198)
T ss_pred HHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CC
Confidence 8888887764 333333 2345899999999988765431 245678899999999999999 99
Q ss_pred ecCCCCCcEEEcCCCceeEeccccccc
Q 018100 161 YRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 161 H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
|+||+|+||+++.++.++|+|||.+..
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCcccc
Confidence 999999999999999999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.6e-18 Score=144.25 Aligned_cols=130 Identities=23% Similarity=0.318 Sum_probs=105.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.||+|++|.||+|.+. +..+++|+....... ..+.+.+|+.++..+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999854 678999986533211 124567899999999887765555555556677899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++|++|.+++.. ... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988754 111 78999999999999999 99999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=160.49 Aligned_cols=140 Identities=22% Similarity=0.295 Sum_probs=112.9
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--Cc------cchHHHHHHHHHHhcCCCCccceeeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GV------QGNREFLVEVLMLSLLHHPNLVNLIGYCA 101 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 101 (361)
......|...+.||+|+||.||+|.+.. ..+++|+.... .. ...+.+.+|+.++..++|++++....++.
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 3345566778999999999999998864 34455543211 11 11245788999999999999988777777
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
+....++||||++|++|.+++. ....++.|++.+|.+||+.+ ++||||||+||++ .++.++|+|
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 7777899999999999998875 34678999999999999999 9999999999999 678999999
Q ss_pred cccccc
Q 018100 182 FGLAKL 187 (361)
Q Consensus 182 fg~~~~ 187 (361)
||++..
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-18 Score=170.15 Aligned_cols=257 Identities=23% Similarity=0.248 Sum_probs=191.9
Q ss_pred hhCcccCCeecccCceEEEEEEECC-CCeEEEEEEeccCC--ccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 108 (361)
...|.+.+.||+|+|+.+-++.... ....++.|.+.... .........|..+-+.+. |+|++..++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4678889999999999998887743 34456666655443 222234445777777776 9999999999999999999
Q ss_pred EEEecCCCCHHHHh-cccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCcEEEcCCC-ceeEeccccc
Q 018100 109 VYEYMPLGSVEDHL-HDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLA 185 (361)
Q Consensus 109 v~e~~~~~~L~~~~-~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~ 185 (361)
+.++.+|+++..-+ +. .....+...+..++.|+..++.|+| ..+ +.|+|++|+|.+++..+ .+++.|||++
T Consensus 99 ~~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 99999999998888 33 1225777788999999999999999 999 99999999999999999 9999999999
Q ss_pred ccCCC-CCCcceeecccc-CcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 186 KLGPV-GDNTHVSTRVMG-TYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 186 ~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
..... ...........| +..|.|||...+. ...+..|+||+|+++..+++|..||......... ...|..
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~------ 245 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS------ 245 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc------
Confidence 87655 344444445667 9999999998874 4568899999999999999999999765433211 011100
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.... +.............+++.+++..+|..|.+.+++-.
T Consensus 246 --~~~~----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 246 --NKGR----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccc----cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000 001111222335677999999999999998888764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.5e-16 Score=134.06 Aligned_cols=135 Identities=21% Similarity=0.228 Sum_probs=103.0
Q ss_pred CCeec-ccCceEEEEEEECCCCeEEEEEEeccCCc-------------cchHHHHHHHHHHhcCCCCcc--ceeeeEEEc
Q 018100 39 ESLLG-EGGFGRVYKGYLESINQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNL--VNLIGYCAD 102 (361)
Q Consensus 39 ~~~lg-~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~ 102 (361)
...|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..+.|+++ ...+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35676 7888888888765 67899998853211 122457889999999988775 556655433
Q ss_pred C-C---eeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 103 G-D---QRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 103 ~-~---~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
. . ..++|+|+++| .+|.+++.. ..++.. .+.||+.+|.+||++| |+|+||||.|||++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 2 2 22599999997 689888764 345554 3678999999999999 9999999999999999999
Q ss_pred eEeccccccc
Q 018100 178 KLSDFGLAKL 187 (361)
Q Consensus 178 ~L~Dfg~~~~ 187 (361)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.7e-16 Score=144.79 Aligned_cols=170 Identities=16% Similarity=0.193 Sum_probs=132.8
Q ss_pred EEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCC
Q 018100 52 KGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 131 (361)
Q Consensus 52 ~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 131 (361)
.|..+.++.+|.++++...+........+-+..|+.++||||+++++.++.+...|+|+|.+ ..|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 46677789999999987665544456777889999999999999999999999999999998 578888876
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchh
Q 018100 132 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211 (361)
Q Consensus 132 l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 211 (361)
+....+..-+.||+.||.|||+.++ ++|++|+.+.|+|+..|..||++|.++........ .......-..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 4577888899999999999986554 99999999999999999999999998754221111 1111122234666665
Q ss_pred hccCCCCccCceehhhHHHHHHhhC
Q 018100 212 AKTGQLTLKSDVYSFGVVLLEILSG 236 (361)
Q Consensus 212 ~~~~~~~~~sDiwslG~~l~~ll~g 236 (361)
+.... -..|.|.|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 42222 456999999999999999
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.1e-16 Score=130.81 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=95.8
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHH----------------------HHHHHHHhcCCCCc-
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREF----------------------LVEVLMLSLLHHPN- 92 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~----------------------~~e~~~l~~l~h~~- 92 (361)
+.+.||+|+||.||+|.+. +++.|+||++....... ...+ ..|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999987 68999999986532211 1111 24555555554332
Q ss_pred -cceeeeEEEcCCeeEEEEEecCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcE
Q 018100 93 -LVNLIGYCADGDQRLLVYEYMPLGSVED-HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNI 169 (361)
Q Consensus 93 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Ni 169 (361)
+...++. ...++||||++++++.. .+.... .. ..+..++.+++.++.++|. .+ ++|+||+|+||
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 3333332 24589999999854321 111100 11 5678999999999999999 98 99999999999
Q ss_pred EEcCCCceeEeccccccc
Q 018100 170 LLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~ 187 (361)
+++ ++.++|+|||.+..
T Consensus 147 li~-~~~~~liDfg~a~~ 163 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EEE-CCcEEEEECccccc
Confidence 999 89999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=123.71 Aligned_cols=135 Identities=23% Similarity=0.199 Sum_probs=111.8
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC--CccceeeeEEEcCCeeEEEEEecCC
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.+.||.|.++.||++.... ..+++|.+..... ...+..|+..+..+++ .++..++.+...++..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 46789999999999999864 6899999865433 4568889999999976 5888888888877889999999987
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
..+..+ +......++.+++.++..+|......++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766543 5566778899999999999985322299999999999999999999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-15 Score=130.53 Aligned_cols=201 Identities=23% Similarity=0.326 Sum_probs=141.6
Q ss_pred HhcCCCCccceeeeEEEcC-----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018100 85 LSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159 (361)
Q Consensus 85 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 159 (361)
|-.+-|.||++++.++.+. ....++.+|+..|++..+++........+......+|+.||+.||.|||+.. |++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 3345689999999988654 3467889999999999999987777788999999999999999999999995 779
Q ss_pred eecCCCCCcEEEcCCCceeEeccccccc--CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCC
Q 018100 160 IYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237 (361)
Q Consensus 160 ~H~dl~p~Nilv~~~~~~~L~Dfg~~~~--~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 237 (361)
+|+++..+.|++..+|-+|++--.-... ..............+.++|.+||.-...+.+.++|||++|++..+|..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999998888763321111 00111111222345678899999877778889999999999999998765
Q ss_pred CccccchH--HHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 238 KAVDTSKA--AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 238 ~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.--..... .....+... ...+.+. .-..++.+|++..|..||++++++.
T Consensus 280 iq~tnseS~~~~ee~ia~~----------i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANV----------IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccCCCcceeehhhhhhhh----------eeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 43211110 000000000 0000000 1123788899999999999998874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.5e-15 Score=138.37 Aligned_cols=250 Identities=24% Similarity=0.266 Sum_probs=184.8
Q ss_pred hCcccCCeecc--cCceEEEEEEE--CCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCee
Q 018100 34 KNFRSESLLGE--GGFGRVYKGYL--ESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 106 (361)
Q Consensus 34 ~~y~~~~~lg~--G~~g~v~~~~~--~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 106 (361)
..+.+.+.+|. |.+|.+|.+.. ..++..+++|.-... .......=.+|+...+.++ |++.+..+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 55677889999 99999999988 778899999984322 2233333445677766664 89999989999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCcEEEcCC-CceeEec
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSD 181 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~i~H~dl~p~Nilv~~~-~~~~L~D 181 (361)
|+-.|.+. .+|..+.+... ..++...++..+.+... ||..+|+.+ ++|-|++|.||++..+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999984 88888887622 34888899999999999 999999999 9999999999999999 8999999
Q ss_pred ccccccCCCCCCc---ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 182 FGLAKLGPVGDNT---HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 182 fg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
||+.......... ....+..+...|++||.. +..++..+|+|+||.++.+..++..++...... .|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W---- 335 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW---- 335 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc----
Confidence 9988764333311 112334678889999987 457888999999999999998887665432110 00
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...+ ...+..++......++...+.+|++.+|..|++.+.+..
T Consensus 336 ~~~r-------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 SQLR-------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc-------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 001112222223335666899999999999998776653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.9e-14 Score=132.37 Aligned_cols=158 Identities=20% Similarity=0.173 Sum_probs=106.4
Q ss_pred ccCcceeHHHHHHHhhC------------cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchH----------
Q 018100 19 ITAQTLTFRELAAATKN------------FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---------- 76 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~~~------------y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~---------- 76 (361)
+.++.+++++++...++ |. .+.||.|++|.||+|+.+. |+.||||+..+.......
T Consensus 91 d~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~ 168 (437)
T TIGR01982 91 DRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLA 168 (437)
T ss_pred cCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHH
Confidence 56666777777755332 22 4689999999999999874 899999997543111000
Q ss_pred ------------------------------HHHHHHHHHhcC----CCCccceeeeEE-EcCCeeEEEEEecCCCCHHHH
Q 018100 77 ------------------------------EFLVEVLMLSLL----HHPNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDH 121 (361)
Q Consensus 77 ------------------------------~~~~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~ 121 (361)
.+.+|+..+..+ ++.+-+.+-.++ ...+..++||||++|++|.++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~ 248 (437)
T TIGR01982 169 RIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDI 248 (437)
T ss_pred HHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccH
Confidence 123344444333 232223333333 234457899999999999887
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 122 LHDLSPGKKPLDWNTRMKIAAGAAR-GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 122 ~~~~~~~~~~l~~~~~~~i~~qi~~-al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
..... ...+ ...++.+++. .+..+|..| ++|+|++|+||+++.++.++|+|||++..
T Consensus 249 ~~~~~---~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 249 AALDE---AGLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred HHHHh---cCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 64311 1122 3345555555 478899999 99999999999999999999999999865
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-14 Score=138.61 Aligned_cols=158 Identities=15% Similarity=0.079 Sum_probs=105.1
Q ss_pred ccCcceeHHHHHHH------------hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc------------
Q 018100 19 ITAQTLTFRELAAA------------TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG------------ 74 (361)
Q Consensus 19 ~~~~~~~~~~~~~~------------~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------ 74 (361)
+.++.++++++++. +.+|+. +.||.|++|.||+|+.+.+|+.||||+..+.-...
T Consensus 93 d~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a 171 (537)
T PRK04750 93 DRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLA 171 (537)
T ss_pred cCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHH
Confidence 45666677666644 345776 79999999999999999889999999986431100
Q ss_pred ----------------------hHH------HHHHHHHHhcC----CCCccceeeeEEE-cCCeeEEEEEecCCCCHHHH
Q 018100 75 ----------------------NRE------FLVEVLMLSLL----HHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDH 121 (361)
Q Consensus 75 ----------------------~~~------~~~e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~ 121 (361)
.+. +.+|+..+.++ .+...+.+-.++. ..+..++||||++|+++.+.
T Consensus 172 ~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~ 251 (537)
T PRK04750 172 RWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDV 251 (537)
T ss_pred HHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhH
Confidence 011 22333333333 2333344444443 25567899999999999874
Q ss_pred h--cccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC----ceeEeccccccc
Q 018100 122 L--HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKL 187 (361)
Q Consensus 122 ~--~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~----~~~L~Dfg~~~~ 187 (361)
- .........+....+..++.|++ ..| ++|+|++|+||+++.+| .++++|||++..
T Consensus 252 ~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 252 AALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 2 22000011344555555556654 478 99999999999999988 999999999865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.4e-13 Score=111.59 Aligned_cols=130 Identities=18% Similarity=0.104 Sum_probs=95.6
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccc-eeeeEEEcCCeeEEEEEecCCCC
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGS 117 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~ 117 (361)
++.|+.|.++.||++... +..+++|+...... ....+..|+.+++.+.+.+++ .++... ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 467899999999999875 77899998754422 123457789998888654444 344433 234579999999888
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 118 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 118 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+... . . ....++.+++++|..||+.+ ...++|||++|.||+++ ++.++++||+.+.
T Consensus 78 l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7543 0 1 11345679999999999987 11249999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-12 Score=108.06 Aligned_cols=136 Identities=15% Similarity=0.111 Sum_probs=97.2
Q ss_pred CCeecccCceEEEEEEECC------CCeEEEEEEeccCC----------------------ccchHHH----HHHHHHHh
Q 018100 39 ESLLGEGGFGRVYKGYLES------INQDVAIKQLDRNG----------------------VQGNREF----LVEVLMLS 86 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~------~~~~v~iK~~~~~~----------------------~~~~~~~----~~e~~~l~ 86 (361)
...||.|.-+.||.|.... .+..+|||++.... ......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998653 35789999985210 0111222 37888888
Q ss_pred cCCC--CccceeeeEEEcCCeeEEEEEecCCCCHH-HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeec
Q 018100 87 LLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSVE-DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYR 162 (361)
Q Consensus 87 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~i~H~ 162 (361)
++.. -++..++++ ...+|||||+.+..+. ..+.. ..++...+..+..+++.+|..| |..| ++||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8753 344445543 3567999999754332 12222 2355567778889999999999 8999 9999
Q ss_pred CCCCCcEEEcCCCceeEeccccccc
Q 018100 163 DLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 163 dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
||++.||++. ++.++|+|||.+..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCcee
Confidence 9999999997 46899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.3e-11 Score=111.29 Aligned_cols=266 Identities=17% Similarity=0.164 Sum_probs=167.6
Q ss_pred ccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeE-----E--EcCCeeEE
Q 018100 37 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGY-----C--ADGDQRLL 108 (361)
Q Consensus 37 ~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-----~--~~~~~~~l 108 (361)
...+.||+|+.+.+|-.-.- ...+.|++.........+. +..|... .||-+..-+.+ + ..+...-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 45678999999999964332 2357888876655433332 2233332 45533221110 1 12233568
Q ss_pred EEEecCCC-CHHHHhcc--cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 109 VYEYMPLG-SVEDHLHD--LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 109 v~e~~~~~-~L~~~~~~--~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
+|+.+.|. ....++.- ......-.+|...+.++..|+.+.+.||..| .+-||++++|+||.+++.+.|.|=+.-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 88888764 23333321 2223456789999999999999999999999 999999999999999999999986644
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhC-CCccccchHHHhh--hHH-Hhhh
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQ--SLV-AWAR 256 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~~~~--~~~-~~~~ 256 (361)
.. ..+.......+|...|.+||.-+ +..-+..+|.|.||+++|+++.| ++||.+-...... -.. ....
T Consensus 165 qi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 32 23444455567999999999753 34567889999999999999985 9999764331111 000 0011
Q ss_pred hhhcc--ccccccccCccccCCCChHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHHHhc
Q 018100 257 PLFQD--RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE--QPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 257 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rps~~~ll~~l~~l~~~ 316 (361)
..|.. .........|.. . --...+.++..|..+|+.. ++.-||++..++..|..+.++
T Consensus 242 g~f~ya~~~~~g~~p~P~~-~-P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRS-I-PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ceeeechhccCCCCCCCCC-C-ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111 001111101100 0 0011233667788999874 367999999999999877754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-11 Score=99.85 Aligned_cols=131 Identities=24% Similarity=0.320 Sum_probs=98.5
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEec-cC----Cccc---hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLD-RN----GVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~-~~----~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..+++|+-+.++.+.+. |..+++|.=. +. ..+. .+.-.+|+.++..+.--.+...+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46789999999999775 5557777521 11 1111 1335678999888765444444444455667779999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
|++|..|.+.+.. . ...++..+-..+.-||..| |+||||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~----~-------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEE----A-------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHh----c-------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999988876 1 2567888889999999999 99999999999998876 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-11 Score=99.02 Aligned_cols=143 Identities=22% Similarity=0.253 Sum_probs=104.4
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEe-c----cCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQL-D----RNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~-~----~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
...+|.+|+-+.|+++.+. |+..+||.= . .+..+ ......+|+..|.++.--.|.-..-++.+.....|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6678999999999999887 778888852 1 11111 224567789988877644444444455556666799
Q ss_pred EEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc---eeEeccccc
Q 018100 110 YEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLA 185 (361)
Q Consensus 110 ~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~---~~L~Dfg~~ 185 (361)
|||++| .++.+++....+ ..........++.+|-+.+.-||.++ ++||||..+||++..++. +.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999985 478888765331 22333334789999999999999999 999999999999976653 589999998
Q ss_pred cc
Q 018100 186 KL 187 (361)
Q Consensus 186 ~~ 187 (361)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 74
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.6e-11 Score=108.24 Aligned_cols=172 Identities=17% Similarity=0.173 Sum_probs=131.4
Q ss_pred CceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEE----cCCeeEEEEEecCC-CCHHH
Q 018100 46 GFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLLVYEYMPL-GSVED 120 (361)
Q Consensus 46 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~ 120 (361)
.-.+.|++..+.+|..|++|.++............-+++++++.|+|+|++.+++. .+..+++|++|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44688999999999999999995544333334445688899999999999998886 35577899999875 46666
Q ss_pred Hhcc-----------cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 121 HLHD-----------LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 121 ~~~~-----------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+.-. +-..+...++..+|.++.||..||.++|+.| +...-|.|.+|+++++.+++|..+|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5422 1122456889999999999999999999999 9999999999999999999999888765422
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 239 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p 239 (361)
... . |.+. -..+-|.=.||.++..|.+|..-
T Consensus 445 ~d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 221 0 1111 12356888999999999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.8e-12 Score=117.80 Aligned_cols=249 Identities=20% Similarity=0.199 Sum_probs=173.1
Q ss_pred HhhCcccCCeecccCceEEEEEEEC-CCCeEEEEEEeccCCccchHH--HHHHHHHHhcC-CCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLE-SINQDVAIKQLDRNGVQGNRE--FLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 107 (361)
...+|..+..||.|.|+.++.+..+ .++..+++|............ -..|+.+...+ .|.+++.....+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567889999999999999987755 567788888875443332222 23455555555 4888888888888778888
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-CceeEecccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK 186 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-~~~~L~Dfg~~~ 186 (361)
+--|||+++++...... ...+.+...+.+..|++.++.++|+.. ++|+|++|+||++..+ +..+++|||+..
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 99999999988776633 456788889999999999999999999 9999999999999886 788999999886
Q ss_pred cCCCCCCcceeeccccCcCc-CCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGY-CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... ......+..| .+++......+..+.|++|||..+.+..++...-..... .......
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------~~~i~~~ 478 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------SLTIRSG 478 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------ceeeecc
Confidence 311111 1111223334 355555667788999999999999999987643211100 0000000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
. .+. .+.....+..+...+...++..||.+.++......
T Consensus 479 ~---~p~-----~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 479 D---TPN-----LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred c---ccC-----CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0 000 01111345557888899999999999887765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.6e-11 Score=101.81 Aligned_cols=142 Identities=19% Similarity=0.242 Sum_probs=107.8
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCC--ccceeeeEEEcC---CeeEEEEEec
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHP--NLVNLIGYCADG---DQRLLVYEYM 113 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~lv~e~~ 113 (361)
+.|+.|..+.+|++.... |..+++|....... .....+..|+.+++.+.+. .+..++.+.... ...++||+|+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998754 67899999764432 1345678899999998653 345666666553 2568999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-------------------------------------- 155 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 155 (361)
+|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 98888765531 34677788888888888888888532
Q ss_pred ---------------CCCeeecCCCCCcEEEcC--CCceeEeccccccc
Q 018100 156 ---------------KPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKL 187 (361)
Q Consensus 156 ---------------~~~i~H~dl~p~Nilv~~--~~~~~L~Dfg~~~~ 187 (361)
...++|||++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 123799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-12 Score=128.03 Aligned_cols=282 Identities=20% Similarity=0.192 Sum_probs=184.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
+.-...+.+.+.+-.|.++.++.+.-..+|....+|+....... ..+....+-.++-..++|.++...-.+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 34556778888999999999999888777766666654332111 111111222222222345544433334445677
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+++++|+.+++|...++. -++.+.+.....+..+..++++||+.. +.|+|++|.|.+...++..++.||+...
T Consensus 880 ~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 899999999999999987 456777788888889999999999998 9999999999999999999999998332
Q ss_pred cCCCC----CC------------------c-------ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCC
Q 018100 187 LGPVG----DN------------------T-------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237 (361)
Q Consensus 187 ~~~~~----~~------------------~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 237 (361)
..... .. . .......++..|.+||...+......+|+|++|+++++.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 21110 00 0 0012346889999999999999999999999999999999999
Q ss_pred CccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHH--HHHHHHHHHh
Q 018100 238 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD--VVTALAYLAS 315 (361)
Q Consensus 238 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~--ll~~l~~l~~ 315 (361)
.||........ +.+...... ....-+........+++...+..+|.+|..+.- .+..-..++.
T Consensus 1033 pp~na~tpq~~----------f~ni~~~~~-----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1033 PPFNAETPQQI----------FENILNRDI-----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred CCCCCcchhhh----------hhccccCCC-----CCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence 99976543221 111111000 001112223346677999999999999976552 2223333444
Q ss_pred ccCCCccccCCCCCCCCC
Q 018100 316 QKYESDAEKVQSPCLDPG 333 (361)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~ 333 (361)
..++........+...+.
T Consensus 1098 ~~~~~l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1098 VDWENLALQKAEFVPQPE 1115 (1205)
T ss_pred CCccccccccCccCCCCC
Confidence 445444444444444443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-09 Score=96.06 Aligned_cols=140 Identities=16% Similarity=0.112 Sum_probs=98.0
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCcc-----------chHHHHHHHHHHhcCCCCcc--ceeeeEEEc----
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----------GNREFLVEVLMLSLLHHPNL--VNLIGYCAD---- 102 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~---- 102 (361)
+.+-......|+++... |+.+.||........ ....+.+|...+..+..-+| ..++.+.+.
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444456666554 788999987543311 11136678887777642222 233344432
Q ss_pred -CCeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-------
Q 018100 103 -GDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR------- 173 (361)
Q Consensus 103 -~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~------- 173 (361)
....+||+|++++. +|.+++.... ..+.+......++.+++..+..||..| ++|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23578999999875 8999886432 234567778899999999999999999 999999999999975
Q ss_pred CCceeEecccccc
Q 018100 174 GYHPKLSDFGLAK 186 (361)
Q Consensus 174 ~~~~~L~Dfg~~~ 186 (361)
+..+.|+||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4679999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.4e-09 Score=92.04 Aligned_cols=134 Identities=18% Similarity=0.091 Sum_probs=100.2
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccC--------------------Cc--cchHHHHHHHHHHhcCCCC--
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--------------------GV--QGNREFLVEVLMLSLLHHP-- 91 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--------------------~~--~~~~~~~~e~~~l~~l~h~-- 91 (361)
+.+...||-|.-+.||.|.... |.+++||.-... +. .......+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 5677899999999999999875 899999975311 00 0113456799999988644
Q ss_pred ccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 92 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
.+...++ .+...+|||+++|..|... +++....-.++..|++-+..+-..| +||||+++-||++
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCccc----cccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 4555554 3455799999997665432 2244556667777777777777888 9999999999999
Q ss_pred cCCCceeEecccccc
Q 018100 172 DRGYHPKLSDFGLAK 186 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~ 186 (361)
+++|.++++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-09 Score=90.75 Aligned_cols=124 Identities=21% Similarity=0.202 Sum_probs=80.7
Q ss_pred EEEEEEECCCCeEEEEEEeccC---------------C------ccc-----hHHHHHHHHHHhcCCCC--ccceeeeEE
Q 018100 49 RVYKGYLESINQDVAIKQLDRN---------------G------VQG-----NREFLVEVLMLSLLHHP--NLVNLIGYC 100 (361)
Q Consensus 49 ~v~~~~~~~~~~~v~iK~~~~~---------------~------~~~-----~~~~~~e~~~l~~l~h~--~i~~~~~~~ 100 (361)
.||.|...+ |..+|+|+.... . ... .....+|+..|..+..- ++..++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 388888755 889999997521 0 000 12456799999998754 344555443
Q ss_pred EcCCeeEEEEEecC--CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 101 ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY-LHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 101 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
..+|||||++ |..+..+... .++......++.+++..+.. +|..| ++||||++.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3469999998 6666554432 12234566778888885555 57999 9999999999999988 99
Q ss_pred eEeccccccc
Q 018100 178 KLSDFGLAKL 187 (361)
Q Consensus 178 ~L~Dfg~~~~ 187 (361)
.++|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-10 Score=110.88 Aligned_cols=152 Identities=19% Similarity=0.225 Sum_probs=104.0
Q ss_pred HHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc-------eeeccccCcCcCCchhhc
Q 018100 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-------VSTRVMGTYGYCAPEYAK 213 (361)
Q Consensus 141 ~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~ 213 (361)
+.+++.|+.|+|+.-+ +||++|.|++|+++.++..||+.|+.+.......... ..........|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445599999998865 9999999999999999999999999876432211111 111233567899999999
Q ss_pred cCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHc
Q 018100 214 TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 292 (361)
Q Consensus 214 ~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 292 (361)
+...+.++|+||+|+++|.+.. |..-+............... +..-...+....+.++.+=+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~--------------~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL--------------LNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc--------------cccccccccccCcHHHHHHHHHH
Confidence 9889999999999999999995 55444433221111111000 00000111234455888899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 018100 293 VHEQPDMRPVIADVVT 308 (361)
Q Consensus 293 l~~dP~~Rps~~~ll~ 308 (361)
+..++..||++..+..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999997766654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.8e-08 Score=84.84 Aligned_cols=105 Identities=25% Similarity=0.257 Sum_probs=80.7
Q ss_pred HHHHHHHHHHhcCCCCc--cceeeeEEEcC----CeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 018100 76 REFLVEVLMLSLLHHPN--LVNLIGYCADG----DQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148 (361)
Q Consensus 76 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 148 (361)
....+|...+..|..-+ ....+.+.+.. ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 45667777776664222 23344444432 2458999999874 799988762 2367778899999999999
Q ss_pred HHHhcCCCCCeeecCCCCCcEEEcCCC---ceeEeccccccc
Q 018100 149 EYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKL 187 (361)
Q Consensus 149 ~~LH~~~~~~i~H~dl~p~Nilv~~~~---~~~L~Dfg~~~~ 187 (361)
.-||.+| ++|+|+++.|||++.++ .+.|+||+-+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.9e-08 Score=81.55 Aligned_cols=137 Identities=15% Similarity=0.124 Sum_probs=101.1
Q ss_pred cccCceEEEEEEECCCCeEEEEEEeccC------CccchHHHHHHHHHHhcCCCC--ccceeeeEEEc-----CCeeEEE
Q 018100 43 GEGGFGRVYKGYLESINQDVAIKQLDRN------GVQGNREFLVEVLMLSLLHHP--NLVNLIGYCAD-----GDQRLLV 109 (361)
Q Consensus 43 g~G~~g~v~~~~~~~~~~~v~iK~~~~~------~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~-----~~~~~lv 109 (361)
|.||.+.|+..... |..+-+|.-... .+.....|.+|+..+..|..- .+..+. ++.. ....+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56899999987766 446888876411 133557799999999888532 233333 3321 2245799
Q ss_pred EEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc--eeEecccccc
Q 018100 110 YEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLAK 186 (361)
Q Consensus 110 ~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~--~~L~Dfg~~~ 186 (361)
+|.+++ .+|.+++.... -.+.+......++.+++.++.-||+.| +.|+|+.+.||+++.++. +.++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997743 68888886522 235677888899999999999999999 999999999999987777 9999998776
Q ss_pred c
Q 018100 187 L 187 (361)
Q Consensus 187 ~ 187 (361)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-07 Score=80.35 Aligned_cols=138 Identities=12% Similarity=0.093 Sum_probs=90.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHH---------HHHHHHHHhcCC---CCccceeee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---------FLVEVLMLSLLH---HPNLVNLIG 98 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~---------~~~e~~~l~~l~---h~~i~~~~~ 98 (361)
...++|.+.+.+.......|.+.... |..+++|..........+. ..+.+..+..+. -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34678888888888777777665544 7899999976543332222 223333333332 222222222
Q ss_pred EEE-----cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC
Q 018100 99 YCA-----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 173 (361)
Q Consensus 99 ~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~ 173 (361)
+.+ -....+++|||++|..|.+... +++ .+...|.+++.-||..| ++|||.+|+|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 222 2234568999999988866532 222 24466778899999999 999999999999996
Q ss_pred CCceeEecccccc
Q 018100 174 GYHPKLSDFGLAK 186 (361)
Q Consensus 174 ~~~~~L~Dfg~~~ 186 (361)
++ ++++||+.-.
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 55 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.77 E-value=2e-07 Score=80.72 Aligned_cols=139 Identities=14% Similarity=0.139 Sum_probs=84.0
Q ss_pred CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc--cceeeeEEEcCCeeEEEEEecCCCC
Q 018100 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGS 117 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~ 117 (361)
..||+|..+.||+.. +..+++|...... ......+|.++++.+..-. +..++++........+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 578999999999842 4567899876432 3355788999998875332 4567777777777889999999864
Q ss_pred -HHHHh---------------------cccCCCCCCCCHHHHHHHHHH----------HHH-HHHHHhc-CCCCCeeecC
Q 018100 118 -VEDHL---------------------HDLSPGKKPLDWNTRMKIAAG----------AAR-GLEYLHD-KAKPPVIYRD 163 (361)
Q Consensus 118 -L~~~~---------------------~~~~~~~~~l~~~~~~~i~~q----------i~~-al~~LH~-~~~~~i~H~d 163 (361)
+...+ +........++.. ...+..+ +.. ...+|.. ...+.++|||
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 1110001111100 0000000 000 1111111 1123489999
Q ss_pred CCCCcEEEcCCCceeEecccccc
Q 018100 164 LKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 164 l~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++|.||++++++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999988 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.1e-08 Score=93.96 Aligned_cols=158 Identities=18% Similarity=0.184 Sum_probs=99.5
Q ss_pred ccCcceeHHHHHHHh------------hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccch-----------
Q 018100 19 ITAQTLTFRELAAAT------------KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----------- 75 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~------------~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----------- 75 (361)
+.++.++++++.+.. .+|. .+.|+.++-|.||.|+.+. |+.||||+..+.-....
T Consensus 99 D~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a 176 (517)
T COG0661 99 DRVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLA 176 (517)
T ss_pred cCCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHH
Confidence 566667777666442 2222 2689999999999999987 99999999753211100
Q ss_pred -----------------------HH------HHHHHHHHhcC----C-CCccceeeeEE-EcCCeeEEEEEecCCCCHHH
Q 018100 76 -----------------------RE------FLVEVLMLSLL----H-HPNLVNLIGYC-ADGDQRLLVYEYMPLGSVED 120 (361)
Q Consensus 76 -----------------------~~------~~~e~~~l~~l----~-h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~ 120 (361)
+. +.+|+.-+.++ + .++ +.+-.++ +-.+...++|||++|..+.+
T Consensus 177 ~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d 255 (517)
T COG0661 177 RLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISD 255 (517)
T ss_pred HHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEeccc
Confidence 00 22233333322 2 222 2232333 33456689999999998887
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 121 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 121 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
..... ...++...+...+.++. +..+-..| ++|+|.+|.||+++.+|.+.+.|||+...
T Consensus 256 ~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 256 IAALK---SAGIDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred HHHHH---hcCCCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceec
Confidence 74221 13355444443333322 22233367 99999999999999999999999998765
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.8e-07 Score=88.09 Aligned_cols=161 Identities=19% Similarity=0.140 Sum_probs=104.0
Q ss_pred cccCcceeHHHHHHHhhC---------c--ccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc------------
Q 018100 18 QITAQTLTFRELAAATKN---------F--RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG------------ 74 (361)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~---------y--~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------ 74 (361)
++.++.+|.+++..+.++ | -..+.||..+.|.||+|+.+. |+.||||+-++.-...
T Consensus 134 qD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~ 212 (538)
T KOG1235|consen 134 QDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLA 212 (538)
T ss_pred hccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHH
Confidence 367888888888876443 2 223689999999999999998 9999999864211100
Q ss_pred -----------h--------H------HHHHHHHHH----hcCCCCcc---ceeeeEE-EcCCeeEEEEEecCCCCHHHH
Q 018100 75 -----------N--------R------EFLVEVLML----SLLHHPNL---VNLIGYC-ADGDQRLLVYEYMPLGSVEDH 121 (361)
Q Consensus 75 -----------~--------~------~~~~e~~~l----~~l~h~~i---~~~~~~~-~~~~~~~lv~e~~~~~~L~~~ 121 (361)
. + .|.+|++-. +.+.|-++ +.+-.++ .-.....|+|||++|..+.++
T Consensus 213 ~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl 292 (538)
T KOG1235|consen 213 KVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDL 292 (538)
T ss_pred HHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCH
Confidence 0 0 022233222 22233331 1122222 223466899999999887765
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC----CCceeEeccccccc
Q 018100 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKL 187 (361)
Q Consensus 122 ~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~----~~~~~L~Dfg~~~~ 187 (361)
-.- . ...++...+...+.+...-.-+. .| ++|+|-+|.||++.. ++.+.+.|||+...
T Consensus 293 ~~i-~--~~gi~~~~i~~~l~~~~~~qIf~--~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 293 DAI-D--KRGISPHDILNKLVEAYLEQIFK--TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred HHH-H--HcCCCHHHHHHHHHHHHHHHHHh--cC---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 321 1 24577777766666654444444 46 999999999999983 67899999999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-06 Score=74.43 Aligned_cols=151 Identities=19% Similarity=0.161 Sum_probs=99.8
Q ss_pred ceeHHHHHHHhhCcccCCeec---ccCceEEEEEEECCCCeEEEEEEeccCCcc-------------------chH----
Q 018100 23 TLTFRELAAATKNFRSESLLG---EGGFGRVYKGYLESINQDVAIKQLDRNGVQ-------------------GNR---- 76 (361)
Q Consensus 23 ~~~~~~~~~~~~~y~~~~~lg---~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------------------~~~---- 76 (361)
..+...+.....+..+....| .|.-+.||+|.... +..+|+|++...... ..+
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~-~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD-GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC-CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 345566777777777776555 56677899988744 889999998632111 111
Q ss_pred -HHHHHHHHHhcCC--CCccceeeeEEEcCCeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 018100 77 -EFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152 (361)
Q Consensus 77 -~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 152 (361)
....|+.-|+++. +-.+.+.+.+. ...|||||+... .-.-.+. .-++...+...+..++++.+.-|-
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHH
Confidence 1234666666653 22333334433 345999998432 1111122 123344467888888999988888
Q ss_pred c-CCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 153 D-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 153 ~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
. .+ +||+||+.-|||+. ++.+.++||+-+..
T Consensus 184 ~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 184 KEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HhcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 7 77 99999999999999 88999999998763
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-06 Score=76.15 Aligned_cols=78 Identities=18% Similarity=0.217 Sum_probs=54.7
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCC--ccceeeeEE---EcCCeeEEEEEec
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP--NLVNLIGYC---ADGDQRLLVYEYM 113 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~ 113 (361)
++.|+.|..+.+|++.... ..+++|..... .....+..|..+++.+... .+..++... ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3578999999999998875 48999987544 3446677888888777432 234455433 2234568999999
Q ss_pred CCCCHHH
Q 018100 114 PLGSVED 120 (361)
Q Consensus 114 ~~~~L~~ 120 (361)
+|..+..
T Consensus 78 ~g~~~~~ 84 (239)
T PF01636_consen 78 PGRPLDD 84 (239)
T ss_dssp SSEEHHH
T ss_pred ccccccc
Confidence 9887776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.1e-06 Score=75.33 Aligned_cols=141 Identities=22% Similarity=0.206 Sum_probs=83.2
Q ss_pred eecccCc-eEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEEEEEecCCCCH
Q 018100 41 LLGEGGF-GRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSV 118 (361)
Q Consensus 41 ~lg~G~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 118 (361)
.|..|.. ..||++... +..+++|...... ...+..|+.+++.+. +--+.+++.+.......++||++++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445554 788988654 4678899875432 345667888888774 33345667777666678899999998777
Q ss_pred HHHh-------------------cccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHhc----
Q 018100 119 EDHL-------------------HDLSPGKKPLDWN--TRMKIAA--------------------GAARGLEYLHD---- 153 (361)
Q Consensus 119 ~~~~-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~al~~LH~---- 153 (361)
.... +.......++... ....... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 1111001111100 0000000 01111122211
Q ss_pred CCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 154 ~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
...+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 112349999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-06 Score=70.86 Aligned_cols=132 Identities=20% Similarity=0.177 Sum_probs=95.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccce-eeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN-LIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~ 112 (361)
...++.+.|++|++|.||+|.+. |..+++|+-... .....+..|+++|..+.-.++-+ ++.+..+ ++.|||
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 34456789999999999999998 568999985443 34577889999999887665544 3333322 355999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC-CCcEEEcCCCceeEeccccccc
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK-CSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~-p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++|-.|.++... .+..+ +..++++---|-..| |-|+.|+ |...++.+++.+.|+||..++.
T Consensus 94 i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998888877653 12233 344555656667778 9999997 5666666666999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.9e-06 Score=71.32 Aligned_cols=74 Identities=14% Similarity=0.143 Sum_probs=44.8
Q ss_pred CCeecccCce-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCC---ccceeeeEEEcC---CeeEEEEE
Q 018100 39 ESLLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCADG---DQRLLVYE 111 (361)
Q Consensus 39 ~~~lg~G~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e 111 (361)
++.|+.|+.. .||+. +..+++|..... .....+..|+.++..+... .+..++...... ...+++|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 3567766665 58875 235778875432 2345788899999877521 223333333221 23478999
Q ss_pred ecCCCCHH
Q 018100 112 YMPLGSVE 119 (361)
Q Consensus 112 ~~~~~~L~ 119 (361)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.3e-05 Score=65.97 Aligned_cols=129 Identities=22% Similarity=0.268 Sum_probs=91.5
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccCC----------------ccchHHHHHHHHHHhcCC------CCccce
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----------------VQGNREFLVEVLMLSLLH------HPNLVN 95 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~ 95 (361)
-...||+|+.-.||.- .. +...+||+..... ....+...+|+.....+. +.+|.+
T Consensus 5 ~~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3568999999999863 22 5567899987655 112345556666555554 789999
Q ss_pred eeeEEEcCCeeEEEEEecC------CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 96 LIGYCADGDQRLLVYEYMP------LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 96 ~~~~~~~~~~~~lv~e~~~------~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
++++.+++...-+|+|.+. ..+|.+++.. ..++. .....+ -+-..+|-+++ |+.+|++|+||
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccE
Confidence 9999999999999999853 2478888854 44665 444444 44566677777 99999999999
Q ss_pred EEcCCC----ceeEec
Q 018100 170 LLDRGY----HPKLSD 181 (361)
Q Consensus 170 lv~~~~----~~~L~D 181 (361)
++.... .++|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 996432 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.1e-05 Score=80.95 Aligned_cols=79 Identities=15% Similarity=0.217 Sum_probs=56.2
Q ss_pred CCeecccCceEEEEEEECCCC--eEEEEEEeccCC-ccchHHHHHHHHHHhcCC-CCcc--ceeeeEEEcC---CeeEEE
Q 018100 39 ESLLGEGGFGRVYKGYLESIN--QDVAIKQLDRNG-VQGNREFLVEVLMLSLLH-HPNL--VNLIGYCADG---DQRLLV 109 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~--~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv 109 (361)
.+.|+.|.+..+|+......+ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567889999999998775432 467888764332 223456889999999985 6554 6667776654 357899
Q ss_pred EEecCCCC
Q 018100 110 YEYMPLGS 117 (361)
Q Consensus 110 ~e~~~~~~ 117 (361)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.4e-05 Score=70.61 Aligned_cols=140 Identities=15% Similarity=0.035 Sum_probs=78.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccc-eeeeEEEcCCeeEEEEEecCCCCHH
Q 018100 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGSVE 119 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~ 119 (361)
.+..|-...+|+... ++..+++|..........-....|..+++.+....+. .++.... .++|++|++|.++.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 456778889998863 3678889976543222111246688888887543332 2333321 36899999986653
Q ss_pred HH-----------------hcccCCCCCCCCHH-HHHHHHHHH---------HHHHHHHhcC-----CCCCeeecCCCCC
Q 018100 120 DH-----------------LHDLSPGKKPLDWN-TRMKIAAGA---------ARGLEYLHDK-----AKPPVIYRDLKCS 167 (361)
Q Consensus 120 ~~-----------------~~~~~~~~~~l~~~-~~~~i~~qi---------~~al~~LH~~-----~~~~i~H~dl~p~ 167 (361)
.. ++.......+++.. .+..+..++ ...+..+-.. ....+||+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 12211112222222 112222111 1112222111 1224899999999
Q ss_pred cEEEcCCCceeEeccccccc
Q 018100 168 NILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 168 Nilv~~~~~~~L~Dfg~~~~ 187 (361)
||++++++ +.|+||+.+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.2e-07 Score=86.64 Aligned_cols=187 Identities=17% Similarity=0.092 Sum_probs=133.0
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc-cceeeeEEEcCCeeEEEEEec
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~ 113 (361)
-|...+.+++++++++++.+...+...+ .+++... ....-++++|.+.+||| .+..++-+..+...++.++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 3444456788999999988766544333 6655443 34456889999999999 566666666677888999998
Q ss_pred CCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 114 PLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 114 ~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
.++ +....+.. ....+-..+...++..-+++++++|+.- =+|+| ||+..+ +..+++||+........
T Consensus 317 s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~- 384 (829)
T KOG0576|consen 317 STGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT- 384 (829)
T ss_pred cCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc-
Confidence 766 22222211 1233555566777888889999999886 58888 665554 68899999987642222
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~ 241 (361)
.......++..++|||+.....+....|+|++|.-..+|--|.+|-.
T Consensus 385 --~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 --MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred --cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 13344678999999999999999999999999987777777766643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.7e-05 Score=68.27 Aligned_cols=80 Identities=14% Similarity=0.099 Sum_probs=56.1
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC---CccceeeeEEEc---CCeeEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---PNLVNLIGYCAD---GDQRLL 108 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~l 108 (361)
.-.-.+.||.|..+.||.....+ ..+++|.... ......+..|+..|+.+.. -.+.++++++.. .+..++
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~--~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ--GNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC--CCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 33445689999999999986543 3577787532 1123578889999988852 356777777654 356899
Q ss_pred EEEecCCCCH
Q 018100 109 VYEYMPLGSV 118 (361)
Q Consensus 109 v~e~~~~~~L 118 (361)
|||+++|.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.1e-05 Score=63.04 Aligned_cols=137 Identities=24% Similarity=0.301 Sum_probs=95.0
Q ss_pred CcccCcceeHHHHHHHhhCcccCCeecccCc-eEEEEEEECCCCeEEEEEEecc---CCc------------------cc
Q 018100 17 DQITAQTLTFRELAAATKNFRSESLLGEGGF-GRVYKGYLESINQDVAIKQLDR---NGV------------------QG 74 (361)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~-g~v~~~~~~~~~~~v~iK~~~~---~~~------------------~~ 74 (361)
+-+++..|+. ...+++.++.||.|.- |.||++... |..+|+|++.. ..+ ..
T Consensus 25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y 97 (207)
T PF13095_consen 25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHY 97 (207)
T ss_pred CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhh
Confidence 4577777765 2378999999999999 999999887 77999999321 111 11
Q ss_pred hHHHHHHHHHHhcCC---CCcc--ceeeeEEEcC------------------CeeEEEEEecCCCCHHHHhcccCCCCCC
Q 018100 75 NREFLVEVLMLSLLH---HPNL--VNLIGYCADG------------------DQRLLVYEYMPLGSVEDHLHDLSPGKKP 131 (361)
Q Consensus 75 ~~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 131 (361)
...|..|.+...+|+ +.++ ++++++..-. ....||.||++... .
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~ 164 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------P 164 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------c
Confidence 234778888877775 4566 7888876211 11246666664322 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 132 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 132 l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
++. .-+.+|.+-+..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 165 ~~~----~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQI----RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cch----hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 232 33556777788999999 999999999975 3489999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=6e-05 Score=65.68 Aligned_cols=75 Identities=16% Similarity=0.128 Sum_probs=47.1
Q ss_pred CCeecccCceEEEEEEECC-CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEEEEecCCC
Q 018100 39 ESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLG 116 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~ 116 (361)
++.|..|-...+|++.... .+..+++|+....... .-....|+.+++.+...++ .+++.... ..++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788888999987543 3568889987543221 1223468888887754333 33443332 23799999987
Q ss_pred CH
Q 018100 117 SV 118 (361)
Q Consensus 117 ~L 118 (361)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.8e-05 Score=66.29 Aligned_cols=101 Identities=28% Similarity=0.291 Sum_probs=79.6
Q ss_pred HHHHHHHhcCCC-CccceeeeEEEcCCeeEEEEEecCCCCHHHH---hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 018100 79 LVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDH---LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154 (361)
Q Consensus 79 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 154 (361)
..|..+++.+++ +++.+++++|. .+++.||...+++... +.. -...+|..+..++.++++.+.+++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 357888888875 68999999983 3578899876655421 111 12368999999999999999999986
Q ss_pred CCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 155 ~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
-...+.-.|++|+||-++++++++++|.+....
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 544488899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.8e-05 Score=79.27 Aligned_cols=196 Identities=20% Similarity=0.184 Sum_probs=134.7
Q ss_pred HHHHHHHHhcCCCCccceeeeEEEcCCee----EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 018100 78 FLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153 (361)
Q Consensus 78 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 153 (361)
...|+..+..+.|+|+..++.+.-..... .+..+++...++...++. -..++....+.+..++.+|+.++|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44577778888999999988876443222 244567777888887776 5678999999999999999999999
Q ss_pred CCCCCeeecCCCCC---cEEEcCCCceeEe--cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCc--cCceehh
Q 018100 154 KAKPPVIYRDLKCS---NILLDRGYHPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL--KSDVYSF 226 (361)
Q Consensus 154 ~~~~~i~H~dl~p~---Nilv~~~~~~~L~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~sDiwsl 226 (361)
.. ..|.-+..+ +.-++..+.+..+ ||+.....+....... ...+..+.++|.......+. ..|+|++
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 97 777777666 5555666777766 8887765333322211 22345577888776555443 4799999
Q ss_pred hHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 018100 227 GVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306 (361)
Q Consensus 227 G~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 306 (361)
|.....+..|..+-..... ....+...+.. ...+...+|+..++++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~~~-----------------------~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV-----------------------PVSLLDVLSTS----ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCcccccccc-----------------------hhhhhccccch----hhhhhhhhhcchhhhhccchhhh
Confidence 9999999887654221100 00000011111 45668899999999999999999
Q ss_pred HHHH
Q 018100 307 VTAL 310 (361)
Q Consensus 307 l~~l 310 (361)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 9754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.3e-05 Score=67.21 Aligned_cols=154 Identities=18% Similarity=0.140 Sum_probs=87.4
Q ss_pred HHHHHhhCccc-----CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc--cceeee--
Q 018100 28 ELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIG-- 98 (361)
Q Consensus 28 ~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~-- 98 (361)
++.....+|.+ .+.|..|....+|+.... +..+++|++.. .....+..|+.++..+.+.+ +..++.
T Consensus 3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~ 77 (296)
T cd05153 3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADR 77 (296)
T ss_pred HHHHHHHHcCCCchhheecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCC
Confidence 44455555554 456777888899988654 45789998764 23345666777777764322 233322
Q ss_pred ----EEEcCCeeEEEEEecCCCCHHH--------------HhcccCCC-C------CCCCHHHH----------HHHHHH
Q 018100 99 ----YCADGDQRLLVYEYMPLGSVED--------------HLHDLSPG-K------KPLDWNTR----------MKIAAG 143 (361)
Q Consensus 99 ----~~~~~~~~~lv~e~~~~~~L~~--------------~~~~~~~~-~------~~l~~~~~----------~~i~~q 143 (361)
+...++..++|++|++|..+.. .++..... . ....+... ......
T Consensus 78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 157 (296)
T cd05153 78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL 157 (296)
T ss_pred CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence 1223456689999998766421 01111000 0 00011000 001112
Q ss_pred HHHHHHHHhcC----CCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 144 AARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 144 i~~al~~LH~~----~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+..++.++... -...+||+|+.|.||++++++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 33344444431 11239999999999999998778899999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00039 Score=63.24 Aligned_cols=158 Identities=16% Similarity=0.153 Sum_probs=87.9
Q ss_pred eHHHHHHHhhCccc-----CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc--cceee
Q 018100 25 TFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLI 97 (361)
Q Consensus 25 ~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~ 97 (361)
+-+++....++|.+ .+.++.|....+|++... +..+++|++.... ..+.+..|+.++..|.... +.+++
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 44666777677766 356677777899988654 3468899875421 1234556677766664222 23332
Q ss_pred eE------EEcCCeeEEEEEecCCCCHH-----------H---HhcccCCCC-C------CCC-HHHHH-----------
Q 018100 98 GY------CADGDQRLLVYEYMPLGSVE-----------D---HLHDLSPGK-K------PLD-WNTRM----------- 138 (361)
Q Consensus 98 ~~------~~~~~~~~lv~e~~~~~~L~-----------~---~~~~~~~~~-~------~l~-~~~~~----------- 138 (361)
.. ....+..+++++|++|..+. . .++.....- . .++ +....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 21 12245678999999875431 0 111111000 0 000 00000
Q ss_pred -HHHHHHHHHHHHHhcC----CCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 139 -KIAAGAARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 139 -~i~~qi~~al~~LH~~----~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
.....+...++++... -...+||+|+++.||++++++...++||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 0011233445555321 12239999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00026 Score=64.74 Aligned_cols=158 Identities=16% Similarity=0.132 Sum_probs=84.3
Q ss_pred eeHHHHHHHhhCccc-----CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-----CCcc
Q 018100 24 LTFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNL 93 (361)
Q Consensus 24 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i 93 (361)
++.++++.....|.+ .+.|+.|....+|+.... +..+++|++.. ...+.+..|+.++..|. .|.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 355667777677766 345667777789988755 33689998752 12233444555555543 2333
Q ss_pred ceee---eEEEcCCeeEEEEEecCCCCHH-----------HH---hcccCCC-------CCCCCH-HHHH----------
Q 018100 94 VNLI---GYCADGDQRLLVYEYMPLGSVE-----------DH---LHDLSPG-------KKPLDW-NTRM---------- 138 (361)
Q Consensus 94 ~~~~---~~~~~~~~~~lv~e~~~~~~L~-----------~~---~~~~~~~-------~~~l~~-~~~~---------- 138 (361)
+... .+....+..+++++|++|..+. .. ++..... ...+.+ ....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 3211 0122345678999999876431 11 1111100 001111 1111
Q ss_pred --HHHHH-HHHHHHHHhcC----CCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 139 --KIAAG-AARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 139 --~i~~q-i~~al~~LH~~----~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
..+.+ +...+..+... -...+||+|++|+||+++++...-++||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 01111 11122232211 11239999999999999976656899999876
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00038 Score=65.06 Aligned_cols=76 Identities=14% Similarity=0.086 Sum_probs=52.3
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccC------C-ccchHHHHHHHHHHhcCC---CCccceeeeEEEcCCeeEE
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRN------G-VQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 108 (361)
.+.||.|.+..||++.....++.++||.-... . +...+....|...|..+. ..++.+++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 35789999999999998753368999985311 1 223456677888887763 23455566553 356789
Q ss_pred EEEecCCC
Q 018100 109 VYEYMPLG 116 (361)
Q Consensus 109 v~e~~~~~ 116 (361)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.76 E-value=2.3e-05 Score=69.62 Aligned_cols=133 Identities=14% Similarity=0.048 Sum_probs=94.7
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--------------------cc--hHHHHHHHHHHhcCC-CCc
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------------------QG--NREFLVEVLMLSLLH-HPN 92 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--------------------~~--~~~~~~e~~~l~~l~-h~~ 92 (361)
+.+.++||-|.-+.+|.+.+.. |...++|.-..... .. +-+..+|+..|+.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 6788999999999999998876 88889986431100 00 012346777777774 322
Q ss_pred -cceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 93 -LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 93 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
+.+.++ .+..++||+.++|.+|...-+- ..+..+...+...+.-|..+| +||||.+--||+|
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 223333 3355789999998887654432 123455666777788889999 9999999999999
Q ss_pred cCCCceeEecccccc
Q 018100 172 DRGYHPKLSDFGLAK 186 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~ 186 (361)
.+++.++++||--+.
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997554
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00086 Score=60.06 Aligned_cols=74 Identities=19% Similarity=0.231 Sum_probs=47.4
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC---CCccceeeeEEEcCCeeEEEEEecC
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~ 114 (361)
-.+.++.|....+|+.. .++..+.+|+-. ......+..|+.-|+.|. .-.+.+++.+...++..+||+||++
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 34678899999999877 457889999865 223356778888888773 3456678888877777899999987
Q ss_pred CC
Q 018100 115 LG 116 (361)
Q Consensus 115 ~~ 116 (361)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 55
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00037 Score=63.21 Aligned_cols=142 Identities=21% Similarity=0.178 Sum_probs=81.1
Q ss_pred CeecccCceEEEEEEECC------CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccc-eeeeEEEcCCeeEEEEEe
Q 018100 40 SLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~ 112 (361)
+.|..|-...+|++.... .+..+++|+..... ........|..++..+...++. +++.++.. ..|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456677777999887643 25789999976543 2223456688888777533333 34444432 357899
Q ss_pred cCCCCHHHH-----------------hcccCCCC--C---CCCHH--HHH--------------------------HHHH
Q 018100 113 MPLGSVEDH-----------------LHDLSPGK--K---PLDWN--TRM--------------------------KIAA 142 (361)
Q Consensus 113 ~~~~~L~~~-----------------~~~~~~~~--~---~l~~~--~~~--------------------------~i~~ 142 (361)
++|.++... ++...... . ..+.. .+. .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 887665421 11111100 0 11100 100 0112
Q ss_pred HHHHHHHHHhc------CCCCCeeecCCCCCcEEEcCC----CceeEecccccc
Q 018100 143 GAARGLEYLHD------KAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAK 186 (361)
Q Consensus 143 qi~~al~~LH~------~~~~~i~H~dl~p~Nilv~~~----~~~~L~Dfg~~~ 186 (361)
.+...+..+-. .....+||+|+.+.||+++++ +.+.|+||+.+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233334432 123349999999999999985 889999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0013 Score=60.82 Aligned_cols=143 Identities=15% Similarity=0.160 Sum_probs=80.2
Q ss_pred CeecccCceEEEEEEECC----CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccc-eeeeEEEcCCeeEEEEEecC
Q 018100 40 SLLGEGGFGRVYKGYLES----INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~ 114 (361)
+.|..|-.-.+|++.... .+..|++|+.........+ -..|..+++.+..-++- ++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455567788999987543 2468999988654332222 25688888877543333 345555333 5789988
Q ss_pred CCCHHHH-----------------hcccCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----hc-
Q 018100 115 LGSVEDH-----------------LHDLSPGKK--PLDWNTRMKIAAGA-----------------ARGLEYL----HD- 153 (361)
Q Consensus 115 ~~~L~~~-----------------~~~~~~~~~--~l~~~~~~~i~~qi-----------------~~al~~L----H~- 153 (361)
+.+|... ++....... ......+..++.++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 122110011 11122332332221 1111111 11
Q ss_pred CCCCCeeecCCCCCcEEEcC-CCceeEeccccccc
Q 018100 154 KAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL 187 (361)
Q Consensus 154 ~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~~~ 187 (361)
.....+||+|+++.||++++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11223899999999999986 46899999998763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0016 Score=58.19 Aligned_cols=30 Identities=30% Similarity=0.391 Sum_probs=25.4
Q ss_pred CeeecCCCCCcEEEcCCCc-eeEeccccccc
Q 018100 158 PVIYRDLKCSNILLDRGYH-PKLSDFGLAKL 187 (361)
Q Consensus 158 ~i~H~dl~p~Nilv~~~~~-~~L~Dfg~~~~ 187 (361)
.++|||++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998873
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0018 Score=58.93 Aligned_cols=30 Identities=20% Similarity=0.218 Sum_probs=27.5
Q ss_pred CeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 158 ~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
.+||+|+.++||++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 399999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0033 Score=56.80 Aligned_cols=141 Identities=19% Similarity=0.223 Sum_probs=88.3
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEec-cCCccchHHHHHHHHHHhcCCC--CccceeeeEEEcCC--eeEEEE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGD--QRLLVY 110 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~-~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~ 110 (361)
..+.+.+..|..-.+|..... ++.++++.-. ...........+|+.+++.+.- .-....++.|.++. ..|.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344555555555555655544 7788888321 1222334556778888877642 22234566666665 679999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHH-HHHHHHHHHHhcCC----------------------------------
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA-AGAARGLEYLHDKA---------------------------------- 155 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH~~~---------------------------------- 155 (361)
+|++|..+.+..... ... ..++ ..+++.|..||+-.
T Consensus 105 ~~veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~ 175 (321)
T COG3173 105 EWVEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG 175 (321)
T ss_pred EEecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence 999976554433221 111 1222 36666666666432
Q ss_pred ---------------------CCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 156 ---------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 156 ---------------------~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
.+.++|||+.+.|++++..+-+=+.||+.+..
T Consensus 176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 11389999999999999998899999999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0033 Score=57.69 Aligned_cols=72 Identities=19% Similarity=0.216 Sum_probs=45.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEecc-------CCccchHHHHHHHHHHhcCC--CCccce-eeeEEEcCCeeEEEE
Q 018100 41 LLGEGGFGRVYKGYLESINQDVAIKQLDR-------NGVQGNREFLVEVLMLSLLH--HPNLVN-LIGYCADGDQRLLVY 110 (361)
Q Consensus 41 ~lg~G~~g~v~~~~~~~~~~~v~iK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~~i~~-~~~~~~~~~~~~lv~ 110 (361)
.||.|....||++.....+..|+||.-.. .-+...+...-|...|+... .|..++ ++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57899999999999764346899997421 11233445556777776653 354443 3332 344566899
Q ss_pred EecC
Q 018100 111 EYMP 114 (361)
Q Consensus 111 e~~~ 114 (361)
|+++
T Consensus 80 EdL~ 83 (370)
T TIGR01767 80 EDLS 83 (370)
T ss_pred hhCc
Confidence 9884
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0021 Score=58.47 Aligned_cols=138 Identities=17% Similarity=0.143 Sum_probs=89.0
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccC------------------------Ccc--chHHHHHHHHHHhcCCCC
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRN------------------------GVQ--GNREFLVEVLMLSLLHHP 91 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~------------------------~~~--~~~~~~~e~~~l~~l~h~ 91 (361)
+.-.|..|.-+.||.|.... |..+|||++..+ ++. ..-....|+.-|++++..
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44578889999999998765 888999998521 000 011244677777777543
Q ss_pred ccceeeeEEEcCCeeEEEEEecCCCC-HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEE
Q 018100 92 NLVNLIGYCADGDQRLLVYEYMPLGS-VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 170 (361)
Q Consensus 92 ~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nil 170 (361)
.|. +-.-+.- ....|||+|+.... ..-.+. .-.++...+..+-.|++..+.-|..... +||.||+--|+|
T Consensus 227 GIP-~PePIlL-k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIP-CPEPILL-KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLL 297 (520)
T ss_pred CCC-CCCceee-ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhhe
Confidence 321 1111111 13358999984211 111222 2456777788888888888877766654 999999999998
Q ss_pred EcCCCceeEecccccc
Q 018100 171 LDRGYHPKLSDFGLAK 186 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~ 186 (361)
+- +|.++++|.+-+.
T Consensus 298 yh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 298 YH-DGKLYIIDVSQSV 312 (520)
T ss_pred EE-CCEEEEEEccccc
Confidence 76 4689999988664
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.006 Score=55.47 Aligned_cols=27 Identities=26% Similarity=0.315 Sum_probs=24.5
Q ss_pred eeecCCCCCcEEEcCCCceeEecccccc
Q 018100 159 VIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 159 i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+||||+++.||+++. +.+.|+||+.+.
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 899999999999998 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0038 Score=57.33 Aligned_cols=144 Identities=17% Similarity=0.203 Sum_probs=78.3
Q ss_pred CCeecccCceEEEEEEECCC---CeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccc-eeeeEEEcCCeeEEEEEecC
Q 018100 39 ESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMP 114 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~ 114 (361)
.+.|..|-.-.+|++..... +..|++|+........ -.-.+|..+++.+..-++- +++.++..+ +|.+|++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhhc
Confidence 34566677888898865432 3479999876443221 1234578888777544443 345554322 4788887
Q ss_pred CCCHHH--------------H---hcccCCCC-C-CCCHHHHHHHHHHH----------------------HHHHHHH--
Q 018100 115 LGSVED--------------H---LHDLSPGK-K-PLDWNTRMKIAAGA----------------------ARGLEYL-- 151 (361)
Q Consensus 115 ~~~L~~--------------~---~~~~~~~~-~-~l~~~~~~~i~~qi----------------------~~al~~L-- 151 (361)
|.+|.. . ++...-.. . +-.+..+..++.++ ...+..+
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 765521 0 11111000 1 11122222222221 1112111
Q ss_pred --hcCC-CCCeeecCCCCCcEEEcC-CCceeEeccccccc
Q 018100 152 --HDKA-KPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL 187 (361)
Q Consensus 152 --H~~~-~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~~~ 187 (361)
...+ ...+||+|+.+.||++++ ++.++++||+.|..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111 223899999999999975 57899999998763
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.13 E-value=6.5e-05 Score=78.68 Aligned_cols=178 Identities=13% Similarity=0.022 Sum_probs=124.2
Q ss_pred EEEEEeccCCccch-----HHHHHHHHHHhcCCCCccceeeeEEE--cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCH
Q 018100 62 VAIKQLDRNGVQGN-----REFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 134 (361)
Q Consensus 62 v~iK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~ 134 (361)
+.+++....+.... +....|..-++...|+++.....-.. +....+..++++.+|.+.+.+-...+....++.
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 46666544322222 22233334444567887766555443 234557889999999999988765544556666
Q ss_pred HHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCcEEEcCCCceeEecccccc-cCCCCCCcceeeccccCcCcCCchh
Q 018100 135 NTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY 211 (361)
Q Consensus 135 ~~~~~i~~qi~~al~~LH~~~--~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~-~~~~~~~~~~~~~~~~~~~y~aPE~ 211 (361)
.-+.....+...+..-+|+.. +...+|.++++-|.+|..+-+++++++|+.+ ..+. ........+++.|+.|++
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHH
Confidence 666665565567777766553 3458999999999999999999999999988 2111 112233456778899999
Q ss_pred hccCCCCccCceehhhHHHHHHhhCCCcccc
Q 018100 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 242 (361)
Q Consensus 212 ~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~ 242 (361)
.+.-.++.++|+|..|+.+|....|..+|-.
T Consensus 1412 ~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1412 KNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred HHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 8888889889999999999999988887743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.011 Score=55.32 Aligned_cols=74 Identities=15% Similarity=0.114 Sum_probs=48.9
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEecc-----CC--ccchHHHHHHHHHHhcCC---CCccceeeeEEEcCCeeE
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDR-----NG--VQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~-----~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 107 (361)
..+.||.|....||+.... +..++||.-.. .. +........|+..|+.+. ..++.+++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3567899999999998864 45699998541 11 012334445577776553 236666777776 4567
Q ss_pred EEEEecCC
Q 018100 108 LVYEYMPL 115 (361)
Q Consensus 108 lv~e~~~~ 115 (361)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0021 Score=54.93 Aligned_cols=29 Identities=34% Similarity=0.411 Sum_probs=21.0
Q ss_pred eeecCCCCCcEEE-cCCCceeEeccccccc
Q 018100 159 VIYRDLKCSNILL-DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 159 i~H~dl~p~Nilv-~~~~~~~L~Dfg~~~~ 187 (361)
++|+|+.|.||++ +.++.++|+||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 8999999999999 8899999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0057 Score=56.89 Aligned_cols=74 Identities=23% Similarity=0.269 Sum_probs=47.8
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEecc------CCccchHHHHHHHHHHhcCC--CCccce-eeeEEEcCCeeEEE
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDR------NGVQGNREFLVEVLMLSLLH--HPNLVN-LIGYCADGDQRLLV 109 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~------~~~~~~~~~~~e~~~l~~l~--h~~i~~-~~~~~~~~~~~~lv 109 (361)
.+.||.|.-.-||++.+...+..|+||.-.. .-+-..++..-|...|+.+. .|..++ ++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4588999999999999854356799997421 11233455666778887663 454444 4433 34456678
Q ss_pred EEecC
Q 018100 110 YEYMP 114 (361)
Q Consensus 110 ~e~~~ 114 (361)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 88874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.042 Score=50.41 Aligned_cols=96 Identities=19% Similarity=0.086 Sum_probs=56.5
Q ss_pred cCcceeHHHHHHHhhCcccC---C-eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc--c
Q 018100 20 TAQTLTFRELAAATKNFRSE---S-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--L 93 (361)
Q Consensus 20 ~~~~~~~~~~~~~~~~y~~~---~-~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i 93 (361)
..+.++.+.|..+.+.+-+. + ..-.+....||...... +..+++|+.... ......+..|+..+..|.... +
T Consensus 7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~-~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv 84 (325)
T PRK11768 7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDED-GRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPV 84 (325)
T ss_pred CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCC-CCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCC
Confidence 34566777778777777553 1 12234556788876543 667999987533 234556777887777663211 1
Q ss_pred ceee---e--EEEcCCeeEEEEEecCCCC
Q 018100 94 VNLI---G--YCADGDQRLLVYEYMPLGS 117 (361)
Q Consensus 94 ~~~~---~--~~~~~~~~~lv~e~~~~~~ 117 (361)
+... + +...+...+.++++++|..
T Consensus 85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 1111 1 1233456788999988654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.019 Score=52.45 Aligned_cols=157 Identities=22% Similarity=0.287 Sum_probs=89.5
Q ss_pred eHHHHHHHhhCcccCC-----eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC---Cccce-
Q 018100 25 TFRELAAATKNFRSES-----LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---PNLVN- 95 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~-----~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~- 95 (361)
+..++..+...|.+.- .|.+ .-..+|+..... |. +++|++... .....+..|+..+..|.- +-.++
T Consensus 12 ~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl 86 (331)
T COG2334 12 TSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPL 86 (331)
T ss_pred ChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 4456666666665542 3334 455788887764 33 489988755 445667778888887742 11111
Q ss_pred --e----eeEEEcCCeeEEEEEecCCCCHHH-H--------------hcc----cC----CCCCCCCHH-----------
Q 018100 96 --L----IGYCADGDQRLLVYEYMPLGSVED-H--------------LHD----LS----PGKKPLDWN----------- 135 (361)
Q Consensus 96 --~----~~~~~~~~~~~lv~e~~~~~~L~~-~--------------~~~----~~----~~~~~l~~~----------- 135 (361)
. +.........+-+++|++|..+.. . ++. .. .......+.
T Consensus 87 ~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~ 166 (331)
T COG2334 87 PSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLD 166 (331)
T ss_pred cCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhc
Confidence 1 111222237788999999877762 0 111 00 000011111
Q ss_pred --HHHHHHHHHHHHHHHHhcCC----CC-C--eeecCCCCCcEEEcCCCc-eeEecccccc
Q 018100 136 --TRMKIAAGAARGLEYLHDKA----KP-P--VIYRDLKCSNILLDRGYH-PKLSDFGLAK 186 (361)
Q Consensus 136 --~~~~i~~qi~~al~~LH~~~----~~-~--i~H~dl~p~Nilv~~~~~-~~L~Dfg~~~ 186 (361)
.-.....++...+..+.+.- .. . +||+|+.|+||+++.+.. +-++||+-|.
T Consensus 167 ~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 167 LVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 00123334445555555432 11 1 899999999999999885 8999999876
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.035 Score=51.98 Aligned_cols=76 Identities=18% Similarity=0.197 Sum_probs=44.0
Q ss_pred CCeecccCceEEEEEEECCCC-e-----EEEEEEeccCCccchHHHHHHHHHHhcCCCCccce-eeeEEEcCCeeEEEEE
Q 018100 39 ESLLGEGGFGRVYKGYLESIN-Q-----DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN-LIGYCADGDQRLLVYE 111 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~-~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e 111 (361)
.+.|..|-...+|++...... . .|.++.......... .-..|+.+++.+...++-+ +++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 346667888899998754321 2 255554322211111 2245888888886544443 4555532 58899
Q ss_pred ecCCCCHH
Q 018100 112 YMPLGSVE 119 (361)
Q Consensus 112 ~~~~~~L~ 119 (361)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99877654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.011 Score=53.87 Aligned_cols=73 Identities=21% Similarity=0.172 Sum_probs=56.9
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
+...|++|++- |+++ ..+. .....++..++++.+..+.-+..+-. +-|||+...||+|+ +|+|-|+||
T Consensus 298 ~~y~yl~~kdh-gt~i-s~ik-------~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPI-SIIK-------ADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Ccee-eeee-------cccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEe
Confidence 33456677753 3443 3333 25678899999999998888887654 89999999999999 999999999
Q ss_pred ccccc
Q 018100 183 GLAKL 187 (361)
Q Consensus 183 g~~~~ 187 (361)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99985
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.035 Score=47.42 Aligned_cols=76 Identities=21% Similarity=0.262 Sum_probs=52.6
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC---CCccceeeeEEEcCCeeEEEEEecCC
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
.+.+..|..-..|...+. ..++.+|+-. ......|..|+.-|..|. .-.+.+++.+.....+.|+|++|.+.
T Consensus 21 r~~v~gG~inea~~v~dg--~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 21 REEVSGGDINEAWRLRDG--TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred ccccCCccccceeEeecC--CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 345666777777776554 4678888743 223355677777766663 45677788888888999999999987
Q ss_pred CCHH
Q 018100 116 GSVE 119 (361)
Q Consensus 116 ~~L~ 119 (361)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 6554
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.043 Score=52.38 Aligned_cols=76 Identities=8% Similarity=0.052 Sum_probs=45.0
Q ss_pred cCCeecccCceEEEEEEECCC--------CeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccc-eeeeEEEcCCeeEE
Q 018100 38 SESLLGEGGFGRVYKGYLESI--------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLL 108 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l 108 (361)
-++.|..|-.-.+|++..... +..|++|+.......-. .-..|..+++.+..-+|- ++++.+. ...
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 345666777778888875421 45799998754332222 234477777766543333 3445443 235
Q ss_pred EEEecCCCCH
Q 018100 109 VYEYMPLGSV 118 (361)
Q Consensus 109 v~e~~~~~~L 118 (361)
|.+|++|.+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7899987644
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.013 Score=55.61 Aligned_cols=50 Identities=24% Similarity=0.332 Sum_probs=39.7
Q ss_pred chHHHHHHHHHHhcCCCCccceeeeEEEcC-CeeEEEEEecCCCCHHHHhcc
Q 018100 74 GNREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHD 124 (361)
Q Consensus 74 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~ 124 (361)
...++.....+++.+.|+|+..++++.... ....+|+|++ +.+|.+....
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 345677788999999999999999887543 3467889998 5899988865
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.024 Score=52.54 Aligned_cols=62 Identities=21% Similarity=0.055 Sum_probs=43.0
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 174 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~ 174 (361)
..++-+|..|.++..++.. ...++..+..++.-..+|+..+---.+ ++|.|++|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEec
Confidence 3566678888898888874 445665666666666666554433322 9999999999999543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.042 Score=46.70 Aligned_cols=103 Identities=16% Similarity=0.135 Sum_probs=63.2
Q ss_pred EEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHH
Q 018100 61 DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 139 (361)
Q Consensus 61 ~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~ 139 (361)
+.++|++...... ...-+.++..++.+++ .|+++..- +....-++.|+|... .... .-.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~--------------~i~~--~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI--------------KINF--SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------------ccch--hHH
Confidence 4556666433222 3345677888887664 34555522 233445888988511 1111 111
Q ss_pred HHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 140 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 140 i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
+... +++|.-.|+.. +..+|||..|+|||-|..|.+||.|=+.-
T Consensus 147 i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 1111 47788889442 23999999999999999999999997654
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 361 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-58 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-43 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = 0.0
Identities = 115/314 (36%), Positives = 167/314 (53%), Gaps = 20/314 (6%)
Query: 12 EDGASDQITAQTLTFRELAAATKNFRSE------SLLGEGGFGRVYKGYLESINQDVAIK 65
+ + +F EL T NF + +GEGGFG VYKGY+ N VA+K
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVK 60
Query: 66 QL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
+L D + ++F E+ +++ H NLV L+G+ +DGD LVY YMP GS+ D
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
L L G PL W+ R KIA GAA G+ +LH+ I+RD+K +NILLD + K+SD
Sbjct: 121 LSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FGLA+ T +++R++GT Y APE G++T KSD+YSFGVVLLEI++G AVD
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
+ Q L+ + + D ++ +VA+ C+HE+ + RP
Sbjct: 236 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 302 VIADVVTALAYLAS 315
I V L + +
Sbjct: 293 DIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 514 bits (1325), Expect = 0.0
Identities = 117/311 (37%), Positives = 166/311 (53%), Gaps = 5/311 (1%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
++ + +A + + +L AT NF + L+G G FG+VYKG L
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAK 65
Query: 62 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 121
VA+K+ QG EF E+ LS HP+LV+LIG+C + ++ +L+Y+YM G+++ H
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
L+ + W R++I GAARGL YLH +I+RD+K NILLD + PK++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241
FG++K G D TH+ST V GT GY PEY G+LT KSDVYSFGVVL E+L R A+
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
S +L WA + I DP L + P + A C+ + RP
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQ-IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 302 VIADVVTALAY 312
+ DV+ L Y
Sbjct: 302 SMGDVLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 497 bits (1281), Expect = e-178
Identities = 126/305 (41%), Positives = 181/305 (59%), Gaps = 6/305 (1%)
Query: 9 EASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD 68
A ED + + REL A+ NF ++++LG GGFG+VYKG L VA+K+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLK 63
Query: 69 RNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 127
QG +F EV M+S+ H NL+ L G+C +RLLVY YM GSV L +
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 128 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187
+ PLDW R +IA G+ARGL YLHD P +I+RD+K +NILLD + + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247
D THV+T V GT G+ APEY TG+ + K+DV+ +GV+LLE+++G++A D ++ A
Sbjct: 184 MDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 248 EQS--LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305
+ L+ W + L +++ + + D +LQG Y Q + VA +C P RP +++
Sbjct: 243 DDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 306 VVTAL 310
VV L
Sbjct: 302 VVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 7e-92
Identities = 76/314 (24%), Positives = 112/314 (35%), Gaps = 29/314 (9%)
Query: 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL 83
L L + + + G FG V+K L N+ VA+K Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 84 MLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 139
L + H N++ IG G L+ + GS+ D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 140 IAAGAARGLEYLH-------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
IA ARGL YLH D KP + +RD+K N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 193 NTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247
+ + +GT Y APE + L+ D+Y+ G+VL E+ S A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 248 EQSLVA--WARPLFQDRTRHSLI--ADPELQGQYPPRGFYQALA-VAAMCVHEQPDMRPV 302
P +D + P L+ + L C + R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 303 IADVVTALAYLASQ 316
V + +
Sbjct: 306 AGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-72
Identities = 77/340 (22%), Positives = 128/340 (37%), Gaps = 49/340 (14%)
Query: 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VE 81
E + N + L+G G +G VYKG L+ + VA+K + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 82 VLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 136
+ + L+ H N+ I + LLV EY P GS+ +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 137 RMKIAAGAARGLEYLH------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---- 186
++A RGL YLH D KP + +RDL N+L+ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 187 --LGPVGDNTHVSTRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEILSGR 237
L G+ + + +GT Y APE + + D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 238 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP---RGFYQALAVAAM--- 291
+ + + + +A+ + T + + Q P +LAV ++
Sbjct: 233 TDLFPGE-SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 292 ---CVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSP 328
C + + R +A L + K SP
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMM---IWERNKSVSP 328
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-70
Identities = 81/288 (28%), Positives = 136/288 (47%), Gaps = 43/288 (14%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHP 91
E +G+GGFG V+KG L VAIK L +G +EF EV ++S L+HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N+V L G + +V E++P G + L D P+ W+ ++++ A G+EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYM 138
Query: 152 HDKAKPPVIYRDLKCSNILLD-----RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
++ PP+++RDL+ NI L K++DFGL++ + H + ++G + +
Sbjct: 139 QNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192
Query: 207 CAPE--YAKTGQLTLKSDVYSFGVVLLEILSGRKAVD--TSKAAAEQSLVAWARPLFQDR 262
APE A+ T K+D YSF ++L IL+G D + +++ ++
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR------EEG 246
Query: 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
R P + PPR + + +C P RP + +V L
Sbjct: 247 LR------PTIPEDCPPR--LRNV--IELCWSGDPKKRPHFSYIVKEL 284
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 5e-70
Identities = 81/284 (28%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 99
+G G FG V++ DVA+K L EFL EV ++ L HPN+V +G
Sbjct: 45 IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
+V EY+ GS+ LH ++ LD R+ +A A+G+ YLH++ PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 219
++R+LK N+L+D+ Y K+ DFGL++L S GT + APE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 220 KSDVYSFGVVLLEILSGR------KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273
KSDVYSFGV+L E+ + + A + R
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----RLEI-------------- 260
Query: 274 QGQYPPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQ 316
PR +A + C +P RP A ++ L L
Sbjct: 261 -----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-67
Identities = 75/311 (24%), Positives = 123/311 (39%), Gaps = 36/311 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+G G FG V K +DVAIKQ++ + + F+VE+ LS ++HPN+V L G C
Sbjct: 16 VGRGAFGVVCKAKWR--AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ LV EY GS+ + LH P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 162 RDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 220
RDLK N+LL G K+ DFG A D T G+ + APE + + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 221 SDVYSFGVVLLEILSGR---KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 277
DV+S+G++L E+++ R + ++ RP
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL------------------ 225
Query: 278 PPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPT 336
+ + + + C + P RP + ++V + +L +D
Sbjct: 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284
Query: 337 RTKGDKERKLN 347
+ +
Sbjct: 285 DGRVEPYVDFA 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-66
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+G GGFG+VY+ + +VA+K D + Q E + ++L HPN++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
G C LV E+ G + L K + + + A ARG+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 158 PVIYRDLKCSNILLDRGYHP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
P+I+RDLK SNIL+ + K++DFGLA+ T + G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP 183
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGR 237
E + + SDV+S+GV+L E+L+G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-65
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 41/279 (14%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 99
L E G ++KG + D+ +K L R+F E L + HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 100 CADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
C + +MP GS+ + LH+ +D + +K A ARG+ +LH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKT 214
+ L ++++D ++S + + S M + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPE 185
Query: 215 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 274
+D++SF V+L E+++ P F D + + L+
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREV------------------P-FADLSNMEIGMKVALE 226
Query: 275 GQYP--PRGFYQALA-VAAMCVHEQPDMRPVIADVVTAL 310
G P P G ++ + +C++E P RP +V L
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 71/310 (22%), Positives = 112/310 (36%), Gaps = 39/310 (12%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
+LG+G FG+ K + + +K+L R + R FL EV ++ L HPN++ IG
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
+ + EY+ G++ + W+ R+ A A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKL------------GPVGDNTHVSTRVMGTYGY 206
+I+RDL N L+ + ++DFGLA+L + V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA---VDTSKAAAEQSLVAWARPLFQDRT 263
APE K DV+SFG+VL EI+ A ++ +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248
Query: 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAE 323
P F+ + C P+ RP + L L
Sbjct: 249 ---------------PPSFFP---ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
Query: 324 KVQSPCLDPG 333
Q LD G
Sbjct: 291 GPQLEQLDRG 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 8e-63
Identities = 61/288 (21%), Positives = 106/288 (36%), Gaps = 50/288 (17%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 99
+G+G FG+VY G + +VAI+ +D + + F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
C ++ ++ + D K LD N +IA +G+ YLH K +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
+++DLK N+ D G ++DFGL + G G + APE +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 217 L---------TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-----RPLFQDR 262
+ SDV++ G + E+ + T A A + W +P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIWQMGTGMKPNL--- 263
Query: 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
++ + L C + + RP ++ L
Sbjct: 264 --------SQIGM---GKEISDIL---LFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 9e-63
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 33/277 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 99
+G G FG VYKG + DVA+K L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159
Q +V ++ S+ HLH + + + IA ARG++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQ 216
I+RDLK +NI L K+ DFGLA +H ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 217 LTLKSDVYSFGVVLLEILSGR---KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273
+ +SDVY+FG+VL E+++G+ ++ E P ++
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL-----------SKV 250
Query: 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
+ P + + A C+ ++ D RP ++ +
Sbjct: 251 RSNCPK-RMKRLM---AECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-62
Identities = 66/302 (21%), Positives = 114/302 (37%), Gaps = 33/302 (10%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNL 96
+G+G +G V+ G + VA+K + E+ L+ H N++
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGF 96
Query: 97 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
I G Q L+ +Y GS+ D+L LD + +K+A + GL +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLH 151
Query: 153 -----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYG 205
+ KP + +RDLK NIL+ + ++D GLA N +GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 206 YCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAWARPL 258
Y PE Q + +D+YSFG++L E+ + + + + P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 259 FQDRTRHSLIAD--PELQGQYPPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLAS 315
++D I P ++ + + + C P R V LA ++
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 316 QK 317
+
Sbjct: 332 SQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-60
Identities = 64/302 (21%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNL 96
+G+G +G V++G + ++VA+K + + + E+ +L H N++
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 97 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
I Q L+ Y +GS+ D+L LD + ++I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 153 -----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV--STRVMGTYG 205
+ KP + +RDLK NIL+ + ++D GLA + N + +GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 206 YCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 259
Y APE + D+++FG+VL E+ S E + +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR----MVSNGIVEDYKPPFYDVVP 238
Query: 260 QDRTRHSLIADPELQGQYP--PRGFYQALAVAAM------CVHEQPDMRPVIADVVTALA 311
D + + + Q P P ++ + ++ C ++ P R + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 312 YL 313
+
Sbjct: 299 KI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-59
Identities = 69/306 (22%), Positives = 121/306 (39%), Gaps = 41/306 (13%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNL 96
+ +G+G FG V++G ++VA+K + R + E+ +L H N++
Sbjct: 47 QESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 97 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
I + Q LV +Y GS+ D+L+ + + +K+A A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 156
Query: 153 -----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYG 205
+ KP + +RDLK NIL+ + ++D GLA +T +GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 206 YCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 259
Y APE K + ++D+Y+ G+V EI + E + + +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR----CSIGGIHEDYQLPYYDLVP 272
Query: 260 QDRTRHSLIADPELQGQYP--PRGFYQALAVAAM------CVHEQPDMRPVIADVVTALA 311
D + + Q P P + A+ M C + R + L+
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 312 YLASQK 317
L+ Q+
Sbjct: 333 QLSQQE 338
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 100
+G G FG V+ G L + N VA+K + +FL E +L HPN+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
+V E + G L L T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY--CAPEYAKTGQLT 218
+RDL N L+ K+SDFG+++ D + ++ + APE G+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 219 LKSDVYSFGVVLLEILS 235
+SDV+SFG++L E S
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 42 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LG G FG VYKG E + VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
+G C L+ + MP G + D++ + K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
+++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 217 LTLKSDVYSFGVVLLEILS-GRK 238
T +SDV+S+GV + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 39 ESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
S LG+G FG V ++ VA+KQL +G R+F E+ +L LH +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 95 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
G ++ LV EY+P G + D L + LD + + ++ +G+EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLG 144
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 207
+ ++RDL NIL++ H K++DFGLAKL P+ + +V G +
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWY 197
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS 235
APE + +SDV+SFGVVL E+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 39 ESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
LG+G FG V ++ + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 95 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
G C +R L+ EY+P GS+ D+L K+ +D ++ + +G+EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG 131
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 207
K I+RDL NIL++ K+ DFGL K+ P G +
Sbjct: 132 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWY 184
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS 235
APE + ++ SDV+SFGVVL E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-43
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 39 ESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
LG+G FG V + + + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 95 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
G C +R L+ EY+P GS+ D+L K+ +D ++ + +G+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG 162
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 207
K I+RDL NIL++ K+ DFGL K+ P + G +
Sbjct: 163 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWY 215
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS 235
APE + ++ SDV+SFGVVL E+ +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
++ E+M G++ D+L ++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG-TYGYCAPEYAKTGQLTLK 220
R+L N L+ + K++DFGL++L + +T+ + + APE + ++K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 221 SDVYSFGVVLLEILS 235
SDV++FGV+L EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-43
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 39 ESLLGEGGFGRVYKGYLESINQD----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 93
LGEG FG+V + + VA+K L +G + E+ +L L+H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 94 VNLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
V G C + L+ E++P GS++++L K ++ ++K A +G++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYL 142
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 206
+ ++RDL N+L++ + K+ DFGL K + +
Sbjct: 143 GSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFW 195
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
APE + + SDV+SFGV L E+L+
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-43
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 42 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LG G FG V+KG ESI V IK + D++G Q + +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
+G C G LV +Y+PLGS+ DH+ + L + A+G+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
+++R+L N+LL +++DFG+A L P D + + + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 217 LTLKSDVYSFGVVLLEILS-GRK 238
T +SDV+S+GV + E+++ G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-43
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 42 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LG G FG VYKG E + VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
+G C L+ + MP G + D++ + K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 216
+++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 217 LTLKSDVYSFGVVLLEILS-GRK 238
T +SDV+S+GV + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-43
Identities = 68/209 (32%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 39 ESLLGEGGFGRVYKGYLESINQD----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 93
LGEG FG+V + N VA+K L G Q + E+ +L L+H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 94 VNLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
+ G C D LV EY+PLGS+ D+L + + + A G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYL 150
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 206
H + I+RDL N+LLD K+ DFGLAK P G + + G +
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFW 203
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
APE K + SDV+SFGV L E+L+
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-43
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
++ E+M G++ D+L ++ + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL N L+ + K++DFGL++L + +T+ + G + APE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 219 LKSDVYSFGVVLLEILS 235
+KSDV++FGV+L EI +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 18/237 (7%)
Query: 8 KEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL 67
+E D +T ++ + + + +G G F VYKG +VA +L
Sbjct: 1 QEERNQQQDDIEELET-KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL 59
Query: 68 DRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD---GDQRLLVY-EYMPLGSVEDH 121
+ + + F E ML L HPN+V G + +++ E M G+++ +
Sbjct: 60 QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLS 180
L K + +GL++LH + PP+I+RDLKC NI + K+
Sbjct: 120 LKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG 174
Query: 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
D GLA L + V+GT + APE + DVY+FG+ +LE+ +
Sbjct: 175 DLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-42
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
LG+G FG VY+G + + +D VAIK ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------GKKPLDWNTRMKIAAGAARGLE 149
L+G + G L++ E M G ++ +L L P P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGT 203
YL+ ++RDL N ++ + K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+PE K G T SDV+SFGVVL EI +
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-42
Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 34 KNFRSESLLGEGGFGRVYKGYL---ESINQDVAIKQL---DRNGVQGNREFLVEVLMLSL 87
K+ R LG+G FG V +G VA+K L + + +F+ EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
L H NL+ L G +V E PLGS+ D L + T + A A G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 133
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 204
+ YL K I+RDL N+LL K+ DFGL + P D+ +V +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 238
+CAPE KT + SD + FGV L E+ + G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-42
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L G C + LV E+M G + D+L + T + + G+ YL +
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPE 210
VI+RDL N L+ K+SDFG+ + V D+ + T GT + +PE
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPE 175
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILS-GRK 238
+ + KSDV+SFGV++ E+ S G+
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 63/294 (21%), Positives = 100/294 (34%), Gaps = 46/294 (15%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
K++ LGEGGF V A+K++ + Q E E M L +HPN+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 94 VNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
+ L+ YC L+ + G++ + + L L + + + G RGLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-------G 202
+H +RDLK +NILL P L D G + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 203 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 256
T Y APE + + ++DV+S G VL ++ G
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGP----------------- 245
Query: 257 PLFQDRTRHSLIADPELQGQY---PPRGFYQAL-AVAAMCVHEQPDMRPVIADV 306
+ + +Q Q AL + + P RP I +
Sbjct: 246 --YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 42 LGEGGFGRVYKGYLESINQ-------DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
LG+G F +++KG + +V +K LD+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
G C GD+ +LV E++ GS++ +L K ++ ++++A A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 155 AKPPVIYRDLKCSNILLDRGYHP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
+I+ ++ NILL R KLSD G++ V + R+
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIPWV--- 184
Query: 207 CAPEYAKTGQL-TLKSDVYSFGVVLLEILS-GRK 238
PE + + L +D +SFG L EI S G K
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-41
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 39 ESLLGEGGFGRVYKGYL--ESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLV 94
+ LG G FG V KGY + + + VA+K L + N E L E ++ L +P +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
+IG C + + +LV E LG + +L + + +++ + G++YL +
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 208
++RDL N+LL ++ K+SDFGL+K +N + + + A
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 238
PE + + KSDV+SFGV++ E S G+K
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-41
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V G + DVA+K + + G EF E + L HP LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+V EY+ G + ++L K L+ + +++ G+ +L I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL N L+DR K+SDFG+ + V D+ + +GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 219 LKSDVYSFGVVLLEILS-GRK 238
KSDV++FG+++ E+ S G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-41
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 39 ESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLV 94
+ LG G FG V +G + DVAIK L + G + E + E ++ L +P +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
LIG C + +LV E G + L ++ + + ++ + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 208
++RDL N+LL ++ K+SDFGL+K D+ + + + A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 238
PE + + +SDV+S+GV + E LS G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-41
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V G DVAIK + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
++ EYM G + ++L + + +++ +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL N L++ K+SDFGL++ V D+ + T +G+ + PE + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 219 LKSDVYSFGVVLLEILS 235
KSD+++FGV++ EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-40
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LGEG FG+V+ +++ VA+K L + ++F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGA 144
G C DGD ++V+EYM G + L P K L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV---- 200
A G+ YL + ++RDL N L+ K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 201 --MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
M PE + T +SDV+SFGV+L EI +
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LGEG FG+V+ ++ + VA+K L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAA 145
G C +G L+V+EYM G + L P PL + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----- 200
G+ YL ++RDL N L+ +G K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 201 -MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
M PE + T +SDV+SFGVVL EI +
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+G+G FG V G VA+K + + + FL E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 102 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
+ L +V EYM GS+ D+L S G+ L + +K + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQ 216
+RDL N+L+ K+SDFGL K +T + ++ APE + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 217 LTLKSDVYSFGVVLLEILS 235
+ KSDV+SFG++L EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 39 ESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLV 94
E ++G G G V G L + VAIK L + R +FL E ++ HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
L G G ++V EYM GS++ L + + G G+ YL D
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEY 211
++RDL N+L+D K+SDFGL+++ + D+ + G + APE
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 212 AKTGQLTLKSDVYSFGVVLLEILS-GRK 238
+ SDV+SFGVV+ E+L+ G +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-40
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+G+G FG V G VA+K + +N + FL E +++ L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR--GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 102 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
+ L +V EYM GS+ D+L S G+ L + +K + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 161 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQ 216
+RDL N+L+ K+SDFGL K +T + ++ APE + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 217 LTLKSDVYSFGVVLLEILS-GRK 238
+ KSDV+SFG++L EI S GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
LGE FG+VYKG+L VAIK L R EF E ++ + L HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAG 143
L+G +++ Y G + + L SP K L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST----- 198
A G+EYL V+++DL N+L+ + K+SD GL + D +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 199 -RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
R M APE G+ ++ SD++S+GVVL E+ S
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 42 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 97
LGEG FG VY+G + +VA+K ++ N+ +F+ E +++ L HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
G + + ++ E P G + +L K L T + + + + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEY 211
++RD+ NIL+ KL DFGL++ + D + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 212 AKTGQLTLKSDVYSFGVVLLEILS-GRK 238
+ T SDV+ F V + EILS G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVN 95
LG G FG VY+G + + D VA+K L + Q +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLH 152
IG R ++ E M G ++ L + P L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 153 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E G T K+D +SFGV+L EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 34 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLL 88
+ ++G G FG VYKG L VAIK L + R +FL E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
H N++ L G + +++ EYM G+++ L + + + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGM 160
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YG 205
+YL + ++RDL NIL++ K+SDFGL+++ + D+ + G
Sbjct: 161 KYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIR 215
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 238
+ APE + T SDV+SFG+V+ E+++ G +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 42 LGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 97
+G G FG VY G L + A+K L+R G +FL E +++ HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 98 GYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
G C + L+V YM G + + + + + + A+G++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYCAPE 210
++RDL N +LD + K++DFGLA+ + V + A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILS 235
+T + T KSDV+SFGV+L E+++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V+ GY + VA+K L + G FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ ++ EYM GS+ D L +P L N + +AA A G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 218
RDL+ +NIL+ K++DFGLA+L + DN + T G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188
Query: 219 LKSDVYSFGVVLLEILS 235
+KSDV+SFG++L EI++
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
E LG+G FG V+ G VAIK L + G FL E ++ L H LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
+ +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 218
++RDL+ +NIL+ K++DFGLA+L + T + APE A G+ T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFT 359
Query: 219 LKSDVYSFGVVLLEILS 235
+KSDV+SFG++L E+ +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 78/322 (24%), Positives = 130/322 (40%), Gaps = 47/322 (14%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLH 89
N + ++G G FG V G L+ VAIK L + R +FL E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
HPN++ L G ++V EYM GS++ L + + G A G++
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMK 161
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGY 206
YL D ++RDL NIL++ K+SDFGL ++ + D+ + G +
Sbjct: 162 YLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRW 216
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265
+PE + T SDV+S+G+VL E++S G RP + + +
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE------------------RP-YWEMSNQ 257
Query: 266 SLIADPELQGQ--YPPRG----FYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 319
+I + +G PP YQ + C + + RP +V+ L L +
Sbjct: 258 DVIKAVD-EGYRLPPPMDCPAALYQ---LMLDCWQKDRNNRPKFEQIVSILDKLI--RNP 311
Query: 320 SDAEKVQSPCLDPGTPTRTKGD 341
+ + S P + +
Sbjct: 312 GSLKIITSAAARPSNLLLDQSN 333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 37 RSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPN 92
S+ ++G+G FG VY G Q+ AIK L R FL E L++ L+HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 93 LVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
++ LIG + ++ YM G + + ++ + ARG+EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG--------T 203
++ ++RDL N +LD + K++DFGLA+ + D + S + T
Sbjct: 141 AEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWT 195
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
A E +T + T KSDV+SFGV+L E+L+
Sbjct: 196 ----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 8e-39
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 39 ESLLGEGGFGRVYKGYLESINQ--DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVN 95
+ LG G FG V +G + DVAIK L E + E ++ L +P +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
LIG C + +LV E G + L ++ + + ++ + G++YL +K
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYA 212
++R+L N+LL ++ K+SDFGL+K D+ + + + APE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECI 511
Query: 213 KTGQLTLKSDVYSFGVVLLEILS-GRK 238
+ + +SDV+S+GV + E LS G+K
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-39
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 42 LGEGGFGRVYKGYLESINQD---VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LGEG FG V +G L+ + VA+K + D + + EFL E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 97 IGYCADGDQR-----LLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLE 149
+G C + + +++ +M G + +L L G K + T +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGT 203
YL ++ ++RDL N +L ++DFGL+K GD +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
A E T KSDV++FGV + EI +
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 39 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLV 94
++G G FG VY G L + A+K L+R + +FL E +++ HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 95 NLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
+L+G C + L+V YM G + + + + + + A+G+++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS 210
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYC 207
K ++RDL N +LD + K++DFGLA+ + V +
Sbjct: 211 KK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---- 263
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILS 235
A E +T + T KSDV+SFGV+L E+++
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
LG G FG VY+G + + D VA+K L + + +FL+E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLH 152
IG R ++ E M G ++ L + P L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 153 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E G T K+D +SFGV+L EI S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
E LG G FG V+ + VA+K + + G FL E ++ L H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 158
+ ++ E+M GS+ D L S + +A A G+ ++ +
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTG 215
I+RDL+ +NIL+ K++DFGLA++ + DN + T G + APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFG 360
Query: 216 QLTLKSDVYSFGVVLLEILS 235
T+KSDV+SFG++L+EI++
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 42 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNL 96
+GEG FG V++G S VAIK +N +FL E L + HP++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
IG + ++ E LG + L K LD + + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPE 210
++RD+ N+L+ KL DFGL++ + D+T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILS-GRK 238
+ T SDV+ FGV + EIL G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 42 LGEGGFGRVYKGYLESINQD---VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNL 96
LG+G FG V + L+ + VA+K L D EFL E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 97 IGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARGL 148
+G + +++ +M G + L G+ P L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MG 202
EYL + I+RDL N +L ++DFGL++ GD +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 203 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
A E T+ SDV++FGV + EI++
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 65/194 (33%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG+G FG V+ G VAIK L + G FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 161
+ +V EYM GS+ D L K L + +AA A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 162 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 221
RDL+ +NIL+ K++DFGLA+L + T + APE A G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 222 DVYSFGVVLLEILS 235
DV+SFG++L E+ +
Sbjct: 446 DVWSFGILLTELTT 459
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 31/282 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHP 91
+++ +G G +GR K +S + + K+LD + + ++ LV EV +L L HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 92 NLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
N+V D L V EY G + + + ++ LD +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 150 YLHDKAKPP--VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
H ++ V++RDLK +N+ LD + KL DFGLA++ + +T + +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYM 183
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267
+PE KSD++S G +L E+ + P F ++ L
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCAL-------------------MPPFTAFSQKEL 224
Query: 268 IADPELQGQYP--PRGFYQAL-AVAAMCVHEQPDMRPVIADV 306
+G++ P + L + ++ + RP + ++
Sbjct: 225 AGKI-REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-38
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 50/289 (17%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
+F+ L+G GGFG+V+K + IK++ N N + EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 94 VNLIGYCADGDQRL----------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 137
V+ G D + E+ G++E + + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
+++ +G++Y+H K +I RDLK SNI L K+ DFGL N
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------------CDT 220
Query: 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
F+ + + D + + + + + ++P+ RP +++
Sbjct: 221 AFETSKFFTDLRDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 42 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPN 92
LGEG FG+V I++D VA+K L + + + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHL------------HDLSPGKKPLDWNTRMKI 140
++NL+G C ++ EY G++ ++L ++ + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 198
ARG+EYL + I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 199 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ M APE T +SDV+SFGV++ EI +
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 39 ESLLGEGGFGRVYKGYL--ESINQDVAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 94
+ ++GEG FG+V K + + + D AIK++ + +R+F E+ ++ L HHPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAA 142
NL+G C L EY P G++ D L L + AA
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST---- 198
ARG++YL K I+RDL NIL+ Y K++DFGL++ + T
Sbjct: 150 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 199 --RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
R M A E T SDV+S+GV+L EI+S
Sbjct: 204 PVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQL-DRNGVQGNREFLVEVLMLSLLH 89
+ +GEG FG V++G S VAIK + +FL E L +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
HP++V LIG + ++ E LG + L K LD + + A + L
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALA 505
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG---- 205
YL K ++RD+ N+L+ KL DFGL++ + D+T+ G
Sbjct: 506 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPI 556
Query: 206 -YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ APE + T SDV+ FGV + EIL
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 42 LGEGGFGRVYKGYLESINQD-------VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPN 92
LGEG FG+V I++D VA+K L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 140
++NL+G C ++ EY G++ ++L P ++ + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 198
ARG+EYL + I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 199 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ M APE T +SDV+SFGV++ EI +
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 94
LG G FG+V + + ++ VA+K L + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGA 144
NL+G C G L++ EY G + + L S + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------ 198
A+G+ +L K I+RD+ N+LL G+ K+ DFGLA+ N V
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 199 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ M APE T++SDV+S+G++L EI S
Sbjct: 231 KWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 35/231 (15%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
+F ++LG+G FG+V K ++ AIK++ + L EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 93 LVNLIGYCADGDQRL-------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 139
+V + + + EY G++ D +H + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 140 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL------------ 187
+ L Y+H + +I+RDLK NI +D + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 188 -GPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSG 236
G + ++++ + GT Y A E TG K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 58/279 (20%), Positives = 93/279 (33%), Gaps = 39/279 (13%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEV-LMLSLLHH 90
++F+ S LG G +G V+K + + A+K+ G + L EV + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P V L +G L E S++ H L L +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAH 172
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH + +++ D+K +NI L KL DFGL +G + G Y APE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE 226
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL--- 267
+ G +DV+S G+ +LE+ + L
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNME------------------LPHGGEGWQQLRQG 267
Query: 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
PE + +V M + P +R +
Sbjct: 268 YLPPEFTAGLSS----ELRSVLVMMLEPDPKLRATAEAL 302
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
+GEG FGRV++ + VA+K L + +F E +++ +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWN 135
L+G CA G L++EYM G + + L +SP G PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195
++ IA A G+ YL ++ ++RDL N L+ K++DFGL++ D
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 196 VSTRV------MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
M PE + T +SDV+++GVVL EI S
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 91
++ LG GG VY +N VAIK + + E L EV S L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N+V++I + D LV EY+ ++ +++ PL +T + G+++
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHA 127
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPE 210
HD +++RD+K NIL+D K+ DFG+AK + + + T V+GT Y +PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPE 182
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
AK +D+YS G+VL E+L G
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 94
LG G FG+V + + + VA+K L + R + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKI 140
NL+G C G L++ EY G + + L + LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 198
+ A+G+ +L K I+RDL NILL G K+ DFGLA+ N V
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 199 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ M APE T +SDV+S+G+ L E+ S
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 95
LGEG FG+V K + VA+K L N + L E +L ++HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHL--------------------HDLSPGKKPLDWN 135
L G C+ LL+ EY GS+ L P ++ L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195
+ A ++G++YL + +++RDL NIL+ G K+SDFGL++ D+
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 196 VST------RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ + M A E T +SDV+SFGV+L EI++
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 52/299 (17%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPN 92
+F LG GGFG V++ + + + AIK++ + RE + EV L+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 93 LVNLIGYCADGD---------QRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 140
+V + + ++ +Y + +++D ++ + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHI 123
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL----------GPV 190
A +E+LH K +++RDLK SNI K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 250
T +GT Y +PE + K D++S G++L E+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------------- 224
Query: 251 LVAWARPLFQDRTRHSLIADPELQGQYP--PRGFYQALA-VAAMCVHEQPDMRPVIADV 306
P R + D ++P Y + + P RP ++
Sbjct: 225 -----YPFSTQMERVRTLTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 50/243 (20%), Positives = 89/243 (36%), Gaps = 25/243 (10%)
Query: 10 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 69
+ + + L F+ ++ + + +G GG +V++ E Q AIK ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL 62
Query: 70 NGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 125
+ E+ L+ L + + L Y +V E + L
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK- 120
Query: 126 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185
KK +D R + +H +++ DLK +N L+ G KL DFG+A
Sbjct: 121 ---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 186 KLGPVGDNTHVSTRVMGTYGYCAPE-----------YAKTGQLTLKSDVYSFGVVLLEIL 234
+ V +GT Y PE +++ KSDV+S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 235 SGR 237
G+
Sbjct: 234 YGK 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 61/200 (30%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLI 97
LG+G FG VY + +A+K L + ++ + EV + S L HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
GY D + L+ EY PLG+V L D A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
VI+RD+K N+LL K++DFG + P + GT Y PE +
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEMIEGRMH 184
Query: 218 TLKSDVYSFGVVLLEILSGR 237
K D++S GV+ E L G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 42 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPN 92
LGEG FG+V +++D VA+K L + + + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR------------MKI 140
++NL+G C ++ EY G++ ++L P +N +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 198
A ARG+EYL K I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 199 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ M APE T +SDV+SFGV+L EI +
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-36
Identities = 64/280 (22%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 90
NFR E +G G F VY+ VA+K++ + + + E+ +L L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
PN++ + ++ +V E G + + K+ + T K LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
+H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPE 206
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270
KSD++S G +L E+ + + P + D+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYSLCK 248
Query: 271 PELQGQYP--PRGFY-QAL-AVAAMCVHEQPDMRPVIADV 306
Q YP P Y + L + MC++ P+ RP + V
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 45/226 (19%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-------------- 80
++R L +G F ++ E N+ A+K+ +++ ++ R+F
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 81 ---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 137
E+ +++ + + + G + D+ ++YEYM S+ K
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 138 MKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193
+++ + Y+H++ + +RD+K SNIL+D+ KLSDFG ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---D 204
Query: 194 THVSTRVMGTYGYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ GTY + PE ++ K D++S G+ L +
Sbjct: 205 KKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-36
Identities = 59/335 (17%), Positives = 133/335 (39%), Gaps = 36/335 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHP 91
+ + +GEG FG+ + IK+++ + + RE EV +L+ + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N+V + +V +Y G + ++ + + L+++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHV 141
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
HD+ +++RD+K NI L + +L DFG+A++ + ++ +GT Y +PE
Sbjct: 142 HDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271
+ KSD+++ G VL E+ + + A F+ + +L+
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA-------------------FEAGSMKNLVLKI 237
Query: 272 ELQGQYP--PRGFYQAL-AVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSP 328
+ G +P + L ++ + P RP + ++ ++A + + + ++ +
Sbjct: 238 -ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL-EKGFIAKRIEKFLSPQLIAE 295
Query: 329 CLDPGTPTRTK---GDKERKLNGGRGSERERTRKL 360
T ++ +R +G +K+
Sbjct: 296 EFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKI 330
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 94
LG G FG+V + I++ VA+K L + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 95 NLIGYCADGDQ-RLLVYEYMPLGSVEDHL------------HDLSPGKKPLDWNTRMKIA 141
NL+G C +++ E+ G++ +L K L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST--- 198
A+G+E+L + I+RDL NILL K+ DFGLA+ +
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 199 ---RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
+ M APE T++SDV+SFGV+L EI S
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 48/219 (21%), Positives = 81/219 (36%), Gaps = 25/219 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 91
+ + +G GG +V++ E Q AIK ++ + E+ L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 92 NL--VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
+ + L Y +V E + L KK +D R +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+H +++ DLK +N L+ G KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 210 E-----------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
E +++ KSDV+S G +L + G+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 50/247 (20%), Positives = 90/247 (36%), Gaps = 25/247 (10%)
Query: 6 RVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIK 65
+ ++ + G D A + ++ + + +G GG +V++ E Q AIK
Sbjct: 28 QHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIK 86
Query: 66 QLDRNGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEYMPLGSVEDH 121
++ + E+ L+ L + + L Y +V E +
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSW 145
Query: 122 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181
L KK +D R + +H +++ DLK +N L+ G KL D
Sbjct: 146 LKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLID 197
Query: 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAKTGQLTLKSDVYSFGVVL 230
FG+A + V +G Y PE +++ KSDV+S G +L
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 231 LEILSGR 237
+ G+
Sbjct: 258 YYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 16/233 (6%)
Query: 9 EASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD 68
E ++ E + +G G FG V++ + A+K++
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 92
Query: 69 RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 128
+ E++ + L P +V L G +G + E + GS L L
Sbjct: 93 LEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS----LGQLIKQ 143
Query: 129 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAK- 186
L + + A GLEYLH + +++ D+K N+LL G L DFG A
Sbjct: 144 MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 187 LGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
L P G + T + GT + APE K D++S ++L +L+G
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 94
LG G FG+V I++ VA+K L R + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------------------GKKPLDWN 135
NL+G C L++EY G + ++L L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195
+ A A+G+E+L K+ ++RDL N+L+ G K+ DFGLA+ N
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 196 VST------RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
V + M APE G T+KSDV+S+G++L EI S
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 79/333 (23%), Positives = 131/333 (39%), Gaps = 50/333 (15%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPN 92
R +L EGGF VY+ ++ A+K+L N + NR + EV M L HPN
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 93 LVNLIGYCADGDQR-------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
+V + G + L+ + G + + L + + PL +T +KI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTC 146
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA---KLGPVGDNTHVSTRVM- 201
R ++++H + KPP+I+RDLK N+LL KL DFG A P + ++
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 202 ------GTYGYCAPE----YAKTGQLTLKSDVYSFGVVLLEILSGRKA-VDTSKAAAEQS 250
T Y PE Y+ + K D+++ G +L + + D +K
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264
Query: 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
+ Q HSLI + P+ R IA+VV L
Sbjct: 265 KYSIPPHDTQYTVFHSLI---------------------RAMLQVNPEERLSIAEVVHQL 303
Query: 311 AYLASQKY---ESDAEKVQSPCLDPGTPTRTKG 340
+A+ + +S ++ G+ T ++G
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 100
+LG+G +G VY G S +AIK++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 160
++ + E +P GS+ L G + T GL+YLHD ++
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 161 YRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-- 217
+RD+K N+L++ K+SDFG +K + + GT Y APE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 218 TLKSDVYSFGVVLLEILSGR 237
+D++S G ++E+ +G+
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 49/207 (23%), Positives = 77/207 (37%), Gaps = 15/207 (7%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 91
+R L+G GG G VY+ + VA+K + + + F E L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
++V + + Q + + + L + PL + I L+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAA 150
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPE 210
H +RD+K NIL+ L DFG+A D +GT Y APE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPE 205
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
T ++D+Y+ VL E L+G
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 91
+ +LG GG V+ ++DVA+K L R + + F + E + L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72
Query: 92 NLVNL--IGYCADGDQRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 146
+V + G A+ L Y EY+ ++ D +H + P+ +++ A A +
Sbjct: 73 AIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQ 127
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGT 203
L + H +I+RD+K +NI++ K+ DFG+A+ + D+ + T+ V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGT 182
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y +PE A+ + +SDVYS G VL E+L+G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 14/200 (7%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLI 97
LG+G FG VY + +A+K L ++ ++ + E+ + S L HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
Y D + L+ E+ P G + L D A L Y H++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 217
VI+RD+K N+L+ K++DFG + P GT Y PE +
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 218 TLKSDVYSFGVVLLEILSGR 237
K D++ GV+ E L G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 39/282 (13%), Positives = 84/282 (29%), Gaps = 55/282 (19%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLLGEGGFGRVYKGYLESI 58
+S ++ A++ S + FR EL + ++LG+ + +
Sbjct: 38 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 97
Query: 59 NQDVAIKQLDRNG----------------------------VQGNREFLVEVLMLSLLHH 90
+ + + + F+ ++
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 91 PNLVNLIGYCADGD--QRLLVYEYM--PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 146
++ + D R +Y M L + + L S K L + R+++ R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
L LH +++ L+ +I+LD+ L+ F G + G+
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----RVVSSVSRGF 268
Query: 207 CAPEY-----------AKTGQLTLKSDVYSFGVVLLEILSGR 237
PE + +T D ++ G+V+ I
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-33
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHP 91
+ F +G+G FG V+KG + VAIK +D + E + E+ +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
+ G + ++ EY+ GS D L PLD I +GL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 135
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H + K I+RD+K +N+LL KL+DFG+A G + D +GT + APE
Sbjct: 136 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSG 236
K K+D++S G+ +E+ G
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARG 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 41/231 (17%), Positives = 76/231 (32%), Gaps = 26/231 (11%)
Query: 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGNREFLVE 81
E +K LLGEG F +VY+ +N Q +K EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG 114
Query: 82 VLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL-SPGKKPLDWNTR 137
++ L + + +LV E G++ + ++ + +K +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-----------KLSDFGLAK 186
+ A +E +HD +I+ D+K N +L G+ L D G +
Sbjct: 175 ISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ + T T G+ E + D + + +L G
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 21/273 (7%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLV 94
F S LG G G V+K + +A K + R ++ E+ +L + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
G + + E+M GS++ L + K++ +GL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
K +++RD+K SNIL++ KL DFG++ +L ++ ++ V GT Y +PE +
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-GTRSYMSPERLQ 203
Query: 214 TGQLTLKSDVYSFGVVLLEILSGR-----KAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268
+++SD++S G+ L+E+ GR + + A
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
+ PP ++ L V+E P P
Sbjct: 264 LNKFGMDSRPPMAIFELL---DYIVNEPPPKLP 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
K + +G+G G VY + Q+VAI+Q++ + E+L++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+VN + GD+ +V EY+ GS+ D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAP 209
I+RD+K NILL KL+DFG A++ P +T V GT + AP
Sbjct: 134 SNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 185
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSG 236
E K D++S G++ +E++ G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 22/219 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 92
+ +LG+G V++G + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 93 LVNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
+V L + R L+ E+ P GS+ L + S L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
L + +++R++K NI+ G KL+DFG A+ + D+ + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEY 181
Query: 207 CAPEYAKTGQL--------TLKSDVYSFGVVLLEILSGR 237
P+ + L D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 32/272 (11%), Positives = 62/272 (22%), Gaps = 44/272 (16%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLLGEGGFGRVYKGYLESI 58
+L+ A + + + Q L+ + + L G V+
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 59 NQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYC--------------- 100
+D A+K E + L +
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 101 -----------ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
LL+ L + L + + + A R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
L K +++ N+ + L D VG S+ Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPVTYA 258
Query: 208 APEY--AKTGQLTLKSDVYSFGVVLLEILSGR 237
E+ A T T + + G+ + +
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
+ + LG+G FG+VYK + A K ++ + +++VE+ +L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V L+G + ++ E+ P G+V+ + +L + L + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLH 134
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAP 209
K I+RDLK N+L+ +L+DFG++ N + +GT + AP
Sbjct: 135 SKRI---IHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAP 186
Query: 210 E-----YAKTGQLTLKSDVYSFGVVLLEILSG 236
E K K+D++S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
+ F LGEG +G VYK + Q VAIKQ+ +E + E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V G +V EY GSV D + K L + I +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH 142
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAP 209
K I+RD+K NILL+ H KL+DFG+ +L NT + GT + AP
Sbjct: 143 FMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAP 194
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSG 236
E + +D++S G+ +E+ G
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLLHH 90
LG G +G V K Q +A+K++ N + +LM + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDC 65
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P V G + E M S++ + + + + KIA + LE+
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAP 209
LH K VI+RD+K SN+L++ K+ DFG+ L + G Y AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAP 178
Query: 210 E----YAKTGQLTLKSDVYSFGVVLLEILSGR 237
E ++KSD++S G+ ++E+ R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-32
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
S +GEG G V + + VA+K +D Q EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V + G++ ++ E++ G++ D + + L+ + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH 158
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 209
+ I+RD+K +ILL KLSDFG A++ + V R ++GT + AP
Sbjct: 159 AQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKRKSLVGTPYWMAP 210
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSG 236
E + D++S G++++E++ G
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 90
+ + LG+GGF + ++ + A K + ++ + + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
++V G+ D D +V E S L +L +K L G +Y
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 209
LH VI+RDLK N+ L+ K+ DFGLA +V+ GT Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 184
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGR 237
E + + DV+S G ++ +L G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 92
++ + ++G G V Y + VAIK+++ Q + + L+ E+ +S HHPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMKIAA---GAARGL 148
+V+ D+ LV + + GSV D + + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 205
EYLH + I+RD+K NILL +++DFG+ A L GD T R +GT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 206 YCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 237
+ APE + + K+D++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 90
++F+ +LLG+G F VY+ +VAIK +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P+++ L Y D + LV E G + +L + K + R G+ Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEAR-HFMHQIITGMLY 127
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH +++RDL SN+LL R + K++DFGLA + H T + GT Y +PE
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPE 182
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
A L+SDV+S G + +L GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 93
+ + LG GGFG V + + + VAIKQ + NRE E+ ++ L+HPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 94 VNLI------GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAAR 146
V+ A D LL EY G + +L+ L + + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISS 132
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP---KLSDFGLAKLGPVGDNTHVSTRVMGT 203
L YLH+ +I+RDLK NI+L G K+ D G AK + + V GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GT 186
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE + + T+ D +SFG + E ++G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 24/220 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 92
+ +LG+G V++G + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 93 LVNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLE 149
+V L + R L+ E+ P GS+ L + P L + + + G+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMN 126
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
+L + +++R++K NI+ G KL+DFG A+ + D+ + GT
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEE 180
Query: 206 YCAPEYAKTGQL--------TLKSDVYSFGVVLLEILSGR 237
Y P+ + L D++S GV +G
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 90
+ + LG+GGF + ++ + A K + ++ + + +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
++V G+ D D +V E S L +L +K L G +Y
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 209
LH VI+RDLK N+ L+ K+ DFGLA +V+ GT Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 210
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGR 237
E + + DV+S G ++ +L G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 35/277 (12%), Positives = 76/277 (27%), Gaps = 54/277 (19%)
Query: 6 RVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDV 62
++ A++ S + FR EL + ++LG+ + + +
Sbjct: 47 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106
Query: 63 AIKQLDR----------------------------NGVQGNREFLVEVLMLSLLHHPNLV 94
+ + + F+ ++ ++
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 95 NLIGYCADGDQRLLV----YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
+ D L + + L S K L + R+++ R L
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH +++ L+ +I+LD+ L+ F G S G+ PE
Sbjct: 227 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPE 277
Query: 211 Y----------AKTGQLTLKSDVYSFGVVLLEILSGR 237
+T D ++ G+ + I
Sbjct: 278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLLH 89
+ + +G G +G V K + Q +A+K++ + + ++LM +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSD 79
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
P +V G + E M + + + S + KI + L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCA 208
+L + K +I+RD+K SNILLDR + KL DFG+ +L ++ TR G Y A
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMA 193
Query: 209 PEYAKTGQL----TLKSDVYSFGVVLLEILSGR 237
PE ++SDV+S G+ L E+ +GR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 65/222 (29%), Positives = 90/222 (40%), Gaps = 32/222 (14%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHP 91
F L+G G +G+VYKG Q AIK +D G E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 92 NLVNLIG-----YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA--- 142
N+ G D +L LV E+ GSV D + + +W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--- 199
RGL +LH I+RD+K N+LL KL DFG++ R
Sbjct: 137 EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNT 188
Query: 200 VMGTYGYCAPEYAKTGQLT-----LKSDVYSFGVVLLEILSG 236
+GT + APE + KSD++S G+ +E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 90
F +LG GGFG V+ +++ + A K+L++ ++ + + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 91 PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGL 148
+V+L Y + L LV M G + H++++ R A GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
E+LH + +IYRDLK N+LLD + ++SD GLA G GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
PE + D ++ GV L E+++ R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 55/295 (18%), Positives = 95/295 (32%), Gaps = 58/295 (19%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEV-LMLSLLH 89
T F +G G FG V+K AIK+ + G + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
H ++V A+ D L+ EY GS+ D + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------KLSDFGLAKLGPV 190
Y+H + +++ D+K SNI + R P K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---R 183
Query: 191 GDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249
+ V G + A E + K+D+++ + ++
Sbjct: 184 ISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA------------- 227
Query: 250 SLVAWARPLFQDRTRHSLIAD---PELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
PL ++ + I P + + + + +H P+ RP
Sbjct: 228 ------EPLPRNGDQWHEIRQGRLPRIPQVLSQ----EFTELLKVMIHPDPERRP 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNL 93
+F + +LG G G + + N+DVA+K++ +RE V++L HPN+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNV 80
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
+ D + + E ++++++ L+ T ++ GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHS 136
Query: 154 KAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 207
+++RDLK NIL+ +SDFGL K L + + V GT G+
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 208 APEY---AKTGQLTLKSDVYSFGVVLLEILSG 236
APE T D++S G V ++S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 41/219 (18%), Positives = 79/219 (36%), Gaps = 22/219 (10%)
Query: 33 TKNFRSESLLGEG--GFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLL 88
+ +++G+G V + + V +++++ FL E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAA 145
+HPN+V ++ +V +M GS +D + IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGD--NTHVSTRVM- 201
+ L+Y+H ++R +K S+IL+ LS + G
Sbjct: 139 KALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 202 -GTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 237
+ +PE + KSD+YS G+ E+ +G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 20/236 (8%)
Query: 11 SEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN 70
S + Q T+ + A + + +G G G+V+K +A+KQ+ R+
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 71 GVQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 127
G + + ++ +V++ P +V G + E M +
Sbjct: 62 GNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKR 116
Query: 128 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AK 186
+ P+ K+ + L YL +K VI+RD+K SNILLD KL DFG+ +
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174
Query: 187 LGPVGDNTHVSTRVMGTYGYCAPE-----YAKTGQLTLKSDVYSFGVVLLEILSGR 237
L + R G Y APE +++DV+S G+ L+E+ +G+
Sbjct: 175 L----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 90
FR +LG+GGFG V + + + A K+L++ ++ + L E +L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 91 PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGL 148
+V+L Y + L LV M G ++ H++ + P R AA GL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGL 299
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
E LH + ++YRDLK NILLD H ++SD GLA P G RV GT GY A
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMA 353
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
PE K + T D ++ G +L E+++G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 73/214 (34%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH 89
K F +G G FG VY ++ VAIK++ +G Q N ++ + EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAAR 146
HPN + G LV EY GS D L KKPL ++IAA GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD---LLEVHKKPLQ---EVEIAAVTHGALQ 165
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYG 205
GL YLH I+RD+K NILL KL DFG + + P N+ +GT
Sbjct: 166 GLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS-----FVGTPY 215
Query: 206 YCAPE---YAKTGQLTLKSDVYSFGVVLLEILSG 236
+ APE GQ K DV+S G+ +E+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 24/209 (11%)
Query: 36 FRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNL 93
+ + + GG G +Y ++N + V +K L +G + + E L+ + HP++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 94 VNLIGYCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
V + + D+ +V EY+ S++ L + L
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPAL 195
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
YLH ++Y DLK NI+L KL D G + + GT G+ A
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYGTPGFQA 245
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
PE T+ +D+Y+ G L +
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 90
++F+ +LGEG F V + +++ AIK L++ + + E ++S L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 149
P V L D ++ Y G + ++ + G + A LE
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDET---CTRFYTAEIVSALE 144
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YLH K +I+RDLK NILL+ H +++DFG AK+ + +GT Y +P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 210 E------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
E K+ SD+++ G ++ ++++G
Sbjct: 202 ELLTEKSACKS------SDLWALGCIIYQLVAGL 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 57/234 (24%), Positives = 86/234 (36%), Gaps = 44/234 (18%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPN 92
SE +LG G G V + VA+K++ + E +++L S HPN
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALME--IKLLTESD-DHPN 70
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR------ 146
++ + E + L DL K D N +++
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LN----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 147 -GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------KLSDFGLAKL---GP 189
G+ +LH +I+RDLK NIL+ +SDFGL K G
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 190 VGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSG 236
T+++ GT G+ APE +LT D++S G V ILS
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 66/242 (27%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 13 DGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV 72
G+ + A F+ E + G+G FG V G +S VAIK++ ++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 73 QGNREFLVEVLMLSLLHHPNLVNLI------GYCADGDQRL-LVYEYMPLGSVEDHLHDL 125
NRE L + L++LHHPN+V L G D L +V EY+P ++ +
Sbjct: 62 FRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY 119
Query: 126 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGL 184
+ R + LH + V +RD+K N+L++ KL DFG
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 185 AK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILS 235
AK L P N + +R Y Y APE Y T D++S G + E++
Sbjct: 179 AKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMML 227
Query: 236 GR 237
G
Sbjct: 228 GE 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNL 96
LLGEG +G+V + A+K L + ++ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 97 --IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-------- 146
+ Y + + +V EY G E + D P K R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ--AHGYFCQLID 120
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
GLEYLH + ++++D+K N+LL G K+S G+A+ G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 207 CAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 237
PE A K D++S GV L I +G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH- 89
+F ++G GGFG VY + A+K LD+ ++ + L E +MLSL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 90 --HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 145
P +V + Y +L + + M G + HL G M+ AA
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEA---DMRFYAAEII 302
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
GLE++H++ V+YRDLK +NILLD H ++SD GLA H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHG 355
Query: 206 YCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 237
Y APE + G S D +S G +L ++L G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 18 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
Q T + ++ ++ LG G +G V + + + AIK + + V +
Sbjct: 21 QATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN 80
Query: 78 FLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 135
+ EV +L LL HPN++ L + D LV E G + D + + +
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEV 136
Query: 136 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGD 192
I G+ YLH +++RDLK N+LL ++ K+ DFGL+ + +
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FEN 191
Query: 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ R+ GT Y APE + + K DV+S GV+L +L+G
Sbjct: 192 QKKMKERL-GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 23/227 (10%)
Query: 22 QTLTFRELAAATKNFRS----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
+ RE + LG G FG V+ S + IK ++++ Q E
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 78 -FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 136
E+ +L L HPN++ + D +V E G + + + K L
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS--- 122
Query: 137 RMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGP 189
A + L Y H + V+++DLK NIL K+ DFGLA+L
Sbjct: 123 -EGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-- 176
Query: 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
+ H + GT Y APE K +T K D++S GVV+ +L+G
Sbjct: 177 FKSDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 18 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
T A + ++ + +LG+G FG V + Q+ A+K + + V+ +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 78 ---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 134
L EV +L L HPN++ L + D LV E G + D + +K
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSE 125
Query: 135 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVG 191
+I G+ Y+H +++RDLK N+LL + + ++ DFGL+
Sbjct: 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HF 179
Query: 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ + +GT Y APE G K DV+S GV+L +LSG
Sbjct: 180 EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
F LG G FGRV + A+K LD+ V ++ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 150
LV L D +V EY+ G + HL + G+ + AA EY
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFS---EPHARFYAAQIVLTFEY 156
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH +IYRDLK N+L+D+ + +++DFG AK V T + GT APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEALAPE 208
Query: 211 ------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y K D ++ GV++ E+ +G
Sbjct: 209 IILSKGYNKA------VDWWALGVLIYEMAAGY 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 99
LGEG +G V + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYL 151
+G+ + L EY G + D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE- 210
H + +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 28/229 (12%)
Query: 22 QTLTFRELAAATKNFRS----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
+ RE F +LG+G FG V K Q+ A+K +++ +
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 78 FLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 135
+ EV +L L HPN++ L D +V E G + D + +K
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFS-- 119
Query: 136 TRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 188
AA + G+ Y+H +++RDLK NILL ++ K+ DFGL+
Sbjct: 120 --EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC- 173
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
NT + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 174 -FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
++ ++G G FG VY+ L + VAIK++ +Q R E+ ++ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 93 LVNLIGY-CADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 146
+V L + + G+++ LV +Y+P +V S K+ L R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGT 203
L Y+H + +RD+K N+LLD KL DFG AK L N + +R
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 204 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y Y APE Y T DV+S G VL E+L G+
Sbjct: 221 Y-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 22 QTLTFRELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
LT + + K R E LG G G V + + VAI+ + +
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 78 FLV--------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 129
E+ +L L+HP ++ + + D + +V E M G +L
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG-------EL---- 226
Query: 130 KPLDW---NTRM--KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHP 177
D N R+ ++YLH+ +I+RDLK N+LL +
Sbjct: 227 --FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281
Query: 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEIL 234
K++DFG +K+ +G+ + + T GT Y APE T D +S GV+L L
Sbjct: 282 KITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 235 SG 236
SG
Sbjct: 339 SG 340
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 99
LGEG +G V + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 100 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYL 151
+G+ + L EY G + D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE- 210
H + +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 8e-24
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 22/202 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
+G G +G V + A K++ + V+ F E+ ++ L HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKP 157
D LV E G E L + K+ AA + + Y H
Sbjct: 77 DNTDIYLVMELCTGG--E--LFERVVHKRVFR----ESDAARIMKDVLSAVAYCHKLN-- 126
Query: 158 PVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214
V +RDLK N L KL DFGLA + T+V GT Y +P+ +
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQVLE- 181
Query: 215 GQLTLKSDVYSFGVVLLEILSG 236
G + D +S GV++ +L G
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCG 203
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 35/240 (14%)
Query: 18 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
I ++ +++ LG G +G V ++ + + AIK + ++ R
Sbjct: 20 AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 78 FLV-------------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 124
E+ +L L HPN++ L D LV E+ G + + + +
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 125 LSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHP 177
+ D AA + G+ YLH +++RD+K NILL + +
Sbjct: 140 ----RHKFD----ECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188
Query: 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
K+ DFGL+ + +GT Y APE K + K DV+S GV++ +L G
Sbjct: 189 KIVDFGLSS---FFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
+F+ LG G FGRV+ + A+K L + V ++ E LMLS++ HP
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 150
++ + G D Q ++ +Y+ G + L + P N K AA LEY
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFP---NPVAKFYAAEVCLALEY 121
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH K +IYRDLK NILLD+ H K++DFG AK V D T+ T + GT Y APE
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPE 173
Query: 211 ------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y K+ D +SFG+++ E+L+G
Sbjct: 174 VVSTKPYNKS------IDWWSFGILIYEMLAGY 200
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
K F +LG G F V+ + A+K + ++ + E+ +L + H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR- 146
+V L LV + + G +L D K A+ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGG-------EL------FDRILERGVYTEKDASLVIQQ 114
Query: 147 ---GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
++YLH+ +++RDLK N+L + ++DFGL+K + N +ST
Sbjct: 115 VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC 168
Query: 201 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
GT GY APE + D +S GV+ +L G
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 63/210 (30%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+GEG +G V+K Q VAIK+ D + + L E+ ML L HPNLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
+ LV+EY LH+L ++ + + I + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT 214
I+RD+K NIL+ + KL DFG A+L GP V+TR Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE---- 172
Query: 215 GQLTLKSDVYSFGV-------VLLEILSGR 237
L + Y V V E+LSG
Sbjct: 173 --LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/208 (32%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
F LLG+G FG+V ++ + A+K L + + E L E +L HP
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 92 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 149
L L Y RL V EY G + HL D R + A L+
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLS--RERVFSED---RARFYGAEIVSALD 262
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YLH + V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y AP
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAP 318
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSGR 237
E + D + GVV+ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 56/244 (22%), Positives = 88/244 (36%), Gaps = 52/244 (21%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-----FLVEVLMLSLLHHPNLVNL 96
+G+G +G V AIK +++N ++ EV ++ LHHPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG------------- 143
D LV E G + D L+ +K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 144 ----------------AAR-------GLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPK 178
+ L YLH++ + +RD+K N L ++ + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 179 LSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEI 233
L DFGL+K G+ ++T+ GT + APE T K D +S GV+L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 234 LSGR 237
L G
Sbjct: 270 LMGA 273
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 33/251 (13%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRS------ESLLGEGGFGRVYKGYL 55
++ K S R + A S +LG G FG+V+K
Sbjct: 51 RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110
Query: 56 ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115
+ +A K + G++ E E+ +++ L H NL+ L + +LV EY+
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 116 GSVEDHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCS 167
G + D + ++L+ + G+ ++H +++ DLK
Sbjct: 171 GELFDRIIDESYNLTE-----------LDTILFMKQICEGIRHMHQMY---ILHLDLKPE 216
Query: 168 NILL-DRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 225
NIL +R K+ DFGLA+ + GT + APE ++ +D++S
Sbjct: 217 NILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 226 FGVVLLEILSG 236
GV+ +LSG
Sbjct: 274 VGVIAYMLLSG 284
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-------------------- 80
+G+G +G V Y E+ N A+K L + + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 81 ------EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
E+ +L L HPN+V L + + D +V+E + G V + P KPL
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPL 134
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192
+ +G+EYLH + +I+RD+K SN+L+ H K++DFG++ G
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGS 190
Query: 193 NTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ +S V GT + APE + DV++ GV L + G+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 18/213 (8%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--------EVLML 85
+ + + S LG G FG V+ + N++V +K + + V + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 86 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
S + H N++ ++ + LV E G L LD I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
+ YL K +I+RD+K NI++ + KL DFG A G + GT
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIE 194
Query: 206 YCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 237
YCAPE + +++S GV L ++
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 63/266 (23%), Positives = 96/266 (36%), Gaps = 77/266 (28%)
Query: 42 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 94
LG G FG+V + I++ VA+K L + +R + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 95 NLIG--------------YCADGDQRLLVY------------------------------ 110
NL+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 111 ---------------------EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
E L VE+ K L + + A+G+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+L + I+RDL NILL K+ DFGLA+ + + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILS 235
E T++SDV+SFGV+L EI S
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 65/215 (30%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
+F LLG+G FG+V ++ + A+K L + + E + E +L HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 92 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 149
L L Y RL V EY G + HL + R + A LE
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEE---RARFYGAEIVSALE 119
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCA 208
YLH + V+YRD+K N++LD+ H K++DFGL K G T + GT Y A
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173
Query: 209 PE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
PE Y + D + GVV+ E++ GR
Sbjct: 174 PEVLEDNDYGRA------VDWWGLGVVMYEMMCGR 202
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSL 87
++ LLG GGFG VY G S N VAIK ++++ + E EV++L
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 88 LHH--PNLVNLIGYCADGDQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 144
+ ++ L+ + D +L+ E P+ + D + + + L
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQV 158
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGT 203
+ + H+ V++RD+K NIL+D KL DFG L +T + GT
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GT 211
Query: 204 YGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGR 237
Y PE+ + + + V+S G++L +++ G
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V++ ++ + K ++ E+ +++ LHHP L+NL
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 102 DGDQRLLVYEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHD 153
D + +L+ E++ G + D + + +S R GL+++H+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSE-----------AEVINYMRQACEGLKHMHE 167
Query: 154 KAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
+ +++ D+K NI+ + K+ DFGLA + + V T + APE
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEI 221
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSG 236
+ +D+++ GV+ +LSG
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 26 FRELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 81
++L + F +G G + + ++ N + A+K +D++ E +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IE 67
Query: 82 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 141
+ +L HPN++ L DG +V E M G + D + +K + A
Sbjct: 68 I-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFS----EREA 118
Query: 142 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL-DRGYHP---KLSDFGLAKLGPVGDN 193
+ +EYLH + V++RDLK SNIL D +P ++ DFG AK +N
Sbjct: 119 SAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174
Query: 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
+ T T + APE + D++S GV+L +L+G
Sbjct: 175 GLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 27 RELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-- 80
RE F +LG+G FG V K Q+ A+K +++ + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 81 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-- 138
EV +L L HPN++ L D +V E G +L D +
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG-------EL------FDEIIKRKR 117
Query: 139 ---KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 188
AA + G+ Y+H +++RDLK NILL ++ K+ DFGL+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC- 173
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
NT + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 174 -FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 37/222 (16%)
Query: 33 TKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLS 86
+ F LG+G F V + ++ + A K ++ + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 87 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIA 141
L HPN+V L + LV++ + G +L + A
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGG-------EL------FEDIVAREFYSEADA 107
Query: 142 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNT 194
+ + + Y H +++R+LK N+LL +G KL+DFGLA V D+
Sbjct: 108 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSE 162
Query: 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
GT GY +PE K + D+++ GV+L +L G
Sbjct: 163 AWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 91
+F +G+G FG+V + A+K +++ E E+ ++ L HP
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 92 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 149
LVNL Y ++ + +V + + G + HL + +K+ L+
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEETVKLFICELVMALD 129
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YL ++ +I+RD+K NILLD H ++DF +A + P T + GT Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 210 E--YAKTGQLTLKS-DVYSFGVVLLEILSGR 237
E ++ G + D +S GV E+L GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPN 92
N+R +G+G F +V ++VAIK +D+ + + EV ++ +L+HPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR------ 146
+V L L+ EY G V D+L + RMK AR
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMK--EKEARSKFRQI 123
Query: 147 --GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
++Y H K +++RDLK N+LLD + K++DFG + + G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAP 177
Query: 205 GYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE Y G + DV+S GV+L ++SG
Sbjct: 178 PYAAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 14 GASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ 73
G++D + + +L E +LGEG RV +Q+ A+K +++
Sbjct: 1 GSTDSFSGRFEDVYQL--------QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH 52
Query: 74 GNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 132
EV ++ H N++ LI + + D+ LV+E M GS+ H+H ++
Sbjct: 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHF 108
Query: 133 DWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP------KLSDF 182
+ A+ + L++LH+K + +RDLK NIL HP K+ DF
Sbjct: 109 N----ELEASVVVQDVASALDFLHNKG---IAHRDLKPENILC---EHPNQVSPVKICDF 158
Query: 183 GLAK-LGPVGDNTHVSTRVM----GTYGYCAPEYAKTGQLTLKS-----DVYSFGVVLLE 232
L + GD + +ST + G+ Y APE + D++S GV+L
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218
Query: 233 ILSG 236
+LSG
Sbjct: 219 LLSG 222
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 36/236 (15%)
Query: 18 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 77
I + + + ++G G FG V++ L ++ VAIK++ +Q R
Sbjct: 24 VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRF 78
Query: 78 FLVEVLMLSLLHHPNLVNLIGY-----CADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKP 131
E+ ++ ++ HPN+V+L + + L LV EY+P +V + K+
Sbjct: 79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQT 137
Query: 132 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LGP 189
+ R L Y+H + +RD+K N+LLD KL DFG AK L
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 190 VGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
N + +R Y Y APE Y T D++S G V+ E++ G+
Sbjct: 195 GEPNVSYICSR----Y-YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 60/247 (24%), Positives = 100/247 (40%), Gaps = 22/247 (8%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
NS LR +E + + T +++ ++F ++G G FG V L++ ++
Sbjct: 43 NSPLR-REKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 62 VAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLG 116
A+K L++ + E F E +L + L + A D + LV +Y G
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGG 159
Query: 117 SVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175
D L LS + L + A ++ +H ++RD+K NIL+D
Sbjct: 160 ---DLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNG 212
Query: 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-----DVYSFGVVL 230
H +L+DFG S V GT Y +PE + + D +S GV +
Sbjct: 213 HIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 231 LEILSGR 237
E+L G
Sbjct: 272 YEMLYGE 278
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 6e-23
Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+GEG +G V K + + VAIK+ D V + + E+ +L L H NLVNL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLL 90
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 157
C + LV+E++ L DL LD+ K G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT 214
+I+RD+K NIL+ + KL DFG A+ P V+TR Y APE
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE---- 194
Query: 215 GQLTLKSDVYSFGV-------VLLEILSGR 237
L + Y V ++ E+ G
Sbjct: 195 --LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------QGNREFLVEVLMLS 86
+R LLG+GGFG V+ G+ + VAIK + RN V L EV +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLW 89
Query: 87 LLH----HPNLVNLIGYCADGDQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIA 141
+ HP ++ L+ + + +LV E +P + D++ + K PL
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFF 145
Query: 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRV 200
+++ H + V++RD+K NIL+D KL DFG L + +
Sbjct: 146 GQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD 199
Query: 201 MGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGR 237
GT Y PE+ Q L + V+S G++L +++ G
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-23
Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 21/245 (8%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
+LR K + D + R+L +++ ++G G FG V +S +
Sbjct: 38 FPALR-KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96
Query: 62 VAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLG 116
A+K L + + + F E +++ + P +V L + A D +V EYMP G
Sbjct: 97 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGG 154
Query: 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176
D ++ +S P W R A L+ +H I+RD+K N+LLD+ H
Sbjct: 155 ---DLVNLMSNYDVPEKW-ARF-YTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 206
Query: 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE----YAKTGQLTLKSDVYSFGVVLLE 232
KL+DFG T V GT Y +PE G + D +S GV L E
Sbjct: 207 LKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
Query: 233 ILSGR 237
+L G
Sbjct: 266 MLVGD 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 35 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM----LSL 87
F +LG+G FG+V+ K Q A+K L + ++ V M L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVE 82
Query: 88 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 145
++HP +V L Y + +L L+ +++ G + L + +K A A
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEE---DVKFYLAELA 136
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTY 204
L++LH +IYRDLK NILLD H KL+DFGL+K + GT
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 205 GYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE + ++ +D +SFGV++ E+L+G
Sbjct: 191 EYMAPEVVNRRGHTQS------ADWWSFGVLMFEMLTGT 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101
LG G FG V++ + + A K + E+ +S+L HP LVNL
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAAR----GLEYLHDKA 155
D ++ +++YE+M G + + + D + +M A R GL ++H+
Sbjct: 225 DDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 156 KPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
++ DLK NI+ R KL DFGL + V GT + APE A+
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAAPEVAE 329
Query: 214 TGQLTLKSDVYSFGVVLLEILSG 236
+ +D++S GV+ +LSG
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--------EVLMLSLLHHPNL 93
LG G G V + + VAIK + + E+ +L L+HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW---NTRM--KIAAGAAR-- 146
+ + + D + +V E M G +L D N R+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGG-------EL------FDKVVGNKRLKEATCKLYFYQM 123
Query: 147 --GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 201
++YLH+ +I+RDLK N+LL + K++DFG +K+ +G+ + + T
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC- 177
Query: 202 GTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILSG 236
GT Y APE T D +S GV+L LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 89
+F +LG+G FG+V+ + NQ AIK L ++ V + + +VE VL L+
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-E 76
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 147
HP L ++ + L V EY+ G + H+ K L R AA G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLS---RATFYAAEIILG 130
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 206
L++LH K ++YRDLK NILLD+ H K++DFG+ K +GD T GT Y
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE + D +SFGV+L E+L G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVN 95
LG G FG+V G + VA+K L+R ++ +V E+ L L HP+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIK 75
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------G 147
L + +V EY+ G + D++ + R++ AR
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEME--ARRLFQQILSA 123
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
++Y H V++RDLK N+LLD + K++DFGL+ + G+ S G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177
Query: 208 APE-YAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE + + D++S GV+L +L G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 55/228 (24%)
Query: 42 LGEGGFGRVYKGYLESI--NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 98
+G G +G VYK + ++D A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 99 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------------ 145
+ + D+++ L+++Y HDL + ++ K
Sbjct: 87 FLSHADRKVWLLFDYAE--------HDL---WHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 146 ---RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKL--GPVGDNTHV 196
G+ YLH V++RDLK +NIL+ K++D G A+L P+ +
Sbjct: 136 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 197 STRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 237
V+ T+ Y APE L L + D+++ G + E+L+
Sbjct: 193 DPVVV-TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 3e-22
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+GEG +G V+K ++ VA+K++ D GV L E+ +L L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLH 67
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 149
+ LV+E+ DL KK D + + +GL
Sbjct: 68 DVLHSDKKLTLVFEFCD--------QDL---KKYFD-SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 207
+ H + V++RDLK N+L++R KL++FGLA+ PV + V+ T Y
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYR 168
Query: 208 APEYAKTGQLTLKSDVYSFGV-------VLLEILSGRKA 239
P+ + + +YS + + E+ + +
Sbjct: 169 PPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EV-LMLSLLHHPNLVNLIG 98
LG G F V + +S Q+ A K L R Q R ++ E+ ++ P ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 99 YCADGDQRLLVYEYMPLGS-----VEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLE 149
+ + +L+ EY G + + +S + G+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-----------NDVIRLIKQILEGVY 145
Query: 150 YLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
YLH +++ DLK NILL K+ DFG+++ +G + + GT Y
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEY 199
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
APE +T +D+++ G++ +L+
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 50/235 (21%)
Query: 32 ATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDR--------NGVQGNREFL 79
+T F +LG G V + + ++ A+K +D VQ RE
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 80 ---VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 136
V++L + HPN++ L LV++ M G +L D+ T
Sbjct: 71 LKEVDILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKG-------EL------FDYLT 116
Query: 137 RM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187
K R + LH +++RDLK NILLD + KL+DFG +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 188 GPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 236
+ + GT Y APE + D++S GV++ +L+G
Sbjct: 174 --LDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-22
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 89
+F ++G+G FG+V ++ A+K L + + +E + E VL+ ++
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-K 97
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 147
HP LV L + +L V +Y+ G + HL R + AA A
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEP---RARFYAAEIASA 151
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 206
L YLH ++YRDLK NILLD H L+DFGL K ++T T GT Y
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEY 205
Query: 207 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE Y +T D + G VL E+L G
Sbjct: 206 LAPEVLHKQPYDRT------VDWWCLGAVLYEMLYGL 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-22
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 35 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LS 86
F +LG+GG+G+V+ K + + A+K L + + N + L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTKAERNILE 76
Query: 87 LLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGA 144
+ HP +V+LI Y +L L+ EY+ G + L G D A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE--GIFMED---TACFYLAEI 130
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GT 203
+ L +LH K +IYRDLK NI+L+ H KL+DFGL K T GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGT 184
Query: 204 YGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE + + D +S G ++ ++L+G
Sbjct: 185 IEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGA 218
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-22
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 95
LG G F V K + ++ A K + + + +R E EV +L + HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 151
L + +L+ E + G E L D K+ L T + A + G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGG--E--LFDFLAEKESL---TEDE-ATQFLKQILDGVHYL 124
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
H K + + DLK NI+L P KL DFG+A + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFV 178
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSG 236
APE L L++D++S GV+ +LSG
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 53/248 (21%), Positives = 89/248 (35%), Gaps = 22/248 (8%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
S L ++ + +E+ +F ++G G F V ++ Q
Sbjct: 30 ASELA-QDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 62 VAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLG 116
A+K +++ + E F E +L + L + A D + LV EY G
Sbjct: 89 YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGG 146
Query: 117 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176
+ L + P + R A ++ +H ++RD+K NILLDR H
Sbjct: 147 DLLTLLSKFGE-RIPAEM-ARF-YLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH 200
Query: 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY-------SFGVV 229
+L+DFG V GT Y +PE + + Y + GV
Sbjct: 201 IRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259
Query: 230 LLEILSGR 237
E+ G+
Sbjct: 260 AYEMFYGQ 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
LGEG +G VYK N+ VAIK++ + GV + EV +L L H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQHRNIIELK 99
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------RGLEYL 151
+ L++EY +DL KK +D N + + + G+ +
Sbjct: 100 SVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHP-----KLSDFGLAKL--GPVGDNTHVSTRVMGTY 204
H + ++RDLK N+LL K+ DFGLA+ P+ TH ++ T
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 237
Y PE + L S YS V + E+L
Sbjct: 202 WYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYC 100
LGEG F K + NQ A+K + + ++ E+ + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAK 156
D LV E + G + + + KK A+ R + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK----KKHFS----ETEASYIMRKLVSAVSHMHDVG- 126
Query: 157 PPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
V++RDLK N+L + K+ DFG A+L P DN + T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLN 182
Query: 214 TGQLTLKSDVYSFGVVLLEILSG 236
D++S GV+L +LSG
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSG 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 54/241 (22%), Positives = 92/241 (38%), Gaps = 33/241 (13%)
Query: 10 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 69
AS G + N+ + LG+G F V + ++ + A K ++
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 70 NGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 127
+ + E + L HPN+V L + LV++ + G +L
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG-------EL-- 115
Query: 128 GKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGY 175
+ A+ + + Y H +++R+LK N+LL +G
Sbjct: 116 ----FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGA 168
Query: 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 235
KL+DFGLA V D+ GT GY +PE K + D+++ GV+L +L
Sbjct: 169 AVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 236 G 236
G
Sbjct: 226 G 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-22
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 39/220 (17%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHH 90
+ + LGEG + VYKG + + VA+K++ G + EV +L L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKH 59
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS----PGKKPLDWNTRMKIAAGAAR 146
N+V L LV+EY+ DL ++ + R
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTY 204
GL Y H + V++RDLK N+L++ KL+DFGLA+ P + V+ T
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 237
Y P+ + L S YS + + E+ +GR
Sbjct: 165 WYRPPD------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 49/217 (22%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+GEG +G VYK +S + VA+K++ + G+ + E+ +L LHHPN+V+LI
Sbjct: 29 VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLI 85
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 149
LV+E+M DL KK LD + + RG+
Sbjct: 86 DVIHSERCLTLVFEFME--------KDL---KKVLD-ENKTGLQDSQIKIYLYQLLRGVA 133
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 207
+ H +++RDLK N+L++ KL+DFGLA+ PV TH V+ T Y
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYR 186
Query: 208 APEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 237
AP+ + + S D++S G + E+++G+
Sbjct: 187 APD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
LG G + VYKG ++ VA+K++ G + E+ ++ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLYD 70
Query: 99 YCADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
++ LV+E+M L D + + L+ N +GL + H+
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 157 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKT 214
+++RDLK N+L+++ KL DFGLA+ PV + V+ T Y AP+
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD---- 178
Query: 215 GQLTLKSDVYSFGV-------VLLEILSGR 237
+ + S YS + +L E+++G+
Sbjct: 179 --VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 53/259 (20%), Positives = 95/259 (36%), Gaps = 43/259 (16%)
Query: 2 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 61
N + + S + + + + + ++G G V + + +
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 62 VAIKQLDRNGVQGNREFLVEVL---------MLSLLHHPNLVNLIGYCADGDQRLLVYEY 112
A+K ++ + + E L EV + + HP+++ LI LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 113 MPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRD 163
M G +L D+ T K R + +LH +++RD
Sbjct: 182 MRKG-------EL------FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRD 225
Query: 164 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQL 217
LK NILLD +LSDFG + + + GT GY APE
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGY 282
Query: 218 TLKSDVYSFGVVLLEILSG 236
+ D+++ GV+L +L+G
Sbjct: 283 GKEVDLWACGVILFTLLAG 301
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 3 SSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDV 62
++ V + +G D++ +F +LG+G FG+V + ++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLT------------DFNFLMVLGKGSFGKVMLSERKGTDELY 48
Query: 63 AIKQLDRNGVQGNREF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLG 116
A+K L ++ V + + +VE VL L P L L C RL V EY+ G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGG 106
Query: 117 SVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175
+ H+ + G+ AA A GL +L K +IYRDLK N++LD
Sbjct: 107 DLMYHIQQV--GRFKEP---HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158
Query: 176 HPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 234
H K++DFG+ K T T+ GT Y APE D ++FGV+L E+L
Sbjct: 159 HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
Query: 235 SGR 237
+G+
Sbjct: 216 AGQ 218
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-21
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
+GEG +G VYK + + A+K++ + G+ + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLY 66
Query: 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 149
+ +LV+E++ DL KK LD + + A G+
Sbjct: 67 DVIHTKKRLVLVFEHLD--------QDL---KKLLD-VCEGGLESVTAKSFLLQLLNGIA 114
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 207
Y HD+ V++RDLK N+L++R K++DFGLA+ PV TH ++ T Y
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYR 167
Query: 208 APEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 237
AP+ + + S YS + + E+++G
Sbjct: 168 APD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM------LSLL 88
+F +LG+G FG+V + ++ A+K L ++ V + + VE M
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPG 399
Query: 89 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAAR 146
P L L C RL V EY+ G + H+ + G+ AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEP---HAVFYAAEIAI 453
Query: 147 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYG 205
GL +L K +IYRDLK N++LD H K++DFG+ K T T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 507
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE D ++FGV+L E+L+G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 95
LG G F V K +S + A K + + + +R E EV +L + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 151
L + +L+ E + G E L D K+ L + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYL 131
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
H K + + DLK NI+L P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSG 236
APE L L++D++S GV+ +LSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 35 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LS 86
NF +LG G +G+V+ K + A+K L + + +
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 87 LLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGA 144
+ P LV L Y + +L L+ +Y+ G + HL + ++I
Sbjct: 115 IRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS--QRERFTEH---EVQIYVGEI 168
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
LE+LH +IYRD+K NILLD H L+DFGL+K + GT
Sbjct: 169 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTI 224
Query: 205 GYCAPE---YAKTGQLTLKS-DVYSFGVVLLEILSGR 237
Y AP+ +G K+ D +S GV++ E+L+G
Sbjct: 225 EYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 89
NF +LG+G FG+V ++ A+K L ++ + + + + E +L L+ +
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-N 82
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 147
HP L L C RL V E++ G + H+ + R + AA
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEA---RARFYAAEIISA 136
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 206
L +LHDK +IYRDLK N+LLD H KL+DFG+ K G T T GT Y
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDY 190
Query: 207 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE Y D ++ GV+L E+L G
Sbjct: 191 IAPEILQEMLYGPA------VDWWAMGVLLYEMLCGH 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 34/164 (20%), Positives = 63/164 (38%), Gaps = 14/164 (8%)
Query: 81 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 140
++ + N V + + + + +++D + + + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHI 169
Query: 141 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----------LGPV 190
A +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 234
T +GT Y +PE + K D++S G++L E+L
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 22/109 (20%), Positives = 42/109 (38%), Gaps = 2/109 (1%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPN 92
+F +G GGFG V++ + + + AIK++ + RE + EV L+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 93 LVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 140
+V + ++ E LS + +++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 95
LG G F V K +S + A K + + + +R E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 151
L + +L+ E + G E L D K+ L + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYL 131
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
H K + + DLK NI+L P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSG 236
APE L L++D++S GV+ +LSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVNL 96
+G+G F V + Q A+K +D + E + +L HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 152
+ + +V+E+M + + + ++ + A+ R L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAV--ASHYMRQILEALRYCH 147
Query: 153 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
D +I+RD+K +LL + KL FG+A +G++ V+ +GT + AP
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSG 236
E K DV+ GV+L +LSG
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 69/223 (30%), Positives = 99/223 (44%), Gaps = 57/223 (25%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL-------DRNGVQGNREFLVEVLMLSLLHHPNLV 94
LGEG F VYK ++ NQ VAIK++ ++G+ NR L E+ +L L HPN++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------- 145
L+ LV+++M DL + + + +
Sbjct: 76 GLLDAFGHKSNISLVFDFME--------TDL---EVIIK---DNSLVLTPSHIKAYMLMT 121
Query: 146 -RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVM 201
+GLEYLH +++RDLK +N+LLD KL+DFGLAK P TH V TR
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-- 176
Query: 202 GTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 237
Y APE L + +Y GV +L E+L
Sbjct: 177 ---WYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLI 97
S+ +LG G G+V + + Q A+K L + +E V+ P++V ++
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QE--VD-HHWQASGGPHIVCIL 88
Query: 98 GYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLE 149
+ L++ E M G + + + + + R AA R ++
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQE----RGDQAFTERE--AAEIMRDIGTAIQ 142
Query: 150 YLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
+LH + +RD+K N+L ++ KL+DFG AK + T T Y
Sbjct: 143 FLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPC-YTPYY 195
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
APE + D++S GV++ +L G
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 89
+F ++G G + +V L+ ++ A+K + + V + + E V + +
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-N 68
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 147
HP LV L C + RL V EY+ G + H+ K P + + +A +
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARFYSAEISLA 122
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 206
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T GT Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 176
Query: 207 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE Y + D ++ GV++ E+++GR
Sbjct: 177 IAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 34/210 (16%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIG 98
+G G FG + + VA+K ++R V E++ L HPN+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 99 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEY 150
++ EY G + + + + R AR G+ Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN----------AGRFSED--EARFFFQQLLSGVSY 131
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
H + +RDLK N LLD P K+ DFG +K + + V GT Y A
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185
Query: 209 PE-YAKTGQLTLKSDVYSFGVVLLEILSGR 237
PE + +DV+S GV L +L G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-21
Identities = 36/204 (17%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 100
LG G FG V++ S + K + G ++ + E+ +L++ H N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF 70
Query: 101 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAAR----GLEYLHDK 154
++ ++++E++ + + + + + + L++LH
Sbjct: 71 ESMEELVMIFEFISGL--D--IFE-----RINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 155 AKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ + D++ NI+ R K+ +FG A+ + + Y APE
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEVH 175
Query: 213 KTGQLTLKSDVYSFGVVLLEILSG 236
+ ++ +D++S G ++ +LSG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 33 TKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLS 86
F E LG+G F V + Q+ A ++ + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 87 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIA 141
LL HPN+V L ++ L+++ + G +L + A
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------EL------FEDIVAREYYSEADA 112
Query: 142 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNT 194
+ + + + H V++R+LK N+LL +G KL+DFGLA V
Sbjct: 113 SHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQ 167
Query: 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
GT GY +PE + D+++ GV+L +L G
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-21
Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 44/217 (20%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 95
LG G F V K +S A K + + + +R + EV +L + HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--------KIAAGAAR- 146
L + +L+ E + G E L D + + A +
Sbjct: 79 LHEVYENKTDVILILELVAGG--E--LFD------------FLAEKESLTEEEATEFLKQ 122
Query: 147 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTR 199
G+ YLH + + DLK NI+L P K+ DFGLA +
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNI 177
Query: 200 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 236
GT + APE L L++D++S GV+ +LSG
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHP 91
++ LG G FG+V G E VA+K L+R ++ E+ L L HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----- 146
+++ L + +V EY+ G + D++ N R+ +R
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEKE--SRRLFQQ 124
Query: 147 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
G++Y H V++RDLK N+LLD + K++DFGL+ + G+ S G+
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 178
Query: 204 YGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE + + D++S GV+L +L G
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 89
+F ++G G + +V L+ ++ A++ + + V + + E V + +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-N 111
Query: 90 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 147
HP LV L C + RL V EY+ G + H+ K P + + +A +
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARFYSAEISLA 165
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 206
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T GT Y
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 219
Query: 207 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
APE Y + D ++ GV++ E+++GR
Sbjct: 220 IAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 250
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 7 VKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQ 66
V ++ G + + + A + F ES LG G VY+ + + A+K
Sbjct: 26 VTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV 85
Query: 67 LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 126
L + + E+ +L L HPN++ L + LV E + G +L
Sbjct: 86 LKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG-------EL- 135
Query: 127 PGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRG 174
D + AA A + + YLH+ +++RDLK N+L
Sbjct: 136 -----FDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPD 187
Query: 175 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 234
K++DFGL+K+ V + T GT GYCAPE + + D++S G++ +L
Sbjct: 188 APLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
Query: 235 SG 236
G
Sbjct: 245 CG 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHP 91
+ LGEG FG+V Q VA+K + R ++ + + E+ L LL HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----- 146
+++ L ++V EY G + D++ + RM R
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAG-GELFDYIVE----------KKRMTEDE--GRRFFQQ 116
Query: 147 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
+EY H +++RDLK N+LLD + K++DFGL+ + G+ S G+
Sbjct: 117 IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 204 YGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE + DV+S G+VL +L GR
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 52/223 (23%)
Query: 42 LGEGGFGRVYKGY-LESINQDVAIKQL----DRNGV--QGNREFLVEVL-MLSLLHHPNL 93
+GEG +G+V+K L++ + VA+K++ G+ RE V VL L HPN+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNV 76
Query: 94 VNLI----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--- 145
V L D + +L LV+E++ DL LD +
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEPGVPTETIKDM 125
Query: 146 -----RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 200
RGL++LH V++RDLK NIL+ KL+DFGLA+ +++ V
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVV 180
Query: 201 MGTYGYCAPEYAKTGQLTLKS------DVYSFGVVLLEILSGR 237
+ T Y APE + L+S D++S G + E+ +
Sbjct: 181 V-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-20
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 54/225 (24%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGN-----REFLVEVL-MLSLLHHP 91
+G G +G VYK VA+K + G G RE V +L L HP
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--VALLRRLEAFEHP 74
Query: 92 NLVNLI----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA- 145
N+V L+ D + ++ LV+E++ DL + LD + A
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPPGLPAETIK 123
Query: 146 -------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 198
RGL++LH +++RDLK NIL+ G KL+DFGLA+ ++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 199 RVMGTYGYCAPEYAKTGQLTLKS------DVYSFGVVLLEILSGR 237
V+ T Y APE + L+S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 52/253 (20%), Positives = 97/253 (38%), Gaps = 67/253 (26%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 92
+K + LG G FG V + + + A+K++ ++ NRE + ++ +L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 93 LVNLIGY-------------------------------------CADGDQRL-LVYEYMP 114
++ L+ Y ++ L ++ EY+P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 174
++ L + + N R + ++H + +RD+K N+L++
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177
Query: 175 YHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVY 224
+ KL DFG AK L P + + +R + Y APE Y T D++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEY------TPSIDLW 226
Query: 225 SFGVVLLEILSGR 237
S G V E++ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 89
K +++ +G G G V Y ++++VAIK+L R N R E++++ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119
Query: 90 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
H N+++L+ + LV E M + +L + + LD +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERMSYLLYQ 172
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVM 201
G+++LH +I+RDLK SNI++ K+ DFGLA+ +V TR
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 202 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE D++S G ++ E++ +
Sbjct: 229 ----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 56/227 (24%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGV--QGNREFLVEVLMLSLLHHPNLVN 95
+G+G FG V+K Q VA+K++ ++ G RE + +L LL H N+VN
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 80
Query: 96 LIGYCADGDQRL--------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA-- 145
LI C LV+++ HDL L N +K
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKR 128
Query: 146 ------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVS 197
GL Y+H +++RD+K +N+L+ R KL+DFGLA+ +
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 237
T + T Y PE L L D++ G ++ E+ +
Sbjct: 186 TNRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 100
LG G G+V + + + + A+K L D + RE VE L P++V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--RE--VE-LHWRASQCPHIVRIVDVY 124
Query: 101 ADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 152
+ L+V E + G + + D + + R A+ + ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLH 178
Query: 153 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+ +RD+K N+L KL+DFG AK + ++T T Y AP
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVAP 232
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSG 236
E + D++S GV++ +L G
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-19
Identities = 28/205 (13%), Positives = 59/205 (28%), Gaps = 41/205 (20%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPN 92
+R G + ++ ++++ VA+ +D GV + +E L L LS + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+ ++ L+V E++ GS+++ ++ A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH 146
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
V S + + L+
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-- 179
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGR 237
+ D+ G L +L R
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-19
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 89
K +++ +G G G V Y + ++VAIK+L R N R + E++++ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 90 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAA 142
H N++ L+ + +V E M + +L + + LD + RM +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELD-HERMSYLLY 134
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 202
G+++LH +I+RDLK SNI++ K+ DFGLA + + T +
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVV 188
Query: 203 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
T Y APE D++S G ++ E++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 89
K + S + +G G +G V + + VAIK+L R + + R E+L+L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQ 81
Query: 90 HPNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
H N++ L+ LV +M + L + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
+GL+Y+H V++RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 187
Query: 204 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ Y APE Y +T D++S G ++ E+L+G+
Sbjct: 188 W-YRAPEVILSWMHYNQT------VDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 89
+R +G G +G V VAIK+L R + + R E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMR 82
Query: 90 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
H N++ L+ + D LV +M L L + L + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLM-KHEKLGEDRIQFLVYQ 136
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
+GL Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 204 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE Y +T D++S G ++ E+++G+
Sbjct: 191 --YRAPEVILNWMRYTQT------VDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHH 90
+ + S +GEG +G V Y VAIK++ + R L E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRH 84
Query: 91 PNLVNLIG----YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGA 144
N++ + + + + +V + M E L+ L + L N +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLL-KTQHLS-NDHICYFLYQI 137
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGT 203
RGL+Y+H A V++RDLK SN+LL+ K+ DFGLA+ P D+T T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 204 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE Y K+ D++S G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKS------IDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 48/232 (20%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREF---------LVE 81
+ + + G +G V G +S VAIK++ + + L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 82 VLMLSLLHHPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHD-LSPGKKPLDWN 135
+ +L+ HHPN++ L + + +L LV E M L + + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVIS-P 133
Query: 136 TRMK-IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194
++ GL LH+ V++RDL NILL + DF LA+ N
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 195 --HVSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+V+ R Y APE + K D++S G V+ E+ + +
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKL------VDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 89
+ +++ S +G G +G V + VA+K+L R + + R E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMK 86
Query: 90 HPNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
H N++ L+ + + LV M L+++ + L + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTDDHVQFLIYQ 140
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
RGL+Y+H +I+RDLK SN+ ++ K+ DFGLA+ +V+TR
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--- 194
Query: 204 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE Y +T D++S G ++ E+L+GR
Sbjct: 195 --YRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNL 93
+R +G G FG +Y G + ++VAIK + + +E + ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 67
Query: 94 VNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+ A+GD ++V E LG S+ED L + K L T + +A +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTY 204
K I+RD+K N L+ G + DFGLAK + H+ R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 205 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 237
Y A G + + + D+ S G VL+ G
Sbjct: 180 RY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHH 90
+ +F+ +SLLGEG +G V + + VAIK+++ + R L E+ +L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 91 PNLVNLIG-YCADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGA 144
N++ + D + ++ E M + LH + + L + ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQ-MLS-DDHIQYFIYQT 121
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRV 200
R ++ LH + VI+RDLK SN+L++ K+ DFGLA +
Sbjct: 122 LRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 201 MGTY----GYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
M + Y APE Y++ DV+S G +L E+ R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRA------MDVWSCGCILAELFLRR 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 46/158 (29%), Positives = 62/158 (39%), Gaps = 15/158 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
NFR +G G FG + G N+ VAIK L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIP 68
Query: 95 NLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
+ + G +V E LG S+ED L DL L T + IA +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPK-----LSDFGLAK 186
K +IYRD+K N L+ R + + DF LAK
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 56/262 (21%), Positives = 100/262 (38%), Gaps = 56/262 (21%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 89
N+ + L+G G +G VY Y ++ ++VAIK+++R + + R L E+ +L+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLK 83
Query: 90 HPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK----- 139
++ L I L +V E + L L L +K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYN 137
Query: 140 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 199
+ G ++H+ + +I+RDLK +N LL++ K+ DFGLA+ +T++
Sbjct: 138 LL----LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 200 VMGTYGYCAPEYAKTGQLT--------------LKS-------DVYSFGVVLLEILSGRK 238
+ QLT L D++S G + E+L+ +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 239 AVDTSKAAAEQSLVAWARPLFQ 260
+ PLF
Sbjct: 251 SHINDPTN--------RFPLFP 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 40/229 (17%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHP 91
+ LG GG G V+ ++ VAIK++ + L E+ ++ L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHD 68
Query: 92 NLVNLIG-YCADGDQRL-------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 137
N+V + G Q +V EYM E L ++ + PL
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLLEEHA 122
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK-LGPVGDNTH 195
RGL+Y+H V++RDLK +N+ ++ K+ DFGLA+ + P +
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 196 VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ + T Y +P Y K D+++ G + E+L+G+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNL 93
FR +G G FG +Y G N++VAIK + + + L E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 94 VNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
N+ + +GD +LV + LG S+ED L + K L T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTY 204
K+ ++RD+K N L+ G + DFGLAK + H+ R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 205 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 237
Y A G + + + D+ S G VL+ L G
Sbjct: 178 RY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 6e-14
Identities = 45/270 (16%), Positives = 79/270 (29%), Gaps = 71/270 (26%)
Query: 18 QITAQT--LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL-------- 67
+Q + F T+ + +GEG FG V++ + + VAIK +
Sbjct: 3 GECSQKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLV 59
Query: 68 DRNGVQGNREFLVEVLMLSLLH---------HPNLVNLIG-YCADG-------------- 103
+ + + E L E+++ L + L +C G
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 104 ---------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
DQ +V E+ G + + K T I L
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASL 174
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-------NTHVSTRVM 201
+ +RDL N+LL + KL K + + +R+
Sbjct: 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
Query: 202 --GTYGYCAPEYAK---TGQLTLKSDVYSF 226
G +C + TG + D+Y
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 20/214 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
+++ +GEG FG +++G NQ VAIK R L L +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIP 69
Query: 95 NLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
N+ + +G +LV + LG S+ED L DL K + T A ++ +H+
Sbjct: 70 NVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRKFSV--KTVAMAAKQMLARVQSIHE 124
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPK-----LSDFGLAKL-GPVGDNTHVSTR----VMGT 203
K+ ++YRD+K N L+ R + DFG+ K H+ R + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y + + + + D+ + G V + L G
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIGYC 100
LG G + V++ + N+ V +K L + + E+ +L +L PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 101 ADGDQR--LLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLH 152
D R LV+E++ + L+ + L + L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAP 209
+++RD+K N+++D + +L D+GLA+ G N V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 210 EYAKTGQLTLKS-DVYSFGVVLLEILSGRK 238
E Q+ S D++S G +L ++ ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 52/262 (19%), Positives = 89/262 (33%), Gaps = 53/262 (20%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLL 88
+ L+G G +G V + Y + + VAIK++ R V + L E+ +L+ L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRL 109
Query: 89 HHPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
+H ++V + I + L +V E + L L +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-----KLGPVGDNTHVST 198
G++Y+H A +++RDLK +N L+++ K+ DFGLA
Sbjct: 165 LLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 199 RVMGTYGYCAPEYAKTGQLT--------------LKSDVYSFGV-------VLLEILSGR 237
QLT L + Y+ + + E+L+
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 238 KAVDTSKAAAEQSLVAWARPLF 259
K A PLF
Sbjct: 282 KENVAYHAD--------RGPLF 295
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 29/175 (16%), Positives = 61/175 (34%), Gaps = 29/175 (16%)
Query: 34 KNFRSESLLGEGGFGRVYKGY--------LESINQDVAIKQLDRNG----------VQGN 75
+ ++ +S G +Y+ Q ++K ++G
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 76 REFLVEVLMLSLLHHPNLVNLIGY-CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLD 133
+ + L + +G+ R LV LG S++ D+S K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQS-ALDVS-PKHVLS 157
Query: 134 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 186
+ +++A LE+LH+ ++ ++ NI +D + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 42/207 (20%), Positives = 74/207 (35%), Gaps = 50/207 (24%)
Query: 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYC 100
LG G G+V + + + + A+K L EV L P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 101 ADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 152
+ L+V E + G + + D + + R A+ + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLH 134
Query: 153 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
+ +RD+K N+L KL+DFG AK + Y
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------ETTGE---KYD---- 176
Query: 210 EYAKTGQLTLKSDVYSFGVVLLEILSG 236
D++S GV++ +L G
Sbjct: 177 ---------KSCDMWSLGVIMYILLCG 194
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 52/239 (21%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 89
+ + LG+G +G V+K + VA+K++ N R E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELS 66
Query: 90 -HPNLVNLIG-YCADGDQRL-LVYEYMPLGSVEDHLH------DLSPG-KKPLDWNTRMK 139
H N+VNL+ AD D+ + LV++YM E LH L P K+ + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQL--- 118
Query: 140 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 199
+ ++YLH +++RD+K SNILL+ H K++DFGL++ V +
Sbjct: 119 -----IKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSR-SFVNIRRVTNNI 169
Query: 200 VMGTYGYCAPEYAKTGQLT--------------LKS-------DVYSFGVVLLEILSGR 237
+ LT L S D++S G +L EIL G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 29/176 (16%), Positives = 66/176 (37%), Gaps = 31/176 (17%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-----------GNRE 77
++ +G+GGFG +Y + S + +K + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 78 FLVEVLMLSLLHHPNLVNLIGYCADGDQ----RLLVYEYMPLG-SVEDHLHDLSPGKKPL 132
+ + + L + + G R ++ + G ++ +++ + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQK-IYEANAKRFSR 151
Query: 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 186
T ++++ LEY+H+ ++ D+K SN+LL+ + L D+GLA
Sbjct: 152 --KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 44/226 (19%), Positives = 90/226 (39%), Gaps = 46/226 (20%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---------- 89
LG G F V+ N VA+K + R E+ +L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 90 -HPNLVNLIGY----CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAG 143
+++ L+ + +G ++V+E LG ++ + PL + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP------KLSDFGLAKLGPVGDNTHVS 197
GL+Y+H + +I+ D+K N+L++ P K++D G A + H +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYT 193
Query: 198 TRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ T Y +PE + +D++S ++ E+++G
Sbjct: 194 NSIQ-TREYRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 32/175 (18%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
+ +G GGFG +Y + + + A + + Q N E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 94 VN---------------LIGY----CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLD 133
+ G R +V E LG ++ G
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQN--GTFKK- 150
Query: 134 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 186
+T +++ LEY+H+ ++ D+K +N+LL + L+D+GL+
Sbjct: 151 -STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 50/221 (22%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL--HHP----NL 93
++G+G FG+V K Y ++Q VA+K + RN + +R+ E+ +L L N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 94 VNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGA 144
++++ C + +E + +L++L + K A
Sbjct: 162 IHMLENFTFRNHIC-------MTFELL-----SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMG 202
+ L+ LH K +I+ DLK NILL + K+ DFG + T++ +R
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264
Query: 203 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE Y + D++S G +L E+L+G
Sbjct: 265 ---YRAPEVILGARY------GMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------- 88
+ +SL+G+G FG+V K Y + VAIK + +N + +EV +L L+
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 89 -HHPNLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRM 138
++ +V+L + C LV+E + +L+DL + + + N
Sbjct: 115 KYY--IVHLKRHFMFRNHLC-------LVFEML-----SYNLYDLLRNTNFRGVSLNLTR 160
Query: 139 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHV 196
K A L +L + +I+ DLK NILL K+ DFG + ++
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 197 STRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+R Y +PE Y L D++S G +L+E+ +G
Sbjct: 220 QSRF-----YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 47/264 (17%), Positives = 83/264 (31%), Gaps = 74/264 (28%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HH 90
+ LG G F V+ + + VA+K + ++ L E+ +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 91 PNLVNLIGYC-------ADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAA 142
PN ++ +G +V+E LG + + + PL KI
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQ 153
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILL------------------------------- 171
+GL+YLH K + +I+ D+K NILL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 172 ------------------DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
K++D G A + TR Y + E
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266
Query: 214 TGQLTLKSDVYSFGVVLLEILSGR 237
+D++S + E+ +G
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 55/244 (22%), Positives = 88/244 (36%), Gaps = 80/244 (32%)
Query: 40 SLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHP--- 91
LGEG FG+V + ++ + VA+K + +N + E+ +L L+
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPN 74
Query: 92 ---NLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMK 139
V ++ + C +V+E LG +D G P + K
Sbjct: 75 STFRCVQMLEWFEHHGHIC-------IVFE--LLGL---STYDFIKENGFLPFRLDHIRK 122
Query: 140 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHP------------------KLS 180
+A + + +LH + + DLK NIL Y K+
Sbjct: 123 MAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 181 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 232
DFG A ++ T VSTR Y APE + + DV+S G +L+E
Sbjct: 180 DFGSATY--DDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIE 226
Query: 233 ILSG 236
G
Sbjct: 227 YYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 48/247 (19%), Positives = 77/247 (31%), Gaps = 86/247 (34%)
Query: 40 SLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLL------ 88
LGEG FG+V + VA+K + RN ++ +E+ +L +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAARLEINVLKKIKEKDKE 79
Query: 89 --HHPNLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTR 137
V + + C + +E LG + + +P
Sbjct: 80 NKFL--CVLMSDWFNFHGHMC-------IAFE--LLGK---NTFEFLKENNFQPYPLPHV 125
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------K 178
+A L +LH+ + + DLK NIL +
Sbjct: 126 RHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 179 LSDFGLAKLGPVGDNTH---VSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVV 229
++DFG A H V+TR Y PE + DV+S G +
Sbjct: 183 VADFGSATF---DHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCI 228
Query: 230 LLEILSG 236
L E G
Sbjct: 229 LFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 57/244 (23%), Positives = 87/244 (35%), Gaps = 76/244 (31%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HHPNLV 94
+G+G FGRV + A+K + RN + R +E +L + ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 95 NLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAA 145
G C L++E PLG L+++
Sbjct: 100 KYHGKFMYYDHMC-------LIFE--PLGP---SLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------------KLS 180
+ L YL + + + DLK NILLD Y KL
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 181 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 232
DFG A D + ++TR Y APE + + SD++SFG VL E
Sbjct: 205 DFGCA--TFKSDYHGSIINTRQ-----YRAPEVILNLGW------DVSSDMWSFGCVLAE 251
Query: 233 ILSG 236
+ +G
Sbjct: 252 LYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.46 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.85 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.73 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.68 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.54 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.3 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.28 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.75 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.1 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.56 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-58 Score=415.74 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=213.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
+.|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++||||+++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997666666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+||+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|..... .
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC--C
Confidence 99999999975 46999999999999999999999999 99999999999999999999999999986322 2
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+... . ..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~------------~~ 288 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---L------------PP 288 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---S------------CC
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---C------------CC
Confidence 22334568999999999999999999999999999999999999999765443322211100 0 00
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....+...+.++.+||.+||+.||++|||+.++++.
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011122344588999999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-58 Score=418.76 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=206.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999999999999999999975533 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
||+||+|.+++.... +..+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++...
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 176 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-- 176 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC--
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec--
Confidence 999999999997522 456899999999999999999999999 9999999999999999999999999998522
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+ .... .+
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~~~~-----------~~ 243 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--ISGS-----------FP 243 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHTC-----------CC
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--HcCC-----------CC
Confidence 1112223457999999999999999999999999999999999999999875443222111 1100 01
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .+...+.++.+||.+||+.||++|||+.++++.
T Consensus 244 ~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 P----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 122344588999999999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-58 Score=411.70 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=214.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999999643 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
||||+||+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 111 mEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
...........+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~~-------- 249 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------KL-------- 249 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HT--------
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------
Confidence 3333333455689999999999999999999999999999999999999997654432221111 00
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ..++...+.++.+||.+||+.||++|||+.+++.
T Consensus 250 ~----~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 250 E----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp C----CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred C----CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0 0122233457889999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=412.51 Aligned_cols=264 Identities=28% Similarity=0.442 Sum_probs=212.7
Q ss_pred hhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|.+.+.||+|+||.||+|.++. ++..||||++........+.|.+|+.+|+.++||||+++++++.+....|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4678888999999999999998753 58899999998766666678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 108 LVYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
+|||||++|+|.+++..... ...++++.+++.++.||++||.|||+++ |+||||||+||||+.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999975321 1356999999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 255 (361)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||...........+...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986433333333445678999999999999999999999999999999999 89999875543322211100
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
. ....|..++.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 277 ----------~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 ----------R-------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ----------C-------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------C-------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0 0112334455889999999999999999999999999988764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=411.55 Aligned_cols=264 Identities=27% Similarity=0.389 Sum_probs=216.7
Q ss_pred hhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|.+.+.||+|+||.||+|.+. .++..||||++........+.|.+|+.+|++++||||+++++++.+++..|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 368999999999999999999875 357889999998766666678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 108 LVYEYMPLGSVEDHLHDLS---------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
+|||||++|+|.+++.... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997521 22457999999999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||...........+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~-- 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG-- 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT--
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence 999999975333222222333468999999999999999999999999999999998 89999875443222111100
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
. ....|..++.++.+|+.+||+.||++|||+.+|.+.|+.+...
T Consensus 247 --------~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 --------R-------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp --------C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------C-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0 0112334455889999999999999999999999999987653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=410.35 Aligned_cols=258 Identities=20% Similarity=0.233 Sum_probs=211.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.+.|++.+.||+|+||.||+|+++.+|+.||||+++.... ..+|+.+++.++||||+++++++.++..+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4568888999999999999999999999999999975432 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEecccccccCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVG 191 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~~~~~~~ 191 (361)
|+||+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.+| .+||+|||+++.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999986 567999999999999999999999999 99999999999999988 5999999999864322
Q ss_pred CCcc---eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 192 DNTH---VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 192 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~------- 271 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SE------- 271 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HS-------
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cC-------
Confidence 1111 1223579999999999999999999999999999999999999997643321111110 00
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
+......++..+..+.++|.+||+.||++|||+.|+++.|.......
T Consensus 272 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 272 --PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp --CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 00011223445568899999999999999999999999988766543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=417.96 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=214.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.+.|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++||||+++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35799999999999999999999999999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
|+||+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+|.....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~-- 299 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-- 299 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS--
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC--
Confidence 999999999975 46999999999999999999999999 99999999999999999999999999976322
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
........+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+... . .+.
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~----------~~~ 366 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---L----------PPR 366 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---C----------CCC
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---C----------CCC
Confidence 222334567999999999999999999999999999999999999999765443322221100 0 000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+.++.+||.+||+.||++|||+.++++.
T Consensus 367 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122334588899999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=395.10 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=196.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999999999999999997542 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+ +|+|.+++.. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 6899999876 577999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+...
T Consensus 164 ~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------- 227 (275)
T 3hyh_A 164 D---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------- 227 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred C---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2 222334679999999999988776 57999999999999999999999765433221111100
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ..++...+.++.+||.+||+.||++|||+.++++.
T Consensus 228 -~----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 -V----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -C----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 01122334578899999999999999999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=398.30 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=206.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
..+++++.+.||+|+||.||+|+++. .||||+++.... ...+.|.+|+.+++.++||||+++++++.+ +.+|+|
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 35788899999999999999998763 599999864432 334679999999999999999999998865 568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 110 mEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999999752 357999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeeccccCcCcCCchhhcc---CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ +.. .
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~----~---- 253 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGR----G---- 253 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHT----T----
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--Hhc----C----
Confidence 3333333445679999999999964 46899999999999999999999999764332211111 100 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
...|.. ...+..++..+.+|+.+||+.||++|||+.+|++.|+.++.
T Consensus 254 -~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 254 -YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp -CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred -CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 001111 12233455688999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=401.16 Aligned_cols=261 Identities=29% Similarity=0.402 Sum_probs=213.1
Q ss_pred hhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
..++++.+.||+|+||.||+|.+. .++..||||++..... ...+.|.+|+.++++++||||+++++++.++...
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 356778899999999999999974 3578999999965433 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC
Q 018100 107 LLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 174 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~ 174 (361)
++|||||++|+|.+++..... ....+++..++.++.||++||.|||+++ |+||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 999999999999999964321 1246999999999999999999999999 9999999999999999
Q ss_pred CceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHH
Q 018100 175 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 253 (361)
Q Consensus 175 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~ 253 (361)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i- 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI- 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH-
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence 9999999999976433333333345678999999999999999999999999999999998 89999876543322211
Q ss_pred hhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
.. .. ....|+.++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 261 --~~-------~~-------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 --RN-------RQ-------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HT-------TC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --Hc-------CC-------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 10 00 0122344556889999999999999999999999999743
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=392.10 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=201.0
Q ss_pred hCc-ccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEc----CCee
Q 018100 34 KNF-RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQR 106 (361)
Q Consensus 34 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 106 (361)
++| ++.+.||+|+||.||+|.++.++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 77788999999999999999999999999986542 2334678999999999999999999999864 3467
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEeccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLA 185 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~ 185 (361)
|+|||||+||+|.+++.. ...+++..+..++.||+.||.|||+++ +.|+||||||+|||++. +|.+||+|||+|
T Consensus 105 ~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999999986 567999999999999999999999875 23999999999999984 799999999999
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
+.... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||......... ...+.. .
T Consensus 180 ~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~~~i~~----~--- 245 (290)
T 3fpq_A 180 TLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTS----G--- 245 (290)
T ss_dssp GGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTT----T---
T ss_pred EeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--HHHHHc----C---
Confidence 75322 22334679999999999865 6999999999999999999999999754322111 111100 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...+..... .+.++.+||.+||+.||++|||+.++++
T Consensus 246 --~~~~~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 --VKPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CCCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCCCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111111 2337888999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-56 Score=398.09 Aligned_cols=248 Identities=26% Similarity=0.326 Sum_probs=200.5
Q ss_pred hCcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
++|++++.||+|+||.||+|++. .+++.||+|++..... .....+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 68999999999999999999874 4678999999975422 223467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|||||+||+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999986 567999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 177 ~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~------- 241 (304)
T 3ubd_A 177 ID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL------KA------- 241 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-------
T ss_pred cC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH------cC-------
Confidence 22 1222334679999999999999999999999999999999999999998754433222111 00
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI-----ADVVT 308 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~ll~ 308 (361)
. ..+|...+.++.+||.+||+.||++|||+ +++++
T Consensus 242 -~----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 -K----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -C----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 11223344588899999999999999985 55553
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-55 Score=400.71 Aligned_cols=272 Identities=26% Similarity=0.376 Sum_probs=218.9
Q ss_pred HHHHHHHhhCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhcCCC-Cccceeee
Q 018100 26 FRELAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHH-PNLVNLIG 98 (361)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~ 98 (361)
..+++.-.++|++.+.||+|+||.||+|.+... ++.||||++...... ..+.+.+|+.+|.+++| |||+++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 345555678999999999999999999998654 367999999765433 34678999999999965 99999999
Q ss_pred EEEc-CCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 018100 99 YCAD-GDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 165 (361)
Q Consensus 99 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~ 165 (361)
+|.+ +..+++|||||++|+|.+++..... ....+++..++.++.||++||.|||+++ |+|||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 9865 4578999999999999999965221 1346899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccch
Q 018100 166 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 244 (361)
Q Consensus 166 p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~ 244 (361)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986444433334445678999999999999999999999999999999998 999997643
Q ss_pred HHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 245 AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.... +...+.. ......|..++.++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 293 ~~~~--~~~~i~~--------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 IDEE--FCRRLKE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSHH--HHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH--HHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2211 1111100 001122334455889999999999999999999999999887654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=380.98 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=192.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCC------
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 104 (361)
..++|++++.||+|+||.||+|+++.+|..||||++...... ..+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 356799999999999999999999999999999999755433 3467889999999999999999999986543
Q ss_pred ------eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 105 ------QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 105 ------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
.+|+|||||++|+|.+++..... ....++..++.++.||++||+|||++| |+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEE
Confidence 36899999999999999976221 123566778999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCCc----------ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh
Q 018100 179 LSDFGLAKLGPVGDNT----------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 248 (361)
|+|||+++........ ......+||+.|+|||++.+..++.++|||||||++|+|++ ||........
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 9999999764322111 11223579999999999999999999999999999999996 7764322111
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+...... ..|.. .+.....+.+||.+||+.||++|||+.++++
T Consensus 236 -~~~~~~~~-----------~~p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 -TLTDVRNL-----------KFPPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHTT-----------CCCHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHhcC-----------CCCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11100000 00000 1223345678999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=382.10 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=199.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC----eeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l 108 (361)
.++|.+.+.||+|+||.||+|.++ |+.||||+++.... .......|+..+..++||||+++++++.++. .+||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 367899999999999999999985 89999999864321 1122334666667889999999999997653 5799
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCeeecCCCCCcEEEcCCCceeEe
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK--------AKPPVIYRDLKCSNILLDRGYHPKLS 180 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~~i~H~dl~p~Nilv~~~~~~~L~ 180 (361)
|||||++|+|.++++. .++++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~---IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC---EECSCCCGGGEEECTTSCEEEC
T ss_pred EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---EeeccCCcccEEECCCCCEEEE
Confidence 9999999999999975 5699999999999999999999987 6 9999999999999999999999
Q ss_pred cccccccCCCCCCcc--eeeccccCcCcCCchhhccC------CCCccCceehhhHHHHHHhhCCCccccchHHHh--h-
Q 018100 181 DFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE--Q- 249 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~--~- 249 (361)
|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ .
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 999997643322211 12235799999999999764 367899999999999999999887753221000 0
Q ss_pred ------hHHHhhhhhhccccccccccCccccC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 250 ------SLVAWARPLFQDRTRHSLIADPELQG-QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 250 ------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
............ ...|.+.. ......+..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~------~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHhcc------cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 000000000000 00111110 11224566788999999999999999999999999988764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=387.00 Aligned_cols=268 Identities=22% Similarity=0.279 Sum_probs=206.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEc------CCe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQ 105 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 105 (361)
++|++++.||+|+||.||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999975433 234568899999999999999999998753 367
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
+|+|||||+ |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 789999876 678999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC--CcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 186 KLGPVGD--NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 186 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
+...... ........+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.........+..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 7532221 12223456899999999998775 56899999999999999999999998766544433322111100000
Q ss_pred ccc--c---------cc--cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TRH--S---------LI--ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~~--~---------~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... . .. ..+.......+..+.++.+||.+||..||++|||+.++++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 00 00000000011234578899999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=376.39 Aligned_cols=204 Identities=25% Similarity=0.345 Sum_probs=173.1
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
.+..+.++|++.+.||+|+||.||+|.++ .+++.||+|++.... ....+.+|+.+|+.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 33456688999999999999999999875 457899999986543 345678899999988 699999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-CceeEecc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDF 182 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-~~~~L~Df 182 (361)
+..|+||||++|++|.+++.. +++.++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred CEEEEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence 999999999999999999853 899999999999999999999999 9999999999999876 89999999
Q ss_pred cccccCCCCCC--------------------------cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhh
Q 018100 183 GLAKLGPVGDN--------------------------THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILS 235 (361)
Q Consensus 183 g~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~ 235 (361)
|+|+....... .......+||+.|+|||++.+. .++.++||||+||++|+|++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99975322110 0112235799999999999775 58999999999999999999
Q ss_pred CCCccccc
Q 018100 236 GRKAVDTS 243 (361)
Q Consensus 236 g~~pf~~~ 243 (361)
|+.||...
T Consensus 243 G~~Pf~~~ 250 (361)
T 4f9c_A 243 GRYPFYKA 250 (361)
T ss_dssp TCSSSSCC
T ss_pred CCCCCCCC
Confidence 99999543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=395.89 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=213.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.++.+|+.||+|++........+.+.+|+.+|+.++||||+++++++.+...+|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 47899999999999999999999999999999999776655667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC--CceeEecccccccCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAKLGPV 190 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~--~~~~L~Dfg~~~~~~~ 190 (361)
|+||+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999998864 2457999999999999999999999999 9999999999999854 8999999999986432
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ....
T Consensus 310 ---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~----------~~~~ 376 (573)
T 3uto_A 310 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD----------WNMD 376 (573)
T ss_dssp ---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC----------CCCC
T ss_pred ---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC----------CCCC
Confidence 223344579999999999999999999999999999999999999998765433322211110 0001
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... ....+.++.+||.+||+.||.+||++.++++.
T Consensus 377 ~~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 12234478899999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=365.96 Aligned_cols=290 Identities=40% Similarity=0.670 Sum_probs=236.7
Q ss_pred cceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEE
Q 018100 22 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 101 (361)
Q Consensus 22 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 101 (361)
..+++.++....++|++.+.||+|+||.||+|.++ ++..|++|++........+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34455566677899999999999999999999975 58899999987766666778999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
+....++||||+++++|.+++.........+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999999764433457999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
||++................|+..|+|||++.+..++.++|||||||++|+|++|..||.............+......
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~- 261 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN- 261 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-
Confidence 9998764333222233345689999999999888999999999999999999999999976543332223322221111
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
........++......++..+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 1222333445555667788899999999999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=389.58 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=203.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHH---HHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFL---VEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+. .++.+++.++||||+++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999999999999999996431 11222233 346677788999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|.
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999986 567999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... ....+||+.|+|||++. +..|+.++|||||||++|+|++|..||..........+..... ..
T Consensus 341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~~---- 409 (689)
T 3v5w_A 341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TM---- 409 (689)
T ss_dssp ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---HC----
T ss_pred ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---CC----
Confidence 643221 23457999999999996 4579999999999999999999999997543322111111110 00
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
...++...+.++.+||.+||+.||.+|++ +++|++
T Consensus 410 --------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01223344558899999999999999998 677775
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=348.75 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=213.5
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 35789999999999999999999999999999999976666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999976 46999999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........|+..|+|||++.+..++.++|||||||++|+|++|..||................ ..
T Consensus 170 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~----- 234 (297)
T 3fxz_A 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--------TP----- 234 (297)
T ss_dssp --TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------SC-----
T ss_pred --ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------CC-----
Confidence 222334578999999999999999999999999999999999999997654433222111000 00
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 235 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 --ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011122344578899999999999999999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=353.96 Aligned_cols=290 Identities=42% Similarity=0.722 Sum_probs=237.2
Q ss_pred CcccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccce
Q 018100 17 DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~ 95 (361)
.......+++.++....++|++.+.||+|+||.||+|.+. ++..||+|++...... ....+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 3455678899999999999999999999999999999865 4889999998754322 2346889999999999999999
Q ss_pred eeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCCeeecCCCCCcEEEc
Q 018100 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK---AKPPVIYRDLKCSNILLD 172 (361)
Q Consensus 96 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~~~~i~H~dl~p~Nilv~ 172 (361)
+++++.+....++||||+++++|.+++.........+++..++.++.||+.||.|||++ + ++||||||+||+++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLD 168 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEEC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEEC
Confidence 99999999999999999999999999987655566799999999999999999999999 8 99999999999999
Q ss_pred CCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh--hh
Q 018100 173 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE--QS 250 (361)
Q Consensus 173 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~--~~ 250 (361)
.++.++|+|||++....... ........|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp TTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 99999999999997643222 2223345589999999999888899999999999999999999999964332211 12
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
...+...... ........+.......+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 248 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 248 LLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 2233322222 222334445555667778889999999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=351.44 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=215.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.+..++..|++|++........+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 47899999999999999999999999999999998766666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999762 356999999999999999999999999 9999999999999999999999999997633222
Q ss_pred Ccc------------eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 193 NTH------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 193 ~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------- 233 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------- 233 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---------
Confidence 111 01135689999999999999999999999999999999999999864322111000
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
...........++..+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 234 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 234 ------LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ------BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000000111223334788899999999999999999999999988764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=352.77 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=211.0
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
...++|++.+.||+|+||.||+|.+..+|..||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34578999999999999999999999999999999986542 2334668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999976 567999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCC-ccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... .......|++.|+|||++.+..++ .++|||||||++|+|++|..||............... .
T Consensus 165 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~----- 230 (328)
T 3fe3_A 165 TVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------K----- 230 (328)
T ss_dssp SSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------C-----
T ss_pred CCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C-----
Confidence 322 123345799999999999887765 8999999999999999999999876543322211100 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+..+.+|+.+||..||.+|||+.++++.
T Consensus 231 -------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 -------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01122234478899999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=343.52 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=219.1
Q ss_pred ccCcceeHHHHHHHhhC----------cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC
Q 018100 19 ITAQTLTFRELAAATKN----------FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL 88 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l 88 (361)
...+.+++++++.+.+. |...+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+++.+
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 44467889999988765 78888999999999999999989999999999877666678899999999999
Q ss_pred CCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 89 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
+||||+++++++......++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+|
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 171 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999999999999999999999999999874 46999999999999999999999999 9999999999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 248 (361)
|+++.++.++|+|||++...... ........|+..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EEECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999998753222 1223345789999999999998999999999999999999999999976543322
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..... . .. .+. .......+..+.+++.+||+.||++|||+.++++.
T Consensus 250 ~~~~~---~---~~-------~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLR---D---SP-------PPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHH---H---SS-------CCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHh---c---CC-------CCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 0 00 000 00112234478899999999999999999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=348.75 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=212.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe---EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.+..++. .||||++..... ...+.+.+|+.+++.++||||+++++++.++...++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 5689999999999999999999986544 599999975432 334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999965 2357999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~----------- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG----------- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------
Confidence 332211 11222345678999999998899999999999999999999 99999765443322211100
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.....+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 001122334458889999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=349.76 Aligned_cols=253 Identities=25% Similarity=0.293 Sum_probs=210.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
+.++|++.+.||+|+||.||+|.++.+|..||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999999999999999999754332 34678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC----ceeEec
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSD 181 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~----~~~L~D 181 (361)
.++||||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++.++ .++|+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999976 567999999999999999999999999 99999999999998877 799999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
||++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 163 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------ 233 (361)
T 2yab_A 163 FGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV------ 233 (361)
T ss_dssp CSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------
T ss_pred cCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------
Confidence 9999764322 1223456999999999999889999999999999999999999999765443222111100
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+.... ..+..+.+||.+||..||.+|||+.++++
T Consensus 234 ----~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 ----SYDFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCCCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000111111 22347889999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=347.32 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=210.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.+|+.||+|++... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 47899999999999999999999999999999998643 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||++|++|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++....
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999976 567999999999999999999999999 9999999999999999999999999997522
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 157 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~-------- 220 (337)
T 1o6l_A 157 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------ME-------- 220 (337)
T ss_dssp C--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC--------
T ss_pred c--CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH------cC--------
Confidence 1 1222334578999999999999999999999999999999999999997654332211111 00
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
. ..++...+..+.++|.+||+.||++|| ++.++++.
T Consensus 221 ~----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 E----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 112233445888999999999999999 89999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=343.01 Aligned_cols=271 Identities=30% Similarity=0.455 Sum_probs=208.1
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
....+....++|++.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 33344455789999999999999999999874 789999998755432 23568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
....++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| ++++||||||+||+++.++.++|+||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence 9999999999999999999975110 123999999999999999999999886 34999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
|++..... .........|+..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 184 g~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~------ 255 (309)
T 3p86_A 184 GLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------ 255 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC------
T ss_pred CCCccccc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------
Confidence 99875222 1122234568999999999999999999999999999999999999997654433222111000
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.....+...+..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 256 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 ----------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 001222334457889999999999999999999999999887643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=352.74 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=214.6
Q ss_pred hhCcccCCeecccCceEEEEEEEC-------CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999974 3456799999875433 2345788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
...|+||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976321 1245899999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhh
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 250 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 250 (361)
+.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999975433322222233456788999999999999999999999999999999 999997654322211
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
... . ......+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 317 ~~~-------~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 317 LLK-------E----------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHH-------T----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHh-------c----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 110 0 0011123344558889999999999999999999999999887643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=344.29 Aligned_cols=263 Identities=26% Similarity=0.331 Sum_probs=211.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
+.++|++.+.||+|+||.||+|.+..++..|++|++...... ..+.+.+|+.+++.++||||+++++++.++...++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 357899999999999999999999999999999998644332 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ..++++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999986 567999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.... ........|+..|+|||++.+..++.++||||||+++|+|++|..||............ . .. .
T Consensus 162 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~----~~---~--- 228 (294)
T 4eqm_A 162 SETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--I----QD---S--- 228 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH--H----SS---C---
T ss_pred cccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--h----hc---c---
Confidence 2221 11223356899999999999999999999999999999999999999875443221100 0 00 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHh
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLAS 315 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~ll~~l~~l~~ 315 (361)
.+.......+..+..+.+++.+||+.||.+|| ++.++.+.|..+..
T Consensus 229 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 229 -VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 01111111223345788999999999999998 89999999886544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=349.01 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=207.4
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.++|++.+.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45899999999999999999999999999999999865433 22356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
...........|+..|+|||++.+..+ +.++|||||||++|+|++|..||......... ...+... ...
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~--------~~~- 227 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK--------KTY- 227 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT--------CTT-
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc--------ccc-
Confidence 222222334578999999999987765 78899999999999999999999764332111 1111100 000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 228 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00012234477889999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=345.46 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=208.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC-----CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
+.++|++.+.||+|+||.||+|.++.+++.||+|++... .....+.+.+|+.+++.++||||+++++++.++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999999999999999998532 122457789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc---eeEeccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFG 183 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~---~~L~Dfg 183 (361)
|+||||+++++|.+++......+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++|+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998888653333456999999999999999999999999 999999999999987655 9999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
++..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||..........+. ..
T Consensus 179 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~---~~------ 247 (351)
T 3c0i_A 179 VAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII---KG------ 247 (351)
T ss_dssp TCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHH---HT------
T ss_pred ceeEecC--CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHH---cC------
Confidence 9976332 222233456899999999999989999999999999999999999999775332111111 00
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+.... ..+..+.+||.+||+.||++||++.++++
T Consensus 248 --~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 --KYKMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCCCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000111111 12347889999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=342.33 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=210.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
+.++|++.+.||+|+||.||+|.++.++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 457899999999999999999999999999999998754322 35678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC----ceeEec
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSD 181 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~----~~~L~D 181 (361)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++ .++|+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999976 567999999999999999999999999 99999999999999887 799999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----- 233 (326)
T 2y0a_A 162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN----- 233 (326)
T ss_dssp CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC-----
T ss_pred CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC-----
Confidence 99997643221 2233568999999999998899999999999999999999999997654332221111000
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......... ..+..+.++|.+||+.||++|||+.++++.
T Consensus 234 -----~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 -----YEFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----CCCCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCcCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000011111 223478889999999999999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=356.28 Aligned_cols=263 Identities=26% Similarity=0.375 Sum_probs=213.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
...++|++.+.||+|+||.||+|.++.++..||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 345789999999999999999999998899999999875422 2234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++... +..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999751 346899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
............++..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~------------- 331 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG------------- 331 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-------------
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2111111111234667999999998899999999999999999998 99999765443322211100
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 332 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 ----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 00112233445788999999999999999999999999988753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=342.43 Aligned_cols=255 Identities=16% Similarity=0.201 Sum_probs=210.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
+.++|++.+.||+|+||.||+|.++.++..|++|.+... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 458999999999999999999999999999999998644 2344568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC--CCceeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~--~~~~~L~Dfg~~~~~~ 189 (361)
|+++++|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+||+++. ++.++|+|||++....
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999965 2346999999999999999999999999 999999999999987 7899999999997643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .......+++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ...
T Consensus 156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------~~~ 222 (321)
T 1tki_A 156 PG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE----------YTF 222 (321)
T ss_dssp TT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------CCC
T ss_pred CC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC----------CCC
Confidence 22 22334568999999999988889999999999999999999999997654432221111000 000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
...... ..+.++.+++.+||..||.+|||+.++++.-
T Consensus 223 ~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 223 DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred Chhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 111111 2234788999999999999999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=355.30 Aligned_cols=257 Identities=19% Similarity=0.243 Sum_probs=210.4
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..+.++|++.+.||+|+||.||+|.++.+|..+|+|++...... ..+.+.+|+.+++.++||||+++++++.++...|
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 45678999999999999999999999999999999998754332 3456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc---CCCceeEecccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGL 184 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~---~~~~~~L~Dfg~ 184 (361)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 87 lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999987 567999999999999999999999999 99999999999998 567899999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
+...... ........|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... +
T Consensus 160 a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~----- 230 (444)
T 3soa_A 160 AIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA--Y----- 230 (444)
T ss_dssp CBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--C-----
T ss_pred eEEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--C-----
Confidence 9753222 222234579999999999999899999999999999999999999997654433222111100 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.....+..+..+.+||.+||+.||++|||+.++++.
T Consensus 231 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 -------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00001112234478899999999999999999999973
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=348.98 Aligned_cols=256 Identities=19% Similarity=0.252 Sum_probs=210.1
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..+.++|++.+.||+|+||.||+|.++.++..||+|++..... ...+.+.+|+.+++.++||||+++++++.++...|
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4567899999999999999999999999999999999975433 23456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC---ceeEecccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGL 184 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~---~~~L~Dfg~ 184 (361)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 105 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999999876 567999999999999999999999999 99999999999998654 599999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
+...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... +.
T Consensus 178 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~---- 248 (362)
T 2bdw_A 178 AIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YD---- 248 (362)
T ss_dssp CBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CC----
T ss_pred ceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CC----
Confidence 9753322 12233568999999999999899999999999999999999999997654332221111000 00
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. . .......+..+.+||.+||+.||++||++.++++.
T Consensus 249 ---~-~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ---Y-P----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---C-C----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---C-C----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 00012234578899999999999999999998863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=347.71 Aligned_cols=273 Identities=26% Similarity=0.338 Sum_probs=207.7
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC----eeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 107 (361)
..++|++.+.||+|+||.||+|.+. ++.||||++.... ........|+.++..++||||+++++++.+.. ..+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3478999999999999999999886 7899999986432 22344566899999999999999999997743 469
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCeeecCCCCCcEEEcCCCce
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK----------AKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+. + ++||||||+|||++.++.+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence 99999999999999975 4599999999999999999999999 9 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhccC-----CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 252 (361)
||+|||++................|+..|+|||++.+. .++.++|||||||++|+|++|..||............
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999764333332233345689999999999763 4567899999999999999999999754321111000
Q ss_pred Hhhhh-----hhccccccccccCccccC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 253 AWARP-----LFQDRTRHSLIADPELQG-QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 253 ~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
..... ...... ......+.+.. ......+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 251 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVV-VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHH-TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhh-hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 000000 00000011100 01124456789999999999999999999999999988764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.15 Aligned_cols=288 Identities=38% Similarity=0.617 Sum_probs=226.8
Q ss_pred cccCcceeHHHHHHHhhCcccC------CeecccCceEEEEEEECCCCeEEEEEEeccCC----ccchHHHHHHHHHHhc
Q 018100 18 QITAQTLTFRELAAATKNFRSE------SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----VQGNREFLVEVLMLSL 87 (361)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~ 87 (361)
+.....+++.++..+.++|... +.||+|+||.||+|.+. +..|++|++.... ....+.+.+|+.+++.
T Consensus 9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 3456788999999999998877 99999999999999874 7899999986432 2234678899999999
Q ss_pred CCCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 018100 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 167 (361)
Q Consensus 88 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~ 167 (361)
++||||+++++++.+....++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||||+
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~ 162 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSA 162 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHH
Confidence 9999999999999999999999999999999999875321 356999999999999999999999999 999999999
Q ss_pred cEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH
Q 018100 168 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247 (361)
Q Consensus 168 Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 247 (361)
||+++.++.++|+|||++................|+..|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999876433333333344568999999998865 57899999999999999999999997643321
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
... .+...............+.. ....+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 242 ~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLL--DIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTT--HHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHH--HHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 110 00000000000001111111 134466778889999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=341.74 Aligned_cols=277 Identities=25% Similarity=0.359 Sum_probs=211.8
Q ss_pred hhCcccCCeecccCceEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc--CCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 106 (361)
.++|++.+.||+|+||.||+|. +..++..||+|++........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5889999999999999999999 566799999999987665556788999999999999999999999854 4568
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999762 245999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||..................... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV-FHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH-HHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH-HHH
Confidence 64322211 1222345677899999999999999999999999999999999998765432111100000000000 000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
............+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000000111122334456889999999999999999999999999988764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=348.04 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=211.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|+||.||+|.++.++..||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 35789999999999999999999999999999999976655556678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC--CCceeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~--~~~~~L~Dfg~~~~~~ 189 (361)
|+++++|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+|||++. ++.++|+|||++....
T Consensus 129 ~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999875 2346999999999999999999999999 999999999999974 5779999999998643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .......||..|+|||++.+..++.++|||||||++|+|++|..||............... ....
T Consensus 203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----------~~~~ 269 (387)
T 1kob_A 203 PD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----------DWEF 269 (387)
T ss_dssp TT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC----------CCCC
T ss_pred CC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------CCCC
Confidence 22 1223346899999999999989999999999999999999999999765443222111100 0000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+ ......+..+.++|.+||+.||++|||+.++++.
T Consensus 270 ~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11 1112334578899999999999999999999964
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=349.19 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=204.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 106 (361)
...++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+..|..++..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3458999999999999999999999999999999998643 223446678899999988 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999976 567999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 173 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~----- 239 (353)
T 3txo_A 173 EGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------ND----- 239 (353)
T ss_dssp CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-----
T ss_pred eccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH------cC-----
Confidence 4221 2222344579999999999998889999999999999999999999997665433221111 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI------ADVVT 308 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~ll~ 308 (361)
...++...+..+.++|.+||+.||.+||++ .++++
T Consensus 240 -------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 -------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011223344578899999999999999998 67765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.58 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=208.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.++..||+|++... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 57899999999999999999999999999999998643 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+.|++|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCcceeeccccCcCcCCchhhcc---CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.. .......||..|+|||++.+ ..++.++|||||||++|+|++|..||..........+......
T Consensus 167 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------- 234 (384)
T 4fr4_A 167 RE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--------- 234 (384)
T ss_dssp TT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---------
T ss_pred CC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---------
Confidence 22 22344579999999999864 4589999999999999999999999975433222222211110
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVT 308 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~ll~ 308 (361)
....++...+..+.+||.+||+.||.+||+ +.++++
T Consensus 235 ------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 ------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 001123334458889999999999999998 666654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=334.47 Aligned_cols=266 Identities=19% Similarity=0.257 Sum_probs=203.6
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999754333 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++ +++.+.+.. ....+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~- 153 (292)
T 3o0g_A 82 FCD-QDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI- 153 (292)
T ss_dssp CCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS-
T ss_pred cCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC-
Confidence 997 566665543 1467999999999999999999999999 99999999999999999999999999976322
Q ss_pred CCcceeeccccCcCcCCchhhccCC-CCccCceehhhHHHHHHhhCCCcc-ccchHHHhhhHH-Hhhhhhhc----cccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLV-AWARPLFQ----DRTR 264 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf-~~~~~~~~~~~~-~~~~~~~~----~~~~ 264 (361)
.........++..|+|||++.+.. ++.++|||||||++|+|++|..|| ............ ........ ....
T Consensus 154 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred -ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 222233456899999999997765 799999999999999999988775 333222221111 11000000 0000
Q ss_pred ------cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 265 ------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 265 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..............+..+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000001111222344568889999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=340.56 Aligned_cols=265 Identities=28% Similarity=0.402 Sum_probs=215.4
Q ss_pred HhhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
..++|++.+.||+|+||.||+|.+. .++..|++|++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4688999999999999999999983 4468999999875432 334678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 165 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~ 165 (361)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976332 1234899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccch
Q 018100 166 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 244 (361)
Q Consensus 166 p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~ 244 (361)
|+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999976433322222333456788999999998889999999999999999999 999997654
Q ss_pred HHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 245 AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
........... .....+...+..+.+++.+||+.||++||++.++++.|+.+..+
T Consensus 258 ~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERLFNLLKTG-----------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhcC-----------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 32221111100 00112233445888999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=343.43 Aligned_cols=271 Identities=23% Similarity=0.349 Sum_probs=198.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCe---EEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
...++|++.+.||+|+||.||+|.+..++. .||+|++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 446789999999999999999999887665 8999998754 23345678999999999999999999999987665
Q ss_pred e------EEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 106 R------LLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 106 ~------~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
. ++||||+++++|.+++.... .....+++..++.++.||+.||.|||++| ++||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 89999999999999986422 12236999999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhh
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWAR 256 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 256 (361)
+|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.............
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~--- 253 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI--- 253 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh---
Confidence 9999999976433322222333456778999999999999999999999999999999 999997654332211110
Q ss_pred hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccCCCc
Q 018100 257 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 321 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~~~~ 321 (361)
.. .....++..+..+.+++.+||+.||++|||+.++++.|+.+....+...
T Consensus 254 ---~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 254 ---GG-----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp ---TT-----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred ---cC-----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 00 0011123344578899999999999999999999999999988765444
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=351.89 Aligned_cols=265 Identities=28% Similarity=0.390 Sum_probs=212.1
Q ss_pred hhCcccCCeecccCceEEEEEEE-----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 47899999999999999999994 4567899999986542 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC---ceeEe
Q 018100 107 LLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLS 180 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~---~~~L~ 180 (361)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976431 2346999999999999999999999999 99999999999999555 59999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhh
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||................
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~--- 303 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--- 303 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 9999864221111222233457889999999999999999999999999999998 999997755433222111000
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
....+...+..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus 304 --------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 304 --------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 01112233447889999999999999999999999999887643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=343.48 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=205.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeE----EEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|++.+.||+|+||.||+|.+..++.. |++|.+.... ....+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 47899999999999999999999877665 5777775432 344577999999999999999999999998764 77
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|++|+.+++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 899999999999998762 356999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----------- 235 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----------- 235 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-----------
Confidence 433333333333456789999999999999999999999999999999 99999765443222211100
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 236 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 236 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 00112233445788999999999999999999999999988764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=351.58 Aligned_cols=273 Identities=26% Similarity=0.372 Sum_probs=217.2
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEE-----ECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcC-CCCccceee
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLI 97 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~ 97 (361)
....+....++|++.+.||+|+||.||+|. +..++..||||++...... ..+.+.+|+.++..+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 445556667999999999999999999999 4556789999999754332 345689999999999 789999999
Q ss_pred eEEEcCC-eeEEEEEecCCCCHHHHhcccCCC------------------------------------------------
Q 018100 98 GYCADGD-QRLLVYEYMPLGSVEDHLHDLSPG------------------------------------------------ 128 (361)
Q Consensus 98 ~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~------------------------------------------------ 128 (361)
+++.+.. ..++||||+++++|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9987754 489999999999999999763311
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc
Q 018100 129 --------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194 (361)
Q Consensus 129 --------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~ 194 (361)
...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122899999999999999999999999 999999999999999999999999999864333333
Q ss_pred ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||........... ... .. .
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~----~~----------~ 313 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLK----EG----------T 313 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH--HHH----HT----------C
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH--HHH----cC----------C
Confidence 33445567889999999999999999999999999999998 9999976432211110 000 00 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0111223344788999999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=339.85 Aligned_cols=263 Identities=20% Similarity=0.174 Sum_probs=212.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++.+ +||||+.+++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 5789999999999999999999999999999999865432 34588899999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc-----eeEecccccc
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLAK 186 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~-----~~L~Dfg~~~ 186 (361)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++. ++|+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999999762 357999999999999999999999999 999999999999999887 9999999997
Q ss_pred cCCCCCCcc-----eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh-hhc
Q 018100 187 LGPVGDNTH-----VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQ 260 (361)
Q Consensus 187 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~ 260 (361)
......... ......||..|+|||++.+..++.++|||||||++|+|++|..||..............+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 643322111 12345789999999999999999999999999999999999999976432222111111100 000
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.. ..... ...+ .+.+++..||+.||.+||++.+|++.|+.+...
T Consensus 239 ~~-------~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 239 TP-------IEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp SC-------HHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CC-------HHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00 00000 1122 788899999999999999999999999877754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=344.08 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=207.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57899999999999999999999999999999998643 122345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6899988876 567999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. .......|++.|+|||++.+..+ +.++|||||||++|+|++|..||........ +...
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------~~~i------ 220 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------FKKV------ 220 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------BCCC------
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------HHHH------
Confidence 22 22334568999999999988776 6899999999999999999999975321100 0000
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.......+...+..+.+||.+||+.||.+|||+.++++.-.
T Consensus 221 --~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 221 --NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp --CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred --HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 00111223334557889999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=350.68 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=202.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 107 (361)
..++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+..|..++..+ +||||+++++++.+....|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3578999999999999999999999999999999997542 22335678899999876 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++|+|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++..
T Consensus 130 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999976 567999999999999999999999999 99999999999999999999999999974
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh--hHHH-hhhhhhccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLVA-WARPLFQDRTR 264 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~ 264 (361)
.. ..........||+.|+|||++.+..++.++|||||||++|+|++|..||......... .... ........
T Consensus 203 ~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--- 277 (396)
T 4dc2_A 203 GL--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--- 277 (396)
T ss_dssp CC--CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC---
T ss_pred cc--cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc---
Confidence 21 1222234467999999999999999999999999999999999999999643211110 0000 00000000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
...++...+..+.+||.+||+.||.+||++
T Consensus 278 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 ---------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 012233345588899999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=344.37 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=208.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeE----EEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|++.+.||+|+||.||+|.+..++.. |++|.+.... ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 46899999999999999999999887765 7778775432 2333567789999999999999999999864 5688
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|+||+.+++|.+++... ...+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+|||++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999998752 356899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||................
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---------- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------
Confidence 544433333444567889999999998999999999999999999999 999997654332222211110
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
. ...+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 235 ~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 235 R-------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp B-------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred C-------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 0111122235677999999999999999999999999887543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=337.88 Aligned_cols=246 Identities=29% Similarity=0.399 Sum_probs=208.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 478999999999999999999999999999999986432 23456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+|||++.+|.++|+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ....
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~------- 219 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAE------- 219 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHCC-------
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-------
Confidence 2 123356899999999999999999999999999999999999999765432221111 0000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
..+++..+.++.++|.+||..||++|| +++++++
T Consensus 220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112233345788999999999999999 8888885
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=345.73 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=208.2
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
......++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 44566789999999999999999999999999999999986532 23456678899998876 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
...|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.++|+|||
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence 999999999999999999976 467999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 164 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------- 233 (345)
T 1xjd_A 164 MCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------- 233 (345)
T ss_dssp TCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred hhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--------
Confidence 99753221 12234457999999999999999999999999999999999999999765443222111100
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA-DVVT 308 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~ll~ 308 (361)
. ..++...+..+.++|.+||..||++||++. ++++
T Consensus 234 ------~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 234 ------N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ------C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------C----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0 112223345788999999999999999997 6653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=345.12 Aligned_cols=268 Identities=26% Similarity=0.416 Sum_probs=215.5
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
+....++|++.+.||+|+||.||+|.+.. ++..|++|++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34456899999999999999999999973 458999999875433 234678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPG--------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 162 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~ 162 (361)
+...++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999999999763221 257999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccc
Q 018100 163 DLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVD 241 (361)
Q Consensus 163 dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~ 241 (361)
||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999875322222222334457889999999998899999999999999999999 999997
Q ss_pred cchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
............ .. . ....+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 279 ~~~~~~~~~~~~------~~----~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAHEEVIYYVR------DG----N-------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCHHHHHHHHH------TT----C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCChHHHHHHHh------CC----C-------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 654332211110 00 0 0112233445888999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=346.57 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=195.2
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
..+.++|++.+.||+|+||.||+|.++.++..||+|++.... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999999999999999999999999987543 345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecccccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAK 186 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Dfg~~~ 186 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++. ++.++|+|||++.
T Consensus 127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999976 567999999999999999999999999 999999999999975 8899999999987
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.... ........|+..|+|||++.+..++.++|||||||++|+|++|..||......... ...... . .
T Consensus 200 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~i~~----~----~ 267 (349)
T 2w4o_A 200 IVEH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FRRILN----C----E 267 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HHHHHT----T----C
T ss_pred ccCc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HHHHHh----C----C
Confidence 5322 11223456899999999999989999999999999999999999999654332211 000000 0 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .......+..+..+.+||.+||+.||++||++.++++.
T Consensus 268 ~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 Y----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp C----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00011112334578899999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=335.54 Aligned_cols=274 Identities=18% Similarity=0.213 Sum_probs=213.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCC--eeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 108 (361)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3578999999999999999999999999999999987543 234567889999999999999999999987655 7799
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE----cCCCceeEecccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGL 184 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv----~~~~~~~L~Dfg~ 184 (361)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999976331 234999999999999999999999999 9999999999999 7888899999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhc--------cCCCCccCceehhhHHHHHHhhCCCccccchHHHh-hh-HHHh
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAK--------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QS-LVAW 254 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-~~-~~~~ 254 (361)
+....... ......|+..|+|||++. +..++.++|||||||++|+|++|..||........ .. +...
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 97633222 223346899999999986 56889999999999999999999999964332111 11 1111
Q ss_pred hhhhhccc-------cc--cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 255 ARPLFQDR-------TR--HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 255 ~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
........ .. ....................+.+++.+||+.||++|||+.++++....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 11100000 00 000001112224456778888999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=345.58 Aligned_cols=271 Identities=26% Similarity=0.370 Sum_probs=219.1
Q ss_pred HHhhCcccCCeecccCceEEEEEEECC-------CCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCA 101 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 101 (361)
...++|++.+.||+|+||.||+|.+.. .+..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 345899999999999999999999753 246799999875433 2346788999999999 8999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
++...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999976331 1246999999999999999999999999 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHh
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 248 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~ 248 (361)
|++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986443332233334456788999999999999999999999999999999 9999976544332
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccCCCc
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 321 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~~~~ 321 (361)
....... .....+...+..+.+++.+||+.||++||++.++++.|+.+........
T Consensus 303 ~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 303 FKLLKEG-----------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHTT-----------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHHcC-----------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 2211100 0011122334478899999999999999999999999999887554443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.19 Aligned_cols=270 Identities=21% Similarity=0.320 Sum_probs=194.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|.++.++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4689999999999999999999999999999999875432 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|++ ++|.+++.... .....+++..+..++.||+.||.|||++| ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886522 22346999999999999999999999999 9999999999999999999999999997632
Q ss_pred CCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hh----hhcccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RP----LFQDRT 263 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~----~~~~~~ 263 (361)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++|..||............... .. .+....
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 22 112233468999999999976 46899999999999999999999999876544332221111 00 000000
Q ss_pred ccccccCccc------------cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 264 RHSLIADPEL------------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 264 ~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... ...+.. ........+..+.+||.+||+.||++|||+.++++.
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLP-KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCT-TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhh-hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 000000 000111234478899999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=330.61 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=212.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.+.. +..|++|++.... ...+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4789999999999999999999875 7889999997543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999965 2356999999999999999999999999 9999999999999999999999999987532211
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........++..|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~---------------- 223 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---------------- 223 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------------
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC----------------
Confidence 111122345678999999998999999999999999999999 99999765443222111100
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00111222344788999999999999999999999999988754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=334.39 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=199.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--------------------------chHHHHHHHHHHh
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------------------GNREFLVEVLMLS 86 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------------------------~~~~~~~e~~~l~ 86 (361)
.++|++.+.||+|+||.||+|.++.++..||+|++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999999999999999998654321 1356889999999
Q ss_pred cCCCCccceeeeEEEc--CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 018100 87 LLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 164 (361)
Q Consensus 87 ~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl 164 (361)
.++||||+++++++.+ +...++||||+++++|.+++. ...+++..++.++.||+.||.|||+++ ++||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986 668899999999999987654 357999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCC---CCccCceehhhHHHHHHhhCCCccc
Q 018100 165 KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVD 241 (361)
Q Consensus 165 ~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~ 241 (361)
||+||+++.++.++|+|||++...... ........|+..|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999998763322 22233457899999999997654 3788999999999999999999997
Q ss_pred cchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
............ ... ...+ ..+..+..+.++|.+||+.||++||++.++++.
T Consensus 242 ~~~~~~~~~~~~------~~~-----~~~~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 242 DERIMCLHSKIK------SQA-----LEFP-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSSHHHHHHHHH------HCC-----CCCC-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CccHHHHHHHHh------ccc-----CCCC-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 654322211110 000 0000 011233478899999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.48 Aligned_cols=269 Identities=26% Similarity=0.376 Sum_probs=212.1
Q ss_pred HHhhCcccCCeecccCceEEEEEEE-----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
...++|++.+.||+|+||.||+|.+ ..++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3468999999999999999999997 3456789999997542 33456789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPG-------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 164 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl 164 (361)
...++||||+++++|.+++...... ...+++..++.++.||+.||.|||++| ++||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999763211 134899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccc
Q 018100 165 KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTS 243 (361)
Q Consensus 165 ~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~ 243 (361)
||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999976433333333344557888999999999999999999999999999998 99999765
Q ss_pred hHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccC
Q 018100 244 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 318 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~ 318 (361)
...... ...... ......+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 279 ~~~~~~--~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDANF--YKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSHHH--HHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHHHH--HHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 322111 111100 00111222334588899999999999999999999999998766543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=330.02 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=212.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|+||.||+|.++. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 35789999999999999999998875 7789999997543 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++... +..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999762 245999999999999999999999999 999999999999999999999999998753322
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ........++..|+|||++.+..++.++||||||+++|+|++ |..||................ .
T Consensus 158 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------~--- 223 (268)
T 3sxs_A 158 Q-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH----------R--- 223 (268)
T ss_dssp C-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----------C---
T ss_pred h-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC----------C---
Confidence 1 111222345677999999998899999999999999999999 999997655433222111000 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
...+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 ----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011122234788899999999999999999999999887654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=345.30 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=202.8
Q ss_pred hhCcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++ .++..||||++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999987 4577899999875432 334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999975 2356999999999999999999999999 999999999999999999999999998763
Q ss_pred CCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||............. ..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~---~~-------- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---EG-------- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH---TT--------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC--------
Confidence 3221111 1112234678999999999999999999999999999998 999997654332221111 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.....+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 001112234457889999999999999999999999999887643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=331.80 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=201.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 5689999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|++ ++|.+++... ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCS-EEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 997 5998888652 356999999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhhh----hcccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPL----FQDRTRH 265 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~----~~~~~~~ 265 (361)
........++..|+|||++.+. .++.++|||||||++|+|++|..||............ ...... +......
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 1122334679999999999764 5899999999999999999999999775543322211 110000 0000000
Q ss_pred ccccCccc-------cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPEL-------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...++.+ ........+..+.+||.+||+.||++|||+.++++
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 -PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp -TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 01111233457889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=338.44 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=201.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCccceeeeEEEcCC----
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 104 (361)
+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4589999999999999999999999999999999997653332 346889999999999999999999986544
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 34999999999999999976 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCC-cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 185 AKLGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 185 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
+........ ........|+..|+|||++.+..++.++||||||+++|+|++|..||............ . ..
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~----~~-- 234 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--V----RE-- 234 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H----HC--
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--h----cC--
Confidence 875332211 11223356899999999999999999999999999999999999999765443221111 0 00
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHHHHHh
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV-TALAYLAS 315 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll-~~l~~l~~ 315 (361)
.......... ..+..+.+++.+||+.||++||++.+++ +.+..+..
T Consensus 235 --~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 235 --DPIPPSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp --CCCCHHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred --CCCCcccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0000000111 1234788899999999999999766554 55555443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=329.01 Aligned_cols=254 Identities=21% Similarity=0.240 Sum_probs=211.0
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.+.++|++.+.||+|+||.||+|.++.++..|++|++........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 45688999999999999999999999999999999998766666788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE---cCCCceeEeccccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv---~~~~~~~L~Dfg~~~~ 187 (361)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999876 567999999999999999999999999 9999999999999 7889999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... .......++..|+|||++.+. ++.++||||||+++|+|++|..||................ .
T Consensus 159 ~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------~ 224 (277)
T 3f3z_A 159 FKPG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT----------F 224 (277)
T ss_dssp CCTT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------C
T ss_pred ccCc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----------C
Confidence 3322 222344689999999998654 8999999999999999999999997654432221111000 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
........ ..+..+.+++.+||+.||++||++.++++.
T Consensus 225 ~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 TFPEKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCchhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000001 123478889999999999999999999963
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=341.89 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=207.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 106 (361)
...++|++.+.||+|+||.||+|.++.+++.||+|++... .....+.+..|..++..+ +||+|+.+++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3468999999999999999999999999999999998653 223456788899999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999976 457999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 170 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~----- 236 (353)
T 2i0e_A 170 ENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EH----- 236 (353)
T ss_dssp CCCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-----
T ss_pred cccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH------hC-----
Confidence 5221 1222334579999999999999999999999999999999999999997654332211110 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
. ..++...+..+.+||.+||..||.+||+ +.++++
T Consensus 237 ---~----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 237 ---N----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---C----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---C----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 1122334458889999999999999995 566664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=335.81 Aligned_cols=267 Identities=21% Similarity=0.222 Sum_probs=204.7
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
......++|++.+.||+|+||.||+|.+..++..|++|++...... ..+.+.+|+.+++.++||||+++++++.++.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 3445678999999999999999999999999999999998754332 2366889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++|+||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~ 180 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGI 180 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCcc
Confidence 99999999999999999986 467999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
+........ .......++..|+|||++.+..++.++||||||+++|+|++|..||............. ... .
T Consensus 181 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~----~ 252 (309)
T 2h34_A 181 ASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---QAI----P 252 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---SCC----C
T ss_pred Ccccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---cCC----C
Confidence 875322211 11223468899999999998899999999999999999999999998765432211111 000 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHhcc
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLASQK 317 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~ll~~l~~l~~~~ 317 (361)
.... .++..+..+.+++.+||+.||++|| +++++++.|+.+....
T Consensus 253 ----~~~~----~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 ----RPST----VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ----CGGG----TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ----Cccc----cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0001 1222334788899999999999999 9999999998765543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.58 Aligned_cols=271 Identities=23% Similarity=0.314 Sum_probs=206.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..++|++.+.||+|+||.||+|.+..++..|++|++..... ...+.+.+|+.+++.++||||+++++++.++...++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 35789999999999999999999999999999999875322 234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999754434567999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ........++..|+|||++.+..++.++||||||+++|+|++|..||......... +...... . .
T Consensus 187 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~---~--~---- 254 (310)
T 2wqm_A 187 SSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKIEQ---C--D---- 254 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHHHHT---T--C----
T ss_pred cCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHHhhc---c--c----
Confidence 221 11223346889999999999989999999999999999999999999654221111 1110000 0 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccCCCc
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 321 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~~~~ 321 (361)
.+.. .....+..+.+++.+||+.||++||++.++++.|+.+.+...++.
T Consensus 255 -~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 255 -YPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp -SCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred -CCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0000 012234478899999999999999999999999999988665443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=339.67 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=202.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|+++.+++.||+|++...... ..+.+.+|..++..+ +||||+++++++.+....|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999999754322 235578899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh---hHHHhhhhhhcccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---SLVAWARPLFQDRTRH 265 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~ 265 (361)
.. .........||..|+|||++.+..++.++|||||||++|+|++|..||......... ............
T Consensus 161 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---- 234 (345)
T 3a8x_A 161 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---- 234 (345)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC----
T ss_pred cC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC----
Confidence 21 122234457999999999999999999999999999999999999999643211100 000000000000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
...++...+..+.++|.+||+.||.+||++
T Consensus 235 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 011233344578899999999999999995
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=340.46 Aligned_cols=246 Identities=24% Similarity=0.272 Sum_probs=208.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.+|..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 478999999999999999999999999999999986432 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++....
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999986 456999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~-------- 253 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------SG-------- 253 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC--------
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH------cC--------
Confidence 21 223468999999999999999999999999999999999999997654332211111 00
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
. ..++...+..+.++|.+||+.||.+||+ +.++++
T Consensus 254 ~----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 K----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 0122233457889999999999999998 888875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=334.49 Aligned_cols=253 Identities=25% Similarity=0.282 Sum_probs=209.5
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
+.++|++.+.||+|+||.||+|.++.+|..||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 457899999999999999999999999999999998754322 35678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC----ceeEec
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSD 181 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~----~~~L~D 181 (361)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++ .++|+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999976 567999999999999999999999999 99999999999999888 799999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~------ 233 (321)
T 2a2a_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------ 233 (321)
T ss_dssp CTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------
T ss_pred CccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------
Confidence 99997533221 123346899999999999889999999999999999999999999765433222111100
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+..... .+..+.++|.+||+.||++|||+.++++
T Consensus 234 ----~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 ----SYDFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----CCCCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----ccccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00001111112 2347888999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=342.24 Aligned_cols=277 Identities=27% Similarity=0.377 Sum_probs=214.5
Q ss_pred hhCcccCCeecccCceEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEE--cCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 106 (361)
.++|++.+.||+|+||.||+|. +..++..|++|++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4789999999999999999999 46679999999998776666677999999999999999999999886 55678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999752 245999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
......... ......++..|+|||++.+..++.++|||||||++|+|++|..||................ .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc--cccHHHH
Confidence 643322211 2223457788999999999899999999999999999999999997654322111000000 0000000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
............+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0000011112223444568899999999999999999999999999876644
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.71 Aligned_cols=258 Identities=21% Similarity=0.257 Sum_probs=199.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|+||.||+|.++.+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 35789999999999999999999999999999999975433 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc--eeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~--~~L~Dfg~~~~~~ 189 (361)
|+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++.++. +||+|||++....
T Consensus 97 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999876 467999999999999999999999999 999999999999987765 9999999987421
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCcc-CceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK-SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
. ........|+..|+|||++.+..++.+ +|||||||++|+|++|..||.......... ..........
T Consensus 170 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~~~~------ 238 (361)
T 3uc3_A 170 L---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRILSVK------ 238 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHHTTC------
T ss_pred c---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHhcCC------
Confidence 1 122233568999999999988777655 899999999999999999997643311110 0000000000
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.........+..+.+||.+||+.||++|||+.++++.-..
T Consensus 239 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 239 ----YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp ----CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred ----CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 0000011223478899999999999999999999986443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=334.07 Aligned_cols=268 Identities=26% Similarity=0.319 Sum_probs=204.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 47899999999999999999999999999999998654332 2456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999988875 567999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hh-------hhcc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RP-------LFQD 261 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~-------~~~~ 261 (361)
. ........++..|+|||++.+ ..++.++||||||+++|+|++|..||............... .. .+..
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 P--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 122234468899999999876 57899999999999999999999999776554333221111 00 0000
Q ss_pred ccc--cccccCccccC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 RTR--HSLIADPELQG---QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~~~--~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... .....++.... ...+..+..+.+++.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000100000 0002234578899999999999999999999963
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=337.89 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=206.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEE----EEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDV----AIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v----~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|++.+.||+|+||.||+|.+..++..+ ++|.+... .....+.+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999998877655 66766433 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|++|+.+++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 889999999999998762 356999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~----------- 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----------- 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 433332222333456778999999999999999999999999999999 99999765443322211100
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.....+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 236 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 236 ------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 011122334457889999999999999999999999999887643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=337.63 Aligned_cols=267 Identities=26% Similarity=0.383 Sum_probs=215.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
...++|++.+.||+|+||.||+|.+ ..++..|++|++..... ...+.+.+|+.+++.+ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457999999999999999999985 45678999999975533 2346788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcE
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Ni 169 (361)
...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999976321 1235999999999999999999999999 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHh
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 248 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~ 248 (361)
+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999986444333333334557788999999999999999999999999999998 9999976432211
Q ss_pred hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 249 QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
. ....... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 257 ~--~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 F--YKMIKEG--------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H--HHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--HHHhccC--------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 1101000 00111223345788999999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=339.10 Aligned_cols=268 Identities=25% Similarity=0.374 Sum_probs=214.2
Q ss_pred HhhCcccCCeecccCceEEEEEEEC-------CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEc
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD 102 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 102 (361)
..++|++.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3589999999999999999999985 3567899999875432 2346788999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEE
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 170 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nil 170 (361)
....++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 99999999999999999999763311 234899999999999999999999999 999999999999
Q ss_pred EcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhh
Q 018100 171 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 249 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~ 249 (361)
++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999976433322222233456788999999988889999999999999999999 99999765433222
Q ss_pred hHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccCC
Q 018100 250 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 319 (361)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~~ 319 (361)
...... . ....+...+..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus 270 ~~~~~~----------~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 270 KLLKEG----------H-------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHT----------C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHhcC----------C-------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111100 0 0111223345788999999999999999999999999988775443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.89 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=202.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+.++|++.+.||+|+||.||+|.+.. +..||+|++...... ..+.+.+|+.+++.++||||+++++++.++...++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 456899999999999999999999965 899999998654322 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||++ ++|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+|||++...
T Consensus 97 v~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 97 VFEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EEECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence 999997 588887765 2456999999999999999999999999 999999999999999999999999999763
Q ss_pred CCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhhh----hccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPL----FQDR 262 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~----~~~~ 262 (361)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||............ ...... +...
T Consensus 170 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 170 GIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp TSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred CCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 222 222333468999999999876 56899999999999999999999999765443322111 111000 0000
Q ss_pred cc-------cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TR-------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.. ..............+..+.++.+||.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00000000000011223457889999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=334.02 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=210.4
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
....++|++.+.||+|+||.||+|.+.. +..|++|++.... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3456899999999999999999998874 7889999997543 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999752 346999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus 172 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~------------- 237 (283)
T 3gen_A 172 DDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------------- 237 (283)
T ss_dssp CHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-------------
T ss_pred ccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-------------
Confidence 211 111122345678999999998899999999999999999998 99999765543322211100
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....+...+..+.+++.+||+.||.+|||+.++++.|..+...
T Consensus 238 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 238 ----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00111122234788899999999999999999999999887653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=329.89 Aligned_cols=255 Identities=26% Similarity=0.326 Sum_probs=204.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.++|++.+.||+|+||.||+|.++.++..|++|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4588999999999999999999999999999999987543 334578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE---cCCCceeEeccccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv---~~~~~~~L~Dfg~~~~ 187 (361)
||+++++|.+++......+..+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.++|+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988653323567999999999999999999999999 9999999999999 4567899999999975
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... .......++..|+|||++. ..++.++||||||+++|+|++|..||..................+
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------- 244 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY-------- 244 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred cCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc--------
Confidence 3221 2233456899999999985 568899999999999999999999998765433322221111000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...... .+..+.+++.+||+.||++|||+.++++
T Consensus 245 ---~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 ---AVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011 2347788999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=328.17 Aligned_cols=266 Identities=21% Similarity=0.207 Sum_probs=213.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ..+.+.+|+.+++.+ +|+|++.+++++.++...++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 4578999999999999999999999999999999986443 234578899999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc-----eeEeccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLA 185 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~-----~~L~Dfg~~ 185 (361)
||+ +++|.+++... +..+++..++.++.||+.||.|||+++ ++||||||+||+++.++. ++|+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 89999999762 346999999999999999999999999 999999999999987776 999999999
Q ss_pred ccCCCCCCc-----ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 186 KLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 186 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
......... .......|+..|+|||++.+..++.++|||||||++|+|++|..||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 764332221 122345689999999999999999999999999999999999999976432211111111100000
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
....+..... .+..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 239 ------~~~~~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 239 ------STPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp ------HSCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------CccHHHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000111112 234788999999999999999999999999988764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=332.89 Aligned_cols=274 Identities=24% Similarity=0.346 Sum_probs=210.3
Q ss_pred hhCcccCCeecccCceEEEEEE----ECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcC--Ce
Q 018100 33 TKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 105 (361)
.++|++.+.||+|+||.||+|. +..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4679999999999999999999 56679999999997543 33457789999999999999999999999876 67
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 89999999999999999542 356999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 186 KLGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 186 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+.................... ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 251 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV--TR 251 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH--HH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH--HH
Confidence 764332221 223345678889999999999999999999999999999999998754432211100000000000 00
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.............+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000001111223344568899999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=350.37 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=200.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..++|++.+.||+|+||.||+|.++.++..||||++... .......+.+|+.+++.++||||+.+++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 357899999999999999999999999999999998643 23334567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+ +| |+||||||+|||++.++.++|+|||++..
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999976 5679999999999999999999998 89 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... .........||..|+|||++.+..++.++|||||||++|+|++|..||...........+.. .
T Consensus 299 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~------ 364 (446)
T 4ejn_A 299 GIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------E------ 364 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C------
T ss_pred ccC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------C------
Confidence 221 22223446799999999999999999999999999999999999999976544332221110 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
. ..++...+..+.+||.+||+.||.+|| ++.++++
T Consensus 365 --~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 --E----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --C----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --C----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 112223345788999999999999999 9999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=340.34 Aligned_cols=257 Identities=23% Similarity=0.296 Sum_probs=205.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 109 (361)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+|+.++..+ +||||+++++++.++...|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 4568899999999999999999999999999999999765332 34578888777 799999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC----CceeEeccccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLA 185 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~----~~~~L~Dfg~~ 185 (361)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+..+ +.++|+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999976 567999999999999999999999999 9999999999998543 35999999999
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||..........+...... .
T Consensus 168 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-------~ 238 (342)
T 2qr7_A 168 KQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS-------G 238 (342)
T ss_dssp EECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-------C
T ss_pred ccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-------C
Confidence 7633221 222345689999999999888899999999999999999999999975432222222111110 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
...+.....+..+..+.+||.+||..||++||++.++++.--
T Consensus 239 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 239 ----KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp ----CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ----CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 001111122334558889999999999999999999997433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=341.61 Aligned_cols=268 Identities=25% Similarity=0.306 Sum_probs=211.7
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEE----cCCe
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQ 105 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~ 105 (361)
....++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++. ....
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 445689999999999999999999999999999999987665556678899999999999999999999986 3457
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.++|+||+++++|.+++......+..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 89999999999999999875444678999999999999999999999999 999999999999999999999999988
Q ss_pred ccCCCCCCcc-------eeeccccCcCcCCchhhccCC---CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 186 KLGPVGDNTH-------VSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 186 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
.......... ......|+..|+|||++.+.. ++.++||||||+++|+|++|..||......... .....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~ 260 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV 260 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh
Confidence 6422111000 011234689999999987543 688999999999999999999999643221111 00000
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
. . ......++..+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 261 ~----~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 Q----N----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H----C----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h----c----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0 00001112334578899999999999999999999999997754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.00 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=217.6
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
...++|++.+.||+|+||.||+|.++.++..|++|++... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 4568899999999999999999999999999999998643 334577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999997633 456999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||............. .
T Consensus 164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~------------ 227 (288)
T 3kfa_A 164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---K------------ 227 (288)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---T------------
T ss_pred Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---c------------
Confidence 22 222233456778999999998999999999999999999999 999997654322211111 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
......+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 228 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 228 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 001112233345788999999999999999999999999877654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=333.25 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=206.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCC-------eEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESIN-------QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
.++|++.+.||+|+||.||+|.++.++ ..|++|++........+.+.+|+.+++.++||||+++++++.++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 578999999999999999999998766 4799999977666667789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc--------e
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------P 177 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~--------~ 177 (361)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999761 234999999999999999999999999 999999999999998887 9
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCC-CccccchHHHhhhHHHhh
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~ 255 (361)
+|+|||++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|. +||..............
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~- 233 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED- 233 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-
Confidence 9999999864211 123457889999999987 67899999999999999999954 55544333222111110
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
. . ..+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 234 ------~--------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 234 ------R--------H----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ------T--------C----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ------c--------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 0 0011112357789999999999999999999999986655
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=327.19 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=208.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+.++|++.+.||+|+||.||+|.++.++..|++|++..... ...+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 56899999999999999999999999999999999865432 2346688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc---eeEecccccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAK 186 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~---~~L~Dfg~~~ 186 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++. ++|+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999988876 567999999999999999999999999 999999999999987655 9999999987
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..... .......++..|+|||++.+..++.++||||||+++|+|++|..||................ ..
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~------ 225 (284)
T 3kk8_A 157 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YD------ 225 (284)
T ss_dssp ECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CC------
T ss_pred EcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc--cc------
Confidence 53322 12233568999999999999999999999999999999999999997654432222111000 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. . .......+..+.+++.+||+.||++|||+.++++.
T Consensus 226 -~-~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 -Y-P----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -C-C----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -C-C----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0 00111233478899999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=330.11 Aligned_cols=269 Identities=24% Similarity=0.281 Sum_probs=203.0
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhcCC---CCccceeeeEEEc
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLH---HPNLVNLIGYCAD 102 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 102 (361)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 346899999999999999999999999999999999864321 12345667787777664 9999999999977
Q ss_pred CC-----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 103 GD-----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 103 ~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
.. ..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 55 5789999996 79999987632 344999999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
+|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 160 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 160 KLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp EECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999999753222 222345689999999999999999999999999999999999999977654433322211110
Q ss_pred hhccccc--cccccCcccc-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 258 LFQDRTR--HSLIADPELQ-------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 258 ~~~~~~~--~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
....... ........+. ....+..+..+.+||.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 0000000000 0011223457889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=335.40 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=199.1
Q ss_pred hhCcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCC----ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 578999999999999999999985 578999999997542 2234557889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999976 467999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
..... .........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 169 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~---- 236 (327)
T 3a62_A 169 KESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL------KC---- 236 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HT----
T ss_pred ccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hC----
Confidence 74221 1122334568999999999998899999999999999999999999997654432221110 00
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
....++..+..+.++|.+||+.||++|| ++.++++.
T Consensus 237 --------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 237 --------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0112233345788999999999999999 77788763
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=333.53 Aligned_cols=263 Identities=29% Similarity=0.437 Sum_probs=211.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEE--EEEEeccC-CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDV--AIKQLDRN-GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v--~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++.++..+ ++|.+... .....+.+.+|+.+++.+ +||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999999888765 99988643 233446788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 109 VYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
||||+++++|.+++.... .....+++..++.++.||+.||.|||++| ++||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997632 22357999999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 255 (361)
++|+|||++..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~--- 254 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--- 254 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG---
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh---
Confidence 99999999873211 111223346788999999988889999999999999999998 99999765433221111
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccC
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 318 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~ 318 (361)
.. . .....+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 255 ~~-------~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 255 PQ-------G-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GG-------T-------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred hc-------C-------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 0 0011222344578899999999999999999999999998887543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.76 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=198.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc----cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.+. +..|++|++..... ...+.+.+|+.+++.++||||+++++++.++...++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 478999999999999999999986 78999999865422 234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC--------CCceeEe
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--------GYHPKLS 180 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~--------~~~~~L~ 180 (361)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+++..+++||||||+||+++. ++.++|+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999863 57999999999999999999999998444789999999999986 7789999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||............. .
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~ 228 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------M 228 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------T
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh------c
Confidence 999987532211 223468999999999999999999999999999999999999997654332211110 0
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
. ......+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 229 ~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 N----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp S----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 00111223344578899999999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=328.91 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=208.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.++|++.+.||+|+||.||+|.++.++..|++|++.... ....+.+.+|+.+++.++||||+++++++.++...++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 5689999999999999999999999999999999986443 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999875 567999999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
...........++..|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+... . ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-------~-~~- 227 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK-------K-TY- 227 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTT-------C-TT-
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhc-------c-cc-
Confidence 222222334568999999999987665 78899999999999999999999764332111 1111100 0 00
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.......+..+.+++.+||+.||++|||+.++++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011223447888999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=345.06 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=209.2
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
+++...++|++.+.||+|+||.||+|+++.++..||+|++... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3344568999999999999999999999999999999998642 1122345788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999975 45999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCC----CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
+....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+......+.
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 97532221 11223467999999999997655 78999999999999999999999976544332221111100000
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 309 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~ll~~ 309 (361)
.+ .....+..+.+||.+||..+|.+ ||++.+|++.
T Consensus 294 ---------~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 ---------FP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---------CC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---------CC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 01123347889999999999988 9999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=343.43 Aligned_cols=247 Identities=26% Similarity=0.325 Sum_probs=197.4
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHH-HhcCCCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..++|++.+.||+|+||.||+|+++.++..||+|++..... .....+..|..+ ++.++||||+++++++.+....|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 35789999999999999999999999999999999975432 223445667766 56789999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++..
T Consensus 116 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999999976 567999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ....
T Consensus 189 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~----- 255 (373)
T 2r5t_A 189 NIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LNKP----- 255 (373)
T ss_dssp GBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH------HHSC-----
T ss_pred cccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------Hhcc-----
Confidence 2221 12234457999999999999999999999999999999999999999765443222111 0000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 305 (361)
..+++..+..+.+||.+||+.||.+||++.+
T Consensus 256 -------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 -------LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0112233457889999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=334.75 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=205.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCC----eEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.++|++.+.||+|+||.||+|.++.++ ..|++|++..... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 467888999999999999999987543 4599999875432 23456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999975 2357999999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 188 GPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 188 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||............. . .
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~---~----~--- 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---D----G--- 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---T----T---
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---C----C---
Confidence 3322111 11122345778999999998899999999999999999998 999997654322211110 0 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.....+...+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001112233457889999999999999999999999999887643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=350.10 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=208.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999986432 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999976 567999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. .......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...........+ ... .
T Consensus 168 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~-----~- 232 (476)
T 2y94_A 168 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI------CDG-----I- 232 (476)
T ss_dssp TT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH------HTT-----C-
T ss_pred cc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hcC-----C-
Confidence 22 22234568999999999988765 68999999999999999999999765432221111 000 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+..+.+||.+||+.||.+|||+.++++.
T Consensus 233 ------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 ------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 01122233478899999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=336.83 Aligned_cols=269 Identities=22% Similarity=0.271 Sum_probs=199.4
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
....++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.++...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999999999999999998654332 2345778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc-----CCCceeEecc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-----RGYHPKLSDF 182 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~-----~~~~~~L~Df 182 (361)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+||
T Consensus 110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999997 699999987 567999999999999999999999999 99999999999994 4556999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
|++...... ........++..|+|||++.+. .++.++|||||||++|+|++|..||.....................
T Consensus 182 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 182 GLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred CCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 998753221 1222334679999999999774 5899999999999999999999999776543332221111000000
Q ss_pred cccccccc-------CccccC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 RTRHSLIA-------DPELQG-----QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 ~~~~~~~~-------~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........ .+.... ..+...+..+.+||.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 000000 001113457889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=337.15 Aligned_cols=274 Identities=23% Similarity=0.229 Sum_probs=209.3
Q ss_pred CCcccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC-----CccchHHHHHHHHHHhcCCC
Q 018100 16 SDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-----GVQGNREFLVEVLMLSLLHH 90 (361)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h 90 (361)
+.+..++--+. ..+.++|++.+.||+|+||.||+|.++.++..||+|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~q~~~~---~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 87 (345)
T 3hko_A 11 RENLYFQGGSL---LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87 (345)
T ss_dssp ---CCCCCBCH---HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC
T ss_pred CccccccCchh---hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC
Confidence 34445554444 45569999999999999999999999999999999998643 33445778999999999999
Q ss_pred CccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCC------------------------------------CCCCCH
Q 018100 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------------------------------KKPLDW 134 (361)
Q Consensus 91 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------------------------------~~~l~~ 134 (361)
|||+++++++.+....++||||+++++|.+++...... ...+++
T Consensus 88 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred CCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 99999999999999999999999999999998631110 123467
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC--ceeEecccccccCCCCC--CcceeeccccCcCcCCch
Q 018100 135 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY--HPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPE 210 (361)
Q Consensus 135 ~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~--~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE 210 (361)
..++.++.||+.||.|||+++ ++||||||+||+++.++ .++|+|||++....... .........|+..|+|||
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 889999999999999999999 99999999999998776 89999999987532211 111233456899999999
Q ss_pred hhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHH
Q 018100 211 YAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 288 (361)
Q Consensus 211 ~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (361)
++.+ ..++.++|||||||++|+|++|..||............. ... .....+. ....+..+.++
T Consensus 245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~------~~~---~~~~~~~-----~~~~~~~~~~l 310 (345)
T 3hko_A 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL------NKK---LCFENPN-----YNVLSPLARDL 310 (345)
T ss_dssp HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC---CCTTSGG-----GGGSCHHHHHH
T ss_pred hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH------hcc---cccCCcc-----cccCCHHHHHH
Confidence 9965 678899999999999999999999997655433221111 000 0000010 11234478899
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 018100 289 AAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 289 i~~~l~~dP~~Rps~~~ll~~ 309 (361)
|.+||+.||.+||++.++++.
T Consensus 311 i~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 311 LSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999973
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=330.71 Aligned_cols=264 Identities=27% Similarity=0.404 Sum_probs=210.3
Q ss_pred HHHHHhhCcccCC-eecccCceEEEEEEE--CCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 28 ELAAATKNFRSES-LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 28 ~~~~~~~~y~~~~-~lg~G~~g~v~~~~~--~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
++....++|++.+ .||+|+||.||+|.+ +.++..|++|++...... ..+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3344467899998 999999999999954 566789999999754332 246789999999999999999999999 5
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred CCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 5678999999999999999987 567999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhc
Q 018100 183 GLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 183 g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
|++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----- 236 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG----- 236 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----
Confidence 9987643322211 1122345678999999988889999999999999999999 99999765543322211100
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....+...+..+.+++.+||+.||++||++.++++.|+.+-..
T Consensus 237 ------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 ------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00112233445888999999999999999999999999887654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=338.95 Aligned_cols=257 Identities=24% Similarity=0.296 Sum_probs=185.7
Q ss_pred HhhCcccC---CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSE---SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~---~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 107 (361)
+..+|++. +.||+|+||.||+|.++.++..||+|++... ....+.+|+.+++.+. ||||+++++++.++...|
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 34567765 7899999999999999999999999998643 3456788999999997 999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC---ceeEecccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGL 184 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~---~~~L~Dfg~ 184 (361)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++ .++|+|||+
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccc
Confidence 99999999999999987 567999999999999999999999999 99999999999998766 899999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh-hHHHhhhhhhcccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRT 263 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 263 (361)
+...... ........++..|+|||++.+..++.++|||||||++|+|++|..||......... ...........
T Consensus 156 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--- 230 (325)
T 3kn6_A 156 ARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--- 230 (325)
T ss_dssp CEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT---
T ss_pred ceecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc---
Confidence 9753222 22233456799999999999999999999999999999999999999764332110 00000100000
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
......... ....+..+.+||.+||+.||.+|||+.++++
T Consensus 231 -~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 231 -GDFSFEGEA----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -TCCCCCSHH----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -CCCCCCccc----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 000000000 1123457889999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=327.06 Aligned_cols=255 Identities=30% Similarity=0.522 Sum_probs=205.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccch-------HHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
.++|++.+.||+|+||.||+|.+..++..||+|++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4899999999999999999999999999999999865433221 57889999999999999999999997655
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc-----eeEe
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLS 180 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~-----~~L~ 180 (361)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++++|+||||+||+++.++. ++|+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999888864 2457999999999999999999999885 34999999999999988776 9999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhc--cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK--TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
|||++..... ......++..|+|||++. ...++.++|||||||++|+|++|..||................
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-- 244 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-- 244 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH--
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc--
Confidence 9999874221 233456899999999983 4567899999999999999999999997544322211111110
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.......+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 245 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 ------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 001112233344588999999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.68 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=205.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
.+.++|++.+.||+|+||.||+|.++.++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4568999999999999999999999999999999999754321 23356789999999999999999999999
Q ss_pred CCeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 103 GDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 103 ~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
....++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 99999999998666 99999976 567999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
||++....... ......|+..|+|||++.+..+ +.++|||||||++|+|++|..||...... ..
T Consensus 174 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~ 238 (335)
T 3dls_A 174 FGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE 238 (335)
T ss_dssp CTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT
T ss_pred cccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh
Confidence 99997643222 2233568999999999988776 78999999999999999999999653210 00
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. . ...+...+..+.+||.+||+.||++|||+.++++.
T Consensus 239 ~-----~-------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 A-----A-------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp T-----C-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred h-----c-------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 01111234478899999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=326.73 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=207.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.++..|++|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 578999999999999999999999999999999985432 12345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++||||+|+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999976 456999999999999999999999999 9999999999999999999999999886422
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 222 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--------------
Confidence 21 123346899999999999989999999999999999999999999865443322211110
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
....+...+..+.+|+.+||+.||.+||++.++++.-
T Consensus 223 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0112223345788999999999999999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=339.68 Aligned_cols=272 Identities=25% Similarity=0.395 Sum_probs=216.9
Q ss_pred eeHHHHHHHhhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceee
Q 018100 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLI 97 (361)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 97 (361)
+..+++....++|++.+.||+|+||.||+|.++ .++..|++|.+..... .....+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455677899999999999999999999886 3578899999875432 2345688999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLS------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
+++.++...++||||+++++|.+++.... .....+++..++.++.||+.||.|||++| ++||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999986521 11246799999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhh
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 250 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 250 (361)
+.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 9999999999999875322221122223456788999999999999999999999999999999 899997654332221
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
... .. . ....+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 252 ~~~------~~----~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVM------EG----G-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHH------TT----C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH------cC----C-------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 110 00 0 011122344578899999999999999999999999976544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=346.30 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=209.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC-eeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 110 (361)
..++|++.+.||+|+||.||+|.++ +..||||++.... ..+.+.+|+.+++.++||||+++++++.+.. ..++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3578999999999999999999986 7799999997543 4578999999999999999999999987655 789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 267 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999998632 334799999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. .....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+ ..
T Consensus 342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~------------ 401 (450)
T 1k9a_A 342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EK------------ 401 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---HT------------
T ss_pred c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc------------
Confidence 1 112346788999999999999999999999999999998 99999765332211111 00
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
......+..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 402 --~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 402 --GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 001122334455889999999999999999999999999988764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=337.92 Aligned_cols=274 Identities=26% Similarity=0.371 Sum_probs=217.1
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEEE-----CCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcC-CCCccceee
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLI 97 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~ 97 (361)
...++....++|++.+.||+|+||.||+|.+ ..++..|++|++...... ..+.+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4455556678999999999999999999985 346789999999754332 345788999999999 699999999
Q ss_pred eEEEcCC-eeEEEEEecCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 018100 98 GYCADGD-QRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 164 (361)
Q Consensus 98 ~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl 164 (361)
+++.... ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987654 589999999999999999763321 123899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccc
Q 018100 165 KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTS 243 (361)
Q Consensus 165 ~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~ 243 (361)
||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999976433333333344567889999999999999999999999999999998 99999764
Q ss_pred hHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 244 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
...... ...... . .....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 255 ~~~~~~--~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEEF--CRRLKE----G----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHHH--HHHHHH----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHHH--HHHhcc----C----------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 322111 000000 0 001112223447889999999999999999999999999887543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.79 Aligned_cols=260 Identities=24% Similarity=0.312 Sum_probs=210.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|.++.+++.|++|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 47899999999999999999999999999999998654221 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC----ceeEecc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 182 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~----~~~L~Df 182 (361)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999976 467999999999999999999999999 99999999999998877 8999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
|++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 226 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV------- 226 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc-------
Confidence 9987532221 123346889999999999889999999999999999999999999765443222111100
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHhc
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT--ALAYLASQ 316 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--~l~~l~~~ 316 (361)
.....+.... ..+..+.+++.+||+.||++||++.++++ .++.+...
T Consensus 227 ---~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 227 ---NYDFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp ---CCCCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred ---ccCCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0000111111 22347888999999999999999999997 45555443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=328.68 Aligned_cols=261 Identities=26% Similarity=0.354 Sum_probs=201.2
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
...++|++.+.||+|+||.||+|.+..+ +..|++|++..... ...+.+.+|+.+++.++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 4468999999999999999999998653 45799999865432 23467889999999999999999999985 4578
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999999752 346999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~---------- 233 (281)
T 1mp8_A 165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------- 233 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------
T ss_pred ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC----------
Confidence 5332211 11222346778999999998899999999999999999997 99999765432221111000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....++..+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 234 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 -------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00112233445888999999999999999999999999987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.19 Aligned_cols=281 Identities=21% Similarity=0.233 Sum_probs=215.3
Q ss_pred CCcccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-----C
Q 018100 16 SDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----H 90 (361)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h 90 (361)
..+.....+++.....+.++|++.+.||+|+||.||+|.+..++..||||++... ....+.+..|+.+++.+. |
T Consensus 17 ~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h 95 (360)
T 3llt_A 17 QGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINN 95 (360)
T ss_dssp ---CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred ecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCC
Confidence 3345555566677777889999999999999999999999999999999998642 233456778999998886 9
Q ss_pred CccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEE
Q 018100 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 170 (361)
Q Consensus 91 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nil 170 (361)
|||+++++++......++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 169 (360)
T 3llt_A 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENIL 169 (360)
T ss_dssp GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEE
Confidence 99999999999999999999999 899999997632 346999999999999999999999999 999999999999
Q ss_pred EcC-------------------------CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceeh
Q 018100 171 LDR-------------------------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 225 (361)
Q Consensus 171 v~~-------------------------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 225 (361)
++. ++.++|+|||++...... .....|+..|+|||++.+..++.++||||
T Consensus 170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHH
Confidence 975 789999999999753221 23456899999999999999999999999
Q ss_pred hhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc--------cccccccCccccCCCC-------------------
Q 018100 226 FGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR--------TRHSLIADPELQGQYP------------------- 278 (361)
Q Consensus 226 lG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~------------------- 278 (361)
|||++|+|++|..||...................... ...............+
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 9999999999999997765443332221111100000 0000000000000000
Q ss_pred -hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 279 -PRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 279 -~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
......+.+|+.+||+.||++|||+.++++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 001146779999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=333.51 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=201.3
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCC-----
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 104 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 104 (361)
.+.++|++.+.||+|+||.||+|.++.++..||||++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 356889999999999999999999999999999999975433 34567899999999999999999999885543
Q ss_pred ----------------------------------------------------eeEEEEEecCCCCHHHHhcccCCCCCCC
Q 018100 105 ----------------------------------------------------QRLLVYEYMPLGSVEDHLHDLSPGKKPL 132 (361)
Q Consensus 105 ----------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~l 132 (361)
..++||||+++++|.+++..... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~ 161 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDR 161 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGS
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccch
Confidence 37999999999999999976332 2345
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc----------ceeecccc
Q 018100 133 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT----------HVSTRVMG 202 (361)
Q Consensus 133 ~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~----------~~~~~~~~ 202 (361)
++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++......... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 77789999999999999999999 999999999999999999999999999764332211 11233468
Q ss_pred CcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHH
Q 018100 203 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 282 (361)
Q Consensus 203 ~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (361)
+..|+|||++.+..++.++|||||||++|+|++|..|+...... ...... . ..+. .....+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-----~~~~~~---~-------~~~~----~~~~~~ 299 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-----ITDVRN---L-------KFPL----LFTQKY 299 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-----HHHHHT---T-------CCCH----HHHHHC
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-----HHHhhc---c-------CCCc----ccccCC
Confidence 99999999999999999999999999999999988775332111 000000 0 0000 012334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 283 YQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 283 ~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..+.+++.+||+.||++||++.++++.
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 467889999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.48 Aligned_cols=270 Identities=24% Similarity=0.363 Sum_probs=204.5
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECC---CCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
.+....++|++.+.||+|+||.||+|.+.. ++..|++|++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334456889999999999999999998765 456899999875432 234668899999999999999999999976
Q ss_pred CC-----eeEEEEEecCCCCHHHHhccc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC
Q 018100 103 GD-----QRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 175 (361)
Q Consensus 103 ~~-----~~~lv~e~~~~~~L~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~ 175 (361)
.. ..++||||+++++|.+++... ......+++..++.++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 54 359999999999999998432 223567999999999999999999999999 99999999999999999
Q ss_pred ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHh
Q 018100 176 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 254 (361)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 263 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL- 263 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-
Confidence 999999999876433322222333457788999999999999999999999999999999 889997654322211110
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.. .....+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 264 -----~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 -----HG-----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -----TT-----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----cC-----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 001112233457889999999999999999999999999887643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=342.38 Aligned_cols=273 Identities=17% Similarity=0.209 Sum_probs=206.5
Q ss_pred HhhCcccCCeeccc--CceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G--~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..++|++.+.||+| +||.||+|.++.++..||||++..... ...+.+.+|+.+++.++||||+++++++.++...+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 999999999999999999999975432 23456888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999997632 356999999999999999999999999 99999999999999999999999998754
Q ss_pred CCCCC-----CcceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-H-hhhhh
Q 018100 188 GPVGD-----NTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-A-WARPL 258 (361)
Q Consensus 188 ~~~~~-----~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~-~~~~~ 258 (361)
..... .........|+..|+|||++.+ ..++.++|||||||++|+|++|..||............ . .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 21111 1111222468889999999987 57899999999999999999999999754322111100 0 00000
Q ss_pred hcccc------------------ccccc--------cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 259 FQDRT------------------RHSLI--------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 259 ~~~~~------------------~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..... ..... .........+...+..+.+||.+||+.||++|||+.++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 00000 00000011223345578899999999999999999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=333.94 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=210.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..++|.+.+.||+|+||.||+|.+..++..|++|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999865422 234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 119 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 119 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999999876 467999999999999999999999999 999999999999999999999999999763
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ........++..|+|||++.+..++.++||||||+++|+|++|..||............. . .
T Consensus 192 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~----~------- 256 (335)
T 2owb_A 192 EYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--K----N------- 256 (335)
T ss_dssp CST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--H----T-------
T ss_pred ccC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--c----C-------
Confidence 221 122334568999999999998899999999999999999999999997654332211110 0 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
. ...+...+..+.++|.+||+.||++||++.++++.-
T Consensus 257 -~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 257 -E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp -C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -C----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0 011222334788899999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=326.20 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=203.4
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC----ccchHHHHHHHHHHhcCCCCccceeeeEE--EcCC
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYC--ADGD 104 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 104 (361)
+..++|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35689999999999999999999999999999999986432 23456789999999999999999999998 4456
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++||||++++ |.+++.... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccc
Confidence 789999999855 777776533 467999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCC--CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
+................++..|+|||++.+.. .+.++||||||+++|+|++|..||............. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~------~~- 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG------KG- 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HC-
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh------cC-
Confidence 97643332333334456899999999997644 3789999999999999999999998654332211111 00
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
. ...+...+..+.+++.+||+.||.+||++.++++.-
T Consensus 229 -------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 229 -------S----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp -------C----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred -------C----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 0 011223344788999999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=329.39 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=207.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.+.++|++.+.||+|+||.||+|.++.+|+.|++|++........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 35689999999999999999999999999999999998655545567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE---cCCCceeEeccccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv---~~~~~~~L~Dfg~~~~ 187 (361)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||+|+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999876 457999999999999999999999999 9999999999999 7889999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||............. ....
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~-------- 224 (304)
T 2jam_A 159 EQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK--EGYY-------- 224 (304)
T ss_dssp CCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HCCC--------
T ss_pred cCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCC--------
Confidence 3221 1223458999999999999899999999999999999999999997654322211110 0000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..........+..+.++|.+||+.||.+||++.++++.
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 ----EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111122334588899999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=343.40 Aligned_cols=271 Identities=23% Similarity=0.293 Sum_probs=197.3
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCC-CCccceeeeEEEcCC--
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD-- 104 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-- 104 (361)
....++|++.+.||+|+||.||+|.++.+++.||||++.... ......+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 356789999999999999999999999999999999986432 233456788999999997 999999999997543
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..|+||||++ ++|..++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 7899999997 789998875 46999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC-------------------CcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccch
Q 018100 185 AKLGPVGD-------------------NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 244 (361)
Q Consensus 185 ~~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~ 244 (361)
++...... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 97532210 1112233578999999999976 678999999999999999999999998765
Q ss_pred HHHhhhHHHhhhh-hhccc----------------cccccccCccccCC------------CChHHHHHHHHHHHHcccC
Q 018100 245 AAAEQSLVAWARP-LFQDR----------------TRHSLIADPELQGQ------------YPPRGFYQALAVAAMCVHE 295 (361)
Q Consensus 245 ~~~~~~~~~~~~~-~~~~~----------------~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~ 295 (361)
.......+..... ..... .............. .....+..+.+|+.+||+.
T Consensus 236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 4433322111000 00000 00000000000000 0012244788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 018100 296 QPDMRPVIADVVTA 309 (361)
Q Consensus 296 dP~~Rps~~~ll~~ 309 (361)
||++|||+.++++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.88 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=213.7
Q ss_pred CcceeHHHHHHHhhCcccC-CeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCC-CCcccee
Q 018100 21 AQTLTFRELAAATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNL 96 (361)
Q Consensus 21 ~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~ 96 (361)
.+...++..+.+.++|.+. +.||+|+||.||+|.++.++..||+|++.... ......+.+|+.+++.+. ||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3444556678888999998 89999999999999999999999999987532 234567889999999985 6999999
Q ss_pred eeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---
Q 018100 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--- 173 (361)
Q Consensus 97 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~--- 173 (361)
++++.+....++||||+++++|.+++.... ...+++..++.++.||+.||.|||++| ++||||||+||+++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTT
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCC
Confidence 999999999999999999999999986422 467999999999999999999999999 999999999999998
Q ss_pred CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH
Q 018100 174 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253 (361)
Q Consensus 174 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~ 253 (361)
++.++|+|||++...... .......|+..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 170 ~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 789999999999753222 11233568999999999999999999999999999999999999997654433221111
Q ss_pred hhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... ...........+..+.++|.+||+.||++|||+.++++.
T Consensus 247 ~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QVN--------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HTC--------------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcc--------------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 110 001111122334578899999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=327.35 Aligned_cols=264 Identities=28% Similarity=0.468 Sum_probs=198.2
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
+...++|++.+.||+|+||.||+|.+.. .|++|++..... ...+.+.+|+.+++.++||||+.++++. .....+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3456899999999999999999998753 599999865433 2346788999999999999999999965 455789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 96 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccc
Confidence 99999999999999864 2456999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
..............|+..|+|||++. +..++.++||||||+++|+|++|..||......... ...... ..
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~----~~- 242 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGR----GS- 242 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHHHH----TS-
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHhcc----cc-
Confidence 33322223334456899999999986 567889999999999999999999999764332211 111100 00
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
. .+. ........+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 243 --~--~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 --L--SPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --C--CCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --c--Ccc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 000 011122334588999999999999999999999999987753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=346.21 Aligned_cols=263 Identities=21% Similarity=0.216 Sum_probs=210.6
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcC
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 103 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 103 (361)
.+++...++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+|..++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344455789999999999999999999999999999999986421 12233478899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
...|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999752 357999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
++...... .........||+.|+|||++. +..++.++|||||||++|+|++|..||...........+......
T Consensus 221 la~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 221 SCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 99753222 122223457999999999986 457899999999999999999999999765543332221110000
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM--RPVIADVVTA 309 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~ll~~ 309 (361)
...+.. ....+..+.+||.+||..+|++ ||+++++++.
T Consensus 300 ---------~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 ---------FQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---------CCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---------ccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 001111 1123447889999999998888 9999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=323.05 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=211.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.+.. +..|++|++..... ..+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 4789999999999999999999974 78999999975433 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999762 356899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........++..|+|||++.+..++.++||||||+++|+|++ |..||............. . .
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~---~---~---------- 221 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---T---G---------- 221 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---T---T----------
T ss_pred -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh---c---C----------
Confidence 111122346778999999998899999999999999999999 899997654332211110 0 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00111222345788999999999999999999999999988753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=327.53 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=208.6
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc-------
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------- 102 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 102 (361)
..+..+|++.+.||+|+||.||+|.+..+++.|++|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 456789999999999999999999999899999999986543 356789999999999999999998854
Q ss_pred ---------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC
Q 018100 103 ---------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 173 (361)
Q Consensus 103 ---------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~ 173 (361)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD 157 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence 445799999999999999997532 357999999999999999999999999 999999999999999
Q ss_pred CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH
Q 018100 174 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253 (361)
Q Consensus 174 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~ 253 (361)
++.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----~~ 229 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF-----FT 229 (284)
T ss_dssp TTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-----HH
T ss_pred CCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-----HH
Confidence 9999999999987643221 123346899999999999989999999999999999999999887532111 00
Q ss_pred hhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
. ... .. .+...+..+.+++.+||+.||.+||++.++++.|..+....
T Consensus 230 ---~-~~~---------~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 ---D-LRD---------GI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ---H-HHT---------TC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ---H-hhc---------cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0 000 00 11122346788999999999999999999999999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.64 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=215.2
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
....+|++.+.||+|+||.||+|.++.++..||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34578999999999999999999999989999999987543 34678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 296 E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999997632 456899999999999999999999999 99999999999999999999999999986322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. ........++..|+|||++.+..++.++|||||||++|+|++ |..||............ ..
T Consensus 371 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~---~~------------ 434 (495)
T 1opk_A 371 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK------------ 434 (495)
T ss_dssp CC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HT------------
T ss_pred Cc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc------------
Confidence 11 111222345678999999998899999999999999999999 99999765432221111 10
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
......+...+..+.+||.+||+.||++||++.+|++.|+.+.
T Consensus 435 --~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 435 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 0111223344558889999999999999999999999998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=330.93 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=202.8
Q ss_pred HhhCcccC-CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEE
Q 018100 32 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 109 (361)
+.++|++. +.||+|+||.||+|.+..++..||||++........+.+.+|+.++..+ +||||+++++++.+++..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45789995 7899999999999999999999999999876666677899999999885 799999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc---eeEecccccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAK 186 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~---~~L~Dfg~~~ 186 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++. ++|+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999986 467999999999999999999999999 999999999999998776 9999999987
Q ss_pred cCCCCCC-----cceeeccccCcCcCCchhhcc-----CCCCccCceehhhHHHHHHhhCCCccccchHHH---------
Q 018100 187 LGPVGDN-----THVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--------- 247 (361)
Q Consensus 187 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~--------- 247 (361)
....... ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 5322111 111223458999999999865 457899999999999999999999997543211
Q ss_pred ---hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 248 ---EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 248 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+..... . ........... ..+..+.+|+.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~i~---~----~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQ---E----GKYEFPDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHH---H----CCCCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHh---c----cCcccCchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000110000 0 00000000001 123478899999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=339.70 Aligned_cols=269 Identities=26% Similarity=0.378 Sum_probs=215.1
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCe-----EEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEE
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQ-----DVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCA 101 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 101 (361)
++...++|++.+.||+|+||.||+|.+..++. .|++|++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44456899999999999999999999977654 799999875433 3346788999999999 8999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
++...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999864210 1346899999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhh
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 250 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 250 (361)
+.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 9999999999999975433333233334456788999999999999999999999999999998 99999764322111
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
....... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 277 -~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 -YKLVKDG--------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -HHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111000 00111222345788999999999999999999999999877653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=338.68 Aligned_cols=252 Identities=22% Similarity=0.272 Sum_probs=201.4
Q ss_pred hCccc--CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRS--ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~--~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..|.+ .+.||+|+||.||+|.+..+|..||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34444 5689999999999999999999999999987655566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE--cCCCceeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv--~~~~~~~L~Dfg~~~~~~ 189 (361)
|+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++....
T Consensus 167 ~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 167 YVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp CCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 9999999988865 1346999999999999999999999999 9999999999999 567899999999997643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+ ....+. .
T Consensus 241 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i--~~~~~~--------~ 307 (373)
T 2x4f_A 241 PRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI--LACRWD--------L 307 (373)
T ss_dssp TTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCCC--------S
T ss_pred Ccc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCC--------C
Confidence 222 223346899999999998888999999999999999999999999765443222111 110000 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...... ..+..+.+||.+||+.||.+||++.++++
T Consensus 308 ~~~~~~----~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 308 EDEEFQ----DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhhhc----cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111 23347889999999999999999999997
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.75 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=208.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999999999999999986431 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999976 456999999999999999999999999 9999999999999999999999999986532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||............. ..
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~~-------- 227 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV------NV-------- 227 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TT--------
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh------cc--------
Confidence 21 1233468999999999999899999999999999999999999997654432221111 00
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+ ...++..+..+.++|.+||+.||.+||++.++++.
T Consensus 228 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0 11223334578899999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=335.45 Aligned_cols=268 Identities=25% Similarity=0.368 Sum_probs=205.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.++|++.+.||+|+||.||+|.+..++..|++|++...... ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 57899999999999999999999999999999998654332 2355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.++... ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99998888887665 567999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-h-------hhhcc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-R-------PLFQD 261 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~-------~~~~~ 261 (361)
. ........++..|+|||++.+. .++.++|||||||++|+|++|..||............... . ..+..
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 1 2222345689999999999775 7899999999999999999999999776543322211100 0 00000
Q ss_pred ccccccccCccccCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 RTRHSLIADPELQGQ-----YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.........+..... ..+..+..+.+|+.+||+.||++|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000111111111 112335578999999999999999999999963
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=329.93 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=199.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--CCCCccceeeeEEEc----CCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCAD----GDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~ 105 (361)
..++|++.+.||+|+||.||+|.+ ++..||||++... ....+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 468999999999999999999988 4899999998643 33455566666665 789999999998643 346
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCcEEEcCCCce
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
.++||||+++++|.+++.. ..+++..++.++.||+.||.||| +++ ++||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCE
Confidence 7999999999999999964 56999999999999999999999 888 9999999999999999999
Q ss_pred eEecccccccCCCCCCcc--eeeccccCcCcCCchhhccC------CCCccCceehhhHHHHHHhhC----------CCc
Q 018100 178 KLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG----------RKA 239 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~~l~~ll~g----------~~p 239 (361)
||+|||++.......... ......|+..|+|||++.+. .++.++|||||||++|+|++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999986532222111 12234689999999999776 455799999999999999999 777
Q ss_pred cccchHHHh--hhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 240 VDTSKAAAE--QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 240 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
|........ ....... ......... .....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 233 f~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVV----CVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHH----TTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHH----hccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 754321111 0000000 000000000 00112234667899999999999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=337.61 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=199.4
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCC--CccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 107 (361)
..++|++.+.||+|+||.||+|.+.. +..||+|++...... ..+.+.+|+.++..++| +||+.+++++.++...+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 45789999999999999999999854 889999998754332 33668899999999976 99999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.++|+|||++..
T Consensus 86 lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99995 57899999987 567999999999999999999999999 99999999999997 67899999999976
Q ss_pred CCCCCCcceeeccccCcCcCCchhhcc-----------CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 256 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 256 (361)
..............|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... +....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~- 234 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHAII- 234 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHH-
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-HHHHh-
Confidence 433332223344579999999999865 67889999999999999999999999753221111 00000
Q ss_pred hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 257 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
++......+...+..+.+++.+||+.||.+|||+.++++...
T Consensus 235 -------------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 235 -------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp -------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -------------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 111112223333457889999999999999999999997544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=335.58 Aligned_cols=267 Identities=23% Similarity=0.317 Sum_probs=199.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
++|++.+.||+|+||.||+|.++.++..||+|++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999999999999999986543221 12345799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
++ ++|.+++... +..+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 6898888752 356999999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC-
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD- 270 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 270 (361)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||..............................
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 222233467999999999876 56899999999999999999999999876554433222111100000000000000
Q ss_pred -------cccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 -------PELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 -------~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+... ....+..+..+.+||.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00112234578899999999999999999999973
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=324.06 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=187.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
...++|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 34578999999999999999999999899999999986432 223467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999999875 2357999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
..... .......++..|+|||++.+..++.++||||||+++|+|++|..||......... .. ..
T Consensus 162 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------~~----~~ 225 (278)
T 3cok_A 162 LKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------NK----VV 225 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CC
T ss_pred ccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------HH----Hh
Confidence 32211 1122346889999999998888999999999999999999999999754321110 00 00
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..+ ...+...+..+.+++.+||+.||++||++.++++
T Consensus 226 ~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LAD----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcc----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 001 1122334457889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=326.65 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=210.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..++|++.+.||+|+||.||+|.++.++..|++|++..... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 35789999999999999999999999999999999865422 234668889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999876 467999999999999999999999999 999999999999999999999999998763
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ........++..|+|||++.+..++.++||||||+++|+|++|..||............. ..
T Consensus 166 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~------- 230 (294)
T 2rku_A 166 EYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------KN------- 230 (294)
T ss_dssp CST--TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TT-------
T ss_pred ccC--ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------hc-------
Confidence 221 122334568999999999998889999999999999999999999997654332211110 00
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
. ...+...+..+.+++.+||+.||++||++.++++..-
T Consensus 231 -~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 231 -E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp -C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred -c----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0 0112223347888999999999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=346.82 Aligned_cols=264 Identities=22% Similarity=0.280 Sum_probs=199.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcC------C
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------D 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 104 (361)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999999999999999999754 223346788999999999999999999999654 4
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..|+||||++ ++|.+.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~-~~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCS-EEHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 5799999997 556666642 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh-hhh------
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARP------ 257 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~-~~~------ 257 (361)
+..... ........||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+.. ...
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 975322 2223445789999999999999999999999999999999999999987654333221111 000
Q ss_pred ---------hhccccccccccCcccc-----C---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 258 ---------LFQDRTRHSLIADPELQ-----G---QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 258 ---------~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.............+... . .........+.+||.+||..||++|||+.++++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000 0 0001125678999999999999999999999973
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=340.34 Aligned_cols=279 Identities=17% Similarity=0.206 Sum_probs=216.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCC--eeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 108 (361)
..++|++.+.||+|+||.||+|.++.++..||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3578999999999999999999999999999999997543 234567889999999999999999999998654 7799
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE----cCCCceeEecccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGL 184 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv----~~~~~~~L~Dfg~ 184 (361)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999976332 234999999999999999999999999 9999999999999 7788899999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhcc--------CCCCccCceehhhHHHHHHhhCCCccccchHHHh--hhHHHh
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE--QSLVAW 254 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~--~~~~~~ 254 (361)
+...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ ..+...
T Consensus 163 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 163 ARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp CEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred ceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 9753221 22233568999999999865 4678899999999999999999999964332111 111111
Q ss_pred hhhhhcc-------ccc--cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 255 ARPLFQD-------RTR--HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 255 ~~~~~~~-------~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
....... ... ....................+.+++.+||+.||++||++.++++.++.+....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1100000 000 00000111122344667788899999999999999999999999998887654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=325.36 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=212.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
..++|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3477999999999999999999999999999999997543 334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 99999999999864 56999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ........++..|+|||++.+..++.++||||||+++|+|++|..||............... ..
T Consensus 172 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~ 236 (303)
T 3a7i_A 172 T--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-------------NP 236 (303)
T ss_dssp T--BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------CC
T ss_pred c--ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-------------CC
Confidence 2 11223456889999999999999999999999999999999999999765433222111100 00
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
+.. +...+..+.+++.+||+.||.+||++.++++.....
T Consensus 237 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 237 PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp CCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred CCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 111 222334788999999999999999999999865443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.05 Aligned_cols=273 Identities=25% Similarity=0.269 Sum_probs=201.2
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhcCCCCccceeeeEEEcC
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADG 103 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 103 (361)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 345568999999999999999999999999999999998643221 124678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
...++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||
T Consensus 85 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 85 SNISLVFDFME-TDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TCCEEEEECCS-EEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CceEEEEEcCC-CCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999997 588888865 2356899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH-Hhhhhhhcc
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQD 261 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~ 261 (361)
++...... ........++..|+|||++.+. .++.++|||||||++|+|++|.+||............ .........
T Consensus 158 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 158 LAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp GGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 99753221 2223345689999999998654 5889999999999999999999999776543322211 110000000
Q ss_pred -ccccccccCc---cccCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 262 -RTRHSLIADP---ELQGQY-----PPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 262 -~~~~~~~~~~---~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
........+. ...... ....+..+.+||.+||+.||++|||+.++++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000000000 000000 122345889999999999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=333.78 Aligned_cols=266 Identities=28% Similarity=0.397 Sum_probs=207.8
Q ss_pred HhhCcccCCeecccCceEEEEEE-----ECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
..++|++.+.||+|+||.||+|. ...++..||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 35899999999999999999999 456688999999864432 334568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeE
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKL 179 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L 179 (361)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+||+++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976331 1245899999999999999999999999 999999999999984 446999
Q ss_pred ecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhh
Q 018100 180 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPL 258 (361)
Q Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 258 (361)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--- 261 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG--- 261 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT---
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC---
Confidence 99999865322222222334457889999999998899999999999999999998 99999765433222111100
Q ss_pred hccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 259 FQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
. ....+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 262 ----~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 ----G----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ----C----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 0 01112233447889999999999999999999999999887643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=347.75 Aligned_cols=195 Identities=26% Similarity=0.346 Sum_probs=156.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEc-----CCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 105 (361)
.++|++.+.||+|+||.||+|.++.++..||||++..... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4789999999999999999999999999999999865422 234678899999999999999999999843 357
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 899999984 899999876 567999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-------------------------ceeeccccCcCcCCchhh-ccCCCCccCceehhhHHHHHHhh
Q 018100 186 KLGPVGDNT-------------------------HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILS 235 (361)
Q Consensus 186 ~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~~l~~ll~ 235 (361)
......... ......+||..|+|||++ .+..++.++|||||||++|+|++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 764321111 112335689999999986 56679999999999999999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=320.96 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=206.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcC--CeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++ +..|++|++..... ...+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 478999999999999999999986 88999999875432 2345788999999999999999999999876 78899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ +.++|+||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999997622 336999999999999999999999875 34999999999999999999999999887532
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCc---cCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL---KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
.. ....++..|+|||++.+..++. ++|||||||++|+|++|..||............. ..
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------~~---- 226 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA------LE---- 226 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH------HS----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH------hc----
Confidence 11 2235789999999998765444 7999999999999999999997654432211110 00
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
......+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00112223344578899999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=347.09 Aligned_cols=255 Identities=25% Similarity=0.323 Sum_probs=207.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+.++|++.+.||+|+||.||+|.++.++..||+|++... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 4568999999999999999999999999999999998643 22345778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc---CCCceeEeccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLA 185 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~---~~~~~~L~Dfg~~ 185 (361)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.++|+|||++
T Consensus 99 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999998876 467999999999999999999999999 99999999999995 4567999999999
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... .......|++.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+
T Consensus 172 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 241 (486)
T 3mwu_A 172 TCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------ 241 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------
T ss_pred eECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 753222 22234568999999999976 58999999999999999999999997655433222111110000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
... .....+..+.+||.+||+.||.+|||+.++++.-
T Consensus 242 ----~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 242 ----DLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp ----CSG----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred ----CCc----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 000 0122345788999999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=332.42 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=208.7
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhcC-CCCccceee
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLL-HHPNLVNLI 97 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~~i~~~~ 97 (361)
.....+.++|++.+.||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.+++.+ +||||+.++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 44456678999999999999999999999988999999998754321 134678899999998 799999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
+++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999976 467999999999999999999999999 9999999999999999999
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCchhhcc------CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 251 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 251 (361)
+|+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 999999987533221 2234568999999999863 3588999999999999999999999976543222211
Q ss_pred HHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 252 VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
+... .+. ....... ..+..+.+++.+||+.||++||++.++++
T Consensus 317 i~~~--~~~--------~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEG--QYQ--------FSSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHT--CCC--------CCHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhC--CCC--------CCCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1100 000 0000001 12346888999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=346.64 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=204.2
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+.++|++.+.||+|+||.||+|.++.++..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35678999999999999999999999999999999987543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC---CceeEeccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLA 185 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~---~~~~L~Dfg~~ 185 (361)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.. +.+||+|||++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998876 467999999999999999999999999 9999999999999764 45999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 187 ~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------- 253 (494)
T 3lij_A 187 AVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK--------- 253 (494)
T ss_dssp EECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred eECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 763322 2233456999999999986 469999999999999999999999998765433222211110
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......... ..+..+.+||.+||+.||.+|||+.++++.
T Consensus 254 -~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 254 -YTFDSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -CCCCSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCCCchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000111111 223478899999999999999999999963
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=332.62 Aligned_cols=268 Identities=27% Similarity=0.408 Sum_probs=212.7
Q ss_pred hhCcccCCeecccCceEEEEEEE----CCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC--ee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 106 (361)
.++|++.+.||+|+||.||+|.+ ..++..|++|++........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 57799999999999999999994 5679999999998766666678999999999999999999999986543 78
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999762 346999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH---------HHhhh
Q 018100 187 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL---------VAWAR 256 (361)
Q Consensus 187 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~---------~~~~~ 256 (361)
......... ......++..|+|||++.+..++.++||||||+++|+|++|..||........... .....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 643322211 12223467789999999988899999999999999999999999875432211100 00000
Q ss_pred hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 257 PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
..... ......+...+..+.+++.+||+.||++||++.++++.|+.+..+
T Consensus 274 ~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKN----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHT----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhc----------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 001112333455889999999999999999999999999988754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=342.34 Aligned_cols=263 Identities=22% Similarity=0.222 Sum_probs=208.8
Q ss_pred HHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEc
Q 018100 26 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 102 (361)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 102 (361)
.++++...++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3445556789999999999999999999999999999999986422 1223457889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
....|+||||++||+|.+++... +..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999752 246999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhc-------cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
|++....... ........||+.|+|||++. +..++.++|||||||++|+|++|..||...........+...
T Consensus 207 Gla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 207 GSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp TTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred hhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9997633221 11223357999999999987 356899999999999999999999999765443322211111
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR---PVIADVVTA 309 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~~ll~~ 309 (361)
... ...+... ...+.++.+||.+||. +|.+| |+++++++.
T Consensus 286 ~~~---------~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 KEH---------LSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHH---------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccC---------cCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000 0011111 1233478899999999 99998 589988753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=348.51 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=210.1
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
.+.++|++.+.||+|+||.||+|.++.++..||||++.... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999986543 334577999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE---cCCCceeEecccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGL 184 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv---~~~~~~~L~Dfg~ 184 (361)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||+
T Consensus 103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999876 567999999999999999999999999 9999999999999 5678999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
+....... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||...........+.....
T Consensus 176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------- 244 (484)
T 3nyv_A 176 STHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY------- 244 (484)
T ss_dssp HHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred eEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 87533221 2233568999999999876 689999999999999999999999987654332221111000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. . .......+..+.+||.+||+.||.+|||+.++++.
T Consensus 245 --~~-~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 --TF-E----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CC-C----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CC-C----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 0 00112234578899999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=327.55 Aligned_cols=247 Identities=22% Similarity=0.229 Sum_probs=195.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 108 (361)
+.++|++.+.||+|+||.||+|.++.++..||||++...... .......|+..+..+ +||||+++++++.++...++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 457899999999999999999999999999999998654332 223445555555544 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+ +++|.+++... +..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 68998888653 356999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... .......|+..|+|||++.+ .++.++|||||||++|+|++|..||........ + .. ..
T Consensus 208 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~---~~----------~~ 268 (311)
T 3p1a_A 208 GTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ--L---RQ----------GY 268 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH--H---TT----------TC
T ss_pred ccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--H---hc----------cC
Confidence 222 22233468999999999876 789999999999999999999766644322110 0 00 00
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..+.... ..+..+.+++.+||+.||++|||+.++++
T Consensus 269 ~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0111111 22347889999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=331.58 Aligned_cols=275 Identities=27% Similarity=0.394 Sum_probs=210.6
Q ss_pred hhCc-ccCCeecccCceEEEEEEE----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEc--CC
Q 018100 33 TKNF-RSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GD 104 (361)
Q Consensus 33 ~~~y-~~~~~lg~G~~g~v~~~~~----~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 104 (361)
.++| ++++.||+|+||.||++.+ ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 4566 9999999999999988764 34688999999975432 334668999999999999999999999987 46
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred eEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence 78999999999999999975 45999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 185 AKLGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 185 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
+......... .......++..|+|||++.+..++.++|||||||++|+|++|..||.......... ..+....... .
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~-~ 258 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTV-L 258 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHH-H
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhH-H
Confidence 9864333221 12233457788999999999899999999999999999999999997654321110 0000000000 0
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
..............+...+..+.+|+.+||+.||.+|||+.++++.|+.+...-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 000000001111223344558899999999999999999999999999887643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=328.51 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=200.1
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhcCCCCccceeeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCA 101 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 101 (361)
..+.++|++.+.||+|+||.||+|.++.++..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 3456899999999999999999999999999999999864321 12235788999999999999999999997
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc---ee
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PK 178 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~---~~ 178 (361)
.+. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++. ++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred CCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 665 8999999999999999876 567999999999999999999999999 999999999999987665 99
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
|+|||++..... ........|+..|+|||++. +..++.++|||||||++|+|++|..||........ +....
T Consensus 158 l~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~ 232 (322)
T 2ycf_A 158 ITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI 232 (322)
T ss_dssp ECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH
T ss_pred EccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH
Confidence 999999875322 11223346899999999974 46788999999999999999999999975432111 00000
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.. ......+..... .+..+.+++.+||+.||++||++.++++
T Consensus 233 ~~-------~~~~~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TS-------GKYNFIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HH-------TCCCCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Hh-------CccccCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 000001111112 2347889999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=323.40 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=210.1
Q ss_pred hhCcccCC-eecccCceEEEEEEEC--CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSES-LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~-~lg~G~~g~v~~~~~~--~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|.+.+ .||+|+||.||+|.+. .++..|++|++..... ...+.+.+|+.+++.++||||+++++++. ....++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence 46777877 9999999999999864 4578899999976432 34567889999999999999999999994 556899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999864 2456999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
...... .......++..|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~----------- 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG----------- 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----------
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-----------
Confidence 322211 11222346788999999988889999999999999999998 99999765433222111100
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.....++..+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 230 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 230 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 001223344558899999999999999999999999998876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=335.43 Aligned_cols=265 Identities=15% Similarity=0.171 Sum_probs=200.4
Q ss_pred hhCcccCCeecccCceEEEEEEECC---CCeEEEEEEeccCCcc-----------chHHHHHHHHHHhcCCCCccceeee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQ-----------GNREFLVEVLMLSLLHHPNLVNLIG 98 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~v~iK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~ 98 (361)
.++|++.+.||+|+||.||+|.+.. ++..+++|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4789999999999999999999987 7889999998754322 1234667888899999999999999
Q ss_pred EEEc----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC
Q 018100 99 YCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 174 (361)
Q Consensus 99 ~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~ 174 (361)
++.. ....|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 77889999999 8999999986 447999999999999999999999999 9999999999999988
Q ss_pred C--ceeEecccccccCCCCCC-----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH
Q 018100 175 Y--HPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247 (361)
Q Consensus 175 ~--~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 247 (361)
+ .++|+|||++........ ........|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999975322111 111133568999999999999999999999999999999999999996432211
Q ss_pred hh--hHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 248 EQ--SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 248 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.. ............... .... ....+..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVL-------KWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHH-------HHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHHhhcccccHHHH-------hhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11 111111000000000 0000 0123347889999999999999999999999997544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=324.34 Aligned_cols=256 Identities=32% Similarity=0.444 Sum_probs=200.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.+. +..|++|++... ...+.+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 478999999999999999999986 788999998643 345678999999999999999999998864 47899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc---CCCCCeeecCCCCCcEEEcCCCc-eeEecccccccC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD---KAKPPVIYRDLKCSNILLDRGYH-PKLSDFGLAKLG 188 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~~~~i~H~dl~p~Nilv~~~~~-~~L~Dfg~~~~~ 188 (361)
+++++|.+++..... ...++...++.++.||++||.|||+ ++ ++||||||+||+++.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999975221 2347899999999999999999999 77 999999999999998886 799999998642
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... .....|+..|+|||++.+..++.++||||||+++|+|++|..||................ .
T Consensus 157 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------~ 220 (307)
T 2eva_A 157 QTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-----------G 220 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-----------T
T ss_pred ccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-----------C
Confidence 211 223458999999999999899999999999999999999999997532221111100000 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccC
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 318 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~ 318 (361)
..+.. +...+..+.+++.+||+.||++|||+.++++.|+.+...-.
T Consensus 221 ~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 221 TRPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCCC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCCCc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 01111 12234478899999999999999999999999998876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=346.56 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=211.9
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
++...++|++.+.||+|+||.||+|.++. +..||||++.... ...+.+.+|+.+++.++||||+++++++. ....++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 34556889999999999999999999975 7889999997543 45678999999999999999999999986 567899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 260 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999997521 236899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 335 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~--------- 401 (454)
T 1qcf_A 335 EDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RG--------- 401 (454)
T ss_dssp CCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---HT---------
T ss_pred CCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC---------
Confidence 2211 111122345678999999998899999999999999999999 999997654432221111 00
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.....+...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 402 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 -----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0011123344588899999999999999999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=323.55 Aligned_cols=250 Identities=21% Similarity=0.259 Sum_probs=202.7
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 107 (361)
.+.++|++.+.||+|+||.||+|.+..++..|++|++..... .....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 456899999999999999999999999999999999875432 3345688899999998 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-------------
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG------------- 174 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~------------- 174 (361)
+||||+++++|.+++.........+++..++.++.||+.||.|||+++ ++||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999763322367999999999999999999999999 9999999999999844
Q ss_pred ------CceeEecccccccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHH
Q 018100 175 ------YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247 (361)
Q Consensus 175 ------~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 247 (361)
..++|+|||.+...... ....++..|+|||++.+. .++.++|||||||++|+|++|..++.......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH
T ss_pred cccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH
Confidence 47999999998763321 123489999999999765 66789999999999999999988765432211
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. + ... ..+ ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 239 ~--~---~~~-----------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 E--I---RQG-----------RLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H--H---HTT-----------CCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H--H---HcC-----------CCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 0 000 001 1122334578899999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=332.85 Aligned_cols=267 Identities=27% Similarity=0.379 Sum_probs=205.0
Q ss_pred ccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceee
Q 018100 19 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLI 97 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 97 (361)
.++..+++.++....++|++.+.||+|+||.||+|.+..+++.|++|++.... ...+.+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp -------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred CcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeee
Confidence 34444555566677899999999999999999999999999999999986543 3456788999999998 799999999
Q ss_pred eEEEc------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 98 GYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 98 ~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
+++.. ....++||||+++++|.+++.... ...+++..++.++.||+.||.|||++| ++|+||+|+||++
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~ 162 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLL 162 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEE
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEE
Confidence 99976 568899999999999999997632 357999999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHH
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 246 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~ 246 (361)
+.++.++|+|||++...... ........++..|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 163 TENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp CTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cCCCCEEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 99999999999998753221 11223346899999999986 567889999999999999999999999765433
Q ss_pred HhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 247 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....... . .. .+.. .+...+..+.++|.+||..||.+||++.++++.
T Consensus 241 ~~~~~~~--~----~~-------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 RALFLIP--R----NP-------APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHH--H----SC-------CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhh--c----Cc-------cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2221110 0 00 0000 011223478889999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=320.31 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=200.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
..++|++.+.||+|+||.||+|.++.+++.|++|++... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 457899999999999999999999989999999998643 22345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999976 456999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||............. . . .
T Consensus 162 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~---~-----~ 227 (276)
T 2h6d_A 162 SDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR---G---G-----V 227 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H---C-----C
T ss_pred CCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh---c---C-----c
Confidence 222 12233468899999999987665 689999999999999999999997654332211110 0 0 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+..+.+++.+||+.||++||++.++++.
T Consensus 228 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122233478889999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=346.02 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=206.3
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-------------cchHHHHHHHHHHhcCCCCccceee
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNLVNLI 97 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~ 97 (361)
.+.++|++.+.||+|+||.||+|.++.++..||+|++..... ...+.+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 457899999999999999999999999999999999875432 2346788999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC--
Q 018100 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-- 175 (361)
Q Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-- 175 (361)
+++.+....|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999999876 467999999999999999999999999 99999999999998876
Q ss_pred -ceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh
Q 018100 176 -HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 176 -~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 254 (361)
.++|+|||++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+..
T Consensus 186 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp SSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 6999999999764322 2233456899999999986 4689999999999999999999999987654332222111
Q ss_pred hhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. ......... ..+..+.+||.+||+.||.+|||+.++++.
T Consensus 262 ~~----------~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GK----------YYFDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CC----------CCCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC----------CCCCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10 000001111 123478899999999999999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=339.56 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=198.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCC--CCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ...+.+.+|+.+++.++ ||||+++++++..+...|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999876 89999999865433 23467889999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 557999999987 567899999999999999999999999 99999999999995 589999999999864
Q ss_pred CCCCCcceeeccccCcCcCCchhhcc-----------CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 257 (361)
.............|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... +....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~~~~-- 281 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHAII-- 281 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHH--
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-HHHHh--
Confidence 33322222344579999999999865 36889999999999999999999999754221110 11100
Q ss_pred hhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 258 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
++.....++...+..+.+||.+||+.||.+||++.++++..
T Consensus 282 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 ------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 01111112222244788999999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.07 Aligned_cols=257 Identities=20% Similarity=0.250 Sum_probs=195.9
Q ss_pred HhhCcccC-CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHh-cCCCCccceeeeEEEc----CCe
Q 018100 32 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHPNLVNLIGYCAD----GDQ 105 (361)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~ 105 (361)
..++|.+. +.||+|+||.||+|.++.++..||||++.. ...+.+|+.++. ..+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 35678777 789999999999999999999999999853 245677888874 4589999999999865 567
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 182 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Df 182 (361)
.|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence 899999999999999997622 346999999999999999999999999 999999999999998 788999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh-hHHHhhhhhhcc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQD 261 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 261 (361)
|++..... ........||..|+|||++.+..++.++|||||||++|+|++|..||......... ....... ..
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~ 282 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MG 282 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HT
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cC
Confidence 99975322 11223456899999999999999999999999999999999999999754321100 0000000 00
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.. .+........+.++.+||.+||+.||++|||+.++++....
T Consensus 283 ---~~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 283 ---QY-----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp ---CC-----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ---cc-----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00 00000112234578899999999999999999999986443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=337.36 Aligned_cols=275 Identities=20% Similarity=0.267 Sum_probs=204.8
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc------
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------ 102 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 102 (361)
+....++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 355678999999999999999999999999999999998644222 2369999999999999999999843
Q ss_pred --------------------------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018100 103 --------------------------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150 (361)
Q Consensus 103 --------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 150 (361)
....++||||++ ++|.+.+......+..+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999997 68887776543346789999999999999999999
Q ss_pred HhcCCCCCeeecCCCCCcEEEc-CCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhH
Q 018100 151 LHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGV 228 (361)
Q Consensus 151 LH~~~~~~i~H~dl~p~Nilv~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~ 228 (361)
||++| |+||||||+||+++ .++.++|+|||++...... .......++..|+|||++.+. .++.++|||||||
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 99999999999998 6889999999999753222 122334678999999998765 4899999999999
Q ss_pred HHHHHhhCCCccccchHHHhhhHH-Hhhhhhh-----ccc-----cccccccCccccCCCChHHHHHHHHHHHHcccCCC
Q 018100 229 VLLEILSGRKAVDTSKAAAEQSLV-AWARPLF-----QDR-----TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 297 (361)
Q Consensus 229 ~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~-----~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 297 (361)
++|+|++|..||............ ....... ... ..............++...+..+.+|+.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999876544332211 1100000 000 00000001111111233345578999999999999
Q ss_pred CCCCCHHHHHH--HHHHHH
Q 018100 298 DMRPVIADVVT--ALAYLA 314 (361)
Q Consensus 298 ~~Rps~~~ll~--~l~~l~ 314 (361)
.+|||+.++++ .++.+.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHH
T ss_pred hhCCCHHHHhcCHHHHHHH
Confidence 99999999996 444443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.42 Aligned_cols=260 Identities=29% Similarity=0.412 Sum_probs=207.9
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+...++|++.+.||+|+||.||+|.++. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 3456789999999999999999999986 5679999987543 345789999999999999999999999876 678999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.... +..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 257 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999997522 356899999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||...........+. .
T Consensus 332 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~----------- 396 (452)
T 1fmk_A 332 DNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R----------- 396 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T-----------
T ss_pred CCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c-----------
Confidence 211 111222346778999999998999999999999999999999 999997654432221110 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
......+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 397 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 397 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 00111233445588899999999999999999999999986653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=320.01 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=210.6
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
....++|++.+.||+|+||.||+|.+.. +..|++|++.... ...+.+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 3445889999999999999999999874 7789999986543 345778999999999999999999999864 468999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.... +..+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++....
T Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999997521 236999999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||............ ...
T Consensus 161 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~~~---------- 226 (279)
T 1qpc_A 161 DNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---ERG---------- 226 (279)
T ss_dssp SSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HTT----------
T ss_pred Ccc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH---hcc----------
Confidence 221 111222346778999999988889999999999999999999 99999765433221111 000
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 ----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 00111223345888999999999999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=327.22 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=207.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEE--cCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++.+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 5789999999999999999999999999999999975432 33466889999999999999999999874 4678899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
||||+++++|.+++.........+++..++.++.||+.||.|||+++ ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999764333456999999999999999999999876 2349999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..... ........++..|+|||++.+..++.++||||||+++|+|++|..||............. .. .
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~------~-- 232 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--EG------K-- 232 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HT------C--
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh--hc------c--
Confidence 53221 111223468899999999998899999999999999999999999998654322211110 00 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
....+...+..+.+++.+||+.||.+||++.++++.+.
T Consensus 233 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 -------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 00112233458889999999999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=323.22 Aligned_cols=258 Identities=24% Similarity=0.289 Sum_probs=207.4
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---------cchHHHHHHHHHHhcCC-CCcccee
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEVLMLSLLH-HPNLVNL 96 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~ 96 (361)
.....+.++|++.+.||+|+||.||+|.++.+++.|++|++..... ...+.+.+|+.+++.+. ||||+++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3345677999999999999999999999999999999999975431 12346788999999995 9999999
Q ss_pred eeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 97 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 97 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
++++.++...++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 9999999999999999999999999986 467999999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhc------cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 250 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~ 250 (361)
++|+|||++....... ......++..|+|||++. ...++.++||||||+++|+|++|..||..........
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 239 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239 (298)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence 9999999987533221 223346889999999885 4568899999999999999999999997654332221
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...... . ..........+..+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~~~~--~------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGN--Y------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTC--C------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCC--c------------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111000 0 0000111233457889999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=322.31 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=201.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc-CCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 110 (361)
..++|++.+.||+|+||.||+|.+. +..|++|++.... ..+.+.+|+.+++.++||||+++++++.+ ....++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3589999999999999999999885 8899999986542 45778999999999999999999998754 45789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997521 223899999999999999999999999 99999999999999999999999999874222
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. .....++..|+|||++.+..++.++||||||+++|+|++ |..||............ . .
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~----~-------- 229 (278)
T 1byg_A 170 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---E----K-------- 229 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH---T----T--------
T ss_pred c-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---h----c--------
Confidence 1 122346788999999998899999999999999999998 99999765332211111 0 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
......+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 230 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 230 --GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0011122334458889999999999999999999999999887643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.23 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=206.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECC---CCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ....+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45889999999999999999999654 34569999987543 23456788999999999999999999998754 568
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999999752 356999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
...... .......++..|+|||++.+..++.++||||||+++|+|++ |..||............... .
T Consensus 163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~----------~ 231 (281)
T 3cc6_A 163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG----------D 231 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT----------C
T ss_pred cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC----------C
Confidence 332211 11223446778999999998899999999999999999998 99999654332221111100 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
. ...+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 232 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 R-------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0 011222344788999999999999999999999999987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.52 Aligned_cols=263 Identities=20% Similarity=0.268 Sum_probs=200.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCC-----
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 104 (361)
..++|++.+.||+|+||.||+|.++.+|..||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 35889999999999999999999999999999999865432 23456889999999999999999999997653
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 105 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 105 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++| ++||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 7999999975 46999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh----
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL---- 258 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 258 (361)
++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 174 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 174 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99863221 233568999999999877 67999999999999999999999999876543332211110000
Q ss_pred h-ccc---------cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 259 F-QDR---------TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 259 ~-~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+ ... ..........+ ....+..+..+.+|+.+||..||++|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 000 00000000000 11122345588999999999999999999999973
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=334.18 Aligned_cols=271 Identities=14% Similarity=0.166 Sum_probs=203.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCC-----CeEEEEEEeccCCccc-----------hHHHHHHHHHHhcCCCCccce
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQG-----------NREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~ 95 (361)
..++|++.+.||+|+||.||+|.++.+ +..||+|++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999764 5789999986543211 122345666777888999999
Q ss_pred eeeEEEcC----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 96 LIGYCADG----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 96 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99998664 4579999999 8999999976 2367999999999999999999999999 9999999999999
Q ss_pred c--CCCceeEecccccccCCCCCC-----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccch
Q 018100 172 D--RGYHPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 244 (361)
Q Consensus 172 ~--~~~~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~ 244 (361)
+ .++.++|+|||++........ ........||..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 889999999999975322111 111123458999999999999999999999999999999999999998533
Q ss_pred HHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 245 AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
....... .....+... .....++.+. ....+..+.+++..||+.||.+||++.+|++.|+.+...
T Consensus 266 ~~~~~~~--~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 266 KDPKYVR--DSKIRYREN--IASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp TCHHHHH--HHHHHHHHC--HHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCHHHHH--HHHHHhhhh--HHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 2211110 000000000 0000000000 012234788899999999999999999999999877654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=321.50 Aligned_cols=260 Identities=28% Similarity=0.379 Sum_probs=204.9
Q ss_pred CcccCCeecccCceEEEEEEECCCCe---EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee-EEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLV 109 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~---~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv 109 (361)
.|.+.+.||+|+||.||+|.+..++. .|++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999999755443 799999875433 2346788999999999999999999999766555 999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
+||+.+++|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999975 2456899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCC--CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCc-cccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGD--NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA-VDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
... .........++..|+|||.+.+..++.++||||||+++|+|++|..| |................
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---------- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC----------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC----------
Confidence 221 11122234578899999999999999999999999999999995554 54332222111111000
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 01112223447889999999999999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=323.16 Aligned_cols=255 Identities=26% Similarity=0.347 Sum_probs=203.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
....++|++.+.||+|+||.||+|.++.+|..|++|.+.... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 345688999999999999999999999999999999987542 346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++... ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999999999998631 467999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. ........++..|+|||++.+..++.++||||||+++|+|++|..||.............. .. .
T Consensus 177 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~--~---- 242 (314)
T 3com_A 177 DT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------NP--P---- 242 (314)
T ss_dssp TT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------SC--C----
T ss_pred hh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc------CC--C----
Confidence 21 1222334688999999999988999999999999999999999999976543322111100 00 0
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+...+..+.+++.+||..||.+||++.++++.
T Consensus 243 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 243 ---PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001122234578899999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=322.12 Aligned_cols=267 Identities=22% Similarity=0.262 Sum_probs=205.3
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEE-EcCCeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLV 109 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 109 (361)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+..|+.+++.++|++++..+..+ ......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 456899999999999999999999999999999998754432 23577899999999887776666555 677888999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE---cCCCceeEecccccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAK 186 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv---~~~~~~~L~Dfg~~~ 186 (361)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.++|+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 89999998742 356999999999999999999999999 9999999999999 788999999999997
Q ss_pred cCCCCCCc-----ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hhhhc
Q 018100 187 LGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQ 260 (361)
Q Consensus 187 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~ 260 (361)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|..||............... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 64332221 1223456899999999999999999999999999999999999999764322111111110 00000
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
. ..+..... .+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 237 ~-------~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 237 T-------PIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp S-------CHHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred c-------hhhhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0 00011112 2347889999999999999999999999999887643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.20 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=169.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcC-----Ce
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 105 (361)
.++|++.+.||+|+||.||+|.++.++..||||++..... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5899999999999999999999999999999999975422 2346788999999999999999999999765 57
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 799999976 567999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc--------------------ceeeccccCcCcCCchhh-ccCCCCccCceehhhHHHHHHhhCCCcc
Q 018100 186 KLGPVGDNT--------------------HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAV 240 (361)
Q Consensus 186 ~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~~l~~ll~g~~pf 240 (361)
......... .......||..|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 864322111 112446789999999986 5567999999999999999999854444
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=350.54 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=208.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.++.+|..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 577999999999999999999999999999999986431 23345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||++||+|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999987532 345999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh-hhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..+......
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----------- 403 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------- 403 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-----------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-----------
Confidence 221 22335799999999999998899999999999999999999999976432111 111111100
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTA 309 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~ 309 (361)
....++...+..+.+||.+||+.||.+|| ++.++++.
T Consensus 404 ----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 ----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00112233445888999999999999999 78888753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=321.43 Aligned_cols=266 Identities=22% Similarity=0.264 Sum_probs=209.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEE-EcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 110 (361)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ..+...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 35799999999999999999999999999999999865432 35688999999999988766665554 6677889999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE---cCCCceeEeccccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv---~~~~~~~L~Dfg~~~~ 187 (361)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.++|+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 89999999742 356999999999999999999999999 9999999999999 4888999999999876
Q ss_pred CCCCCCc-----ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hhhhcc
Q 018100 188 GPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQD 261 (361)
Q Consensus 188 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 261 (361)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|..||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 4332221 1123456899999999999999999999999999999999999999764321111111100 000000
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
..+.... ..+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 238 -------~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 238 -------PIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -------CHHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------chHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0001111 22347889999999999999999999999999877643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=340.28 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=195.9
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhcCCCCccceeeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCA 101 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 101 (361)
..+.++|++.+.||+|+||.||+|.++.++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4567899999999999999999999999999999999864321 11234788999999999999999999986
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC---cee
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPK 178 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~---~~~ 178 (361)
. ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++ .+|
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 5 467999999999999998876 567999999999999999999999999 99999999999997544 599
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhcc---CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
|+|||++..... ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ....
T Consensus 283 l~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i 357 (419)
T 3i6u_A 283 ITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQI 357 (419)
T ss_dssp ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHH
T ss_pred EeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHH
Confidence 999999985322 222334568999999999853 57889999999999999999999999754221110 0000
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. ......+.... ..+..+.+++.+||+.||++||++.++++.
T Consensus 358 ~~-------~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TS-------GKYNFIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HT-------TCCCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hc-------CCCCCCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000111111 123478899999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=326.30 Aligned_cols=271 Identities=23% Similarity=0.311 Sum_probs=204.7
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC--CCCccceeeeEEEc
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL--HHPNLVNLIGYCAD 102 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~ 102 (361)
+...-..+.++|++.+.||+|+||.||+|.+. +..||+|++... .......|.+++..+ +||||+++++++..
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 33444566799999999999999999999986 899999998543 233445566665554 89999999999987
Q ss_pred C----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCeeecCCCCCcEE
Q 018100 103 G----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK--------AKPPVIYRDLKCSNIL 170 (361)
Q Consensus 103 ~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~~i~H~dl~p~Nil 170 (361)
. ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + ++||||||+||+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil 174 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL 174 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence 7 788999999999999999975 4699999999999999999999998 8 999999999999
Q ss_pred EcCCCceeEecccccccCCCCCCcc--eeeccccCcCcCCchhhccCCCCcc------CceehhhHHHHHHhhC------
Q 018100 171 LDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTGQLTLK------SDVYSFGVVLLEILSG------ 236 (361)
Q Consensus 171 v~~~~~~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------sDiwslG~~l~~ll~g------ 236 (361)
++.++.+||+|||++.......... ......|+..|+|||++.+...+.. +|||||||++|+|++|
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 9999999999999986532222111 1123468999999999987766655 9999999999999999
Q ss_pred ----CCccccchHHHh--hhHHHhhhhhhccccccccccCcccc-CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 237 ----RKAVDTSKAAAE--QSLVAWARPLFQDRTRHSLIADPELQ-GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 237 ----~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..||........ ....... .. ... .+... ......++..+.+++.+||+.||++|||+.++++.
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~----~~----~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIV----CI----KKL-RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHH----TT----SCC-CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccccHhhhcCCCCchhhhHHHH----hh----hcc-CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 555543211100 0000000 00 000 00000 01123567789999999999999999999999999
Q ss_pred HHHHHhcc
Q 018100 310 LAYLASQK 317 (361)
Q Consensus 310 l~~l~~~~ 317 (361)
|+.+....
T Consensus 326 L~~l~~~~ 333 (337)
T 3mdy_A 326 LAKMSESQ 333 (337)
T ss_dssp HHHHHHTT
T ss_pred HHHHHhhc
Confidence 99887643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=335.93 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=207.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4789999999999999999999999999999999875432 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|+++++|.+++.. ...+++..++.++.||+.||.|||++ + ++|+||||+||+++.++.++|+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999976 45799999999999999999999996 8 99999999999999999999999998864211
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh-----hhc---cc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-----LFQ---DR 262 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~---~~ 262 (361)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||................. ... ..
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 112234689999999999999999999999999999999999999976554332211100000 000 00
Q ss_pred cc------------------cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 263 TR------------------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 263 ~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
.. .................+..+.+||.+||+.||++|||+.++++.-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00 0000000000000112345788999999999999999999999743
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=347.86 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=208.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+..|+.+++.++||||+.+++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999999999999999986432 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||++|++|.+++.........+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999998765444567999999999999999999999999 9999999999999999999999999997633
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH-hhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+.... ...
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~~------- 408 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LEQ------- 408 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HHC-------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hhc-------
Confidence 221 12233579999999999999999999999999999999999999997643210 01111100 000
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI-----ADVVT 308 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~ll~ 308 (361)
...++...+..+.+||.+||+.||.+||++ .++++
T Consensus 409 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 -----AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 011233344588899999999999999975 55653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=318.99 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=202.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
.+|.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999999999999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEecccccccCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Dfg~~~~~~~~~ 192 (361)
++++|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||++......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 9999999997632 1345789999999999999999999999 999999999999987 899999999998753221
Q ss_pred CcceeeccccCcCcCCchhhccC--CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
........++..|+|||++.+. .++.++||||||+++|+|++|..||............. ....
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~---------- 242 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---GMFK---------- 242 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---HHHC----------
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---cccc----------
Confidence 1122345689999999998764 37899999999999999999999996543222111100 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+...+..+.+++.+||+.||++||++.++++
T Consensus 243 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 --VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011122334457889999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=322.93 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=205.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEE-EcCCee
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQR 106 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 106 (361)
...+|++.+.||+|+||.||+|.+..+ ...|++|.+..... ...+.+.+|+.+++.++||||+++++++ ..+...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 356799999999999999999997543 34689999875433 2346788999999999999999999986 456678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999965 2456899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCC--cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 187 LGPVGDN--THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 187 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
....... ........++..|+|||.+.+..++.++||||||+++|+|++ |.+||...............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 248 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--------
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--------
Confidence 5332211 111223456788999999999999999999999999999999 56666544322211111000
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
. ....+...+..+.+++.+||+.||++||++.++++.|+.+...-
T Consensus 249 --~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 --R-------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --C-------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00111223347889999999999999999999999999887643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=328.71 Aligned_cols=270 Identities=22% Similarity=0.301 Sum_probs=204.6
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEc--------
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 102 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 102 (361)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47899999999999999999999999999999998654332 24567899999999999999999999876
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
....++||||++ ++|.+.+... ...+++..++.++.||+.||.|||++| ++||||||+|||++.++.++|+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 446899999997 5777776542 356999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCC--cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhh
Q 018100 183 GLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 183 g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||...................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99876432211 122234568999999999876 457999999999999999999999998765544333222211100
Q ss_pred c-----cccccccccCccccC--CCC-hH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 260 Q-----DRTRHSLIADPELQG--QYP-PR------GFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 260 ~-----~~~~~~~~~~~~~~~--~~~-~~------~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ............... ... .. ....+.+||.+||+.||++|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 000000000000000 000 00 13457889999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=327.06 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=203.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++.+.||+|+||.||+|.+..++..|++|++........+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45899999999999999999999999999999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++++|.+++... ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK- 169 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc-
Confidence 99999999988652 356999999999999999999999999 99999999999999999999999998643110
Q ss_pred CCcceeeccccCcCcCCchhh-----ccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.........++..|+|||++ .+..++.++||||||+++|+|++|..||............ ... . ..
T Consensus 170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~----~--~~ 240 (302)
T 2j7t_A 170 -TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AKS----D--PP 240 (302)
T ss_dssp -HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHS----C--CC
T ss_pred -cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--hcc----C--Cc
Confidence 01112234688999999998 3567889999999999999999999999765433221111 000 0 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
....+...+..+.+++.+||+.||++|||+.++++
T Consensus 241 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112233457889999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=334.74 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=194.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEE-------
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCA------- 101 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~------- 101 (361)
.....+|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++..+. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 445679999999999999999999999999999999987665555677899999999996 999999999983
Q ss_pred -cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEe
Q 018100 102 -DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 180 (361)
Q Consensus 102 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~ 180 (361)
.....++|+||+. |+|.+++..... ...+++..++.++.||+.||.|||+++ ++++|+||||+|||++.++.++|+
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 3445789999996 899888865332 356999999999999999999999875 239999999999999999999999
Q ss_pred cccccccCCCCCCcc----------eeeccccCcCcCCchhh---ccCCCCccCceehhhHHHHHHhhCCCccccchHHH
Q 018100 181 DFGLAKLGPVGDNTH----------VSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 247 (361)
|||++.......... ......++..|+|||++ .+..++.++|||||||++|+|++|..||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999997643221111 11134588999999998 56678999999999999999999999996532211
Q ss_pred hhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 248 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.. .. ..........+..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus 261 ~~------~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 IV------NG--------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hh------cC--------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 00 0000001111225778999999999999999999999999887643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=330.77 Aligned_cols=251 Identities=30% Similarity=0.393 Sum_probs=204.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.+..++..||||++...... ..+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999999999999999998754332 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+. |+|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 7888877542 357999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
. .....|+..|+|||++. +..++.++|||||||++|+|++|..||............ .. ..
T Consensus 206 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--~~----~~---- 269 (348)
T 1u5q_A 206 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ----NE---- 269 (348)
T ss_dssp S------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH----SC----
T ss_pred C------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--Hh----cC----
Confidence 2 12346899999999984 567899999999999999999999999765433221111 10 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 312 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~ 312 (361)
.+.. .+...+..+.++|.+||+.||++|||+.++++....
T Consensus 270 ---~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 270 ---SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp ---CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ---CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 0000 011233478889999999999999999999975443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.44 Aligned_cols=266 Identities=21% Similarity=0.267 Sum_probs=197.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCC-----
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 104 (361)
..++|++.+.||+|+||.||+|.+..++..||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 35899999999999999999999999999999999875422 23456889999999999999999999997654
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 105 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 105 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
..|+||||++ ++|.+++. ..+++..+..++.||+.||.|||++| ++||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999997 67888875 34899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH-hhh------
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WAR------ 256 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~------ 256 (361)
++..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||............. ...
T Consensus 173 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 173 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp C-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred ccccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9975322 112234568999999999999899999999999999999999999997765432221110 000
Q ss_pred ---------hhhcccccccccc----Ccccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 257 ---------PLFQDRTRHSLIA----DPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 257 ---------~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
............. .+... .......+..+.+||.+||+.||++|||+.++++.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000000000000 00000 000112356789999999999999999999999743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=336.81 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=208.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC-CccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.++|++.+.||+|+||.||+|.+..++..||||++...... ..+..|+.+++.++| +++..+..++......++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999999999999999987654332 457889999999986 56666666677888999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE---cCCCceeEeccccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv---~~~~~~~L~Dfg~~~~ 187 (361)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++..
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 89999999752 356999999999999999999999999 9999999999999 6889999999999976
Q ss_pred CCCCCCc-----ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh-hhhcc
Q 018100 188 GPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQD 261 (361)
Q Consensus 188 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 261 (361)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|..||..............+. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 4332221 11224578999999999999999999999999999999999999997644322221111111 00000
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
. ...+...+ +.++.+++..||+.||++||++.+|++.|+.+..
T Consensus 236 ~-------~~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 236 S-------IEALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp C-------HHHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred c-------HHHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0 00111122 3478899999999999999999999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=322.02 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=192.5
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.++...++.++||||+++++++.++...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4589999999999999999999999999999999987543221 23344555567888999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
|||++ ++|.+++......+..+++..++.++.||+.||.|||++ | ++||||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 688887765433467899999999999999999999998 9 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccCcCcCCchhh----ccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYA----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
... .......++..|+|||++ .+..++.++|||||||++|+|++|..||.......... ...... .
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~----~-- 230 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQVVEE----P-- 230 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH-HHHHHS----C--
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH-HHHhcc----C--
Confidence 222 222334689999999996 45678999999999999999999999997533221111 111100 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.. .....+..+.+++.+||+.||++|||+.++++.
T Consensus 231 -----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 231 -----SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -----CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -----CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 0000 011234478899999999999999999999973
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=354.60 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=209.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 107 (361)
..++|++++.||+|+||.||+|.++.+++.||||++... .....+.+..|..++..+ +||+|+.+++++.+...+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999998643 223456788899999987 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999986 467999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ...
T Consensus 492 ~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~------ 557 (674)
T 3pfq_A 492 NIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEH------ 557 (674)
T ss_dssp CCC--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HSS------
T ss_pred ccc--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------HhC------
Confidence 222 122234567999999999999999999999999999999999999999875443222111 110
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI-----ADVVT 308 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~ll~ 308 (361)
...++...+.++.+||.+||+.||++||++ ++|++
T Consensus 558 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 012233445588999999999999999997 66654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=325.31 Aligned_cols=260 Identities=17% Similarity=0.224 Sum_probs=202.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEc--CCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv 109 (361)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47899999999999999999999999999999998643 3567889999999997 9999999999987 6778999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEecccccccC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLG 188 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~~~~ 188 (361)
|||+++++|.+++.. +++..++.++.||+.||.|||++| ++||||||+|||++.++ .++|+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999864 899999999999999999999999 99999999999999777 8999999999753
Q ss_pred CCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhh--hHHHhhh--hhhcccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLVAWAR--PLFQDRT 263 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~--~~~~~~~ 263 (361)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .+..... .......
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 3222 2233468899999999877 67899999999999999999999999543221111 0000000 0000000
Q ss_pred ccc----------------cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 264 RHS----------------LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 264 ~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
... ...........+...+..+.+||.+||+.||++|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000000111112224568899999999999999999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=340.29 Aligned_cols=249 Identities=15% Similarity=0.160 Sum_probs=192.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHH---HHhcCCCCccceee-------eE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVL---MLSLLHHPNLVNLI-------GY 99 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~ 99 (361)
.++|++.+.||+|+||.||+|.++.+|+.||||++... .....+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47799999999999999999999988999999999743 3334567889995 45555799999988 66
Q ss_pred EEcCC-----------------eeEEEEEecCCCCHHHHhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018100 100 CADGD-----------------QRLLVYEYMPLGSVEDHLHDLS---PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159 (361)
Q Consensus 100 ~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 159 (361)
+.+.+ ..|+||||+ +|+|.+++.... .....+++..++.++.||+.||.|||++| |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 589999997521 11123445888999999999999999999 9
Q ss_pred eecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccC-----------CCCccCceehhhH
Q 018100 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----------QLTLKSDVYSFGV 228 (361)
Q Consensus 160 ~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDiwslG~ 228 (361)
+||||||+|||++.++.+||+|||++.... .......| ..|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999997521 12334567 999999999877 8999999999999
Q ss_pred HHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 229 VLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 229 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
++|+|++|..||........... .. . .....+..+.+||.+||+.||++||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~------~~------------~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW------IF------------R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG------GG------------S----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhh------hh------------h----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999965432111000 00 0 01122347889999999999999999999996
Q ss_pred --HHHHH
Q 018100 309 --ALAYL 313 (361)
Q Consensus 309 --~l~~l 313 (361)
.+..+
T Consensus 360 hp~f~~~ 366 (377)
T 3byv_A 360 TPEYEQL 366 (377)
T ss_dssp SHHHHHH
T ss_pred ChHHHHH
Confidence 44443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=329.38 Aligned_cols=260 Identities=16% Similarity=0.148 Sum_probs=208.2
Q ss_pred HHHhhCcccCCeecccCceEEEEEE-----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC---CCccceeeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCA 101 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 101 (361)
....++|++.+.||+|+||.||+|. +..++..||+|++... ....+..|+.++..++ |+||+.+++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3446789999999999999999994 6667999999998654 3456777888887776 899999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-------
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR------- 173 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~------- 173 (361)
.++..|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 99999999999999999999975322 2467999999999999999999999999 999999999999998
Q ss_pred ----CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh
Q 018100 174 ----GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249 (361)
Q Consensus 174 ----~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~ 249 (361)
++.+||+|||++................||..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 89999999999965333333344455679999999999999999999999999999999999999986432210
Q ss_pred hHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHHHhcc
Q 018100 250 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR-PVIADVVTALAYLASQK 317 (361)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-ps~~~ll~~l~~l~~~~ 317 (361)
.. . ...+ ... .....+.+++..||+.+|.+| |++.++.+.|+.+....
T Consensus 293 ---------~~----~----~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ---------CK----P----EGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ---------EE----E----CSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------ee----e----chhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00 0 0000 111 123466789999999999988 57888888888776654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=329.70 Aligned_cols=267 Identities=17% Similarity=0.190 Sum_probs=206.4
Q ss_pred hhCcccCCeecccCceEEEEEEECC--------CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccce---------
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES--------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN--------- 95 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--------- 95 (361)
.++|++.+.||+|+||.||+|.+.. .+..||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999987 3889999998643 45788999999999999887
Q ss_pred ------eeeEEEc-CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 96 ------LIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 96 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 5666665 77889999999 899999998631 367999999999999999999999999 9999999999
Q ss_pred EEEcCCC--ceeEecccccccCCCCCC-----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccc
Q 018100 169 ILLDRGY--HPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 241 (361)
Q Consensus 169 ilv~~~~--~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~ 241 (361)
|+++.++ .++|+|||++........ ........|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999975322111 111233478999999999999899999999999999999999999997
Q ss_pred cchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 242 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
........ +........... ....... ......+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 270 ~~~~~~~~-~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 270 NCLPNTED-IMKQKQKFVDKP---GPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp GGTTCHHH-HHHHHHHHHHSC---CCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCcCHHH-HHHHHHhccCCh---hhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 65321111 111111100000 0000000 000122347889999999999999999999999999887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=330.83 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=188.7
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcC------
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 103 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 103 (361)
..++|++.+.||+|+||.||+|.+..+|..||||++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 35899999999999999999999999999999999865422 2346688999999999999999999998654
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
...|+|++++ +++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999998 6899888864 56999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hhh---
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPL--- 258 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~--- 258 (361)
++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ...
T Consensus 178 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 178 LARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9975321 1233568999999999877 67899999999999999999999999876543332221110 000
Q ss_pred -hcccc---------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 259 -FQDRT---------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 259 -~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..... .........+ ....+..+..+.+||.+||..||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCH-HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCH-HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 0000000000 00011224478899999999999999999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=331.17 Aligned_cols=263 Identities=26% Similarity=0.390 Sum_probs=199.0
Q ss_pred hCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEE-cCCeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 108 (361)
..|++.+.||+|+||.||+|.+..+ +..|++|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3477889999999999999997543 3468999986532 234567899999999999999999999875 4567899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999975 2356899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCc--ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 189 PVGDNT--HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 189 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||.............. .
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~----------~ 312 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----------G 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT----------T
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc----------C
Confidence 222111 11223456778999999999999999999999999999999 6778865432211111100 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhccCC
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 319 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~~~ 319 (361)
.. ...+...+..+.+++.+||+.||++||++.++++.|+.+...-..
T Consensus 313 ~~-------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 313 RR-------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CC-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 00 011223345788999999999999999999999999988765443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=322.46 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=199.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCC-C--eEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI-N--QDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~-~--~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|.+... + ..|++|++.... ....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 57899999999999999999987432 2 368999986542 233467889999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++|+||+++++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999998752 246899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 187 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 187 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||............. ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~-- 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEG-- 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSC--
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH------ccC--
Confidence 643322211 1223456778999999988889999999999999999999 999997654432211110 000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.....+...+..+.+++.+||..||.+||++.++++.|+.+....
T Consensus 242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 001112233457889999999999999999999999998876543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=326.84 Aligned_cols=269 Identities=24% Similarity=0.288 Sum_probs=204.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcC-----Ce
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 105 (361)
..++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 357999999999999999999999999999999999754322 336788999999999999999999998654 46
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.|+|+||+. ++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 699999875 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCC-cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh-hhhhhccc
Q 018100 186 KLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQDR 262 (361)
Q Consensus 186 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 262 (361)
........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.............. ........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 75322211 111233578999999998754 5589999999999999999999999976544332221110 00000000
Q ss_pred c--------cc--ccccC--ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 T--------RH--SLIAD--PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~--------~~--~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .. ..... ........+..+..+.+||.+||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 00000 000000112234578899999999999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.42 Aligned_cols=277 Identities=21% Similarity=0.236 Sum_probs=198.3
Q ss_pred eHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 25 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
...+.....++|++.+.||+|+||.||+|.++.++..||||++.... ........++..+..++||||+++++++....
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34566777899999999999999999999999999999999986432 33455677888888899999999999986533
Q ss_pred e-------eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeecCCCCCcEEEcC-C
Q 018100 105 Q-------RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKAKPPVIYRDLKCSNILLDR-G 174 (361)
Q Consensus 105 ~-------~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~i~H~dl~p~Nilv~~-~ 174 (361)
. .++||||++ ++|...+.........+++..++.++.||+.||.||| ++| |+||||||+|||++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCC
Confidence 2 789999997 5665555433333677999999999999999999999 999 999999999999997 8
Q ss_pred CceeEecccccccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH
Q 018100 175 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253 (361)
Q Consensus 175 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~ 253 (361)
+.++|+|||++...... .......|+..|+|||++.+. .++.++|||||||++|+|++|..||.............
T Consensus 169 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TEEEECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CcEEEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 99999999999753322 222345689999999998664 48999999999999999999999998765433322111
Q ss_pred h-hhh----hhc----cccccc-----cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 254 W-ARP----LFQ----DRTRHS-----LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 254 ~-~~~----~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. ... .+. ...... ...-...........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 000 000 000000 0000011122233356789999999999999999999999963
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=323.53 Aligned_cols=274 Identities=23% Similarity=0.329 Sum_probs=210.7
Q ss_pred eeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--CCCCccceeeeEEE
Q 018100 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCA 101 (361)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~ 101 (361)
.+...-..+.++|++.+.||+|+||.||+|.+. ++.||+|++... ....+..|+.++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344455667799999999999999999999984 899999998643 34567788888877 78999999999998
Q ss_pred cCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCcE
Q 018100 102 DGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNI 169 (361)
Q Consensus 102 ~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~i~H~dl~p~Ni 169 (361)
... ..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +++ ++||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 775 78999999999999999975 46999999999999999999999 888 99999999999
Q ss_pred EEcCCCceeEecccccccCCCCCCcc--eeeccccCcCcCCchhhccC------CCCccCceehhhHHHHHHhhC-----
Q 018100 170 LLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG----- 236 (361)
Q Consensus 170 lv~~~~~~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~~l~~ll~g----- 236 (361)
+++.++.++|+|||++.......... ......|+..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999987533322111 12344689999999999765 234789999999999999999
Q ss_pred -----CCccccchHHHhhhHHHhhhhhhccccccccccCccccC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 237 -----RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG-QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 237 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
..||......... ...+....... ...+.+.. ......+..+.+|+.+||+.||++||++.++++.|
T Consensus 259 ~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPS-VEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp BCCCCCCTTTTTSCSSCC-HHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCccccCcCccc-HHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 6777543211000 00000000000 00011100 01235667889999999999999999999999999
Q ss_pred HHHHhcc
Q 018100 311 AYLASQK 317 (361)
Q Consensus 311 ~~l~~~~ 317 (361)
+.+..+.
T Consensus 332 ~~i~~~~ 338 (342)
T 1b6c_B 332 SQLSQQE 338 (342)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9987653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=329.95 Aligned_cols=275 Identities=22% Similarity=0.249 Sum_probs=203.0
Q ss_pred eeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc-----------hHHHHHHHHHHhcCCCCc
Q 018100 24 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----------NREFLVEVLMLSLLHHPN 92 (361)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~ 92 (361)
..+.++..+.++|++.+.||+|+||.||+|.+.. +..||||++....... .+.+.+|+.+++.++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 4567888999999999999999999999999876 8999999986432221 267889999999999999
Q ss_pred cceeeeEEEc-----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 018100 93 LVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 167 (361)
Q Consensus 93 i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~ 167 (361)
|+++++++.. ....|+||||+. ++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 163 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPG 163 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChH
Confidence 9999999843 346899999997 788888764 2457999999999999999999999999 999999999
Q ss_pred cEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHH
Q 018100 168 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 246 (361)
Q Consensus 168 Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~ 246 (361)
||+++.++.++|+|||++..... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999974222 222334568899999999876 67899999999999999999999999875543
Q ss_pred HhhhHH-Hhhhhh------------hcccc-ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 247 AEQSLV-AWARPL------------FQDRT-RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 247 ~~~~~~-~~~~~~------------~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...... ...... ..... ...............+..+..+.+||.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 322211 110000 00000 0000000000001112234578899999999999999999999963
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=347.22 Aligned_cols=260 Identities=29% Similarity=0.411 Sum_probs=210.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+...++|++.+.||+|+||.||+|.++. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+ ...++|
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 4456789999999999999999999986 5679999997543 345789999999999999999999999876 678999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++++|.+++.... +..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 340 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp ECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999997522 346899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...........+. . .
T Consensus 415 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~---~----~------ 480 (535)
T 2h8h_A 415 DNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R----G------ 480 (535)
T ss_dssp CHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH---T----T------
T ss_pred CCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c----C------
Confidence 110 111122345678999999998999999999999999999999 999997654332221111 0 0
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.....+..++..+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 481 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 481 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0111223345588899999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.32 Aligned_cols=265 Identities=25% Similarity=0.285 Sum_probs=198.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc------CCeeE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRL 107 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~ 107 (361)
.+|++.+.||+|+||.||+|.++.+++.||||++..... ...+|+.+++.++||||+++++++.. ...++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 469999999999999999999999999999999864322 23469999999999999999998843 12367
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-CceeEecccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK 186 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-~~~~L~Dfg~~~ 186 (361)
+||||++ ++|.+.+.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 130 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 9999997 5777766543333578999999999999999999999999 9999999999999965 568999999997
Q ss_pred cCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-HHhhhh----hhc
Q 018100 187 LGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARP----LFQ 260 (361)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~----~~~ 260 (361)
...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........... ...... .+.
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 532221 22335689999999998764 789999999999999999999999987654332211 111000 000
Q ss_pred c-ccccccccCcccc-----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 261 D-RTRHSLIADPELQ-----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 261 ~-~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. .........+.+. ..+++..+.++.+||.+||..||.+||++.++++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0000000001100 01223345688999999999999999999999963
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=346.85 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=203.5
Q ss_pred CcccCC-eecccCceEEEEEEECC--CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 35 NFRSES-LLGEGGFGRVYKGYLES--INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 35 ~y~~~~-~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++.+.+ .||+|+||.||+|.++. ++..||||++..... ...+.+.+|+.+++.++||||+++++++.. ...++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 79999999999998753 467799999976433 356789999999999999999999999976 5689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999865 2456999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 191 GDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 191 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~------------- 555 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------- 555 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-------------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2211 11122335678999999999999999999999999999998 99999765443322111100
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.....+..++..+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 556 ----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 556 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0112233445688999999999999999999999999987654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=324.96 Aligned_cols=268 Identities=25% Similarity=0.387 Sum_probs=188.7
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
....++|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 455689999999999999999999998889999999986543 2334668889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 109 VYEYMPLGSVEDHLHDLS----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
||||+++++|.+++.... .....+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999986421 12456999999999999999999999999 99999999999999999999999998
Q ss_pred cccCCCCCC---cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhc
Q 018100 185 AKLGPVGDN---THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 260 (361)
Q Consensus 185 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 260 (361)
+........ ........++..|+|||++.+ ..++.++||||||+++|+|++|..||............ ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~ 245 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQNDPP 245 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HTSSCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hccCCC
Confidence 865322211 111233468999999999865 56899999999999999999999999765432221111 000000
Q ss_pred cccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 261 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.......++... ...+..+.+++.+||+.||.+||++.++++
T Consensus 246 --~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 --SLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --CTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --ccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000001111111 223347889999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=327.90 Aligned_cols=273 Identities=25% Similarity=0.356 Sum_probs=197.1
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHH--HhcCCCCccceeeeEEEc-----CC
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM--LSLLHHPNLVNLIGYCAD-----GD 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~ 104 (361)
..++|++.+.||+|+||.||+|.+ ++..||||++... ....+..|..+ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 358999999999999999999977 4899999998643 23334444444 445899999999975532 33
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCeeecCCCCCcEEEcCCC
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK---------AKPPVIYRDLKCSNILLDRGY 175 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~~i~H~dl~p~Nilv~~~~ 175 (361)
..++||||+++++|.+++.. ...++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTS
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCC
Confidence 56899999999999999975 4468999999999999999999999 8 99999999999999999
Q ss_pred ceeEecccccccCCCCC------CcceeeccccCcCcCCchhhcc-------CCCCccCceehhhHHHHHHhhCCCcccc
Q 018100 176 HPKLSDFGLAKLGPVGD------NTHVSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILSGRKAVDT 242 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~~l~~ll~g~~pf~~ 242 (361)
.+||+|||++....... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999997633221 1111223468999999999976 3566789999999999999999777643
Q ss_pred chHHHhhh-HHH---hhhhhhccc--cccccccCcccc--CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 243 SKAAAEQS-LVA---WARPLFQDR--TRHSLIADPELQ--GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 243 ~~~~~~~~-~~~---~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
........ ... ...+.+... ........+.+. .......+..+.+||.+||+.||++|||+.++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 22110000 000 000000000 000000001111 1112346668999999999999999999999999999888
Q ss_pred hcc
Q 018100 315 SQK 317 (361)
Q Consensus 315 ~~~ 317 (361)
..-
T Consensus 318 ~~~ 320 (336)
T 3g2f_A 318 MIW 320 (336)
T ss_dssp HCC
T ss_pred HHH
Confidence 643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=315.61 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=207.8
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
.-..+.++|++.+.||+|+||.||+|.++.+++.|++|++.... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 34566789999999999999999999999999999999986432 3345778999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC---CceeEecc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDF 182 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~---~~~~L~Df 182 (361)
.++|+||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.+ +.++|+||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999998876 456999999999999999999999999 9999999999999764 46999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
|++....... ......++..|+|||++.+ .++.++||||||+++|+|++|..||.............. ..+
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~--- 239 (287)
T 2wei_A 169 GLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKY--- 239 (287)
T ss_dssp TGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC---
T ss_pred CcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC---
Confidence 9987533221 1223357889999999865 489999999999999999999999976544322211110 000
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
........ ..+..+.+++.+||+.||++|||+.++++.
T Consensus 240 -----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 -----AFDLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -----CCCSGGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----CCCchhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00000111 223478899999999999999999999973
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=318.04 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=201.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEc----CCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 106 (361)
.+.|++.+.||+|+||.||+|.+..++..|++|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 455899999999999999999999999999999986542 2344678899999999999999999998865 4568
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc-CCCceeEeccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLA 185 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~-~~~~~~L~Dfg~~ 185 (361)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++++|+||||+||+++ .++.++|+|||++
T Consensus 105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999999976 467999999999999999999999885 2399999999999998 7899999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
...... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||............ ... .
T Consensus 180 ~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~----~--- 245 (290)
T 1t4h_A 180 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTS----G--- 245 (290)
T ss_dssp GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTT----T---
T ss_pred cccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH--Hhc----c---
Confidence 753221 2233468999999998864 5899999999999999999999999764332221100 000 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........ ..+..+.+++.+||+.||.+|||+.++++
T Consensus 246 --~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 --VKPASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CCCGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCccccCC----CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00011111 12237889999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=319.68 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=203.9
Q ss_pred HHhhCcccCCeecccCceEEEEEEEC-CCCeEEEEEEeccCCc--cchHHHHHHHHHHhcC---CCCccceeeeEEE---
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLE-SINQDVAIKQLDRNGV--QGNREFLVEVLMLSLL---HHPNLVNLIGYCA--- 101 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~--- 101 (361)
.+.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45689999999999999999999995 6789999999864322 2223566777777665 8999999999987
Q ss_pred --cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeE
Q 018100 102 --DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 179 (361)
Q Consensus 102 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L 179 (361)
.....++||||++ ++|.+++.... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEE
Confidence 5567899999997 79999987633 345999999999999999999999999 999999999999999999999
Q ss_pred ecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH-hhhh-
Q 018100 180 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WARP- 257 (361)
Q Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~- 257 (361)
+|||++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||............. ....
T Consensus 162 ~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 162 ADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999875321 122234568999999999998899999999999999999999999998765433222111 1000
Q ss_pred ---hhccccc----cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 258 ---LFQDRTR----HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 258 ---~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+..... ............+.+..+..+.+|+.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 00000000011122334557889999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=323.69 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=199.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEE----------
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA---------- 101 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------- 101 (361)
+.++|++.+.||+|+||.||+|.+..+++.|++|++........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999999999999999997666556678899999999999999999999873
Q ss_pred ----cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc-CCCc
Q 018100 102 ----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYH 176 (361)
Q Consensus 102 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~-~~~~ 176 (361)
+....++||||++ ++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+||+++ .++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 3467899999997 799999864 56999999999999999999999999 99999999999997 5679
Q ss_pred eeEecccccccCCCCCC-cceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHh
Q 018100 177 PKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 254 (361)
++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||..............
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999975322111 111233457889999998865 6789999999999999999999999987654332221111
Q ss_pred hhhhhcccccc-----------ccccCcc-ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 255 ARPLFQDRTRH-----------SLIADPE-LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 255 ~~~~~~~~~~~-----------~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
..+........ .....+. ......+..+..+.++|.+||+.||++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000000000 0000000 0000112234578899999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=348.46 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=201.6
Q ss_pred CeecccCceEEEEEEE--CCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~--~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.+ +.++..||||++..... ...+.+.+|+.+++.++||||+++++++..+ ..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence 3799999999999955 45578999999975432 3357799999999999999999999999754 57899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC-c
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-T 194 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~-~ 194 (361)
++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++........ .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999976 567999999999999999999999999 99999999999999999999999999976433221 1
Q ss_pred ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+... .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-----------------~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----------------E 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------------C
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 12223346778999999999999999999999999999998 99999876544322222110 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
....+...+..+.+||.+||+.||++||++.+|++.|+.+-.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233345588999999999999999999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=333.01 Aligned_cols=204 Identities=22% Similarity=0.316 Sum_probs=175.7
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC------CCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------HHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 105 (361)
...+|++.+.||+|+||.||+|.+..++..||||++... ....+.+.+|+.+++.+ +|+||+.+++.+.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457899999999999999999999999999999998643 22335667788777766 57899999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc--eeEeccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFG 183 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~--~~L~Dfg 183 (361)
.++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 79999887632 345999999999999999999999999 999999999999999987 9999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 247 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 247 (361)
++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 98653221 223468999999999999999999999999999999999999998765443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=326.96 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=202.6
Q ss_pred ccCcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCC--CCccc
Q 018100 19 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH--HPNLV 94 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~ 94 (361)
.....++++.+....++|++.+.||+|+||.||+|.+.. +..||+|++..... ...+.+.+|+.++..++ |+||+
T Consensus 13 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 13 LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp -------CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred CCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence 344555666667778899999999999999999999865 88999999865432 23467889999999997 59999
Q ss_pred eeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC
Q 018100 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 174 (361)
Q Consensus 95 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~ 174 (361)
++++++.++...++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||++++
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD- 162 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence 99999999999999999 457999999986 567999999999999999999999999 999999999999965
Q ss_pred CceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc-----------CCCCccCceehhhHHHHHHhhCCCccccc
Q 018100 175 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTS 243 (361)
Q Consensus 175 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 243 (361)
+.++|+|||++................|+..|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 8999999999976433222222334568999999999865 46888999999999999999999999754
Q ss_pred hHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 244 KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
...... +.... ++.....++...+..+.+++.+||+.||++||++.++++..
T Consensus 243 ~~~~~~-~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 243 INQISK-LHAII--------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CSHHHH-HHHHH--------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHH-HHHHH--------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 322111 11100 01111112222345788999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=320.62 Aligned_cols=265 Identities=18% Similarity=0.232 Sum_probs=206.4
Q ss_pred HhhCcccCCeecccCceEEEEEEE-CCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCC------ccceeeeEEEcCC
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYL-ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP------NLVNLIGYCADGD 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~ 104 (361)
+.++|++.+.||+|+||.||+|.+ +.++..||+|++... ....+.+.+|+.+++.++|+ +++.+++++.+..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 357999999999999999999998 567899999998643 23346688899998887654 5999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-----------
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----------- 173 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~----------- 173 (361)
..++||||+ +++|.+++.... ..++++..++.++.||+.||.|||+++ ++||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 799999987622 346899999999999999999999999 999999999999987
Q ss_pred --------CCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchH
Q 018100 174 --------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 245 (361)
Q Consensus 174 --------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 245 (361)
++.++|+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999998753221 2334689999999999998999999999999999999999999987654
Q ss_pred HHhhhHHHhhhhhhcc-----ccccccc---------------------cCccccCCCChHHHHHHHHHHHHcccCCCCC
Q 018100 246 AAEQSLVAWARPLFQD-----RTRHSLI---------------------ADPELQGQYPPRGFYQALAVAAMCVHEQPDM 299 (361)
Q Consensus 246 ~~~~~~~~~~~~~~~~-----~~~~~~~---------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 299 (361)
................ ....... .............+..+.+|+.+||+.||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 4333222111110000 0000000 0000011223455778999999999999999
Q ss_pred CCCHHHHHH
Q 018100 300 RPVIADVVT 308 (361)
Q Consensus 300 Rps~~~ll~ 308 (361)
|||+.++++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=329.50 Aligned_cols=265 Identities=18% Similarity=0.199 Sum_probs=203.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC--------CCccceeeeEEE--
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA-- 101 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~-- 101 (361)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 358999999999999999999999999999999998643 233467888999998885 788999999987
Q ss_pred --cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCC---
Q 018100 102 --DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGY--- 175 (361)
Q Consensus 102 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~--- 175 (361)
+....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 566889999999 577777665422 35699999999999999999999998 9 99999999999999775
Q ss_pred ----------------------------------------------ceeEecccccccCCCCCCcceeeccccCcCcCCc
Q 018100 176 ----------------------------------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209 (361)
Q Consensus 176 ----------------------------------------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (361)
.++|+|||++...... .....||..|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999753221 2334689999999
Q ss_pred hhhccCCCCccCceehhhHHHHHHhhCCCccccchHHH------hh-hHHHhhhh--------------hhccccccccc
Q 018100 210 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA------EQ-SLVAWARP--------------LFQDRTRHSLI 268 (361)
Q Consensus 210 E~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~------~~-~~~~~~~~--------------~~~~~~~~~~~ 268 (361)
|++.+..++.++|||||||++|+|++|..||....... .. .+...... .+.........
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 99999999999999999999999999999997543211 10 01110000 00000000000
Q ss_pred cCc---------cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 269 ADP---------ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 269 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
... ......+...+..+.+||.+||+.||++|||+.++++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 0011345666778999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=323.11 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=201.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCee---
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--- 106 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 106 (361)
+.++|.+.+.||+|+||.||+|.++.+|..||+|++...... ..+.+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 358999999999999999999999999999999999754332 246788999999999999999999999876654
Q ss_pred ---EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 107 ---LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 107 ---~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
++||||+. ++|.+++. ..+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 78888774 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhh----
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL---- 258 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 258 (361)
++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 190 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 190 LARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9975322 1233468999999999977 68899999999999999999999999876543322211110000
Q ss_pred hcccc----------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 259 FQDRT----------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 259 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+.... ......... .....+..+..+.+||.+||+.||++|||+.++++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCC-HHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchh-HHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 000000000 000112234588899999999999999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.41 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=196.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCC------e
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------Q 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~ 105 (361)
...+|++.+.||+|+||.||+|.+..++. |++|++...... ..+|+.+++.++||||+++++++.... .
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35689999999999999999999987655 888887543222 236999999999999999999985433 3
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc-CCCceeEecccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGL 184 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~-~~~~~~L~Dfg~ 184 (361)
.++||||+++ ++...+.........+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 7899999974 554444332223567999999999999999999999999 99999999999999 799999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-h------
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-R------ 256 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~------ 256 (361)
+....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||...........+... .
T Consensus 189 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 189 AKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 97532222 22345689999999998765 5899999999999999999999999876543332211110 0
Q ss_pred -----hhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 257 -----PLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 257 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+.+.. ..............+++..+.++.+||.+||+.||.+|||+.++++.
T Consensus 266 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYME-HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSS-SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhh-hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000 00000000011111223345588999999999999999999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=329.32 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=202.7
Q ss_pred hhCcccCCeecccCceEEEEEEEC---CCCeEEEEEEeccCC----ccchHHHHHHHHHHhcC-CCCccceeeeEEEcCC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNG----VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 104 (361)
.++|++.+.||+|+||.||+|.+. .++..||||++.... ....+.+.+|+.+++.+ +||||+.+++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 478999999999999999999984 478999999986432 12335567799999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999976 457999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCccccchHHHhh-hHHHhhhhhhcc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQD 261 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 261 (361)
+....... ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... .+.... ...
T Consensus 206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~ 281 (355)
T 1vzo_A 206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKS 281 (355)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HHC
T ss_pred CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---hcc
Confidence 87532211 112233568999999999975 35789999999999999999999999643221111 111000 000
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVTAL 310 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~l 310 (361)
. ..++...+..+.+||.+||..||.+|| ++.++++..
T Consensus 282 --------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 112233445788899999999999999 999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=325.22 Aligned_cols=265 Identities=19% Similarity=0.232 Sum_probs=203.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc-----------------hHHHHHHHHHHhcCCCCccce
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----------------NREFLVEVLMLSLLHHPNLVN 95 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~ 95 (361)
.++|++.+.||+|+||.||+|.+ ++..||+|++....... .+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 57999999999999999999999 69999999986432211 177899999999999999999
Q ss_pred eeeEEEcCCeeEEEEEecCCCCHHHH------hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCc
Q 018100 96 LIGYCADGDQRLLVYEYMPLGSVEDH------LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSN 168 (361)
Q Consensus 96 ~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~N 168 (361)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ +| ++|+||+|+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 433 114679999999999999999999999 99 9999999999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccC-CCCc-cCceehhhHHHHHHhhCCCccccchH-
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTL-KSDVYSFGVVLLEILSGRKAVDTSKA- 245 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDiwslG~~l~~ll~g~~pf~~~~~- 245 (361)
|+++.++.++|+|||++...... ......++..|+|||++.+. .++. ++|||||||++|+|++|..||.....
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999998753222 23445689999999999877 6666 99999999999999999999976543
Q ss_pred HHhhhHHHhhhhhhcccccccc-ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 246 AAEQSLVAWARPLFQDRTRHSL-IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.............+........ ..............+..+.+++.+||+.||.+||++.++++
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111000000000000000 00000000111234458889999999999999999999996
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=316.22 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=196.4
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc---------
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------- 102 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 102 (361)
+.++|++.+.||+|+||.||+|.+..++..|++|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 568899999999999999999999999999999998642 2334678899999999999999999998754
Q ss_pred ----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCcee
Q 018100 103 ----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 103 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 3567999999999999999975 1356889999999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCC------------cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchH
Q 018100 179 LSDFGLAKLGPVGDN------------THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 245 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 245 (361)
|+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999875322110 1112334688999999999764 68999999999999999998 5543221
Q ss_pred HHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 246 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. ........ . .......++...+..+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~--~~~~~~~~-------~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RV--NILKKLRS-------V----SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH--HHHHHHHS-------T----TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HH--HHHHhccc-------c----ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11 11111100 0 0111122334445578899999999999999999999963
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=322.05 Aligned_cols=269 Identities=22% Similarity=0.266 Sum_probs=203.6
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcC-----Ce
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 105 (361)
+.++|++.+.||+|+||.||+|.+..+|..||||++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 45899999999999999999999999999999999964332 2345678999999999999999999987654 67
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 799998875 46999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcc--------eeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh
Q 018100 186 KLGPVGDNTH--------VSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 256 (361)
Q Consensus 186 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 256 (361)
.......... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 7643221110 1123468999999998764 678999999999999999999999998765433222111100
Q ss_pred hhhccccccccccC----------ccc----cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 257 PLFQDRTRHSLIAD----------PEL----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 257 ~~~~~~~~~~~~~~----------~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.............. +.. .....+..+..+.+|+.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000 000 000112334578899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.83 Aligned_cols=255 Identities=11% Similarity=0.014 Sum_probs=183.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcC--CCCccceee-------eEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL--HHPNLVNLI-------GYC 100 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 100 (361)
..+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999976543 2235567775444443 699988754 454
Q ss_pred EcC-----------------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 018100 101 ADG-----------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR------MKIAAGAARGLEYLHDKAKP 157 (361)
Q Consensus 101 ~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~ 157 (361)
... ...|+||||++ ++|.+++.... ..++...+ +.++.||+.||.|||++|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 33799999998 89999997531 23444455 677899999999999999
Q ss_pred CeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhh
Q 018100 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILS 235 (361)
Q Consensus 158 ~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~ 235 (361)
|+||||||+|||++.++.+||+|||++..... ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999985321 1223456799999999987 679999999999999999999
Q ss_pred CCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 236 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 236 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
|..||.......... +... ...............+..+..+.+||.+||+.||++||++.++++
T Consensus 289 g~~Pf~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS--------WKRP-SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTC--------CCBC-CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccc--------hhhh-hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999997653211100 0000 000000111111112244558899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.96 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=200.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEcCCe-----
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 105 (361)
.++|.+.+.||+|+||.||+|.++.+|..||||++...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999999999999999999754322 24568899999999999999999999977654
Q ss_pred -eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 106 -RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 106 -~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
.|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++| ++||||||+||+++.++.++|+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 68877764 34999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh----hh
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP----LF 259 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----~~ 259 (361)
+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||................. .+
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8753211 223468999999999876 6789999999999999999999999987654332211110000 00
Q ss_pred ccc----------cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 260 QDR----------TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 260 ~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... ........ .......+..+..+.+||.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPR-KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSS-CCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCC-ccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000000 00112223445688999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.16 Aligned_cols=265 Identities=16% Similarity=0.212 Sum_probs=202.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-----------CCccceeeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCA 101 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 101 (361)
.++|++.+.||+|+||.||+|.+..++..||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 47899999999999999999999999999999998643 233466788999988876 789999999987
Q ss_pred cCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEc----
Q 018100 102 DGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLD---- 172 (361)
Q Consensus 102 ~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~---- 172 (361)
... ..++|||++ +++|.+++.... ...+++..++.++.||+.||.|||++ | |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 643 789999999 899999997643 35699999999999999999999998 9 99999999999994
Q ss_pred --CCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHh--
Q 018100 173 --RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-- 248 (361)
Q Consensus 173 --~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-- 248 (361)
..+.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4457999999998753221 2234689999999999999999999999999999999999999975432111
Q ss_pred -----hhHHHhhhh--------------hhccccccccccC---------ccccCCCChHHHHHHHHHHHHcccCCCCCC
Q 018100 249 -----QSLVAWARP--------------LFQDRTRHSLIAD---------PELQGQYPPRGFYQALAVAAMCVHEQPDMR 300 (361)
Q Consensus 249 -----~~~~~~~~~--------------~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 300 (361)
..+...... .+........... ......++...+..+.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 011110000 0000000000000 001124566778899999999999999999
Q ss_pred CCHHHHHHH
Q 018100 301 PVIADVVTA 309 (361)
Q Consensus 301 ps~~~ll~~ 309 (361)
||+.++++.
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.43 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=203.4
Q ss_pred CcceeHHHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCC--CCc
Q 018100 21 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLH--HPN 92 (361)
Q Consensus 21 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~ 92 (361)
....+..+...+.++|++.+.||+|+||.||+|.+..++..||||++...... ..+.+.+|+.+++.++ |+|
T Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 109 (320)
T 3a99_A 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109 (320)
T ss_dssp ----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred hccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence 34445566677889999999999999999999999999999999998654322 2244667999999986 599
Q ss_pred cceeeeEEEcCCeeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 93 LVNLIGYCADGDQRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 93 i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
|+++++++.+....++|+|++.+ ++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||++
T Consensus 110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 182 (320)
T 3a99_A 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILI 182 (320)
T ss_dssp BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEE
Confidence 99999999999999999999976 899999976 567999999999999999999999999 9999999999999
Q ss_pred c-CCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhh
Q 018100 172 D-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 249 (361)
Q Consensus 172 ~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~ 249 (361)
+ .++.++|+|||++...... ......|+..|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 257 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR- 257 (320)
T ss_dssp ETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-
T ss_pred eCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc-
Confidence 9 7899999999998763321 1223468999999999987665 6889999999999999999999975422100
Q ss_pred hHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 250 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. .. .+...+..+.+++.+||+.||++||++.++++.
T Consensus 258 -----------~~--------~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 -----------GQ--------VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----------CC--------CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------cc--------cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 112233478899999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.64 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=203.3
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
++.....++|++.+.||+|+||.||+|.++. .+++|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3445557899999999999999999999864 49999986432 223355778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++||||+++++|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||||+||+++ ++.++|+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999975 2346999999999999999999999999 99999999999998 67999999999
Q ss_pred cccCCCCC---CcceeeccccCcCcCCchhhcc---------CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHH
Q 018100 185 AKLGPVGD---NTHVSTRVMGTYGYCAPEYAKT---------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 252 (361)
Q Consensus 185 ~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 252 (361)
+....... .........|+..|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 76532211 1112223458899999999864 35788999999999999999999999765443222111
Q ss_pred HhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 253 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
... . .+... ....+..+.+++.+||..||.+||++.++++.|+.+...
T Consensus 256 ~~~--------~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 GTG--------M-----KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HTT--------C-----CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ccC--------C-----CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0 00000 011223678899999999999999999999999877654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=319.08 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=183.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHH-HHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.++|++.+.||+|+||.||+|.++.+++.||||++..... .....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4899999999999999999999999999999999975432 22344555665 677789999999999999999999999
Q ss_pred EecCCCCHHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 111 EYMPLGSVEDHLHDL-SPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 111 e~~~~~~L~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||++ ++|.+++... ......+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 5888777531 11246799999999999999999999999 9 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccCcCcCCchhh----ccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYA----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
... .......|+..|+|||++ .+..++.++|||||||++|+|++|..||......... ....
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~~~~-- 242 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------LTQV-- 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCC--
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------HHHH--
Confidence 221 122234689999999998 4567899999999999999999999999764321110 0000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.....+.+........+..+.+++.+||+.||++||++.++++.
T Consensus 243 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 243 -VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00001111111122334578899999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=319.74 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=194.1
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcC----CCCcccee
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLL----HHPNLVNL 96 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~ 96 (361)
.....+.++|++.+.||+|+||.||+|.+..++..|++|++...... ....+.+|+.++..+ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34566789999999999999999999999999999999999654332 123355688888888 89999999
Q ss_pred eeEEEcCCeeEEEEEe-cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc-CC
Q 018100 97 IGYCADGDQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RG 174 (361)
Q Consensus 97 ~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~-~~ 174 (361)
++++.+.+..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++ .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 9999999999999999 788999999986 456999999999999999999999999 99999999999999 88
Q ss_pred CceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCC-ccCceehhhHHHHHHhhCCCccccchHHHhhhHHH
Q 018100 175 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253 (361)
Q Consensus 175 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~ 253 (361)
+.++|+|||++....... .....++..|+|||++.+..+. .++||||||+++|+|++|..||........
T Consensus 177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----- 247 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE----- 247 (312)
T ss_dssp TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-----
T ss_pred CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh-----
Confidence 999999999987643221 2334589999999999776664 589999999999999999999975422100
Q ss_pred hhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
. . ...+...+..+.++|.+||+.||++||++.++++.
T Consensus 248 -------~--------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 -------A--------E----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------T--------C----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------h--------c----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 01122334478899999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=317.78 Aligned_cols=265 Identities=18% Similarity=0.217 Sum_probs=203.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCC-eEEEEEEeccCCccchHHHHHHHHHHhcCCCCc------cceeeeEEEcCC
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN------LVNLIGYCADGD 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~ 104 (361)
+.++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+.+++.++|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4589999999999999999999998776 78999998643 234466788999998887654 889999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE-------------
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL------------- 171 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv------------- 171 (361)
..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999 577777776522 357999999999999999999999999 9999999999999
Q ss_pred ------cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchH
Q 018100 172 ------DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 245 (361)
Q Consensus 172 ------~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 245 (361)
+.++.++|+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999753221 2334689999999999999999999999999999999999999987654
Q ss_pred HHhhhHHHhhhhhhcc-----ccccccc---------------------cCccccCCCChHHHHHHHHHHHHcccCCCCC
Q 018100 246 AAEQSLVAWARPLFQD-----RTRHSLI---------------------ADPELQGQYPPRGFYQALAVAAMCVHEQPDM 299 (361)
Q Consensus 246 ~~~~~~~~~~~~~~~~-----~~~~~~~---------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 299 (361)
................ ....... .............+..+.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 4332221111100000 0000000 0000011122344668889999999999999
Q ss_pred CCCHHHHHH
Q 018100 300 RPVIADVVT 308 (361)
Q Consensus 300 Rps~~~ll~ 308 (361)
|||+.++++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=322.26 Aligned_cols=206 Identities=25% Similarity=0.299 Sum_probs=174.7
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CC-----ccceeeeEEEc
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HP-----NLVNLIGYCAD 102 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~ 102 (361)
...+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+..|+.+++.++ |+ +|+.+++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 345578999999999999999999999999999999998643 223455677888887774 44 59999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCCCeeecCCCCCcEEEc--CCCcee
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD--KAKPPVIYRDLKCSNILLD--RGYHPK 178 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~~~~i~H~dl~p~Nilv~--~~~~~~ 178 (361)
....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++ .++.+|
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred CCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 999999999996 69999987632 3469999999999999999999994 67 99999999999995 478899
Q ss_pred EecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHH
Q 018100 179 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 246 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~ 246 (361)
|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999764221 23356899999999999999999999999999999999999999876543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=317.74 Aligned_cols=257 Identities=19% Similarity=0.230 Sum_probs=177.5
Q ss_pred HHhhCcccCC-eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc----CCe
Q 018100 31 AATKNFRSES-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQ 105 (361)
Q Consensus 31 ~~~~~y~~~~-~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 105 (361)
.+.++|++.+ .||+|+||.||+|.++.+++.||+|++... .....+....++.+.||||+++++++.. +..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3568999965 699999999999999999999999998642 1222223334566789999999999865 455
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 182 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Df 182 (361)
.++||||+++++|.+++.... ...+++..++.++.||+.||.|||++| ++||||||+||+++. ++.++|+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 899999999999999997632 357999999999999999999999999 999999999999986 455999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
|++...... ......++..|+|||++.+..++.++|||||||++|+|++|..||............ ...
T Consensus 176 g~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~~- 244 (336)
T 3fhr_A 176 GFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM------KRR- 244 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH------HHh-
Confidence 998753221 122346789999999998888999999999999999999999999654332110000 000
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
... .............+..+.+|+.+||+.||.+|||+.++++.-
T Consensus 245 ~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 245 IRL---GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhc---cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000 000011111123345788999999999999999999999843
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=341.03 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=208.4
Q ss_pred HHHHhhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCC
Q 018100 29 LAAATKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 104 (361)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 104 (361)
.....++|++.+.||+|+||.||+|.+..+ +..|++|.+..... ...+.+.+|+.+++.++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 344467899999999999999999998653 56799999865432 23467889999999999999999999985 45
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..++||||+++++|.+++... +..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999752 346999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
+........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-------- 608 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------- 608 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT--------
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--------
Confidence 976432211 11223346778999999998899999999999999999997 99999765443322111100
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.....++..+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 609 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 609 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0011223344588899999999999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.37 Aligned_cols=208 Identities=24% Similarity=0.333 Sum_probs=159.5
Q ss_pred HHhhCccc-CCeecccCceEEEEEEEC--CCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEE--cCCe
Q 018100 31 AATKNFRS-ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQ 105 (361)
Q Consensus 31 ~~~~~y~~-~~~lg~G~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 105 (361)
...+.|++ .+.||+|+||.||+|.++ .++..||+|++.... ....+.+|+.+++.++||||+++++++. .+..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44566887 458999999999999976 468899999986543 2356889999999999999999999994 4778
Q ss_pred eEEEEEecCCCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE----cCCCc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYH 176 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv----~~~~~ 176 (361)
.++||||+. ++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 999999996 68888775311 11235999999999999999999999999 9999999999999 67889
Q ss_pred eeEecccccccCCCCCC-cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccch
Q 018100 177 PKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSK 244 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~ 244 (361)
++|+|||++........ ........||..|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999976432211 1222345789999999999874 58999999999999999999999996543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.95 Aligned_cols=236 Identities=16% Similarity=0.146 Sum_probs=187.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
+.++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+..+..++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4478999999999999999999999999999999997654332 3678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||++|++|.+++.. . ....++..++.||+.||.|||++| |+||||||+|||++.+|.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999854 2 356678999999999999999999 9999999999999999999998543
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
|++ .++.++|||||||++|+|++|..||.......... ... ....
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~----------~~~-~~~~ 219 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----------PAE-RDTA 219 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE----------ECC-BCTT
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH----------HHH-HHhc
Confidence 222 36889999999999999999999997642211000 000 0000
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
..+.......+..+..+.+++.+||+.||++| |+.++++.|+.+....
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00000001112334578899999999999999 9999999999887654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.99 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=184.1
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
...++|++.+.||+|+||.||+|.++.++..|++|++....... .+.+.++..+++.++||||+++++++.++...++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 44688999999999999999999999999999999997553322 2334455567788899999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ | ++|+||+|+||+++.++.++|+|||++..
T Consensus 102 v~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999 56666655431 35699999999999999999999995 9 99999999999999999999999999865
Q ss_pred CCCCCCcceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
.... .......++..|+|||++. +..++.++|||||||++|+|++|..||......... +.... ...
T Consensus 175 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~----~~~ 246 (318)
T 2dyl_A 175 LVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVL----QEE 246 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHH----HSC
T ss_pred ccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHHHh----ccC
Confidence 3221 1223346899999999984 456889999999999999999999999753222111 11000 000
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. +.. ......+..+.+++.+||+.||.+||++.++++
T Consensus 247 --~-----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 --P-----PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --C-----CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --C-----CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 000 001122347889999999999999999999997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.81 Aligned_cols=280 Identities=24% Similarity=0.291 Sum_probs=207.6
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEc------C
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------G 103 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 103 (361)
...++|++.+.||+|+||.||+|.+..+|..||||++... .....+.+.+|+.+++.++||||+++++++.. +
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3458999999999999999999999999999999998654 22335678899999999999999999998755 6
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc---eeEe
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLS 180 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~---~~L~ 180 (361)
...++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| ++||||+|+||+++.++. ++|+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence 678999999999999999976332 346899999999999999999999999 999999999999997765 8999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhH-H-Hhhhh-
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-V-AWARP- 257 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~-~-~~~~~- 257 (361)
|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||........... . .....
T Consensus 167 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 167 DLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp SCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred cccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 999998643222 22345689999999999999999999999999999999999999975432211000 0 00000
Q ss_pred -hhccc--cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHHHhcc
Q 018100 258 -LFQDR--TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD-----VVTALAYLASQK 317 (361)
Q Consensus 258 -~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~-----ll~~l~~l~~~~ 317 (361)
..... ...................+..+.+++.+||..||++|||+.+ +.+.++.+....
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000 0000000111123345567789999999999999999999988 445666665544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=316.98 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=188.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.++...|+|||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 3556677899999999998754 446999999998643 345678899999876 89999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC-------------C
Q 018100 112 YMPLGSVEDHLHDLSPGKKP---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-------------Y 175 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~-------------~ 175 (361)
|+. ++|.+++......... .++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 996 6999999763211111 133456789999999999999999 9999999999999754 4
Q ss_pred ceeEecccccccCCCCCCcc--eeeccccCcCcCCchhhcc-------CCCCccCceehhhHHHHHHhh-CCCccccchH
Q 018100 176 HPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 245 (361)
Q Consensus 176 ~~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~ 245 (361)
.++|+|||++.......... ......||..|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999998643322111 1223568999999999965 568999999999999999999 9999975433
Q ss_pred HHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 246 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.... +. ..... .+..........+.++.++|.+||+.||.+||++.++++
T Consensus 246 ~~~~-i~---~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESN-II---RGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH-HH---HTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHH-Hh---cCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 2211 11 00000 011111223456678999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=318.52 Aligned_cols=252 Identities=23% Similarity=0.260 Sum_probs=187.8
Q ss_pred HHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEE
Q 018100 31 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 109 (361)
....+|.+.+.||+|+||.|+.. ...+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....|+|
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 34567999999999999997643 344589999999865432 2356799999998 799999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---C--CceeEecccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---G--YHPKLSDFGL 184 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~--~~~~L~Dfg~ 184 (361)
|||+. ++|.+++.... ..++...++.++.||+.||.|||+++ |+||||||+|||++. + ..++|+|||+
T Consensus 97 ~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99996 79999987522 33555567899999999999999999 999999999999953 2 3577999999
Q ss_pred cccCCCCCC-cceeeccccCcCcCCchhhc---cCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhh
Q 018100 185 AKLGPVGDN-THVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 185 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
+........ ........||..|+|||++. ...++.++|||||||++|+|++ |..||.............
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~------ 243 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG------ 243 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT------
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc------
Confidence 976432211 12223456999999999997 4567889999999999999999 999996543322211100
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ... ............+.+||.+||+.||.+||++.++++
T Consensus 244 -~-~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 -A-CSL-------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -C-CCC-------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c-CCc-------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 000 000112234556788999999999999999999994
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=296.84 Aligned_cols=232 Identities=20% Similarity=0.304 Sum_probs=183.6
Q ss_pred HhhCcccC-CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHH-hcCCCCccceeeeEEEc----CCe
Q 018100 32 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIGYCAD----GDQ 105 (361)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~ 105 (361)
+.++|.+. +.||+|+||.||+|.++.++..||+|++.. ...+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 45788888 789999999999999999999999999853 35677888888 55689999999999876 677
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 182 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Df 182 (361)
.++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+||+++. ++.++|+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 899999999999999998632 347999999999999999999999999 999999999999998 788999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
|++.... +..++.++|||||||++|+|++|..||.......... . ....
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------~-~~~~ 213 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------G-MKTR 213 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------C-SCCS
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------H-HHHH
Confidence 9886311 2356789999999999999999999996543211100 0 0000
Q ss_pred cccccccCccccCCCC----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 263 TRHSLIADPELQGQYP----PRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.... ....+ ...+..+.+++.+||+.||.+|||+.++++.--
T Consensus 214 ~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 214 IRMG-------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp SCTT-------CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred Hhhc-------cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 0000 00111 123457889999999999999999999997543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.04 Aligned_cols=242 Identities=21% Similarity=0.311 Sum_probs=194.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECC-CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCe----
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ---- 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 105 (361)
+.++|++.+.||+|+||.||+|.+.. ++..|+||++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 35899999999999999999999976 689999999865432 334568899999999999999999999977554
Q ss_pred -eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 106 -RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 106 -~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
.|+||||++|++|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 699999999999988764 26999999999999999999999999 9999999999999985 899999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
+...... ....||..|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------ 282 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------ 282 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------
T ss_pred chhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------------------
Confidence 9763221 334689999999998765 488999999999999999999888642110
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVTALAYLA 314 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~ll~~l~~l~ 314 (361)
.+.. .......+..+.++|.+||+.||.+||+ ++++.+.|..+.
T Consensus 283 --~~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 --GLPE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --SCCT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --cccc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 0001122357788999999999999995 666777776554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.63 Aligned_cols=244 Identities=16% Similarity=0.153 Sum_probs=183.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcCCC-Cccc---------eeeeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH-PNLV---------NLIGY 99 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~---------~~~~~ 99 (361)
.++|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++| .|.. ...+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458888999999999999999999999999999874322 235778999999999976 2211 11111
Q ss_pred ------------EEc-----CCeeEEEEEecCCCCHHHHhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018100 100 ------------CAD-----GDQRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 159 (361)
Q Consensus 100 ------------~~~-----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 159 (361)
+.. ....+++|+.+ +++|.+++... ......+++..++.++.||++||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 111 22456777766 58999988522 223456888899999999999999999999 9
Q ss_pred eecCCCCCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhh----------ccCCCCccCceehhhHH
Q 018100 160 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------KTGQLTLKSDVYSFGVV 229 (361)
Q Consensus 160 ~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDiwslG~~ 229 (361)
+||||||+|||++.++.+||+|||++..... ......| ..|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999875221 1334467 999999999 55568889999999999
Q ss_pred HHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 230 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 230 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
+|+|++|..||......... ...+. .... .+..+.+||.+||+.||++||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~------~~~~~------------~~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS------EWIFR------------SCKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS------GGGGS------------SCCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhH------HHHHh------------hccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999754321110 00000 0012 2347889999999999999999888764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.33 Aligned_cols=242 Identities=17% Similarity=0.142 Sum_probs=184.1
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhcCC---------CCccce
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLH---------HPNLVN 95 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~~i~~ 95 (361)
.++|++.+.||+|+||.||+|.+ +|..||||++..... ...+.+.+|+.+++.++ ||||+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 57899999999999999999998 489999999975432 23367888999988875 666666
Q ss_pred eeeEE-----------------Ec-------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHH
Q 018100 96 LIGYC-----------------AD-------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145 (361)
Q Consensus 96 ~~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~ 145 (361)
+.+++ .+ ....|+||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 66553 32 6789999999999977666643 5689999999999999
Q ss_pred HHHHHHh-cCCCCCeeecCCCCCcEEEcCCC--------------------ceeEecccccccCCCCCCcceeeccccCc
Q 018100 146 RGLEYLH-DKAKPPVIYRDLKCSNILLDRGY--------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204 (361)
Q Consensus 146 ~al~~LH-~~~~~~i~H~dl~p~Nilv~~~~--------------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~ 204 (361)
.||.||| +++ |+||||||+|||++.++ .+||+|||+++.... ....||.
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 999 99999999999999887 899999999985322 1346899
Q ss_pred CcCCchhhccCCCCccCceehhhHH-HHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccccCCCChHHHH
Q 018100 205 GYCAPEYAKTGQLTLKSDVYSFGVV-LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 283 (361)
Q Consensus 205 ~y~aPE~~~~~~~~~~sDiwslG~~-l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (361)
.|+|||++.+.. +.++||||||++ .++++.|..||........ ... ...... .. ........++..+.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~~~---~~~~~~-~~----~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--LTD---KMLKQM-TF----KTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--HHH---HHHHTC-CC----SSCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH--HHH---hhhhhh-cc----CcccchhhhhhcCH
Confidence 999999998766 899999998777 7778889999854211110 000 000000 00 00011112345677
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHH
Q 018100 284 QALAVAAMCVHEQPDMRPVIADVV 307 (361)
Q Consensus 284 ~l~~li~~~l~~dP~~Rps~~~ll 307 (361)
++.+||.+||+.| |+.+++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8999999999976 888888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=267.36 Aligned_cols=186 Identities=17% Similarity=0.114 Sum_probs=132.0
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCc----------cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEEEE
Q 018100 42 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV----------QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 42 lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
...|+.|....++..-.|+.+++|++..... ...+.+.+|+.+|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3445555555555555688999999864321 1224688999999999 6999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||++|++|.+++.. +++++.. .|+.||+.||+|||++| ||||||||+|||++.+|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999986 6677765 47899999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCcc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 240 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf 240 (361)
........+||+.|+|||++.+ .+..++|+||+|++++.+.++..++
T Consensus 392 --~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 --DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred --CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2222344679999999999976 4667899999999998887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=231.18 Aligned_cols=186 Identities=21% Similarity=0.250 Sum_probs=141.1
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc--------hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
+...+.||+|+||.||+|... +..+++|......... .+.+.+|+.+++.++||||+.+..++......|
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ----------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 345679999999999999544 7788999865432211 234789999999999999996555555677789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||+++++|.+++.. ++.++.||++||.|||+++ |+||||||+|||++. .+||+|||+++.
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999874 5689999999999999999 999999999999999 999999999986
Q ss_pred CCCCCCcc-----eeeccccCcCcCCchhhcc--CCCCccCceehhhHHHHHHhhCCCcc
Q 018100 188 GPVGDNTH-----VSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAV 240 (361)
Q Consensus 188 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf 240 (361)
........ ......||+.|+|||++.+ ..|+..+|+|+..+-..+.+.++.++
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 43211110 1134578999999999976 56888899999988887777665554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=197.94 Aligned_cols=150 Identities=14% Similarity=0.069 Sum_probs=120.0
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------------------chHHHHHHHHHHhcCCCC
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------------------GNREFLVEVLMLSLLHHP 91 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~ 91 (361)
......|.+.+.||+|+||.||+|.+ .+|..||+|++...... ....+.+|+.+++.++
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 33455566779999999999999999 77999999998643221 2346889999999998
Q ss_pred ccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 92 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
| +.+.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++| ++||||||+|||+
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 566665544 45699999999999988 421 134579999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhcc
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 214 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (361)
+ ++.++|+|||++. .+..+.|||.+..
T Consensus 227 ~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSV---------------EVGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence 9 9999999999986 3445789998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-21 Score=170.04 Aligned_cols=136 Identities=14% Similarity=0.049 Sum_probs=106.7
Q ss_pred cccCCeecccCceEEEEEEECCCCeE--EEEEEeccCCccc------------------------hHHHHHHHHHHhcCC
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRNGVQG------------------------NREFLVEVLMLSLLH 89 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~--v~iK~~~~~~~~~------------------------~~~~~~e~~~l~~l~ 89 (361)
|.+.+.||+|+||.||+|.+..+|.. ||||++....... ...+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999667889 9999975432110 125788999999998
Q ss_pred CCcc--ceeeeEEEcCCeeEEEEEecCC-C----CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeee
Q 018100 90 HPNL--VNLIGYCADGDQRLLVYEYMPL-G----SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVIY 161 (361)
Q Consensus 90 h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~i~H 161 (361)
|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.||+.||.+|| ++| ++|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 7754 333332 356899999942 3 67766543 234567899999999999999 999 999
Q ss_pred cCCCCCcEEEcCCCceeEeccccccc
Q 018100 162 RDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 162 ~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
|||||+|||++. .++|+|||++..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-18 Score=157.25 Aligned_cols=135 Identities=13% Similarity=0.083 Sum_probs=97.7
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--------------chH--------HHHHHHHHHhcCCCCcc
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------GNR--------EFLVEVLMLSLLHHPNL 93 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------------~~~--------~~~~e~~~l~~l~h~~i 93 (361)
|++...||.|++|.||+|.+. +|+.||||++...... ... ....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999986 4999999997532110 001 12346666666644433
Q ss_pred ceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC
Q 018100 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 173 (361)
Q Consensus 94 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~ 173 (361)
. +...+.. ...+|||||++|++|..+... .....++.||+.+|.+||++| +|||||||.|||+++
T Consensus 176 ~-vp~p~~~-~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 P-VPEPIAQ-SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp S-CCCEEEE-ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred C-CCeeeec-cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 2 1111111 123799999998888655431 134578899999999999999 999999999999988
Q ss_pred CC----------ceeEecccccc
Q 018100 174 GY----------HPKLSDFGLAK 186 (361)
Q Consensus 174 ~~----------~~~L~Dfg~~~ 186 (361)
++ .++|+||+-+.
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCcccccccccceEEEEeCCcc
Confidence 76 38999999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1e-13 Score=121.85 Aligned_cols=148 Identities=18% Similarity=0.116 Sum_probs=115.2
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCee
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 106 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 106 (361)
.+......|++...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++.+....
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 34556678999999999999999998754 6789999986432223345888999998884 56677889998888899
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------- 155 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------- 155 (361)
|+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999999999876421 1123477889999999999810
Q ss_pred -------------------------CCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 156 -------------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 156 -------------------------~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
...++|||++|.||++++++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876566799998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=4.9e-12 Score=110.67 Aligned_cols=141 Identities=14% Similarity=0.063 Sum_probs=101.8
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc--cceeeeEEEcCCeeE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRL 107 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~ 107 (361)
......|.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +..++.+...++..+
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred HHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 44455666655545667799999865 34678999997543 2245778999888885434 445888888777889
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-------------------------------- 155 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------- 155 (361)
+||||++|.+|. ... .+ ...++.+++.+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp EEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred EEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 999999988884 221 12 2356777888888888643
Q ss_pred -----------------------CCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 156 -----------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 156 -----------------------~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
...++|||++|.||++++++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=6.1e-11 Score=109.00 Aligned_cols=161 Identities=14% Similarity=0.166 Sum_probs=111.9
Q ss_pred ccCcceeHHHHHHHhh-------CcccCCeecccCceEEEEEEECCCCeEEEEEEec--cCC-ccchHHHHHHHHHHhcC
Q 018100 19 ITAQTLTFRELAAATK-------NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNG-VQGNREFLVEVLMLSLL 88 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~~-------~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~--~~~-~~~~~~~~~e~~~l~~l 88 (361)
.....++...+..... .....+.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+++.+
T Consensus 16 ~~~~~ld~~~l~~~l~~~~~~~~~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L 93 (359)
T 3dxp_A 16 ADQQRFDTEALEAWMRQHVEGFAGPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDAL 93 (359)
T ss_dssp ----CCCHHHHHHHHHHHSTTCCCCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHH
T ss_pred CcccCCCHHHHHHHHHHhCCCCCCCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHh
Confidence 3444555555554422 2334568899999999998765 4678899875 221 12234677899999988
Q ss_pred C--CCccceeeeEEEcC---CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------
Q 018100 89 H--HPNLVNLIGYCADG---DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-------- 155 (361)
Q Consensus 89 ~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------- 155 (361)
. +..+.+++.++.+. ...|+||||++|.++.+.. -..++......++.+++.+|..||+..
T Consensus 94 ~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~ 167 (359)
T 3dxp_A 94 AGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGD 167 (359)
T ss_dssp TTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTT
T ss_pred hcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccc
Confidence 6 34567788887765 3479999999987774321 234788889999999999999999731
Q ss_pred -----------------------------------------------CCCeeecCCCCCcEEEcCCCc--eeEecccccc
Q 018100 156 -----------------------------------------------KPPVIYRDLKCSNILLDRGYH--PKLSDFGLAK 186 (361)
Q Consensus 156 -----------------------------------------------~~~i~H~dl~p~Nilv~~~~~--~~L~Dfg~~~ 186 (361)
...++|||++|.||+++.++. +.|+||+.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 168 YGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp SSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred cCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 134999999999999997753 6899999886
Q ss_pred c
Q 018100 187 L 187 (361)
Q Consensus 187 ~ 187 (361)
.
T Consensus 248 ~ 248 (359)
T 3dxp_A 248 L 248 (359)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.1e-10 Score=104.77 Aligned_cols=184 Identities=18% Similarity=0.183 Sum_probs=121.3
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCc--cceeeeEEEcCC---eeEEEEEe
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPN--LVNLIGYCADGD---QRLLVYEY 112 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~ 112 (361)
.+.++.|....||++. ..+++|+.... .....+..|+.+++.+. +.. +..++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4678999999999863 46899986422 33466888999998773 322 233444333332 34889999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------- 155 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 155 (361)
++|.+|..... ..++..+...++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988865332 23677888888999999999998621
Q ss_pred ------------------CCCeeecCCCCCcEEEcC--CCceeEecccccccCCCCCCcceeeccccCcCc---CCchhh
Q 018100 156 ------------------KPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY---CAPEYA 212 (361)
Q Consensus 156 ------------------~~~i~H~dl~p~Nilv~~--~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y---~aPE~~ 212 (361)
.+.++|||++|.||++++ .+.+.|+||+.+..... ..... ....+ ..|+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~---~~Dl~---~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP---DNDFI---SLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT---THHHH---TTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh---HHHHH---HHHhhccccCHHHH
Confidence 123899999999999998 55678999998764211 11000 01111 223321
Q ss_pred cc-----C---------CCCccCceehhhHHHHHHhhCCCccc
Q 018100 213 KT-----G---------QLTLKSDVYSFGVVLLEILSGRKAVD 241 (361)
Q Consensus 213 ~~-----~---------~~~~~sDiwslG~~l~~ll~g~~pf~ 241 (361)
.. . ......+.|+++.++|.+.+|..+|-
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 10 0 01223588999999999999998874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=6.5e-08 Score=84.93 Aligned_cols=144 Identities=19% Similarity=0.170 Sum_probs=103.4
Q ss_pred HHhhCcccCCeecccCce-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCeeEE
Q 018100 31 AATKNFRSESLLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 108 (361)
.....|+.. .+..|..+ .||+......+..+++|+.... ....+..|...|+.+. +--+.+++.++.+.+..++
T Consensus 22 ~~l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l 97 (272)
T 4gkh_A 22 ADLYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL 97 (272)
T ss_dssp HHHTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred ccccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence 333445543 34445544 6898887777788999986432 3456788999988774 3335667888888889999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------------
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK-------------------------------- 156 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-------------------------------- 156 (361)
||++++|.++.+.... .......++.+++..|..||+...
T Consensus 98 vme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 9999999888776543 112334567778888888885420
Q ss_pred -----------------------CCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 157 -----------------------PPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 157 -----------------------~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+.++|||+++.||++++++.+-|+||+.+.
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 027999999999999988777899999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.8e-07 Score=83.81 Aligned_cols=136 Identities=21% Similarity=0.165 Sum_probs=94.8
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCC---ccceeeeEEE-cCCeeEEEEEecC
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCA-DGDQRLLVYEYMP 114 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~ 114 (361)
.+.++.|....||+. +..+++|+.. .......+..|+.+|+.+.+. .+..++.+.. ..+..++||++++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356888888899987 4678899853 223345788999999988642 2444555553 4456789999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 018100 115 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--------------------------------------- 155 (361)
Q Consensus 115 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------------- 155 (361)
|.++....- ..++......++.+++..|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 12455566666666666666666532
Q ss_pred ------------------CCCeeecCCCCCcEEEcC---CCc-eeEeccccccc
Q 018100 156 ------------------KPPVIYRDLKCSNILLDR---GYH-PKLSDFGLAKL 187 (361)
Q Consensus 156 ------------------~~~i~H~dl~p~Nilv~~---~~~-~~L~Dfg~~~~ 187 (361)
.+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999997 455 47999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=4.4e-07 Score=82.96 Aligned_cols=81 Identities=11% Similarity=0.016 Sum_probs=53.6
Q ss_pred CCee-cccCceEEEEEEEC--C----CCeEEEEEEeccCC---ccchHHHHHHHHHHhcCC-C--CccceeeeEEEcC--
Q 018100 39 ESLL-GEGGFGRVYKGYLE--S----INQDVAIKQLDRNG---VQGNREFLVEVLMLSLLH-H--PNLVNLIGYCADG-- 103 (361)
Q Consensus 39 ~~~l-g~G~~g~v~~~~~~--~----~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~-- 103 (361)
.+.| +.|....+|++... . ++..+++|+..... ......+..|+.+++.+. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999988654 1 15678999865332 111245677888887774 2 2455677776554
Q ss_pred -CeeEEEEEecCCCCHH
Q 018100 104 -DQRLLVYEYMPLGSVE 119 (361)
Q Consensus 104 -~~~~lv~e~~~~~~L~ 119 (361)
...++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.4e-06 Score=80.87 Aligned_cols=76 Identities=20% Similarity=0.172 Sum_probs=48.6
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCc-------cchHHHHHHHHHHhcCCC--Cccc-eeeeEEEcCCeeEE
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------QGNREFLVEVLMLSLLHH--PNLV-NLIGYCADGDQRLL 108 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~i~-~~~~~~~~~~~~~l 108 (361)
.+.||.|..+.||++....++..+++|....... ...+.+..|..+++.+.. +..+ .++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4688999999999997665578899998643211 123456778888887632 3333 44433 3445689
Q ss_pred EEEecCCC
Q 018100 109 VYEYMPLG 116 (361)
Q Consensus 109 v~e~~~~~ 116 (361)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.2e-05 Score=72.73 Aligned_cols=154 Identities=19% Similarity=0.283 Sum_probs=83.2
Q ss_pred HHHHHHh-hCccc----CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-----CCcccee
Q 018100 27 RELAAAT-KNFRS----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNLVNL 96 (361)
Q Consensus 27 ~~~~~~~-~~y~~----~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~ 96 (361)
.++.... ..|.+ .+.|+.|..+.+|++... +..+++|+.... ...+..|+.+++.|. .|.++..
T Consensus 20 ~~l~~~l~~~~~~~~~~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~ 93 (346)
T 2q83_A 20 TELAENVLQGWDVQAEKIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPN 93 (346)
T ss_dssp HHHHHHHGGGSCCCCCEEEECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCC
T ss_pred HHHHHHHHHHcCCceEEeeeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeec
Confidence 4444333 55543 234556778899998765 345899998642 233444555555442 3444431
Q ss_pred e-e--EEEcCCeeEEEEEecCCCCHH--------------HHhcccCCCC--C--------CCCHHH-------------
Q 018100 97 I-G--YCADGDQRLLVYEYMPLGSVE--------------DHLHDLSPGK--K--------PLDWNT------------- 136 (361)
Q Consensus 97 ~-~--~~~~~~~~~lv~e~~~~~~L~--------------~~~~~~~~~~--~--------~l~~~~------------- 136 (361)
. + +....+..+++++|++|.++. ..++...... . .-.+..
T Consensus 94 ~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 173 (346)
T 2q83_A 94 KKGSLYSKHGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWK 173 (346)
T ss_dssp TTSCSCEEETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHH
Confidence 1 0 123456789999999976542 1112111000 0 011111
Q ss_pred ------------------HHHHHHHHHHHHHHHhc--------C--CCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 137 ------------------RMKIAAGAARGLEYLHD--------K--AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 137 ------------------~~~i~~qi~~al~~LH~--------~--~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+..+..++..++..|+. . ....+||||+++.||+++.++.+.|+||+.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 174 LMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHhccCCcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234445666653 0 12239999999999999888899999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.9e-05 Score=69.72 Aligned_cols=80 Identities=18% Similarity=0.205 Sum_probs=56.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCC---ccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv 109 (361)
..+..-++.+|.|..+.||++...+ |+.|++|+...........+..|+..|+.|... .+..++... ..++|
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3456667889999999999998764 889999987655444455678899998887421 233344432 23689
Q ss_pred EEecCCCC
Q 018100 110 YEYMPLGS 117 (361)
Q Consensus 110 ~e~~~~~~ 117 (361)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.07 E-value=2.4e-05 Score=69.95 Aligned_cols=75 Identities=21% Similarity=0.173 Sum_probs=58.0
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC---CCccceeeeEEEcCCeeEEEEEecCC
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
.+.|+.|....+|+.... +..+++|+.... ....+..|+..|+.|. ...+.+++.+.......++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 467899999999998753 678889987532 3456788988888774 35567788888777889999999998
Q ss_pred CCH
Q 018100 116 GSV 118 (361)
Q Consensus 116 ~~L 118 (361)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=3.8e-05 Score=71.77 Aligned_cols=28 Identities=14% Similarity=0.259 Sum_probs=25.7
Q ss_pred eeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 159 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 159 i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++|||++|.|||++.++ +.++||+.+..
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 99999999999999876 99999998874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.91 E-value=4.4e-05 Score=63.53 Aligned_cols=101 Identities=15% Similarity=0.096 Sum_probs=66.6
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCcc
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 195 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~ 195 (361)
-+|.+.+..+ +.+++++++|.++.|.+.+|..+-.... -...=+.|..|++..+|+|-+.+ ..+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 4788888763 4789999999999999999888732110 12333567999999999988764 1110
Q ss_pred eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCC
Q 018100 196 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237 (361)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 237 (361)
.....+.|||... ...+.+.=|||||++||..+--.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1233467888752 34567788999999999998733
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.89 E-value=0.0002 Score=64.08 Aligned_cols=159 Identities=15% Similarity=0.146 Sum_probs=87.4
Q ss_pred eeHHHHHHHhhCcccC-----CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-----CCcc
Q 018100 24 LTFRELAAATKNFRSE-----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNL 93 (361)
Q Consensus 24 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i 93 (361)
++.+++..+..+|.+. +.|+.|....+|++.... + .+++|+..... ..+.+..|+.++..+. .|.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 5667888888888763 356678888999987653 3 68899886521 2234556777766653 2333
Q ss_pred ceee-e--EEEcCCeeEEEEEecCCCCHHH--------------HhcccCCC-CCC----CC---HHHHHH---------
Q 018100 94 VNLI-G--YCADGDQRLLVYEYMPLGSVED--------------HLHDLSPG-KKP----LD---WNTRMK--------- 139 (361)
Q Consensus 94 ~~~~-~--~~~~~~~~~lv~e~~~~~~L~~--------------~~~~~~~~-~~~----l~---~~~~~~--------- 139 (361)
+... + +....+..+++++|++|..+.. .++..... ..+ .. +...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3211 0 1123456789999998765311 11211100 000 11 111000
Q ss_pred ---HHHHHHHHHHHHhcC----CCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 140 ---IAAGAARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 140 ---i~~qi~~al~~LH~~----~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
+...+...+..++.. ....+||+|+++.||++++++.+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133444555421 12239999999999999987666899998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.85 E-value=5.7e-05 Score=67.14 Aligned_cols=74 Identities=8% Similarity=0.058 Sum_probs=44.5
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEEEEec-
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYM- 113 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~- 113 (361)
+.-.+.|+.|....+|++ ..+++|+........ -....|+.+++.+...++ .+++... ....+++++|+
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 333788999999999998 458999876432211 123457777766642222 3444433 33456899999
Q ss_pred CCCCH
Q 018100 114 PLGSV 118 (361)
Q Consensus 114 ~~~~L 118 (361)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 65544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00015 Score=66.62 Aligned_cols=143 Identities=17% Similarity=0.198 Sum_probs=82.2
Q ss_pred CCeecccCceEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc-cceeeeEEEcCCeeEEEE
Q 018100 39 ESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 110 (361)
.+.|..|-...+|++.... ++..+++|+... .......+.+|..+++.|...+ ..+++..+.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 3567778888999988642 357899998633 2234556778999988774222 2445555543 2899
Q ss_pred EecCCCCHHH--------------H---hcccCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 018100 111 EYMPLGSVED--------------H---LHDLSP-GKKPLD--WNTRMKIAAGAAR-------------------GLEYL 151 (361)
Q Consensus 111 e~~~~~~L~~--------------~---~~~~~~-~~~~l~--~~~~~~i~~qi~~-------------------al~~L 151 (361)
+|++|.+|.. . ++.... .+.... +.++..++.++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998755431 0 122111 011122 3455555544322 12222
Q ss_pred ----hcCC-CCCeeecCCCCCcEEEcCC----CceeEecccccc
Q 018100 152 ----HDKA-KPPVIYRDLKCSNILLDRG----YHPKLSDFGLAK 186 (361)
Q Consensus 152 ----H~~~-~~~i~H~dl~p~Nilv~~~----~~~~L~Dfg~~~ 186 (361)
...+ ...+||+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 2349999999999999876 789999999876
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.68 E-value=8.3e-05 Score=69.61 Aligned_cols=74 Identities=18% Similarity=0.234 Sum_probs=49.1
Q ss_pred CCeecccCceEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEEE
Q 018100 39 ESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 110 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 110 (361)
.+.|+.|....+|++.... .+..+++|+.... .....+..|+.+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888899999998653 2578999998432 122556679988888753333 445555432 2889
Q ss_pred EecCCCCH
Q 018100 111 EYMPLGSV 118 (361)
Q Consensus 111 e~~~~~~L 118 (361)
+|++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986433
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00098 Score=59.67 Aligned_cols=162 Identities=15% Similarity=0.094 Sum_probs=90.5
Q ss_pred CcceeHHHHHHHhhCcccC-----CeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCc--c
Q 018100 21 AQTLTFRELAAATKNFRSE-----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--L 93 (361)
Q Consensus 21 ~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i 93 (361)
...++.+.+..+...|-+. ..|+ |....||++... +|..+++|...... .....+..|..++..+.... +
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 4456777788777777542 3466 778899987654 36679999986332 23456667887777663211 2
Q ss_pred ceeeeE-----EEcCCeeEEEEEecCCCCHH-----HH---------hcccCC-----CCCCCCHHHH------------
Q 018100 94 VNLIGY-----CADGDQRLLVYEYMPLGSVE-----DH---------LHDLSP-----GKKPLDWNTR------------ 137 (361)
Q Consensus 94 ~~~~~~-----~~~~~~~~lv~e~~~~~~L~-----~~---------~~~~~~-----~~~~l~~~~~------------ 137 (361)
..++.. ...++..++++++++|.++. .+ ++.... ....++....
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 223322 22345668899999874431 10 111100 0111222111
Q ss_pred ----------HHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 138 ----------MKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 138 ----------~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
...+.+++..+..+-.. ....++|||+++.||+++ + .+.++||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11222222223222111 123389999999999999 4 899999987763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00073 Score=60.75 Aligned_cols=30 Identities=30% Similarity=0.311 Sum_probs=26.5
Q ss_pred CeeecCCCCCcEEEcCC----CceeEeccccccc
Q 018100 158 PVIYRDLKCSNILLDRG----YHPKLSDFGLAKL 187 (361)
Q Consensus 158 ~i~H~dl~p~Nilv~~~----~~~~L~Dfg~~~~ 187 (361)
.++|||+++.|||++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999875 6789999998874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00058 Score=64.28 Aligned_cols=75 Identities=12% Similarity=-0.010 Sum_probs=47.0
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEEEEecCCCC
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGS 117 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~ 117 (361)
.+.|+.|-...+|++.....+..+++|+......... ....|..++..|...++ .++++.+. + ..|++|++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3567888889999998764457899998754321111 12468888888865444 34666553 2 25999998744
Q ss_pred H
Q 018100 118 V 118 (361)
Q Consensus 118 L 118 (361)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00054 Score=62.61 Aligned_cols=75 Identities=9% Similarity=0.051 Sum_probs=42.7
Q ss_pred CCeecccCceEEEEEEECC--------CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEE
Q 018100 39 ESLLGEGGFGRVYKGYLES--------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLV 109 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv 109 (361)
.+.|+.|....+|++.... .+..+++|+...... .......|..+++.+...++ .+++... . .++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567788888999988653 126889998754321 11123567777777643233 3455443 2 3689
Q ss_pred EEecCCCCH
Q 018100 110 YEYMPLGSV 118 (361)
Q Consensus 110 ~e~~~~~~L 118 (361)
++|++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0035 Score=56.57 Aligned_cols=30 Identities=17% Similarity=0.221 Sum_probs=26.8
Q ss_pred CeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 158 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 158 ~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999999888899999987763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.019 Score=53.26 Aligned_cols=75 Identities=11% Similarity=0.067 Sum_probs=46.3
Q ss_pred CCeecccCceEEEEEEECCC-------CeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEEE
Q 018100 39 ESLLGEGGFGRVYKGYLESI-------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 110 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 110 (361)
.+.|..|-...+|++..... +..+++|+....... .-...+|..+++.+...++ .++++.+ . .+.|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 45677788889999887531 478999987543211 1123467888777742222 3444433 2 26889
Q ss_pred EecCCCCH
Q 018100 111 EYMPLGSV 118 (361)
Q Consensus 111 e~~~~~~L 118 (361)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99997653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.75 E-value=0.043 Score=50.53 Aligned_cols=29 Identities=28% Similarity=0.281 Sum_probs=25.0
Q ss_pred eeecCCCCCcEEE------cCCCceeEeccccccc
Q 018100 159 VIYRDLKCSNILL------DRGYHPKLSDFGLAKL 187 (361)
Q Consensus 159 i~H~dl~p~Nilv------~~~~~~~L~Dfg~~~~ 187 (361)
+||+|+.+.||++ ++++.+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.10 E-value=0.82 Score=37.93 Aligned_cols=115 Identities=11% Similarity=0.093 Sum_probs=77.3
Q ss_pred CCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCCC
Q 018100 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE-YLHDKAKPPVIYRDLKCS 167 (361)
Q Consensus 89 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~i~H~dl~p~ 167 (361)
.||++ -..+-.+++.+.+.++.-+++.=...+. .++....+.++.+|+.... +++ . -+|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeCc
Confidence 57877 4445566777777666543332223343 3788999999999988776 443 3 578889999
Q ss_pred cEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCcee-hhhHHHHHHhhCCCcccc
Q 018100 168 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY-SFGVVLLEILSGRKAVDT 242 (361)
Q Consensus 168 Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiw-slG~~l~~ll~g~~pf~~ 242 (361)
|++++.++.+++.-.|+-.. ++|.-+ ...|.| .+=|++..++.+...|+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~------~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW------DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCSC------CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999998776432 222211 111222 577888999999888764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.56 E-value=0.76 Score=38.00 Aligned_cols=116 Identities=12% Similarity=0.155 Sum_probs=77.2
Q ss_pred CCCccceeeeEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCc
Q 018100 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 168 (361)
Q Consensus 89 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N 168 (361)
.||+++.. .+-.+++.+.+.++.-+ ...++-.- ..++....+.++.+|+....+++ . -+|--|+|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~--~---r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR--T---RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG--S---SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc--C---ceEEEEecce
Confidence 57888866 56666666666555432 22222221 23788999999999999885544 2 4788899999
Q ss_pred EEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCce-ehhhHHHHHHhhCCCcccc
Q 018100 169 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV-YSFGVVLLEILSGRKAVDT 242 (361)
Q Consensus 169 ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi-wslG~~l~~ll~g~~pf~~ 242 (361)
++++.++.+++.--|+... ++|.- .+ ..|. -.+=|++..++.+...|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~~-----~~-ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPLP-----VS-EAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCCC-----CC-HHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999987776432 11110 01 1122 2567889999999888864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 361 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-76 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-54 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-50 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 1e-76
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 27/285 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPN 92
+G G FG VYKG + DVA+K L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
++ +GY Q +V ++ S+ HLH + + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
K +I+RDLK +NI L K+ DFGLA + +H ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 213 KT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269
+ + +SDVY+FG+VL E+++G+ + + L D ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314
++ + A C+ ++ D RP+ ++ ++ LA
Sbjct: 239 PKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-68
Identities = 76/280 (27%), Positives = 121/280 (43%), Gaps = 31/280 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
+ + LG G FG V+ GY + VA+K L + G FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L + ++ EYM GS+ D L P L N + +AA A G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
+ I+RDL+ +NIL+ K++DFGLA+L + + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273
G T+KSDV+SFG++L EI++ R + T +I + E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHG------------------RIPYPGMTNPEVIQNLE- 224
Query: 274 QGQYPPRGFY---QALAVAAMCVHEQPDMRPVIADVVTAL 310
+G R + + +C E+P+ RP + + L
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 1e-67
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 27/290 (9%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
+ + LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L+G C ++ E+M G++ D+L + ++ + + +A + +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
K I+RDL N L+ + K++DFGL++L GD + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL--IADP 271
+ ++KSDV++FGV+L EI + + + + +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGM------------------SPYPGIDLSQVYELLEK 231
Query: 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESD 321
+ + + P + + C P RP A++ A + + SD
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-66
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
K+ LG G FG V G DVAIK + + G EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L G C ++ EYM G + ++L + +++ +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
K ++RDL N L++ K+SDFGL++ D S + PE
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DP 271
+ + KSD+++FGV++ EI S + ++ T
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYS------------------LGKMPYERFTNSETAEHIAQ 216
Query: 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
L+ P + + C HE+ D RP +++ +
Sbjct: 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 3e-66
Identities = 71/309 (22%), Positives = 123/309 (39%), Gaps = 42/309 (13%)
Query: 23 TLTFRELAAATKNFRSE---------SLLGEGGFGRVYKGYLESINQD---VAIKQLDRN 70
TF + A + F E ++G G FG V G+L+ + VAIK L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 71 GVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 129
+ R+FL E ++ HPN+++L G +++ E+M GS++ L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 130 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189
+ + G A G++YL D ++RDL NIL++ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 190 VGDNTHVSTRV---MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 246
+ T + APE + + T SDV+S+G+V+ E++S
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS----------- 228
Query: 247 AEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA 304
+ + D T +I + + + P + C + + RP
Sbjct: 229 -------YGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 305 DVVTALAYL 313
+V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-66
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNL 93
+F S LG G G V+K + +A K + R + E+ +L + P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V G + + E+M GS++ L + K++ +GL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
K K +++RD+K SNIL++ KL DFG++ ++ +GT Y +PE +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 214 TGQLTLKSDVYSFGVVLLEILSGR 237
+++SD++S G+ L+E+ GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-65
Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 25/281 (8%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L G C + LV+E+M G + D+L + T + + G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
VI+RDL N L+ K+SDFG+ + D ST + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273
+ + KSDV+SFGV++ E+ S K +++ +E + +D + + P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314
+ C E+P+ RP + ++ LA +A
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-65
Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 43/291 (14%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
K + +G+G FG V G VA+K + + + FL E +++ L H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 94 VNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
V L+G + L +V EYM GS+ D+L S G+ L + +K + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
++RDL N+L+ K+SDFGL K +T + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL 172
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--- 269
+ + + KSDV+SFG++L EI S R + ++
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFG------------------RVPYPRIPLKDVVPRVE 214
Query: 270 ---DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317
+ PP V C H MRP + L ++ + +
Sbjct: 215 KGYKMDAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-65
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPN 92
++ +G G +GR K +S + + K+LD + + + EV +L L HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 93 LVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
+V D L V EY G + + + ++ LD +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 151 LHDK--AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
H + V++RDLK +N+ LD + KL DFGLA++ + +T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268
PE KSD++S G +L E+ + P F ++ L
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCAL-------------------MPPFTAFSQKELA 223
Query: 269 A------DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 307
+ +Y + + ++ + RP + +++
Sbjct: 224 GKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 6e-65
Identities = 64/300 (21%), Positives = 120/300 (40%), Gaps = 29/300 (9%)
Query: 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 98
+ +G+G FG V++G ++VA+K + + E+ +L H N++ I
Sbjct: 8 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIA 64
Query: 99 YCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
+ Q LV +Y GS+ D+L+ + + +K+A A GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 155 A-----KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYC 207
KP + +RDLK NIL+ + ++D GLA +T +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 208 APEY------AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQ 260
APE K + ++D+Y+ G+V EI + + + P +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 261 DRTRHSL--IADPELQGQYPPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQK 317
+ + P + ++ + +A + C + R + L+ L+ Q+
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (522), Expect = 1e-64
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 51/305 (16%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLL 88
N +GEG FGRV++ + VA+K L + +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 89 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------------------LSPG 128
+PN+V L+G CA G L++EYM G + + L SPG
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 129 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188
PL ++ IA A G+ YL + ++RDL N L+ K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248
D + PE + T +SDV+++GVVL EI S
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG----------- 239
Query: 249 QSLVAWARPLFQDRTRHSL---IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305
+ + + D + P + + +C + P RP
Sbjct: 240 -------LQPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 306 VVTAL 310
+ L
Sbjct: 292 IHRIL 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-64
Identities = 70/306 (22%), Positives = 112/306 (36%), Gaps = 50/306 (16%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNRE-FLVEV-LMLSL 87
N +LG G FG+V I++ VA+K L RE + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------------------DLSPG 128
H N+VNL+G C L++EY G + ++L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 129 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188
L + + A A+G+E+L K ++RDL N+L+ G K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 248
N V + APE G T+KSDV+S+G++L EI S
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG----------- 263
Query: 249 QSLVAWARPLFQDRTRHSL---IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 305
+ + + + P + + C RP +
Sbjct: 264 -------VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 306 VVTALA 311
+ + L
Sbjct: 317 LTSFLG 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-64
Identities = 73/308 (23%), Positives = 128/308 (41%), Gaps = 36/308 (11%)
Query: 27 RELAAATKNFRSESL-LGEGGFGRVYKGYLESIN--QDVAIKQLDRNGVQGNRE-FLVEV 82
++L N + LG G FG V +G DVAIK L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 83 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 142
++ L +P +V LIG C + +LV E G + L ++ + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 143 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVM 201
+ G++YL +K ++RDL N+LL ++ K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 202 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261
+ APE + + +SDV+S+GV + E LS + ++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG------------------QKPYKK 215
Query: 262 RTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 319
++A + + + PP + A+ + C + + RP V + Y
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM----RACYY 271
Query: 320 SDAEKVQS 327
S A KV+
Sbjct: 272 SLASKVEG 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-64
Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 24/275 (8%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPN 92
+++ LGEG +G V + VA+K +D + V E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V G+ +G+ + L EY G + D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 213 KTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271
K + DV+S G+VL +L+G D + ++ + + + + D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK---IDS 234
Query: 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
LA+ + E P R I D+
Sbjct: 235 A------------PLALLHKILVENPSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-63
Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 29/298 (9%)
Query: 41 LLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNL 96
++G G FG VY G L + A+K L+R G +FL E +++ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 97 IGYCADGDQR-LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
+G C + L+V YM G + + + + A+G+++L K
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK- 149
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAK 213
++RDL N +LD + K++DFGLA+ D+ H T + A E +
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273
T + T KSDV+SFGV+L E+++ + + L Q R L
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGR--------RLL 254
Query: 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLD 331
Q +Y P Y+ V C H + +MRP +++V+ ++ + S V + ++
Sbjct: 255 QPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 309
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-62
Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 34/278 (12%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHH 90
++F LG+G FG VY + +A+K L + ++ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
PN++ L GY D + L+ EY PLG+V L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSY 121
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
H K VI+RD+K N+LL K++DFG + P + T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270
+ K D++S GV+ E L G +P F+ T
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVG-------------------KPPFEANTYQETYKR 215
Query: 271 -PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 307
++ +P A + + + P RP++ +V+
Sbjct: 216 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-62
Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 32/281 (11%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 91
+ + + +G G F VYKG +VA +L + + + F E ML L HP
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 92 NLVNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
N+V + +LV E M G+++ +L K + +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKG 124
Query: 148 LEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
L++LH + PP+I+RDLKC NI + K+ D GLA L + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266
APE + + DVY+FG+ +LE+ + + AA+ +
Sbjct: 180 MAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YR 223
Query: 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 307
+ + + + C+ + D R I D++
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-62
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 38/282 (13%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
+ LG+G FG+VYK + + A K +D + +++VE+ +L+ HPN+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
L+ + ++ E+ G+V+ + +L ++PL + + L YLHD
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-- 212
+I+RDLK NIL KL+DFG++ +GT + APE
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMC 184
Query: 213 ---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269
K K+DV+S G+ L+E+ P + ++
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEI-------------------EPPHHELNPMRVLL 225
Query: 270 DPELQGQYPPRGFY-----QALAVAAMCVHEQPDMRPVIADV 306
+ + P C+ + D R + +
Sbjct: 226 K-IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-62
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 42/302 (13%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGV-QGNREFLVEV-LMLSLLH 89
+ + + ++GEG FG+V K ++ + D AIK++ +R+F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD------------LSPGKKPLDWNTR 137
HPN++NL+G C L EY P G++ D L + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 138 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 197
+ AA ARG++YL + I+RDL NIL+ Y K++DFGL++ V
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 198 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP 257
T + A E T SDV+S+GV+L EI+S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG------------------GT 225
Query: 258 LFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315
+ T L + + P + + C E+P RP A ++ +L +
Sbjct: 226 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 316 QK 317
++
Sbjct: 286 ER 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-62
Identities = 68/287 (23%), Positives = 123/287 (42%), Gaps = 32/287 (11%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNR-EFLVEVLMLSLLH 89
+ ++G G FG VYKG L++ + VAIK L + R +FL E ++
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
H N++ L G + +++ EYM G+++ L + + + G A G++
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMK 124
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 208
YL ++RDL NIL++ K+SDFGL++ L + T+ ++ + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 209 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268
PE + T SDV+SFG+V+ E+++ + + + H ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYG------------------ERPYWELSNHEVM 223
Query: 269 A--DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313
+ + P + C ++ RP AD+V+ L L
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-62
Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNRE-FLVEVLMLS-L 87
LG G FG+V + + VA+K L + RE + E+ +LS L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------------LSPGKKPLD 133
+H N+VNL+G C G L++ EY G + + L + + LD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 134 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193
+ + A+G+ +L K I+RDL NILL G K+ DFGLA+ N
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253
V + APE T +SDV+S+G+ L E+ S + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-- 258
Query: 254 WARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
+ + P + + C P RP +V +
Sbjct: 259 -------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 5e-62
Identities = 74/279 (26%), Positives = 115/279 (41%), Gaps = 29/279 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 93
++ R E LG+G FG V+ G VAIK L + G FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 94 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 153
V L + +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 154 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
++RDL+ +NIL+ K++DFGLA+L + + APE A
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DP 271
G+ T+KSDV+SFG++L E+ + R + ++ +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKG------------------RVPYPGMVNREVLDQVER 229
Query: 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
+ PP + C ++P+ RP + L
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-62
Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 39 ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLV 94
+ LG G FG V KGY + + + VA+K L E L E ++ L +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
+IG C + + +LV E LG + +L + + +++ + G++YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 155 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAK 213
++RDL N+LL ++ K+SDFGL+K L + T + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DP 271
+ + KSDV+SFGV++ E S + ++ + A +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYG------------------QKPYRGMKGSEVTAMLEK 225
Query: 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
+ P + + +C + RP A V L
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (499), Expect = 5e-61
Identities = 75/287 (26%), Positives = 108/287 (37%), Gaps = 47/287 (16%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLH 89
K F +G G FG VY ++ VAIK++ +G Q N ++ + EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
HPN + G LV EY + + KKPL + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLA 129
Query: 150 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 209
YLH +I+RD+K NILL KL DFG A + + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 210 EYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266
E GQ K DV+S G+ +E+ +P + S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAER-------------------KPPLFNMNAMS 221
Query: 267 LI------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVV 307
+ P LQ + F C+ + P RP ++
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLL 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-59
Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 35/287 (12%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGV---QGNREFLVEVLMLSL 87
K+ R LG+G FG V +G ++ + VA+K L + + + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
L H NL+ L G ++ V E PLGS+ D L + T + A A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGY 206
+ YL K I+RDL N+LL K+ DFGL + P D+ +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266
CAPE KT + SD + FGV L E+ + + +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYG------------------QEPWIGLNGSQ 222
Query: 267 LIADPELQGQYPPRGFY---QALAVAAMCVHEQPDMRPVIADVVTAL 310
++ + +G+ PR V C +P+ RP + L
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-59
Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 32/288 (11%)
Query: 36 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDR-NGVQGNREFLVEVLMLSLLHH 90
F+ +LG G FG VYKG E + VAIK+L + N+E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P++ L+G C +L + + MP G + D++ + K + + A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
L D+ +++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA- 269
T +SDV+S+GV + E+++ + + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG------------------SKPYDGIPASEISSI 225
Query: 270 -DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316
+ + PP + C D RP +++ + +A
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 3e-59
Identities = 63/296 (21%), Positives = 118/296 (39%), Gaps = 34/296 (11%)
Query: 16 SD-QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG 74
SD +I + + + K + +G+G G VY + Q+VAI+Q++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 75 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 134
+ E+L++ +PN+VN + GD+ +V EY+ GS+ D + + +D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDE 115
Query: 135 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194
+ + LE+LH VI+RD+K NILL KL+DFG +
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQ 170
Query: 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254
+ ++GT + APE K D++S G++ +E++ G
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG------------------ 212
Query: 255 ARPLFQDRTR----HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
P + + + + + + Q P + C+ + R ++
Sbjct: 213 -EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-58
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 37/292 (12%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSL 87
+ LG+G FG VY+G + + +D VAIK ++ R EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 88 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIA 141
+ ++V L+G + G L++ E M G ++ +L L +P P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 142 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 201
A G+ YL+ ++RDL N ++ + K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 202 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261
+ +PE K G T SDV+SFGVVL EI + +Q
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA------------------EQPYQG 238
Query: 262 RTRHSL---IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310
+ + + + L P + MC P MRP ++++++
Sbjct: 239 LSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 2e-57
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 30/284 (10%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHP 91
+F+ +LGEG F V + +++ AIK L++ + E ++S L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
V L D ++ Y G + ++ D A LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H +I+RDLK NILL+ H +++DFG AK+ + +GT Y +PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD- 270
SD+++ G ++ ++++G P F+ + +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAG-------------------LPPFRAGNEYLIFQKI 222
Query: 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314
+L+ +P + F +A + + R ++ A
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-56
Identities = 70/296 (23%), Positives = 107/296 (36%), Gaps = 34/296 (11%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNRE-FLVEVLMLSLLHH 90
+GEG FG V++G S VAIK RE FL E L + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P++V LIG + + ++ E LG + L K LD + + A + L Y
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAY 123
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
L K ++RD+ N+L+ KL DFGL++ + +++ + APE
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270
+ T SDV+ FGV + EIL R
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPF------------QGVKNNDVIGRIENGER 227
Query: 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQ 326
+ PP ++ C P RP ++ L+ + + EK Q
Sbjct: 228 LPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE------EKAQ 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-55
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 38/299 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQG-NREFLVEV-LMLSL 87
+ LG G FG+V + I++ VA+K L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 88 LHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHD------------LSPGKKPLDW 134
HH N+VNL+G C G +++ E+ G++ +L K L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 135 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 194
+ + A+G+E+L + I+RDL NILL K+ DFGLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 254
+ APE T++SDV+SFGV+L EI S + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEE 245
Query: 255 ARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313
++ TR P + C H +P RP +++V L L
Sbjct: 246 FCRRLKEGTR------MRAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-55
Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 44/304 (14%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGN-REFLVEV-LML 85
LGEG FG+V +++D VA+K L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 86 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLD 133
+ H N++NL+G C ++ EY G++ ++L P ++ L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 134 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193
+ A ARG+EYL K I+RDL N+L+ K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 253
+T + APE T +SDV+SFGV+L EI +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG---------------- 234
Query: 254 WARPLFQDRTRHSL--IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311
+ L + + P + + C H P RP +V L
Sbjct: 235 --GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 312 YLAS 315
+ +
Sbjct: 293 RIVA 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 4e-54
Identities = 57/279 (20%), Positives = 99/279 (35%), Gaps = 35/279 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
++ LG G FG V++ + + A K + E+ +S+L HP LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
NL D ++ +++YE+M G + + + D + + ++ +GL ++H+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 155 AKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
++ DLK NI+ R KL DFGL D GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI---- 268
+ + +D++S GV+ +LSG F +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSG-------------------LSPFGGENDDETLRNVK 238
Query: 269 -ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
D + + P+ R I
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-53
Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 37/303 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSL-LHH 90
+F +LG+G FG+V+ + NQ AIK L ++ V + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P L ++ + V EY+ G + H+ D + AA GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH K ++YRDLK NILLD+ H K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270
+ D +SFGV+L E+L G + F + L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIG-------------------QSPFHGQDEEELFHS 214
Query: 271 PELQGQYPPRGF-YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPC 329
+ + PR +A + +P+ R + + E + E+++
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR----EINWEELERKE 270
Query: 330 LDP 332
+DP
Sbjct: 271 IDP 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 4e-53
Identities = 51/279 (18%), Positives = 101/279 (36%), Gaps = 35/279 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
+ LG G FG V++ ++ + K ++ E+ +++ LHHP L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
NL D + +L+ E++ G + D + + + A GL+++H+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 155 AKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+++ D+K NI+ + + K+ DFGLA + + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI---- 268
+ +D+++ GV+ +LSG F +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSG-------------------LSPFAGEDDLETLQNVK 241
Query: 269 -ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
D E +A + ++P R + D
Sbjct: 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (433), Expect = 1e-51
Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 39/288 (13%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLH 89
+ + +LG GG V+ +++DVA+K L + + F E + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 90 HPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
HP +V + G +V EY+ ++ D +H + P+ +++ A A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY 204
+ L + H +I+RD+K +NI++ K+ DFG+A+ + G++ + V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 205 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264
Y +PE A+ + +SDVYS G VL E+L+G P F +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG-------------------EPPFTGDSP 219
Query: 265 HSLIADPELQGQYPPRGFYQAL-----AVAAMCVHEQPDMRPVIADVV 307
S+ + PP ++ L AV + + P+ R A +
Sbjct: 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 2e-51
Identities = 59/280 (21%), Positives = 94/280 (33%), Gaps = 32/280 (11%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHP 91
+ +LG G F V + + VAIK + + ++G E+ +L + HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N+V L G L+ + + G + D + + K ++ ++YL
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYL 123
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
HD + LD +SDFGL+K+ D V + GT GY APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEV 180
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI--- 268
+ D +S GV+ +L G P F D L
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCG-------------------YPPFYDENDAKLFEQI 221
Query: 269 --ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
A+ E Y A + + P+ R
Sbjct: 222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (438), Expect = 2e-51
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 33/274 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-- 89
+F ++G GGFG VY + A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 90 -HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
P +V + D+ + + M G + HL AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGL 120
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 208
E++H++ V+YRDLK +NILLD H ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 209 PEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267
PE + G +D +S G +L ++L G K + + R +L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMTL 222
Query: 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 301
EL + P + ++ + + R
Sbjct: 223 TMAVELPDSFSP----ELRSLLEGLLQRDVNRRL 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-50
Identities = 46/279 (16%), Positives = 103/279 (36%), Gaps = 36/279 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
+ LG G FG V++ S + K + G E+ +L++ H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 95 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
+L ++ ++++E++ + + ++ L+ + L++LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 155 AKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
+ + D++ NI+ R K+ +FG A+ GDN + + Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI---- 268
+ ++ +D++S G ++ +LSG F T +I
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG-------------------INPFLAETNQQIIENIM 216
Query: 269 -ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
A+ + +A+ + ++ R ++
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 6e-50
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 90
++F+ LG G FGRV+ + A+K L + V ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P ++ + G D Q ++ +Y+ L L + AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH K +IYRDLK NILLD+ H K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGRK 238
T D +SFG+++ E+L+G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (421), Expect = 8e-50
Identities = 62/293 (21%), Positives = 106/293 (36%), Gaps = 50/293 (17%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEV-LM 84
N+ + +LG G V + + ++ A+K +D G + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 85 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 144
+ HPN++ L LV++ M G + D+L + K L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 204
+ LH +++RDLK NILLD + KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 205 GYCAPEYAKTGQL------TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 258
Y APE + + D++S GV++ +L+G P
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-------------------SPP 214
Query: 259 FQDRTRHSLI-----ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
F R + ++ + + + + + QP R +
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-47
Identities = 70/282 (24%), Positives = 108/282 (38%), Gaps = 25/282 (8%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVN 95
LGEG F VYK ++ NQ VAIK++ NR L E+ +L L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 96 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 155
L+ LV+++M D + L + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 156 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 215
+++RDLK +N+LLD KL+DFGLAK G T + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 216 QL-TLKSDVYSFGVVLLEILSGRKAV--DTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272
++ + D+++ G +L E+L + D+ + P + + D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 273 LQGQYPPRGFY--------QALAVAAMCVHEQPDMRPVIADV 306
+P + L + P R
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (406), Expect = 2e-47
Identities = 57/300 (19%), Positives = 96/300 (32%), Gaps = 31/300 (10%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPN 92
+++ +GEG FG +++G NQ VAIK R + E LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+ N+ + +G +LV + + L + T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHP-----KLSDFGLAKLGPVGDNT-----HVSTRVMG 202
+K ++YRD+K N L+ R + DFG+ K + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 203 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262
T Y + + + + D+ + G V + L G KAA + Q
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA-YLASQKYESD 321
L A P FY+ + D P + + L D
Sbjct: 236 PLRELCAG-------FPEEFYK---YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-47
Identities = 64/286 (22%), Positives = 103/286 (36%), Gaps = 44/286 (15%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLH 89
+ + LG G F V K +S A K + + + +R + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 90 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 149
HPN++ L + +L+ E + L D K+ L + G+
Sbjct: 72 HPNVITLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 150 YLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
YLH + + DLK NI+L K+ DFGLA D + + GT
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265
+ APE L L++D++S GV+ +LSG F T+
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------ASPFLGDTKQ 222
Query: 266 SLIA-----DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
+A + E + +Y A + + P R I D
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-47
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 7/208 (3%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHP 91
+ + S +GEG +G V Y VAIK++ Q + L E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N++ + + Y+ + L+ L + L + RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE 210
H V++RDLK SN+LL+ K+ DFGLA+ P D+T T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 211 YAKTGQLTLKS-DVYSFGVVLLEILSGR 237
+ KS D++S G +L E+LS R
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-46
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 94
++ ++G G FG VY+ L + VAIK++ ++ NR E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 95 NLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 148
L + ++ LV +Y+P H S K+ L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 149 EYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 207
Y+H + +RD+K N+LLD KL DFG AK + + + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 208 APEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
T DV+S G VL E+L G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 3e-46
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 29/296 (9%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 95
+R +G G FG +Y G + ++VAIK + + +E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 96 LIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 154
I +C A+GD ++V E + + + T + +A +EY+H K
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 155 AKPPVIYRDLKCSNIL---LDRGYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGY 206
I+RD+K N L +G + DFGLAK + + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 207 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266
+ + + + D+ S G VL+ G KAA ++ + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERISEKKM 233
Query: 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA-YLASQKYESD 321
L YP + C + D +P + + Q + D
Sbjct: 234 STPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 61/292 (20%), Positives = 106/292 (36%), Gaps = 23/292 (7%)
Query: 32 ATKNFRSESLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLL 88
A + + + +GEG +G+V+K L++ + VA+K++ + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 89 ---HHPNLVNLIGYCADGDQRLLVYEYMPLGSV--EDHLHDLSPGKKPLDWNTRMKIAAG 143
HPN+V L C + V + + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 203
RGL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 204 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263
Y APE D++S G + E+ + S + + L +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 264 RHSLIADPELQ---------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
+A P ++ + C+ P R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 9e-45
Identities = 59/281 (20%), Positives = 104/281 (37%), Gaps = 44/281 (15%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE------FLVEVLMLSLLH 89
++ LLG GGFG VY G S N VAIK ++++ + E +EV++L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 90 --HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 147
++ L+ + D +L+ E L D + L
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQ---DLFDFITERGALQEELARSFFWQVLEA 122
Query: 148 LEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 206
+ + H+ V++RD+K NIL+D KL DFG L V T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 207 CAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265
PE+ + + + V+S G++L +++ G F+
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-------------------DIPFEHDE-E 215
Query: 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
+ + + + + C+ +P RP ++
Sbjct: 216 IIRGQVFFRQRVSS----ECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-45
Identities = 54/285 (18%), Positives = 107/285 (37%), Gaps = 20/285 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPN 92
NF+ +GEG +G VYK + + VA+K++ D + E+ +L L+HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V L+ ++ LV+E++ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
V++RDLK N+L++ KL+DFGLA+ V + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILL 175
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272
+ D++S G + E+++ R + + + + + P+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 273 LQGQYP-----------PRGFYQALAVAAMCVHEQPDMRPVIADV 306
+ +P P ++ + +H P+ R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-44
Identities = 52/273 (19%), Positives = 96/273 (35%), Gaps = 29/273 (10%)
Query: 41 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 100
+LG G G+V + + + + A+K L ++ + RE L P++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV---ELHWRASQCPHIVRIVDVY 74
Query: 101 ----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 156
A L+V E + G + + D G + +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 157 PPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 213
+ +RD+K N+L KL+DFG AK ++ T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 214 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273
+ D++S GV++ +L G ++ A + + E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGMKTRIRMGQYEF 236
Query: 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
+ + + +P R I +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-43
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 90
+F LLG+G FG+V ++ + A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
P L L D+ V EY G + HL ++ A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEY 120
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
LH + V+YRD+K N++LD+ H K++DFGL K G T GT Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
+ D + GVV+ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (368), Expect = 5e-42
Identities = 50/285 (17%), Positives = 107/285 (37%), Gaps = 22/285 (7%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPN 92
+ +GEG +G VYK + A+K++ ++ + E+ +L L H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 93 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 152
+V L + +LV+E++ +D L + L+ T G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 153 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 212
D+ V++RDLK N+L++R K++DFGLA+ + + ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 213 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272
+ + + D++S G + E+++G A + + + ++ P+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 273 LQGQYPPRGFY-----------QALAVAAMCVHEQPDMRPVIADV 306
+ + + + + P+ R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-41
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 22/287 (7%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHP 91
+ + +GEG +G V+K ++ VA+K++ D + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N+V L + LV+E+ +D LD +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H + V++RDLK N+L++R KL++FGLA+ + S V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVL 173
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ------------SLVAWARPLF 259
+ D++S G + E+ + + + +Q +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADV 306
D + + P+ + + P R +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-40
Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 20/216 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPN 92
+ + +G+G FG V+K Q VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 93 LVNLIGYCADGDQR--------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 144
+VNLI C LV+++ + L + ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML 126
Query: 145 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS--TRVMG 202
GL Y+H + +++RD+K +N+L+ R KL+DFGLA+ + N+ + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 203 TYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 237
T Y PE + D++ G ++ E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 3e-40
Identities = 64/271 (23%), Positives = 94/271 (34%), Gaps = 35/271 (12%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHP 91
F LG G FGRV + A+K LD+ V ++ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
LV L D +V EY+ G + HL AA EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL 157
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H +IYRDLK N+L+D+ + +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271
+ D ++ GV++ E+ +G P F +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG-------------------YPPFFADQPIQIYEKI 250
Query: 272 ELQGQYPPRGFYQAL-AVAAMCVHEQPDMRP 301
P F L + + R
Sbjct: 251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-40
Identities = 40/206 (19%), Positives = 82/206 (39%), Gaps = 9/206 (4%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 91
+R +G G +G V VAIK+L R + E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 92 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
N++ L+ + ++ + + L + + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 152 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 211
H +I+RDLK N+ ++ K+ DFGLA+ ++ ++ V+ +
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVI 190
Query: 212 AKTGQLTLKSDVYSFGVVLLEILSGR 237
+ T D++S G ++ E+++G+
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 2e-36
Identities = 39/207 (18%), Positives = 80/207 (38%), Gaps = 19/207 (9%)
Query: 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNL 93
+++ LG G + V++ + N+ V +K L + + E+ ++ +L PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 94 VNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 151
+ L D R LV+E++ + + L + L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 145
Query: 152 HDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
H +++RD+K N+++D +L D+GLA+ + RV Y
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPEL 200
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
D++S G +L ++ +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-35
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV----QGNREFLVEVLMLS 86
+NF +LG G +G+V+ S + A+K L + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 87 LL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
+ P LV L + L+ +Y+ G + HL ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIV 139
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
LE+LH +IYRD+K NILLD H L+DFGL+K V D T + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 206 YCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGR 237
Y AP+ + G D +S GV++ E+L+G
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-34
Identities = 42/207 (20%), Positives = 85/207 (41%), Gaps = 9/207 (4%)
Query: 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHH 90
+ +++ S +G G +G V + VA+K+L R + + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 91 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 150
N++ L+ + + + + + L + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 151 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 210
+H +I+RDLK SN+ ++ K+ DFGLA+ + ++ V +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEI 189
Query: 211 YAKTGQLTLKSDVYSFGVVLLEILSGR 237
D++S G ++ E+L+GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-33
Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHP 91
K +++ +G G G V Y ++++VAIK+L R + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 92 NLVNLIGYCA------DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
N+++L+ + LV E M + + LD +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 205
G+++LH +I+RDLK SNI++ K+ DFGLA+ + + T + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRY 183
Query: 206 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
Y APE D++S G ++ E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (301), Expect = 1e-31
Identities = 38/215 (17%), Positives = 76/215 (35%), Gaps = 16/215 (7%)
Query: 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 95
+ LG G F V+ N VA+K + + V E+ +L ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTK 73
Query: 96 LIGYCADGDQRLLVYEY------------MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 143
A+ +LL + + + + +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 144 AARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMG 202
GL+Y+H + +I+ D+K N+L++ L +A LG T +
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 203 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 237
T Y +PE +D++S ++ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 1e-18
Identities = 21/161 (13%), Positives = 45/161 (27%), Gaps = 30/161 (18%)
Query: 40 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV----------QGNREFLVEVLMLSLLH 89
L+GEG V+ Y E + +K G+ F V + +
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 90 HPNLVNLIGYCA----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 145
L L G + ++ E + + ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMIL 113
Query: 146 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186
+ + + +++ DL N+L+ + DF +
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-57 Score=398.74 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=208.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.++|++.+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 35789999999999999999999999999999999975433 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999975 567999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
...........||+.|+|||++.+..+ +.++|||||||++|+|++|..||............ ....
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~~------------ 222 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEK------------ 222 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHTT------------
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-HhcC------------
Confidence 333333445679999999999988776 57899999999999999999999765432211111 0000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..........+.++.+|+.+||+.||++|||++++++
T Consensus 223 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 --KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000111223457889999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=396.33 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=212.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+++.++||||+++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999999999999999998666666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
+||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 99999998875 46999999999999999999999999 999999999999999999999999999863222
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
........||+.|+|||++.+..++.++|||||||++|+|++|..||................ . .
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------~-------~ 234 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--------T-------P 234 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------S-------C
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------C-------C
Confidence 223345579999999999999999999999999999999999999997654433221111000 0 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
....+...+..+.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122334558889999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=389.20 Aligned_cols=247 Identities=28% Similarity=0.419 Sum_probs=210.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998642 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... .
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------~ 220 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------E 220 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------C
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------C
Confidence 2 223457999999999999999999999999999999999999999765443322211100 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...+...+.++.+||.+||+.||++|||+.++++.
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11223344588899999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=394.87 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=209.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++++.||+|+||.||+|.++.+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999999999999999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||++||+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999886 567999999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .. .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~--------~ 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KL--------E 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TT--------C
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH------cC--------C
Confidence 333333344679999999999999999999999999999999999999998654332221110 00 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 310 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l 310 (361)
..++...+.++.+||.+||+.||.+|||++|+++..
T Consensus 227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 112223345788999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=392.02 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=209.6
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
+.|++++.||+|+||.||+|+++.++..||+|++........+.+.+|+.+|+.++||||+++++++.+++..|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46999999999999999999999999999999998776667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++|+|.+++... ..++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... .
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 999999987642 356999999999999999999999999 99999999999999999999999999864211 1
Q ss_pred cceeeccccCcCcCCchhhc-----cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccc
Q 018100 194 THVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
........||+.|+|||++. +..++.++|||||||++|+|++|..||...........+ ...
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~~~----------- 230 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AKS----------- 230 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HHS-----------
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--HcC-----------
Confidence 11223457999999999984 456889999999999999999999999765432221111 100
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.......+...+.++.+||.+||+.||++|||+.++++
T Consensus 231 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 231 --EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011122344558899999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=389.40 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=199.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEc--CCeeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 109 (361)
++|++.+.||+|+||.||+|+++.+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+ +..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999999999999999999765432 34568899999999999999999999864 4568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--CCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK--PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
||||++|+|.+++......+..+++..++.++.||+.||.|||+++. ..|+||||||+|||++.++.+||+|||++..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999987543335779999999999999999999998641 2399999999999999999999999999976
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ...
T Consensus 164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~--~~~--------- 230 (269)
T d2java1 164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--EGK--------- 230 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTC---------
T ss_pred ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH--cCC---------
Confidence 322 2222334678999999999999999999999999999999999999997654432221111 000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ...+...+.++.+||.+||+.||.+|||+.++++
T Consensus 231 --~----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 --F----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --C----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 0112233458899999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=385.13 Aligned_cols=262 Identities=28% Similarity=0.469 Sum_probs=205.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
.++|++.+.||+|+||.||+|+++. .||||++.... ....+.+.+|+.+++.++||||+++++++.+ ...++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 5789999999999999999998753 59999986543 3345678999999999999999999998754 5689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+++|+|.+++... +..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 83 Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999652 356999999999999999999999999 99999999999999999999999999976443
Q ss_pred CCCcceeeccccCcCcCCchhhcc---CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~~-------- 226 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRGY-------- 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHTS--------
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCC--------
Confidence 333333445678999999999864 35789999999999999999999999764432221111 10000
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
..+. ....+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 227 -~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 227 -LSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -CCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0000 0112233445888999999999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-55 Score=391.16 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=197.2
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.++|++.+.||+|+||.||+|.++.+|+.||||++...... ....+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457799999999999999999999999999999999754332 2356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc---CCCceeEeccccccc
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKL 187 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~---~~~~~~L~Dfg~~~~ 187 (361)
|||+||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||++. +++.+||+|||++..
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999976 678999999999999999999999999 99999999999994 578999999999975
Q ss_pred CCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 160 ~~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------ 224 (307)
T d1a06a_ 160 EDP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------ 224 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------------
T ss_pred ccC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Confidence 322 22233457999999999999999999999999999999999999999765443322111100
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.........+..+.++.+||.+||+.||++|||+.++++.
T Consensus 225 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 --EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111111223344588999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-55 Score=390.36 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=216.1
Q ss_pred HHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 30 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
+...++|++.+.||+|+||.||+|.++.++..||||++... ....+.+.+|+.+|+.++||||+++++++.++...++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 34457899999999999999999999999999999998654 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 92 ~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999986532 467999999999999999999999999 9999999999999999999999999998633
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCcc-ccchHHHhhhHHHhhhhhhccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHSLI 268 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (361)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|..|| ............ ..
T Consensus 167 ~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i---~~----------- 231 (287)
T d1opja_ 167 GD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK----------- 231 (287)
T ss_dssp SS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HT-----------
T ss_pred CC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH---hc-----------
Confidence 22 122223345788999999999999999999999999999999976665 333222211111 10
Q ss_pred cCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 269 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
......+...+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 232 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 232 ---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01112233445588999999999999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-54 Score=394.10 Aligned_cols=254 Identities=21% Similarity=0.290 Sum_probs=212.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++||||+++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57899999999999999999999999999999999876666667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC--CCceeEecccccccCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~--~~~~~L~Dfg~~~~~~~ 190 (361)
|+||+|.+++.. ....+++..++.++.||+.||.|||++| ++||||||+|||++. ++.+||+|||++.....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999998854 2457999999999999999999999999 999999999999964 67899999999975332
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... +
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~----------- 242 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--W----------- 242 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C-----------
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-----------
Confidence 2 22344578999999999999999999999999999999999999997654433221111000 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.......+..+.++.+||.+||+.||++|||++++++.
T Consensus 243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011112334578899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.9e-54 Score=393.97 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=213.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
..++|++++.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++||||+++++++.++...|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35789999999999999999999999999999999987655556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc--CCCceeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~--~~~~~~L~Dfg~~~~~~ 189 (361)
||+||+|.+++.. .+.++++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 107 ~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999988764 2457999999999999999999999999 99999999999998 67899999999998643
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 181 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------- 243 (352)
T d1koba_ 181 PD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------- 243 (352)
T ss_dssp TT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------
T ss_pred CC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 22 2234457899999999999999999999999999999999999999875543322111100
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.........+..+.++.+||.+||+.||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111112223344588999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-54 Score=384.66 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=202.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe---EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++.++. .|+||.+..... ...+.+.+|+.+|+.++||||+++++++.++...++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999999986654 588998765433 344679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++|+|.+++.. ....+++.+++.++.||++||.|||+++ ++||||||+||||+.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998865 2356999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcc---eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 189 PVGDNTH---VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 189 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........+ ..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i---~~------- 248 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQ------- 248 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HT-------
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-------
Confidence 3222111 1122357889999999999999999999999999999998 89999765443222111 10
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 249 -------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 -------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 001112334455889999999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=378.22 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=202.9
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||+|+||.||+|.++. +..||||++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 579999999999999999999875 778999998754 344577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999998865 2466899999999999999999999999 99999999999999999999999999976332221
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......||..|+|||++.+..++.++|||||||++|||++ |.+||...........+... .
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~----------~------ 219 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------F------ 219 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT----------C------
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc----------C------
Confidence 12233568899999999999999999999999999999999 45666554332222111100 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
....+...+.++.+|+.+||+.||++|||+++|++.|+.+.+
T Consensus 220 -~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 220 -RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 011122334578899999999999999999999999998865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=393.11 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=208.0
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
..++|++++.||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.++...|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35789999999999999999999999999999999975433 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
||++||+|.+++.. ...+++..+..++.||+.||.|||+ +| |+||||||+|||++.+|.+||+|||+|....
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999976 5679999999999999999999997 58 9999999999999999999999999987532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH-hhhhhhc-------c
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WARPLFQ-------D 261 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~-------~ 261 (361)
. ......+||..|+|||++.+..++.++||||+||++|+|++|+.||............. ....... .
T Consensus 157 ~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 D----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp H----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred C----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 1 11234579999999999999999999999999999999999999997644322111000 0000000 0
Q ss_pred cccc--ccccC--c-------------cccCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 RTRH--SLIAD--P-------------ELQGQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 ~~~~--~~~~~--~-------------~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.... ....+ + ......+ ...+.++.+||.+||+.||.+|||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000 00000 0 0000000 1124578899999999999999999999973
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=383.47 Aligned_cols=253 Identities=24% Similarity=0.297 Sum_probs=209.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc------cchHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
+.++|++.+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.++..
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34789999999999999999999999999999999864322 234678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC----ceeEec
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSD 181 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~----~~~L~D 181 (361)
.|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999976 567999999999999999999999999 99999999999998876 499999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 161 fG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~----- 232 (293)
T d1jksa_ 161 FGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN----- 232 (293)
T ss_dssp CTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-----
T ss_pred hhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----
Confidence 9999764322 22334568999999999999999999999999999999999999998654433221111100
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........ +..+..+.+||.+||+.||++|||++++++
T Consensus 233 -----~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 -----YEFEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCCCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCCchhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111 123447889999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-53 Score=382.75 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=211.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
.++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.++..+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36899999999999999999999999999999999743 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++....
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999987 677999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 157 ~--~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------- 220 (337)
T d1o6la_ 157 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------- 220 (337)
T ss_dssp C--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c--CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------
Confidence 2 222234467999999999999999999999999999999999999999876543322111100
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
. ..+|...+.++.+||.+||+.||.+|++ +.++++
T Consensus 221 ~----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 E----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 1123334457889999999999999995 788876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-53 Score=383.38 Aligned_cols=247 Identities=29% Similarity=0.375 Sum_probs=205.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
+.|++++.||+|+||.||+|+++.++..||||++....... .+.+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999999999999999997654332 346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
|||.+|+|..++.. ..++++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999988777665 567999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeeccccCcCcCCchhhcc---CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ... .
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--~~~----~----- 230 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQN----E----- 230 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHS----C-----
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhC----C-----
Confidence 233569999999999864 45899999999999999999999999765433221111 100 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.+.. .+...+..+.+||.+||+.||++|||+.++++.
T Consensus 231 --~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 231 --SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 0011 112234578899999999999999999999873
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=375.27 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=200.0
Q ss_pred hCc-ccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEc----CCee
Q 018100 34 KNF-RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQR 106 (361)
Q Consensus 34 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 106 (361)
++| ++.+.||+|+||.||+|.++.++..||+|++.... ....+.+.+|+.+|+.++||||+++++++.+ +...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 67788999999999999999999999999986542 2334578899999999999999999999864 4567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEc-CCCceeEeccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLA 185 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~-~~~~~~L~Dfg~~ 185 (361)
|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ +.|+||||||+|||++ +++.+||+|||++
T Consensus 88 ~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999999976 567999999999999999999999875 3399999999999996 5789999999999
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccc
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 265 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (361)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......... ...+.. .
T Consensus 163 ~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~~i~~----~--- 228 (270)
T d1t4ha_ 163 TLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTS----G--- 228 (270)
T ss_dssp GGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTT----T---
T ss_pred eeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HHHHHc----C---
Confidence 75222 12234579999999999865 5999999999999999999999999754322211 111100 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
...+.+... .+.++.+||.+||+.||++|||+.|+++
T Consensus 229 --~~~~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 --VKPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CCCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 001111112 2336888999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=386.43 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=209.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCe-----EEEEEEeccC-CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQ-----DVAIKQLDRN-GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 105 (361)
.++|++.+.||+|+||.||+|++..++. .||+|.+... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4789999999999999999999876543 6999998643 333456788999999988 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSP-------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 166 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p 166 (361)
.|+|||||++|+|.+++..... ....+++..++.++.||++||.|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975321 1245899999999999999999999999 99999999
Q ss_pred CcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchH
Q 018100 167 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 245 (361)
Q Consensus 167 ~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~ 245 (361)
+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999976444433333445568999999999999999999999999999999997 8999976433
Q ss_pred HHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 246 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
.... ...... ......+...+.++.+||.+||+.||++|||+.+|++.|.
T Consensus 273 ~~~~--~~~~~~--------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANF--YKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHH--HHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH--HHHHhc--------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2211 111110 0111223344568899999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=368.42 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=210.7
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEec
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 113 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 113 (361)
++|++.+.||+|+||.||+|+++ ++..||||++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 68999999999999999999986 58899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++|+|..++... ...+++..++.++.||++||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999986542 356899999999999999999999999 99999999999999999999999999975433222
Q ss_pred cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCcc
Q 018100 194 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 272 (361)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (361)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...........+... .
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~----------~------ 218 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----------L------ 218 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT----------C------
T ss_pred -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC----------C------
Confidence 22233568899999999999999999999999999999998 89999876544332211100 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 018100 273 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 311 (361)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~ 311 (361)
....|...+..+.+|+.+||+.||++|||+.++++.|.
T Consensus 219 -~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 219 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 01112233458889999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=375.02 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=207.9
Q ss_pred hCcccCCe-ecccCceEEEEEEECC--CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEE
Q 018100 34 KNFRSESL-LGEGGFGRVYKGYLES--INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~-lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
++|.+.+. ||+|+||.||+|.++. ++..||||++..... ...+.+.+|+.+|+.++||||+++++++.++ ..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 56777775 9999999999998764 355799999975433 3356799999999999999999999998754 67899
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998754 2457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCc-ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 190 VGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 190 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
..... .......|+..|+|||++.+..++.++|||||||++|||++ |..||...........+. .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~---~---------- 227 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---Q---------- 227 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---T----------
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---c----------
Confidence 32221 22233467899999999999999999999999999999998 999997654332221111 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
......++..+.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 228 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 228 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0011223445568899999999999999999999999987554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.5e-53 Score=373.79 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=206.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCccceeeeEEEcCC----e
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGD----Q 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 105 (361)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999999999999999997653332 346889999999999999999999987643 4
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.|+||||++|++|.+++.. .+.+++.+++.++.||+.||.|||++| |+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998876 567999999999999999999999999 999999999999999999999999988
Q ss_pred ccCCCCC-CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 186 KLGPVGD-NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 186 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|..||............ . ...
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~--~----~~~-- 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--V----RED-- 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H----HCC--
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH--H----hcC--
Confidence 6532222 222234457999999999999999999999999999999999999999865443221111 0 000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLA 314 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~ll~~l~~l~ 314 (361)
+.......+..+..+.++|.+||+.||++|| |++++++.|.++.
T Consensus 231 ------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0000111122344888999999999999999 8999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=372.02 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=206.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.++. +..||||++... ....+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 5789999999999999999999874 788999999754 3445789999999999999999999998755 567999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999876522 346999999999999999999999999 9999999999999999999999999998643221
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCC-ccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK-AVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........|+..|+|||++.+..++.++|||||||++|||++|.. ||...........+ .. .
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i---~~-------~------ 226 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---ER-------G------ 226 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-------T------
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh-------c------
Confidence 122233568899999999998899999999999999999999654 55443332221111 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.....+...+.++.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus 227 -~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 011122334457889999999999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-52 Score=376.75 Aligned_cols=245 Identities=29% Similarity=0.395 Sum_probs=209.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6799999999999999999999999999999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||++||+|..++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++.....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999987 677999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... .
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------------~ 217 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--------------E 217 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------C
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------C
Confidence 2 23457999999999999999999999999999999999999999875443322211100 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
...++..+.++.+++.+||..||.+|+ +++++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 112233445788999999999999996 8999886
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=370.47 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=200.5
Q ss_pred CeecccCceEEEEEEECC--CCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEecCC
Q 018100 40 SLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 115 (361)
Q Consensus 40 ~~lg~G~~g~v~~~~~~~--~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 115 (361)
+.||+|+||.||+|.++. +++.||||++..... ...+.+.+|+.+|++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 479999999999998653 457899999864332 2346799999999999999999999999754 57899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCCc-
Q 018100 116 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT- 194 (361)
Q Consensus 116 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~- 194 (361)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999987 677999999999999999999999999 999999999999999999999999999764333222
Q ss_pred ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccCccc
Q 018100 195 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 273 (361)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (361)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+... .
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-----------------~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----------------E 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------------C
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 22233568899999999999999999999999999999998 89999875443322211100 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 274 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
....+...+.++.+|+.+||+.||++|||+++|++.|+..
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122334455889999999999999999999999888653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-52 Score=369.91 Aligned_cols=253 Identities=24% Similarity=0.288 Sum_probs=209.5
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccc---------hHHHHHHHHHHhcCC-CCccceeeeEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLH-HPNLVNLIGYCA 101 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 101 (361)
+.++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+++.++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 3589999999999999999999999999999999997543321 235788999999997 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 102 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 102 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
+++..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999999976 567999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhcc------CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 255 (361)
||++....... ......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||...........+...
T Consensus 154 FG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 154 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred chheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 99998643322 2334579999999999853 35688999999999999999999999876543322211100
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ........+..+.++.+|+.+||+.||++|||+.++++
T Consensus 231 ------~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 ------N--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ------C--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ------C--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00111112234558899999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=369.00 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=202.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCC----eEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~----~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+|++.+.||+|+||.||+|.++.++ ..||||++...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 57889999999999999999987654 47999998654332 34568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+.++++.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999988765 2467999999999999999999999999 999999999999999999999999999763
Q ss_pred CCCCC-cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCcc-ccchHHHhhhHHHhhhhhhccccccc
Q 018100 189 PVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 189 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
..... ........||..|+|||++.+..++.++|||||||++|||++|..|| ........ ...+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~--------- 228 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAIND--------- 228 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHT---------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH---HHHHhc---------
Confidence 32211 12223346789999999999999999999999999999999965554 43322211 111110
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 229 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 -----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 011122333445788999999999999999999999999887653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=375.16 Aligned_cols=254 Identities=16% Similarity=0.206 Sum_probs=209.8
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++++|++++.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 46899999999999999999999999999999999975532 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCC--CceeEecccccccCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAKLGP 189 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~--~~~~L~Dfg~~~~~~ 189 (361)
||+|++|.+++.. .+..+++.+++.++.||+.||.|||++| |+||||||+|||++.+ +.++|+|||++....
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999975 2347999999999999999999999999 9999999999999854 579999999997532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. ........+++.|+|||.+.+..++.++|||||||++|+|++|..||...........+... ....
T Consensus 156 ~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~----------~~~~ 222 (321)
T d1tkia_ 156 P---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA----------EYTF 222 (321)
T ss_dssp T---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------CCCC
T ss_pred c---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------CCCC
Confidence 2 22334456899999999999999999999999999999999999999876543222111100 0000
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
...... ..+.++.+||.+||..||.+|||+.++++.
T Consensus 223 ~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 123478899999999999999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=375.55 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=206.5
Q ss_pred hCcccCCeecccCceEEEEEEECCCCe----EEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~----~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.+|++++.||+|+||.||+|.+..+|+ .||+|.+... .....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 579999999999999999999987765 5888888643 334567899999999999999999999999875 5677
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
+++++.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8889999999988765 2467999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.............||..|+|||++.+..++.++|||||||++|||++ |..||...........+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~------------ 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------------ 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT------------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------
Confidence 44333333344568999999999999999999999999999999998 88999765433222211100
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....++..+..+.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 01122334455889999999999999999999999999887653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=377.72 Aligned_cols=245 Identities=24% Similarity=0.271 Sum_probs=208.4
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 110 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 110 (361)
++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6799999999999999999999999999999998642 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCC
Q 018100 111 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 190 (361)
Q Consensus 111 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~ 190 (361)
||+.+|+|..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 191 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... .
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------------~ 254 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--------------K 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------C
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--------------C
Confidence 1 23456999999999999999999999999999999999999999765433222111100 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRP-----VIADVVT 308 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~ 308 (361)
...+...+.++.+||.+||+.||.+|+ +++++++
T Consensus 255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011223345788999999999999994 8999886
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=375.40 Aligned_cols=248 Identities=29% Similarity=0.424 Sum_probs=207.0
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHh-cCCCCccceeeeEEEcCCeeEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLV 109 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 109 (361)
++|++++.||+|+||+||+|.++.+|+.||||++... .....+.+..|..++. .++||||+++++++.++...|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999999999999999999643 1233455667777665 68999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 189 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~ 189 (361)
|||+++|+|.+++.. ...+++.++..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccccccccc
Q 018100 190 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 269 (361)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (361)
. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 155 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------------- 218 (320)
T d1xjda_ 155 L--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------------- 218 (320)
T ss_dssp C--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c--ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 2 222334457999999999999999999999999999999999999999865543322211100
Q ss_pred CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 018100 270 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIA-DVVT 308 (361)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~ll~ 308 (361)
.+ .++...+.++.+||.+||+.||++||++. ++++
T Consensus 219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 12223345788999999999999999996 6764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=364.63 Aligned_cols=259 Identities=26% Similarity=0.364 Sum_probs=201.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.+..+ +..|+||.+...... ..+.+.+|+.+++.++||||+++++++. ++..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 47899999999999999999998654 456899988654333 3466899999999999999999999996 467899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccC
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 188 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~ 188 (361)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765 2457999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhcccccccc
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 267 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (361)
.... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+. . .
T Consensus 159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~---~-- 225 (273)
T d1mp8a_ 159 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------N---G-- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------T---T--
T ss_pred cCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------c---C--
Confidence 3221 122234567899999999999999999999999999999998 899997654432221111 0 0
Q ss_pred ccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 268 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.....++..+..+.+||.+||+.||++|||+.+|++.|+.+.++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00122334456889999999999999999999999999887653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=365.67 Aligned_cols=262 Identities=25% Similarity=0.232 Sum_probs=199.0
Q ss_pred cCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 38 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 38 ~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999999999999999998654322 134688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+.++++..+... ...+++..+..++.||+.||.|||++| ++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~- 153 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 153 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC-
Confidence 998777766654 567999999999999999999999999 999999999999999999999999999753222
Q ss_pred CcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh-hh----hhccccccc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RP----LFQDRTRHS 266 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~----~~~~~~~~~ 266 (361)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... .. .+.......
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 154 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 222334578999999999865 46799999999999999999999999766544332221111 00 000000000
Q ss_pred cccCccccCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 267 LIADPELQGQY-----PPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 267 ~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
........... .+..+.++.+||.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000000 1123457889999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-51 Score=376.17 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=202.3
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHH---HHHHHHhcCCCCccceeeeEEEcCCeeE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFL---VEVLMLSLLHHPNLVNLIGYCADGDQRL 107 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 107 (361)
++|++.+.||+|+||.||+|+++.+|+.||||++..... .....+. .++.+++.++||||+++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 589999999999999999999999999999999864211 1122233 3477788889999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||++..
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999987 567899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccc
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS 266 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (361)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........+.... .
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~------- 222 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L------- 222 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---S-------
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---c-------
Confidence 3322 1234569999999999964 56899999999999999999999999764332221111100 0
Q ss_pred cccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 267 LIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
......+...+.++.+||.+||+.||++||+ ++++++
T Consensus 223 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 -----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0011122334458899999999999999999 688875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=362.08 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=201.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc-CCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 467899999999999999999986 789999998643 345779999999999999999999999854 456899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+++|+|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-
Confidence 999999999986521 235899999999999999999999999 99999999999999999999999999875221
Q ss_pred CCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
......++..|+|||++.+..++.++|||||||++|||++ |.+||........... +..
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~---i~~------------- 215 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEK------------- 215 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH---HTT-------------
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHc-------------
Confidence 1223457889999999999999999999999999999998 7888866433322111 110
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 271 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
......++..+..+.+|+.+||+.||++|||+.++++.|+.++..
T Consensus 216 -~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 216 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111223334445888999999999999999999999999988653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=367.03 Aligned_cols=256 Identities=29% Similarity=0.405 Sum_probs=202.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEEe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 112 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 112 (361)
.++|++.+.||+|+||.||+|.++. +..||||++... ....+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 5789999999999999999999986 467999998644 3455789999999999999999999999854 567899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCC
Q 018100 113 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 192 (361)
Q Consensus 113 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~ 192 (361)
+++|+|..++.... ...+++.+++.++.||+.||.|||+++ ++||||||+||||+.++.+||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999886522 356999999999999999999999999 9999999999999999999999999997532222
Q ss_pred CcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCcc-ccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 193 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
........++..|+|||++.+..++.++|||||||++|+|++|..|| ...........+. .
T Consensus 168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~-------------- 229 (285)
T d1fmka3 168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R-------------- 229 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T--------------
T ss_pred -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---h--------------
Confidence 12233356899999999999999999999999999999999965554 4333222211111 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
......+...+.++.+++.+||+.||++||++.+|++.|+..-
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 0011223334558899999999999999999999999887533
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=365.35 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=203.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++++.||+|+||.||+|.++.+|+.||||++..... ...+.+.+|+.++++++||||+++++++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999999999999999999965432 235678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
|+. +.+.+++... ....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~-~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~- 154 (298)
T d1gz8a_ 82 FLH-QDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV- 154 (298)
T ss_dssp CCS-EEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-
T ss_pred ecC-Cchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC-
Confidence 997 4555554332 2467999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeeccccCcCcCCchhhccCC-CCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccC
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 270 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (361)
.........|++.|+|||++.... ++.++|||||||++|+|++|+.||..............................
T Consensus 155 -~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 155 -PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp -CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 222233457899999999886655 578999999999999999999999866543322211110000000000000000
Q ss_pred ccccCC-----------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 271 PELQGQ-----------YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 271 ~~~~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
+..... ..+..+.++.+|+.+||..||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 011234578899999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-51 Score=368.61 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=211.9
Q ss_pred HhhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCccceeeeEEEcCCe
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 105 (361)
-.++|++.+.||+|+||.||+|+++. ++..||||++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45789999999999999999999863 4678999998754333 34579999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 165 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~ 165 (361)
.+++|||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999999864221 1235899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCC-Cccccch
Q 018100 166 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSK 244 (361)
Q Consensus 166 p~Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~ 244 (361)
|+|||++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999987533332223334456889999999999999999999999999999999985 6776654
Q ss_pred HHHhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 245 AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
.......+. . .. ....+...+.++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 248 ~~e~~~~v~---~-------~~-------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYVR---D-------GN-------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHH---T-------TC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHH---c-------CC-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 433222111 0 00 01123334458889999999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=373.54 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=201.2
Q ss_pred HhhCcccCC-eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc-CCCCccceeeeEEEc----CCe
Q 018100 32 ATKNFRSES-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL-LHHPNLVNLIGYCAD----GDQ 105 (361)
Q Consensus 32 ~~~~y~~~~-~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~ 105 (361)
+.++|.+.. .||+|+||.||+|.++.+++.||||++.. ...+.+|+.++.+ .+||||+++++++.+ +..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 357899875 69999999999999999999999999853 3567789988655 589999999999865 467
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 182 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Df 182 (361)
+|+|||||+||+|.+++.... ...+++.+++.++.||+.||.|||++| |+||||||+|||++. .+.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence 899999999999999997522 357999999999999999999999999 999999999999985 567999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ...
T Consensus 159 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------~~~- 228 (335)
T d2ozaa1 159 GFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KTR- 228 (335)
T ss_dssp TTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C-
T ss_pred ceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------HHH-
Confidence 999763332 2234457999999999999999999999999999999999999999754321111000 000
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
... ....+........+.++.+||.+||+.||++|||+.++++.
T Consensus 229 i~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCS---CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Hhc---CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 00001011112345688999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=364.37 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=209.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeE--EEEEEeccC-CccchHHHHHHHHHHhcC-CCCccceeeeEEEcCCeeEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRN-GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 108 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~--v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 108 (361)
.++|++.+.||+|+||.||+|.++.+|.. |+||.+... .....+.+.+|+.+|..+ +||||+++++++.++...++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 37899999999999999999999988764 677877543 333456799999999998 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccc------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCc
Q 018100 109 VYEYMPLGSVEDHLHDL------------SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 176 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~ 176 (361)
||||+++|+|.++++.. ......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999998642 123467999999999999999999999999 999999999999999999
Q ss_pred eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCC-CccccchHHHhhhHHHhh
Q 018100 177 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWA 255 (361)
Q Consensus 177 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~ 255 (361)
+||+|||++..... ........|+..|+|||.+.+..++.++|||||||++|+|++|. +||...........+
T Consensus 166 ~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i--- 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--- 239 (309)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG---
T ss_pred eEEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH---
Confidence 99999999874221 11122345889999999999999999999999999999999965 567654433221111
Q ss_pred hhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhcc
Q 018100 256 RPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 317 (361)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~~ 317 (361)
.. ......+...+.++.+||.+||+.||++|||+.+|++.|+.+....
T Consensus 240 ~~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 PQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred Hh--------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 00 0011223344558899999999999999999999999999887644
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=364.65 Aligned_cols=264 Identities=27% Similarity=0.398 Sum_probs=210.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCC-------eEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESIN-------QDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 103 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-------~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 103 (361)
.++|++.+.||+|+||.||+|++..++ ..||||++..... .....+.+|...+..+ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999976544 4799999876543 2346688888888887 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 104 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 104 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
...++||||+++|+|.+++..... ....+++.+++.++.||+.||.|||+++ ++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975321 1356899999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhh
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 250 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 250 (361)
+.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999986444433333445668899999999999999999999999999999998 788987655433221
Q ss_pred HHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 251 LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
.+. .. .....+...+..+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 249 ~i~-------~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 249 LLK-------EG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHH-------TT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-------cC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111 00 01112233445889999999999999999999999999988653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=362.36 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=199.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCC---CeEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|++..+ ...||||++.... ....+.+.+|+.+|+.++||||+++++++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 47899999999999999999987543 3478999986542 22346789999999999999999999999764 67
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
++||||++++++.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999887652 356999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhhhHHHhhhhhhccccc
Q 018100 187 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTR 264 (361)
Q Consensus 187 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 264 (361)
......... ......++..|+|||++.+..++.++||||||+++|||++ |..||...........+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~------~~--- 230 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KE--- 230 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TS---
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH------hC---
Confidence 643332222 2233457889999999999999999999999999999998 899997654443321111 00
Q ss_pred cccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 265 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
......++..+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 231 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 -------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011112233445888999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=367.79 Aligned_cols=269 Identities=26% Similarity=0.366 Sum_probs=202.0
Q ss_pred HHHHHhhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEE
Q 018100 28 ELAAATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYC 100 (361)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 100 (361)
+++.-.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+..|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 333445789999999999999999999754 346899999865433 3345677788887776 689999999987
Q ss_pred Ec-CCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 018100 101 AD-GDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 167 (361)
Q Consensus 101 ~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~ 167 (361)
.. +..+++|||||++|+|.+++..... ....+++..++.++.||++||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 65 4568999999999999999864211 1345899999999999999999999999 999999999
Q ss_pred cEEEcCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhC-CCccccchHH
Q 018100 168 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAA 246 (361)
Q Consensus 168 Nilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~ 246 (361)
||||+.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|+|++| ..||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999764333333333446789999999999999999999999999999999986 5677654322
Q ss_pred HhhhHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 247 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
... ...... . .....+...+.++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 244 ~~~--~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEF--CRRLKE----G----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHH--HHHHHH----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--HHHHhc----C----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 111100 0 0111223344578999999999999999999999999987754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=363.81 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=199.5
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhcCC--CCccceeeeEEEcCC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLH--HPNLVNLIGYCADGD 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 104 (361)
.++|++.+.||+|+||.||+|+++.+|+.||||++...... ....+.+|+.+++.++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 57899999999999999999999999999999998643221 1233667999999886 899999999999999
Q ss_pred eeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-CCceeEecc
Q 018100 105 QRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDF 182 (361)
Q Consensus 105 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-~~~~~L~Df 182 (361)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999975 577788776 567999999999999999999999999 999999999999985 479999999
Q ss_pred cccccCCCCCCcceeeccccCcCcCCchhhccCCC-CccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 183 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ..
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~------------~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------------RG 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------------HC
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh------------hc
Confidence 999753222 2234579999999999987665 577999999999999999999997642210 00
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.. .++...+.++.+||.+||+.||++|||++++++
T Consensus 220 --------~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 --------QV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------cc----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 111223447889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=357.80 Aligned_cols=267 Identities=22% Similarity=0.246 Sum_probs=200.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCC-CeEEEEEEeccCC--ccchHHHHHHHHHHhcC---CCCccceeeeEEEc----
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESI-NQDVAIKQLDRNG--VQGNREFLVEVLMLSLL---HHPNLVNLIGYCAD---- 102 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~-~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---- 102 (361)
.++|++++.||+|+||.||+|++..+ ++.||||++.... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57999999999999999999999655 6789999986432 22234466777777665 79999999999853
Q ss_pred -CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEec
Q 018100 103 -GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 181 (361)
Q Consensus 103 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~D 181 (361)
....++++||++++.+...... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3467899999987666544332 2567999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhh-h---
Q 018100 182 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-P--- 257 (361)
Q Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~--- 257 (361)
||++... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||................ .
T Consensus 160 fg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 9998742 22233445679999999999999999999999999999999999999998765443322221110 0
Q ss_pred -hhcccccc----ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 258 -LFQDRTRH----SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 258 -~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.+...... ................+..+.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0000000111122234457889999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=361.66 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=213.2
Q ss_pred hhCcccCCeecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcC-CCCccceeeeEEEcCCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 105 (361)
.++|++.+.||+|+||.||+|.+. .++..||||++..... .....+.+|+.+++.+ +||||+++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 379999999999999999999863 4567899999975433 3345688999999998 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEE
Q 018100 106 RLLVYEYMPLGSVEDHLHDLS--------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 171 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv 171 (361)
.++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986532 12346999999999999999999999999 9999999999999
Q ss_pred cCCCceeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhh-CCCccccchHHHhh-
Q 018100 172 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ- 249 (361)
Q Consensus 172 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~- 249 (361)
+.++.++|+|||.+................|++.|+|||.+.+..++.++|||||||++|+|++ |.+||.........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987554444444455678999999999999999999999999999999998 55666544332211
Q ss_pred hHHHhhhhhhccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 250 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
.++. . ......+...+..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 259 ~~i~---~--------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 KMIK---E--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHH---H--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh---c--------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111 0 01111223344588899999999999999999999999986543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-49 Score=354.36 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=202.1
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++++.||+|+||.||+|+++ +|+.||||++..... ...+.+.+|+.+|+.++||||+++++.+.+++..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999987 589999999965432 235679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
++.++.+..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9986666666554 577999999999999999999999999 999999999999999999999999998763221
Q ss_pred CCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhh-----hhcccccc
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-----LFQDRTRH 265 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~ 265 (361)
........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||................. .+......
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 1222334688999999998654 568999999999999999999999976554333221111100 00000000
Q ss_pred ------ccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 266 ------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 266 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
.....+.......+..+..+.+|+.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001111122233457889999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=354.08 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=202.4
Q ss_pred CCeecccCceEEEEEEECCCC---eEEEEEEeccC-CccchHHHHHHHHHHhcCCCCccceeeeEEEc-CCeeEEEEEec
Q 018100 39 ESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYM 113 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~---~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 113 (361)
.+.||+|+||+||+|.+..++ ..||||+++.. .....+.+.+|+.+|++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 568999999999999986543 36899998753 33345679999999999999999999999765 56889999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCCCC
Q 018100 114 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 193 (361)
Q Consensus 114 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~~~ 193 (361)
++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998875 2456888999999999999999999999 99999999999999999999999999986433221
Q ss_pred c--ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccccccccccCc
Q 018100 194 T--HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 271 (361)
Q Consensus 194 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (361)
. .......|+..|+|||.+.+..++.++||||||+++|||++|..||........ +..... .. .
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i~---~g----~----- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL---QG----R----- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TT----C-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHHH---cC----C-----
Confidence 1 122234688999999999999999999999999999999998887754322111 111110 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 272 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
....+...+..+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0112233445788999999999999999999999999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=354.84 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=199.3
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHH--HHHHHHhcCCCCccceeeeEEEcCC----ee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNLIGYCADGD----QR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 106 (361)
.++|.+.+.||+|+||.||+|++. |..||||++... ..+.+. .|+..+..++||||+++++++.++. ..
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 478999999999999999999874 889999998643 223333 4555556789999999999997643 57
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc--------CCCCCeeecCCCCCcEEEcCCCcee
Q 018100 107 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD--------KAKPPVIYRDLKCSNILLDRGYHPK 178 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--------~~~~~i~H~dl~p~Nilv~~~~~~~ 178 (361)
++||||+++|+|.++++. .++++..++.++.|++.||.|||+ ++ |+||||||+||||+.++.+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeE
Confidence 999999999999999986 469999999999999999999997 46 99999999999999999999
Q ss_pred EecccccccCCCCCCcc--eeeccccCcCcCCchhhccCC------CCccCceehhhHHHHHHhhCCCccccchHHHhhh
Q 018100 179 LSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTGQ------LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 250 (361)
Q Consensus 179 L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~ 250 (361)
|+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||..........
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 99999997643332211 223467999999999987642 6788999999999999999998875432111000
Q ss_pred H--------HHhhhhhhccccccccccCccccCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhc
Q 018100 251 L--------VAWARPLFQDRTRHSLIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 316 (361)
Q Consensus 251 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~~ 316 (361)
. .......... ....|.+... ........+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0 0000000000 0001111111 1223456788999999999999999999999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=354.35 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=210.9
Q ss_pred hhCcccCCeecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCCee
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 106 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 106 (361)
.++|++.+.||+|+||.||+|.++. ++..||||+++.... .....+.+|+.++++++||||+++++++..+...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4899999999999999999999853 357899999975433 2334688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccc------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEe
Q 018100 107 LLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 180 (361)
Q Consensus 107 ~lv~e~~~~~~L~~~~~~~------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~ 180 (361)
++||||+++|+|.+++... ......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988542 112245799999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhC-CCccccchHHHhhhHHHhhhhhh
Q 018100 181 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|||+++...............+++.|+|||.+.+..++.++|||||||++|||++| ..||...........+. .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~--~--- 250 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--E--- 250 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH--T---
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--h---
Confidence 99999764333332333344688999999999999999999999999999999997 47776554433222111 0
Q ss_pred ccccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 018100 260 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 313 (361)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l 313 (361)
. .....++..+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 251 --~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 --G----------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp --T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --C----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 0 00112233445899999999999999999999999998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=349.21 Aligned_cols=270 Identities=22% Similarity=0.268 Sum_probs=200.9
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCccceeeeEEEc--------
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 102 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 102 (361)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 489999999999999999999999999999999986442 2344678899999999999999999998854
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecc
Q 018100 103 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 182 (361)
Q Consensus 103 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Df 182 (361)
+...|+||||+.++.+...... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3467999999986666555444 567999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCC--cceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhh
Q 018100 183 GLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 259 (361)
Q Consensus 183 g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 259 (361)
|++........ ........||..|+|||++.+. .++.++|||||||++|+|++|+.||...................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99975433221 1122335689999999998765 68999999999999999999999998765544433222211111
Q ss_pred ccccccc-----cccCcccc--CCCCh-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 260 QDRTRHS-----LIADPELQ--GQYPP-------RGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 260 ~~~~~~~-----~~~~~~~~--~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
....... ....-... ..... .....+.+||.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 00000000 00000 113356789999999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=355.73 Aligned_cols=263 Identities=19% Similarity=0.239 Sum_probs=199.3
Q ss_pred HhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCC-----
Q 018100 32 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 104 (361)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 104 (361)
+.++|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 35899999999999999999999999999999999975432 23456889999999999999999999997654
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccc
Q 018100 105 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 183 (361)
Q Consensus 105 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg 183 (361)
..|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 569999999 5788887764 56999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc-
Q 018100 184 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD- 261 (361)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 261 (361)
++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.....................
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 99863222 234568999999999876 45789999999999999999999999876544332221111000000
Q ss_pred -------------ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 262 -------------RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 262 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
......... .............+.+||.+||..||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhcchhhhhhhccCCcccc-cchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00011122334478899999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=353.10 Aligned_cols=263 Identities=25% Similarity=0.278 Sum_probs=196.8
Q ss_pred CcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCccceeeeEEEc------CCeeEE
Q 018100 35 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLL 108 (361)
Q Consensus 35 ~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~l 108 (361)
+|+..+.||+|+||+||+|+++.+|+.||||++...... ..+|+.+|+.++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 689999999999999999999999999999999654322 3369999999999999999999843 335789
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEeccccccc
Q 018100 109 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKL 187 (361)
Q Consensus 109 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~~~ 187 (361)
||||++++ +...+.........+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999755 43333322223567999999999999999999999999 99999999999999775 899999999876
Q ss_pred CCCCCCcceeeccccCcCcCCchhhcc-CCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhh---------hh
Q 018100 188 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA---------RP 257 (361)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---------~~ 257 (361)
..... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............... ..
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 43222 2234568999999998765 57899999999999999999999999766543332211100 00
Q ss_pred hhccc--cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 258 LFQDR--TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 258 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
..... ................+..+.++.+|+.+||..||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000001111122334557889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=342.06 Aligned_cols=266 Identities=18% Similarity=0.217 Sum_probs=206.8
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEcCCeeEEEEE
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 111 (361)
++|++++.||+|+||+||+|+++.+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 589999999999999999999999999999999865433 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccccccCCCC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 191 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~~~~~ 191 (361)
++.+++|..++.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9998888888775 678999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcceeeccccCcCcCCchhhccCC-CCccCceehhhHHHHHHhhCCCccccchH-HHhhhHHHh-hhhhh----ccc--
Q 018100 192 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAW-ARPLF----QDR-- 262 (361)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~-~~~~~~~~~-~~~~~----~~~-- 262 (361)
........++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ......... ..... ...
T Consensus 155 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22223345778899999987654 68999999999999999999998643322 221111111 10000 000
Q ss_pred ----cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 263 ----TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 263 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
................+.....+.+|+.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000011111222334557889999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=351.70 Aligned_cols=269 Identities=23% Similarity=0.288 Sum_probs=199.4
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCccceeeeEEEcCC----eeE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRL 107 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 107 (361)
..+|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4689999999999999999999999999999999975433 23457889999999999999999999986543 234
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 108 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 108 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
++++++.+++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 44556678999999975 46999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCC-cceeeccccCcCcCCchhhc-cCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc---
Q 018100 188 GPVGDN-THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR--- 262 (361)
Q Consensus 188 ~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 262 (361)
...... ........|++.|+|||++. +..++.++||||+||++|+|++|..||......................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 322211 11223456899999999984 4567899999999999999999999997765433332221110000000
Q ss_pred ------cccccccCcccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 263 ------TRHSLIADPELQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 263 ------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
........+... ....+.....+.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 00011223468899999999999999999999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.2e-47 Score=344.85 Aligned_cols=260 Identities=17% Similarity=0.224 Sum_probs=198.7
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEc--CCeeEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLV 109 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv 109 (361)
.++|++++.||+|+||+||+|+++.+|+.||||++... ..+.+.+|+.+|+.++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 36899999999999999999999999999999998643 3567889999999995 9999999999974 4568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCC-ceeEecccccccC
Q 018100 110 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLG 188 (361)
Q Consensus 110 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~-~~~L~Dfg~~~~~ 188 (361)
|||+.+++|..+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++ .++|+|||++...
T Consensus 111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 9999999987654 34999999999999999999999999 99999999999998655 6999999999753
Q ss_pred CCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhh--hHHHh---------hh
Q 018100 189 PVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLVAW---------AR 256 (361)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~--~~~~~---------~~ 256 (361)
.... ......+|..|+|||.+.+. .++.++||||+||++|+|++|+.||......... .+... ..
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 181 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 3222 23345689999999998765 5799999999999999999999999654322111 00000 00
Q ss_pred h-hhcccccccccc--------CccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 018100 257 P-LFQDRTRHSLIA--------DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 308 (361)
Q Consensus 257 ~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 308 (361)
. ............ ............+.++.+||.+||..||++|||++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000000 000111111233457889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-47 Score=339.34 Aligned_cols=263 Identities=21% Similarity=0.208 Sum_probs=201.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 111 (361)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+.+++.++|+++ +.+..++.++...++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3679999999999999999999999999999999865432 2457889999999987654 555566678889999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC---CCceeEecccccccC
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLG 188 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~---~~~~~L~Dfg~~~~~ 188 (361)
|+ +++|...+.. ....+++..++.++.|++.||+|||++| |+||||||+|||++. +..++|+|||++...
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 4677666544 2467999999999999999999999999 999999999999864 457999999999864
Q ss_pred CCCCC-----cceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc
Q 018100 189 PVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 263 (361)
Q Consensus 189 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (361)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~--- 233 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM--- 233 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH---
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC---
Confidence 33221 1123345799999999999999999999999999999999999999976544332222111110000
Q ss_pred ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 018100 264 RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 314 (361)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~ 314 (361)
....+..... .+.++.+++..||+.||++||++.++.+.|+.+.
T Consensus 234 ---~~~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 234 ---STPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ---HSCHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ---CCChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0001111122 2347888999999999999999999988887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-46 Score=337.14 Aligned_cols=264 Identities=21% Similarity=0.218 Sum_probs=208.8
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC-CccceeeeEEEcCCeeEEEEE
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 111 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 111 (361)
.++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+..++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 5789999999999999999999999999999999865432 2456778999998865 899999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcC-----CCceeEecccccc
Q 018100 112 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAK 186 (361)
Q Consensus 112 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~-----~~~~~L~Dfg~~~ 186 (361)
|+ +++|.+++... +..++...+..++.|++.||.|||++| |+||||||+|||++. ++.++|+|||+++
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 69999988652 357999999999999999999999999 999999999999974 5789999999998
Q ss_pred cCCCCCCc-----ceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcc
Q 018100 187 LGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 261 (361)
Q Consensus 187 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (361)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-
Confidence 64332211 123345799999999999999999999999999999999999999975433222211111110000
Q ss_pred ccccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 018100 262 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 315 (361)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~l~~l~~ 315 (361)
....+.+...+ +.++.+++..|+..+|++||+++.+.+.|+.+..
T Consensus 234 -----~~~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 234 -----STPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp -----HSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----CCChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 00011122223 3478889999999999999999999888876643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=348.67 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=194.2
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCccceeeeEEEc------CC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GD 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 104 (361)
.++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3789999999999999999999999999999999975433 233468899999999999999999999853 46
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
.+|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 889999999754 444443 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHH-h--------h
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-W--------A 255 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-~--------~ 255 (361)
+..... ........+|+.|+|||++.+..++.++||||+||++|+|++|..||............. . +
T Consensus 166 ~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 875322 223344568999999999999999999999999999999999999997654433221110 0 0
Q ss_pred hh-------hhccccccccc-----cCcccc---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 256 RP-------LFQDRTRHSLI-----ADPELQ---GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 256 ~~-------~~~~~~~~~~~-----~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.. ........... ...... .......+.++.+||.+||..||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000000000 000000 01122346678999999999999999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=345.90 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=203.1
Q ss_pred hhCcccCCeecccCceEEEEEEE---CCCCeEEEEEEeccCC----ccchHHHHHHHHHHhcCCC-CccceeeeEEEcCC
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYL---ESINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGD 104 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~---~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 104 (361)
.++|++++.||+|+||.||+|.+ +.+|+.||||++.... ....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999987 4468999999986432 2234567889999999966 89999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEecccc
Q 018100 105 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 184 (361)
Q Consensus 105 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~ 184 (361)
..+++|||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999987 567899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccCcCcCCchhhccC--CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhccc
Q 018100 185 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR 262 (361)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 262 (361)
+....... ........|+..|+|||.+.+. .++.++|||||||++|+|++|..||................ ..
T Consensus 176 a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~-- 250 (322)
T d1vzoa_ 176 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK-- 250 (322)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH--
T ss_pred hhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--cc--
Confidence 87532221 2223345689999999998654 57889999999999999999999997654322211111000 00
Q ss_pred cccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 018100 263 TRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-----IADVVT 308 (361)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~ll~ 308 (361)
.....+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 251 ----------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 ----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001123344558899999999999999994 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=342.57 Aligned_cols=263 Identities=20% Similarity=0.251 Sum_probs=198.0
Q ss_pred hhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcCCCCccceeeeEEEc-----CCe
Q 018100 33 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQ 105 (361)
Q Consensus 33 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 105 (361)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||++++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999999999999999999754332 34568899999999999999999999853 233
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCceeEeccccc
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 185 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~ 185 (361)
.+++++++.+++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.++++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4566677789999999864 56999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccCcCcCCchhhccC-CCCccCceehhhHHHHHHhhCCCccccchHHHhhhHHHhhhhhhcccc-
Q 018100 186 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT- 263 (361)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 263 (361)
.... .......|+..|+|||.+.+. .++.++|||||||++|+|++|..||...........+...........
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 6421 222335688999999987665 568999999999999999999999977654433322211110000000
Q ss_pred -------------ccccccCccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 018100 264 -------------RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 309 (361)
Q Consensus 264 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 309 (361)
.........+. ......+..+.+||.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000 0001234478899999999999999999999963
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-41 Score=311.26 Aligned_cols=265 Identities=17% Similarity=0.178 Sum_probs=190.2
Q ss_pred hCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-----------CCccceeeeEEEc
Q 018100 34 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCAD 102 (361)
Q Consensus 34 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 102 (361)
++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 56999999999999999999999999999999997542 23356778888887765 5789999988754
Q ss_pred --CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCcEEEcCCCc---
Q 018100 103 --GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYH--- 176 (361)
Q Consensus 103 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~Nilv~~~~~--- 176 (361)
....++++.++..+.......... ....+++..+..++.||+.||.|||+ .| |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 345666666664443322222211 25678999999999999999999997 88 999999999999986653
Q ss_pred ---eeEecccccccCCCCCCcceeeccccCcCcCCchhhccCCCCccCceehhhHHHHHHhhCCCccccchHHHhh----
Q 018100 177 ---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---- 249 (361)
Q Consensus 177 ---~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~---- 249 (361)
++++|||.+..... ......|++.|+|||++.+..++.++||||+||++++|++|..||.........
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999875322 123456899999999999999999999999999999999999999654321111
Q ss_pred hHHHhhh-----------------hhhccccccccccC---------ccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 018100 250 SLVAWAR-----------------PLFQDRTRHSLIAD---------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 303 (361)
Q Consensus 250 ~~~~~~~-----------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (361)
.+..... ..+........... ...........+..+.+||.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 0000000 00000000000000 011223445677889999999999999999999
Q ss_pred HHHHH
Q 018100 304 ADVVT 308 (361)
Q Consensus 304 ~~ll~ 308 (361)
.++++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.6e-24 Score=178.03 Aligned_cols=164 Identities=13% Similarity=0.075 Sum_probs=117.9
Q ss_pred cccCCeecccCceEEEEEEECCCCeEEEEEEeccCCcc------------------chHHHHHHHHHHhcCCCCccceee
Q 018100 36 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------------------GNREFLVEVLMLSLLHHPNLVNLI 97 (361)
Q Consensus 36 y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~i~~~~ 97 (361)
+.+.+.||+|+||.||+|.+. +|+.||||++...... .......|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999986 5899999987532110 012245678888999999988877
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCcEEEcCCCce
Q 018100 98 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 177 (361)
Q Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~Nilv~~~~~~ 177 (361)
++.. .+++|||+++..+.. ++...+..++.||+.+|.|||++| ++||||||+|||++++ .+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred EecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 6542 379999998655432 333456789999999999999999 9999999999999965 48
Q ss_pred eEecccccccCCCCCCcceeeccccCcCcCCc------hhhccCCCCccCceehhhHHH
Q 018100 178 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP------EYAKTGQLTLKSDVYSFGVVL 230 (361)
Q Consensus 178 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~sDiwslG~~l 230 (361)
+|+|||.+........ ..|... +.+ ...|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999999864221111 111111 111 35678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.98 E-value=2.2e-09 Score=91.80 Aligned_cols=149 Identities=17% Similarity=0.105 Sum_probs=107.3
Q ss_pred HHHHHHhhCcccCCeecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-CCccceeeeEEEcCCe
Q 018100 27 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 105 (361)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 105 (361)
.+++...+.|+..+..+.++.+.||+... ++..+++|............+..|...+..+. +--+..++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 57788888999888766666789998764 36678899876554444445677888877664 3334567778888889
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------------------------
Q 018100 106 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP---------------------------- 157 (361)
Q Consensus 106 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~---------------------------- 157 (361)
.++||++++|.++.+.... . . ....++.++++.+..||+....
T Consensus 85 ~~lv~~~l~G~~~~~~~~~----~--~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED----E--Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT----C--S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc----c--c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999998888665432 1 1 1234566677777777754210
Q ss_pred ----------------------------CeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 158 ----------------------------PVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 158 ----------------------------~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 17999999999999987767799999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.31 E-value=2.4e-06 Score=71.87 Aligned_cols=130 Identities=16% Similarity=0.108 Sum_probs=85.0
Q ss_pred eecccC-ceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC--CccceeeeEEEcCCeeEEEEEecCCCC
Q 018100 41 LLGEGG-FGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLGS 117 (361)
Q Consensus 41 ~lg~G~-~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~ 117 (361)
.+..|. .+.||+..... +..+++|....... ..+..|+..++.+.. -.+..++.+..+++..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 344554 46789887654 66788998654332 345667777776632 234557777788888999999998766
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 018100 118 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------------ 155 (361)
Q Consensus 118 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------ 155 (361)
+.+. ..+. ...+.++...|..||+..
T Consensus 93 ~~~~---------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSS---------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTS---------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccc---------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 5321 1111 122334555555555321
Q ss_pred -------------CCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 156 -------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 156 -------------~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
...++|+|+.|.|||++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0127999999999999987667899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.23 E-value=3e-06 Score=76.26 Aligned_cols=77 Identities=17% Similarity=0.108 Sum_probs=47.9
Q ss_pred CCeecccCceEEEEEEECCCCeEEEEEEeccC-------CccchHHHHHHHHHHhcCC--CCc-cceeeeEEEcCCeeEE
Q 018100 39 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-------GVQGNREFLVEVLMLSLLH--HPN-LVNLIGYCADGDQRLL 108 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~~~~~v~iK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~l 108 (361)
.+.||.|....||++....+++.+++|.-... -.........|...|+.+. .|. +..++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999988777888999975321 1123344566888877653 233 3444443 3456678
Q ss_pred EEEecCCCC
Q 018100 109 VYEYMPLGS 117 (361)
Q Consensus 109 v~e~~~~~~ 117 (361)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.52 E-value=0.00078 Score=58.31 Aligned_cols=165 Identities=17% Similarity=0.098 Sum_probs=89.6
Q ss_pred ccCcceeHHHHHHHhhCcccC---Ceec-ccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCCC---C
Q 018100 19 ITAQTLTFRELAAATKNFRSE---SLLG-EGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---P 91 (361)
Q Consensus 19 ~~~~~~~~~~~~~~~~~y~~~---~~lg-~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h---~ 91 (361)
.+...++.+.|..+.+.+-+. +.+. .+..-.||++...+ |..+++|+.... ....+.+..|...+..|.. |
T Consensus 3 ~~f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gip 80 (325)
T d1zyla1 3 FTFQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVP 80 (325)
T ss_dssp CCCCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCC
Confidence 455667777776665554221 1111 12234799987754 888999998644 3345667788888877642 2
Q ss_pred --ccceee--eEEEcCCeeEEEEEecCCCCHH-----HH---------hcc----cC-CCCCCCCH--------------
Q 018100 92 --NLVNLI--GYCADGDQRLLVYEYMPLGSVE-----DH---------LHD----LS-PGKKPLDW-------------- 134 (361)
Q Consensus 92 --~i~~~~--~~~~~~~~~~lv~e~~~~~~L~-----~~---------~~~----~~-~~~~~l~~-------------- 134 (361)
..+..- ..+..+...+.++++++|..+. .+ ++. .. .....++.
T Consensus 81 v~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~ 160 (325)
T d1zyla1 81 VAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDA 160 (325)
T ss_dssp BCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTC
T ss_pred CCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHc
Confidence 111111 1234566778899998754221 10 111 00 00011111
Q ss_pred -----H---HHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCcEEEcCCCceeEeccccccc
Q 018100 135 -----N---TRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 187 (361)
Q Consensus 135 -----~---~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~~ 187 (361)
. .....+.++...+.-+-.. ....+||||+.++|||++++ ..++||+-|..
T Consensus 161 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 161 TLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1 1223333343333332211 12238999999999999743 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.37 E-value=0.0039 Score=53.26 Aligned_cols=159 Identities=14% Similarity=0.039 Sum_probs=84.5
Q ss_pred eeHHHHHHHhhCcccCCeec-----ccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcCC-----CCcc
Q 018100 24 LTFRELAAATKNFRSESLLG-----EGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNL 93 (361)
Q Consensus 24 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i 93 (361)
+|.++++.+..+|.+.+... .|-.-+.|+....+ | .+++|++.... ..+.+..|+.++..|. .|..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 57789999999998866554 45556789887664 3 58999986432 2234455666665553 2322
Q ss_pred ceeee---EEEcCCeeEEEEEecCCCCHHH--------------Hhccc----CC-CCCCCCH-----------------
Q 018100 94 VNLIG---YCADGDQRLLVYEYMPLGSVED--------------HLHDL----SP-GKKPLDW----------------- 134 (361)
Q Consensus 94 ~~~~~---~~~~~~~~~lv~e~~~~~~L~~--------------~~~~~----~~-~~~~l~~----------------- 134 (361)
+...+ +...+.....++.+..+..... .++.. .. .......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 22110 1222345566667665432210 00100 00 0000000
Q ss_pred -HHHHHHHHHHHHHHHHHhcCC-CCCeeecCCCCCcEEEcCCCceeEecccccc
Q 018100 135 -NTRMKIAAGAARGLEYLHDKA-KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 186 (361)
Q Consensus 135 -~~~~~i~~qi~~al~~LH~~~-~~~i~H~dl~p~Nilv~~~~~~~L~Dfg~~~ 186 (361)
......+..+...+...+..+ ...+||+|+.++||+++++...-++||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011222233333333333221 1239999999999999998877899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.00065 Score=60.54 Aligned_cols=74 Identities=18% Similarity=0.234 Sum_probs=49.4
Q ss_pred CCeecccCceEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhcCCCCcc-ceeeeEEEcCCeeEEEE
Q 018100 39 ESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 110 (361)
Q Consensus 39 ~~~lg~G~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 110 (361)
++.|+.|-.=.+|++.... ....|+++++... ...-...+|..+++.+.-.++ .+++.++.+ ..|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578888888999988653 2456888887532 223345678888888753344 456666643 5789
Q ss_pred EecCCCCH
Q 018100 111 EYMPLGSV 118 (361)
Q Consensus 111 e~~~~~~L 118 (361)
+|++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99986543
|